sample_id,temperature,variation_id,label,source_text,variation_text,delta_score_2gram,delta_entropy_2gram,delta_variance_2gram,delta_score_3gram,delta_entropy_3gram,delta_variance_3gram,delta_score_4gram,delta_entropy_4gram,delta_variance_4gram,delta_score_5gram,delta_entropy_5gram,delta_variance_5gram
0,0.5,1,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Does loss of consciousness indicate neuropsychological decline following a concussion? The findings of this study challenge the significance of LOC as a predictor of long-term neuropsychological impairments. While LOC is commonly considered a marker of concussion severity, our results imply that other factors might have a greater impact on cognitive recovery.",1.1842986367842703e-07,0.07010482778396376,0.0181755829903978,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
0,0.5,2,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Is loss of consciousness a predictor of neuropsychological deficits after a concussion? This study's results question the role of LOC in forecasting long-term neuropsychological damage. Although LOC is frequently used to gauge concussion severity, our data suggest other variables could be more crucial for cognitive recovery.",2.3685972735685406e-07,0.17546534344178966,0.0181755829903978,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
0,0.5,3,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Can loss of consciousness predict neuropsychological impairments post-concussion? The study's findings undermine the importance of LOC as a long-term predictor of neuropsychological deficits. Despite its frequent use as a severity marker, LOC may be less critical than other factors in cognitive recovery.",3.316036182995957e-07,0.3023678240960912,0.0061994170096022,0.025387970506946217,0.30010459245033916,0.0,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
0,0.5,4,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Does experiencing loss of consciousness forecast neuropsychological decline after a concussion? The study casts doubt on LOC's value as a predictor of lasting neuropsychological deficits. LOC is often used to assess concussion severity, but our findings indicate other factors may play a more important role.",2.6054570009253947e-07,0.19793819929384737,0.0181755829903978,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
0,0.5,5,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Is loss of consciousness a reliable predictor of neuropsychological decrements following concussion? The research questions the predictive power of LOC for long-term neuropsychological issues. Although LOC is commonly seen as a concussion severity marker, other elements may be more influential in cognitive recovery.",3.079176455639103e-07,0.2444582149287413,0.0181755829903978,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
0,0.5,6,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Does loss of consciousness serve as an indicator for neuropsychological deficits after concussion? This study suggests LOC may not be a significant predictor of long-term neuropsychological problems. While LOC is often a severity marker, our findings propose that other factors could be more pivotal in cognitive recovery.",2.1317375462116866e-07,0.15348643672301465,0.0181755829903978,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
0,0.5,7,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Can loss of consciousness be used to predict neuropsychological outcomes post-concussion? The results challenge the importance of LOC as a predictor of enduring neuropsychological deficits. LOC is typically a marker of severity, but other factors might have greater influence on cognitive recovery.",3.316036182995957e-07,0.26855576650780133,0.0181755829903978,0.025387970506946217,0.30010459245033916,0.0,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
0,0.5,8,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Is loss of consciousness a key predictor of neuropsychological decline after concussion? The study's findings question LOCâ€™s role in predicting long-term neuropsychological deficits. Although it is used as a severity marker, other factors may be more critical for recovery.",4.026615365066517e-07,0.34454167348572273,0.0181755829903978,0.030828249901291835,0.37806613392004973,0.0,0.030783626196198732,0.3867729750960107,0.0,4.026615365066519e-07,0.39589565709201446,0.0
0,0.5,9,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Does loss of consciousness predict long-term neuropsychological deficits following concussion? The study casts doubt on the significance of LOC as a predictor of such deficits. LOC is often used as a marker of severity, but our findings highlight the potential importance of other factors in cognitive recovery.",2.1317375462116866e-07,0.1836232706604033,0.0035528120713305966,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
0,0.5,10,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Is loss of consciousness an accurate predictor of neuropsychological decrements after a concussion? The results suggest that LOC may not be as important in predicting long-term neuropsychological deficits. While LOC is frequently used as a severity indicator, other factors might play a more substantial role in cognitive recovery.",1.8948778188548325e-07,0.1319802315020513,0.0181755829903978,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
1,0.5,1,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is transgastric endoscopic splenectomy feasible? The procedure seems technically achievable in a porcine model, involving spleen access via the stomach for minimally invasive removal, showing promising results and potential advantages over conventional laparoscopic methods.",2.605457000925387e-07,0.2561753824263291,0.02271498107084911,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
1,0.5,2,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Can transgastric endoscopic splenectomy be performed? In a porcine model, this technique appears technically possible, utilizing stomach access to remove the spleen minimally invasively, with encouraging findings indicating benefits compared to traditional laparoscopy.",2.84231672828224e-07,0.2869470410930828,0.02271498107084911,0.0217611175773825,0.32721291120841567,0.0,0.021729618491434434,0.33647223662121295,0.0,2.8423167282822487e-07,0.3462762367178347,0.0
1,0.5,3,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is it possible to conduct transgastric endoscopic splenectomy? Evidence from a porcine model suggests technical feasibility by accessing the spleen through the stomach, enabling minimally invasive extraction and demonstrating promising outcomes that may surpass standard laparoscopic surgery.",1.8948778188548283e-07,0.16916400543669896,0.02271498107084911,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
1,0.5,4,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Does transgastric endoscopic splenectomy work? The approach is technically viable in a porcine model, involving spleen removal through the stomach in a minimally invasive manner, with study results indicating potential improvements over typical laparoscopic procedures.",2.3685972735685343e-07,0.26709578283899704,0.006669775586634827,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
1,0.5,5,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Can transgastric endoscopic splenectomy be done? The technique shows technical feasibility in a porcine model by accessing the spleen transgastrically for minimally invasive removal, with promising results that suggest advantages over traditional laparoscopy.",2.84231672828224e-07,0.2869470410930828,0.02271498107084911,0.0217611175773825,0.32721291120841567,0.0,0.021729618491434434,0.33647223662121295,0.0,2.8423167282822487e-07,0.3462762367178347,0.0
1,0.5,6,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is transgastric endoscopic splenectomy achievable? In a porcine model, this novel method is technically feasible, allowing spleen removal via the stomach in a minimally invasive way, with encouraging results pointing to benefits over conventional laparoscopic surgery.",2.1317375462116813e-07,0.23694329272110703,0.005831731731919049,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
1,0.5,7,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is the transgastric endoscopic approach to splenectomy possible? The porcine model study indicates technical feasibility, using stomach access for minimally invasive spleen removal and showing promising outcomes that suggest advantages over standard laparoscopic techniques.",2.605457000925387e-07,0.2561753824263291,0.02271498107084911,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
1,0.5,8,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Can the spleen be removed endoscopically through the stomach? Transgastric endoscopic splenectomy appears technically feasible in a porcine model, enabling minimally invasive removal and demonstrating promising results compared to traditional laparoscopic surgery.",3.0791764556390933e-07,0.3186957394076626,0.02271498107084911,0.02357454404216438,0.36000273403140737,0.0,0.023540420032387308,0.3703737882968947,0.0,3.079176455639103e-07,0.3813675565291037,0.0
1,0.5,9,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is it feasible to perform transgastric endoscopic splenectomy? The study in a porcine model shows technical feasibility by accessing the spleen through the stomach, allowing for minimally invasive removal and suggesting potential benefits over conventional laparoscopy.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
1,0.5,10,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is transgastric endoscopic splenectomy a viable procedure? Findings from a porcine model suggest technical feasibility, involving spleen access through the stomach for minimally invasive removal, with promising results indicating possible advantages over traditional laparoscopic methods.",2.3685972735685343e-07,0.2263224192766473,0.02271498107084911,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
2,0.5,1,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Question: In patients with treated hypertension, does blood pressure vary based on whether a physician or a nurse takes the measurement? Answer: In a study involving 200 patients, systolic blood pressure recorded by physicians was significantly lower (p < 0.001) compared to measurements taken by nurses, attributed to the 'white coat' effect caused by the physician's perceived authority.",7.105791820705622e-08,0.02068363365800252,0.050238191293164106,0.005440279394345618,0.05218575317056917,0.0,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
2,0.5,2,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Question: Among treated hypertensive patients, is there a difference in blood pressure readings when measured by a doctor versus a nurse? Answer: A study of 200 patients showed that systolic blood pressure measured by doctors was significantly lower (p < 0.001) than that measured by nurses, due to the 'white coat' effect linked to the physician's perceived authority.",7.105791820705622e-08,0.10282628676544592,0.039735113354433624,0.005440279394345618,0.05218575317056917,0.0,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
2,0.5,3,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Question: Does the blood pressure of treated hypertensive patients differ when measured by a physician compared to a nurse? Answer: Research on 200 patients found that systolic BP recorded by physicians was significantly lower (p < 0.001) than readings taken by nurses, explained by the 'white coat' effect stemming from the physician's perceived authority.",1.6580180914979784e-07,0.06912203423657415,0.06777645659928656,0.012693985253473108,0.12629372532429084,0.0,0.012675610786670066,0.12861737782209381,0.0,1.6580180914979784e-07,0.13102826240640475,0.0
2,0.5,4,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Question: For patients with treated hypertension, does blood pressure measurement vary depending on whether a physician or nurse conducts the measurement? Answer: In a study of 200 patients, systolic blood pressure measured by physicians was significantly lower (p < 0.001) than that measured by nurses, attributed to the 'white coat' effect due to the physician's perceived authority.",9.474389094274162e-08,0.08832802639925497,0.014376670198432154,0.0072537058591274906,0.07020425867324764,0.0,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
2,0.5,5,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Question: Is there a change in blood pressure readings in treated hypertensive patients based on whether a nurse or physician measures it? Answer: Systolic blood pressure measured by physicians was significantly lower (p < 0.001) than by nurses in a 200-patient study, attributed to the 'white coat' effect caused by the physician's perceived authority.",1.6580180914979784e-07,0.09527853161619504,0.048915509853724434,0.012693985253473108,0.12629372532429084,0.0,0.012675610786670066,0.12861737782209381,0.0,1.6580180914979784e-07,0.13102826240640475,0.0
2,0.5,6,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Question: Among treated hypertensive patients, does blood pressure differ when taken by a physician versus a nurse? Answer: A study of 200 patients revealed that systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses, due to the 'white coat' effect linked to the physician's perceived authority.",1.8948778188548325e-07,0.14148924309649402,0.02937645659928656,0.014507411718254981,0.14571181118139354,0.0,0.014486412327622933,0.14842000511827358,0.0,1.8948778188548325e-07,0.15123096972392336,0.0
2,0.5,7,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Question: Does the measurement of blood pressure in treated hypertensive patients differ depending on whether a nurse or physician performs it? Answer: In a study with 200 patients, systolic blood pressure was significantly lower (p < 0.001) when measured by physicians compared to nurses, attributed to the 'white coat' effect from the physician's perceived authority.",1.4211583641411244e-07,0.07610201902293667,0.04926453064699038,0.010880558788691236,0.10724553035359774,0.0,0.0108648092457172,0.10919929196499112,0.0,1.4211583641411244e-07,0.11122563511022499,0.0
2,0.5,8,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Question: In treated hypertensive patients, is there a difference in blood pressure readings based on whether a nurse or physician measures it? Answer: Systolic blood pressure measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a 200-patient study, explained by the 'white coat' effect related to the physician's perceived authority.",1.1842986367842703e-07,0.0824914665969474,0.031464601846705575,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
2,0.5,9,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Question: Does the blood pressure of treated hypertensive patients change depending on whether it is taken by a nurse or a physician? Answer: A study of 200 patients found systolic blood pressure measured by physicians was significantly lower (p < 0.001) than by nurses, attributed to the 'white coat' effect due to the physician's perceived authority.",1.1842986367842703e-07,0.0824914665969474,0.031464601846705575,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
2,0.5,10,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Question: For patients with treated hypertension, does blood pressure vary when measured by a nurse compared to a physician? Answer: Research involving 200 patients showed systolic BP measured by physicians was significantly lower (p < 0.001) than that taken by nurses, attributed to the 'white coat' effect caused by the physician's perceived authority.",1.8948778188548325e-07,0.11482973615188063,0.048553080974526854,0.014507411718254981,0.14571181118139354,0.0,0.014486412327622933,0.14842000511827358,0.0,1.8948778188548325e-07,0.15123096972392336,0.0
3,0.5,1,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are we overlooking some prognostic indicators? Answer: We present for the first time the cause of ESLD as a survival prognostic factor. Renal function (measured by serum creatinine) and urinary sodium (<5 mEq/l) at diagnosis were linked to outcomes.,1.1842986367842703e-07,0.11506932978478668,0.0,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
3,0.5,2,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: could we be missing prognostic factors? Answer: For the first time, we identify ESLD etiology as a prognostic factor for survival. Renal function (serum creatinine) and urinary sodium (<5 mEq/l) at diagnosis were associated with prognosis.",1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
3,0.5,3,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are there prognostic factors we haven't identified? Answer: We report ESLD etiology as a novel prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis showed association with outcomes.,2.3685972735685364e-07,0.24512245803298427,0.0,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
3,0.5,4,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: might some prognostic factors be overlooked? Answer: Our study reports ESLD etiology as a new prognostic factor for survival. Renal function (serum creatinine) and urinary sodium (<5 mEq/l) at diagnosis correlated with prognosis.,2.6054570009253894e-07,0.2732933349996811,0.0,0.019947691112600606,0.2803019651541576,0.0,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
3,0.5,5,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are some prognostic factors missing? Answer: We reveal for the first time that ESLD etiology is a prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis were related to prognosis.,1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
3,0.5,6,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: could we be missing important prognostic factors? Answer: We identify ESLD etiology as a prognostic factor for survival for the first time. Renal function (serum creatinine) and urinary sodium (<5 mEq/l) at diagnosis were connected to outcomes.,1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
3,0.5,7,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are there prognostic factors yet to be discovered? Answer: We report ESLD etiology as a prognostic factor for survival for the first time. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis were linked to prognosis.,1.4211583641411244e-07,0.13976194237515838,0.0,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
3,0.5,8,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: might we be missing prognostic factors? Answer: We demonstrate for the first time that ESLD etiology serves as a prognostic factor for survival. Renal function (serum creatinine) and urinary sodium (<5 mEq/l) at diagnosis were associated with outcomes.,1.4211583641411244e-07,0.13976194237515838,0.0,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
3,0.5,9,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: could some prognostic factors be overlooked? Answer: We show for the first time that ESLD etiology is a prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis were related to prognosis.,1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
3,0.5,10,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are we missing key prognostic factors? Answer: We report for the first time that ESLD etiology is a prognostic factor for survival. Renal function (serum creatinine) and urinary sodium (<5 mEq/l) at diagnosis were found to be associated with prognosis.,9.474389094274162e-08,0.09097177820572666,0.0,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
4,0.5,1,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Could aripiprazole be a novel risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The review indicated that aripiprazole may trigger pathological gambling, an impulse control disorder also seen with other atypical antipsychotics. More research is necessary to clarify the risk factors and mechanisms behind this effect.",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
4,0.5,2,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Is aripiprazole a potential new risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed alongside existing case reports. The review revealed that aripiprazole can cause pathological gambling, an impulse control disorder noted with other atypical antipsychotics. Further studies are required to fully understand the underlying risk factors and mechanisms.",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
4,0.5,3,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Aripiprazole: could it be a new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated in the context of previously reported cases. The review demonstrated that aripiprazole might induce pathological gambling, an impulse control disorder also associated with other atypical antipsychotics. Additional research is needed to better understand the risk factors and mechanisms involved.",0.0,0.024755256448569796,0.017851239669421492,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,0.5,4,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Does aripiprazole represent a new risk factor for pathological gambling? Answer: Adverse drug reactions were reviewed against prior case reports. The findings suggest that aripiprazole can lead to pathological gambling, an impulse control disorder observed with other atypical antipsychotics. More investigation is necessary to comprehend the risk factors and mechanisms at play.",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
4,0.5,5,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Could aripiprazole be linked to pathological gambling as a new risk factor? Answer: Adverse drug reactions were compared with earlier published case studies. The review found that aripiprazole may cause pathological gambling, an impulse control disorder seen with other atypical antipsychotics. Further research is essential to understand the underlying risk factors and mechanisms.",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
4,0.5,6,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Is aripiprazole a novel risk factor for pathological gambling? Answer: Adverse drug reactions were examined alongside existing case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder also reported with other atypical antipsychotics. Additional studies are needed to fully elucidate the risk factors and mechanisms.",1.4211583641411244e-07,0.08857342885843433,0.017851239669421492,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
4,0.5,7,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Aripiprazole as a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with previously published cases. The review indicated that aripiprazole may trigger pathological gambling, an impulse control disorder observed with other atypical antipsychotics. More research is required to understand the risk factors and mechanisms involved.",1.6580180914979784e-07,0.10877613617595294,0.017851239669421492,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
4,0.5,8,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Could aripiprazole be a new risk factor contributing to pathological gambling? Answer: Adverse drug reactions were assessed in relation to other published case reports. The review demonstrated that aripiprazole can induce pathological gambling, an impulse control disorder also found with other atypical antipsychotics. Further studies are necessary to clarify the risk factors and mechanisms.",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
4,0.5,9,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Is aripiprazole associated with pathological gambling as a new risk factor? Answer: Adverse drug reactions were reviewed alongside other published case reports. The review revealed that aripiprazole might cause pathological gambling, an impulse control disorder noted with other atypical antipsychotics. Additional research is needed to fully understand the risk factors and mechanisms.",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
4,0.5,10,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Aripiprazole: is it a new risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published reports. The review found that aripiprazole can lead to pathological gambling, an impulse control disorder observed with other atypical antipsychotics. More investigation is required to understand the underlying risk factors and mechanisms.",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
5,0.5,1,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Does Ultra High Risk (UHR) criteria for psychosis indicate varying levels of risk for transitioning to psychosis? Our findings suggest yes. Individuals identified by attenuated psychotic symptoms have a notably greater risk of developing psychosis than those identified through genetic risk or functional decline, emphasizing the need for thorough assessment of multiple risk factors in UHR cases.",4.026615365066519e-07,0.20813674927132642,0.04102040816326531,0.03082824990129189,0.2500788454346994,0.013886133703630227,0.030783626196198746,0.27369583047704094,0.0,4.026615365066519e-07,0.2782033284972374,0.0
5,0.5,2,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Are there different degrees of risk for psychosis transition within Ultra High Risk (UHR) criteria? Data indicates that individuals with attenuated psychotic symptoms show a significantly elevated risk compared to those with genetic risk or functional decline, underscoring the importance of comprehensive evaluation of UHR individuals.",6.632072365991914e-07,0.42682595023615644,0.04102040816326531,0.05077594101389249,0.47322239674890865,0.013886133703630227,0.05070244314668028,0.501479761347754,0.0,6.632072365991914e-07,0.5108256237659905,0.0
5,0.5,3,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Is the risk of transitioning to psychosis different among those meeting Ultra High Risk (UHR) criteria? Our research shows that individuals with attenuated psychotic symptoms have a higher likelihood of transition than those identified by genetic risk or functional decline, highlighting the need for a detailed assessment of various risk factors.",5.447773729207643e-07,0.32146543457833054,0.04102040816326531,0.041708808689983126,0.36559173255654365,0.013886133703630227,0.041648435441915946,0.3914788661334252,0.0,5.447773729207643e-07,0.3983476403393005,0.0
5,0.5,4,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Does the Ultra High Risk (UHR) criteria for psychosis reveal varying transition risks? Our data reveals that people with attenuated psychotic symptoms face a significantly increased risk of psychosis compared to those with genetic predisposition or functional decline, stressing the importance of a multifaceted risk assessment.",6.632072365991914e-07,0.42682595023615644,0.04102040816326531,0.05077594101389249,0.47322239674890865,0.013886133703630227,0.05070244314668028,0.501479761347754,0.0,6.632072365991914e-07,0.5108256237659905,0.0
5,0.5,5,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Are there distinct levels of psychosis transition risk within Ultra High Risk (UHR) criteria? Findings indicate that individuals meeting UHR criteria due to attenuated psychotic symptoms have a much higher risk than those identified through genetic risk or functional decline, pointing to the necessity of comprehensive evaluation.",6.39521263863506e-07,0.40484704351738143,0.04102040816326531,0.04896251454911062,0.45074954089685093,0.013886133703630227,0.04889164160572741,0.47849024312305444,0.0,6.39521263863506e-07,0.4872951263557961,0.0
5,0.5,6,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Do different risk levels exist for psychosis transition under Ultra High Risk (UHR) criteria? The data suggests that those with attenuated psychotic symptoms are at significantly greater risk than those with genetic risk or functional decline, highlighting the value of thorough assessments considering multiple risk factors.",6.632072365991914e-07,0.45763249159437613,0.01880966436161242,0.05077594101389249,0.47322239674890865,0.013886133703630227,0.05070244314668028,0.501479761347754,0.0,6.632072365991914e-07,0.5108256237659905,0.0
5,0.5,7,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Is there variation in risk for psychosis transition among Ultra High Risk (UHR) individuals? Our data shows that those meeting UHR criteria via attenuated psychotic symptoms have a higher transition risk than those identified by genetic risk or functional decline, emphasizing comprehensive risk factor assessment.",6.868932093348768e-07,0.44929880608821415,0.04102040816326531,0.05258936747867436,0.49621191497360817,0.013886133703630227,0.052513244687633145,0.5250102587579484,0.0,6.868932093348768e-07,0.5349231753450505,0.0
5,0.5,8,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Are different levels of risk for psychosis transition present in Ultra High Risk (UHR) criteria? Our findings suggest individuals with attenuated psychotic symptoms have a significantly higher risk compared to those with genetic risk or functional decline, underscoring the importance of a broad assessment of risk factors.",6.39521263863506e-07,0.4349838774547701,0.019292013101536915,0.04896251454911062,0.45074954089685093,0.013886133703630227,0.04889164160572741,0.47849024312305444,0.0,6.39521263863506e-07,0.4872951263557961,0.0
5,0.5,9,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Does the Ultra High Risk (UHR) criteria for psychosis indicate varying transition risks? Research shows that individuals with attenuated psychotic symptoms face a notably greater risk than those with genetic risk or functional decline, highlighting the need for comprehensive evaluation.",8.053230730133037e-07,0.5699267938768315,0.04102040816326531,0.061656499802583725,0.619825870940784,0.013886133703630227,0.06156725239239748,0.6517619643970907,0.0,8.053230730133038e-07,0.6649763035932481,0.0
5,0.5,10,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Are there varying degrees of risk for psychosis transition within Ultra High Risk (UHR) criteria? Our data suggests that individuals meeting UHR criteria due to attenuated psychotic symptoms have a significantly higher risk than those with genetic risk or functional decline, underscoring the importance of evaluating multiple risk factors.",5.921493183921352e-07,0.3622874290985849,0.04102040816326531,0.04533566161954687,0.40726442895711257,0.013886133703630227,0.04527003852382168,0.4340384805522217,0.0,5.921493183921352e-07,0.44183275227903884,0.0
6,0.5,1,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",This inquiry addresses the key issue of determining the best duration of acid suppression therapy for patients suffering from severe reflux oesophagitis to maximize healing.,1.0184968276344708e-06,0.9360652728005707,0.09120685311161499,0.0779773379856206,1.0121516060633393,0.0302734375,0.07786446626097335,1.06201721098163,0.015380859375,1.0184968276344725e-06,1.1143606456362498,0.0
6,0.5,2,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",The question explores how long acid suppression should be administered to patients with Los Angeles grades C and D reflux oesophagitis to achieve optimal healing.,1.0184968276344708e-06,0.9360652728005707,0.09120685311161499,0.0779773379856206,1.0121516060633393,0.0302734375,0.07786446626097335,1.06201721098163,0.015380859375,1.0184968276344725e-06,1.1143606456362498,0.0
6,0.5,3,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",This topic investigates the ideal length of acid suppression treatment necessary for maximal recovery in severe reflux oesophagitis cases.,1.1606126640485828e-06,1.223747345252351,0.09120685311161499,0.08885789677431188,1.3144324779362728,0.0302734375,0.08872927550669059,1.3804709421001644,0.015380859375,1.1606126640485847e-06,1.450832882257461,0.0
6,0.5,4,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",The focus here is on identifying the optimal timing for acid suppression to ensure the best healing outcomes in patients with advanced reflux oesophagitis.,1.0421828003701562e-06,0.9786248872193664,0.09120685311161499,0.07979076445040248,1.0566033686341734,0.0302734375,0.07967526780192623,1.1085372266165239,0.015380859375,1.0421828003701579e-06,1.163150809805681,0.0
6,0.5,5,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",This question examines the most effective duration of acid suppression therapy to promote maximal healing in severe reflux oesophagitis.,1.1606126640485828e-06,1.223747345252351,0.09120685311161499,0.08885789677431188,1.3144324779362728,0.0302734375,0.08872927550669059,1.3804709421001644,0.015380859375,1.1606126640485847e-06,1.450832882257461,0.0
6,0.5,6,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",The inquiry centers on finding the optimal acid suppression period that leads to the greatest healing in patients with Los Angeles grade C and D reflux oesophagitis.,9.711248821631002e-07,0.8560225651270335,0.09120685311161499,0.07435048505605685,0.9287699971242889,0.0302734375,0.07424286317906761,0.9750058339920002,0.015380859375,9.711248821631017e-07,1.0233888674305218,0.0
6,0.5,7,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",This discussion seeks to determine the best time frame for acid suppression to maximize healing in severe reflux oesophagitis.,1.1606126640485828e-06,1.223747345252351,0.09120685311161499,0.08885789677431188,1.3144324779362728,0.0302734375,0.08872927550669059,1.3804709421001644,0.015380859375,1.1606126640485847e-06,1.450832882257461,0.0
6,0.5,8,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",The question investigates how to optimize acid suppression duration for improved healing in patients with severe reflux oesophagitis.,1.1842986367842682e-06,1.2809057590922999,0.09120685311161499,0.09067132323909376,1.3750570997527078,0.0302734375,0.09054007704764347,1.445009463237735,0.015380859375,1.1842986367842699e-06,1.519825753744413,0.0
6,0.5,9,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",This analysis focuses on identifying the ideal acid suppression therapy length to achieve maximal healing in severe reflux oesophagitis cases.,1.1369266913128974e-06,1.1696801239820758,0.09120685311161499,0.08704447030953,1.257274064096324,0.0302734375,0.08691847396573772,1.3198463202837294,0.015380859375,1.1369266913128993e-06,1.3862943611198904,0.0
6,0.5,10,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",The question considers the optimal acid suppression time required to maximize healing in patients with advanced reflux oesophagitis.,1.1842986367842682e-06,1.2809057590922999,0.09120685311161499,0.09067132323909376,1.3750570997527078,0.0302734375,0.09054007704764347,1.445009463237735,0.015380859375,1.1842986367842699e-06,1.519825753744413,0.0
7,0.5,1,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it possible to predict discordance between TEOAE and AABR results in newborns? Given current screening methods, some degree of mismatch between TEOAE and AABR outcomes might be unavoidable in certain types of hearing loss among seemingly healthy newborns whose mothers had prenatal care. This suggests that relying on perinatal morbidities for targeted screening in these cases requires more investigation.",9.474389094274162e-08,0.05012541892821387,0.014389675859663914,0.0072537058591274906,0.04932782794894042,0.01592684955790791,0.007243206163811466,0.04843840057857163,0.017538265306122455,9.474389094274162e-08,0.07410797215372167,0.0
7,0.5,2,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can discordant results between TEOAE and AABR in newborns be anticipated? With the screening technologies available, discrepancies between TEOAE and AABR may be inevitable for some hearing loss categories in apparently healthy newborns whose mothers underwent prenatal care. Therefore, the limitations of using perinatal morbidities as a basis for targeted screening need further study.",4.737194547137081e-08,0.06510005977848854,0.02008814524741904,0.0036268529295637453,0.06538722407355735,0.01988807404770383,0.003621603081905733,0.06564852320269532,0.019599999999999992,4.737194547137081e-08,0.03922071315328246,0.0
7,0.5,3,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is the discordance between TEOAE and AABR outcomes in newborns predictable? Considering current screening tools, some discordance between TEOAE and AABR is likely unavoidable in certain hearing loss types among apparently healthy newborns with prenatal care history. Hence, the effectiveness of targeting screening based on perinatal morbidities deserves more research.",1.4211583641411244e-07,0.17826906970315282,0.04467579956840667,0.010880558788691236,0.17875431542786036,0.043710296269926036,0.0108648092457172,0.17913556125142005,0.04246913580246913,1.4211583641411244e-07,0.152739156029722,0.021728395061728398
7,0.5,4,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can we foresee discordant TEOAE and AABR results in newborns? Given the screening technologies at hand, discordance between these tests may be inevitable in some hearing loss categories among healthy newborns whose mothers had prenatal care. This indicates the need to further evaluate the role of perinatal morbidities in targeted screening.",1.1842986367842703e-07,0.044899475763602315,0.03631185475258099,0.009067132323909363,0.07149163065513164,0.01851192595229618,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
7,0.5,5,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it predictable when TEOAE and AABR results will be discordant in newborns? With available screening technology, discordance between TEOAE and AABR might be unavoidable in certain hearing loss cases among apparently healthy newborns whose mothers received prenatal care. This highlights the importance of further examining perinatal morbidities as criteria for targeted screening.",7.105791820705622e-08,0.05899777649954663,0.0020881452474190224,0.005440279394345618,0.058668538416332794,0.001088074047703811,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
7,0.5,6,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Are discordant outcomes between TEOAE and AABR in newborns foreseeable? Given current screening methods, some discordance may be unavoidable in specific hearing loss types among apparently healthy newborns whose mothers had prenatal care. Therefore, the limitations of using perinatal morbidities for targeted screening warrant additional research.",2.3685972735685406e-07,0.1502599914214282,0.03631185475258099,0.018134264647818726,0.17912229484749664,0.01851192595229618,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
7,0.5,7,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it possible to predict when TEOAE and AABR results will not agree in newborns? Considering the screening technologies available, discordance between TEOAE and AABR may be inevitable for certain hearing loss categories in apparently healthy newborns with prenatal care. This suggests further study is needed on the use of perinatal morbidities for targeted screening.",2.3685972735685406e-08,0.019282670224506138,0.0006703937681290656,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
7,0.5,8,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can discordance in TEOAE and AABR outcomes among newborns be predicted? With current screening technologies, some level of discordance might be unavoidable in certain hearing loss types in apparently healthy newborns whose mothers received prenatal care. This implies that the potential limitations of perinatal morbidities as a basis for targeted screening should be further explored.",2.3685972735685406e-08,0.03206156537252758,0.03631185475258099,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
7,0.5,9,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it feasible to predict discordance in TEOAE and AABR results in newborns? Given the existing screening technology, discordant outcomes between TEOAE and AABR may be inevitable in some hearing loss categories among apparently healthy newborns whose mothers had prenatal care. Thus, there is a need to further investigate the role of perinatal morbidities in targeted screening.",2.3685972735685406e-08,0.018918696646262223,0.0006465598280268187,0.0018134264647818726,0.01881590444635073,0.0003363429618983803,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
7,0.5,10,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can we predict when TEOAE and AABR results will be discordant in newborns? Based on current screening technologies, discordance between TEOAE and AABR may be unavoidable for certain types of hearing loss in apparently healthy newborns whose mothers received prenatal care. This underscores the necessity for further research on perinatal morbidities as a basis for targeted screening.",2.3685972735685406e-08,0.018918696646262223,0.0006465598280268187,0.0018134264647818726,0.01881590444635073,0.0003363429618983803,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
8,0.5,1,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",This paper explores whether the RAQ is culturally suitable for Australian contexts and highlights the necessity for developing comprehensive and inclusive recovery outcome measures.,3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
8,0.5,2,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",The study examines the cultural relevance of the RAQ within Australian settings and emphasizes the importance of creating rigorous and inclusive recovery outcome metrics.,3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
8,0.5,3,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This article addresses the cultural appropriateness of the RAQ in Australia and points out the need to establish robust, inclusive recovery outcome measures.",3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
8,0.5,4,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",The paper investigates the fit of the RAQ with Australian cultural contexts and stresses the requirement for thorough and inclusive recovery outcome measures.,3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
8,0.5,5,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This research considers the cultural suitability of the RAQ in Australian environments and identifies a need for the development of rigorous, inclusive recovery outcome assessments.",2.842316728282236e-07,0.3669569314103902,0.02775510204081633,0.021761117577382555,0.41985384556026384,0.0,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
8,0.5,6,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The study discusses the RAQ's cultural alignment in Australia and underscores the importance of designing comprehensive, inclusive recovery outcome tools.",4.026615365066502e-07,0.6005717825918953,0.02775510204081633,0.030828249901291953,0.6649763035932486,0.0,0.030783626196198847,0.6931471805599458,0.0,4.0266153650665164e-07,0.7239188392266991,0.0
8,0.5,7,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",This paper evaluates the cultural relevance of the RAQ in Australian settings and highlights the demand for developing robust and inclusive recovery outcome measures.,3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
8,0.5,8,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",The article explores the appropriateness of the RAQ culturally in Australia and calls for the creation of rigorous and inclusive recovery outcome evaluations.,3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
8,0.5,9,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",This work reviews the cultural fit of the RAQ in Australia and points to the necessity of establishing inclusive and rigorous recovery outcome measures.,3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
8,0.5,10,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper considers cultural factors in relation to the RAQ in Australia and stresses the need for the development of inclusive, rigorous recovery outcome measures.",2.842316728282236e-07,0.3669569314103902,0.02775510204081633,0.021761117577382555,0.41985384556026384,0.0,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
9,0.5,1,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","This study explored whether diffusion-weighted echo-planar MR imaging (DW-EPI) can distinguish different histologic subtypes of primary parotid gland tumors, finding it may differentiate benign from malignant tumors, though more research is required to confirm its precision in identifying specific subtypes.",6.868932093348767e-07,0.43362596835941325,0.0874089490114464,0.052589367478674306,0.4843426172096601,0.05946082136558325,0.05251324468763313,0.5367279093482633,0.0302734375,6.868932093348768e-07,0.5908683314395264,0.0
9,0.5,2,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","The research examined the ability of diffusion-weighted echo-planar MR imaging (DW-EPI) to predict various histological subtypes of primary parotid gland tumors, suggesting it can separate benign from malignant tumors, but further studies are necessary to verify its accuracy for subtype prediction.",6.632072365991914e-07,0.4083081603751215,0.0874089490114464,0.050775941013892434,0.4583671308064021,0.05946082136558325,0.050702443146680265,0.5100596622661024,0.0302734375,6.632072365991914e-07,0.5634693572514111,0.0
9,0.5,3,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","Diffusion-weighted echo-planar MR imaging (DW-EPI) was studied to assess its potential in differentiating histologic subtypes of primary parotid gland tumors; results indicated it might distinguish benign versus malignant tumors, though additional research is needed to clarify its predictive accuracy for specific subtypes.",6.39521263863506e-07,0.3836155477847498,0.0874089490114464,0.04896251454911056,0.4330493228221104,0.05946082136558325,0.0488916416057274,0.48408417586284447,0.0302734375,6.39521263863506e-07,0.5368011101692503,0.0
9,0.5,4,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","This investigation focused on the use of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate histologic subtypes of primary parotid gland tumors, showing potential in distinguishing benign from malignant tumors, but requiring more research to confirm its effectiveness in subtype prediction.",6.868932093348767e-07,0.43362596835941325,0.0874089490114464,0.052589367478674306,0.4843426172096601,0.05946082136558325,0.05251324468763313,0.5367279093482633,0.0302734375,6.868932093348768e-07,0.5908683314395264,0.0
9,0.5,5,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","The study assessed diffusion-weighted echo-planar MR imaging (DW-EPI) for its capability to predict different histological subtypes of primary parotid gland tumors, revealing potential to differentiate benign and malignant tumors, with further validation needed for precise subtype identification.",7.579511275419326e-07,0.5136686760329474,0.0874089490114464,0.058029646873019924,0.5665807154466331,0.05946082136558325,0.05794564931049174,0.621285297376327,0.0302734375,7.57951127541933e-07,0.6778797084291566,0.0
9,0.5,6,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","Researchers evaluated diffusion-weighted echo-planar MR imaging (DW-EPI) as a method to differentiate histologic subtypes of primary parotid gland tumors, finding it may help distinguish benign from malignant tumors, though more investigation is required to establish its accuracy for specific subtypes.",6.868932093348767e-07,0.43362596835941325,0.0874089490114464,0.052589367478674306,0.4843426172096601,0.05946082136558325,0.05251324468763313,0.5367279093482633,0.0302734375,6.868932093348768e-07,0.5908683314395264,0.0
9,0.5,7,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","Diffusion-weighted echo-planar MR imaging (DW-EPI) was analyzed to determine if it can predict various histologic subtypes of primary parotid gland tumors; findings suggest it can differentiate benign and malignant tumors, but further research is necessary to confirm its predictive reliability for subtypes.",6.39521263863506e-07,0.4174276053730397,0.0630339490114464,0.04896251454911056,0.4330493228221104,0.05946082136558325,0.0488916416057274,0.48408417586284447,0.0302734375,6.39521263863506e-07,0.5368011101692503,0.0
9,0.5,8,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","This study investigated diffusion-weighted echo-planar MR imaging (DW-EPI) for differentiating histological subtypes of primary parotid gland tumors, indicating it might separate benign from malignant tumors, yet additional studies are needed to verify its accuracy for subtype prediction.",7.579511275419326e-07,0.5136686760329474,0.0874089490114464,0.058029646873019924,0.5665807154466331,0.05946082136558325,0.05794564931049174,0.621285297376327,0.0302734375,7.57951127541933e-07,0.6778797084291566,0.0
9,0.5,9,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","The potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to distinguish different histologic subtypes of primary parotid gland tumors was studied, showing promise in differentiating benign and malignant tumors, but requiring further research to determine its accuracy for specific subtype prediction.",6.868932093348767e-07,0.43362596835941325,0.0874089490114464,0.052589367478674306,0.4843426172096601,0.05946082136558325,0.05251324468763313,0.5367279093482633,0.0302734375,6.868932093348768e-07,0.5908683314395264,0.0
9,0.5,10,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","Researchers explored whether diffusion-weighted echo-planar MR imaging (DW-EPI) can predict histologic subtypes of primary parotid gland tumors, with results suggesting it may differentiate benign from malignant tumors, although more research is needed to confirm its accuracy in subtype classification.",7.10579182070562e-07,0.4596014547626712,0.0874089490114464,0.05440279394345618,0.511010864291821,0.05946082136558325,0.054324046228586,0.5641268835363786,0.0302734375,7.105791820705622e-07,0.6190392084062233,0.0
10,0.5,1,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Is there a correlation between end-tidal carbon dioxide measurements and arterial carbon dioxide levels in extremely low birth weight infants during their first week of life?,1.4211583641411218e-06,1.116133751817511,0.14341431979070476,0.10880558788691266,1.1702454470001378,0.05928537093414515,0.1086480924571721,1.249941708466971,0.024081694863587855,1.4211583641411242e-06,1.2987707651117932,0.012193263222069812
10,0.5,2,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Does measuring end-tidal carbon dioxide reflect arterial carbon dioxide in extremely low birth weight newborns within their initial week?,1.5869601732909192e-06,1.4662023977403003,0.12798155354695234,0.12149957314038581,1.515085933291867,0.05928537093414515,0.1213237032438422,1.6128472021563396,0.024081694863587855,1.5869601732909216e-06,1.6817630173678983,0.012193263222069812
10,0.5,3,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
","In extremely low birth weight infants, how well does end-tidal carbon dioxide measurement correspond to arterial carbon dioxide during the first week of life?",1.4685303096124926e-06,1.2043372541865445,0.13995644559419418,0.11243244081647641,1.2572568239897675,0.05928537093414515,0.11226969553907784,1.340913486672699,0.024081694863587855,1.468530309612495e-06,1.3940809449161184,0.012193263222069812
10,0.5,4,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Can end-tidal carbon dioxide levels be used to estimate arterial carbon dioxide in extremely low birth weight babies during their first week?,1.515902255083863e-06,1.3010493817136792,0.1358448753462603,0.11605929374604018,1.3525670037940927,0.05928537093414515,0.11589129862098359,1.4409969452296805,0.024081694863587855,1.5159022550838656e-06,1.499441460573944,0.012193263222069812
10,0.5,5,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",What is the relationship between end-tidal and arterial carbon dioxide measurements in extremely low birth weight infants in the first week after birth?,1.4922162823481778e-06,1.1885153488826004,0.18334487534626032,0.1142458672812583,1.3037768396246614,0.05928537093414515,0.11408049708003071,1.3897036508421303,0.024081694863587855,1.4922162823481804e-06,1.4453742393036686,0.012193263222069812
10,0.5,6,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Does end-tidal CO2 monitoring correlate with arterial CO2 in extremely low birth weight infants during their first week of life?,1.5632742005552338e-06,1.3351188230744757,0.18334487534626032,0.11968614667560393,1.4579275194519181,0.05928537093414515,0.11951290170288933,1.5522225803399046,0.024081694863587855,1.5632742005552364e-06,1.6172244962303277,0.012193263222069812
10,0.5,7,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Is there evidence supporting a correlation between ETCO2 and PaCO2 in extremely low birth weight infants within their first week?,1.5632742005552338e-06,1.3351188230744757,0.18334487534626032,0.11968614667560393,1.4579275194519181,0.05928537093414515,0.11951290170288933,1.5522225803399046,0.024081694863587855,1.5632742005552364e-06,1.6172244962303277,0.012193263222069812
10,0.5,8,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",How closely do end-tidal carbon dioxide readings match arterial carbon dioxide in extremely low birth weight infants during their first week?,1.5395882278195484e-06,1.35314024674292,0.13348337950138497,0.11787272021082205,1.4038602981816428,0.05928537093414515,0.11770210016193647,1.4950641664999558,0.024081694863587855,1.539588227819551e-06,1.5565998744138927,0.012193263222069812
10,0.5,9,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",To what extent does end-tidal carbon dioxide correlate with arterial carbon dioxide in extremely low birth weight infants in the initial week of life?,1.4685303096124926e-06,1.2043372541865445,0.13995644559419418,0.11243244081647641,1.2572568239897675,0.05928537093414515,0.11226969553907784,1.340913486672699,0.024081694863587855,1.468530309612495e-06,1.3940809449161184,0.012193263222069812
10,0.5,10,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Are end-tidal carbon dioxide measurements reliable indicators of arterial carbon dioxide in extremely low birth weight infants during their first week?,1.5395882278195484e-06,1.35314024674292,0.13348337950138497,0.11787272021082205,1.4038602981816428,0.05928537093414515,0.11770210016193647,1.4950641664999558,0.024081694863587855,1.539588227819551e-06,1.5565998744138927,0.012193263222069812
11,0.5,1,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity result in worse depression outcomes? Answer: These analyses indicate that the slightly elevated depression rates up to age 35 in the comorbid MD/AUD group were due to greater exposure to adverse childhood conditions in this group. Adolescent MD/AUD comorbidity is likely to be,1.4211583641411244e-07,0.08374901575834537,0.01694411414982164,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
11,0.5,2,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does having both major depression and alcohol use disorder during adolescence lead to poorer depression outcomes? Answer: The findings suggest that the marginally higher depression rates by age 35 in the comorbid MD/AUD group can be attributed to increased adverse childhood experiences among them. Adolescent MD/AUD comorbidity is likely to be,1.8948778188548325e-07,0.12221529658614116,0.01694411414982164,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
11,0.5,3,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Major depression and alcohol use disorder in adolescence: Is comorbidity associated with worse depression outcomes? Answer: Results show that the slightly higher depression rates through age 35 in the comorbid MD/AUD group were explained by more frequent adverse childhood circumstances in this group. Adolescent MD/AUD comorbidity is likely to be,2.1317375462116866e-07,0.14201792388232093,0.01694411414982164,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
11,0.5,4,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does comorbidity of major depression and alcohol use disorder in adolescence lead to poorer depression outcomes? Answer: Analyses suggest that the marginally elevated depression rates until age 35 in the comorbid MD/AUD group were due to greater exposure to adverse childhood environments. Adolescent MD/AUD comorbidity is likely to be,2.3685972735685406e-07,0.16222063119983954,0.01694411414982164,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
11,0.5,5,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Major depression and alcohol use disorder comorbidity in adolescence: Does it cause worse depression outcomes? Answer: The study results indicate that slightly higher depression rates up to age 35 among the comorbid MD/AUD group were explained by their increased exposure to negative childhood circumstances. Adolescent MD/AUD comorbidity is likely to be,1.8948778188548325e-07,0.12221529658614116,0.01694411414982164,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
11,0.5,6,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,"Question: In adolescents, does comorbidity of major depression and alcohol use disorder lead to poorer depression outcomes? Answer: Findings suggest that the marginally increased depression rates by age 35 in the comorbid MD/AUD group were due to more adverse childhood experiences. Adolescent MD/AUD comorbidity is likely to be",2.8423167282822487e-07,0.20389332760040846,0.01694411414982164,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
11,0.5,7,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does the coexistence of major depression and alcohol use disorder in adolescence worsen depression outcomes? Answer: The analyses reveal that the slightly higher depression rates through age 35 among the comorbid MD/AUD group were explained by increased adverse childhood exposures. Adolescent MD/AUD comorbidity is likely to be,2.8423167282822487e-07,0.20389332760040846,0.01694411414982164,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
11,0.5,8,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Major depression and alcohol use disorder in adolescence: Does having both conditions lead to poorer depression outcomes? Answer: Results suggest that the marginally elevated depression rates until age 35 in the comorbid MD/AUD group were due to greater adverse childhood experiences. Adolescent MD/AUD comorbidity is likely to be,2.6054570009253947e-07,0.1828399184025753,0.01694411414982164,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
11,0.5,9,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does adolescent comorbidity of major depression and alcohol use disorder predict worse depression outcomes? Answer: These analyses indicate that the slightly higher depression rates by age 35 in the comorbid MD/AUD group were explained by increased exposure to adverse childhood environments. Adolescent MD/AUD comorbidity is likely to be,2.6054570009253947e-07,0.1828399184025753,0.01694411414982164,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
11,0.5,10,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Is comorbidity of major depression and alcohol use disorder in adolescence linked to poorer depression outcomes? Answer: The findings suggest that the marginally higher depression rates through age 35 among the comorbid MD/AUD group were due to greater exposure to adverse childhood circumstances. Adolescent MD/AUD comorbidity is likely to be,2.1317375462116866e-07,0.14201792388232093,0.01694411414982164,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
12,0.5,1,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Does having an optimistic perspective predict improved survival rates in advanced age?,9.474389094274137e-07,1.4795658751761551,0.039150354019158694,0.07253705859127504,1.581712025211702,0.019991670137442734,0.07243206163811484,1.6945957207744073,0.0,9.474389094274156e-07,1.7917594692280554,0.0
12,0.5,2,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Is an optimistic attitude linked to longer survival in elderly individuals?,9.711248821630991e-07,1.5748760549804803,0.039150354019158694,0.07435048505605693,1.687072540869528,0.019991670137442734,0.07424286317906771,1.8123787564307912,0.0,9.71124882163101e-07,1.9252908618525773,0.0
12,0.5,3,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Can optimism serve as an indicator of better longevity among older adults?,9.474389094274137e-07,1.4795658751761551,0.039150354019158694,0.07253705859127504,1.581712025211702,0.019991670137442734,0.07243206163811484,1.6945957207744073,0.0,9.474389094274156e-07,1.7917594692280554,0.0
12,0.5,4,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Does maintaining a positive outlook contribute to increased lifespan in advanced years?,9.474389094274137e-07,1.4795658751761551,0.039150354019158694,0.07253705859127504,1.581712025211702,0.019991670137442734,0.07243206163811484,1.6945957207744073,0.0,9.474389094274156e-07,1.7917594692280554,0.0
12,0.5,5,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Is there a correlation between optimism and enhanced survival among the elderly?,9.474389094274137e-07,1.4795658751761551,0.039150354019158694,0.07253705859127504,1.581712025211702,0.019991670137442734,0.07243206163811484,1.6945957207744073,0.0,9.474389094274156e-07,1.7917594692280554,0.0
12,0.5,6,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Does a hopeful mindset predict greater longevity in older populations?,9.948108548987843e-07,1.6802365706383062,0.039150354019158694,0.0761639115208388,1.8048555765259118,0.019991670137442734,0.07605366472002059,1.945910149055313,0.0,9.948108548987862e-07,2.079441541679836,0.0
12,0.5,7,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Is a positive attitude associated with better survival outcomes at advanced ages?,9.474389094274137e-07,1.4795658751761551,0.039150354019158694,0.07253705859127504,1.581712025211702,0.019991670137442734,0.07243206163811484,1.6945957207744073,0.0,9.474389094274156e-07,1.7917594692280554,0.0
12,0.5,8,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Can an optimistic viewpoint forecast longer life expectancy in senior adults?,9.711248821630991e-07,1.5748760549804803,0.039150354019158694,0.07435048505605693,1.687072540869528,0.019991670137442734,0.07424286317906771,1.8123787564307912,0.0,9.71124882163101e-07,1.9252908618525773,0.0
12,0.5,9,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Is optimism a significant factor in predicting survival among older individuals?,9.711248821630991e-07,1.5748760549804803,0.039150354019158694,0.07435048505605693,1.687072540869528,0.019991670137442734,0.07424286317906771,1.8123787564307912,0.0,9.71124882163101e-07,1.9252908618525773,0.0
12,0.5,10,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Does holding an optimistic perspective lead to improved longevity in advanced age?,9.474389094274137e-07,1.4795658751761551,0.039150354019158694,0.07253705859127504,1.581712025211702,0.019991670137442734,0.07243206163811484,1.6945957207744073,0.0,9.474389094274156e-07,1.7917594692280554,0.0
13,0.5,1,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor for adverse maternal and neonatal outcomes? ACR independently predicts negative maternal and neonatal outcomes in suspected preeclampsia and may help assess risk.,2.1317375462116813e-07,0.11901825291155843,0.07603102289579254,0.01632083818303686,0.11441593590487953,0.08488117132035533,0.016297213868575813,0.10913402242451653,0.09418282548476452,2.1317375462116866e-07,0.14639999113971136,0.07271468144044323
13,0.5,2,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia serve as a prognostic indicator for adverse outcomes in mothers and newborns? ACR is an independent predictor of poor maternal and neonatal outcomes in suspected preeclampsia and could be valuable for risk assessment.,2.3685972735685406e-08,0.1498999132883303,0.08861569254324797,0.0018134264647818726,0.1841865369595701,0.11426592797783926,0.0018108015409528666,0.15555853180256562,0.09418282548476452,2.3685972735685406e-08,0.12553372434393006,0.07271468144044323
13,0.5,3,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of having preeclampsia predict maternal and neonatal adverse outcomes? ACR independently forecasts maternal and neonatal complications in suspected preeclampsia and may aid in risk evaluation.,2.3685972735685343e-07,0.15033569627408783,0.07437023891966765,0.01813426464781874,0.14550445552614732,0.08399249047783926,0.018108015409528687,0.13990568109127022,0.09418282548476452,2.3685972735685406e-07,0.1781486894542912,0.07271468144044323
13,0.5,4,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a reliable prognostic factor for adverse outcomes in both mother and baby? ACR independently predicts maternal and neonatal adverse events in suspected preeclampsia and might be useful for risk stratification.,7.105791820705622e-08,0.08461051535046815,0.10858898891966764,0.005440279394345618,0.08887635715524445,0.11426592797783926,0.0054324046228586,0.05792006223864776,0.09418282548476452,7.105791820705622e-08,0.025450265786948645,0.07271468144044323
13,0.5,5,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does measuring the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia provide prognostic information about maternal and neonatal adverse outcomes? ACR is an independent prognostic marker for adverse maternal and neonatal outcomes in suspected preeclampsia and may inform risk management.,7.105791820705622e-08,0.050798457762178284,0.08431178642131132,0.005440279394345618,0.054218998127248064,0.08928236453273734,0.0054324046228586,0.05792006223864776,0.09418282548476452,7.105791820705622e-08,0.025450265786948645,0.07271468144044323
13,0.5,6,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial ACR in women suspected of preeclampsia a prognostic factor for negative maternal and neonatal outcomes? ACR independently predicts adverse outcomes for mother and child in suspected preeclampsia and could be helpful in risk assessment.,1.8948778188548283e-07,0.011630555309439572,0.13296398891966765,0.014507411718254981,0.04465503546927829,0.11426592797783926,0.01448641232762294,0.07928105927483475,0.09418282548476452,1.8948778188548325e-07,0.11562833247295767,0.07271468144044323
13,0.5,7,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Can the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia independently predict adverse maternal and neonatal outcomes? ACR is an independent prognostic factor for poor outcomes in mother and newborn in suspected preeclampsia and may assist in risk evaluation.,9.474389094274162e-08,0.09372996034838632,0.13296398891966765,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03194457583538979,0.09418282548476452,9.474389094274162e-08,0.0012179812952122226,0.07271468144044323
13,0.5,8,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a significant predictor of maternal and neonatal adverse outcomes? ACR independently forecasts adverse outcomes in both mother and neonate in suspected preeclampsia and may be useful for risk assessment.,9.474389094274162e-08,0.05907260132038994,0.10798042547456574,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03194457583538979,0.09418282548476452,9.474389094274162e-08,0.0012179812952122226,0.07271468144044323
13,0.5,9,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the first urinary albumin/creatinine ratio (ACR) measurement in women suspected of preeclampsia serve as an independent prognostic factor for adverse maternal and neonatal outcomes? ACR independently predicts negative outcomes in mothers and newborns in suspected preeclampsia and may help guide risk assessment.,4.737194547137081e-08,0.14252012451781804,0.13296398891966765,0.0036268529295637453,0.11356896974561614,0.11426592797783926,0.003621603081905733,0.08323787022293949,0.09418282548476452,4.737194547137081e-08,0.05142575219020662,0.07271468144044323
13,0.5,10,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia an independent prognostic indicator for adverse maternal and neonatal outcomes? ACR independently forecasts poor outcomes in mothers and neonates with suspected preeclampsia and may be useful in informing risk.,9.474389094274162e-08,0.09372996034838632,0.13296398891966765,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03194457583538979,0.09418282548476452,9.474389094274162e-08,0.0012179812952122226,0.07271468144044323
14,0.5,1,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Are Pap smears with glandular cell abnormalities identified during rapid prescreening? Yes, these Pap smears are frequently marked as ""abnormal"" in rapid prescreening, prompting a detailed manual examination by a cytotechnologist to assess the significance of the abnormalities or the need for further analysis.",7.105791820705622e-08,0.051003485144437644,0.08383648918619602,0.005440279394345618,0.023426752587707433,0.06632653061224489,0.0054324046228586,0.007604187163049225,0.045351473922902494,7.105791820705622e-08,0.04008125783265193,0.023242630385487524
14,0.5,2,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Do rapid prescreenings detect glandular cell abnormalities in Pap smears? Pap smears showing glandular cell abnormalities are commonly detected as ""abnormal"" in rapid prescreening, which leads to a cytotechnologist conducting a thorough manual review to decide if the abnormalities are clinically important or warrant additional testing.",2.3685972735685406e-08,0.03628563889351,0.040752588959438646,0.0018134264647818726,0.038440078197148786,0.043611549541395775,0.0018108015409528666,0.04002386182620521,0.045351473922902494,2.3685972735685406e-08,0.008708906336779787,0.023242630385487524
14,0.5,3,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Can rapid prescreening identify glandular cell abnormalities in Pap smears? Typically, Pap smears with glandular cell abnormalities are flagged as ""abnormal"" during rapid prescreening, resulting in a cytotechnologist performing a manual review to evaluate the importance of these abnormalities or the necessity for further examination.",4.737194547137081e-08,0.04321902706520664,0.06172764564878104,0.0036268529295637453,0.014717846250927646,0.043083900226757364,0.003621603081905733,0.01649336441601079,0.045351473922902494,4.737194547137081e-08,0.01538864524228023,0.023242630385487524
14,0.5,4,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Are glandular cell abnormalities in Pap smears caught by rapid prescreening? Yes, such abnormalities are often detected and labeled as ""abnormal"" in rapid prescreening, which then requires a cytotechnologist to manually review the sample to determine if the abnormalities are significant or need more investigation.",4.737194547137081e-08,0.07472571709065878,0.08436413850083442,0.0036268529295637453,0.04695724999790185,0.06632653061224489,0.003621603081905733,0.01649336441601079,0.045351473922902494,4.737194547137081e-08,0.01538864524228023,0.023242630385487524
14,0.5,5,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Does rapid prescreening detect Pap smears with glandular cell abnormalities? Pap smears exhibiting glandular cell abnormalities are usually flagged as ""abnormal"" during rapid prescreening, triggering a manual review by a cytotechnologist to decide on the clinical relevance or need for further study.",1.1842986367842703e-07,0.03200927527442232,0.05842691707332719,0.009067132323909363,0.025363411581724282,0.06632653061224489,0.009054007704764333,0.05761460773771265,0.045351473922902494,1.1842986367842703e-07,0.09137455222020163,0.023242630385487524
14,0.5,6,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Yes, Pap smears with glandular cell abnormalities are often identified as ""abnormal"" at the rapid prescreening stage, leading to a cytotechnologist's manual assessment to determine if further investigation is necessary.",1.1842986367842703e-07,0.06582133286271263,0.03436443813124031,0.009067132323909363,0.060020770609720664,0.04134296716714297,0.009054007704764333,0.05761460773771265,0.045351473922902494,1.1842986367842703e-07,0.09137455222020163,0.023242630385487524
14,0.5,7,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Are Pap smears showing glandular cell abnormalities recognized in rapid prescreening? These smears are frequently marked ""abnormal"" during rapid prescreening, prompting a cytotechnologist to manually review the findings to assess the significance or need for additional testing.",2.3685972735685364e-07,0.09443828834604018,0.10707911957168353,0.018134264647818726,0.15889480420624702,0.06632653061224489,0.018108015409528673,0.19481572925119517,0.045351473922902494,2.3685972735685406e-07,0.23245315048010795,0.023242630385487524
14,0.5,8,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Can rapid prescreening detect abnormalities in glandular cells on Pap smears? Yes, such abnormalities are commonly flagged as ""abnormal"" in rapid prescreening, which initiates a cytotechnologist's manual review to evaluate if the abnormalities are significant or require further follow-up.",1.8948778188548304e-07,0.07685249763155033,0.08078255273457616,0.014507411718254981,0.10332495305143485,0.06632653061224489,0.014486412327622933,0.13765731541124682,0.045351473922902494,1.8948778188548325e-07,0.17361265045717467,0.023242630385487524
14,0.5,9,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Are glandular cell abnormalities in Pap smears identified by rapid prescreening? Pap smears with these abnormalities are often detected as ""abnormal"" during rapid prescreening, necessitating a manual review by a cytotechnologist to determine the clinical importance or need for further investigation.",1.4211583641411244e-07,0.023735131716210667,0.08209555612658162,0.010880558788691236,0.05068121956601601,0.06632653061224489,0.0108648092457172,0.08359009414097063,0.045351473922902494,1.4211583641411244e-07,0.1180427993023625,0.023242630385487524
14,0.5,10,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Does rapid prescreening flag Pap smears with glandular cell abnormalities? Yes, these smears are often labeled ""abnormal"" in rapid prescreening, leading to a cytotechnologist's manual review to decide if the abnormalities are significant or require additional examination.",2.3685972735685364e-07,0.09443828834604018,0.10707911957168353,0.018134264647818726,0.15889480420624702,0.06632653061224489,0.018108015409528673,0.19481572925119517,0.045351473922902494,2.3685972735685406e-07,0.23245315048010795,0.023242630385487524
15,0.5,1,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Do provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program? The Medicaid Managed Care Program in Florida has traditionally utilized HMOs and primary care case management as its primary service delivery frameworks. Although provider service networks (PSNs) have been considered, there remains no definitive evidence assessing their cost-effectiveness relative to these established models. Additional studies are required to evaluate the possible financial impact of adopting PSNs in Florida's Medicaid system.",2.3685972735685406e-08,0.0034337950655682903,0.011259148057796889,0.0018134264647818865,0.004134079883721498,0.012088888888888885,0.0018108015409528666,0.013134223077855722,0.00016641406224814775,2.3685972735685406e-08,0.013072081567353955,0.0
15,0.5,2,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Are expenditures lower with provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? Historically, Florida's Medicaid Managed Care Program has relied on HMOs and primary care case management as its main service delivery methods. Provider service networks (PSNs) have been investigated, but no conclusive data currently exists to compare their cost-effectiveness against these models. More research is necessary to understand the cost implications of PSNs in Florida's Medicaid program.",1.4211583641411244e-07,0.11360136639501484,0.050127333141373034,0.010880558788691319,0.08475762662414077,0.004121487082545686,0.0108648092457172,0.08152379139268184,0.0010677832229420807,1.4211583641411244e-07,0.08112554481236778,0.0
15,0.5,3,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Do provider service networks result in decreased spending compared to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Managed Care Program has primarily implemented HMOs and primary care case management as service delivery models. Provider service networks (PSNs) have been explored, yet there is no definitive evidence comparing their cost efficiency to these existing models. Further investigation is needed to clarify the potential cost effects of introducing PSNs in Florida's Medicaid program.",1.1842986367842703e-07,0.0980858049758968,0.04830121845351547,0.009067132323909433,0.07012547004328074,0.003388662131519289,0.009054007704764333,0.06746671462543308,0.0008776371736328465,1.1842986367842703e-07,0.0671393028376297,0.0
15,0.5,4,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Is there a reduction in expenditures with provider service networks versus HMOs or primary care case management in Florida's Medicaid program? The Medicaid Managed Care Program in Florida has predominantly used HMOs and primary care case management as core service delivery models. Provider service networks (PSNs) have been examined, but conclusive evidence on their cost-effectiveness compared to these models is lacking. Additional research is required to determine the financial impact of PSNs in Florida's Medicaid program.",1.1842986367842703e-07,0.07262523824410483,0.0056488506124028615,0.009067132323909433,0.07012547004328074,0.003388662131519289,0.009054007704764333,0.06746671462543308,0.0008776371736328465,1.1842986367842703e-07,0.0671393028376297,0.0
15,0.5,5,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Do provider service networks lower costs compared to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Managed Care Program has traditionally employed HMOs and primary care case management as primary service delivery approaches. While provider service networks (PSNs) have been studied, there is no conclusive proof regarding their cost-effectiveness relative to these models. Further research is necessary to assess the cost implications of implementing PSNs in Florida's Medicaid program.",1.8948778188548325e-07,0.1453598011809989,0.053929559954963444,0.014507411718255092,0.11467694664264716,0.005648335437241629,0.014486412327622933,0.11024478516934888,0.001464363234917809,1.8948778188548325e-07,0.10969891725642178,0.0
15,0.5,6,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Are provider service networks associated with reduced expenditures compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Managed Care Program in Florida has mainly utilized HMOs and primary care case management for service delivery. Although provider service networks (PSNs) have been explored, there is currently no definitive evidence comparing their cost-effectiveness against these models. More research is needed to evaluate the potential cost impact of PSNs in Florida's Medicaid program.",1.4211583641411244e-07,0.08779673795063037,0.0068666004985143275,0.010880558788691319,0.08475762662414077,0.0041214870825456995,0.0108648092457172,0.08152379139268184,0.0010677832229420807,1.4211583641411244e-07,0.08112554481236778,0.0
15,0.5,7,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Do provider service networks achieve lower spending than HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Managed Care Program has historically adopted HMOs and primary care case management as its main service delivery models. Provider service networks (PSNs) have been considered, but conclusive evidence regarding their cost-effectiveness compared to these models is not yet available. Further investigation is required to understand the cost implications of PSNs in Florida's Medicaid program.",1.6580180914979784e-07,0.12935688943056434,0.052002784807034394,0.012693985253473206,0.09960596729613957,0.004874432910419085,0.012675610786670066,0.09578121771036496,0.0012632821723730786,1.6580180914979784e-07,0.09531017980432566,0.0
15,0.5,8,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Is cost expenditure lower with provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Managed Care Program in Florida has primarily depended on HMOs and primary care case management as service delivery models. Provider service networks (PSNs) have been explored, but no conclusive evidence exists comparing their cost-effectiveness to these models. Additional research is needed to determine the possible cost outcomes of implementing PSNs in Florida's Medicaid program.",1.1842986367842703e-07,0.07262523824410394,0.005648850612402889,0.009067132323909433,0.07012547004328074,0.003388662131519289,0.009054007704764333,0.06746671462543308,0.0008776371736328465,1.1842986367842703e-07,0.0671393028376297,0.0
15,0.5,9,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Do provider service networks provide cost savings compared to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Managed Care Program has traditionally used HMOs and primary care case management as primary service delivery systems. Provider service networks (PSNs) have been investigated, but there is no conclusive evidence about their cost-effectiveness relative to these models. More research is necessary to assess the financial implications of PSNs in Florida's Medicaid program.",1.8948778188548325e-07,0.1453598011809989,0.053929559954963444,0.014507411718255092,0.11467694664264716,0.005648335437241629,0.014486412327622933,0.11024478516934888,0.001464363234917809,1.8948778188548325e-07,0.10969891725642178,0.0
15,0.5,10,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Are provider service networks more cost-effective than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Managed Care Program in Florida has historically relied on HMOs and primary care case management as the main service delivery methods. Although provider service networks (PSNs) have been explored, definitive evidence comparing their cost-effectiveness to these models is lacking. Further research is needed to evaluate the potential cost impact of PSNs in Florida's Medicaid program.",1.6580180914979784e-07,0.10319877292529878,0.008116313857626442,0.012693985253473206,0.09960596729613957,0.004874432910419078,0.012675610786670066,0.09578121771036496,0.0012632821723730786,1.6580180914979784e-07,0.09531017980432566,0.0
16,0.5,1,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
",Is lumbar drainage an effective method for managing postoperative cerebrospinal fluid fistulas following spine surgery? Lumbar drainage appears to be both safe and effective in preventing and treating CSF fistulas after spine surgery. It reduces the chance of complications like pseudomeningocele and enhances patient recovery.,4.737194547137081e-08,0.015684784721507583,0.020673448681217014,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
16,0.5,2,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Does lumbar drainage work well for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is considered a safe and effective approach to prevent and treat CSF fistulas post-spine surgery, lowering risks of complications such as pseudomeningocele and improving outcomes.",1.6580180914979774e-07,0.1403520917441563,0.01776516105400517,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
16,0.5,3,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Is lumbar drainage effective in treating cerebrospinal fluid fistulas after spine surgery? Evidence suggests lumbar drainage is a safe and effective way to manage and prevent CSF fistulas following spine surgery, reducing complications like pseudomeningocele and benefiting patient prognosis.",1.8948778188548304e-07,0.1672629994437167,0.01709186291495875,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
16,0.5,4,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Can lumbar drainage effectively manage postoperative CSF fistulas after spine surgery? Lumbar drainage has proven to be a safe and effective technique to both prevent and treat CSF fistulas after spine surgery, decreasing the likelihood of pseudomeningocele and enhancing patient outcomes.",1.4211583641411244e-07,0.21811771061236884,0.05537700234669933,0.010880558788691236,0.2141928621596434,0.05113221329437545,0.0108648092457172,0.1830849047476617,0.026296566837107373,1.4211583641411244e-07,0.1502822030493367,0.0
16,0.5,5,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Is lumbar drainage a safe and effective treatment for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage seems to effectively prevent and treat CSF fistulas, lowering the risk of complications such as pseudomeningocele and improving recovery.",2.3685972735685364e-07,0.2233569668559814,0.015633327711249794,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
16,0.5,6,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","How effective is lumbar drainage for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is regarded as a safe and effective method to prevent and treat CSF fistulas, reducing the incidence of pseudomeningocele and improving patient outcomes.",2.1317375462116834e-07,0.19491723113549364,0.01638225691255996,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
16,0.5,7,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Is lumbar drainage beneficial in the management of CSF fistulas after spine surgery? Lumbar drainage appears both safe and effective in preventing and treating postoperative CSF fistulas, minimizing complications like pseudomeningocele and enhancing recovery.",3.0791764556390954e-07,0.3138690871817724,0.013114992252066124,0.023574544042164365,0.3409265869705931,0.0,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
16,0.5,8,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Does lumbar drainage provide effective treatment for cerebrospinal fluid fistulas following spine surgery? Lumbar drainage is considered a safe and effective approach to both prevent and manage CSF fistulas postoperatively, reducing pseudomeningocele risk and improving patient outcomes.",2.3685972735685364e-07,0.2233569668559814,0.015633327711249794,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
16,0.5,9,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Is lumbar drainage a reliable treatment option for postoperative CSF fistulas after spine surgery? Lumbar drainage is effective and safe in preventing and treating CSF fistulas, decreasing complications such as pseudomeningocele and improving patient recovery.",2.8423167282822424e-07,0.2827805675605046,0.014003673094582187,0.021761117577382486,0.3101549283038394,0.0,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
16,0.5,10,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","How effective and safe is lumbar drainage for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is a proven method to prevent and treat CSF fistulas, lowering the risk of complications like pseudomeningocele and enhancing patient outcomes.",2.1317375462116834e-07,0.19491723113549364,0.01638225691255996,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
17,0.5,1,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Question: Do higher depression rates in women result from differences in symptom reporting? Answer: Both men and women in this community sample showed similar depressive symptom patterns. This indicates that gender differences in depression rates might not be just because women report symptoms more readily. More research is necessary to explore the biological, social, and psychological factors behind gender disparities in depression.",1.6580180914979784e-07,0.1540861151378765,0.03274920999712727,0.012693985253473108,0.11034805716886531,0.0,0.012675610786670066,0.11211729812070548,0.0,1.6580180914979784e-07,0.1139442593492177,0.0
17,0.5,2,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Question: Are women's higher depression rates explained by different symptom reporting? Answer: Men and women in this community sample reported depressive symptoms similarly. This implies that the higher prevalence of depression in women may not be simply due to greater symptom reporting. Further investigation is required to understand the biological, social, and psychological contributors to gender differences in depression.",2.3685972735685406e-07,0.15906469462968964,0.0,0.018134264647818726,0.16164135155641457,0.0,0.018108015409528666,0.16430305129127465,0.0,2.3685972735685406e-07,0.16705408466316563,0.0
17,0.5,3,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Question: Is the higher incidence of depression in women due to differential symptom reporting? Answer: In this community sample, men and women reported similar depressive symptom patterns. This suggests that gender differences in depression prevalence are not solely caused by women's increased symptom reporting. Additional research is needed to clarify the biological, social, and psychological factors influencing gender disparities in depression.",1.8948778188548325e-07,0.1251631429540092,0.0,0.014507411718254981,0.12715517548524602,0.0,0.014486412327622933,0.1292117314800052,0.0,1.8948778188548325e-07,0.13133600206108653,0.0
17,0.5,4,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Question: Are increased depression rates in women accounted for by differences in symptom reporting? Answer: Men and women in this community sample exhibited comparable depressive symptom patterns. This indicates that the gender gap in depression prevalence may not be entirely due to women's greater symptom disclosure. More studies are necessary to investigate the complex biological, social, and psychological factors contributing to gender differences in depression.",9.474389094274162e-08,0.08228547120893381,0.015621063240110858,0.0072537058591274906,0.0615578929994296,0.0,0.007243206163811466,0.06252035698133263,0.0,9.474389094274162e-08,0.06351340572232633,0.0
17,0.5,5,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Question: Does differential symptom reporting explain higher depression rates in women? Answer: Both men and women in this community sample reported depressive symptoms similarly. This suggests that women's higher depression rates might not be solely because they report symptoms more often. Further research is essential to understand the biological, social, and psychological dynamics behind gender disparities in depression.",2.6054570009253947e-07,0.22509834474927448,0.035041322314049606,0.0199476911126006,0.204096185104385,0.017851239669421492,0.019918816950481533,0.18232155679395312,0.0,2.6054570009253947e-07,0.1854032233313614,0.0
17,0.5,6,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Question: Are women's higher depression rates a result of reporting symptoms differently? Answer: Men and women in this community sample showed similar patterns of depressive symptoms. This implies that gender differences in depression prevalence are not just due to women's increased willingness to report symptoms. Additional research is needed to explore the biological, social, and psychological factors affecting gender disparities in depression.",1.6580180914979784e-07,0.10863384100279827,0.0,0.012693985253473108,0.11034805716886531,0.0,0.012675610786670066,0.11211729812070548,0.0,1.6580180914979784e-07,0.1139442593492177,0.0
17,0.5,7,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Question: Is the greater prevalence of depression in women due to differential symptom reporting? Answer: In this community sample, men and women reported depressive symptoms in similar ways. This suggests that the gender difference in depression rates is not solely attributable to women's greater symptom reporting. Further study is required to understand the complex biological, social, and psychological factors contributing to gender disparities in depression.",9.474389094274162e-08,0.06062462181643724,0.0,0.0072537058591274906,0.0615578929994296,0.0,0.007243206163811466,0.06252035698133263,0.0,9.474389094274162e-08,0.06351340572232633,0.0
17,0.5,8,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Question: Are higher rates of depression in women explained by differences in how symptoms are reported? Answer: Men and women in this community sample reported depressive symptoms similarly. This indicates that women's higher depression prevalence may not be entirely due to reporting differences. More research is needed to examine the biological, social, and psychological contributors to gender disparities in depression.",2.1317375462116866e-07,0.14197026127038992,0.0,0.016320838183036854,0.14424960884454574,0.0,0.0162972138685758,0.14660347419187403,0.0,2.1317375462116866e-07,0.14903557916048715,0.0
17,0.5,9,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Question: Does the difference in symptom reporting account for higher depression rates in women? Answer: Men and women in this community sample exhibited similar depressive symptom patterns. This suggests that the observed gender differences in depression prevalence might not be solely due to women's greater symptom reporting. Further research is necessary to investigate the biological, social, and psychological factors influencing gender disparities in depression.",1.1842986367842703e-07,0.0763729787845735,0.0,0.009067132323909363,0.07755823434587317,0.0,0.009054007704764333,0.07878087785311383,0.0,1.1842986367842703e-07,0.08004270767353727,0.0
17,0.5,10,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Question: Are women's elevated depression rates attributable to differential symptom reporting? Answer: Both men and women in this community sample reported depressive symptoms similarly. This suggests that the higher prevalence of depression in women may not be solely explained by their increased symptom reporting. Additional research is required to understand the biological, social, and psychological factors contributing to gender differences in depression.",1.6580180914979784e-07,0.10863384100279827,0.0,0.012693985253473108,0.11034805716886531,0.0,0.012675610786670066,0.11211729812070548,0.0,1.6580180914979784e-07,0.1139442593492177,0.0
18,0.5,1,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a link between crime and over-the-counter pharmacy syringe sales? Our research shows that OTC pharmacy syringe sales did not correlate with a rise in reported crime in Los Angeles neighborhoods from 2006 to 2008.,4.73719454713706e-08,0.10324992977309444,0.03180708532418292,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
18,0.5,2,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does crime relate to the sale of syringes over the counter at pharmacies? Findings indicate no association between OTC pharmacy syringe sales and increased crime reports in Los Angeles communities between 2006 and 2008.,0.0,0.08401784006787238,0.06035379812695108,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
18,0.5,3,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime connected to over-the-counter syringe purchases at pharmacies? Our study found that OTC syringe sales at pharmacies were not linked to higher crime rates in local Los Angeles areas during 2006-2008.,4.73719454713706e-08,0.02149748308653887,0.06035379812695108,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
18,0.5,4,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales associated with crime? Evidence from 2006 to 2008 in Los Angeles shows no increase in reported crime related to OTC syringe sales in local communities.,9.47438909427412e-08,0.09299714524385472,0.02591502261674699,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,0.5,5,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there an association between crime and OTC pharmacy syringe sales? Data from Los Angeles between 2006 and 2008 reveal no connection between OTC syringe sales and local crime increases.,9.47438909427412e-08,0.04519389141213459,0.06035379812695108,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,0.5,6,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does selling syringes over the counter in pharmacies relate to crime rates? Our findings indicate no correlation between OTC pharmacy syringe sales and elevated crime in Los Angeles neighborhoods from 2006 to 2008.,2.36859727356853e-08,0.0532461814011187,0.06035379812695108,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
18,0.5,7,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime linked to over-the-counter syringe sales at pharmacies? The results demonstrate that OTC syringe sales did not lead to increased crime reports in Los Angeles localities during 2006-2008.,1.184298636784265e-07,0.12979572412054274,0.024688503202396905,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
18,0.5,8,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are OTC pharmacy syringe sales tied to crime? Research from 2006-2008 in Los Angeles communities shows no association between OTC syringe sales and crime rate increases.,1.894877818854824e-07,0.24906567097520282,0.020423242571395522,0.014507411718255037,0.28768207245178123,0.0,0.014486412327622988,0.29849298855599704,0.0,1.8948778188548325e-07,0.3101549283038394,0.0
18,0.5,9,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a relationship between crime and the sale of syringes over the counter in pharmacies? Our findings confirm that OTC pharmacy syringe sales were not associated with a rise in reported crime in Los Angeles areas from 2006 to 2008.,1.658018091497971e-07,0.2763897327153284,0.06035379812695108,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
18,0.5,10,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does the sale of syringes over the counter at pharmacies influence crime rates? Data from Los Angeles between 2006 and 2008 suggest no link between OTC pharmacy syringe sales and increased local crime.,2.36859727356853e-08,0.0532461814011187,0.06035379812695108,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
19,0.5,1,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is specialized breast pathology evaluation essential for managing ductal carcinoma in situ? Expert breast pathology evaluations remain crucial in managing ductal carcinoma in situ (DCIS) because of the disease's heterogeneity and the critical role of precise subtyping in prognosis and treatment planning.,2.1317375462116866e-07,0.13961795852021242,0.03986914135570091,0.016320838183036854,0.13079695377514478,0.05086164465099239,0.0162972138685758,0.1565419764677376,0.036598953524161267,2.1317375462116866e-07,0.15357019257431448,0.04246913580246913
19,0.5,2,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is expert breast pathology assessment required for the treatment of ductal carcinoma in situ? Expert assessments in breast pathology are still necessary for managing ductal carcinoma in situ (DCIS) due to the disease's variability and the need for accurate subtyping to guide prognosis and therapy.,1.4211583641411244e-07,0.028272231029455863,0.06847311069636174,0.010880558788691236,0.02140097788649875,0.07748051011038021,0.0108648092457172,0.04688799505453023,0.06222222222222222,1.4211583641411244e-07,0.07758428559639308,0.04246913580246913
19,0.5,3,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
","Does the management of ductal carcinoma in situ require expert breast pathology evaluation? Yes, expert breast pathology assessments are essential in managing ductal carcinoma in situ (DCIS) because of its heterogeneous nature and the significance of accurate subtyping for prognosis and treatment choices.",1.8948778188548325e-07,0.1453072195784566,0.019416256037950774,0.014507411718254981,0.13822579589364903,0.028008459055424498,0.014486412327622933,0.13033551825195833,0.0372386587771203,1.8948778188548325e-07,0.1275947061710565,0.04246913580246913
19,0.5,4,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is a specialist breast pathology review important for ductal carcinoma in situ management? Expert breast pathology assessments remain important in managing ductal carcinoma in situ (DCIS) owing to the disease's heterogeneity and the necessity for precise subtyping to inform prognosis and treatment.,2.1317375462116866e-07,0.13961795852021242,0.03986914135570091,0.016320838183036854,0.13079695377514478,0.05086164465099239,0.0162972138685758,0.1565419764677376,0.036598953524161267,2.1317375462116866e-07,0.15357019257431448,0.04246913580246913
19,0.5,5,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
","Is expert evaluation by breast pathologists necessary in ductal carcinoma in situ care? Yes, expert breast pathology evaluations continue to be necessary in the management of ductal carcinoma in situ (DCIS) because of the disease's heterogeneity and the critical importance of accurate subtyping for prognosis and treatment decisions.",7.105791820705622e-08,0.014223308019983172,0.051919956733369396,0.005440279394345618,0.01800603878122997,0.0573347107438016,0.0054324046228586,0.00870166492579827,0.04001147842056933,7.105791820705622e-08,0.006966718382439119,0.04246913580246913
19,0.5,6,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is expert breast pathology assessment indispensable in managing ductal carcinoma in situ? Expert breast pathology assessments are still indispensable for ductal carcinoma in situ (DCIS) management due to the heterogeneous nature of the disease and the importance of accurate subtyping for prognosis and treatment guidance.,1.4211583641411244e-07,0.05977892105490801,0.046289886425094656,0.010880558788691236,0.053640381633472956,0.05432218868147152,0.0108648092457172,0.04688799505453023,0.06222222222222222,1.4211583641411244e-07,0.07758428559639308,0.04246913580246913
19,0.5,7,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is specialized breast pathology expertise required for ductal carcinoma in situ management? The management of ductal carcinoma in situ (DCIS) still requires expert breast pathology assessments because of the disease's heterogeneity and the crucial role of accurate subtyping in prognosis and treatment.,2.1317375462116866e-07,0.13961795852021242,0.03986914135570091,0.016320838183036854,0.13079695377514478,0.05086164465099239,0.0162972138685758,0.1565419764677376,0.036598953524161267,2.1317375462116866e-07,0.15357019257431448,0.04246913580246913
19,0.5,8,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
","Is expert pathology evaluation necessary for ductal carcinoma in situ treatment? Yes, expert breast pathology assessments remain necessary in the treatment of ductal carcinoma in situ (DCIS) because of its heterogeneity and the importance of precise subtyping for prognosis and therapy decisions.",2.1317375462116866e-07,0.10580590093192299,0.06357520498465143,0.016320838183036854,0.13079695377514478,0.05086164465099239,0.0162972138685758,0.1565419764677376,0.036598953524161267,2.1317375462116866e-07,0.15357019257431448,0.04246913580246913
19,0.5,9,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is expert breast pathology assessment a necessity for managing ductal carcinoma in situ? Expert breast pathology assessments are necessary for managing ductal carcinoma in situ (DCIS) due to the disease's heterogeneity and the critical need for accurate subtyping to inform prognosis and treatment.,1.8948778188548325e-07,0.17831422817654907,0.002599002463794242,0.014507411718254981,0.1720378534819389,0.0043023954264739955,0.014486412327622933,0.16499287727995604,0.012360726377346885,1.8948778188548325e-07,0.16314071543054043,0.016845867104408177
19,0.5,10,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is expert breast pathology evaluation essential for the management of ductal carcinoma in situ? Expert breast pathology evaluations continue to be essential in managing ductal carcinoma in situ (DCIS) because of the heterogeneity of the disease and the importance of accurate subtyping for prognosis and treatment decisions.,9.474389094274162e-08,0.03998456806921036,0.029210766853411146,0.0072537058591274906,0.005312282779206701,0.05637484411944804,0.007243206163811466,0.00036797941963628844,0.06222222222222222,9.474389094274162e-08,0.029956236607138642,0.04246913580246913
20,0.5,1,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night effect on sleep bruxism? The findings indicated no general first night impact on the severity of RMMA frequency in young, healthy individuals with sleep bruxism. Clinically, a single night of sleep recording might suffice for patients with moderate to high frequency SB. Nevertheless, low RMMA frequency observed on the first night may require confirmation through a second night recording.",7.105791820705622e-08,0.09981618699108408,0.03870393423203919,0.005440279394345618,0.12008648492512908,0.0507015306122449,0.0054324046228586,0.07433248054275143,0.017236072637734686,7.105791820705622e-08,0.05129329438754926,0.0
20,0.5,2,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does a first night effect influence sleep bruxism? Results revealed no significant first night effect on RMMA frequency severity among young, healthy patients with sleep bruxism. In practice, one night of sleep monitoring could be adequate for those with moderate to high frequency SB. However, a low RMMA frequency during the first night should be validated by a second night of recording.",2.3685972735685406e-08,0.041671016699209584,0.0187744079113127,0.0018134264647818726,0.06419175608347238,0.034039651841776646,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
20,0.5,3,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there an initial night effect on sleep bruxism? The study showed no overall first night effect on the severity of RMMA frequency in young, healthy sleep bruxism patients. For clinical purposes, a single night of sleep recording may be enough for patients with moderate to high SB frequency. Yet, low RMMA frequency on the first night might need confirmation with a second night.",7.105791820705622e-08,0.0861170406838565,0.05702720159715802,0.005440279394345618,0.0977268984554529,0.034576832950326056,0.0054324046228586,0.07433248054275143,0.017236072637734686,7.105791820705622e-08,0.05129329438754926,0.0
20,0.5,4,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does sleep bruxism exhibit a first night effect? The results demonstrated no overall first night effect on RMMA frequency severity in young, healthy patients with sleep bruxism. Clinically, one night's sleep recording may be sufficient for patients with moderate to high frequency SB. However, if RMMA frequency is low on the first night, a second night recording could confirm this.",2.3685972735685406e-08,0.06005357640592601,0.08510093852355759,0.0018134264647818726,0.053395110426456505,0.0507015306122449,0.0018108015409528666,0.006509884203991234,0.017236072637734686,2.3685972735685406e-08,0.01769957709940062,0.0
20,0.5,5,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night effect on sleep bruxism severity? Findings showed no general first night effect on RMMA frequency severity in young, healthy SB patients. In clinical settings, a single night of sleep recording may be adequate for moderate to high frequency SB cases. Nonetheless, low RMMA frequency during the first night might be confirmed by a second night of recording.",2.3685972735685406e-08,0.018944879631669576,0.0022487501275380295,0.0018134264647818726,0.041086850064807834,0.017407832633647986,0.0018108015409528666,0.017499545679907413,0.0002919584879130452,2.3685972735685406e-08,0.01739174271186883,0.0
20,0.5,6,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the first night affect sleep bruxism? The study found no overall first night effect on the severity of RMMA frequency in young, healthy patients with sleep bruxism. One night of sleep recording may be sufficient for moderate to high frequency SB patients in clinical practice. However, low RMMA frequency on the first night might require confirmation by a second night.",0.0,0.023104906018664995,0.016794204672992613,0.0,0.046993029190503854,0.033757416462423265,0.0,0.023901626915860064,0.017236072637734686,0.0,0.0,0.0
20,0.5,7,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there an effect of the first night on sleep bruxism? Results indicated no overall first night effect on RMMA frequency severity in young, healthy individuals with sleep bruxism. For clinical purposes, one night of sleep recording may be enough for patients with moderate to high frequency SB, but a second night may be needed to confirm low RMMA frequency detected on the first night.",9.474389094274162e-08,0.1252453620756433,0.07358024691358028,0.0072537058591274906,0.13608682627157265,0.0507015306122449,0.007243206163811466,0.09059300141453264,0.017236072637734686,9.474389094274162e-08,0.0678225963387602,0.0
20,0.5,8,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the initial night impact sleep bruxism? The findings showed no general first night effect on RMMA frequency severity in young, healthy patients with sleep bruxism. Clinically, one night of sleep recording may suffice for moderate to high frequency SB patients, though low RMMA frequency on the first night might be validated by a second night.",1.1842986367842703e-07,0.00992815747771214,0.0994906143832215,0.009067132323909363,0.01806385355568718,0.0507015306122449,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
20,0.5,9,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night influence on sleep bruxism? The results demonstrated no significant first night effect on the severity of RMMA frequency in young, healthy sleep bruxism patients. In clinical practice, a single night sleep recording may be adequate for moderate to high frequency SB patients, but low RMMA frequency on the first night should be confirmed by a second night.",2.3685972735685406e-08,0.0643971537667487,0.03546390342327557,0.0018134264647818726,0.08729666210213693,0.0507015306122449,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
20,0.5,10,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the first night affect sleep bruxism severity? The study showed no overall first night effect on RMMA frequency severity in young, healthy patients with sleep bruxism. One night of sleep recording may be sufficient for moderate to high frequency SB patients clinically, though low RMMA frequency on the first night could require a second night for confirmation.",7.105791820705622e-08,0.010406662690786384,0.028290899182082302,0.005440279394345618,0.006451465833382741,0.03285029094282341,0.0054324046228586,0.02920819839808786,0.017236072637734686,7.105791820705622e-08,0.05406722127027486,0.0
21,0.5,1,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns result in less pain? Minimal access surgery for repairing esophageal atresia or congenital diaphragmatic hernia does not lead to reduced cumulative opioid use.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.5,2,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain reduced with minimal access major surgery in newborns? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia does not correlate with lower total opioid doses.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.5,3,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery cause less pain in newborn major surgeries? The use of minimal access techniques for esophageal atresia or congenital diaphragmatic hernia repair does not decrease overall opioid consumption.,4.73719454713706e-08,0.06742663438990348,0.0020762161887946107,0.003626852929563759,0.06669137449867346,0.0,0.003621603081905747,0.06899287148695077,0.0,4.737194547137081e-08,0.07145896398214369,0.0
21,0.5,4,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain after minimal access major surgery in newborns? Minimal access surgery to fix esophageal atresia or congenital diaphragmatic hernia is not linked to reduced cumulative opioid requirements.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.5,5,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns lead to less pain? Repairing esophageal atresia or congenital diaphragmatic hernia via minimal access surgery does not reduce total opioid dosage.,1.421158364141118e-07,0.2709556937716999,0.045171407099086576,0.010880558788691277,0.2705631540617417,0.03993055555555556,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,0.5,6,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is minimal access major surgery less painful for newborns? Minimal access procedures for esophageal atresia or congenital diaphragmatic hernia do not result in lower cumulative opioid doses.,1.421158364141118e-07,0.21763667988247315,0.007182518210197705,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,0.5,7,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Do newborns experience less pain with minimal access major surgery? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia is not associated with decreased opioid use overall.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.5,8,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery reduce pain in newborn major surgeries? The repair of esophageal atresia or congenital diaphragmatic hernia through minimal access methods does not lower cumulative opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.5,9,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain less intense with minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not correspond to reduced total opioid consumption.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.5,10,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns lead to less opioid use? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia is not linked to decreased cumulative opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
22,0.5,1,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Does family practice at residency teaching sites mirror community practice? The residency training locations of the Northeastern Ohio Universities College of Medicine offer patient care across diverse settings such as community health centers, rural hospitals, and private practices. This variety ensures residents acquire experience in multiple clinical environments, equipping them for various practice settings.",2.6054570009253947e-07,0.1452694710225555,0.03121748178980229,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
22,0.5,2,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Is family practice at residency teaching sites representative of community practice? At the Northeastern Ohio Universities College of Medicine, residency training sites provide care in numerous settings including community health centers, rural hospitals, and private practices. This range of environments allows residents to gain experience across different clinical contexts, preparing them for diverse practice settings.",2.3685972735685406e-07,0.12657733801040116,0.03121748178980229,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
22,0.5,3,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Do residency teaching sites for family practice reflect the community practice environment? The Northeastern Ohio Universities College of Medicineâ€™s residency sites deliver patient care in a mix of settings like community health centers, rural hospitals, and private practices. This diversity helps residents develop experience in various clinical settings, readying them for a broad spectrum of practice environments.",1.8948778188548325e-07,0.09020969383952693,0.03121748178980229,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
22,0.5,4,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Is family practice at residency teaching sites aligned with community practice? Residency training sites affiliated with the Northeastern Ohio Universities College of Medicine provide care in multiple settings, including community health centers, rural hospitals, and private practices. This assortment ensures residents experience a wide range of clinical environments, preparing them for different practice scenarios.",2.6054570009253947e-07,0.1452694710225555,0.03121748178980229,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
22,0.5,5,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Does the family practice at residency teaching sites reflect the reality of community practice? The residency sites of Northeastern Ohio Universities College of Medicine offer patient care in diverse settings such as community health centers, rural hospitals, and private practices. This variety ensures residents gain exposure to multiple clinical environments, equipping them for various practice settings.",2.1317375462116866e-07,0.1082281993422054,0.03121748178980229,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
22,0.5,6,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Are family practice residency teaching sites reflective of community practice? The residency training sites at Northeastern Ohio Universities College of Medicine provide patient care in a variety of environments including community health centers, rural hospitals, and private practices. This diversity allows residents to experience a broad range of clinical settings, preparing them for multiple practice settings.",2.1317375462116866e-07,0.1082281993422054,0.03121748178980229,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
22,0.5,7,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Does family practice at residency teaching sites represent community practice? The residency training sites of the Northeastern Ohio Universities College of Medicine deliver patient care across different settings like community health centers, rural hospitals, and private practices. This mix ensures residents gain experience in varied clinical environments, preparing them for a wide array of practice settings.",2.1317375462116866e-07,0.1082281993422054,0.03121748178980229,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
22,0.5,8,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Is family practice at residency teaching sites similar to community practice? The Northeastern Ohio Universities College of Medicineâ€™s residency training sites provide patient care in diverse settings, including community health centers, rural hospitals, and private practices. This diversity ensures residents obtain experience in a range of clinical environments, equipping them for various practice settings.",2.6054570009253947e-07,0.1452694710225555,0.03121748178980229,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
22,0.5,9,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Does family practice at residency teaching sites correspond to community practice? Residency training sites associated with the Northeastern Ohio Universities College of Medicine offer patient care in various settings such as community health centers, rural hospitals, and private practices. This variety ensures residents gain experience across multiple clinical environments, preparing them for diverse practice settings.",2.3685972735685406e-07,0.12657733801040116,0.03121748178980229,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
22,0.5,10,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Is family practice at residency teaching sites indicative of community practice? The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a range of settings including community health centers, rural hospitals, and private practices. This range guarantees residents experience multiple clinical environments, preparing them for a variety of practice settings.",2.1317375462116866e-07,0.1082281993422054,0.03121748178980229,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
23,0.5,1,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Is the length of psychological treatment for depression connected to the chances of returning to treatment? The findings indicate that extended treatment duration might reduce the likelihood of needing to return for further treatment. This underscores the significance of offering adequate treatment time to those with depression to ensure lasting recovery and minimize relapse risk.,7.105791820705622e-08,0.11152289858974962,0.039150354019158694,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
23,0.5,2,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Does the duration of psychological therapy for depression influence the probability of returning to treatment? Results imply that longer treatment periods could help prevent patients from needing additional treatment. This emphasizes the necessity of sufficient treatment duration for individuals with depression to achieve sustained recovery and lower relapse chances.,7.105791820705622e-08,0.006260137066634641,0.039150354019158694,0.005440279394345618,0.06187540371808753,0.0,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
23,0.5,3,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Is there a relationship between how long psychological treatment for depression lasts and the likelihood of returning for treatment? The evidence suggests that longer treatment durations may help avoid subsequent treatment episodes. This highlights the importance of providing enough treatment time to support enduring recovery and reduce relapse in depression.,4.737194547137081e-08,0.014359150136101118,0.039150354019158694,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
23,0.5,4,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Does the length of depression treatment affect the risk of patients returning to therapy? Findings suggest that prolonged treatment may decrease the chances of returning to treatment. This points to the critical role of adequate treatment duration in promoting lasting recovery and preventing relapse in depression.,1.4211583641411244e-07,0.10160519956242586,0.016939610217505802,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
23,0.5,5,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Is the duration of psychological treatment for depression associated with the likelihood of returning to treatment? Results show that extended treatment duration may help prevent relapse and the need for further treatment. This stresses the importance of sufficient treatment time for achieving lasting recovery in depression patients.,1.1842986367842703e-07,0.04881975148543116,0.039150354019158694,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
23,0.5,6,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Is there a link between the duration of psychological treatment for depression and the probability of re-entering treatment? The findings indicate that longer treatment duration can reduce the chance of returning to therapy. This finding highlights the need for providing ample treatment time to ensure sustained recovery and lower relapse risk.,2.3685972735685406e-08,0.034561857453619726,0.039150354019158694,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
23,0.5,7,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Does the length of treatment for depression influence the chances of returning to therapy? The results suggest that longer treatment duration might prevent the need for additional treatment. This underscores the importance of adequate treatment time to foster lasting recovery and decrease relapse likelihood.,1.8948778188548325e-07,0.1162610322809634,0.039150354019158694,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
23,0.5,8,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Is the time spent in psychological treatment for depression related to the risk of returning to treatment? Evidence suggests that longer treatment periods may help prevent patients from returning. This highlights the importance of sufficient treatment duration to promote durable recovery and reduce relapse rates.,1.6580180914979784e-07,0.09327151405626388,0.039150354019158694,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
23,0.5,9,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Is the length of psychological treatment for depression connected to the chance of returning for treatment? Findings suggest that a longer treatment duration may lower the risk of relapse and returning to therapy. This stresses the importance of providing enough treatment time for sustained recovery.,1.6580180914979784e-07,0.09327151405626388,0.039150354019158694,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
23,0.5,10,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Is the duration of treatment for depression linked to the probability of returning to treatment? The results imply that longer treatment duration could help prevent relapse and reduce the need for further treatment. This highlights the importance of adequate treatment time to achieve lasting recovery.,1.6580180914979784e-07,0.09327151405626388,0.039150354019158694,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
24,0.5,1,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is it possible for a new surgical technique targeting the temporomandibular joint to enhance access and minimize complications? Answer: The VMPA offers direct access and excellent visibility to the TMJ area, resulting in favorable aesthetic and functional outcomes. It can be regarded as the preferred method for typical TMJ surgeries.",4.737194547137081e-08,0.12862063739118046,0.06265295796173082,0.0036268529295637453,0.0711683211052474,0.021266540642722105,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
24,0.5,2,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can an innovative surgical method for the temporomandibular joint improve surgical access and decrease complication rates? Answer: The VMPA allows direct access and clear visibility to the TMJ region, leading to good cosmetic and functional results. It is considered the optimal approach for standard TMJ procedures.",4.737194547137081e-08,0.04282808173713892,0.06091623303744516,0.0036268529295637453,0.013989487235059883,0.021266540642722105,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
24,0.5,3,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,Question: Does a novel surgical approach to the temporomandibular joint enhance accessibility and reduce the risk of complications? Answer: The VMPA provides direct access with good visibility to the TMJ area and achieves satisfactory aesthetic and functional outcomes. This approach is often preferred for common TMJ surgeries.,4.737194547137081e-08,0.04282808173713892,0.06091623303744516,0.0036268529295637453,0.013989487235059883,0.021266540642722105,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
24,0.5,4,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a new surgical technique for the TMJ improve access and lower complication risks? Answer: The VMPA grants direct access and excellent visualization of the TMJ region, producing favorable esthetic and functional results. It is considered the approach of choice for routine TMJ surgeries.",9.474389094274162e-08,0.03450022694720989,0.03729315417627106,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.5,5,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is a novel surgical approach to the temporomandibular joint effective in improving access and minimizing complications? Answer: The VMPA affords direct access and good visibility to the TMJ area, yielding positive aesthetic and functional outcomes. It is regarded as the preferred approach for common TMJ operations.",4.737194547137081e-08,0.012691247799749839,0.03925619834710743,0.0036268529295637453,0.013989487235059883,0.021266540642722105,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
24,0.5,6,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a new surgical method for the temporomandibular joint improve access and reduce complications? Answer: The VMPA provides direct and clear access to the TMJ region, resulting in excellent esthetic and functional results. It is often chosen as the approach for typical TMJ surgeries.",9.474389094274162e-08,0.028513153103694844,0.08264462809917356,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.5,7,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Does a novel surgical approach to the TMJ enhance accessibility and decrease complication rates? Answer: The VMPA offers direct access and favorable visualization of the TMJ area, delivering good cosmetic and functional outcomes. It is considered the preferred technique for standard TMJ surgeries.",1.1842986367842703e-07,0.026715768867978884,0.05940199771368603,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
24,0.5,8,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can an innovative surgical approach to the temporomandibular joint improve access and lower the likelihood of complications? Answer: The VMPA enables direct access and good visibility to the TMJ region, leading to excellent esthetic and functional results. This method is the approach of choice for common TMJ surgeries.",0.0,0.057762265046662264,0.041056726397850296,0.0,0.02949562470467848,0.021266540642722105,0.0,0.0,0.0,0.0,0.0,0.0
24,0.5,9,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Is it possible for a novel surgical technique to improve access to the temporomandibular joint and reduce complications? Answer: The VMPA provides direct access and clear visibility to the TMJ area, producing favorable functional and esthetic outcomes. It is considered the preferred surgical approach for typical TMJ procedures.",0.0,0.0866433975699934,0.06182072588097527,0.0,0.02949562470467848,0.021266540642722105,0.0,0.0,0.0,0.0,0.0,0.0
24,0.5,10,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Question: Can a new surgical approach to the TMJ improve access and minimize complications? Answer: The VMPA grants direct access and excellent visibility to the TMJ region, resulting in good esthetic and functional results. It is regarded as the best approach for common TMJ surgeries.",9.474389094274162e-08,0.06600691697266203,0.014827852370440625,0.0072537058591274906,0.09169126505879133,0.001976089742765419,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
25,0.5,1,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and health professionals consider it acceptable to break confidentiality to protect a patient's wife from an STD? Most people in France base their decision on situational factors when determining if a doctor should breach confidentiality to safeguard the spouse of a patient infected with a sexually transmitted disease.,2.3685972735685406e-08,0.0340182126061217,0.038602079862557266,0.0018134264647818726,0.035249067127276934,0.039930555555555566,0.0018108015409528666,0.007672434452772325,0.020399305555555556,2.3685972735685406e-08,0.02105340919783316,0.0
25,0.5,2,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Is breaching confidentiality to protect a patient's wife from an STD acceptable among French laypeople and health professionals? In France, most individuals are influenced by the context when deciding if a physician should reveal confidential information to protect the spouse of a patient with an STD.",1.4211583641411244e-07,0.0744229571875259,0.03638300619834711,0.010880558788691236,0.07238159706508807,0.039930555555555566,0.0108648092457172,0.10232846076155644,0.020399305555555556,1.4211583641411244e-07,0.13353139262452318,0.0
25,0.5,3,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health professionals and laypeople find it acceptable to violate confidentiality to protect a patient's wife from a sexually transmitted infection? Most French people consider situational factors when deciding whether a doctor should breach confidentiality to protect the patient's spouse.,2.6054570009253947e-07,0.23071416954168367,0.008732254155124665,0.0199476911126006,0.22855559411318938,0.014307286857494612,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
25,0.5,4,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Are French laypeople and health professionals in favor of breaching confidentiality to protect a patient's wife from an STD? In France, the majority are influenced by the circumstances when deciding if a physician should disclose confidential information to protect the spouse of an infected patient.",1.6580180914979784e-07,0.0975959617068165,0.03587876892915089,0.012693985253473108,0.09537111528978759,0.039930555555555566,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
25,0.5,5,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and healthcare professionals accept breaching confidentiality to protect a patient's wife from a sexually transmitted disease? Most individuals in France take situational factors into account when deciding if a doctor should breach confidentiality to protect the spouse of a patient with an STD.,1.4211583641411244e-07,0.10522949854574559,0.014245453623580318,0.010880558788691236,0.10388828709054065,0.017215574484706456,0.0108648092457172,0.10232846076155644,0.020399305555555556,1.4211583641411244e-07,0.13353139262452318,0.0
25,0.5,6,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is it acceptable for French laypeople and health professionals to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Most people in France rely on situational factors when deciding if a physician should disclose confidential information to safeguard the spouse of a patient infected with an STD.,4.737194547137081e-08,0.041541392511001085,0.05859375,0.0036268529295637453,0.014629779924541175,0.039930555555555566,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,0.5,7,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and medical professionals find breaching confidentiality acceptable to protect a patient's wife from an STD? The majority of people in France are influenced by the situation when deciding if a physician should break confidentiality to protect the spouse of a patient with a sexually transmitted infection.,7.105791820705622e-08,0.007959027215065362,0.037769847781801716,0.005440279394345618,0.006423629273291986,0.039930555555555566,0.0054324046228586,0.034887179966024195,0.020399305555555556,7.105791820705622e-08,0.06453852113757153,0.0
25,0.5,8,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Do French laypeople and health experts consider it acceptable to breach confidentiality to protect a patient's wife from an STD? In France, most people are guided by situational factors when deciding if a doctor should breach confidentiality to protect the spouse of an infected patient.",1.6580180914979784e-07,0.1606093417577208,0.009223025728732931,0.012693985253473108,0.159849922783736,0.00647039625884064,0.012675610786670066,0.15886596676984244,0.0033960543492629995,1.6580180914979784e-07,0.1576289442035832,0.0
25,0.5,9,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is breaching confidentiality to protect a patient's wife from an STD considered acceptable by French laypeople and health professionals? Most French individuals are influenced by the context when deciding if a physician should disclose confidential information to protect the spouse of a patient with a sexually transmitted disease.,9.474389094274162e-08,0.029626928594246316,0.0373272093572779,0.0072537058591274906,0.027929834494255346,0.039930555555555566,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
25,0.5,10,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and healthcare providers accept breaching confidentiality to protect a patient's wife from a sexually transmitted infection? Most people in France consider situational factors when deciding whether a doctor should breach confidentiality to protect the spouse of an infected patient.,2.3685972735685406e-07,0.2043309540718976,0.00994154750164366,0.018134264647818726,0.2023491358974101,0.014946992110453645,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
26,0.5,1,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: Our conclusion is that the elevated cardiovascular risk in individuals carrying the D allele of the ACE gene I/D polymorphism cannot be attributed to variations in insulin sensitivity, implying that this polymorphism is unlikely to be a primary candidate gene for insulin resistance.",2.3685972735685406e-08,0.07397370395838454,0.16204320863999863,0.0018134264647818726,0.04410303847698671,0.10726600943196622,0.0018108015409528666,0.013245132239090296,0.05268778924884296,2.3685972735685406e-08,0.018649723075861324,0.0008988878685848023
26,0.5,2,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? Answer: We find that the higher cardiovascular risk associated with the D allele of the ACE gene I/D polymorphism is not due to differences in insulin sensitivity, indicating that the ACE gene I/D polymorphism may not serve as a key candidate gene for insulin resistance.",2.3685972735685406e-08,0.00711931766324847,0.029987505206164,0.0018134264647818726,0.0059993139368019754,0.02614379084967322,0.0018108015409528666,0.028699534116926273,0.04086663535002674,2.3685972735685406e-08,0.05215046877558871,0.05594132201983588
26,0.5,3,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Does the insertion allele of the ACE gene I/D polymorphism represent a candidate gene for insulin resistance? Answer: Our results suggest that the increased cardiovascular risk seen in individuals with the D allele of the ACE gene I/D polymorphism is not explained by insulin sensitivity differences, thus the ACE gene I/D polymorphism is unlikely to be a primary candidate gene for insulin resistance.",4.737194547137081e-08,0.010579495652399018,0.05997501041232822,0.0036268529295637453,0.013098327952559163,0.063052672049212,0.003621603081905733,0.015780652939769713,0.06550373798504808,4.737194547137081e-08,0.01863890006613733,0.06743801652892559
26,0.5,4,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Is the ACE gene I/D polymorphism insertion allele associated with insulin resistance? Answer: We conclude that the greater cardiovascular risk in carriers of the D allele of the ACE gene I/D polymorphism is not due to changes in insulin sensitivity, suggesting the ACE gene I/D polymorphism may not be a main candidate gene for insulin resistance.",1.1842986367842703e-07,0.047247188809462326,0.017662023651304204,0.009067132323909363,0.041398537993367235,0.006144114308388571,0.009054007704764333,0.06077372923798707,0.015472552509790044,1.1842986367842703e-07,0.08063181749208193,0.02532325456515453
26,0.5,5,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Could the ACE gene I/D polymorphism insertion allele be a candidate gene for insulin resistance? Answer: The increased cardiovascular risk linked to the D allele of the ACE gene I/D polymorphism does not appear to be explained by insulin sensitivity differences, implying this polymorphism is not likely a primary candidate gene for insulin resistance.",1.6580180914979784e-07,0.003147482121072187,0.18061774094806216,0.012693985253473108,0.029449376607946665,0.13044412004998068,0.012675610786670066,0.05642454598043933,0.08065139584506215,1.6580180914979784e-07,0.08409473944941226,0.03197024793388432
26,0.5,6,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Is the insertion allele of the ACE gene I/D polymorphism a likely candidate gene for insulin resistance? Answer: Our findings indicate that the elevated cardiovascular risk in individuals with the D allele of the ACE gene I/D polymorphism is not due to insulin sensitivity variations, suggesting the ACE gene I/D polymorphism is not a primary candidate gene for insulin resistance.",2.3685972735685406e-08,0.09953894173790756,0.09262807163681797,0.0018134264647818726,0.09998537231781057,0.0940307633185622,0.0018108015409528666,0.10040441486450646,0.09344273160183494,2.3685972735685406e-08,0.10079237618330295,0.09145166671432794
26,0.5,7,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Does the D allele of the ACE gene I/D polymorphism contribute to insulin resistance? Answer: We conclude that the increased cardiovascular risk in individuals possessing the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity, indicating that this polymorphism may not be a primary candidate gene for insulin resistance.",1.1842986367842703e-07,0.014882935050861246,0.1684830394742932,0.009067132323909363,0.038063082172026697,0.0991941200499807,0.009054007704764333,0.09273840395485244,0.028752447490209998,1.1842986367842703e-07,0.14922870314481962,0.0417457242883379
26,0.5,8,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Is the ACE gene I/D polymorphism insertion allele implicated in insulin resistance? Answer: Our study shows that the higher cardiovascular risk found in carriers of the D allele of the ACE gene I/D polymorphism is not due to insulin sensitivity differences, suggesting it is unlikely to be a primary candidate gene for insulin resistance.",1.6580180914979784e-07,0.04819675347595975,0.21574344023323616,0.012693985253473108,0.022863618151293785,0.16736009227220286,0.012675610786670066,0.029765039035825946,0.09972744749020998,1.6580180914979784e-07,0.08409473944941226,0.03197024793388432
26,0.5,9,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Could the insertion allele of the ACE gene I/D polymorphism be involved in insulin resistance? Answer: We conclude that the increased cardiovascular risk associated with the D allele of the ACE gene I/D polymorphism is not explained by changes in insulin sensitivity, indicating this polymorphism may not be a primary candidate gene for insulin resistance.",1.4211583641411244e-07,0.018469016994206555,0.18280595614095985,0.010880558788691236,0.008335345690273943,0.132131604142257,0.0108648092457172,0.062023819694388305,0.06315868447479975,1.4211583641411244e-07,0.1174729320512502,0.005905803711263556
26,0.5,10,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Is the ACE gene I/D polymorphism insertion allele a primary candidate gene for insulin resistance? Answer: Our findings suggest that the increased cardiovascular risk in individuals with the D allele of the ACE gene I/D polymorphism is not due to differences in insulin sensitivity, implying that this polymorphism is unlikely to be a primary candidate gene for insulin resistance.",4.737194547137081e-08,0.03014559385746285,0.14493960849645984,0.0036268529295637453,0.024172818873432256,0.10534409842368313,0.003621603081905733,0.006243244412766469,0.05121916346654133,4.737194547137081e-08,0.037652208409397314,0.0018295384669701
27,0.5,1,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Is there a relationship between androgens and sexual desire in women? In this study, free testosterone (FT) and androstenedione showed a significant association with sexual desire, indicating a possible connection between these hormones and female libido.",0.0,0.03960841031771123,0.02854671280276816,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
27,0.5,2,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Does a correlation exist between androgens and sexual desire in women? The current research found that FT and androstenedione were statistically linked to sexual desire, suggesting these androgens may influence female libido.",9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
27,0.5,3,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Are androgens related to sexual desire in women? Findings from this study reveal that FT and androstenedione correlate significantly with sexual desire, implying a potential role of these hormones in female libido.",9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
27,0.5,4,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Is there an association between androgens and sexual desire among women? The study demonstrated that FT and androstenedione had a statistical relationship with sexual desire, indicating a possible connection to female libido.",9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
27,0.5,5,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Does sexual desire in women correlate with androgen levels? Our research showed that FT and androstenedione were significantly associated with sexual desire, suggesting these androgens might impact female libido.",1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
27,0.5,6,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Is sexual desire in women linked to androgens? The present study identified a statistical association between FT, androstenedione, and sexual desire, pointing to a potential link with female libido.",1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
27,0.5,7,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Is there a connection between androgens and female sexual desire? This study found that FT and androstenedione were statistically related to sexual desire, suggesting these hormones might play a role in female libido.",7.10579182070559e-08,0.05000374837197574,0.02854671280276816,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
27,0.5,8,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Are androgen levels connected to sexual desire in women? Results of the study indicated that FT and androstenedione correlated with sexual desire, implying a relationship with female libido.",1.894877818854824e-07,0.21990278516737272,0.02854671280276816,0.014507411718255037,0.2682639865946794,0.0,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
27,0.5,9,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Can sexual desire in women be associated with androgens? The studyâ€™s findings show a statistical association between FT, androstenedione, and sexual desire, indicating a possible link to female libido.",1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
27,0.5,10,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Is there a statistical link between androgens and sexual desire in women? The current study found that FT and androstenedione were associated with sexual desire, suggesting these androgens may influence female libido.",9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
28,0.5,1,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals pertinent and useful for practitioners and athletes? There is a lack of research focusing on diagnostic and treatment methods in sports, leading to a gap in evidence-based practice. Sports medicine journals are essential as they offer practitioners the newest research, clinical guidelines, and case studies to enhance athlete care and performance.",9.474389094274162e-08,0.07499994574745728,0.0025434730105059616,0.0072537058591274906,0.07459489795819252,0.0013226814394396783,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
28,0.5,2,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Do sports medicine journals hold relevance and applicability for practitioners and athletes? The scarcity of studies on diagnostic and treatment interventions in sports results in a gap in evidence-based practice. These journals are vital for providing practitioners with updated research, clinical guidelines, and case reports to improve athlete care and performance.",1.8948778188548325e-07,0.10061675128655345,0.03443877551020409,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
28,0.5,3,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals important and applicable to practitioners and athletes? A shortage of studies on sports-related diagnostic and treatment interventions creates a gap in evidence-based practice. Sports medicine journals serve a key role by delivering the latest research, clinical protocols, and case studies to help practitioners optimize athlete care and performance.",1.6580180914979784e-07,0.13517860874017318,0.004711578508954602,0.012693985253473108,0.13443319592494518,0.0024534048313202793,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
28,0.5,4,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Is the content of sports medicine journals relevant and practical for practitioners and athletes? Due to limited studies on diagnostic and treatment approaches in sports, there is a gap in evidence-based practice. Sports medicine journals are critical in supplying practitioners with current research, clinical guidelines, and case studies to enhance care and performance for athletes.",9.474389094274162e-08,0.07499994574745728,0.0025434730105059616,0.0072537058591274906,0.07459489795819252,0.0013226814394396783,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
28,0.5,5,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals applicable and significant for practitioners and athletes? The paucity of research addressing diagnostic and treatment interventions in sports leads to a gap in evidence-based practice. These journals provide practitioners with the latest research findings, clinical guidelines, and case studies to maximize athlete care and performance.",2.3685972735685406e-07,0.14143874580680782,0.03443877551020409,0.018134264647818726,0.16858271242063472,0.017538265306122455,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
28,0.5,6,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Do sports medicine journals offer relevant and applicable information to practitioners and athletes? There is a shortage of studies on diagnostic and treatment methods in sports, resulting in a gap in evidence-based practice. Sports medicine journals play an important role by furnishing practitioners with up-to-date research, clinical guidelines, and case studies to improve athlete care and performance.",4.737194547137081e-08,0.036798578876688914,0.0012265194143500774,0.0036268529295637453,0.036602480918583424,0.0006373176842753465,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
28,0.5,7,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals useful and relevant to practitioners and athletes? A deficiency in studies on diagnostic and treatment interventions in sports causes a gap in evidence-based practice. These journals are crucial for providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance.",2.1317375462116866e-07,0.12081945860407206,0.03443877551020409,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
28,0.5,8,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals meaningful and applicable for practitioners and athletes? The lack of studies addressing diagnostic and treatment interventions in sports creates a gap in evidence-based practice. Sports medicine journals contribute significantly by offering practitioners the latest research, clinical guidelines, and case studies to enhance athlete care and performance.",2.1317375462116866e-07,0.17740290191508779,0.006303641873227343,0.016320838183036854,0.17641043574613224,0.0032856369120758296,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
28,0.5,9,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals relevant and beneficial to practitioners and athletes? Due to insufficient studies on diagnostic and treatment interventions in sports, there is a gap in evidence-based practice. These journals are essential in delivering the latest research, clinical guidelines, and case studies to help practitioners optimize athlete care and performance.",1.8948778188548325e-07,0.10061675128655345,0.03443877551020409,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
28,0.5,10,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals pertinent and useful for practitioners and athletes? The limited number of studies on diagnostic and treatment interventions in sports leads to a gap in evidence-based practice. Sports medicine journals play a vital role by providing practitioners with current research, clinical guidelines, and case studies to improve athlete care and performance.",1.1842986367842703e-07,0.09466083792181923,0.003239040714324924,0.009067132323909363,0.09414610249387811,0.0016851103186372555,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
29,0.5,1,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Does the number of needles influence acupuncture treatment for neck pain? The effectiveness is not mainly dependent on using 5 or 10 needles. Instead, acupuncture points are selected according to the patient's unique pain pattern and cause. The practitioner's expertise plays a key role in achieving the best outcome.",1.4211583641411244e-07,0.06643880005935054,0.036982248520710054,0.010880558788691236,0.0939878144624422,0.018860946745562133,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
29,0.5,2,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","When treating neck pain with acupuncture, does the quantity of needles matter? The main factor is not whether 5 or 10 needles are used, but how acupuncture points are chosen based on the individual's pain and cause. The skill of the practitioner is essential for effective treatment.",1.8948778188548325e-07,0.10899841447814707,0.036982248520710054,0.014507411718254981,0.13747292640218056,0.018860946745562133,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
29,0.5,3,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","In acupuncture for neck pain, is the needle count significant? The effectiveness does not rely primarily on using 5 versus 10 needles. Points are picked according to the specific pain pattern and underlying reasons, and the practitioner's proficiency is vital for success.",3.079176455639103e-07,0.22406774426293374,0.036982248520710054,0.023574544042164344,0.25525596205856393,0.018860946745562133,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
29,0.5,4,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Does using more needles improve acupuncture treatment for neck pain? Whether 5 or 10 needles are used, this is not the key to effectiveness. Instead, points are carefully selected based on the patient's pain pattern and cause, with the practitioner's experience being crucial.",2.8423167282822487e-07,0.19997019268387373,0.036982248520710054,0.02176111757738247,0.23056334946819224,0.018860946745562133,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
29,0.5,5,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Is the number of needles important in acupuncture for neck pain? The treatment's success doesn't mainly depend on using 5 or 10 needles, but on selecting points tailored to the individual's pain and cause. The practitioner's skill is critical.",3.789755637709663e-07,0.30005365124085515,0.036982248520710054,0.029014823436509962,0.3332175035282745,0.018860946745562133,0.028972824655245866,0.3677247801253176,0.0,3.789755637709665e-07,0.37647757123491177,0.0
29,0.5,6,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Regarding acupuncture for neck pain, does needle quantity affect results? The number of needles, 5 or 10, is not the main factor. Points are chosen based on the person's specific pain and underlying cause, with the practitioner's expertise essential for optimal results.",3.079176455639103e-07,0.22406774426293374,0.036982248520710054,0.023574544042164344,0.25525596205856393,0.018860946745562133,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
29,0.5,7,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","For neck pain acupuncture, does the number of needles used matter? The effectiveness isn't primarily determined by using 5 or 10 needles, but by selecting acupuncture points based on the patient's pain pattern and cause. Practitioner skill is key to success.",3.316036182995957e-07,0.24876035685330544,0.036982248520710054,0.025387970506946217,0.28057377004285566,0.018860946745562133,0.025351221573340132,0.31365755885504143,0.0,3.316036182995957e-07,0.3209077200800996,0.0
29,0.5,8,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","In acupuncture treatment for neck pain, is the needle count a major factor? The difference between 5 or 10 needles isn't the primary concern. The points are selected based on the individual's pain and cause, and the practitioner's experience is crucial.",3.316036182995957e-07,0.24876035685330544,0.036982248520710054,0.025387970506946217,0.28057377004285566,0.018860946745562133,0.025351221573340132,0.31365755885504143,0.0,3.316036182995957e-07,0.3209077200800996,0.0
29,0.5,9,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Does the number of needles impact acupuncture effectiveness for neck pain? Using 5 or 10 needles is not the main factor; rather, points are chosen according to the patient's specific pain and cause, with the practitioner's skill being vital.",3.789755637709663e-07,0.30005365124085515,0.036982248520710054,0.029014823436509962,0.3332175035282745,0.018860946745562133,0.028972824655245866,0.3677247801253176,0.0,3.789755637709665e-07,0.37647757123491177,0.0
29,0.5,10,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","When using acupuncture to treat neck pain, does the number of needles affect outcomes? The key factor is not the count of needles but the strategic selection of points based on the pain pattern and cause, alongside the practitioner's expertise.",3.55289591035281e-07,0.3096241740970811,0.0113589798226491,0.02720139697172809,0.30654925644611364,0.018860946745562133,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
30,0.5,1,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are we adhering to guidelines when preparing high-fall-risk patients for discharge after rehabilitation? Answer: Evidence shows minimal systematic falls risk assessments for high-risk individuals during rehab. When risks were found, strategies were usually applied. However, failure to",2.8423167282822456e-07,0.16773549884436934,0.08098765432098766,0.02176111757738247,0.20103867488178784,0.06222222222222222,0.0217296184914344,0.2358082908112875,0.04246913580246913,2.8423167282822487e-07,0.272144037935544,0.021728395061728398
30,0.5,2,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we follow guidelines in readying patients at high risk of falls for discharge post-rehabilitation? Answer: There is scant evidence that systematic falls risk assessments occur for high-risk patients during rehabilitation. When risks are detected, a strategy is typically put in place. However, failure to",9.474389094274162e-08,0.02800907828172461,0.08098765432098766,0.0072537058591274906,0.00036797941963628844,0.06222222222222222,0.007243206163811466,0.029956236607138642,0.04246913580246913,9.474389094274162e-08,0.06083494426833802,0.021728395061728398
30,0.5,3,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Is the preparation of patients at high fall risk for discharge after rehabilitation aligned with guidelines? Answer: Little evidence exists that systematic falls risk assessments are conducted during rehabilitation for high-risk patients. When risks are identified, strategies are generally implemented. However, failure to",1.4211583641411244e-07,0.01745329579503263,0.08098765432098766,0.010880558788691236,0.04688799505453023,0.06222222222222222,0.0108648092457172,0.07758428559639308,0.04246913580246913,1.4211583641411244e-07,0.10962510843776974,0.021728395061728398
30,0.5,4,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are guidelines met when preparing high-fall-risk patients for discharge following rehabilitation? Answer: There is limited evidence that systematic falls risk assessment is performed during rehabilitation for those at high risk. When risks are recognized, strategies tend to be applied. However, failure to",1.6580180914979784e-07,0.04098379320522705,0.08098765432098766,0.012693985253473108,0.07098554663359025,0.06222222222222222,0.012675610786670066,0.10227689818676478,0.04246913580246913,1.6580180914979784e-07,0.13494291642206147,0.021728395061728398
30,0.5,5,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: How well do we meet guidelines in preparing patients at high risk of falls for discharge after rehabilitation? Answer: Evidence is scarce that patients at high fall risk undergo systematic risk assessments during rehabilitation. When risks are found, strategies are usually enacted. However, failure to",9.474389094274162e-08,0.033604004434714785,0.03663935794456798,0.0072537058591274906,0.03187466944508888,0.03950724115137311,0.007243206163811466,0.029956236607138642,0.04246913580246913,9.474389094274162e-08,0.06083494426833802,0.021728395061728398
30,0.5,6,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: When discharging high-fall-risk patients after rehabilitation, do we comply with guidelines? Answer: There is little evidence that systematic falls risk assessments are conducted during rehab for high-risk patients. When risks are identified, a strategy is generally implemented. However, failure to",2.1317375462116866e-07,0.08977395737465876,0.08098765432098766,0.016320838183036854,0.12099596720825367,0.06222222222222222,0.0162972138685758,0.15357019257431448,0.04246913580246913,2.1317375462116866e-07,0.1875866499074803,0.021728395061728398
30,0.5,7,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we meet the guidelines in preparing patients at high risk of falls for discharge post-rehabilitation? Answer: Evidence suggests minimal systematic falls risk assessment during rehabilitation for high-risk individuals. When a risk is detected, a strategy is usually put in place. However, failure to",1.1842986367842703e-07,0.005536222429666893,0.08098765432098766,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
30,0.5,8,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are patients at high risk of falls properly prepared for discharge after rehabilitation according to guidelines? Answer: There is little evidence of systematic falls risk assessment during rehabilitation for high-risk patients. When risks are identified, strategies are generally implemented. However, failure to",1.6580180914979784e-07,0.04098379320522705,0.08098765432098766,0.012693985253473108,0.07098554663359025,0.06222222222222222,0.012675610786670066,0.10227689818676478,0.04246913580246913,1.6580180914979784e-07,0.13494291642206147,0.021728395061728398
30,0.5,9,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Is the discharge preparation for patients at high fall risk after rehabilitation guideline-compliant? Answer: Evidence indicates that systematic falls risk assessment during rehabilitation is rare for high-risk patients. When risks are found, strategies are typically applied. However, failure to",2.3685972735685396e-07,0.11509176535895049,0.08098765432098766,0.018134264647818726,0.14697145361151165,0.06222222222222222,0.018108015409528666,0.18023843965647535,0.04246913580246913,2.3685972735685406e-07,0.21498562409559563,0.021728395061728398
30,0.5,10,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we follow recommended guidelines in preparing high-fall-risk patients for discharge after rehabilitation? Answer: There is limited evidence that systematic falls risk assessments occur during rehabilitation for those at high risk. When risks are detected, strategies are generally put in place. However, failure to",1.1842986367842703e-07,0.005536222429666893,0.08098765432098766,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
31,0.5,1,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Do symptoms influence the selection of patients for phase I clinical trials? Older adults with more symptoms participating in PICT might trade off Quality of Life (QOL) for access to experimental treatments, raising ethical issues about exploiting vulnerable groups and emphasizing the importance of thorough informed consent and patient-focused trial design.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
31,0.5,2,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Are symptoms important when choosing patients for phase I clinical trials? Older adults enrolled in PICT who have more symptoms may compromise their Quality of Life (QOL) to gain access to experimental treatments, which poses ethical concerns regarding the exploitation of vulnerable populations and underlines the need for strong informed consent and patient-centered trial protocols.",4.737194547137081e-08,0.03774032798284743,0.0,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
31,0.5,3,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","When considering patients for phase I clinical trials, do symptoms matter? Older adults with more symptoms in PICT might sacrifice their Quality of Life (QOL) to access experimental therapies, raising ethical questions about exploiting vulnerable individuals and highlighting the necessity for comprehensive informed consent and patient-focused trial design.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
31,0.5,4,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Is symptom presence significant in selecting patients for phase I clinical trials? Older adults enrolled in PICT who experience more symptoms may give up some Quality of Life (QOL) to receive experimental treatments, which raises ethical concerns about potential exploitation and stresses the need for robust informed consent and patient-centered trial frameworks.",2.3685972735685406e-08,0.019418085857102696,0.0,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
31,0.5,5,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Does symptom severity affect patient eligibility for phase I clinical trials? Older adults with numerous symptoms in PICT may sacrifice their Quality of Life (QOL) for experimental treatment access, prompting ethical concerns about exploiting vulnerable populations and emphasizing the importance of thorough informed consent and patient-centered trial design.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
31,0.5,6,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Are symptoms a factor when considering patients for phase I clinical trials? Older adults enrolled in PICT with more symptoms might compromise their Quality of Life (QOL) to obtain experimental treatments, raising ethical issues about the exploitation of vulnerable groups and highlighting the need for strong informed consent procedures and patient-centered trial designs.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
31,0.5,7,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Do symptoms play a role in selecting patients for phase I clinical trials? Older adults in PICT who have more symptoms may trade off Quality of Life (QOL) to access experimental therapies, which raises ethical concerns about exploiting vulnerable populations and underscores the importance of robust informed consent and patient-focused trial design.",2.3685972735685406e-08,0.019418085857102696,0.0,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
31,0.5,8,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Is symptom burden relevant when enrolling patients in phase I clinical trials? Older adults with more symptoms in PICT might sacrifice their Quality of Life (QOL) to receive experimental treatments, raising ethical questions about potential exploitation of vulnerable individuals and stressing the need for comprehensive informed consent and patient-centered trial design.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
31,0.5,9,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","When selecting patients for phase I clinical trials, do symptoms matter? Older adults enrolled in PICT who experience more symptoms may give up Quality of Life (QOL) for access to experimental treatments, which raises ethical concerns about exploitation and highlights the necessity for robust informed consent and patient-focused trial protocols.",7.105791820705622e-08,0.05942342047080107,0.0,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
31,0.5,10,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Are symptoms significant when considering patients for phase I clinical trials? Older adults with more symptoms in PICT may compromise their Quality of Life (QOL) to gain access to experimental treatments, prompting ethical concerns about the exploitation of vulnerable populations and underscoring the need for thorough informed consent and patient-centered trial designs.",2.3685972735685406e-08,0.019418085857102696,0.0,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
32,0.5,1,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgery might enhance blood lipid profiles in OSA patients, particularly those with dyslipidemia before surgery, possibly offering significant metabolic and cardiovascular advantages. Further prospective research is needed to confirm this.",4.737194547137081e-08,0.07950674446691508,0.09,0.0036268529295637453,0.016850758504693975,0.046400951814396206,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
32,0.5,2,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can airway surgery decrease serum lipid levels in obstructive sleep apnea patients? Surgical intervention may improve lipid levels in the blood of OSA patients, especially those who have dyslipidemia prior to surgery, potentially providing important metabolic and cardiovascular benefits. Prospective studies should investigate this.",2.3685972735685406e-08,0.03855843438316109,0.04359904818560379,0.0018134264647818726,0.007941301485662411,0.02260559190957765,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
32,0.5,3,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is there a reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients? Surgery could lead to improved blood lipid levels in OSA patients, notably in those with preexisting dyslipidemia, which might result in substantial metabolic and cardiovascular improvements. This warrants further prospective study.",4.737194547137081e-08,0.1403416887352531,0.0682716049382716,0.0036268529295637453,0.10994118157070565,0.046400951814396206,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
32,0.5,4,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does performing airway surgery lower serum lipid levels among patients with obstructive sleep apnea? It is possible that surgery improves blood lipid levels in OSA patients, particularly those with preoperative dyslipidemia, potentially offering major benefits in metabolism and cardiovascular outcomes. Prospective studies are recommended.",2.3685972735685406e-08,0.0707978381301353,0.06675736961451248,0.0018134264647818726,0.04094831008375399,0.046400951814396206,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
32,0.5,5,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can surgery on the airway reduce serum lipid levels in obstructive sleep apnea patients? Airway surgery may enhance blood lipid profiles in patients with OSA, especially if they have dyslipidemia before surgery, which might produce significant metabolic and cardiovascular benefits. This should be examined in prospective studies.",4.737194547137081e-08,0.17047852267264174,0.09,0.0036268529295637453,0.10994118157070565,0.046400951814396206,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
32,0.5,6,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery have an effect on lowering serum lipid levels in patients suffering from obstructive sleep apnea? Surgery may help improve blood lipid levels in OSA patients, particularly those with preoperative dyslipidemia, potentially leading to important metabolic and cardiovascular benefits. Prospective studies should explore this.",2.3685972735685406e-08,0.08688653323742734,0.045651703623580314,0.0018134264647818726,0.055961635693195344,0.023685970743547096,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
32,0.5,7,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is serum lipid level reduction observed after airway surgery in obstructive sleep apnea patients? Airway surgery might improve lipid levels in the blood of OSA patients, especially those with dyslipidemia prior to the procedure, possibly resulting in major metabolic and cardiovascular advantages. Further prospective studies are necessary.",4.737194547137081e-08,0.1403416887352531,0.0682716049382716,0.0036268529295637453,0.10994118157070565,0.046400951814396206,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
32,0.5,8,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery contribute to lowering serum lipid levels in patients with obstructive sleep apnea? Surgery could improve blood lipid levels in OSA patients, particularly those with preoperative dyslipidemia, potentially providing significant metabolic and cardiovascular benefits. This should be further studied in prospective research.",2.3685972735685406e-08,0.03855843438316109,0.04359904818560379,0.0018134264647818726,0.007941301485662411,0.02260559190957765,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
32,0.5,9,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can airway surgery lead to decreased serum lipid levels in obstructive sleep apnea patients? Surgical treatment might enhance lipid profiles in OSA patients, especially in those with dyslipidemia before surgery, potentially yielding important metabolic and cardiovascular improvements. This requires investigation through prospective studies.",4.737194547137081e-08,0.07950674446691508,0.09,0.0036268529295637453,0.016850758504693975,0.046400951814396206,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
32,0.5,10,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is there evidence that airway surgery lowers serum lipid levels in obstructive sleep apnea patients? Surgery may improve blood lipid levels in patients with OSA, especially those with preoperative dyslipidemia, potentially offering major metabolic and cardiovascular benefits. Prospective studies should be conducted to examine this.",0.0,0.06301338005090429,0.0446485260770975,0.0,0.032239403746974205,0.023158321428908682,0.0,0.0,0.0,0.0,0.0,0.0
33,0.5,1,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerised tomography a viable substitute for bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our results indicate that routine bone scintigraphy for patients with metastatic breast cancer is unnecessary if CT scans of the thorax, abdomen, and pelvis are conducted.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.5,2,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans replace bone scintigraphy in detecting bone metastases in breast cancer patients? Answer: Our findings suggest that routine bone scintigraphy is not needed when CT imaging of the thorax, abdomen, and pelvis is performed in patients with metastatic breast cancer.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.5,3,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it possible to use computerised tomography instead of bone scintigraphy for detecting bone metastases from breast cancer? Answer: The data indicates that routine bone scintigraphy is not required if thorax, abdomen, and pelvis CT scans are done for patients with metastatic breast cancer.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,0.5,4,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can bone scintigraphy be replaced by computerised tomography in the detection of bone metastases from breast cancer? Answer: Our study suggests that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are performed.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,0.5,5,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Does computerised tomography serve as an alternative to bone scintigraphy for identifying bone metastases in breast cancer? Answer: Findings imply that routine bone scintigraphy is not needed in metastatic breast cancer patients undergoing CT of the thorax, abdomen, and pelvis.",1.184298636784265e-07,0.09887403359652636,0.02498356344510192,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
33,0.5,6,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT imaging replace bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Our evidence suggests that routine bone scintigraphy is redundant if CT scans of the thorax, abdomen, and pelvis are carried out in metastatic breast cancer patients.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.5,7,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerised tomography sufficient to substitute bone scintigraphy for detecting bone metastases in breast cancer? Answer: Results show that routine bone scintigraphy is not necessary when CT of the thorax, abdomen, and pelvis is performed in patients with metastatic breast cancer.",1.421158364141119e-07,0.12441194762660457,0.024375,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,0.5,8,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can bone scintigraphy be omitted in favor of computerised tomography for detecting bone metastases in breast cancer? Answer: Our findings indicate that routine bone scintigraphy is not required if CT scans covering thorax, abdomen, and pelvis are done in metastatic breast cancer cases.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.5,9,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is CT a feasible replacement for bone scintigraphy in the detection of bone metastases from breast cancer? Answer: The findings suggest that routine bone scintigraphy is unnecessary for metastatic breast cancer patients if CT of the thorax, abdomen, and pelvis is performed.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.5,10,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerised tomography fully replace bone scintigraphy in identifying bone metastases from breast cancer? Answer: According to our findings, routine bone scintigraphy is not required when CT scans of the thorax, abdomen, and pelvis are utilized in patients with metastatic breast cancer.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
34,0.5,1,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain considered a clinically important issue in general adult psychiatry? We discovered that pain can indeed be a major clinical concern for psychiatric patients who have an elevated risk of chronic pain disorders, likely because these patients often experience higher rates of depression, anxiety, and substance abuse.",1.4211583641411244e-07,0.0939878144624422,0.018860946745562133,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
34,0.5,2,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Does pain represent a clinically relevant problem in general adult psychiatry? Evidence suggests that pain is a significant clinical issue among psychiatric patients prone to chronic pain conditions, probably due to the increased occurrence of depression, anxiety, and substance abuse in this group.",2.6054570009253947e-07,0.20646579788913222,0.018860946745562133,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
34,0.5,3,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a noteworthy clinical problem within general adult psychiatry? Our findings indicate that pain can be a critical clinical issue for psychiatric patients who are more susceptible to chronic pain, likely because of the higher prevalence of depression, anxiety, and substance abuse among them.",2.1317375462116866e-07,0.15994578225423828,0.018860946745562133,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
34,0.5,4,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a clinically significant problem in the field of general adult psychiatry? Research shows that pain may be a substantial clinical challenge in psychiatric patients who face a greater risk of chronic pain conditions, which is probably linked to the higher rates of depression, anxiety, and substance abuse in these individuals.",4.737194547137081e-08,0.012309783448174905,0.018860946745562133,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
34,0.5,5,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Can pain be considered a clinically relevant issue in general adult psychiatry? We found that pain is often a major clinical problem in psychiatric patients at increased risk for chronic pain, likely due to the common co-occurrence of depression, anxiety, and substance abuse.",2.6054570009253947e-07,0.20646579788913222,0.018860946745562133,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
34,0.5,6,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a clinically pertinent problem in general adult psychiatry? Evidence reveals that pain can be a significant clinical concern among psychiatric patients who have a higher likelihood of chronic pain conditions, possibly because these patients frequently suffer from depression, anxiety, and substance abuse.",2.3685972735685406e-07,0.1829353004789378,0.018860946745562133,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
34,0.5,7,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a relevant clinical problem in general adult psychiatry? Our study found that pain may be a significant clinical issue in psychiatric patients with an increased risk for chronic pain, probably because of the greater prevalence of depression, anxiety, and substance abuse in this population.",1.8948778188548325e-07,0.13747292640218056,0.018860946745562133,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
34,0.5,8,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Does pain pose a clinically relevant problem in general adult psychiatry? Findings suggest that pain is a notable clinical problem in psychiatric patients who are more vulnerable to chronic pain conditions, likely due to the higher incidence of depression, anxiety, and substance abuse.",2.6054570009253947e-07,0.2394728064872238,0.004934413159256423,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
34,0.5,9,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a clinically important issue in general adult psychiatry? We observed that pain can be a major clinical problem in psychiatric patients at elevated risk for chronic pain, likely because these patients have a higher prevalence of depression, anxiety, and substance abuse.",2.6054570009253947e-07,0.20646579788913222,0.018860946745562133,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
34,0.5,10,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain recognized as a clinically relevant problem in general adult psychiatry? Evidence indicates that pain is a significant clinical challenge in psychiatric patients who are at increased risk for chronic pain, likely due to the common presence of depression, anxiety, and substance abuse.",2.3685972735685406e-07,0.1829353004789378,0.018860946745562133,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
35,0.5,1,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.5,2,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Do preoperative statins lower the risk of atrial fibrillation following coronary artery bypass grafting? Our research suggests that using statins before surgery may decrease the incidence of AF after CABG.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
35,0.5,3,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,"Is there a reduction in atrial fibrillation after coronary artery bypass grafting with preoperative statin use? According to our findings, preoperative statin treatment appears to lessen AF occurrence post-CABG.",4.73719454713706e-08,0.02459745925658252,0.035665294924554176,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.5,4,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Can preoperative statins help prevent atrial fibrillation after coronary artery bypass grafting? Our study shows that pre-surgery statin therapy likely reduces AF development following CABG.,4.73719454713706e-08,0.08004270767353727,0.0,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
35,0.5,5,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Do statins administered before coronary artery bypass grafting reduce the chance of atrial fibrillation? Our results indicate that preoperative statin use is associated with a lower risk of AF after CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,0.5,6,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Does taking statins before coronary artery bypass grafting reduce atrial fibrillation? Our investigation revealed that preoperative statin therapy seems to diminish AF incidence post-CABG.,7.10579182070559e-08,0.1226023220923329,0.0,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
35,0.5,7,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Are preoperative statins effective in decreasing atrial fibrillation after coronary artery bypass grafting? Our study found that statin therapy prior to surgery appears to reduce AF development after CABG.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.5,8,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Do preoperative statins have an impact on atrial fibrillation rates after coronary artery bypass grafting? Our research suggests that statin therapy before CABG may reduce the occurrence of AF.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.5,9,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Is atrial fibrillation less common after coronary artery bypass grafting when preoperative statins are used? Our study indicates that preoperative statin treatment might lower AF development following CABG.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.5,10,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Does preoperative statin therapy reduce the incidence of atrial fibrillation after coronary artery bypass grafting? Our findings suggest that using statins before CABG helps in reducing AF occurrence.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
36,0.5,1,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals pertinent and useful for practitioners and athletes? There is a shortage of research on diagnostic and treatment methods in sports medicine literature. The evidence supporting sports medicine needs to grow in both quantity and quality.,1.4211583641411222e-07,0.15843063997897167,0.015054169816074561,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.5,2,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals hold relevance and applicability for practitioners and athletes? Few studies focus on diagnostic and treatment interventions within sports medicine literature. The foundation of evidence in sports medicine must expand in volume and quality.,1.8948778188548283e-07,0.2173163361995467,0.02121632966912254,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.5,3,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals valuable and applicable to both practitioners and athletes? The sports medicine literature lacks sufficient studies on diagnostic and treatment interventions. It is essential for the evidence base in sports medicine to increase in both amount and quality.,9.474389094274162e-08,0.10280071813615255,0.00952255325029372,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
36,0.5,4,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and relevant to practitioners and athletes? There is a scarcity of research addressing diagnostic and treatment interventions in sports medicine literature. The evidence supporting sports medicine should continue to improve in volume and quality.,1.4211583641411222e-07,0.15843063997897167,0.015054169816074561,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.5,5,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals important and useful for practitioners and athletes? The literature in sports medicine shows a deficiency in studies on diagnostic and treatment interventions. The evidence base in sports medicine must grow in both quantity and quality.,1.4211583641411222e-07,0.19491207053475845,0.042539682539682544,0.010880558788691236,0.18774961821473912,0.027006172839506164,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.5,6,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and beneficial to practitioners and athletes? There is a lack of studies focusing on diagnostic and treatment interventions in sports medicine literature. The evidence base for sports medicine needs to increase in both volume and quality.,9.474389094274162e-08,0.10280071813615255,0.00952255325029372,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
36,0.5,7,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and significant for practitioners and athletes? The sports medicine literature has limited studies on diagnostic and treatment interventions. The evidence base must expand in terms of volume and quality.,2.605457000925387e-07,0.25478560916743653,0.0626970840419501,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
36,0.5,8,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals meaningful and practical for practitioners and athletes? There is a shortage of research on diagnostic and treatment interventions within sports medicine literature. The evidence supporting sports medicine should continue to grow in both quantity and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.5,9,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and useful to practitioners and athletes? There is a deficiency of studies addressing diagnostic and treatment interventions in sports medicine literature. The evidence base in sports medicine must continue to increase in volume and quality.,1.1842986367842692e-07,0.1657772513196747,0.03897392290249441,0.009067132323909363,0.16009538652296218,0.026296566837107373,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.5,10,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and valuable to practitioners and athletes? The sports medicine literature lacks sufficient studies on diagnostic and treatment interventions. The evidence base must grow in volume and quality.,3.0791764556390933e-07,0.3200162190541853,0.060748299319727896,0.02357454404216438,0.36000273403140737,0.0,0.023540420032387308,0.3703737882968947,0.0,3.079176455639103e-07,0.3813675565291037,0.0
37,0.5,1,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? This study demonstrated for the first time that RALP causes less tissue trauma than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.5,2,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy result in less invasiveness than retropubic radical prostatectomy? The study revealed that RALP leads to reduced tissue trauma compared to RRP for the first time.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.5,3,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,"Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? According to this study, RALP produces less tissue trauma than RRP, marking a first-time finding.",4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.5,4,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,"Is robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? This research found that RALP causes less tissue damage than RRP, a novel discovery.",2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.5,5,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy cause less tissue trauma than retropubic radical prostatectomy? This study showed for the first time that RALP is less invasive than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.5,6,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy associated with reduced invasiveness relative to retropubic radical prostatectomy? This study demonstrated that RALP results in lower tissue trauma than RRP for the first time.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.5,7,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP less invasive than RRP? The study provided first evidence that robotically assisted laparoscopic radical prostatectomy induces less tissue trauma than retropubic radical prostatectomy.,9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
37,0.5,8,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the robotically assisted laparoscopic radical prostatectomy procedure less invasive than retropubic radical prostatectomy? This study revealed for the first time that RALP causes less tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,0.5,9,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy produce less tissue trauma than retropubic radical prostatectomy? This study showed for the first time that RALP is less invasive than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.5,10,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than retropubic radical prostatectomy? This study found that RALP induces less tissue trauma than RRP for the first time.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
38,0.5,1,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the optimal duration of acid suppression for maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: Following 4 weeks of acid-suppressive treatment for LA grade C or D oesophagitis, healing seems to plateau, with further increases in intragastric pH>4 hours not yielding significant additional improvement.",2.8423167282822487e-07,0.21511137961694615,0.0,0.02176111757738247,0.21905356606268356,0.0,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
38,0.5,2,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there an ideal acid suppression time for best healing outcomes in Los Angeles grade C and D reflux oesophagitis? Answer: After 4 weeks of acid suppression therapy in LA grade C or D oesophagitis, healing reaches a limit beyond which more hours of intragastric pH>4 do not significantly enhance recovery.",2.6054570009253947e-07,0.24967323707056588,0.039150354019158694,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
38,0.5,3,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What duration of acid suppression optimizes healing in Los Angeles grades C and D reflux oesophagitis? Answer: Successful healing in LA grade C or D oesophagitis plateaus after 4 weeks of acid-suppressive therapy, with no notable gains despite increased intragastric pH>4 duration.",4.737194547137081e-07,0.4224717753598153,0.023795359904818555,0.03626852929563745,0.3973017974690025,0.0,0.03621603081905733,0.4054651081081633,0.0,4.737194547137081e-07,0.4139757977760743,0.0
38,0.5,4,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: How long should acid suppression be administered for maximal healing in Los Angeles grade C and D reflux oesophagitis? Answer: Four weeks of acid-suppressive therapy appears sufficient for LA grade C or D oesophagitis, as healing improvements plateau despite longer periods with intragastric pH>4.",4.263475092423373e-07,0.37445144115228235,0.02271498107084911,0.03264167636607371,0.3496737484797481,0.0,0.0325944277371516,0.35667494393873156,0.0,4.263475092423373e-07,0.36396537720141087,0.0
38,0.5,5,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there a maximum effective acid suppression period for healing Los Angeles grade C and D reflux oesophagitis? Answer: Healing in LA grade C or D oesophagitis seems to reach a threshold after 4 weeks of acid suppression, beyond which additional intragastric pH>4 hours offer limited benefit.",3.552895910352811e-07,0.30648240803971216,0.0212665406427221,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,0.5,6,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the optimal acid suppression duration for healing in Los Angeles grades C and D reflux oesophagitis? Answer: After 4 weeks of acid-suppressive therapy, healing of LA grade C or D oesophagitis plateaus, with no further significant improvement despite increased intragastric pH>4 time.",4.263475092423373e-07,0.34294475112682976,0.0,0.03264167636607371,0.3496737484797481,0.0,0.0325944277371516,0.35667494393873156,0.0,4.263475092423373e-07,0.36396537720141087,0.0
38,0.5,7,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Does maximal healing of Los Angeles grade C and D reflux oesophagitis require a specific acid suppression time? Answer: Four weeks of acid suppression therapy achieves near-maximal healing in LA grade C or D oesophagitis, with further increases in intragastric pH>4 hours yielding minimal additional benefit.",3.789755637709665e-07,0.35876665643077477,0.04338842975206612,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
38,0.5,8,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: How does the duration of acid suppression affect healing in Los Angeles grade C and D reflux oesophagitis? Answer: Healing seems to reach a ceiling after 4 weeks of acid-suppressive therapy for LA grade C or D oesophagitis, with extra hours of intragastric pH>4 not significantly improving outcomes.",3.316036182995957e-07,0.2848145066605312,0.020823902218198284,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
38,0.5,9,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there an optimal acid suppression timeframe for maximal healing of Los Angeles grade C and D reflux oesophagitis? Answer: After 4 weeks of acid suppression, healing in LA grade C or D oesophagitis plateaus, and further increases in intragastric pH>4 duration do not produce substantial additional healing.",3.316036182995957e-07,0.2848145066605312,0.020823902218198284,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
38,0.5,10,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the ideal period of acid suppression for healing Los Angeles grade C and D reflux oesophagitis? Answer: Successful healing in LA grade C or D oesophagitis seems to plateau after 4 weeks of acid-suppressive therapy, with no significant gains despite longer intragastric pH>4 exposure.",3.789755637709665e-07,0.3286298224933857,0.021728395061728398,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
39,0.5,1,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Does viral infection contribute to benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, especially in spring and autumn. Viral infections may trigger BPPV attacks by causing vestibulopathy or lead to secondary BPPV through neurolabyrinthitis linked to viral infection.",2.8423167282822477e-07,0.26826398659468076,0.0,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
39,0.5,2,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a role for viral infections in benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, particularly in spring and autumn months. Viral infections might provoke BPPV episodes by inducing vestibulopathy or cause secondary BPPV via viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.5,3,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections influence benign paroxysmal positional vertigo? Positive viral serology is associated with BPPV, mainly during spring and autumn. Viral infections could facilitate BPPV attacks by developing vestibulopathy or cause secondary BPPV through neurolabyrinthitis related to viral infection.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.5,4,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections involved in benign paroxysmal positional vertigo? BPPV shows a connection with positive viral serology, especially in spring and autumn seasons. Viral infections might trigger BPPV by causing vestibulopathy or lead to secondary BPPV through viral neurolabyrinthitis.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.5,5,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Can viral infections play a part in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, notably during spring and autumn. Viral infection might initiate BPPV attacks via vestibulopathy or cause secondary BPPV due to viral neurolabyrinthitis.",3.0791764556391007e-07,0.29423947299793873,0.0,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.5,6,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there an association between viral infections and benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, particularly in spring and autumn months. Viral infections may promote BPPV attacks by inducing vestibulopathy or secondary BPPV through viral neurolabyrinthitis.",2.8423167282822477e-07,0.3038099958541647,0.025623268698060954,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
39,0.5,7,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",Do viral infections have a connection with benign paroxysmal positional vertigo? BPPV correlates with positive viral serology mainly in spring and autumn. Viral infections might cause BPPV attacks by vestibulopathy development or secondary BPPV via viral neurolabyrinthitis.,3.5528959103528067e-07,0.38681487096598977,0.02775510204081633,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,0.5,8,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections a factor in benign paroxysmal positional vertigo? Positive viral serology is associated with BPPV, especially in spring and autumn. Viral infection could trigger BPPV through vestibulopathy or secondary BPPV via viral neurolabyrinthitis.",4.0266153650665127e-07,0.4054651081081633,0.0,0.03082824990129185,0.4155154439616653,0.0,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
39,0.5,9,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Might viral infections contribute to benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, mainly during spring and autumn. Viral infections could provoke BPPV attacks by causing vestibulopathy or induce secondary BPPV through viral neurolabyrinthitis.",3.5528959103528067e-07,0.38681487096598977,0.02775510204081633,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,0.5,10,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",Could viral infections be involved in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology particularly in spring and autumn months. Viral infection might promote BPPV attacks by developing vestibulopathy or cause secondary BPPV via viral neurolabyrinthitis.,3.0791764556391007e-07,0.29423947299793873,0.0,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
40,0.5,1,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness impact microvascular function in healthy adults at risk for Type 2 diabetes? In this at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. Nevertheless, within the at-risk group, those with greater aerobic fitness showed improved microvascular and endothelial responsiveness.",1.6580180914979784e-07,0.1434837353305185,0.005276046948742272,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
40,0.5,2,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is microvascular function in healthy adults at risk of Type 2 diabetes affected by aerobic fitness? Among this at-risk population with skin microvascular dysfunction, maximal oxygen uptake did not differ from healthy controls. Yet, within this group, individuals with higher aerobic fitness had enhanced microvascular and endothelial function.",1.8948778188548325e-07,0.10677487948168984,0.03631185475258099,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.5,3,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults at risk of developing Type 2 diabetes? In the at-risk group exhibiting skin microvascular dysfunction, maximal oxygen uptake was comparable to healthy controls. However, those at risk with higher aerobic fitness demonstrated better microvascular and endothelial responsiveness.",2.3685972735685406e-07,0.2118730741378676,0.008036441623838701,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
40,0.5,4,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness influence microvascular function in healthy adults at risk for Type 2 diabetes? Maximal oxygen uptake was not decreased in this at-risk group with skin microvascular dysfunction compared to healthy controls. Still, within the at-risk group, higher aerobic fitness correlated with improved microvascular and endothelial responsiveness.",1.8948778188548325e-07,0.13627050418636832,0.015045314109858886,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.5,5,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there an effect of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes? In the group at risk with skin microvascular dysfunction, maximal oxygen uptake was similar to that of healthy controls. However, among these individuals, those with greater aerobic fitness had superior microvascular and endothelial responsiveness.",7.105791820705622e-08,0.05899777649954663,0.0020881452474190224,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
40,0.5,6,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness have an impact on microvascular function in healthy adults at risk for Type 2 diabetes? Maximal oxygen uptake was not diminished in the at-risk group with skin microvascular dysfunction compared to healthy controls. Yet, within this group, individuals with higher aerobic fitness exhibited better microvascular and endothelial responsiveness.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.5,7,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness relate to microvascular function in healthy adults at risk of developing Type 2 diabetes? This at-risk group with skin microvascular dysfunction showed no reduction in maximal oxygen uptake versus healthy controls. Nonetheless, those with higher aerobic fitness within this group had enhanced microvascular and endothelial responsiveness.",1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
40,0.5,8,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness modify microvascular function in healthy adults at risk for Type 2 diabetes? In this at-risk population with skin microvascular dysfunction, maximal oxygen uptake remained unchanged relative to healthy controls. However, higher aerobic fitness within this group was associated with improved microvascular and endothelial function.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.5,9,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is aerobic fitness linked to microvascular function in healthy adults at risk of Type 2 diabetes? Maximal oxygen uptake was not lowered in the at-risk group with skin microvascular dysfunction compared to healthy controls. Still, individuals with higher aerobic fitness in this group showed better microvascular and endothelial responsiveness.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
40,0.5,10,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness correlate with microvascular function in healthy adults at risk of developing Type 2 diabetes? In this at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not reduced compared to healthy controls. However, those with higher aerobic fitness within the group demonstrated improved microvascular and endothelial responsiveness.",1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
41,0.5,1,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates",Our findings indicate that UHR intake criteria forecast transition to psychosis within 6 months in this sequence: Trait alone<APS<BLIPS.,1.0895547458415266e-06,1.24685047607101,0.015621063240110858,0.08341761737996627,1.309921382335319,0.0,0.08329687088383199,1.3545456628053105,0.0,1.0895547458415283e-06,1.4028236630711,0.0
41,0.5,2,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The data imply that among UHR criteria, the risk of transition to psychosis over 6 months ranks as Trait alone<APS<BLIPS.",1.0658687731058412e-06,1.1927832548007347,0.015621063240110858,0.0816041909151844,1.2527629684953703,0.0,0.08148606934287912,1.2939210409888755,0.0,1.065868773105843e-06,1.3382851419335293,0.0
41,0.5,3,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","According to our results, the likelihood of psychosis transition in UHR patients over 6 months follows the order Trait alone<APS<BLIPS.",1.0658687731058412e-06,1.1927832548007347,0.015621063240110858,0.0816041909151844,1.2527629684953703,0.0,0.08148606934287912,1.2939210409888755,0.0,1.065868773105843e-06,1.3382851419335293,0.0
41,0.5,4,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates",UHR intake criteria appear to predict psychosis transition risk over 6 months in the hierarchy Trait alone<APS<BLIPS.,1.1369266913128972e-06,1.3646335117273938,0.015621063240110858,0.08704447030953001,1.4350845252893247,0.0,0.08691847396573774,1.4880770554298333,0.0,1.136926691312899e-06,1.5459245067117733,0.0
41,0.5,5,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The evidence suggests that BLIPS patients have the highest short-term risk of psychosis transition, supporting the 'early' versus 'late' prodrome hypothesis.",1.0421828003701558e-06,1.1414899604131845,0.015621063240110858,0.07979076445040251,1.198695747225095,0.0,0.07967526780192624,1.2367626271489267,0.0,1.0421828003701577e-06,1.2776605201170943,0.0
41,0.5,6,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","BLIPS individuals show the greatest risk for transitioning to psychosis shortly after intake, aligning with the early/late prodrome model.",1.0895547458415266e-06,1.24685047607101,0.015621063240110858,0.08341761737996627,1.309921382335319,0.0,0.08329687088383199,1.3545456628053105,0.0,1.0895547458415283e-06,1.4028236630711,0.0
41,0.5,7,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The highest transition risk over the short term is observed in BLIPS patients, consistent with the model distinguishing early and late prodromal phases.",9.948108548987852e-07,1.0461797806088593,0.015621063240110858,0.07616391152083875,1.0986122886681136,0.0,0.07605366472002051,1.1314021114911013,0.0,9.94810854898787e-07,1.1664348850068702,0.0
41,0.5,8,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Our data support the concept that BLIPS patients are at the greatest risk of psychosis transition in the short term, which fits the early versus late prodrome framework.",8.763809912203587e-07,0.8413853679628454,0.015621063240110858,0.06709677919692936,0.8850381883700527,0.0,0.06699965701525613,0.9082585601768915,0.0,8.7638099122036e-07,0.9328200338253652,0.0
41,0.5,9,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The order of transition risk over 6 months among UHR criteria is Trait alone<APS<BLIPS, with BLIPS at the highest risk, consistent with prodrome phase models.",9.474389094274146e-07,0.9591684036192296,0.015621063240110858,0.07253705859127499,1.0076405104623856,0.0,0.07243206163811475,1.036091931686776,0.0,9.474389094274162e-07,1.0663514264498888,0.0
41,0.5,10,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Findings show UHR criteria predict psychosis transition risk in the sequence Trait alone<APS<BLIPS, and BLIPS patients' high risk supports the early/late prodrome theory.",9.948108548987852e-07,1.0461797806088593,0.015621063240110858,0.07616391152083875,1.0986122886681136,0.0,0.07605366472002051,1.1314021114911013,0.0,9.94810854898787e-07,1.1664348850068702,0.0
42,0.5,1,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Is the preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Preoperative platelet count serves as a predictor for long-term survival and recurrence in esophageal squamous cell carcinoma (ESCC) patients. Higher platelet levels correlate with advanced tumor stage, lymph node metastasis, and worse prognosis. Additional studies are required to understand the mechanisms and clinical significance of this link.",1.1842986367842703e-07,0.1121848148602207,0.0217969821673525,0.009067132323909363,0.11038725179524045,0.01985834253211058,0.009054007704764333,0.10840407091439896,0.017538265306122455,1.1842986367842703e-07,0.08552217343816082,0.0
42,0.5,2,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Does the preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? The count of platelets before surgery is a prognostic marker for survival and recurrence in ESCC patients. Elevated platelet counts are linked to higher tumor stages, lymph node involvement, and unfavorable prognosis. More research is necessary to clarify the biological and clinical relevance of this relationship.",1.6580180914979784e-07,0.02918841795512872,0.06222222222222222,0.012693985253473108,0.07377369085892838,0.03171190540177372,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
42,0.5,3,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Can preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? Platelet levels measured before surgery predict long-term survival and recurrence risk in patients with ESCC. Increased platelet counts are associated with more advanced tumors, lymph node metastases, and poorer clinical outcomes. Further investigation is needed to explore the underlying biological mechanisms and clinical implications.",2.3685972735685406e-07,0.08325563922540358,0.06222222222222222,0.018134264647818726,0.12883346804195694,0.03171190540177372,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
42,0.5,4,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Is platelet count before surgery a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count is indicative of long-term survival and recurrence in ESCC cases. Elevated platelet counts correspond with advanced tumor stage, lymph node spread, and worse prognosis. Further studies are essential to understand the mechanisms and clinical impact of this association.",2.6054570009253947e-07,0.1281042696171788,0.04336127547666009,0.0199476911126006,0.14788166301265004,0.03171190540177372,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
42,0.5,5,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Does the platelet count prior to surgery influence prognosis in esophageal squamous cell carcinoma? Preoperative platelet count acts as a predictor for survival and recurrence in patients with ESCC. High platelet counts are linked to increased tumor stage, lymph node metastasis, and poorer outcomes. Additional research is required to clarify the clinical and biological significance of this finding.",1.6580180914979784e-07,0.05350937165898628,0.04468395691609976,0.012693985253473108,0.07377369085892838,0.03171190540177372,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
42,0.5,6,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Is the pre-surgery platelet count a prognostic marker in esophageal squamous cell carcinoma? The platelet count before surgery forecasts long-term survival and recurrence in ESCC patients. Elevated platelet levels are associated with advanced tumor stages, lymph node metastasis, and unfavorable prognosis. More research is needed to understand the underlying mechanisms and clinical relevance.",2.8423167282822487e-07,0.1476554741528644,0.04299884659746251,0.02176111757738247,0.16729974886975274,0.03171190540177372,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
42,0.5,7,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Can platelet count before surgery serve as a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival and recurrence in ESCC patients. Higher platelet counts correlate with advanced tumor stage, lymph node involvement, and poorer prognosis. Further studies are necessary to elucidate the mechanisms and clinical implications.",3.316036182995957e-07,0.18794256758393146,0.04223055208477949,0.025387970506946217,0.2073050834834511,0.03171190540177372,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
42,0.5,8,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Is the platelet count before operation a predictor of prognosis in esophageal squamous cell carcinoma? Preoperative platelet count is a prognostic factor for survival and recurrence in ESCC. Elevated platelet counts are associated with higher tumor stage, lymph node metastasis, and worse prognosis. Additional research is needed to understand the biological and clinical significance.",2.6054570009253947e-07,0.1281042696171788,0.04336127547666009,0.0199476911126006,0.14788166301265004,0.03171190540177372,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
42,0.5,9,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Does the platelet count measured before surgery predict prognosis in esophageal squamous cell carcinoma? Preoperative platelet count is predictive of long-term survival and recurrence risk in ESCC patients. Increased platelet levels are linked to advanced tumor stage, lymph node metastasis, and poorer clinical outcomes. Further investigation is required to clarify the underlying mechanisms and clinical relevance.",2.1317375462116866e-07,0.0901118525775697,0.04404663923182442,0.016320838183036854,0.11014133502980261,0.03171190540177372,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
42,0.5,10,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Is preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? The platelet count before surgery predicts survival and recurrence in patients with ESCC. Elevated platelet counts are associated with advanced tumor stages, lymph node metastasis, and worse prognosis. More research is necessary to explore the biological mechanisms and clinical implications of this association.",2.1317375462116866e-07,0.0901118525775697,0.04404663923182442,0.016320838183036854,0.11014133502980261,0.03171190540177372,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
43,0.5,1,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do the leadership skills of residents correlate with their technical skill ratings? Research on general surgery residents found that intraoperative leadership abilities significantly correlated with their perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions might offer an extra personalized intraoperative evaluation measure. Further study is needed.,7.105791820705622e-08,0.0623235119648653,0.0012239022181982917,0.005440279394345618,0.06187540371808753,0.0,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
43,0.5,2,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,"Is there a relationship between residents' leadership skills and their technical skill ratings? In general surgery research, residents' intraoperative leadership skills were significantly linked to their views on skill decline and task difficulty during bowel repair. Analyzing residents' directional commands could provide an additional individualized intraoperative assessment tool. More research is warranted.",7.105791820705622e-08,0.0623235119648653,0.0012239022181982917,0.005440279394345618,0.06187540371808753,0.0,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
43,0.5,3,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are residents' leadership abilities associated with ratings of their technical skills? Studies on general surgery research residents revealed that intraoperative leadership skills had significant correlations with their perceptions of skill decay and task difficulty in bowel repair. Evaluating directional instructions given by residents may offer a supplementary personalized intraoperative evaluation metric. Further investigation is required.,1.4211583641411244e-07,0.14666416817971495,0.020823902218198284,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
43,0.5,4,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Does the leadership aptitude of residents relate to their technical skill ratings? Research involving general surgery residents showed significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional guidance might add an individualized intraoperative assessment parameter. Additional evaluation is necessary.,2.3685972735685406e-08,0.04950041972606645,0.020823902218198284,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
43,0.5,5,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,How do residents' leadership skills relate to ratings of their technical skills? General surgery research residents' intraoperative leadership skills were significantly correlated with their perceptions of skill decay and task difficulty during bowel repair. Reviewing residents' directional instructions may provide another individualized intraoperative assessment measure. Further assessment is advised.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.5,6,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,"Is there a connection between resident leadership skills and technical skill ratings? In general surgery research, residents' intraoperative leadership skills significantly correlated with their perceptions of skill decay and task difficulty during bowel repair. Evaluating their directional instructions could serve as an additional personalized intraoperative assessment metric. Further evaluation is recommended.",4.737194547137081e-08,0.04197723982118706,0.0008322320807555503,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
43,0.5,7,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do residents' leadership abilities impact their technical skill ratings? Research on general surgery residents found significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty in bowel repair. Analyzing directional instructions may provide an extra individualized intraoperative assessment tool. More research is needed.,4.737194547137081e-08,0.013678481895465833,0.020823902218198284,0.0036268529295637453,0.04348511193973836,0.0,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
43,0.5,8,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are intraoperative leadership skills of residents linked to their technical skill ratings? General surgery research residents demonstrated significant correlations between leadership skills and perceptions of skill decay and task difficulty during bowel repair. Assessing directional instructions might offer an additional personalized intraoperative evaluation metric. Further study is necessary.,2.3685972735685406e-08,0.021667901379180954,0.00044263842452381755,0.0018134264647818726,0.02150620522096336,0.0,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
43,0.5,9,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,What is the relationship between residents' leadership skills and their technical skill ratings? Research on general surgery residents showed that intraoperative leadership skills significantly correlated with perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions could provide another individualized intraoperative assessment measure. Further evaluation is needed.,4.737194547137081e-08,0.04197723982118706,0.0008322320807555503,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
43,0.5,10,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,"Do leadership skills in residents correspond with ratings of their technical skills? In general surgery research, residents' intraoperative leadership skills had significant correlations with their perceptions of skill decay and task difficulty during bowel repair. Assessing directional instructions may offer an additional personalized intraoperative assessment metric. Further investigation is warranted.",2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
44,0.5,1,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there a link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive individuals? Answer: The ACE-DD genotype is identified as a potential risk factor for causing and progressing chronic kidney failure in hypertensive patients.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.5,2,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene contribute to chronic kidney disease among those with hypertension? Answer: Findings suggest that the ACE-DD genotype may increase the risk of chronic kidney failure development in hypertensive patients.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.5,3,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Can the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease in hypertensive patients? Answer: It has been concluded that the ACE-DD genotype could be a risk factor for the onset and progression of chronic kidney failure in hypertensive individuals.,4.73719454713706e-08,0.05494143744312874,0.0026076399575938047,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
44,0.5,4,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the ACE-1 gene polymorphism associated with chronic kidney disease in patients with hypertension? Answer: The ACE-DD genotype is likely a risk factor for both the causation and development of chronic kidney failure among hypertensive patients.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.5,5,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the ACE-1 gene polymorphism influence the occurrence of chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype may serve as a risk factor for chronic kidney failure in patients with hypertension.,1.184298636784265e-07,0.11012465718226894,0.02219569830246914,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
44,0.5,6,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there an association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive individuals? Answer: The ACE-DD genotype is concluded to be a risk factor for developing chronic kidney failure in those with hypertension.,7.10579182070559e-08,0.04888364744311113,0.02392242299970098,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
44,0.5,7,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the presence of ACE-1 gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that the ACE-DD genotype may contribute to the risk of chronic kidney failure in hypertensive patients.,7.10579182070559e-08,0.04888364744311113,0.02392242299970098,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
44,0.5,8,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Can ACE-1 gene polymorphism cause chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype is considered a risk factor for the causation and progression of chronic kidney failure in hypertensive individuals.,1.421158364141118e-07,0.18553079338508116,0.009753086419753088,0.010880558788691264,0.17693070815907896,0.0,0.010864809245717234,0.18232155679395534,0.0,1.4211583641411244e-07,0.18805223150294026,0.0
44,0.5,9,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is chronic kidney disease among hypertensive patients linked to ACE-1 gene polymorphism? Answer: The ACE-DD genotype may be a significant risk factor for causing and developing chronic kidney failure in hypertensive patients.,1.421158364141118e-07,0.14220909460008446,0.021251654012666835,0.010880558788691264,0.17693070815907896,0.0,0.010864809245717234,0.18232155679395534,0.0,1.4211583641411244e-07,0.18805223150294026,0.0
44,0.5,10,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism result in chronic kidney disease in hypertensive patients? Answer: It is concluded that the ACE-DD genotype might be a risk factor for the causation and progression of chronic kidney failure among hypertensive patients.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
45,0.5,1,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are laboratories accurately reporting serum quantitative hCG results? Numerous factors lead to errors in hCG result reporting, such as (a) the complexity of the hCG molecule and confusion over the different forms of hCG; (b) a lack of awareness among laboratory staff.",2.3685972735685406e-08,0.008909457019031564,0.023795359904818555,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
45,0.5,2,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Do laboratories report serum quantitative hCG results correctly? Errors in hCG reporting arise from multiple factors, including (a) the complex nature of the hCG molecule and confusion about its various forms; (b) insufficient knowledge among laboratory personnel.",1.42115836414112e-07,0.12114367122916603,0.023795359904818555,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
45,0.5,3,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are serum quantitative hCG results being reported correctly by laboratories? Several factors cause incorrect hCG reporting, including (a) the complexity of the hCG molecule and confusion regarding its different forms; (b) laboratory staff's lack of awareness.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
45,0.5,4,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Is the reporting of serum quantitative hCG results by laboratories accurate? Many factors contribute to mistakes in hCG result reporting, such as (a) the complexity of the hCG molecule and confusion about its various forms; (b) laboratory personnel not being fully aware.",2.3685972735685406e-08,0.008909457019031564,0.023795359904818555,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
45,0.5,5,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Do labs report serum quantitative hCG results accurately? Errors often stem from (a) the complexity of the hCG molecule and confusion about its different forms; (b) a lack of awareness among lab personnel.,2.3685972735685321e-07,0.23892670688554984,0.023795359904818555,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
45,0.5,6,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are serum quantitative hCG results reported correctly in laboratories? Several reasons lead to errors, including (a) the complex structure of the hCG molecule and confusion over its forms; (b) laboratory staff's limited awareness.",2.3685972735685321e-07,0.23892670688554984,0.023795359904818555,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
45,0.5,7,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are laboratories correctly reporting serum quantitative hCG results? Many factors cause erroneous hCG reports, including (a) the complexity of the hCG molecule and confusion about its forms; (b) lack of awareness among laboratory personnel.",2.1317375462116791e-07,0.20815504821879616,0.023795359904818555,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
45,0.5,8,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Is the serum quantitative hCG reporting by laboratories accurate? Errors arise due to (a) the complexity of the hCG molecule and confusion regarding its various forms; (b) insufficient awareness among lab staff.,2.605457000925385e-07,0.27067540520012967,0.023795359904818555,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
45,0.5,9,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are the serum quantitative hCG results being reported accurately by laboratories? Multiple factors contribute to errors, including (a) the complexity of the hCG molecule and confusion about its different forms; (b) laboratory personnel's lack of awareness.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
45,0.5,10,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Do laboratories provide correct serum quantitative hCG results? Errors in reporting are caused by (a) the complexity of the hCG molecule and confusion of nomenclature on its forms; (b) laboratory staff's lack of awareness.,2.1317375462116791e-07,0.20815504821879616,0.023795359904818555,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
46,0.5,1,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex found in cervical disk disease? Biochemical studies of damaged cervical intervertebral disks showed increased fibronectin and aggrecan levels, indicating this complex exists in cervical disk disease. This discovery could aid in understanding the disease's pathogenesis and identifying therapeutic targets.",2.1317375462116866e-07,0.20580554688734187,0.00834964598084132,0.016320838183036854,0.20453710908972944,0.004383329862557267,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
46,0.5,2,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Does cervical disk disease involve the fibronectin-aggrecan complex? Analysis of injured cervical intervertebral disks demonstrated elevated fibronectin and aggrecan, suggesting the complex's presence in this disease. This insight may help clarify the condition's pathogenesis and guide treatment options.",3.3160361829959537e-07,0.2665432353303001,0.039150354019158694,0.025387970506946217,0.30077817974963716,0.019991670137442734,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
46,0.5,3,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Biochemical examination of affected cervical intervertebral disks revealed higher fibronectin and aggrecan, implying the complex exists in cervical disk disease. This finding might enhance understanding of disease mechanisms and therapeutic approaches.",2.3685972735685406e-07,0.1977011388585077,0.014775354019158693,0.018134264647818726,0.19541766409181127,0.019991670137442734,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
46,0.5,4,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Are fibronectin and aggrecan complexed in cervical disk disease? Injured cervical intervertebral disks showed increased levels of these proteins through biochemical analysis, indicating the complex's presence. This could contribute to better understanding and treatment of the disease.",3.5528959103528067e-07,0.29394220951841543,0.039150354019158694,0.02720139697172809,0.328949056716334,0.019991670137442734,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
46,0.5,5,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Does the fibronectin-aggrecan complex occur in cervical disk disease? Elevated fibronectin and aggrecan levels were detected in injured cervical intervertebral disks, suggesting the complex's involvement. This may provide insights into disease pathogenesis and potential therapies.",4.0266153650665127e-07,0.3511006233583638,0.039150354019158694,0.03082824990129185,0.3877895567392673,0.019991670137442734,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
46,0.5,6,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex associated with cervical disk disease? Biochemical analysis revealed increased fibronectin and aggrecan in damaged cervical disks, indicating the complex's presence. This finding may help explain disease mechanisms and therapeutic targets.",4.2634750924233657e-07,0.38095358650804556,0.039150354019158694,0.03264167636607373,0.418561215406021,0.019991670137442734,0.03259442773715163,0.4578330936254802,0.0,4.263475092423373e-07,0.47000362924573613,0.0
46,0.5,7,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex found in cervical intervertebral disk disease? Analysis of injured disks showed elevated fibronectin and aggrecan, implying the complex exists in this condition. This could aid understanding of pathogenesis and treatment strategies.",4.0266153650665127e-07,0.3511006233583638,0.039150354019158694,0.03082824990129185,0.3877895567392673,0.019991670137442734,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
46,0.5,8,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Does cervical disk disease feature the fibronectin-aggrecan complex? Biochemical studies of injured cervical disks revealed increased fibronectin and aggrecan, suggesting the complex is present. This may contribute to understanding disease progression and therapy.",4.5003348197802187e-07,0.41172524517479925,0.039150354019158694,0.03445510283085561,0.4503099137206008,0.019991670137442734,0.0344052292781045,0.4906229164484719,0.0,4.500334819780227e-07,0.5039051809214179,0.0
46,0.5,9,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the presence of the fibronectin-aggrecan complex confirmed in cervical disk disease? Injured cervical intervertebral disks exhibited elevated fibronectin and aggrecan levels, indicating the complex's presence. This discovery could inform pathogenesis and therapeutic development.",4.2634750924233657e-07,0.38095358650804556,0.039150354019158694,0.03264167636607373,0.418561215406021,0.019991670137442734,0.03259442773715163,0.4578330936254802,0.0,4.263475092423373e-07,0.47000362924573613,0.0
46,0.5,10,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex detectable in cervical disk disease? Biochemical analysis of damaged cervical disks showed increased fibronectin and aggrecan, suggesting the complex's involvement. This may enhance understanding and treatment of the condition.",4.5003348197802187e-07,0.41172524517479925,0.039150354019158694,0.03445510283085561,0.4503099137206008,0.019991670137442734,0.0344052292781045,0.4906229164484719,0.0,4.500334819780227e-07,0.5039051809214179,0.0
47,0.5,1,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? We discovered that USMLE Step 2 scores, the count of honors received in medical school, and research output were significantly linked to performance in orthopaedic surgery residency. Nevertheless, these factors accounted for only a minor part of the variation in resident performance, indicating that additional elements like personality traits and non-academic experiences might also influence outcomes.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
47,0.5,2,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Is there a correlation between Residency Selection Criteria and performance in Orthopaedic Surgery Residency? Our findings show that USMLE Step 2 results, the number of medical school honors, and research productivity significantly correlate with orthopaedic surgery residency performance. However, these variables explained only a small fraction of the differences in resident performance, implying that other factors such as personality and extracurricular experiences may also be important.",0.0,0.04265521111137982,0.030664926264958384,0.0,0.04332169878499492,0.031217481789802295,0.0,0.02200467239872772,0.01586888657648284,0.0,0.0,0.0
47,0.5,3,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Can Residency Selection Criteria predict how well someone performs in Orthopaedic Surgery Residency? We found significant associations between USMLE Step 2 scores, medical school honors, and research productivity with residency performance in orthopaedic surgery. Despite this, these factors only explained a limited amount of the variability in performance, suggesting that other influences like personality traits and non-academic experiences could also be relevant.",9.474389094274162e-08,0.02225672612279439,0.029656896751069486,0.0072537058591274906,0.021216822352577047,0.031217481789802295,0.007243206163811466,0.0435926100870887,0.01586888657648284,9.474389094274162e-08,0.06669137449867257,0.0
47,0.5,4,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Does performance in Orthopaedic Surgery Residency relate to Residency Selection Criteria? Our study indicated that USMLE Step 2, the number of honors earned in medical school, and research productivity were significantly linked to residency performance. Still, these factors only accounted for a small portion of the performance variability, hinting that other factors such as personality and non-academic experiences may contribute.",1.4211583641411244e-07,0.05636352391809929,0.029101671490136743,0.010880558788691236,0.05511837402825748,0.031217481789802295,0.0108648092457172,0.07807878615825725,0.01586888657648284,1.4211583641411244e-07,0.10178269430994202,0.0
47,0.5,5,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Is performance in Orthopaedic Surgery Residency predicted by Residency Selection Criteria? We identified that USMLE Step 2 scores, medical school honors count, and research productivity were significantly associated with performance. However, these factors only explained a small part of the variability in resident performance, suggesting that other elements like personality traits and non-academic experiences might also play a role.",1.6580180914979784e-07,0.04996144268214664,0.046045785639958384,0.012693985253473108,0.0725101167401263,0.031217481789802295,0.012675610786670066,0.09577836325765787,0.01586888657648284,1.6580180914979784e-07,0.1198011998126205,0.0
47,0.5,6,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Does the selection criteria for residency forecast performance in Orthopaedic Surgery Residency? Our results showed that USMLE Step 2, number of honors during medical school, and research productivity were significantly related to performance. Yet, these factors explained only a small portion of the variability, implying that other aspects such as personality traits and non-academic experiences could also be influential.",1.6580180914979784e-07,0.04996144268214664,0.046045785639958384,0.012693985253473108,0.0725101167401263,0.031217481789802295,0.012675610786670066,0.09577836325765787,0.01586888657648284,1.6580180914979784e-07,0.1198011998126205,0.0
47,0.5,7,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Are Residency Selection Criteria predictive of performance in Orthopaedic Surgery Residency? We found significant correlations between USMLE Step 2 scores, honors in medical school, and research productivity with residency performance. However, these variables explained only a minor part of the variability, suggesting that additional factors like personality and non-academic experiences may also affect outcomes.",2.8423167282822487e-07,0.14011253967644466,0.046045785639958384,0.02176111757738247,0.1643176659932486,0.031217481789802295,0.0217296184914344,0.18930442126848224,0.01586888657648284,2.8423167282822487e-07,0.21511137961694615,0.0
47,0.5,8,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Do Residency Selection Criteria determine performance in Orthopaedic Surgery Residency? Our findings revealed significant associations between USMLE Step 2, medical school honors, and research productivity with performance. Nonetheless, these factors accounted for only a small fraction of the variation, indicating that other factors such as personality traits and non-academic experiences might also be important.",2.8423167282822487e-07,0.14011253967644466,0.046045785639958384,0.02176111757738247,0.1643176659932486,0.031217481789802295,0.0217296184914344,0.18930442126848224,0.01586888657648284,2.8423167282822487e-07,0.21511137961694615,0.0
47,0.5,9,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Is performance in Orthopaedic Surgery Residency influenced by Residency Selection Criteria? We observed that USMLE Step 2 scores, the number of honors in medical school, and research productivity were significantly linked to performance. However, these factors explained only a small part of the variability, suggesting that other influences like personality and non-academic experiences may also play a role.",1.8948778188548325e-07,0.06735318539401547,0.046045785639958384,0.014507411718254981,0.09020969383952693,0.031217481789802295,0.014486412327622933,0.11379686876033634,0.01586888657648284,1.8948778188548325e-07,0.13815033848081626,0.0
47,0.5,10,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Can Residency Selection Criteria predict success in Orthopaedic Surgery Residency? Our study found that USMLE Step 2, medical school honors, and research productivity were significantly associated with residency performance. Still, these factors only explained a small portion of the variability, implying that other factors such as personality traits and non-academic experiences may also contribute.",2.8423167282822487e-07,0.14011253967644466,0.046045785639958384,0.02176111757738247,0.1643176659932486,0.031217481789802295,0.0217296184914344,0.18930442126848224,0.01586888657648284,2.8423167282822487e-07,0.21511137961694615,0.0
48,0.5,1,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Is the visual loss caused by amblyopia permanent? Answer: Elderly individuals with a history of amblyopia who suffer visual loss in their previously unaffected eye may regain visual function in the amblyopic eye gradually over time. This improvement in vision takes place over a period.,4.737194547137081e-08,0.1113740439594606,0.047164256198347104,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
48,0.5,2,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Does amblyopia result in permanent visual loss? Answer: Older adults with amblyopia who experience vision loss in their previously normal eye can see a restoration of visual function in the amblyopic eye after some time. This visual recovery unfolds gradually.,7.105791820705622e-08,0.024397549661296924,0.06937499999999999,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
48,0.5,3,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Is visual impairment from amblyopia irreversible? Answer: In older patients with a history of amblyopia, if the previously normal eye loses vision, the amblyopic eye can recover visual function progressively over time. This restoration of sight occurs over a duration.",7.105791820705622e-08,0.024397549661296924,0.06937499999999999,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
48,0.5,4,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Is the vision loss caused by amblyopia permanent? Answer: Older people who have amblyopia and develop vision loss in the formerly normal eye may regain visual function in the amblyopic eye over time. This recovery of vision happens gradually.,9.474389094274152e-08,0.0720122768419631,0.018242786705624542,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
48,0.5,5,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Does amblyopia cause lasting visual loss? Answer: Individuals with amblyopia who are older and lose vision in their previously normal eye can experience a gradual recovery of visual function in the amblyopic eye. This improvement occurs over a period.,9.474389094274152e-08,0.0009202583229948047,0.06937499999999999,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
48,0.5,6,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Is the visual loss due to amblyopia permanent? Answer: Older adults with a history of amblyopia who undergo vision loss in the previously normal eye might recover visual function in the amblyopic eye over time. This visual function recovery happens gradually.,4.737194547137081e-08,0.018533952924911112,0.02072279750164366,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
48,0.5,7,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Is vision loss from amblyopia permanent? Answer: In older people with amblyopia, if the previously normal eye develops visual loss, the amblyopic eye can regain visual function gradually over time. This recovery process takes place over a period.",1.1842986367842682e-07,0.02689574472625278,0.06937499999999999,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
48,0.5,8,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Does amblyopia lead to irreversible vision loss? Answer: Older individuals with amblyopia who lose vision in their previously normal eye may experience a restoration of visual function in the amblyopic eye over time. This visual recovery occurs gradually.,1.1842986367842682e-07,0.02689574472625278,0.06937499999999999,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
48,0.5,9,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Is the visual deficit caused by amblyopia permanent? Answer: Older patients with a history of amblyopia who develop vision loss in their previously normal eye can regain visual function in the amblyopic eye over a period of time. This recovery in vision happens gradually.,2.3685972735685406e-08,0.11970772946562258,0.06937499999999999,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
48,0.5,10,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Is the loss of vision from amblyopia permanent? Answer: Elderly people with amblyopia who experience visual loss in their previously normal eye may see a recovery of visual function in the amblyopic eye over time. This improvement unfolds progressively.,9.474389094274152e-08,0.0009202583229948047,0.06937499999999999,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
49,0.5,1,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Are high flow nasal cannulae louder than bubble CPAP for preterm infants? At the studied gas flows, HFNC are not. A recent study measured noise levels near the infant's ear using a sound level meter and found no significant difference between HFNC and bubble CPAP.",2.8423167282822487e-07,0.19165154391974815,0.03566529492455417,0.02176111757738247,0.2461330695389088,0.0,0.0217296184914344,0.25131442828090744,0.0,2.8423167282822487e-07,0.2567198468478131,0.0
49,0.5,2,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? According to recent research at the gas flows tested, HFNC are not noisier. Noise levels measured near the infant's ear showed no significant difference between the two methods.",3.552895910352811e-07,0.2622691111337021,0.03566529492455417,0.02720139697172809,0.3184537311185349,0.0,0.027162023114293,0.3254224004346309,0.0,3.552895910352811e-07,0.33270575382573453,0.0
49,0.5,3,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
",Is the noise level of high flow nasal cannulae higher than that of bubble CPAP for preterm infants? The study at the examined gas flows indicates HFNC are not louder. Measurements near the infant's ear revealed no significant noise difference between HFNC and bubble CPAP.,2.8423167282822487e-07,0.19165154391974815,0.03566529492455417,0.02176111757738247,0.2461330695389088,0.0,0.0217296184914344,0.25131442828090744,0.0,2.8423167282822487e-07,0.2567198468478131,0.0
49,0.5,4,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Are high flow nasal cannulae noisier compared to bubble CPAP in preterm infants? At the gas flows studied, HFNC do not produce more noise. A recent study using a sound level meter near the infant's ear found no meaningful difference in noise levels between the two.",2.6054570009253947e-07,0.16917868806769043,0.03566529492455417,0.0199476911126006,0.22314355131420927,0.0,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
49,0.5,5,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Do high flow nasal cannulae generate more noise than bubble CPAP for preterm infants? At the tested gas flows, HFNC are not noisier. Noise measurements near the infant's ear showed no significant difference between HFNC and bubble CPAP.",4.500334819780224e-07,0.3649232651937844,0.03566529492455417,0.03445510283085558,0.4238142467763608,0.0,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
49,0.5,6,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Are high flow nasal cannulae louder than bubble CPAP for preterm infants at the gas flows studied? No, HFNC are not. A recent study using a sound level meter near the infant's ear found no significant noise difference between the two.",3.789755637709665e-07,0.2869617237240738,0.03566529492455417,0.029014823436509962,0.34377153910282665,0.0,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
49,0.5,7,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Is there more noise from high flow nasal cannulae than from bubble CPAP in preterm infants? At the gas flows tested, HFNC are not noisier. Sound level measurements near the infant's ear showed no significant difference between the two.",4.263475092423371e-07,0.3382550181116235,0.03566529492455417,0.03264167636607371,0.3964152725882455,0.0,0.0325944277371516,0.40546510810816505,0.0,4.263475092423373e-07,0.41494385206270756,0.0
49,0.5,8,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
",Are high flow nasal cannulae noisier than bubble CPAP in preterm infants? The study at the gas flows examined found that HFNC are not. Noise levels measured near the infant's ear showed no significant difference.,5.210914001850783e-07,0.44948065322184805,0.03566529492455417,0.03989538222520121,0.5108256237659909,0.0,0.039837633900963086,0.5232481437645489,0.0,5.210914001850789e-07,0.5363047090669744,0.0
49,0.5,9,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
",Do high flow nasal cannulae produce higher noise levels than bubble CPAP for preterm infants? The recent study at the gas flows tested indicates HFNC are not noisier. Noise measurements near the infant's ear showed no significant difference.,4.500334819780224e-07,0.3649232651937844,0.03566529492455417,0.03445510283085558,0.4238142467763608,0.0,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
49,0.5,10,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Is the noise from high flow nasal cannulae greater than that from bubble CPAP for preterm infants? At the gas flows studied, HFNC are not noisier. Measurements near the infant's ear showed no significant difference in noise levels between the two.",3.789755637709665e-07,0.2869617237240738,0.03566529492455417,0.029014823436509962,0.34377153910282665,0.0,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
50,0.5,1,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","This case report describes a novel method for handling acute overt-obscure gastrointestinal bleeding by integrating emergency double-balloon enteroscopy with real-time capsule endoscopy viewing, enabling effective diagnosis and treatment and demonstrating the advantages of this combined technique in difficult cases.",4.974054274493933e-07,0.27547568201256567,0.11649408284023668,0.038081955760419325,0.3539185902387523,0.06858710562414265,0.0380268323600102,0.43521137567458235,0.017538265306122455,4.974054274493935e-07,0.47000362924573613,0.0
50,0.5,2,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","In this case report, the use of emergency double-balloon enteroscopy alongside real-time capsule endoscopy viewing is highlighted as a successful approach for diagnosing and treating acute overt-obscure gastrointestinal bleeding, showcasing the utility of this combined strategy in complex scenarios.",4.974054274493933e-07,0.27547568201256567,0.11649408284023668,0.038081955760419325,0.3539185902387523,0.06858710562414265,0.0380268323600102,0.43521137567458235,0.017538265306122455,4.974054274493935e-07,0.47000362924573613,0.0
50,0.5,3,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","The report presents a distinctive approach to acute overt-obscure gastrointestinal bleeding management, combining emergency double-balloon enteroscopy with real-time capsule endoscopy visualization, which facilitated accurate diagnosis and treatment and underscored the promise of this combined method in tough cases.",5.210914001850786e-07,0.30214392909472654,0.11649408284023668,0.0398953822252012,0.3813175644268676,0.06858710562414265,0.039837633900963065,0.4633822526412792,0.017538265306122455,5.210914001850789e-07,0.49899116611898764,0.0
50,0.5,4,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","This case study illustrates the feasibility of combining emergency double-balloon enteroscopy with real-time capsule endoscopy viewing to effectively diagnose and treat acute overt-obscure gastrointestinal bleeding, emphasizing the benefits of this integrated approach in challenging clinical situations.",5.684633456564492e-07,0.3577137802495387,0.11649408284023668,0.04352223515476495,0.43847597826681595,0.06858710562414265,0.04345923698286881,0.5222227526642125,0.017538265306122455,5.684633456564497e-07,0.5596157879354231,0.0
50,0.5,5,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","A unique combined approach involving emergency double-balloon enteroscopy and real-time capsule endoscopy viewing is detailed in this case report, demonstrating successful diagnosis and treatment of acute overt-obscure gastrointestinal bleeding and highlighting the potential of this method in complex cases.",4.974054274493933e-07,0.27547568201256567,0.11649408284023668,0.038081955760419325,0.3539185902387523,0.06858710562414265,0.0380268323600102,0.43521137567458235,0.017538265306122455,4.974054274493935e-07,0.47000362924573613,0.0
50,0.5,6,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","The case report showcases an innovative strategy for acute overt-obscure gastrointestinal bleeding by merging emergency double-balloon enteroscopy with real-time capsule endoscopy, resulting in effective diagnosis and treatment and illustrating the advantages of this combined technique in difficult cases.",5.210914001850786e-07,0.30214392909472654,0.11649408284023668,0.0398953822252012,0.3813175644268676,0.06858710562414265,0.039837633900963065,0.4633822526412792,0.017538265306122455,5.210914001850789e-07,0.49899116611898764,0.0
50,0.5,7,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","This report details a combined approach using emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy for managing acute overt-obscure gastrointestinal bleeding, which proved successful for diagnosis and treatment and highlights the potential benefits of this method in challenging cases.",4.73719454713708e-07,0.2495001956093077,0.11649408284023668,0.03626852929563745,0.3272503431565914,0.06858710562414265,0.03621603081905733,0.407812401486467,0.017538265306122455,4.737194547137081e-07,0.4418327522790393,0.0
50,0.5,8,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","In this case, the integration of emergency double-balloon enteroscopy with real-time capsule endoscopy viewing enabled successful diagnosis and treatment of acute overt-obscure gastrointestinal bleeding, as reported here, demonstrating the feasibility and advantages of this combined approach in complex situations.",4.974054274493933e-07,0.27547568201256567,0.11649408284023668,0.038081955760419325,0.3539185902387523,0.06858710562414265,0.0380268323600102,0.43521137567458235,0.017538265306122455,4.974054274493935e-07,0.47000362924573613,0.0
50,0.5,9,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","The case report presents a feasible combined method of emergency double-balloon enteroscopy and real-time capsule endoscopy viewing to manage acute overt-obscure gastrointestinal bleeding, facilitating effective diagnosis and treatment and underscoring the benefits of this approach in difficult cases.",5.210914001850786e-07,0.30214392909472654,0.11649408284023668,0.0398953822252012,0.3813175644268676,0.06858710562414265,0.039837633900963065,0.4633822526412792,0.017538265306122455,5.210914001850789e-07,0.49899116611898764,0.0
50,0.5,10,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","This case highlights the successful use of a combined emergency double-balloon enteroscopy and real-time capsule endoscopy viewing technique for acute overt-obscure gastrointestinal bleeding, emphasizing the potential effectiveness of this integrated approach in challenging clinical cases.",5.921493183921345e-07,0.3867013171227902,0.11649408284023668,0.04533566161954683,0.4683289414164977,0.06858710562414265,0.045270038523821686,0.5529944113309662,0.017538265306122455,5.921493183921352e-07,0.5913644862500029,0.0
51,0.5,1,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could errors in gestational age account for the birthweight differences between Australian Aborigines and whites? Answer: It is improbable that gestational age misclassification explains the observed birthweight disparities between Aborigines and whites. These findings may assist in understanding other population-based comparisons.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.5,2,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification responsible for the birthweight gap between Australian Aborigines and whites? Answer: Gestational age misclassification is unlikely to be the reason for the reported birthweight differences between Aborigines and whites. The results may aid in interpreting other comparisons across populations.,2.3685972735685406e-08,0.05742706313623902,0.0242279317005899,0.0018134264647818726,0.024298102261311794,0.0005527295193310314,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.5,3,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does misclassifying gestational age clarify the birthweight differences between Australian Aborigines and whites? Answer: Misclassification of gestational age probably does not explain the birthweight variation seen between Aborigines and whites. These outcomes could help interpret other inter-population comparisons.,1.4211583641411222e-07,0.16152769578287884,0.010550571210042589,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
51,0.5,4,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Can gestational age misclassification explain the birthweight differences observed in Australian Aborigines and whites? Answer: It is unlikely that gestational age misclassification accounts for the reported differences in average birthweights between Aborigines and whites. The findings might facilitate understanding of other between-population analyses.,2.3685972735685406e-08,0.025187659389265704,0.0015582242712670613,0.0018134264647818726,0.024298102261311794,0.0005527295193310314,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.5,5,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? Answer: Gestational age misclassification is an improbable cause for the documented birthweight differences between Aborigines and whites. This evidence may assist in interpreting other population comparisons.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.5,6,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does inaccurate gestational age explain the disparity in birthweights for Australian Aborigines and whites? Answer: The misclassification of gestational age is an unlikely explanation for the observed birthweight differences between Aborigines and whites. These results could help clarify other comparisons among populations.,4.737194547137081e-08,0.018013962754721113,0.020316775728732916,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
51,0.5,7,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could gestational age errors be behind the birthweight differences between Australian Aborigines and whites? Answer: It seems unlikely that gestational age misclassification explains the reported birthweight divergence between Aborigines and whites. The findings may support interpretation of other population comparisons.,9.474389094274162e-08,0.07010482778396288,0.017955279883857596,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,0.5,8,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification a factor in the birthweight differences between Australian Aborigines and whites? Answer: Gestational age misclassification is unlikely to explain the observed differences in average birthweights between Aborigines and whites. These results might aid in understanding other between-population comparisons.,4.737194547137081e-08,0.0510209713528158,0.0031891414310303706,0.0036268529295637453,0.0492007028305701,0.0011323696145124768,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
51,0.5,9,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does gestational age misclassification account for the birthweight variance between Australian Aborigines and whites? Answer: It is improbable that gestational age misclassification explains the reported birthweight variance between Aborigines and whites. The findings may help interpret other population comparisons.,1.1842986367842692e-07,0.20383796400968102,0.05761575022282414,0.009067132323909363,0.16433741333177476,0.029226505416981616,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
51,0.5,10,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could errors in gestational age classification explain birthweight differences for Australian Aborigines and whites? Answer: Misclassification of gestational age is unlikely to be the cause of the reported birthweight differences between Aborigines and whites. These results might assist in interpreting other comparisons across populations.,0.0,0.0,1.3877787807814457e-17,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0
52,0.5,1,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Question: Can a zero central line-associated bloodstream infection rate be maintained? Answer: Consistent high-quality training, adherence to evidence-based protocols, and meticulous environmental cleanliness are vital. Ongoing surveillance, data evaluation, and proactive measures are key to long-term achievement.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
52,0.5,2,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Question: Is it possible to sustain a zero central line-associated bloodstream infection rate? Answer: Ensuring high-quality training, strict observance of evidence-based guidelines, and comprehensive environmental hygiene is critical. Continuous monitoring, data analysis, and preventive actions are necessary for lasting success.",1.184298636784265e-07,0.13720112151348252,0.0,0.009067132323909377,0.14107859825990632,0.0,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
52,0.5,3,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Question: Can zero central line-associated bloodstream infection rates be upheld? Answer: Maintaining excellent training, rigorous compliance with evidence-based practices, and thorough environmental sanitation are essential. Persistent monitoring, analyzing data, and proactive interventions ensure continued success.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
52,0.5,4,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Question: Is maintaining a zero central line-associated bloodstream infection rate achievable? Answer: High-quality education, strict adherence to evidence-based guidelines, and diligent environmental hygiene are fundamental. Continuous oversight, data review, and proactive steps are vital for sustained outcomes.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
52,0.5,5,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Question: Is a zero central line-associated bloodstream infection rate sustainable? Answer: Consistent training of high quality, strict compliance with evidence-based protocols, and thorough environmental hygiene are crucial. Ongoing monitoring, data analysis, and proactive interventions are indispensable for sustained success.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
52,0.5,6,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Question: Can a zero rate of central line-associated bloodstream infections be sustained? Answer: High-quality training, strict adherence to evidence-based guidelines, and meticulous environmental hygiene are essential. Continuous monitoring, data analysis, and proactive measures are critical for long-term success.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
52,0.5,7,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Question: Is it feasible to sustain zero central line-associated bloodstream infection rates? Answer: Providing high-quality training, ensuring strict compliance with evidence-based guidelines, and maintaining thorough environmental hygiene are key. Continuous monitoring, data analysis, and proactive interventions support sustained success.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
52,0.5,8,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Question: Is sustaining zero central line-associated bloodstream infections possible? Answer: High-quality training, rigorous adherence to evidence-based guidelines, and comprehensive environmental hygiene are necessary. Continuous monitoring, data evaluation, and proactive interventions are essential for ongoing success.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
52,0.5,9,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Question: Can zero central line-associated bloodstream infection rates be maintained over time? Answer: High-quality training, strict compliance with evidence-based protocols, and thorough environmental hygiene are vital. Continuous surveillance, data analysis, and proactive interventions are required for sustained success.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
52,0.5,10,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Question: Is the zero central line-associated bloodstream infection rate sustainable? Answer: Ensuring high-quality training, strict adherence to evidence-based guidelines, and maintaining thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive measures are fundamental for lasting success.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
53,0.5,1,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism characterized after injury and hemorrhagic shock, and are hormonal differences the cause? Answer: Female gender independently offers protection against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to age-matched men, which contradicts earlier experimental findings and established knowledge.",1.6580180914979784e-07,0.13883644485421742,0.0,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
53,0.5,2,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What characterizes gender dimorphism following injury and hemorrhagic shock, and do hormones play a role? Answer: The female gender shows a significant independent protective effect against multiple organ failure and hospital-acquired infections in both premenopausal and postmenopausal women relative to men of similar age, opposing prior experimental results and accepted understanding.",7.105791820705622e-08,0.05715841383995013,0.0,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
53,0.5,3,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: In the context of injury and hemorrhagic shock, how is gender dimorphism defined, and are hormonal differences responsible? Answer: Female gender independently reduces the risk of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to similarly aged men, which is inconsistent with previous experimental studies and known data.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
53,0.5,4,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How does gender dimorphism present after injury and hemorrhagic shock, and is it due to hormonal differences? Answer: Female gender independently confers protection against multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women when compared to men of the same age, contrary to earlier experimental research and established knowledge.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
53,0.5,5,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What is the characterization of gender dimorphism after injury and hemorrhagic shock, and are hormones the cause? Answer: Female gender independently protects against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women relative to age-matched men, which contradicts previous experimental findings and current understanding.",1.6580180914979784e-07,0.13883644485421742,0.0,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
53,0.5,6,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: After injury and hemorrhagic shock, how is gender dimorphism characterized, and do hormonal differences explain it? Answer: Female gender has an independent protective effect on multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women compared to men of similar age, opposing earlier experimental data and established knowledge.",7.105791820705622e-08,0.05715841383995013,0.0,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
53,0.5,7,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism described following injury and hemorrhagic shock, and are hormonal differences to blame? Answer: Female gender independently reduces the incidence of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women versus similarly aged men, which contradicts previous experimental studies and accepted knowledge.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
53,0.5,8,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What defines gender dimorphism after injury and hemorrhagic shock, and are hormones responsible? Answer: Female gender independently provides protection against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to men of the same age, contrary to prior experimental research and known data.",1.6580180914979784e-07,0.13883644485421742,0.0,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
53,0.5,9,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How can gender dimorphism be characterized after injury and hemorrhagic shock, and do hormonal differences account for it? Answer: Female gender independently offers significant protection against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women relative to similarly aged men, which is inconsistent with earlier experimental findings and accepted understanding.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
53,0.5,10,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What is the nature of gender dimorphism following injury and hemorrhagic shock, and are hormones the cause? Answer: Female gender independently decreases the rates of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to men of similar age, opposing previous experimental studies and established knowledge.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
54,0.5,1,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Do African American women need fewer calories to keep their weight stable? The findings do not back the idea that African American women are more prone to obesity because they require fewer calories. The research showed that, on average, African American women have similar calorie needs for weight maintenance as other racial groups. Still, individual factors such as physical activity and genetics should be taken into account when assessing calorie requirements.",0.0,0.034754152123556814,0.07476780809574107,0.0,0.027674529056294972,0.04432080610735504,0.0,0.0,0.0,0.0,0.0,0.0
54,0.5,2,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Is it true that African American women require fewer calories to maintain their weight? The evidence does not support the notion that African American women face a higher obesity risk due to lower calorie needs. The study indicated that African American women generally need about the same calories as women from other racial backgrounds to maintain their weight. Nonetheless, factors like activity level and genetic makeup are important when determining calorie needs.",2.3685972735685406e-08,0.12423928025503361,0.17809246512865645,0.0018134264647818865,0.07949101268195147,0.11805475932106219,0.0018108015409528666,0.03316695226007216,0.058810425484517675,2.3685972735685406e-08,0.0148150857851439,0.0
54,0.5,3,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Do African American women have lower calorie requirements to maintain weight? The results do not confirm that African American women have a greater obesity risk because of needing fewer calories. On average, African American women require similar calorie amounts to maintain weight compared to other races. However, individual differences such as exercise habits and genetics must be considered when calculating calorie needs.",2.1317375462116866e-07,0.23172126164945617,0.12714613683770615,0.016320838183036868,0.1977062402023,0.07045959576595835,0.0162972138685758,0.1654667758656423,0.01694411414982164,2.1317375462116866e-07,0.14424960884454574,0.0
54,0.5,4,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Are fewer calories needed by African American women to maintain their weight? The data does not support that African American women are at higher obesity risk due to reduced calorie requirements. The study found that African American women generally require the same calorie intake for weight maintenance as other racial groups. Still, personal factors like activity levels and genetics are important in determining calorie needs.",1.4211583641411244e-07,0.15485529466825287,0.10258931004954557,0.01088055878869125,0.14520009886848317,0.06634371395617071,0.0108648092457172,0.11473290660069324,0.016124697661918843,1.4211583641411244e-07,0.09381875521765437,0.0
54,0.5,5,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Do African American women need less caloric intake to maintain their weight? The study's findings do not endorse the belief that African American women are more susceptible to obesity because of lower calorie needs. On average, African American women require about the same calories to maintain weight as women from other racial groups. However, individual aspects such as physical activity and genetic factors should be considered.",1.1842986367842703e-07,0.13743332734066982,0.10028433702136093,0.009067132323909377,0.1066296496439767,0.04898592692876872,0.009054007704764333,0.0763729787845735,0.0,1.1842986367842703e-07,0.07755823434587317,0.0
54,0.5,6,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Is the calorie requirement lower for African American women to maintain weight? The results do not uphold the idea that African American women have a higher obesity risk due to needing fewer calories. The research showed that African American women need roughly the same amount of calories for weight maintenance as other racial groups. Nevertheless, individual factors like genetics and activity levels are important when determining calorie needs.",7.105791820705622e-08,0.10346415782553642,0.0958864297488438,0.005440279394345632,0.09530192217506173,0.06260788629177164,0.0054324046228586,0.06644804083616318,0.015380859375,7.105791820705622e-08,0.04580953603129334,0.0
54,0.5,7,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Do African American women require fewer calories to sustain their weight? The findings do not support the claim that African American women are at increased risk for obesity because of lower calorie requirements. The study revealed that, on average, African American women need the same calorie intake as other racial groups to maintain weight. However, it's crucial to consider individual differences such as genetics and activity level.",9.474389094274162e-08,0.09930172897074119,0.08209870862501448,0.007253705859127504,0.09033319463060696,0.04799463358328079,0.007243206163811466,0.06062462181643724,0.0,9.474389094274162e-08,0.0615578929994296,0.0
54,0.5,8,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Are fewer calories necessary for African American women to maintain weight? The evidence does not support the perspective that African American women are more prone to obesity due to reduced calorie needs. The study found that African American women generally need the same amount of calories as other racial groups to maintain weight. Still, factors like genetics and physical activity must be taken into account when assessing calorie requirements.",4.737194547137081e-08,0.10728466337092613,0.10915385950950977,0.003626852929563759,0.07920521821008553,0.06143811499783736,0.003621603081905733,0.05085742316665165,0.01514792899408284,4.737194547137081e-08,0.030305349495328038,0.0
54,0.5,9,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Do African American women require a lower calorie intake to keep their weight stable? The results do not back the idea that African American women have a higher risk of obesity because they need fewer calories. The research indicated that African American women require, on average, the same calorie amount as other racial groups to maintain weight. However, individual factors such as genetics and activity levels should be considered.",4.737194547137081e-08,0.08689798158975126,0.0937871085003227,0.003626852929563759,0.07920521821008553,0.06143811499783736,0.003621603081905733,0.05085742316665165,0.01514792899408284,4.737194547137081e-08,0.030305349495328038,0.0
54,0.5,10,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Is a lower calorie requirement needed by African American women to maintain their weight? The findings do not support the notion that African American women are at greater risk for obesity due to lower calorie needs. The study showed that African American women need about the same calories as other racial groups to maintain weight. Nonetheless, individual factors like genetics and activity levels are important when determining calorie needs.",4.737194547137081e-08,0.14805802693327674,0.1394510036880275,0.003626852929563759,0.07920521821008553,0.06143811499783736,0.003621603081905733,0.05085742316665165,0.01514792899408284,4.737194547137081e-08,0.030305349495328038,0.0
55,0.5,1,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Does increased neutrophil migration after major trauma play a role in causing acute respiratory distress syndrome? Data show that major blunt trauma triggers a strong neutrophil migratory response, which might contribute to ARDS development. Further research is necessary, but these results imply that inhibiting neutrophil activation and migration could be a potential treatment approach for trauma-induced ARDS.",2.3685972735685406e-07,0.08028521122340315,0.060353798126951096,0.018134264647818726,0.12439887355178492,0.030738221214411676,0.018108015409528666,0.1482381874028995,0.015621063240110858,2.3685972735685406e-07,0.17284281283941416,0.0
55,0.5,2,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Is heightened neutrophil migration following severe trauma a factor in the onset of acute respiratory distress syndrome? Our data reveal that major blunt trauma elicits a significant neutrophil migratory response that may lead to ARDS. Although more studies are required, the findings suggest that therapies targeting neutrophil activity and migration could benefit ARDS patients post-trauma.",2.8423167282822487e-07,0.11665285539427739,0.060353798126951096,0.02176111757738247,0.161440145232135,0.030738221214411676,0.0217296184914344,0.18597851538574695,0.015621063240110858,2.8423167282822487e-07,0.21130909366720996,0.0
55,0.5,3,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Could increased neutrophil migration after major trauma be involved in the etiology of acute respiratory distress syndrome? Evidence indicates that major blunt trauma provokes a strong neutrophil migratory reaction, possibly contributing to ARDS. Further investigation is warranted, but targeting neutrophil migration and activation appears to be a promising therapeutic avenue for trauma-related ARDS.",3.316036182995957e-07,0.1810526903217382,0.041130422502191386,0.025387970506946217,0.1999064260599308,0.030738221214411676,0.025351221573340132,0.2251992285390294,0.015621063240110858,3.316036182995957e-07,0.25131442828090833,0.0
55,0.5,4,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Is an enhanced neutrophil migratory response after significant trauma a contributing factor to acute respiratory distress syndrome? The data demonstrate that major blunt trauma induces a robust neutrophil migration, which may play a role in ARDS development. While additional research is needed, these findings suggest that modulating neutrophil activation and migration could serve as an effective treatment strategy for ARDS following trauma.",1.1842986367842703e-07,0.005236962214757668,0.060353798126951096,0.009067132323909363,0.037387496562156564,0.030738221214411676,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
55,0.5,5,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Does major trauma-induced neutrophil migration contribute to the development of acute respiratory distress syndrome? Findings indicate that severe blunt trauma causes a pronounced neutrophil migratory response that might be involved in ARDS pathogenesis. Although more studies are necessary, targeting neutrophil activation and migration holds therapeutic promise for trauma-associated ARDS.",4.263475092423373e-07,0.23443589105066165,0.060353798126951096,0.03264167636607371,0.2815844570741981,0.030738221214411676,0.0325944277371516,0.3085808374780803,0.015621063240110858,4.263475092423373e-07,0.3364722366212156,0.0
55,0.5,6,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Is the increased migration of neutrophils after major trauma a factor in the pathogenesis of acute respiratory distress syndrome? Data suggest that major blunt trauma triggers a strong neutrophil migratory response, potentially leading to ARDS. Further research is required, but these results support the idea that inhibiting neutrophil migration and activation may be beneficial in treating ARDS post-trauma.",2.1317375462116866e-07,0.06258563412400253,0.060353798126951096,0.016320838183036854,0.10638036804910644,0.030738221214411676,0.0162972138685758,0.12988904873470375,0.015621063240110858,2.1317375462116866e-07,0.15415067982725983,0.0
55,0.5,7,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Could the rise in neutrophil migratory activity following major trauma be linked to acute respiratory distress syndrome? The data indicate that major blunt trauma elicits a potent neutrophil migration, which may contribute to ARDS development. While additional studies are needed, the findings propose that targeting neutrophil activation and migration might be an effective therapeutic strategy for ARDS after trauma.",1.8948778188548325e-07,0.0451938914121337,0.060353798126951096,0.014507411718254981,0.08868079094970582,0.030738221214411676,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
55,0.5,8,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Is neutrophil migration increased after major trauma, and does it play a role in acute respiratory distress syndrome? Evidence shows that major blunt trauma induces a strong neutrophil migratory response, possibly contributing to ARDS. Further investigation is warranted, but these findings highlight the potential for therapies aimed at neutrophil activation and migration in trauma-induced ARDS.",2.8423167282822487e-07,0.11665285539427739,0.060353798126951096,0.02176111757738247,0.161440145232135,0.030738221214411676,0.0217296184914344,0.18597851538574695,0.015621063240110858,2.8423167282822487e-07,0.21130909366720996,0.0
55,0.5,9,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Does the enhanced neutrophil migratory response following major trauma contribute to acute respiratory distress syndrome? Data reveal that major blunt trauma provokes a significant neutrophil migration, which may be involved in ARDS pathogenesis. Although more research is needed, targeting neutrophil activation and migration could be a promising treatment approach for ARDS after trauma.",3.316036182995957e-07,0.15439318337712482,0.060353798126951096,0.025387970506946217,0.1999064260599308,0.030738221214411676,0.025351221573340132,0.2251992285390294,0.015621063240110858,3.316036182995957e-07,0.25131442828090833,0.0
55,0.5,10,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Is the increased neutrophil migration after major trauma a key factor in acute respiratory distress syndrome development? Findings suggest that major blunt trauma causes a robust neutrophil migratory response potentially contributing to ARDS. Further studies are necessary, but targeting neutrophil activation and migration appears promising for ARDS therapy post-trauma.",4.263475092423373e-07,0.23443589105066165,0.060353798126951096,0.03264167636607371,0.2815844570741981,0.030738221214411676,0.0325944277371516,0.3085808374780803,0.015621063240110858,4.263475092423373e-07,0.3364722366212156,0.0
56,0.5,1,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? The benefit of decompression in spinal cord sarcoidosis accompanied by compressive myelopathy was unclear. Early diagnosis of sarcoidosis from other organs and steroid treatment is necessary.,9.474389094274131e-08,0.04234075403772852,0.042543194048985565,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
56,0.5,2,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery work for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression for spinal cord sarcoidosis with compressive myelopathy was not demonstrated. Early identification of sarcoidosis in other organs and steroid therapy should be implemented.,7.1057918207056e-08,0.12314482940369542,0.03213756530709844,0.005440279394345618,0.15851648407532748,0.056658247038503896,0.0054324046228586,0.16002122850737477,0.05702135940111259,7.105791820705622e-08,0.16145491887239505,0.056932966023875105
56,0.5,3,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis presenting with compressive cervical myelopathy? The impact of decompression in spinal cord sarcoidosis with compressive myelopathy was not apparent. Early diagnosis from other organ involvement and steroid treatment is required.,9.474389094274131e-08,0.07980816920313138,0.015970918079774396,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
56,0.5,4,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery effectively treat spinal cord sarcoidosis with compressive cervical myelopathy? The role of decompression in spinal cord sarcoidosis with compressive myelopathy was not clear. Early diagnosis of sarcoidosis in other organs and steroid therapy is essential.,9.474389094274131e-08,0.1172755843685338,0.010098997813985489,0.0072537058591274906,0.15157032769515633,0.03278313225429821,0.007243206163811466,0.1518843960161691,0.03130969732581415,9.474389094274162e-08,0.15199899867257427,0.029384756657483937
56,0.5,5,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompression surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompressive surgery in spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis from other organ sarcoidosis and steroid treatment are necessary.,9.474389094274131e-08,0.1172755843685338,0.010098997813985489,0.0072537058591274906,0.15157032769515633,0.03278313225429821,0.007243206163811466,0.1518843960161691,0.03130969732581415,9.474389094274162e-08,0.15199899867257427,0.029384756657483937
56,0.5,6,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompression help in spinal cord sarcoidosis with compressive cervical myelopathy? The benefit of decompression for spinal cord sarcoidosis accompanied by compressive myelopathy was not obvious. Early diagnosis of sarcoidosis from other organs and steroid therapy is needed.,9.474389094274131e-08,0.04234075403772852,0.042543194048985565,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
56,0.5,7,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is surgical decompression effective for spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression in spinal cord sarcoidosis with compressive myelopathy was not clear. Early diagnosis of sarcoidosis from other organs and steroid treatment should be pursued.,7.1057918207056e-08,0.08666339884790908,0.007385483304308674,0.005440279394345618,0.12104906890992506,0.030588331144744012,0.0054324046228586,0.12151305180959993,0.02974005310124702,7.105791820705622e-08,0.12184650855468426,0.02854671280276816
56,0.5,8,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a useful treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis of sarcoidosis in other organs and steroid therapy is important.,4.7371945471370706e-08,0.09249223651892446,0.0290117808821633,0.0036268529295637453,0.12790429855470276,0.053944732528827095,0.003621603081905733,0.1294999697221435,0.05482655829155839,4.737194547137081e-08,0.13108357466582587,0.055363321799307974
56,0.5,9,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery show effectiveness in spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not apparent. Early diagnosis of sarcoidosis from other organs and steroid treatment is necessary.,7.1057918207056e-08,0.08666339884790908,0.007385483304308688,0.005440279394345618,0.12104906890992506,0.030588331144744012,0.0054324046228586,0.12151305180959993,0.02974005310124702,7.105791820705622e-08,0.12184650855468426,0.02854671280276816
56,0.5,10,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective in cases of spinal cord sarcoidosis with compressive cervical myelopathy? The benefit of decompression in spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis from other organ sarcoidosis and steroid therapy should be considered.,4.7371945471370706e-08,0.056946227259440096,0.0048037447265246586,0.0036268529295637453,0.09142286799891597,0.02850585109390017,0.003621603081905733,0.09203255455674064,0.028254282322347224,4.737194547137081e-08,0.09257539796805103,0.02775510204081633
57,0.5,1,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a contraindication for laparoscopic surgery to treat GERD? Answer: Laparoscopic antireflux surgery remains a safe and effective option for GERD in elderly patients, showing low morbidity and mortality and symptom improvement similar to younger individuals.",9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
57,0.5,2,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age contraindicate GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is safe and effective for GERD even in older patients, with low morbidity and mortality and symptom relief comparable to that in younger patients.",1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.5,3,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is being elderly a contraindication for laparoscopic surgery in GERD cases? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD among elderly patients, with low risks and symptom improvement on par with younger patients.",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.5,4,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Can advanced age prevent someone from having GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is safe and effective for GERD in elderly patients, showing low morbidity and mortality and symptom improvement similar to younger patients.",1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.5,5,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age considered a contraindication for laparoscopic surgery in GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, associated with low morbidity, mortality, and symptom improvement comparable to younger patients.",9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
57,0.5,6,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does old age contraindicate laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective approach for GERD in elderly patients, with low complication rates and symptom improvement similar to younger patients.",1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
57,0.5,7,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is elderly age a contraindication for GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is safe and effective for GERD even in elderly patients, with low morbidity and mortality and symptom relief comparable to younger patients.",1.6580180914979731e-07,0.22192996711166568,0.02854671280276816,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.5,8,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a reason to avoid laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality rates and symptom improvement on par with younger patients.",4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
57,0.5,9,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does being of advanced age contraindicate laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low risks and symptom improvement comparable to younger individuals.",1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.5,10,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is laparoscopic surgery for GERD contraindicated in elderly patients due to age? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, showing low morbidity and mortality rates and symptom improvement similar to younger patients.",4.737194547137081e-08,0.11810488222542581,0.049861495844875335,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
58,0.5,1,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Is it acceptable for French lay people and health professionals to break confidentiality to protect a patient's wife from a sexually transmitted infection? Answer: This presents a challenging ethical issue without a straightforward solution. French law emphasizes patient confidentiality while acknowledging the importance of safeguarding public health. The choice to reveal sensitive information should be evaluated individually, taking all circumstances into account.",9.474389094274162e-08,0.04151589696436542,0.01514792899408284,0.0072537058591274906,0.06351340572232633,0.0,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
58,0.5,2,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Do French non-experts and healthcare providers find it permissible to violate confidentiality to safeguard a patient's spouse from an STD? Answer: This ethical question is complex and lacks a simple resolution. French legislation prioritizes patient privacy but also supports public health protection. Decisions about disclosing confidential information must be made case by case, considering all relevant factors.",2.1317375462116866e-07,0.12559901417490682,0.01514792899408284,0.016320838183036854,0.14903557916048715,0.0,0.0162972138685758,0.15154989812720032,0.0,2.1317375462116866e-07,0.15415067982725983,0.0
58,0.5,3,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Is breaching confidentiality to protect a patient's wife from a sexually transmitted disease deemed acceptable by French laypersons and medical professionals? Answer: This is a nuanced ethical dilemma with no clear-cut answer. French law values patient confidentiality but also acknowledges the necessity of protecting public health. Ultimately, disclosure decisions should be made on an individual basis, weighing all factors.",1.6580180914979784e-07,0.09111283810373827,0.01514792899408284,0.012693985253473108,0.1139442593492177,0.0,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
58,0.5,4,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Do French health professionals and laypeople accept breaking confidentiality to protect a patient's wife from an STD? Answer: This ethical issue is complex and lacks an easy answer. French legal frameworks prioritize patient confidentiality yet recognize the need to protect public health. Disclosure of sensitive information must be decided case by case, considering all involved factors.",2.3685972735685406e-07,0.16805384772287724,0.0027033106753386518,0.018134264647818726,0.16705408466316563,0.0,0.018108015409528666,0.16989903679539609,0.0,2.3685972735685406e-07,0.17284281283941416,0.0
58,0.5,5,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Is it considered acceptable by French lay people and healthcare workers to breach confidentiality to shield a patient's wife from a sexually transmitted infection? Answer: This ethical dilemma is complicated and does not have a simple answer. French law emphasizes confidentiality but also the importance of public health protection. The decision to disclose sensitive data should be made individually, taking all relevant factors into consideration.",2.3685972735685406e-08,0.005736987886179712,0.01514792899408284,0.0018134264647818726,0.015504186535965303,0.0,0.0018108015409528666,0.015748356968136257,0.0,2.3685972735685406e-08,0.01600034134644357,0.0
58,0.5,6,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Do French laypersons and health professionals find it acceptable to violate confidentiality in order to protect a patient's wife from an STI? Answer: This is a complex ethical issue with no straightforward solution. French legislation prioritizes patient confidentiality while also recognizing the need to protect public health. Decisions to disclose sensitive information must be made on a case-by-case basis, considering all factors.",9.474389094274162e-08,0.06387548343404159,0.0009767686678360064,0.0072537058591274906,0.06351340572232633,0.0,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
58,0.5,7,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Is breaching confidentiality to protect a patient's wife from a sexually transmitted disease acceptable to French lay people and medical professionals? Answer: This presents a challenging ethical dilemma with no easy answer. French law upholds patient confidentiality but also acknowledges the importance of protecting public health. Ultimately, decisions about disclosure should be made individually, weighing all circumstances.",2.1317375462116866e-07,0.12559901417490682,0.01514792899408284,0.016320838183036854,0.14903557916048715,0.0,0.0162972138685758,0.15154989812720032,0.0,2.1317375462116866e-07,0.15415067982725983,0.0
58,0.5,8,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Do French healthcare providers and laypeople find it permissible to break confidentiality to protect a patient's wife from an STD? Answer: This ethical dilemma is complex and lacks a simple answer. French law prioritizes confidentiality but also recognizes the need to safeguard public health. The decision to disclose sensitive information must be made on a case-by-case basis, considering all relevant factors.",1.1842986367842703e-07,0.05777641783614662,0.01514792899408284,0.009067132323909363,0.08004270767353727,0.0,0.009054007704764333,0.08134563945395268,0.0,1.1842986367842703e-07,0.08269171584511614,0.0
58,0.5,9,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Is it acceptable for French lay people and health professionals to breach confidentiality to protect a patient's wife from an STI? Answer: This is a complicated ethical issue without a straightforward answer. French law emphasizes patient confidentiality but also the necessity of protecting public health. Disclosure decisions must be made individually, taking all factors into account.",2.3685972735685406e-07,0.14329859127430744,0.01514792899408284,0.018134264647818726,0.16705408466316563,0.0,0.018108015409528666,0.16989903679539609,0.0,2.3685972735685406e-07,0.17284281283941416,0.0
58,0.5,10,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Do French non-experts and health professionals consider it acceptable to violate confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: This is a complex ethical dilemma with no simple answer. French law prioritizes patient confidentiality while also recognizing the importance of protecting public health. Ultimately, decisions about revealing sensitive information should be made on a case-by-case basis, considering all factors involved.",4.737194547137081e-08,0.009767198649785591,0.01514792899408284,0.0036268529295637453,0.03125254350410156,0.0,0.003621603081905733,0.031748698314579826,0.0,4.737194547137081e-08,0.03226086221822477,0.0
59,0.5,1,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: can it predict different histologic subtypes? epiDWI may help distinguish pleomorphic adenoma and myoepithelial adenomas from other types. However, there is overlap between benign and malignant lesions.",3.3160361829959516e-07,0.3364722366212134,0.0,0.025387970506946224,0.34484048629172914,0.0,0.025351221573340146,0.35364004024357776,0.0,3.316036182995957e-07,0.3629054936893681,0.0
59,0.5,2,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Is it possible to predict different histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? epiDWI shows potential in differentiating pleomorphic adenoma and myoepithelial adenomas from other entities, though overlap exists among benign and malignant lesions.",2.6054570009253926e-07,0.25423413838424036,0.0,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
59,0.5,3,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Can diffusion-weighted echo-planar MR imaging of primary parotid gland tumors predict various histologic subtypes? epiDWI can differentiate pleomorphic adenoma and myoepithelial adenomas from other tumors, but overlaps occur within benign and malignant groups.",4.0266153650665106e-07,0.42608439531090037,0.0,0.030828249901291863,0.43721380642274443,0.0,0.030783626196198767,0.44895022004790297,0.0,4.026615365066519e-07,0.4613455665026214,0.0
59,0.5,4,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Does diffusion-weighted echo-planar MR imaging allow prediction of histologic subtypes in primary parotid gland tumors? epiDWI is capable of distinguishing pleomorphic adenoma and myoepithelial adenomas from other examined entities, although some overlap is present between benign and malignant lesions.",2.6054570009253926e-07,0.25423413838424036,0.0,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
59,0.5,5,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Is predicting different histologic subtypes of primary parotid gland tumors possible with diffusion-weighted echo-planar MR imaging? epiDWI can separate pleomorphic adenoma and myoepithelial adenomas from others, but overlaps exist within benign and malignant lesions.",3.7897556377096576e-07,0.3953127366441467,0.0,0.029014823436509983,0.4054651081081646,0.0,0.028972824655245893,0.41616039722491127,0.0,3.789755637709665e-07,0.4274440148269396,0.0
59,0.5,6,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Can primary parotid gland tumor subtypes be predicted using diffusion-weighted echo-planar MR imaging? epiDWI shows promise in differentiating pleomorphic adenoma and myoepithelial adenomas from other entities, despite overlaps between benign and malignant lesions.",4.0266153650665106e-07,0.42608439531090037,0.0,0.030828249901291863,0.43721380642274443,0.0,0.030783626196198767,0.44895022004790297,0.0,4.026615365066519e-07,0.4613455665026214,0.0
59,0.5,7,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Does diffusion-weighted echo-planar MR imaging help predict various histologic subtypes of primary parotid gland tumors? epiDWI may distinguish pleomorphic adenoma and myoepithelial adenomas from other types, though there is overlap among benign and malignant lesions.",3.5528959103528046e-07,0.3654597734944649,0.0,0.027201396971728103,0.3746934494414109,0.0,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
59,0.5,8,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Is it feasible to predict different histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? epiDWI can differentiate pleomorphic adenoma and myoepithelial adenomas from other entities, but overlaps occur within benign and malignant groups.",3.0791764556390986e-07,0.30830135965451655,0.0,0.023574544042164344,0.31585294941847764,0.0,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
59,0.5,9,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Can diffusion-weighted echo-planar MR imaging predict histologic subtypes of primary parotid gland tumors? epiDWI has potential to distinguish pleomorphic adenoma and myoepithelial adenomas from other examined lesions, although some overlap exists between benign and malignant lesions.",3.3160361829959516e-07,0.3364722366212134,0.0,0.025387970506946224,0.34484048629172914,0.0,0.025351221573340146,0.35364004024357776,0.0,3.316036182995957e-07,0.3629054936893681,0.0
59,0.5,10,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Is diffusion-weighted echo-planar MR imaging effective in predicting different histologic subtypes of primary parotid gland tumors? epiDWI can differentiate pleomorphic adenoma and myoepithelial adenomas from other entities, despite overlaps within benign and malignant lesions.",3.7897556377096576e-07,0.3953127366441467,0.0,0.029014823436509983,0.4054651081081646,0.0,0.028972824655245893,0.41616039722491127,0.0,3.789755637709665e-07,0.4274440148269396,0.0
60,0.5,1,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
",Can quantitative real-time PCR assays made in-house yield results comparable to commercial kits for detecting BCRABL transcripts?,8.053230730133015e-07,1.0562566215211713,0.05975554549569943,0.061656499802583795,1.1554783753529083,0.020399305555555556,0.0615672523923976,1.2321436812926327,0.0,8.053230730133034e-07,1.2851982442485208,0.0
60,0.5,2,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
",Is it possible for homebrew quantitative real-time PCR assays to provide results consistent with commercial kits in BCRABL transcript detection?,7.342651548062455e-07,0.8844063645945122,0.05975554549569943,0.05621622040823817,0.9731568185589539,0.020399305555555556,0.05613484776953899,1.037987666851675,0.0,7.342651548062474e-07,1.0775588794702768,0.0
60,0.5,3,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
",Do in-house developed quantitative real-time PCR assays produce correlated outcomes with commercial assays for BCRABL transcript detection?,8.053230730133015e-07,1.0562566215211713,0.05975554549569943,0.061656499802583795,1.1554783753529083,0.020399305555555556,0.0615672523923976,1.2321436812926327,0.0,8.053230730133034e-07,1.2851982442485208,0.0
60,0.5,4,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
",Are the results from homemade quantitative real-time PCR tests for BCRABL transcript detection comparable to those from commercial kits?,7.579511275419309e-07,0.9384735858647875,0.05975554549569943,0.05802964687302005,1.0303152323989027,0.020399305555555556,0.057945649310491856,1.09861228866811,0.0,7.579511275419327e-07,1.1420974006078475,0.0
60,0.5,5,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
",Can home-developed quantitative real-time PCR assays reliably detect BCRABL transcripts with results similar to commercial kits?,8.290090457489869e-07,1.120795142658742,0.05975554549569943,0.06346992626736567,1.2244712468398604,0.020399305555555556,0.06337805393335048,1.306251653446354,0.0,8.290090457489888e-07,1.3652409519220572,0.0
60,0.5,6,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
",Is there a correlation between results from homebrew and commercial quantitative real-time PCR assays for BCRABL transcript detection?,7.816371002776162e-07,0.9956319997047363,0.05975554549569943,0.05984307333780192,1.0909398542153377,0.020399305555555556,0.05975645085144474,1.1631508098056806,0.0,7.81637100277618e-07,1.2110902720947996,0.0
60,0.5,7,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
",Are quantitative real-time PCR assays created in-house able to deliver results that align with commercial kits for BCRABL transcript detection?,7.342651548062455e-07,0.8844063645945122,0.05975554549569943,0.05621622040823817,0.9731568185589539,0.020399305555555556,0.05613484776953899,1.037987666851675,0.0,7.342651548062474e-07,1.0775588794702768,0.0
60,0.5,8,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
",Can in-house quantitative real-time PCR assays be trusted to yield results highly correlated with commercial kits for detecting BCRABL transcripts?,7.342651548062455e-07,0.8844063645945122,0.05975554549569943,0.05621622040823817,0.9731568185589539,0.020399305555555556,0.05613484776953899,1.037987666851675,0.0,7.342651548062474e-07,1.0775588794702768,0.0
60,0.5,9,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
",Do homebrew quantitative real-time PCR tests for BCRABL transcript detection provide results that match those from commercial kits?,7.816371002776162e-07,0.9956319997047363,0.05975554549569943,0.05984307333780192,1.0909398542153377,0.020399305555555556,0.05975645085144474,1.1631508098056806,0.0,7.81637100277618e-07,1.2110902720947996,0.0
60,0.5,10,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
",Is it feasible for quantitative real-time PCR assays developed internally to produce results consistent with commercial assays for BCRABL transcript detection?,7.105791820705601e-07,0.833113070206962,0.05975554549569943,0.05440279394345629,0.9190895972886786,0.020399305555555556,0.054324046228586116,0.9808292530117262,0.0,7.10579182070562e-07,1.0169342576538418,0.0
61,0.5,1,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging necessary to diagnose appendicitis in children? Clinical evaluation remains the primary method for diagnosing appendicitis. However, for girls over 10 years old, imaging should be selectively used to prevent unnecessary surgeries. In unclear cases, the preferred imaging method is...",9.474389094274162e-08,0.032296799753420924,0.045351473922902494,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
61,0.5,2,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Do we require imaging to identify appendicitis in pediatric patients? Diagnosis mainly relies on clinical examination. Yet, in females older than 10, imaging is recommended selectively to avoid unwarranted appendectomies. The imaging modality of choice in uncertain cases is...",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
61,0.5,3,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Should imaging be used to diagnose appendicitis in children? The diagnosis depends chiefly on clinical assessment. Still, in girls aged over 10, selective imaging use is advised to minimize unnecessary appendectomies. For ambiguous cases, the imaging technique of choice is...",1.1842986367842692e-07,0.05761460773771265,0.045351473922902494,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
61,0.5,4,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is it necessary to use imaging for diagnosing appendicitis in children? Clinical assessment is fundamental for diagnosis. Nevertheless, in girls older than 10 years, selective imaging helps prevent unneeded appendectomies. The preferred imaging in doubtful cases should be...",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
61,0.5,5,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Do children with suspected appendicitis need imaging for diagnosis? Diagnosis primarily depends on clinical evaluation. However, for girls above 10 years, selective imaging is recommended to avoid unnecessary surgeries. The imaging option of choice in equivocal cases is...",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
61,0.5,6,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging required to diagnose appendicitis in pediatric patients? Clinical assessment is key for diagnosis. Yet, for girls older than 10, selective imaging use is important to prevent unnecessary appendectomies. The imaging modality preferred in uncertain cases is...",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
61,0.5,7,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Should we rely on imaging to diagnose appendicitis in children? Clinical examination is the main diagnostic tool. However, selective imaging in girls over 10 years old should be used to avoid unnecessary appendectomies. The imaging of choice in ambiguous cases should be...",7.105791820705622e-08,0.007604187163049225,0.045351473922902494,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
61,0.5,8,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging needed to confirm appendicitis diagnosis in children? Diagnosis is primarily clinical. Nonetheless, in girls older than 10 years, imaging should be selectively used to prevent unnecessary appendectomies. The preferred imaging in equivocal cases is...",2.1317375462116813e-07,0.16582819237794366,0.045351473922902494,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
61,0.5,9,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Do we need to perform imaging to diagnose appendicitis in children? Clinical assessment is the cornerstone of diagnosis. Still, in girls older than 10 years, selected imaging use is recommended to avoid unnecessary surgeries. The imaging method of choice for uncertain cases is...",4.737194547137081e-08,0.01649336441601079,0.045351473922902494,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
61,0.5,10,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging necessary for diagnosing appendicitis in children? The diagnosis relies mainly on clinical assessment. However, in girls above 10 years, selective imaging is advised to reduce unnecessary appendectomies. The imaging technique preferred in equivocal cases is...",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
62,0.5,1,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Using MEP and SSEP monitoring, it is safe to sacrifice up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair, leading to low rates of immediate and delayed paraplegia. This suggests that routine surgical reimplantation of segmental vessels is unnecessary.",0.0,0.023901626915860064,0.017236072637734686,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
62,0.5,2,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: In thoracic and thoracoabdominal aneurysm repair, does reimplanting spinal cord arteries provide benefit? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low incidence of immediate and delayed paraplegia, indicating that routine reimplantation may be redundant.",1.6580180914979784e-07,0.12861737782209381,0.0,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
62,0.5,3,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair worthwhile? Answer: Monitoring MEP and SSEP shows that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation in TAA/A repair is safe and associated with low rates of immediate and delayed paraplegia, suggesting routine reimplantation is not necessary.",1.4211583641411244e-07,0.10919929196499112,0.0,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
62,0.5,4,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Does reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair provide significant advantage? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to acceptably low rates of paraplegia, implying that routine segmental vessel reimplantation may be unnecessary.",1.4211583641411244e-07,0.10919929196499112,0.0,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
62,0.5,5,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is it beneficial to reimplant spinal cord arteries? Answer: Using MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low immediate and delayed paraplegia rates, suggesting routine reimplantation is not essential.",1.8948778188548325e-07,0.14842000511827358,0.0,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
62,0.5,6,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: In TAA/A repair, is reimplantation of spinal cord arteries effective or futile? Answer: Monitoring with MEP and SSEP confirms that sacrificing up to 15 intercostal and lumbar arteries without reimplantation is safe and associated with low rates of immediate and delayed paraplegia, indicating routine reimplantation may be unnecessary.",2.3685972735685406e-07,0.18924199963852795,0.0,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
62,0.5,7,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair necessary? Answer: With MEP and SSEP monitoring, it is safe to sacrifice as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair, resulting in low rates of immediate and delayed paraplegia, suggesting routine reimplantation is not required.",1.4211583641411244e-07,0.10919929196499112,0.0,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
62,0.5,8,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: should spinal cord arteries be reimplanted? Answer: Using MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to acceptably low paraplegia rates, suggesting routine reimplantation is unnecessary.",3.316036182995957e-07,0.2762533766281572,0.0,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
62,0.5,9,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Is the reimplantation of spinal cord arteries during TAA/A repair justified? Answer: Monitoring MEP and SSEP shows that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation is safe and results in low immediate and delayed paraplegia rates, implying routine reimplantation may be a waste of time.",2.1317375462116866e-07,0.1686227124357922,0.0,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
62,0.5,10,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Does reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair improve outcomes? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low rates of immediate and delayed paraplegia, indicating routine reimplantation may not be necessary.",1.6580180914979784e-07,0.12861737782209381,0.0,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
63,0.5,1,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study indicates a potential link, especially in those with extensive cervical cord lesions. More research is necessary to understand the relationship and its clinical significance.",4.974054274493934e-07,0.22655906276921556,0.1743767313019391,0.038081955760419325,0.2519791674173133,0.13225682429834681,0.0380268323600102,0.2822137094911721,0.1184159938485198,4.974054274493935e-07,0.31360660715529365,0.10380622837370242
63,0.5,2,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Does cervical cord plaque presence relate to discopathy in patients with multiple sclerosis? Data from the study suggests a possible association, notably in patients exhibiting widespread cervical cord lesions. Further investigation is required to define this relationship and its clinical impact.",4.737194547137081e-07,0.235009963581434,0.1501385041551247,0.03626852929563745,0.22600368101405532,0.13225682429834681,0.03621603081905733,0.2555454624090112,0.1184159938485198,4.737194547137081e-07,0.2862076329671783,0.10380622837370242
63,0.5,3,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Are cervical cord plaques associated with discopathy in individuals with multiple sclerosis? The findings point to a potential correlation, particularly in cases with significant cervical cord lesions. Additional studies are needed to elucidate the exact nature and clinical relevance of this link.",4.500334819780227e-07,0.17481469052335807,0.17562500000000003,0.03445510283085558,0.2006858730297636,0.13225682429834681,0.034405229278104466,0.22956997600575324,0.1184159938485198,4.500334819780227e-07,0.25953938588501746,0.10380622837370242
63,0.5,4,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Is there any association between cervical cord plaques and discopathy among multiple sclerosis patients? Study results imply a possible connection, mainly in those with extensive cervical cord lesions. More research is needed to clarify the relationship and its implications for treatment.",4.737194547137081e-07,0.2003526045534363,0.17501643655489812,0.03626852929563745,0.22600368101405532,0.13225682429834681,0.03621603081905733,0.2555454624090112,0.1184159938485198,4.737194547137081e-07,0.2862076329671783,0.10380622837370242
63,0.5,5,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Does a relationship exist between cervical cord plaques and discopathy in multiple sclerosis patients? The data suggests a potential correlation, especially in patients with more pronounced cervical cord lesions. Further research is essential to understand the clinical significance of this association.",4.737194547137081e-07,0.2003526045534363,0.17501643655489812,0.03626852929563745,0.22600368101405532,0.13225682429834681,0.03621603081905733,0.2555454624090112,0.1184159938485198,4.737194547137081e-07,0.2862076329671783,0.10380622837370242
63,0.5,6,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Is there a link between cervical cord plaques and discopathy in patients suffering from multiple sclerosis? The study data hints at a possible connection, particularly in individuals with extensive cervical cord lesions. Additional research is necessary to better understand this relationship and its clinical consequences.",3.789755637709665e-07,0.10189175574656684,0.17728501892915094,0.029014823436509962,0.12836521145013746,0.13225682429834681,0.028972824655245866,0.1554620038520298,0.1184159938485198,3.789755637709665e-07,0.18355347890709606,0.10380622837370242
63,0.5,7,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Are cervical cord plaques related to discopathy in multiple sclerosis patients? Evidence from the study indicates a potential correlation, especially among those with widespread cervical cord lesions. Further studies are needed to clarify the exact relationship and its clinical importance.",4.974054274493934e-07,0.22655906276921556,0.1743767313019391,0.038081955760419325,0.2519791674173133,0.13225682429834681,0.0380268323600102,0.2822137094911721,0.1184159938485198,4.974054274493935e-07,0.31360660715529365,0.10380622837370242
63,0.5,8,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Is there any correlation between cervical cord plaques and discopathy in patients with multiple sclerosis? The study suggests a possible association, notably in patients with more extensive cervical cord lesions. More research is required to determine the precise nature and clinical implications of this link.",3.789755637709665e-07,0.16490513579747113,0.1321832242712671,0.029014823436509962,0.16060461519711167,0.1090141939128593,0.028972824655245866,0.1554620038520298,0.1184159938485198,3.789755637709665e-07,0.18355347890709606,0.10380622837370242
63,0.5,9,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Does the presence of cervical cord plaques relate to discopathy in multiple sclerosis patients? Study findings suggest a possible correlation, particularly in individuals with extensive cervical cord lesions. Further investigation is necessary to clarify the relationship and its clinical relevance.",4.974054274493934e-07,0.22655906276921556,0.1743767313019391,0.038081955760419325,0.2519791674173133,0.13225682429834681,0.0380268323600102,0.2822137094911721,0.1184159938485198,4.974054274493935e-07,0.31360660715529365,0.10380622837370242
63,0.5,10,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study data indicates a potential association, especially in those with significant cervical cord lesions. Additional research is needed to define the clinical implications of this relationship.",4.737194547137081e-07,0.2003526045534363,0.17501643655489812,0.03626852929563745,0.22600368101405532,0.13225682429834681,0.03621603081905733,0.2555454624090112,0.1184159938485198,4.737194547137081e-07,0.2862076329671783,0.10380622837370242
64,0.5,1,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Question: Are the 30-day and 1-year mortality rates following emergency general surgery laparotomies a significant concern requiring enhancement? Answer: This article examines the concerningly high mortality rates linked to emergency general surgery laparotomies, emphasizing the critical need for advancements in surgical methods, pre-operative evaluations, and post-operative management to reduce these risks.",0.0,4.440892098500626e-16,1.3877787807814457e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
64,0.5,2,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Question: Is there a pressing issue with 30-day and 1-year mortality rates in emergency general surgery laparotomies that demands improvement? Answer: This article investigates the notably elevated mortality rates in emergency general surgery laparotomies, underlining the necessity for better surgical techniques, thorough pre-operative assessments, and enhanced post-operative care to lower these risks.",2.3685972735685406e-08,0.03293092291112609,0.037125361876701346,0.0018134264647818726,0.06240911991656439,0.05899577951060701,0.0018108015409528666,0.06425587776378805,0.060964083175803374,2.3685972735685406e-08,0.03670885584882866,0.04158790170132326
64,0.5,3,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Question: Do 30-day and 1-year mortality rates in emergency general surgery laparotomies represent a problem that needs addressing? Answer: This article discusses the alarmingly high mortality associated with emergency general surgery laparotomies, stressing the urgent requirement for improved surgical procedures, pre-operative assessments, and post-operative care to mitigate these dangers.",4.737194547137081e-08,0.015406597899722652,0.01816764379437616,0.0036268529295637453,0.04287659944973932,0.0008672350871665457,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
64,0.5,4,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Question: Is the mortality within 30 days and 1 year after emergency general surgery laparotomies an area of concern and improvement? Answer: This article highlights the high mortality rates tied to emergency general surgery laparotomies and the pressing need for advancements in surgical techniques, pre-operative evaluation, and post-operative care to reduce these risks.",4.737194547137081e-08,0.042419853986635836,0.0022794938505515533,0.0036268529295637453,0.013932571519406967,0.018751048463603138,0.003621603081905733,0.013096107297856374,0.019991670137442734,4.737194547137081e-08,0.04167269640056892,0.0
64,0.5,5,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Question: Are the 30-day and 1-year mortality outcomes in emergency general surgery laparotomies concerning and in need of enhancement? Answer: This article explores the significantly high mortality rates connected to emergency general surgery laparotomies, emphasizing the urgent need for better surgical methods, pre-operative assessments, and post-operative care to diminish these risks.",0.0,0.027725887222397994,0.019824989940143853,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
64,0.5,6,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Question: Is there a cause for concern regarding 30-day and 1-year mortality rates in emergency general surgery laparotomies that calls for improvement? Answer: This article reviews the alarmingly high mortality rates in emergency general surgery laparotomies, highlighting the critical need for improved surgical techniques, pre-operative evaluation, and post-operative management to lessen these risks.",4.737194547137081e-08,0.01089915990259005,0.035310095065640576,0.0036268529295637453,0.04043191323039341,0.05746398099944673,0.003621603081905733,0.042355667146938725,0.05975554549569943,4.737194547137081e-08,0.014910746910446804,0.040742417383431435
64,0.5,7,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Question: Are 30-day and 1-year mortality rates in emergency general surgery laparotomies an issue that requires urgent improvement? Answer: This article analyzes the high mortality rates associated with emergency general surgery laparotomies, stressing the necessity for enhanced surgical procedures, pre-operative assessments, and post-operative care to reduce these risks.",7.105791820705622e-08,0.06718461616492943,0.003777512355540233,0.005440279394345618,0.06502401390341284,0.0013290895061728418,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
64,0.5,8,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Question: Is the mortality rate at 30 days and 1 year post emergency general surgery laparotomies an area needing attention and improvement? Answer: This article focuses on the alarmingly high mortality rates related to emergency general surgery laparotomies, highlighting the urgent demand for improved surgical techniques, thorough pre-operative assessments, and effective post-operative care to mitigate these risks.",1.4211583641411244e-07,0.14699583407705807,0.02409025057114525,0.010880558788691236,0.11859925675699046,0.002223722565157755,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
64,0.5,9,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Question: Are the 30-day and 1-year mortality figures in emergency general surgery laparotomies a concern that requires action? Answer: This article investigates the high mortality rates following emergency general surgery laparotomies, underscoring the need for advancements in surgical methods, pre-operative evaluations, and post-operative care to lower these risks.",7.105791820705622e-08,0.037688991460250953,0.017286409693230288,0.005440279394345618,0.06502401390341284,0.0013290895061728418,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
64,0.5,10,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Question: Should the 30-day and 1-year mortality rates in emergency general surgery laparotomies be considered an area needing improvement? Answer: This article examines the concerning mortality rates in emergency general surgery laparotomies, emphasizing the urgent need for better surgical techniques, comprehensive pre-operative assessments, and improved post-operative care to reduce these risks.",0.0,0.05545177444479554,0.039009886603066035,0.0,0.08487516496652381,0.06058834876543211,0.0,0.08664339756999295,0.06222222222222222,0.0,0.05899124940935696,0.04246913580246913
65,0.5,1,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Emergency double-balloon enteroscopy (DBE) combined with real-time capsule endoscopy viewing is a viable method for managing acute overt-obscure gastrointestinal bleeding (OGIB).,4.974054274493914e-07,0.6840277355620277,0.024375,0.038081955760419436,0.744440474947496,0.0,0.03802683236001032,0.7731898882334796,0.0,4.974054274493933e-07,0.8043728156701704,0.0
65,0.5,2,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","In cases of acute OGIB, emergency DBE paired with live capsule endoscopy visualization is a practical and effective approach.",5.447773729207622e-07,0.7893882512198531,0.024375,0.041708808689983196,0.8556661100577201,0.0,0.04164843544191606,0.8909729238898634,0.0,5.44777372920764e-07,0.929535958624176,0.0
65,0.5,3,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Using emergency DBE alongside real-time capsule endoscopy monitoring is a feasible technique for acute overt-obscure GI bleeding.,5.921493183921328e-07,0.9071712868762369,0.024375,0.04533566161954694,0.9808292530117257,0.0,0.045270038523821804,1.0245043165143861,0.0,5.921493183921347e-07,1.0726368022648494,0.0
65,0.5,4,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",The combination of emergency DBE and real-time capsule endoscopy viewing is safe and effective for acute OGIB.,5.921493183921328e-07,0.9071712868762369,0.024375,0.04533566161954694,0.9808292530117257,0.0,0.045270038523821804,1.0245043165143861,0.0,5.921493183921347e-07,1.0726368022648494,0.0
65,0.5,5,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Emergency double-balloon enteroscopy with simultaneous capsule endoscopy viewing can diagnose and treat most acute OGIB cases, potentially avoiding major surgery.",5.210914001850768e-07,0.7353210299495778,0.024375,0.039895382225201316,0.7985076962177713,0.0,0.03983763390096319,0.8303483020734284,0.0,5.210914001850787e-07,0.8649974374866054,0.0
65,0.5,6,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Acute overt-obscure gastrointestinal bleeding can be managed safely and effectively by emergency DBE combined with real-time capsule endoscopy.,5.684633456564475e-07,0.8465466650598019,0.024375,0.04352223515476507,0.9162907318741551,0.0,0.04345923698286894,0.955511445027434,0.0,5.684633456564493e-07,0.9985288301111281,0.0
65,0.5,7,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Emergency DBE integrated with real-time capsule endoscopy is a feasible approach that may prevent the need for major surgery in acute OGIB.,4.737194547137061e-07,0.6352375713925964,0.024375,0.03626852929563756,0.6931471805599458,0.0,0.03621603081905744,0.7191226669632043,0.0,4.7371945471370796e-07,0.7472144018302216,0.0
65,0.5,8,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","The use of emergency DBE along with real-time capsule endoscopy viewing is a practical, safe, and effective strategy for acute OGIB.",4.974054274493914e-07,0.6840277355620277,0.024375,0.038081955760419436,0.744440474947496,0.0,0.03802683236001032,0.7731898882334796,0.0,4.974054274493933e-07,0.8043728156701704,0.0
65,0.5,9,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Combining emergency double-balloon enteroscopy with live capsule endoscopy viewing offers a feasible and successful treatment for acute overt-obscure GI bleeding.,5.210914001850768e-07,0.7353210299495778,0.024375,0.039895382225201316,0.7985076962177713,0.0,0.03983763390096319,0.8303483020734284,0.0,5.210914001850787e-07,0.8649974374866054,0.0
65,0.5,10,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Emergency DBE with real-time capsule endoscopy is an effective, safe, and feasible method to diagnose and treat acute OGIB, possibly avoiding surgical intervention.",4.500334819780208e-07,0.5887175557577025,0.024375,0.03445510283085568,0.6443570163905146,0.0,0.03440522927810457,0.6678293725756541,0.0,4.500334819780226e-07,0.6931471805599463,0.0
66,0.5,1,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex affect the outcome of intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis might alter the typical survival and recovery benefits seen in men during the natural progression of ischemic stroke.,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
66,0.5,2,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests that intravenous thrombolysis could change the usual survival and recovery advantage observed in men in the natural course of ischemic stroke.,2.3685972735685406e-08,0.02264861413960606,0.0004823487399244937,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
66,0.5,3,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does gender impact the effectiveness of intravenous thrombolysis in ischemic stroke patients? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register imply that intravenous thrombolysis may modify the expected survival and recovery benefits for men during ischemic stroke's natural progression.,9.474389094274162e-08,0.0938419528664296,0.0020669648430901577,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
66,0.5,4,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is there a sex-based difference in response to intravenous thrombolysis for ischemic stroke? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest intravenous thrombolysis may alter the survival and recovery advantage typically seen in men with ischemic stroke.,1.1842986367842703e-07,0.1187445534356879,0.002646604938271603,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
66,0.5,5,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,","Does biological sex influence how patients respond to intravenous thrombolysis in ischemic stroke? According to data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis might change the survival and recovery benefits usually expected for men in ischemic stroke's natural course.",4.737194547137081e-08,0.07732830868434881,0.023623078861174096,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
66,0.5,6,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the response to intravenous thrombolysis in ischemic stroke patients affected by sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis may modify the survival and recovery advantage generally observed in men during ischemic stroke.,9.474389094274162e-08,0.0938419528664296,0.0020669648430901577,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
66,0.5,7,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex play a role in the response to intravenous thrombolysis in ischemic stroke? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data suggest that intravenous thrombolysis could alter the survival and recovery benefits typically seen in men in the natural progression of ischemic stroke.,0.0,0.030136833937389085,0.021660034690337726,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
66,0.5,8,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the effectiveness of intravenous thrombolysis in ischemic stroke influenced by sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may change the expected survival and recovery advantage for men during ischemic stroke.,1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
66,0.5,9,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,","Does sex impact the response to intravenous thrombolysis in ischemic stroke? According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis might modify the survival and recovery benefits usually observed in men in ischemic stroke's natural course.",1.4211583641411244e-07,0.17893982649376383,0.028133100783146937,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
66,0.5,10,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is there an influence of sex on the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may alter the survival and recovery advantage expected for men in the natural progression of ischemic stroke.,2.3685972735685406e-08,0.02214741445367352,0.00046185441900629606,0.0018134264647818726,0.021978906718775004,0.0,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
67,0.5,1,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Do mossy fibers release GABA? We have presented strong evidence indicating a GABAergic signal from mossy fibers. The exact physiological function of this signal is still unknown, but our results imply that GABA release from mossy fibers could play a role in modulating hippocampal neuronal activity.",1.1842986367842703e-07,0.1392477111518673,0.02435662623897695,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
67,0.5,2,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Are mossy fibers capable of releasing GABA? Our data strongly support the existence of a GABAergic signal originating from mossy fibers. While the physiological role of this signal is not yet clear, it appears that GABA release by mossy fibers may influence neuronal activity regulation within the hippocampus.",7.105791820705622e-08,0.06364514120036802,0.0012748705052793678,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
67,0.5,3,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Is GABA released by mossy fibers? We have demonstrated convincing evidence of a GABAergic signal associated with mossy fibers. The functional significance of this signal remains to be clarified, but it is suggested that mossy fiber GABA release may help control neuronal activity in the hippocampus.",1.1842986367842703e-07,0.0776346284354279,0.019991670137442734,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
67,0.5,4,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Do mossy fibers emit GABA? Our findings provide compelling proof of a GABAergic signal from mossy fibers. Although the physiological role of this signal is still undetermined, the evidence points to mossy fiber GABA release contributing to the regulation of hippocampal neuronal activity.",1.8948778188548325e-07,0.14662749992237956,0.019991670137442734,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
67,0.5,5,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Can mossy fibers release GABA? There is strong evidence supporting a GABAergic signal from mossy fibers. The physiological role of this signal is yet to be established, but our findings indicate that GABA release from mossy fibers may aid in regulating neuronal activity in the hippocampus.",1.1842986367842703e-07,0.1392477111518673,0.02435662623897695,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
67,0.5,6,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Is there GABA release from mossy fibers? We have supplied convincing evidence that mossy fibers produce a GABAergic signal. The exact physiological purpose of this signal is unknown, but it likely plays a role in modulating hippocampal neuronal activity.",2.8423167282822466e-07,0.24671095847936098,0.019991670137442734,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
67,0.5,7,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Do mossy fibers discharge GABA? Our research provides compelling evidence for a GABAergic signal from mossy fibers. The physiological role of this signal remains unclear, yet our data suggest that GABA release by mossy fibers may regulate neuronal activity in the hippocampus.",2.1317375462116866e-07,0.20453710908972944,0.004383329862557267,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
67,0.5,8,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Are mossy fibers a source of GABA release? We have shown strong evidence of a GABAergic signal from mossy fibers. The function of this signal in physiology is not yet defined, but it appears that mossy fiber GABA release could influence neuronal activity regulation in the hippocampus.",9.474389094274162e-08,0.055655721716652895,0.019991670137442734,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
67,0.5,9,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Do mossy fibers secrete GABA? We have presented convincing evidence demonstrating a GABAergic signal from mossy fibers. The physiological role of this signal is still to be determined, but it suggests that GABA release from mossy fibers may contribute to controlling neuronal activity in the hippocampus.",1.1842986367842703e-07,0.1392477111518673,0.02435662623897695,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
67,0.5,10,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Is there evidence that mossy fibers release GABA? We have provided compelling data indicating a GABAergic signal from mossy fibers. Although the physiological function of this signal remains unknown, it suggests that GABA release by mossy fibers may play a role in regulating hippocampal neuronal activity.",1.1842986367842703e-07,0.1084411697936476,0.0022190736642101576,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
68,0.5,1,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements is essential for understanding and clarifying gender disparities in mortality risks related to marital status. The effects of living alone versus living with a partner appear to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.5,2,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Analyzing living arrangements is key to identifying and explaining gender-based differences in mortality risks associated with marital status. The influence of living alone compared to living with a partner seems to",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
68,0.5,3,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluating living arrangements plays a vital role in revealing and explaining gender-specific mortality risk differences by marital status. The impact of residing alone and cohabiting with a partner appears to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.5,4,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Understanding living arrangements is fundamental for detecting and interpreting gender variations in mortality risks linked to marital status. The effect of living alone versus living with a partner seems to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.5,5,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Considering living arrangements is important for identifying and elucidating gender differences in mortality risk related to marital status. The consequences of living alone and living with a partner seem to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.5,6,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The assessment of living arrangements is critical for uncovering and explaining gender disparities in mortality risks by marital status. The role of living alone compared to living with a partner appears to",4.737194547137081e-08,0.04689523646551175,0.0010318865838346326,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
68,0.5,7,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Investigating living arrangements is necessary for recognizing and clarifying gender differences in mortality risks associated with marital status. The impact of living alone versus cohabiting with a partner seems to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.5,8,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Examining living arrangements is crucial for identifying and explaining gender-based mortality risk differences by marital status. The influence of living alone and living with a partner appears to",4.737194547137081e-08,0.01538864524228023,0.023242630385487524,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
68,0.5,9,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The evaluation of living arrangements is essential for detecting and interpreting gender disparities in mortality risks related to marital status. The effect of living alone compared to living with a partner seems to",7.105791820705622e-08,0.06954385060511781,0.0015142353237591263,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
68,0.5,10,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements is vital for uncovering and explaining gender-specific differences in mortality risks by marital status. The consequences of living alone versus living with a partner appear to",2.3685972735685406e-08,0.008708906336779787,0.023242630385487524,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
69,0.5,1,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Question: Are aromatase inhibitor-related musculoskeletal symptoms best addressed by preventing osteoporosis? Answer: Patients taking aromatase inhibitors (AIs) who develop osteoporosis tend to have a higher incidence of musculoskeletal symptoms. Preventing osteoporosis is important, but effective symptom management also involves exercise, calcium and vitamin D supplements, and pain relief strategies.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
69,0.5,2,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Question: Is osteoporosis prevention the key to eliminating musculoskeletal symptoms caused by aromatase inhibitors? Answer: Individuals on AIs who develop osteoporosis are more prone to musculoskeletal symptoms. Although osteoporosis prevention is vital, treating these symptoms requires a comprehensive approach including physical activity, supplementation with calcium and vitamin D, and pain control.",2.3685972735685406e-08,0.0207685417506287,0.0004076354181128221,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
69,0.5,3,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Question: Does preventing osteoporosis eliminate aromatase inhibitor-induced musculoskeletal symptoms? Answer: Patients receiving AIs who develop osteoporosis are at increased risk for musculoskeletal symptoms. Preventing osteoporosis is essential, but managing these symptoms also demands exercise, calcium and vitamin D intake, and pain management.",1.8948778188548325e-07,0.18376856733910074,0.003975694444444445,0.014507411718254981,0.1823215567939549,0.0,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
69,0.5,4,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Question: Are musculoskeletal symptoms related to aromatase inhibitors best managed by focusing on osteoporosis prevention? Answer: Those on AIs who develop osteoporosis are more likely to suffer musculoskeletal symptoms. While preventing osteoporosis is critical, symptom management also involves exercise, vitamin D and calcium supplementation, and pain treatment.",7.105791820705622e-08,0.034887179966024195,0.020399305555555556,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
69,0.5,5,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Question: Is the key to stopping aromatase inhibitor-related musculoskeletal symptoms the prevention of osteoporosis? Answer: Patients on AIs who develop osteoporosis have a greater likelihood of experiencing musculoskeletal symptoms. Preventing osteoporosis is important, but addressing these symptoms requires a multifaceted strategy including exercise, calcium and vitamin D supplements, and pain management.",2.3685972735685406e-08,0.04849442897302669,0.020399305555555556,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
69,0.5,6,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Question: Can preventing osteoporosis eliminate musculoskeletal symptoms caused by aromatase inhibitors? Answer: Patients treated with AIs who develop osteoporosis are more susceptible to musculoskeletal symptoms. Prevention of osteoporosis is crucial, but symptom control also needs exercise, calcium and vitamin D supplementation, and pain relief.",1.4211583641411244e-07,0.10232846076155644,0.020399305555555556,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
69,0.5,7,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Question: Is preventing osteoporosis the main approach to reduce musculoskeletal symptoms in patients on aromatase inhibitors? Answer: Those on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. Preventing osteoporosis is necessary but managing symptoms also requires exercise, calcium and vitamin D supplements, and pain management.",4.737194547137081e-08,0.04287659944973932,0.0008672350871665457,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
69,0.5,8,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Question: Does preventing osteoporosis play a central role in eliminating musculoskeletal symptoms linked to aromatase inhibitors? Answer: Patients on AIs who develop osteoporosis tend to have more musculoskeletal symptoms. Osteoporosis prevention is important, but symptom management also includes physical activity, supplementation with calcium and vitamin D, and pain control.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
69,0.5,9,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Question: Is osteoporosis prevention the key factor in addressing aromatase inhibitor-related musculoskeletal symptoms? Answer: Patients treated with AIs who develop osteoporosis have a higher risk of musculoskeletal symptoms. Preventing osteoporosis is vital, but managing these symptoms requires a combination of exercise, calcium and vitamin D supplements, and pain management.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
69,0.5,10,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Question: Could preventing osteoporosis be the solution to aromatase inhibitor-associated musculoskeletal symptoms? Answer: Patients on AIs developing osteoporosis are more likely to experience musculoskeletal symptoms. While osteoporosis prevention is essential, managing symptoms involves a comprehensive approach including exercise, calcium and vitamin D supplementation, and pain relief.",9.474389094274162e-08,0.0568660866847992,0.020399305555555556,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
70,0.5,1,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Colorectal cancer in young individuals might represent a distinct clinical entity. Additional studies are necessary to confirm our results and establish the best management strategies for this group.,0.0,4.440892098500626e-16,0.0,0.0,0.03648143055578679,0.026172568965361766,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
70,0.5,2,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients represent a separate clinical entity? Answer: Colorectal cancer occurring in young patients could be considered a distinct clinical entity. More research is required to validate these findings and determine the optimal treatment approach for this population.,7.105791820705611e-08,0.08172497413789737,0.0053829717291255935,0.005440279394345618,0.07865527994541788,0.0019215668371073726,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
70,0.5,3,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer among young patients a distinct clinical condition? Answer: Colorectal cancer in younger patients may be a unique clinical entity. Further investigation is needed to corroborate our findings and to define the ideal management for this group.,0.0,0.07109201851896874,0.05076562019082794,0.0,0.03648143055578634,0.026296566837107373,0.0,0.0,0.0,0.0,0.0,0.0
70,0.5,4,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be classified as a distinct clinical entity? Answer: Colorectal cancer in young individuals may constitute a distinct clinical entity. Additional research is needed to confirm our observations and to establish the best approach for this population.,7.105791820705611e-08,0.01571095694171243,0.04048474149825497,0.005440279394345618,0.011031164768838142,0.04641811460333585,0.0054324046228586,0.04330418244171419,0.02498356344510192,7.105791820705622e-08,0.08004270767353416,0.0
70,0.5,5,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a clinically distinct entity? Answer: Colorectal cancer among young patients might represent a distinct clinical entity. Further studies are essential to validate our findings and to determine the optimal care strategy for this subgroup.,2.36859727356853e-08,0.0626411177067503,0.02652739304401356,0.0018134264647818726,0.06245691695904432,0.026296566837107373,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.5,6,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients form a separate clinical entity? Answer: Colorectal cancer in young patients may be a distinct clinical entity. More research is needed to confirm these results and to define the most effective treatment approach for this population.,7.105791820705611e-08,0.0487179655398049,0.017793936595875623,0.005440279394345618,0.011031164768837698,0.04641811460333585,0.0054324046228586,0.008646823413716476,0.049861495844875335,7.105791820705622e-08,0.04449669841405024,0.025623268698060954
70,0.5,7,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young people a unique clinical entity? Answer: Colorectal cancer in young people might be considered a distinct clinical entity. Additional studies are necessary to validate our findings and to identify the best management practices for this group.,4.7371945471370706e-08,0.021400217999956617,0.020031856180504848,0.0036268529295637453,0.016197352140654875,0.04821037253469686,0.003621603081905733,0.01844828503354945,0.05113221329437545,4.737194547137081e-08,0.017585790714489846,0.026296566837107373
70,0.5,8,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a distinct clinical syndrome? Answer: Colorectal cancer among young patients may constitute a distinct clinical syndrome. Further research is needed to verify our findings and to determine the optimal therapeutic approach for this population.,2.36859727356853e-08,0.006673600349243802,0.02237654320987656,0.0018134264647818726,0.026910907699560394,0.0006732981390464195,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,0.5,9,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be a distinct clinical syndrome? Answer: Colorectal cancer in young patients might be a distinct clinical syndrome. More studies are needed to confirm these observations and to define the ideal treatment strategy for this group.,4.7371945471370706e-08,0.08003595476491387,0.08710592079969243,0.0036268529295637453,0.08551207019664941,0.09615241275472936,0.003621603081905733,0.053994294293033374,0.0763888888888889,4.737194547137081e-08,0.017585790714489846,0.026296566837107373
70,0.5,10,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients considered a distinct clinical entity? Answer: Colorectal cancer in young patients may represent a distinct clinical entity. Further research is required to validate our findings and to establish the best approach for managing this population.,4.7371945471370706e-08,0.04622389717662356,0.06565192743764175,0.0036268529295637453,0.050854711168652145,0.07246886526165809,0.003621603081905733,0.01844828503354945,0.05113221329437545,4.737194547137081e-08,0.017585790714489846,0.026296566837107373
71,0.5,1,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? The current study indicates that septoplasty does not impact compensatory hypertrophy of the middle turbinate, even after one year.",9.47438909427412e-08,0.05448931277926761,0.04922902494331072,0.007253705859127518,0.003184971378198842,0.09000000000000004,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,0.5,2,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Is the dimension of compensatory hypertrophy of the middle turbinate changed by septoplasty? Findings from this study suggest that septoplasty does not affect compensatory hypertrophy of the middle turbinate even after one year.,4.73719454713706e-08,0.11413966149202048,0.03533607681755831,0.003626852929563759,0.11537028863693077,0.036200274348422476,0.003621603081905747,0.11652455967956632,0.03654320987654323,4.737194547137081e-08,0.1175787092227627,0.03636488340192046
71,0.5,3,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Does septoplasty modify the compensatory hypertrophy dimensions of the middle turbinate? According to this study, septoplasty does not influence compensatory hypertrophy of the middle turbinate after one year.",1.658018091497971e-07,0.22146291115353378,0.006180555555555592,0.012693985253473157,0.1657032772324163,0.05160000000000003,0.012675610786670115,0.16021668036153214,0.06222222222222223,1.6580180914979784e-07,0.2112142011978504,0.0322222222222222
71,0.5,4,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Does septoplasty affect the size of compensatory hypertrophy in the middle turbinate? The study results show that compensatory hypertrophy of the middle turbinate remains unchanged by septoplasty even after a year.,9.47438909427412e-08,0.05448931277926761,0.04922902494331072,0.007253705859127518,0.003184971378198842,0.09000000000000004,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,0.5,5,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Is compensatory hypertrophy of the middle turbinate altered in size by septoplasty? The findings suggest that septoplasty does not change the dimensions of compensatory hypertrophy of the middle turbinate even one year post-operation.,4.73719454713706e-08,0.11413966149202048,0.03533607681755831,0.003626852929563759,0.11537028863693077,0.03620027434842245,0.003621603081905747,0.11652455967956632,0.03654320987654323,4.737194547137081e-08,0.1175787092227627,0.03636488340192046
71,0.5,6,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Does septoplasty impact the dimensions of middle turbinate compensatory hypertrophy? This study's findings indicate no effect of septoplasty on compensatory hypertrophy of the middle turbinate after one year.,1.658018091497971e-07,0.11877443995946724,0.07857330703484555,0.012693985253473157,0.11238426334318952,0.09000000000000004,0.012675610786670115,0.16021668036153214,0.06222222222222223,1.6580180914979784e-07,0.2112142011978504,0.0322222222222222
71,0.5,7,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Does septoplasty lead to changes in the size of compensatory hypertrophy of the middle turbinate? The present research suggests that septoplasty does not alter compensatory hypertrophy of the middle turbinate even after one year.,2.36859727356853e-08,0.03479518903602763,0.0033505086537191087,0.0018134264647818796,0.034709994919936094,0.002746730083234214,0.0018108015409528735,0.034543646623288016,0.001987052450786085,2.3685972735685406e-08,0.03428046192097023,0.0010714757563747151
71,0.5,8,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Is the compensatory hypertrophy of the middle turbinate affected dimensionally by septoplasty? The study findings imply that septoplasty does not affect the size of compensatory hypertrophy in the middle turbinate after one year.,4.73719454713706e-08,0.027496263922027975,0.02280882547232134,0.003626852929563759,0.018787230181123604,0.05777777777777784,0.003621603081905747,0.02210487643242276,0.06222222222222223,4.737194547137081e-08,0.021972201559322446,0.0322222222222222
71,0.5,9,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Does septoplasty result in changes to the compensatory hypertrophy dimensions of the middle turbinate? According to this study, septoplasty does not affect compensatory hypertrophy of the middle turbinate one year post-surgery.",9.47438909427412e-08,0.10069912481659715,0.016790123456790138,0.007253705859127518,0.05098822520991897,0.055561224489795946,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,0.5,10,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Does septoplasty cause dimensional changes in compensatory hypertrophy of the middle turbinate? The current study concludes that compensatory hypertrophy of the middle turbinate is not influenced by septoplasty even after one year.,7.10579182070559e-08,0.10815655763902221,0.010644718792866922,0.005440279394345639,0.10791285581450571,0.008765432098765416,0.005432404622858621,0.10740318290669926,0.006364883401920436,7.105791820705622e-08,0.1065740342677306,0.0034430727023319757
72,0.5,1,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Does the nature of general practice affect the adoption of IT innovations in primary care? The analysis indicates that structural features like practice size, location, and staff makeup significantly impact the uptake of new IT tools. Larger practices, those in urban areas, and those with more nurses and administrative personnel tend to adopt new IT innovations more readily.",2.6054570009253947e-07,0.20471166296809962,0.020338715942920176,0.0199476911126006,0.1793409286558152,0.0,0.019918816950481533,0.18232155679395312,0.0,2.6054570009253947e-07,0.1854032233313614,0.0
72,0.5,2,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Do characteristics of general practices influence the acceptance of IT innovations in primary care? Results show that factors such as the size of the practice, its location, and the composition of its staff are closely linked to the adoption of new IT technologies. Practices with bigger patient bases, urban settings, and more nurses and administrative staff have higher adoption rates.",2.1317375462116866e-07,0.12158357948921505,0.014702606371129422,0.016320838183036854,0.14424960884454574,0.0,0.0162972138685758,0.14660347419187403,0.0,2.1317375462116866e-07,0.14903557916048715,0.0
72,0.5,3,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Is the uptake of IT innovations in primary care affected by general practice characteristics? The findings reveal that structural aspects like practice size, geographic location, and staff composition significantly correlate with the adoption of new IT tools. Practices serving larger populations, located in cities, and employing more nurses and administrative staff are more inclined to implement IT innovations.",2.6054570009253947e-07,0.1560697555603836,0.014702606371129422,0.0199476911126006,0.1793409286558152,0.0,0.019918816950481533,0.18232155679395312,0.0,2.6054570009253947e-07,0.1854032233313614,0.0
72,0.5,4,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Do general practice features influence how IT innovations are adopted in primary care? Analysis shows that structural characteristics such as the size of the practice, where it is located, and its staffing profile are significantly associated with IT tool adoption. Larger patient populations, urban locations, and higher numbers of nurses and administrative staff increase the likelihood of adopting new IT innovations.",1.8948778188548325e-07,0.10477646117283435,0.014702606371129422,0.014507411718254981,0.12715517548524602,0.0,0.014486412327622933,0.1292117314800052,0.0,1.8948778188548325e-07,0.13133600206108653,0.0
72,0.5,5,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Can the characteristics of a general practice impact the adoption of IT innovations in primary care? The analysis demonstrates that structural factors including practice size, location, and staff composition play a significant role in the uptake of new IT tools. Practices with larger patient groups, urban locations, and more nurses and administrative personnel are more likely to adopt these innovations.",2.1317375462116866e-07,0.12158357948921505,0.014702606371129422,0.016320838183036854,0.14424960884454574,0.0,0.0162972138685758,0.14660347419187403,0.0,2.1317375462116866e-07,0.14903557916048715,0.0
72,0.5,6,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Do the attributes of a general practice influence the uptake of IT innovations in primary care? The data show that structural characteristics like size, location, and staff makeup are significantly linked to the adoption of new IT technologies. Practices with larger patient populations, situated in urban areas, and having more nurses and administrative staff tend to adopt new IT innovations more frequently.",1.6580180914979784e-07,0.13369943335670165,0.01804660362599784,0.012693985253473108,0.11034805716886531,0.0,0.012675610786670066,0.11211729812070548,0.0,1.6580180914979784e-07,0.1139442593492177,0.0
72,0.5,7,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Are general practice characteristics influential in the adoption of IT innovations in primary care? The analysis reveals that structural features such as practice size, location, and staff composition significantly affect the adoption of IT tools. Practices with larger patient populations, urban locations, and a greater proportion of nurses and administrative staff are more likely to embrace new IT innovations.",2.3685972735685406e-07,0.21038289359609585,0.03686764156275489,0.018134264647818726,0.21028325896413058,0.035041322314049606,0.018108015409528666,0.18905830773984444,0.017851239669421492,2.3685972735685406e-07,0.16705408466316563,0.0
72,0.5,8,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Does the uptake of IT innovations in primary care depend on general practice characteristics? Findings indicate that structural aspects like the size of the practice, its location, and staff composition are significantly correlated with the adoption of new IT tools. Practices with larger patient bases, urban settings, and more nurses and administrative staff show higher adoption rates.",2.8423167282822487e-07,0.17376933265978423,0.014702606371129422,0.02176111757738247,0.19735943415849366,0.0,0.0217296184914344,0.20067069546214888,0.0,2.8423167282822487e-07,0.20409535634351572,0.0
72,0.5,9,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Are the characteristics of a general practice associated with the adoption of IT innovations in primary care? The analyses demonstrate that structural factors such as practice size, location, and staff composition are significantly linked to IT innovation uptake. Larger practices, urban-based, and those with more nurses and administrative personnel are more likely to adopt new IT technologies.",2.8423167282822487e-07,0.17376933265978423,0.014702606371129422,0.02176111757738247,0.19735943415849366,0.0,0.0217296184914344,0.20067069546214888,0.0,2.8423167282822487e-07,0.20409535634351572,0.0
72,0.5,10,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Do structural characteristics of general practices affect the uptake of IT innovations in primary care? The analysis shows that factors like practice size, location, and staff composition significantly influence the adoption of new IT tools. Practices with larger patient populations, urban locations, and higher numbers of nurses and administrative staff tend to adopt IT innovations more readily.",2.8423167282822487e-07,0.19852458910835402,0.0031486332982920695,0.02176111757738247,0.19735943415849366,0.0,0.0217296184914344,0.20067069546214888,0.0,2.8423167282822487e-07,0.20409535634351572,0.0
73,0.5,1,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is the fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) involves eosinophilic inflammation in the esophageal lining. Although mucosal fragility may be present, it is not a definitive diagnostic sign. More typical features include linear furrows, white plaques, and esophageal rings.",9.474389094274162e-08,0.05872079088953619,0.014004679839606855,0.0072537058591274906,0.05338320072892344,0.01922337562475971,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
73,0.5,2,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Can fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is marked by eosinophilic inflammation of the esophagus. While mucosal fragility can occur, it is not a specific sign; other signs such as linear furrows, white plaques, and rings are more indicative.",4.737194547137081e-08,0.011795223940886501,0.03581840899625154,0.0036268529295637453,0.012561206208669073,0.01922337562475971,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
73,0.5,3,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is esophageal mucosal fragility a hallmark endoscopic feature of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is defined by eosinophilic inflammation in the esophageal mucosa. Although fragility may be seen, it is not pathognomonic. More characteristic findings include linear furrows, white plaques, and rings.",2.3685972735685406e-07,0.1367052120870511,0.05172613262992271,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
73,0.5,4,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Does fragility of the esophageal mucosa serve as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal lining. Mucosal fragility may be noted but is not a definitive sign. Typical features include linear furrows, white plaques, and rings.",1.1842986367842703e-07,0.08110831069574109,0.012746540793188016,0.009067132323909363,0.10393223463143508,0.0020431650179623916,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
73,0.5,5,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is the fragile nature of the esophageal mucosa a diagnostic endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) involves eosinophilic inflammation in the esophagus. Although mucosal fragility can be observed, it is not a pathognomonic feature. More typical signs are linear furrows, white plaques, and rings.",1.4211583641411244e-07,0.04501394702825978,0.05370222237268814,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
73,0.5,6,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Can esophageal mucosal fragility be considered a definitive endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the mucosa. Fragility may be present but is not pathognomonic; linear furrows, white plaques, and rings are more characteristic.",2.6054570009253947e-07,0.1610033143483629,0.05117340311059168,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
73,0.5,7,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is mucosal fragility of the esophagus a pathognomonic endoscopic sign in primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) features eosinophilic inflammation of the mucosa. While fragility can be seen, it is not a definitive sign. More characteristic features include linear furrows, white plaques, and rings.",2.1317375462116866e-07,0.1444896701662821,0.02961728909250775,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
73,0.5,8,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Does the fragility of the esophageal mucosa indicate primary eosinophilic esophagitis as a pathognomonic endoscopic sign? Primary eosinophilic esophagitis (EE) is marked by eosinophilic inflammation. Although mucosal fragility may be observed, it is not pathognomonic. More typical findings include linear furrows, white plaques, and rings.",2.1317375462116866e-07,0.1444896701662821,0.029617289092507743,0.016320838183036854,0.1956234996902264,0.004019254760727814,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
73,0.5,9,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is the fragility of the esophageal mucosa an exclusive endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) involves eosinophilic inflammation in the esophagus. Mucosal fragility can occur but is not pathognomonic. More characteristic signs are linear furrows, white plaques, and rings.",2.6054570009253947e-07,0.1610033143483629,0.05117340311059168,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
73,0.5,10,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is esophageal mucosal fragility a unique endoscopic marker of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the mucosa. While fragility may be present, it is not pathognomonic. Linear furrows, white plaques, and rings are more typical features.",2.6054570009253947e-07,0.1610033143483629,0.05117340311059168,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
74,0.5,1,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is untethering required before scoliosis correction in a patient with myelomeningocele? The study indicates that spinal cord untethering might not be needed for MM patients undergoing scoliosis surgery if they show no clinical signs of tethered cord, despite radiographic evidence of tethering.",2.1317375462116866e-07,0.19845093872383757,0.0,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
74,0.5,2,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For a patient with myelomeningocele, is untethering necessary before scoliosis correction? According to the study, spinal cord untethering may be unnecessary in MM patients having scoliosis surgery who lack clinical symptoms of tethered cord, even if imaging shows tethering.",2.8423167282822466e-07,0.27443684570175897,0.0,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
74,0.5,3,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does a patient with myelomeningocele need untethering before scoliosis correction? Study findings suggest spinal cord untethering might not be required in MM patients undergoing scoliosis surgery without clinical tethered cord symptoms, despite radiographic tethering.",4.0266153650665116e-07,0.4155154439616653,0.0,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
74,0.5,4,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering essential prior to scoliosis surgery in myelomeningocele patients? The research suggests untethering may be unnecessary if patients have no clinical signs of tethered cord, even when imaging reveals tethering.",4.2634750924233646e-07,0.446287102628419,0.0,0.032641676366073735,0.4578330936254802,0.0,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
74,0.5,5,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Should untethering be performed before scoliosis correction in patients with myelomeningocele? The study results imply that untethering the spinal cord may not be needed for MM patients undergoing scoliosis correction who do not exhibit clinical symptoms of tethered cord, despite radiographic evidence.",2.1317375462116866e-07,0.23226299631212743,0.024375,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
74,0.5,6,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In myelomeningocele patients, is untethering required before scoliosis corrective surgery? Study data suggest that spinal cord untethering might be unnecessary if there are no clinical symptoms of tethered cord, even if radiographs show tethering.",4.0266153650665116e-07,0.4155154439616653,0.0,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
74,0.5,7,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is it necessary to untether the spinal cord before scoliosis correction in a patient with myelomeningocele? The study suggests that untethering may be unnecessary in MM patients without clinical signs of tethered cord, even when radiographic tethering is present.",2.8423167282822466e-07,0.27443684570175897,0.0,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
74,0.5,8,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For scoliosis correction in myelomeningocele patients, is spinal cord untethering needed beforehand? The study indicates untethering may not be required if there are no clinical symptoms of tethered cord, despite radiographic tethering.",4.5003348197802176e-07,0.4780358009429988,0.0,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
74,0.5,9,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is untethering the spinal cord mandatory prior to scoliosis surgery in patients with myelomeningocele? According to the study, it may be unnecessary if patients do not show clinical symptoms of tethered cord, even though imaging shows tethering.",3.3160361829959526e-07,0.32850406697203516,0.0,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
74,0.5,10,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does scoliosis correction in myelomeningocele patients require prior spinal cord untethering? The study suggests that untethering may be unnecessary in the absence of clinical tethered cord symptoms, despite radiographic evidence of tethering.",4.5003348197802176e-07,0.4780358009429988,0.0,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
75,0.5,1,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","What is the clinical importance of bile duct sludge compared to bile duct stones? The results suggest that symptomatic bile duct sludge has a clinical impact similar to that of small bile duct stones. Bile duct sludge can lead to biliary colic, pancreatitis, and cholangitis, though it is less prone to causing obstruction than larger stones. Differentiating between these two is crucial since treatment approaches may differ.",0.0,0.058913734527436645,0.2152978589984772,0.0,0.0080499714425315,0.031746031746031744,0.0,0.021660849392496573,0.015621063240110858,0.0,0.0,0.0
75,0.5,2,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","How does the clinical significance of bile duct sludge differ from that of bile duct stones? The evidence shows that symptomatic bile duct sludge shares similar clinical implications with small bile duct stones. While bile duct sludge can cause biliary colic, pancreatitis, and cholangitis, it is less likely to result in obstruction compared to larger stones. Proper distinction between the two conditions is essential because treatment strategies might change.",4.737194547137081e-08,0.04439262854744275,0.223058317656544,0.0036268529295637453,0.0030780049779899343,0.04518951316058832,0.003621603081905733,0.05243250805924937,0.015621063240110858,4.737194547137081e-08,0.03125254350410156,0.0
75,0.5,3,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","Is the clinical relevance of bile duct sludge distinct from that of bile duct stones? Findings reveal that symptomatic bile duct sludge has a clinical significance comparable to small bile duct stones. Bile duct sludge may cause biliary colic, pancreatitis, and cholangitis but is less likely to cause obstruction than larger stones. It is important to distinguish between these conditions as their management may differ.",4.737194547137081e-08,0.11671699373639166,0.24530401473870495,0.0036268529295637453,0.06291687568040771,0.050095112118921675,0.003621603081905733,0.010087848922083253,0.015621063240110858,4.737194547137081e-08,0.03226086221822477,0.0
75,0.5,4,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","What is the difference in clinical significance between bile duct sludge and bile duct stones? The data indicate that symptomatic bile duct sludge is clinically similar to small bile duct stones. Bile duct sludge can provoke biliary colic, pancreatitis, and cholangitis, though it is less likely to obstruct the bile duct than larger stones. Differentiating these conditions is important because treatment options could vary.",7.105791820705622e-08,0.15652834323485942,0.3941966685222867,0.005440279394345618,0.05775633286826665,0.034817334341143896,0.0054324046228586,0.026348369793864457,0.015621063240110858,7.105791820705622e-08,0.04879016416943571,0.0
75,0.5,5,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","Does bile duct sludge have a different clinical significance than bile duct stones? Findings indicate that the clinical impact of symptomatic bile duct sludge is akin to that of small bile duct stones. Bile duct sludge can cause biliary colic, pancreatitis, and cholangitis but tends to cause less obstruction than larger stones. Recognizing the difference is key as treatment may differ.",1.4211583641411244e-07,0.17141031801081397,0.24998921702316834,0.010880558788691236,0.11005625667522079,0.038206069336527065,0.0108648092457172,0.07677922342075583,0.015621063240110858,1.4211583641411244e-07,0.10008345855698497,0.0
75,0.5,6,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","How significant is bile duct sludge clinically compared to bile duct stones? The study shows that symptomatic bile duct sludge presents clinical features similar to small bile duct stones. It can cause biliary colic, pancreatitis, and cholangitis but is less likely to cause obstruction than larger stones. Differentiation is crucial since treatment approaches may vary.",2.8423167282822487e-07,0.21608098219164162,0.08556452566514365,0.02176111757738247,0.1875966426117559,0.011877274468849543,0.0217296184914344,0.18597851538574695,0.015621063240110858,2.8423167282822487e-07,0.21130909366720996,0.0
75,0.5,7,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","What clinical differences exist between bile duct sludge and bile duct stones? The findings demonstrate that symptomatic bile duct sludge has clinical effects comparable to small bile duct stones. Bile duct sludge can lead to biliary colic, pancreatitis, and cholangitis, though it is less likely to cause obstruction than larger stones. Distinguishing between these conditions is important for treatment decisions.",1.6580180914979784e-07,0.19142168108091706,0.2565070674949764,0.012693985253473108,0.12811382178963537,0.03941484001007814,0.012675610786670066,0.09417096613262466,0.015621063240110858,1.6580180914979784e-07,0.11778303565638559,0.0
75,0.5,8,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","Is there a clinical difference between bile duct sludge and bile duct stones? The evidence suggests that symptomatic bile duct sludge is clinically similar to small bile duct stones. It can cause biliary colic, pancreatitis, and cholangitis but is less likely to cause obstruction than larger stones. Differentiating the two is vital as treatment options may differ.",2.3685972735685406e-07,0.17512903127103208,0.07835505820952256,0.018134264647818726,0.1496042255721468,0.012562638224013874,0.018108015409528666,0.1482381874028995,0.015621063240110858,2.3685972735685406e-07,0.17284281283941416,0.0
75,0.5,9,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","How does symptomatic bile duct sludge compare clinically to bile duct stones? Results indicate that the clinical significance of symptomatic bile duct sludge mirrors that of small bile duct stones. It can cause biliary colic, pancreatitis, and cholangitis but is less likely to cause obstruction than larger stones. Distinguishing between these two is important due to differences in treatment.",1.8948778188548325e-07,0.15967119071207625,0.09061173107632196,0.014507411718254981,0.13732269835742184,0.00430310109963793,0.014486412327622933,0.13662579968059507,0.0022301764293106343,1.8948778188548325e-07,0.13580154115906407,0.0
75,0.5,10,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","What is the clinical importance of symptomatic bile duct sludge versus bile duct stones? Findings reveal that symptomatic bile duct sludge has a clinical profile similar to small bile duct stones. It can cause biliary colic, pancreatitis, and cholangitis but tends to cause less obstruction than larger stones. Differentiation is essential as treatment may vary.",2.8423167282822487e-07,0.24175309999015848,0.10604199338692642,0.02176111757738247,0.21375313999137635,0.006939595010117341,0.0217296184914344,0.21263802233036033,0.0036023123846488526,2.8423167282822487e-07,0.21130909366720996,0.0
76,0.5,1,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Are correlated results achievable from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? The findings indicate that quantitative real-time PCR assays for BCRABL can yield comparable results across different laboratories despite methodological differences, provided the same positive control cell line and quality control gene are utilized. Standardization of assays between labs is essential.",2.3685972735685406e-07,0.2035936914059513,0.024145840009505665,0.018134264647818726,0.17699463782030733,0.0029920601690792935,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
76,0.5,2,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Is it possible to obtain correlated results from homebrew assays detecting BCRABL transcripts by quantitative real-time PCR? The data suggest that quantitative real-time PCR assays for BCRABL detection can be consistent across laboratories even with diverse methodologies if the identical positive control cell line and quality control gene are employed. Implementing some assay standardization among labs is crucial.,1.6580180914979784e-07,0.09683107044398387,0.01367921648367984,0.012693985253473108,0.09577836325765787,0.01586888657648284,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
76,0.5,3,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can homebrew assays for BCRABL transcript detection via quantitative real-time PCR produce correlated results? Results imply that despite methodological variations, quantitative real-time PCR assays for BCRABL detection can be comparable between labs when the same positive control cell line and quality control gene are used. Some degree of assay standardization between laboratories is necessary.",2.6054570009253947e-07,0.24989546054103773,0.04375128122560795,0.0199476911126006,0.22320534930060631,0.02253111342351717,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
76,0.5,4,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Are consistent results possible from homebrew quantitative real-time PCR assays for BCRABL transcript detection? The evidence shows that quantitative real-time PCR assays for BCRABL can be comparable across laboratories despite significant methodological differences if the same positive control cell line and quality control gene are applied. It is vital that laboratories adopt some standardization of assays.,2.1317375462116866e-07,0.23425495944401398,0.058782518210197685,0.016320838183036854,0.2348344786225991,0.057731113423517146,0.0162972138685758,0.23531196363183238,0.056400000000000027,2.1317375462116866e-07,0.21294915948110926,0.03840000000000001
76,0.5,5,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Is correlated detection of BCRABL transcripts feasible using homebrew quantitative real-time PCR assays? Findings suggest that quantitative real-time PCR assays for BCRABL can be comparable between labs even with differing methodologies, as long as the same positive control cell line and quality control gene are used. Assay standardization among labs is imperative.",3.079176455639103e-07,0.23810023660015078,0.007932872229356399,0.023574544042164344,0.23683293578706,0.0041227835609598945,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
76,0.5,6,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can quantitative real-time PCR homebrew assays for BCRABL transcript detection yield correlated results? The results indicate that despite methodological differences, quantitative real-time PCR assays for BCRABL detection may be comparable among laboratories if the same positive control cell line and quality control gene are employed. Some level of assay standardization is essential between labs.",2.6054570009253947e-07,0.24989546054103773,0.04375128122560795,0.0199476911126006,0.22320534930060631,0.02253111342351717,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
76,0.5,7,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Is it feasible to get correlated results from homebrew assays detecting BCRABL transcripts by quantitative real-time PCR? The study suggests that quantitative real-time PCR assays for BCRABL detection can be consistent across laboratories despite methodological variations, provided the same positive control cell line and quality control gene are used. Standardizing assays between labs is critical.",2.3685972735685406e-07,0.15224945580891802,0.012705555837506113,0.018134264647818726,0.15083814044068644,0.01586888657648284,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
76,0.5,8,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Are correlated outcomes achievable from homebrew quantitative real-time PCR assays for BCRABL transcript detection? Data suggest that quantitative real-time PCR assays for BCRABL can be comparable between labs despite significant methodological differences if the same positive control cell line and quality control gene are utilized. Assay standardization between labs is necessary.,3.316036182995957e-07,0.3698937024809177,0.08655111325151997,0.025387970506946217,0.3424766425042125,0.06511876774450481,0.025351221573340132,0.3425767717071935,0.06222222222222222,3.316036182995957e-07,0.31971751187260944,0.04246913580246913
76,0.5,9,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Is it possible to obtain correlated results from homebrew quantitative real-time PCR assays detecting BCRABL transcripts? Results indicate that quantitative real-time PCR assays for BCRABL detection can be comparable across laboratories even with diverse methodologies if the same positive control cell line and quality control gene are applied. Some assay standardization among labs is imperative.,2.3685972735685406e-07,0.2035936914059513,0.024145840009505665,0.018134264647818726,0.20315113519992778,0.021808929648046177,0.018108015409528666,0.20255017340827708,0.01922337562475971,2.3685972735685406e-07,0.17904823144898518,0.0
76,0.5,10,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can homebrew quantitative real-time PCR assays for BCRABL transcript detection produce correlated results? The findings imply that despite methodological differences, quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories if the same positive control cell line and quality control gene are used. It is crucial to adopt some assay standardization between laboratories.",2.3685972735685406e-07,0.25493792700298457,0.06041100634014361,0.018134264647818726,0.2554641299591687,0.05909987643892741,0.018108015409528666,0.25586918729750385,0.057476051645147866,2.3685972735685406e-07,0.23341271619878468,0.039150354019158694
77,0.5,1,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does the fibronectin-aggrecan complex exist in cervical disk disease? Biochemical studies of damaged cervical intervertebral disks show inflammatory markers like MCP, fragments of matrix proteins such as FAC, and a link with pH. Further analysis of FAC is ongoing.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
77,0.5,2,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex found in cervical disk disease? Injured cervical intervertebral disks exhibit inflammatory markers including MCP, structural protein fragments like FAC, and a pH correlation according to biochemical analysis. Additional study on FAC is being conducted.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
77,0.5,3,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex present in cervical disk disease? Biochemical analysis of affected cervical intervertebral disks indicates inflammatory markers such as MCP, fragments of matrix proteins like FAC, and a relationship with pH. Further investigation of FAC continues.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
77,0.5,4,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does cervical disk disease involve the fibronectin-aggrecan complex? Biochemical examination of injured cervical disks reveals inflammatory markers including MCP, fragments of structural proteins such as FAC, along with a pH association. Further evaluation of FAC is underway.",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
77,0.5,5,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex detected in cervical disk disease? Biochemical analysis of damaged cervical intervertebral disks identifies inflammatory markers like MCP, fragments of matrix proteins such as FAC, and a pH correlation. Further study of FAC is ongoing.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
77,0.5,6,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex associated with cervical disk disease? Analysis of injured cervical intervertebral disks shows inflammatory markers such as MCP, structural protein fragments like FAC, and a correlation with pH. Further evaluation of FAC is in progress.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
77,0.5,7,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex observed in cervical disk disease? Biochemical studies of damaged cervical disks reveal inflammatory markers including MCP, fragments of matrix proteins like FAC, and a link to pH. Further analysis of FAC is continuing.",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
77,0.5,8,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex involved in cervical disk disease? Injured cervical intervertebral disks display inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and a relationship with pH, based on biochemical analysis. Further study of FAC is ongoing.",1.1842986367842703e-07,0.08697649429816368,0.02221074380165289,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
77,0.5,9,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Biochemical examination of injured cervical disks shows inflammatory markers including MCP, fragments of matrix proteins such as FAC, and a pH correlation. Further evaluation of FAC is underway.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
77,0.5,10,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex found in cases of cervical disk disease? Biochemical analysis of damaged cervical intervertebral disks reveals inflammatory markers like MCP, fragments of structural proteins such as FAC, and an association with pH. Further investigation of FAC continues.",1.4211583641411233e-07,0.1122943022824554,0.02221074380165289,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
78,0.5,1,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis be an early indicator of bronchiectasis? Answer: A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi might play a role in neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. It is still unclear if this mechanism contributes to the progression from PBB to bronchiectasis.,9.474389094274162e-08,0.07362193352346624,0.002455283499887863,0.0072537058591274906,0.07322945486480048,0.0012758533145614953,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
78,0.5,2,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is alveolar macrophage phagocytic dysfunction in pediatric protracted bacterial bronchitis a precursor to bronchiectasis? Answer: A weakened alveolar macrophage phagocytic response to apoptotic cells or NTHi could lead to neutrophilic inflammation and NTHi colonization observed in both PBB and bronchiectasis. The role of this mechanism in advancing PBB to bronchiectasis is yet unknown.,4.737194547137081e-08,0.03894356239886809,0.0013659614719480281,0.0036268529295637453,0.03872771712894396,0.0007114496724635287,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
78,0.5,3,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis precede bronchiectasis? Answer: Reduced alveolar macrophage phagocytosis of apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this also drives the progression from PBB to bronchiectasis is not yet established.,1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.0921109178578674,0.01851192595229618,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
78,0.5,4,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is impaired alveolar macrophage phagocytosis in children with protracted bacterial bronchitis an early step towards bronchiectasis? Answer: A decreased alveolar macrophage phagocytic response to apoptotic cells or NTHi might promote neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. It remains uncertain if this process leads to PBB progressing into bronchiectasis.,7.105791820705622e-08,0.03233826955493324,0.017088479127821278,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.5,5,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could dysfunction in alveolar macrophage phagocytosis in pediatric protracted bacterial bronchitis signal the onset of bronchiectasis? Answer: A lowered alveolar macrophage phagocytic activity against apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization seen in PBB and bronchiectasis. The involvement of this mechanism in the transition from PBB to bronchiectasis is still unknown.,2.3685972735685406e-08,0.04367395309483202,0.018460615083159496,0.0018134264647818726,0.04402125646671262,0.01851192595229618,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
78,0.5,6,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is alveolar macrophage phagocytic impairment in children with protracted bacterial bronchitis a potential precursor to bronchiectasis? Answer: Reduced phagocytic activity of alveolar macrophages towards apoptotic cells or NTHi could facilitate neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this dysfunction promotes progression from PBB to bronchiectasis remains unclear.,9.474389094274162e-08,0.02509684846742255,0.03631185475258099,0.0072537058591274906,0.051288923337613035,0.01851192595229618,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
78,0.5,7,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis indicate early bronchiectasis development? Answer: A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. The role of this mechanism in PBB evolving into bronchiectasis is not yet known.,2.3685972735685406e-08,0.019282670224506138,0.0006703937681290656,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.5,8,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is alveolar macrophage phagocytic dysfunction in pediatric protracted bacterial bronchitis a forerunner to bronchiectasis? Answer: A reduced phagocytic host response by alveolar macrophages to apoptotic cells or NTHi might contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism drives progression from PBB to bronchiectasis remains unknown.,7.105791820705622e-08,0.005678762610319854,0.03631185475258099,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.5,9,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis lead to bronchiectasis? Answer: A decreased alveolar macrophage phagocytic response to apoptotic cells or NTHi may play a role in neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. It is still unclear if this contributes to PBB progressing to bronchiectasis.,4.737194547137081e-08,0.03894356239886809,0.0013659614719480281,0.0036268529295637453,0.03872771712894396,0.0007114496724635287,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
78,0.5,10,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is impaired alveolar macrophage phagocytosis in children with protracted bacterial bronchitis an initial step towards bronchiectasis? Answer: Reduced alveolar macrophage phagocytic activity against apoptotic cells or NTHi might promote neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism is involved in PBB advancing to bronchiectasis is unknown.,9.474389094274162e-08,0.052279090842322073,0.016711854752580996,0.0072537058591274906,0.051288923337613035,0.01851192595229618,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
79,0.5,1,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers (BTMs) are frequently utilized to evaluate bone metabolism, but their relationship with bone histomorphometryâ€”the gold standard for bone structure assessmentâ€”remains uncertain. A study involving 370 postmenopausal women examined this connection and found that specific BTMs, especially those related to bone formation, showed significant correlations with bone histomorphometric measures. This suggests that BTMs offer meaningful information about bone turnover processes.",9.474389094274162e-08,0.056992461259396165,0.0048687407760766716,0.007253705859127546,0.05264373348542595,0.0,0.007243206163811466,0.05334598070529406,0.0,9.474389094274162e-08,0.054067221270275745,0.0
79,0.5,2,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","Do biochemical markers of bone turnover accurately reflect bone histomorphometry in 370 postmenopausal women? While bone turnover markers (BTMs) are commonly used to monitor bone metabolism, their association with bone histomorphometry, the definitive method for assessing bone structure, is not well established. Research on 370 postmenopausal women revealed that some BTMs, particularly those indicating bone formation, significantly correlated with bone histomorphometric parameters, indicating that BTMs can effectively represent bone turnover dynamics.",2.1317375462116866e-07,0.11328086087259948,0.0027932220806913405,0.01632083818303698,0.1226023220923329,0.0,0.016297213868575813,0.12429771667757539,0.0,2.1317375462116866e-07,0.12604072089536533,0.0
79,0.5,3,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","Question: Can biochemical markers of bone turnover represent bone histomorphometry in 370 postmenopausal women? Bone turnover markers (BTMs) serve as common tools to assess bone metabolism, but their correlation with bone histomorphometryâ€”the gold standard for bone structure evaluationâ€”is unclear. A study conducted on 370 postmenopausal women demonstrated that certain BTMs, mainly those reflecting bone formation, were significantly associated with bone histomorphometric parameters, suggesting BTMs provide valuable insights into bone turnover.",2.3685972735685406e-07,0.10125147208170482,0.04664078865553065,0.018134264647818865,0.1372011215134865,0.0,0.01810801540952868,0.1391128024627193,0.0,2.3685972735685406e-07,0.14107859825990587,0.0
79,0.5,4,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","Are biochemical markers of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? Bone turnover markers (BTMs) are widely used to evaluate bone metabolism; however, their correlation with bone histomorphometry, considered the gold standard for bone structural analysis, is uncertain. A study with 370 postmenopausal women found that specific BTMs, especially those linked to bone formation, had significant correlations with bone histomorphometric measures, implying BTMs can offer meaningful information about bone turnover.",1.6580180914979784e-07,0.07543454318367893,0.03466589660828882,0.012693985253473206,0.0940289496482789,0.0,0.012675610786670066,0.09531017980432566,0.0,1.6580180914979784e-07,0.09662683568906782,0.0
79,0.5,5,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","Do biochemical markers of bone turnover correspond to bone histomorphometry in 370 postmenopausal women? Bone turnover markers (BTMs) are commonly utilized to assess bone metabolism, yet their relationship with bone histomorphometryâ€”the gold standard for bone structure assessmentâ€”is unclear. A study of 370 postmenopausal women discovered that certain BTMs, particularly those indicating bone formation, significantly correlated with bone histomorphometric parameters, suggesting BTMs can provide important insights into bone turnover dynamics.",2.6054570009253947e-07,0.14481815639637396,0.00018546840759678385,0.019947691112600738,0.1520162072986304,0.0,0.019918816950481547,0.15415067982725983,0.0,2.6054570009253947e-07,0.15634607039069337,0.0
79,0.5,6,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","Are biochemical markers of bone turnover indicative of bone histomorphometry in a study of 370 postmenopausal women? Bone turnover markers (BTMs) are frequently used to evaluate bone metabolism, but their connection with bone histomorphometry, the gold standard for assessing bone structure, remains unclear. Research involving 370 postmenopausal women showed that specific BTMs, especially those reflecting bone formation, were significantly associated with bone histomorphometric parameters, suggesting BTMs offer valuable information about bone turnover.",1.8948778188548325e-07,0.09050552253018651,0.03389199408146625,0.014507411718255092,0.10821358464023678,0.0,0.014486412327622947,0.10969891725642178,0.0,1.8948778188548325e-07,0.11122563511022143,0.0
79,0.5,7,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","Can biochemical markers of bone turnover represent bone histomorphometry in 370 postmenopausal women? Bone turnover markers (BTMs) are commonly applied to assess bone metabolism, but their correlation with bone histomorphometryâ€”the gold standard for bone structure evaluationâ€”is not well defined. A study on 370 postmenopausal women found that certain BTMs, particularly those related to bone formation, significantly correlated with bone histomorphometric parameters, indicating that BTMs provide meaningful insights into bone turnover.",2.3685972735685406e-07,0.10125147208170482,0.04664078865553067,0.018134264647818865,0.1372011215134865,0.0,0.01810801540952868,0.1391128024627193,0.0,2.3685972735685406e-07,0.14107859825990587,0.0
79,0.5,8,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","Are biochemical markers of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? Bone turnover markers (BTMs) are widely used to monitor bone metabolism, though their association with bone histomorphometryâ€”the definitive method for bone structure assessmentâ€”is unclear. A study involving 370 postmenopausal women found that specific BTMs, especially those indicating bone formation, significantly correlated with bone histomorphometric measures, suggesting BTMs can effectively represent bone turnover dynamics.",3.079176455639103e-07,0.1983798690408518,0.018006255927259435,0.023574544042164483,0.18232155679395845,0.0,0.02354042003238728,0.18492233849401263,0.0,3.079176455639103e-07,0.18759861389479493,0.0
79,0.5,9,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","Do biochemical markers of bone turnover accurately represent bone histomorphometry in 370 postmenopausal women? Bone turnover markers (BTMs) are commonly utilized to assess bone metabolism, but their relationship with bone histomorphometry, the gold standard for evaluating bone structure, is not fully understood. Research on 370 postmenopausal women revealed that certain BTMs, particularly those reflecting bone formation, showed significant correlations with bone histomorphometric parameters, indicating BTMs provide valuable insights into bone turnover.",2.1317375462116866e-07,0.0860016822313936,0.04725799987340208,0.01632083818303698,0.1226023220923329,0.0,0.016297213868575813,0.12429771667757539,0.0,2.1317375462116866e-07,0.12604072089536533,0.0
79,0.5,10,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","Are biochemical markers of bone turnover correlated with bone histomorphometry in 370 postmenopausal women? Bone turnover markers (BTMs) are commonly used to assess bone metabolism; however, their association with bone histomorphometry, considered the gold standard for bone structure evaluation, is unclear. A study of 370 postmenopausal women found that certain BTMs, especially those related to bone formation, significantly correlated with bone histomorphometric parameters, suggesting BTMs can offer important insights into bone turnover dynamics.",1.6580180914979784e-07,0.12847739054158147,0.05322147029763741,0.012693985253473206,0.11355422234010781,0.014081632653061225,0.012675610786670066,0.09531017980432566,0.0,1.6580180914979784e-07,0.09662683568906782,0.0
80,0.5,1,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Documentation of opioid dependence and MMT is essential for patients undergoing MMT and medical care to ensure accurate diagnosis, treatment planning, and monitoring, including dates of diagnosis, treatment start, and progress.",9.474389094274162e-08,0.09717882314338322,0.00584194214876034,0.0072537058591274906,0.0938419528664296,0.0020669648430901577,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
80,0.5,2,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? For patients on MMT and receiving medical care, it is vital to document opioid dependence and MMT for precise diagnosis, treatment planning, and tracking progress, including diagnosis date, treatment commencement, and ongoing status.",4.737194547137081e-08,0.016611320542142316,0.01918476147481997,0.0036268529295637453,0.04582161865889667,0.0009865860091207122,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
80,0.5,3,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Proper recording of opioid dependence and MMT among patients receiving MMT and medical care is important for accurate diagnosis, treatment planning, and monitoring, covering diagnosis date, treatment initiation, and progress updates.",4.737194547137081e-08,0.04741786190036201,0.0027934727610052362,0.0036268529295637453,0.07732830868434881,0.023623078861174096,0.003621603081905733,0.07770177782373144,0.023242630385487524,4.737194547137081e-08,0.04652001563489394,0.0
80,0.5,4,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Are opioid dependence and methadone maintenance treatment (MMT) documented within the medical record? For patients undergoing MMT and medical care, documenting opioid dependence and MMT is critical for proper diagnosis, treatment planning, and monitoring, including the dates of diagnosis, start of treatment, and ongoing progress.",7.105791820705622e-08,0.04048447372866537,0.01818158392833716,0.005440279394345618,0.06954385060511781,0.0015142353237591263,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
80,0.5,5,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Is opioid dependence and methadone maintenance treatment (MMT) included in the medical record documentation? Documentation of opioid dependence and MMT is essential for patients on MMT and medical care to facilitate accurate diagnosis, treatment planning, and monitoring, with details such as diagnosis date, treatment initiation, and progress.",2.3685972735685406e-08,0.006707001018294356,0.020144628099173528,0.0018134264647818726,0.02264861413960606,0.0004823487399244937,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
80,0.5,6,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the patient's medical record? For patients receiving MMT and medical care, it is crucial to document opioid dependence and MMT to ensure accurate diagnosis, treatment planning, and ongoing monitoring, including diagnosis date, treatment start, and progress notes.",2.3685972735685406e-08,0.006707001018294356,0.020144628099173528,0.0018134264647818726,0.02264861413960606,0.0004823487399244937,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
80,0.5,7,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Does the medical record contain documentation of opioid dependence and methadone maintenance treatment (MMT)? Accurate documentation of opioid dependence and MMT is necessary for patients undergoing MMT and medical care for diagnosis, treatment planning, and monitoring, including dates of diagnosis, treatment initiation, and progress.",9.474389094274162e-08,0.16165763063733074,0.050732870126599605,0.0072537058591274906,0.15985597006261676,0.049277522098034904,0.007243206163811466,0.1607145382425914,0.04865220249835634,9.474389094274162e-08,0.12996753883232204,0.02498356344510192
80,0.5,8,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Is opioid dependence and methadone maintenance treatment (MMT) documented in the patient's medical records? For those receiving MMT and medical care, documenting opioid dependence and MMT is critical to support accurate diagnosis, treatment planning, and monitoring, including the date of diagnosis, treatment start, and ongoing progress.",4.737194547137081e-08,0.04741786190036201,0.0027934727610052362,0.0036268529295637453,0.04582161865889667,0.0009865860091207122,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
80,0.5,9,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Are opioid dependence and methadone maintenance treatment (MMT) recorded in medical documentation? For patients receiving MMT and medical care, it is important to document opioid dependence and MMT for proper diagnosis, treatment planning, and monitoring, including diagnosis date, treatment initiation, and progress tracking.",1.1842986367842703e-07,0.09000512650883863,0.016033057851239638,0.009067132323909363,0.1187445534356879,0.002646604938271603,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
80,0.5,10,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Is opioid dependence and methadone maintenance treatment (MMT) noted in the medical records? Documentation of opioid dependence and MMT is essential for patients on MMT and medical care to provide accurate diagnosis, treatment planning, and monitoring, including the dates of diagnosis, treatment start, and ongoing progress.",4.737194547137081e-08,0.04741786190036201,0.0027934727610052362,0.0036268529295637453,0.04582161865889667,0.0009865860091207122,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
81,0.5,1,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Can the current prediction equations accurately estimate basal metabolic rate in Chinese individuals? Answer: Currently, the Singapore equation is the most precise for predicting basal metabolic rate in Chinese adults, surpassing formulas such as Mifflin-St Jeor and Harris-Benedict. Nonetheless, more studies are necessary to confirm its validity among various Chinese subgroups and ages.",1.1842986367842703e-07,0.12307220576519917,0.02339851508152594,0.009067132323909363,0.12314416267924644,0.02243472933109826,0.009054007704764333,0.12313528631205406,0.021299114349737202,1.1842986367842703e-07,0.12303606702672365,0.019991670137442734
81,0.5,2,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Are existing prediction equations suitable for estimating basal metabolic rate in the Chinese population? Answer: The newly developed Singapore equation provides the most accurate basal metabolic rate predictions for Chinese adults, outperforming traditional equations like Mifflin-St Jeor and Harris-Benedict. However, additional research is required to assess its applicability across different Chinese demographics and age ranges.",7.105791820705622e-08,0.031815648607090186,0.015258393181303322,0.005440279394345618,0.031097431661075703,0.016529396361753424,0.0054324046228586,0.030304520734458773,0.017851239669421492,7.105791820705622e-08,0.056089466651043196,0.0
81,0.5,3,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: How accurate are current prediction equations for basal metabolic rate in Chinese individuals? Answer: The Singapore equation is currently the most accurate for estimating basal metabolic rate in Chinese adults, exceeding the performance of well-known equations such as Mifflin-St Jeor and Harris-Benedict. Further validation is needed for its use in diverse Chinese subpopulations and age groups.",4.737194547137081e-08,0.062407464857966666,0.019435669225879006,0.0036268529295637453,0.06269223125544832,0.019322583011394195,0.003621603081905733,0.06295662331933816,0.019131008851288562,4.737194547137081e-08,0.06319776905997099,0.018860946745562133
81,0.5,4,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Are the existing basal metabolic rate prediction equations valid for Chinese adults? Answer: The Singapore equation, recently developed, is the most accurate for predicting basal metabolic rate in Chinese adults, outperforming established models like Mifflin-St Jeor and Harris-Benedict. More research is necessary to confirm its effectiveness across various Chinese subpopulations and ages.",1.4211583641411244e-07,0.09081342510663681,0.0131702479338843,0.010880558788691236,0.0897659700774085,0.015441322314049613,0.0108648092457172,0.08857342885843433,0.017851239669421492,1.4211583641411244e-07,0.11551288712184427,0.0
81,0.5,5,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Is the current basal metabolic rate prediction equation applicable to Chinese populations? Answer: At present, the Singapore equation is the most precise tool for estimating basal metabolic rate in Chinese adults, surpassing traditional methods such as Mifflin-St Jeor and Harris-Benedict. However, further studies are needed to verify its suitability for different Chinese subgroups and age brackets.",4.737194547137081e-08,0.037652208409397314,0.0018295384669700931,0.0036268529295637453,0.012281527214724974,0.016865739323651804,0.003621603081905733,0.01161238772230444,0.017851239669421492,4.737194547137081e-08,0.037041271680350096,0.0
81,0.5,6,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Can basal metabolic rate be accurately predicted in Chinese adults using current equations? Answer: The Singapore equation is the most accurate prediction model for basal metabolic rate in Chinese adults to date, outperforming the Mifflin-St Jeor and Harris-Benedict equations. Additional research is needed to validate its use across various Chinese subpopulations and age groups.",9.474389094274162e-08,0.1024425544286296,0.022029752066115675,0.0072537058591274906,0.07643044163395452,0.002636493910479411,0.007243206163811466,0.04935271570515187,0.017851239669421492,9.474389094274162e-08,0.07550755250814589,0.0
81,0.5,7,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Are the current prediction formulas for basal metabolic rate effective for Chinese people? Answer: The Singapore equation newly developed offers the best accuracy for predicting basal metabolic rate in Chinese adults, better than the Mifflin-St Jeor and Harris-Benedict formulas. Nonetheless, further validation is required for its application among different Chinese subpopulations and age categories.",9.474389094274162e-08,0.05109831883159632,0.014587999413174256,0.0072537058591274906,0.05027394425433407,0.016180375568487473,0.007243206163811466,0.04935271570515187,0.017851239669421492,9.474389094274162e-08,0.07550755250814589,0.0
81,0.5,8,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: How well do current basal metabolic rate prediction equations work for Chinese adults? Answer: The Singapore equation is the most accurate for estimating basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, more research is needed to confirm its applicability to various Chinese subpopulations and age groups.",1.1842986367842703e-07,0.07075921100595828,0.013892431709355293,0.009067132323909363,0.06982514879001966,0.015817946689289895,0.009054007704764333,0.06877080156225457,0.017851239669421492,1.1842986367842703e-07,0.09531017980432566,0.0
81,0.5,9,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Is the newly developed Singapore equation the best for predicting basal metabolic rate in Chinese adults? Answer: Yes, it currently outperforms other established equations such as Mifflin-St Jeor and Harris-Benedict, but further studies are essential to confirm its accuracy across diverse Chinese subpopulations and age ranges.",2.8423167282822487e-07,0.1600967333097434,0.05157024793388431,0.02176111757738247,0.18774687065651463,0.035041322314049606,0.0217296184914344,0.21640680036831794,0.017851239669421492,2.8423167282822487e-07,0.2461330695389088,0.0
81,0.5,10,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Are existing basal metabolic rate prediction models suitable for use in Chinese adults? Answer: The Singapore equation is currently the most accurate for predicting basal metabolic rate in Chinese adults, surpassing traditional models like Mifflin-St Jeor and Harris-Benedict. However, additional research is necessary to validate its use across different Chinese subpopulations and age groups.",9.474389094274162e-08,0.07677043663011274,0.0037930738654236504,0.0072537058591274906,0.05027394425433407,0.016180375568487473,0.007243206163811466,0.04935271570515187,0.017851239669421492,9.474389094274162e-08,0.07550755250814589,0.0
82,0.5,1,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, prevent colon cancer in coronary artery disease patients? Our findings from patients with coronary artery disease support the hypothesis that bezafibrate may have a preventive effect against colon cancer.",1.1842986367842682e-07,0.09985860583782591,0.016905864197530852,0.009067132323909363,0.09820510360836066,0.02049382716049385,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
82,0.5,2,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, effective in preventing colon cancer in individuals with coronary artery disease? Data from coronary artery disease patients back the theory that bezafibrate could help prevent colon cancer.",2.1317375462116802e-07,0.17889474339882705,0.03999024334251606,0.016320838183036868,0.1751480396207037,0.047500000000000014,0.01629721386857582,0.21402410631629154,0.024375,2.1317375462116866e-07,0.25489224962878954,0.0
82,0.5,3,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Can the peroxisome proliferator-activated receptor ligand bezafibrate, used for lowering lipids, prevent colon cancer in patients with coronary artery disease? Our data from such patients support the idea that bezafibrate might prevent colon cancer.",2.3685972735685332e-07,0.20998326302009485,0.03910156249999999,0.018134264647818747,0.20591969828745738,0.047500000000000014,0.018108015409528694,0.24577280463087137,0.024375,2.3685972735685406e-07,0.28768207245178123,0.0
82,0.5,4,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, a lipid-lowering ligand of peroxisome proliferator-activated receptors, inhibit colon cancer development in coronary artery disease patients? Evidence from these patients supports the possibility of a preventive role for bezafibrate.",3.079176455639092e-07,0.2632845227904843,0.06937499999999999,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
82,0.5,5,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Is there a protective effect of the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate against colon cancer in coronary artery disease patients? Our patient data support this potential preventive hypothesis.,3.552895910352798e-07,0.3322773942774351,0.06937499999999999,0.027201396971728145,0.37581873508285435,0.047500000000000014,0.02716202311429306,0.4216634710945355,0.024375,3.552895910352811e-07,0.47000362924573613,0.0
82,0.5,6,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does treatment with bezafibrate, a peroxisome proliferator-activated receptor ligand that lowers lipids, prevent colon cancer in patients with coronary artery disease? Data from these patients suggest a possible preventive effect of bezafibrate.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,0.5,7,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the lipid-lowering drug bezafibrate, which activates peroxisome proliferator-activated receptors, prevent colon cancer in coronary artery disease patients? Our patient-derived data support the hypothesis of a preventive effect.",3.789755637709651e-07,0.36864503844830976,0.06937499999999999,0.029014823436510025,0.41355906306570134,0.047500000000000014,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
82,0.5,8,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Could bezafibrate, a peroxisome proliferator-activated receptor ligand used for lipid lowering, prevent colon cancer in patients with coronary artery disease? Data from these patients back the hypothesis of its preventive potential.",3.079176455639092e-07,0.2632845227904843,0.06937499999999999,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
82,0.5,9,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, capable of preventing colon cancer in patients with coronary artery disease? Our findings from these patients support the preventive hypothesis.",3.789755637709651e-07,0.36864503844830976,0.06937499999999999,0.029014823436510025,0.41355906306570134,0.047500000000000014,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
82,0.5,10,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the use of bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, reduce the risk of colon cancer in coronary artery disease patients? Patient data support the hypothesis of a preventive effect.",3.079176455639092e-07,0.2632845227904843,0.06937499999999999,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
83,0.5,1,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey reveals considerable dissatisfaction among consultant radiologists regarding the current service, highlights a limited number of paediatric radiologists involved in this area, and indicates a possibility to boost the number of radiology child abuse specialists by 27% through enhanced training.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
83,0.5,2,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists content with the training and support provided for suspected child abuse cases? Answer: The survey indicates notable dissatisfaction among consultant radiologists with the existing service, confirms few paediatric radiologists are engaged in this work, and suggests a 27% increase in radiology child abuse experts could be achieved with better training.",7.105791820705622e-08,0.08261751549369967,0.01982657655510754,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
83,0.5,3,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do UK radiologists feel adequately trained and supported in cases of suspected child abuse? Answer: According to the survey, there is significant dissatisfaction among consultant radiologists about the current service, a low number of paediatric radiologists working in this field, and a potential 27% increase in child abuse radiology experts if training is improved.",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
83,0.5,4,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are consultant radiologists in the UK satisfied with their training and support in suspected child abuse cases? Answer: The survey shows a high level of dissatisfaction, confirms that few paediatric radiologists handle these cases, and suggests that improved training could raise the number of radiology child abuse experts by 27%.",1.4211583641411244e-07,0.11629931608083233,0.002140430468021242,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
83,0.5,5,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: How satisfied are UK radiologists with the training and support they receive for suspected child abuse? Answer: The survey demonstrates significant dissatisfaction among consultant radiologists with current services, identifies a small number of paediatric radiologists involved, and indicates that better training might increase radiology child abuse specialists by 27%.",1.6580180914979784e-07,0.13706785783146103,0.002548065886134064,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
83,0.5,6,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Is the training and support for suspected child abuse cases adequate for UK radiologists? Answer: The survey highlights considerable dissatisfaction among consultant radiologists, a limited number of paediatric radiologists engaged in this work, and the potential to increase child abuse radiology experts by 27% with improved training.",2.1317375462116866e-07,0.17994445728120034,0.00341530097330061,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
83,0.5,7,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists happy with the current training and support for suspected child abuse? Answer: Survey results reveal notable dissatisfaction among consultant radiologists, confirm a low number of paediatric radiologists involved, and suggest a 27% potential increase in child abuse radiology experts if training improves.",2.6054570009253947e-07,0.19393394451626023,0.017851239669421492,0.0199476911126006,0.22314355131420927,0.0,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
83,0.5,8,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: What is the level of satisfaction among UK radiologists regarding training and support in suspected child abuse? Answer: The survey indicates significant dissatisfaction among consultant radiologists, a small cohort of paediatric radiologists involved, and a possible 27% increase in radiology child abuse experts with enhanced training.",2.3685972735685406e-07,0.17195503779748522,0.017851239669421492,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
83,0.5,9,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do UK radiologists feel supported and well-trained for suspected child abuse cases? Answer: The survey shows substantial dissatisfaction among consultant radiologists with current services, a low number of paediatric radiologists participating, and suggests a 27% rise in child abuse radiology experts could result from better training.",2.3685972735685406e-07,0.20209187173487386,0.003877155392306906,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
83,0.5,10,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists satisfied with the support and training provided for suspected child abuse? Answer: The survey reveals significant dissatisfaction among consultant radiologists, confirms few paediatric radiologists are engaged in this work, and suggests that improving training could increase the number of radiology child abuse experts by 27%.",1.8948778188548325e-07,0.1293954233786887,0.017851239669421492,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
84,0.5,1,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Can Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: Our study showed that USMLE Step 2 scores, the count of honors received during medical school clerkships, and AOA membership had the strongest links to resident performance. We aimed to offer residency programs broad insight into which criteria might be considered ""high"".",4.737194547137081e-08,0.037041271680350096,0.0,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
84,0.5,2,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Is there a predictive relationship between Residency Selection Criteria and Performance in Orthopaedic Surgery Residency? Answer: We discovered that USMLE Step 2 results, the number of honors earned in medical school clerkships, and AOA membership correlated most strongly with how residents performed. Our objective was to help residency programs understand which criteria could be deemed ""high.""",2.3685972735685406e-08,0.018018505502678472,0.0,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
84,0.5,3,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Do Residency Selection Criteria Forecast Performance in Orthopaedic Surgery Residency? Answer: Findings indicated that USMLE Step 2 scores, honors count in medical school clerkships, and AOA membership were the strongest predictors of resident performance. Our purpose was to give residency programs a general idea of which criteria might be ""high.""",1.1842986367842703e-07,0.09531017980432566,0.0,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
84,0.5,4,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Does the Residency Selection Criteria Predict Orthopaedic Surgery Residency Performance? Answer: We identified USMLE Step 2, the number of honors in medical school clerkships, and AOA membership as having the strongest associations with resident performance. Our aim was to provide residency programs with an understanding of which criteria may be considered ""high.""",7.105791820705622e-08,0.056089466651043196,0.0,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
84,0.5,5,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Can Orthopaedic Surgery Residency Performance be Predicted by Residency Selection Criteria? Answer: The strongest correlations with resident performance were found with USMLE Step 2 scores, honors earned during medical school clerkships, and AOA membership. Our goal was to inform residency programs about which criteria might be ""high.""",1.8948778188548325e-07,0.15718558352241319,0.0,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
84,0.5,6,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Are Residency Selection Criteria Predictive of Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, the number of honors in medical school clerkships, and AOA membership showed the strongest correlation with resident performance. Our aim was to provide residency programs with insight into which criteria may be considered ""high.""",7.105791820705622e-08,0.056089466651043196,0.0,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
84,0.5,7,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Does Performance in Orthopaedic Surgery Residency Depend on Residency Selection Criteria? Answer: Our analysis revealed that USMLE Step 2 scores, honors during medical school clerkships, and AOA membership had the strongest ties to resident performance. We intended to give residency programs a better sense of which criteria might be ""high.""",1.1842986367842703e-07,0.09531017980432566,0.0,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
84,0.5,8,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Is Resident Performance in Orthopaedic Surgery Predicted by Residency Selection Criteria? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership had the strongest correlations with resident performance. Our goal was to help residency programs identify which criteria may be ""high.""",1.6580180914979784e-07,0.13613217432458002,0.0,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
84,0.5,9,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Do Selection Criteria for Residency Predict Orthopaedic Surgery Resident Performance? Answer: The strongest predictors of resident performance were USMLE Step 2, honors in medical school clerkships, and AOA membership. Our goal was to provide residency programs a clearer understanding of which criteria might be ""high.""",2.3685972735685406e-07,0.20067069546215155,0.0,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
84,0.5,10,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Can Residency Selection Metrics Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2 scores, the number of honors earned during medical school clerkships, and AOA membership correlated most strongly with resident performance. Our objective was to offer residency programs insight into which criteria may be ""high.""",1.1842986367842703e-07,0.09531017980432566,0.0,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
85,0.5,1,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy an effective treatment for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative approach for managing gallbladder carcinoma, but more research is needed to clarify its role in palliative or adjuvant therapy.",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,0.5,2,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external palliative radiotherapy work well for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative treatment for gallbladder carcinoma, though additional studies are required to define its role in palliative or adjuvant care.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.5,3,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy effective as palliative care for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative option for gallbladder carcinoma, but further research is necessary to establish its role in palliative or adjuvant treatment.",1.8948778188548283e-07,0.2146736688067965,0.01001184787640548,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.5,4,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy appears to be a safe and effective method for palliative management of gallbladder carcinoma, yet more studies are needed to determine its role in palliative or adjuvant therapy.",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.5,5,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a safe and effective palliative treatment for gallbladder carcinoma? External radiotherapy seems to offer a safe and effective palliative management option for gallbladder carcinoma, but further investigation is required to clarify its role in palliative or adjuvant treatment.",9.474389094274162e-08,0.2402409539214041,0.09997724580028093,0.0072537058591274906,0.17203709359539587,0.05314625850340137,0.007243206163811466,0.17304631966855455,0.05246913580246914,9.474389094274162e-08,0.1401215692254847,0.027006172839506164
85,0.5,6,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy provide effective palliative care for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, although more studies are necessary to establish its role in palliative or adjuvant settings.",1.6580180914979753e-07,0.22266058671934008,0.03509835306671685,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.5,7,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy beneficial for treating gallbladder carcinoma? External radiotherapy is seen as a safe and effective palliative method for gallbladder carcinoma, but additional research is needed to determine its role in palliative or adjuvant therapy.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.5,8,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How effective is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy seems to be a safe and effective approach to palliative care in gallbladder carcinoma, but further studies are essential to understand its role in palliative or adjuvant treatment.",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,0.5,9,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a reliable palliative treatment for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative management strategy for gallbladder carcinoma, though more research is necessary to define its role in palliative or adjuvant therapy.",1.4211583641411222e-07,0.15655295525254376,0.007117661879566646,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,0.5,10,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","What is the effectiveness of external palliative radiotherapy in gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative treatment for gallbladder carcinoma; however, further studies are needed to determine its role in palliative or adjuvant care.",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
86,0.5,1,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Can central venous pressure predict fluid responsiveness? Answer: No evidence supports using central venous pressure to guide fluid therapy, so this method should be discontinued.",2.36859727356853e-07,0.36815896487538335,0.02246211904228749,0.018134264647818796,0.36529559575252746,0.012203145043839323,0.018108015409528735,0.36101334553733055,0.0,2.3685972735685406e-07,0.3746934494414109,0.0
86,0.5,2,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a reliable predictor of fluid responsiveness? Answer: Data do not back the common use of central venous pressure for guiding fluid therapy; this practice should be stopped.,9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
86,0.5,3,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Does measuring central venous pressure help predict fluid responsiveness? Answer: There is no data validating central venous pressure as a guide for fluid therapy, and this approach should be abandoned.",1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
86,0.5,4,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Can central venous pressure be used to predict fluid responsiveness? Answer: Current evidence does not support using central venous pressure to guide fluid therapy, so this practice should end.",1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,0.5,5,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure useful for predicting fluid responsiveness? Answer: No data support its widespread use in guiding fluid therapy; this method should be discontinued.,2.36859727356853e-07,0.2572554159857914,0.056932966023875105,0.018134264647818796,0.30753333070586697,0.029384756657483937,0.018108015409528735,0.36101334553733055,0.0,2.3685972735685406e-07,0.3746934494414109,0.0
86,0.5,6,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure effectively predict fluid responsiveness? Answer: The use of central venous pressure to guide fluid therapy lacks supporting data and should be abandoned.,2.131737546211677e-07,0.32467273061096247,0.019455922865013776,0.016320838183036916,0.32216311063040726,0.010545798898071623,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
86,0.5,7,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Can central venous pressure guide fluid responsiveness prediction? Answer: There is no evidence supporting this practice, and it should be stopped.",3.316036182995942e-07,0.4316088031305698,0.056932966023875105,0.025387970506946314,0.48985488749982187,0.029384756657483937,0.02535122157334023,0.55206858230004,0.0,3.3160361829959553e-07,0.5753641449035616,0.0
86,0.5,8,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a valid measure for predicting fluid responsiveness? Answer: The approach of using central venous pressure for fluid therapy guidance is unsupported and should be abandoned.,1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,0.5,9,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Does central venous pressure predict fluid responsiveness accurately? Answer: There is no supporting data for using central venous pressure in fluid therapy, so this practice should be discontinued.",1.658018091497971e-07,0.242947756473066,0.014072951135888224,0.012693985253473157,0.24109453064651598,0.00759749186322611,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
86,0.5,10,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Can central venous pressure be relied upon to predict fluid responsiveness? Answer: No data back its widespread use in guiding fluid therapy, and this approach should be abandoned.",1.658018091497971e-07,0.14392673067878725,0.056932966023875105,0.012693985253473157,0.1897502950494827,0.029384756657483937,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
87,0.5,1,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG an effective surrogate tracer for assessing tumor hypoxia? This study demonstrated that FDG does not serve well as a surrogate tracer for tumor hypoxia in both normal and low-oxygen environments. Only particular hypoxia...,2.36859727356853e-08,0.009684843941082377,0.0283203125,0.0018134264647818796,0.011237261367182061,0.0302734375,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
87,0.5,2,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Can (18)F-FDG be used as a surrogate tracer to evaluate tumor hypoxia? Findings from this study indicate that FDG is not a reliable surrogate tracer for tumor hypoxia under ambient or hypoxic conditions. Only specific hypoxia...,4.73719454713706e-08,0.0612410097391578,0.0017267246972318406,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
87,0.5,3,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Does (18)F-FDG function as a surrogate tracer for tumor hypoxia measurement? The research showed FDG is ineffective as a surrogate tracer for tumor hypoxia in either normal or hypoxic states. Only specific hypoxia...,2.36859727356853e-08,0.24869293134279769,0.14724135539940827,0.0018134264647818796,0.25534456301133623,0.15532544378698224,0.0018108015409528735,0.21762907097231032,0.13017751479289943,2.3685972735685406e-08,0.17731131317084214,0.10207100591715977
87,0.5,4,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG suitable as a surrogate tracer to detect tumor hypoxia? The study revealed that FDG is not an appropriate surrogate tracer for tumor hypoxia under both ambient and hypoxic circumstances. Only specific hypoxia...,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
87,0.5,5,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Can (18)F-FDG act as a surrogate tracer for tumor hypoxia? This investigation found that FDG is not a good surrogate tracer for tumor hypoxia under ambient or hypoxic conditions. Only specific hypoxia...,4.73719454713706e-08,0.1546689557654517,0.06538982780612247,0.003626852929563759,0.15695814521223062,0.06632653061224487,0.003621603081905747,0.11449462833039359,0.03443877551020409,4.737194547137081e-08,0.06899287148695077,0.0
87,0.5,6,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG a reliable surrogate tracer for measuring tumor hypoxia? The study concluded that FDG is not effective as a surrogate tracer for tumor hypoxia in either ambient or hypoxic conditions. Only specific hypoxia...,0.0,0.042008920033936636,0.030080360626951082,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0,0.0,0.0,0.0
87,0.5,7,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG appropriate as a surrogate tracer for tumor hypoxia assessment? The study demonstrated that FDG does not serve well as a surrogate tracer for tumor hypoxia under both normal and hypoxic conditions. Only specific hypoxia...,4.73719454713706e-08,0.1368010418493979,0.13381693110879903,0.003626852929563759,0.14324219599531274,0.14268727705112957,0.003621603081905747,0.10551532315441081,0.1189060642092747,4.737194547137081e-08,0.06542657521741946,0.09274673008323425
87,0.5,8,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Can (18)F-FDG be considered a surrogate tracer for tumor hypoxia? Research showed that FDG is not a suitable surrogate tracer for tumor hypoxia in ambient or hypoxic environments. Only specific hypoxia...,7.10579182070559e-08,0.19193069588237854,0.06849199459876545,0.005440279394345639,0.19404658047669354,0.06858710562414266,0.005432404622858621,0.15129320720708161,0.035665294924554176,7.105791820705622e-08,0.10536051565782545,0.0
87,0.5,9,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG effective as a surrogate tracer for tumor hypoxia? The findings indicated that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia...,2.36859727356853e-08,0.11872783498780848,0.06247329258323425,0.0018134264647818796,0.1211870441932823,0.06420927467300831,0.0018108015409528735,0.07899963486032124,0.033293697978596916,2.3685972735685406e-08,0.03390155167568176,0.0
87,0.5,10,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG a valid surrogate tracer for tumor hypoxia measurement? This study found that FDG is not effective as a surrogate tracer for tumor hypoxia in both ambient and hypoxic conditions. Only specific hypoxia...,0.0,0.12602676010180858,0.0886326267092747,0.0,0.12996509635499054,0.09274673008323425,0.0,0.08943834587870247,0.06420927467300831,0.0,0.046209812037329545,0.033293697978596916
88,0.5,1,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is it essential to have expert breast pathology evaluation for managing ductal carcinoma in situ? Expert breast pathology evaluations remain crucial for DCIS management.,1.421158364141118e-07,0.16113593447999897,0.048232199546485235,0.010880558788691277,0.20515441107351418,0.02565444323686082,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.5,2,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Does the management of ductal carcinoma in situ require expert breast pathology assessment? Managing DCIS still necessitates expert breast pathology assessments.,2.1317375462116776e-07,0.3189799772175905,0.03563456790123452,0.016320838183036916,0.3617073663260584,0.01853678135729419,0.016297213868575862,0.4054651081081646,0.0,2.1317375462116844e-07,0.4248831939652664,0.0
88,0.5,3,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology assessment required in the treatment of ductal carcinoma in situ? Expert assessments in breast pathology are still needed for managing DCIS.,1.184298636784265e-07,0.055791249358307926,0.0928120982986767,0.009067132323909398,0.09768926845177583,0.07100591715976333,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.5,4,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is specialized breast pathology evaluation important for ductal carcinoma in situ management? Such expert assessments continue to be vital for DCIS care.,1.894877818854824e-07,0.13156037693617106,0.13439999999999996,0.014507411718255037,0.2374512108269351,0.07100591715976333,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
88,0.5,5,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert evaluation by breast pathologists necessary for managing ductal carcinoma in situ? Expert breast pathology assessment remains essential in DCIS management.,1.894877818854824e-07,0.13156037693617106,0.13439999999999996,0.014507411718255037,0.2374512108269351,0.07100591715976333,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
88,0.5,6,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology review necessary for the management of ductal carcinoma in situ? The management of DCIS continues to require expert breast pathology assessments.,1.184298636784265e-07,0.22907804449829472,0.025600000000000067,0.009067132323909398,0.21823660420133173,0.0151618832937514,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.5,7,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is it necessary to have expert breast pathology assessment in ductal carcinoma in situ management? Expert pathology evaluations of the breast are still required for DCIS management.,7.10579182070559e-08,0.08201372336188983,0.13439999999999996,0.005440279394345639,0.01430765951272539,0.07100591715976333,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
88,0.5,8,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Does managing ductal carcinoma in situ demand expert breast pathology assessments? The management of DCIS still depends on expert breast pathology evaluation.,1.894877818854824e-07,0.26358841132854094,0.040217174515235404,0.014507411718255037,0.30676592888292964,0.021144421314887994,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
88,0.5,9,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology assessment indispensable for ductal carcinoma in situ management? Expert assessments remain necessary for managing DCIS.,2.6054570009253846e-07,0.2857110567634278,0.13439999999999996,0.019947691112600672,0.39997014032470934,0.07100591715976333,0.019918816950481606,0.5232481437645484,0.0,2.6054570009253915e-07,0.5500463369192721,0.0
88,0.5,10,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology assessment needed for the treatment of ductal carcinoma in situ? Expert breast pathology evaluations continue to be necessary in managing DCIS.,1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.157962936326554,0.0276174874076972,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
89,0.5,1,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Question: Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple pregnancies? Answer: Our research indicates that pregnancy-induced glomerular hyperfiltration does not negatively impact the kidneys of women with higher parity. Pregnancy might provide protective effects for the kidneys against the harmful consequences of glomerular hyperfiltration.,9.474389094274162e-08,0.10669126422197195,0.05815057174961992,0.0072537058591274906,0.0906144490840246,0.005144400421012316,0.007243206163811466,0.09018744774573095,0.003605878992988247,9.474389094274162e-08,0.08963693449175114,0.0018910788526508258
89,0.5,2,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Question: Is kidney damage caused by glomerular hyperfiltration in pregnant women with multiple births? Answer: According to our findings, glomerular hyperfiltration from pregnancy does not cause kidney damage in women with more pregnancies. Pregnancy may offer protective mechanisms to safeguard the kidneys from the adverse effects of glomerular hyperfiltration.",7.105791820705622e-08,0.015825434862972276,0.05333333333333336,0.005440279394345618,0.021302257949105563,0.05975554549569943,0.0054324046228586,0.006595458310516555,0.040742417383431435,7.105791820705622e-08,0.03565738861424084,0.020823902218198284
89,0.5,3,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Question: Does increased glomerular filtration in pregnancy lead to kidney injury in women with many pregnancies? Answer: Our study suggests that pregnancy-related glomerular hyperfiltration does not adversely affect the kidneys in women with higher parity. Pregnancy could have potential protective roles for the kidney against the detrimental effects of glomerular hyperfiltration.,2.3685972735685406e-08,0.08783905250842405,0.075625,0.0018134264647818726,0.0346832326941664,0.03935623994014388,0.0018108015409528666,0.035964156108279965,0.040742417383431435,2.3685972735685406e-08,0.007827723325497526,0.020823902218198284
89,0.5,4,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Question: Can glomerular hyperfiltration during pregnancy damage kidneys in women who have had several pregnancies? Answer: We propose that glomerular hyperfiltration caused by pregnancy does not harm the kidneys of women with multiple parities. Pregnancy might involve protective mechanisms that guard the kidneys from the negative impacts of glomerular hyperfiltration.,4.737194547137081e-08,0.06650467632468526,0.07481313817212414,0.0036268529295637453,0.042355667146938725,0.05975554549569943,0.003621603081905733,0.014910746910446804,0.040742417383431435,4.737194547137081e-08,0.013678481895465833,0.020823902218198284
89,0.5,5,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Question: Does glomerular hyperfiltration in pregnant women with many children damage their kidneys? Answer: Our study suggests that glomerular hyperfiltration due to pregnancy does not have harmful effects on the kidneys of women with more parities. Pregnancy may provide protective mechanisms to prevent kidney damage from glomerular hyperfiltration.,9.474389094274162e-08,0.022424173825775107,0.07308641975308644,0.0072537058591274906,0.00020394727185779615,0.05975554549569943,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.5,6,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Question: Is kidney damage linked to glomerular hyperfiltration in women with multiple pregnancies? Answer: Findings from our study indicate that pregnancy-induced glomerular hyperfiltration does not negatively affect the kidneys in women with higher parity. Pregnancy might have protective effects that shield the kidneys from the adverse consequences of glomerular hyperfiltration.,4.737194547137081e-08,0.009921233013669095,0.034567901234567905,0.0036268529295637453,0.013474534623608037,0.03893164327750115,0.003621603081905733,0.014910746910446804,0.040742417383431435,4.737194547137081e-08,0.013678481895465833,0.020823902218198284
89,0.5,7,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Question: Does pregnancy-related glomerular hyperfiltration cause kidney harm in women with greater parity? Answer: Our results suggest that glomerular hyperfiltration during pregnancy does not damage kidneys in women with multiple pregnancies. Pregnancy may confer protective benefits to the kidneys against the harmful effects of glomerular hyperfiltration.,1.4211583641411244e-07,0.054489312779265386,0.049229024943310676,0.010880558788691236,0.0761623998681431,0.03704056442485032,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.5,8,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Question: Can repeated pregnancies and associated glomerular hyperfiltration lead to kidney damage? Answer: Our research indicates that glomerular hyperfiltration from pregnancy does not adversely impact the kidneys of women with more parities. Pregnancy may have protective mechanisms that help prevent kidney injury from glomerular hyperfiltration.,1.6580180914979784e-07,0.0160492345821166,0.09284057448470645,0.012693985253473108,0.06764522806739004,0.05975554549569943,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.5,9,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Question: Does glomerular hyperfiltration during pregnancy adversely affect the kidneys of women with many births? Answer: Our study suggests that pregnancy-related glomerular hyperfiltration does not cause kidney damage in women with higher parity. Pregnancy might provide protective mechanisms against the negative effects of glomerular hyperfiltration on the kidneys.,9.474389094274162e-08,0.018204390107936508,0.006567952249770456,0.0072537058591274906,0.00020394727185779615,0.05975554549569943,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.5,10,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Question: Is kidney injury caused by glomerular hyperfiltration in women with multiple pregnancies? Answer: According to our findings, glomerular hyperfiltration due to pregnancy does not harm the kidneys of women with more parities. Pregnancy may have protective roles that shield the kidneys from the harmful consequences of glomerular hyperfiltration.",7.105791820705622e-08,0.015825434862972276,0.05333333333333336,0.005440279394345618,0.021302257949105563,0.05975554549569943,0.0054324046228586,0.006595458310516555,0.040742417383431435,7.105791820705622e-08,0.03565738861424084,0.020823902218198284
90,0.5,1,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Are the home blood pressure readings reported by stroke patients dependable? This elderly group of stroke patients successfully recorded their blood pressures accurately, showing strong consistency with clinic measurements. This indicates that home blood pressure monitoring is a useful method for managing hypertension in these patients.",4.737194547137081e-08,0.13590473601439745,0.06632653061224489,0.0036268529295637453,0.07595845259628531,0.02271498107084911,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
90,0.5,2,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Can stroke patients be trusted to report their home blood pressure readings accurately? Elderly stroke patients in this study reliably measured their blood pressures, with results closely matching those taken in clinical settings. This demonstrates that home monitoring of blood pressure can effectively assist in hypertension management for this group.",4.737194547137081e-08,0.014910746910446804,0.04074241738343143,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
90,0.5,3,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Do stroke patients provide trustworthy home blood pressure readings? The elderly stroke patients examined were capable of accurately recording their blood pressure, with good correlation to clinic readings. This implies that home blood pressure monitoring is a beneficial approach for managing hypertension in these individuals.",7.105791820705622e-08,0.16047803786815296,0.06781677572873293,0.005440279394345618,0.09968068454250645,0.023242630385487524,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
90,0.5,4,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Is the accuracy of home blood pressure readings reported by stroke patients reliable? The elderly stroke patients in this study consistently recorded their blood pressures, aligning well with clinical measurements. This supports the use of home blood pressure monitoring as a valuable tool for hypertension management in this population.",2.3685972735685406e-08,0.12335225341882206,0.10275824770146022,0.0018134264647818726,0.0374850441883936,0.04246913580246913,0.0018108015409528666,0.008157927218613636,0.021728395061728398,2.3685972735685406e-08,0.022472855852057716,0.0
90,0.5,5,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Are home blood pressure readings reported by stroke patients dependable? This group of elderly stroke patients accurately documented their blood pressures, showing strong agreement with measurements taken in clinics. This suggests home monitoring can be an effective strategy for managing hypertension in these patients.",9.474389094274162e-08,0.12118688976346981,0.023242630385487524,0.0072537058591274906,0.09097177820572666,0.0,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
90,0.5,6,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Can elderly stroke patients reliably report their home blood pressure readings? The study found that these patients recorded their blood pressures with good accuracy, matching clinic measurements closely. This suggests that home blood pressure monitoring is a practical tool for managing hypertension among stroke survivors.",7.105791820705622e-08,0.1289713478427008,0.045351473922902494,0.005440279394345618,0.09968068454250645,0.023242630385487524,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
90,0.5,7,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Do reports of home blood pressure readings from stroke patients hold up to clinical standards? Elderly stroke patients reliably recorded their blood pressures, demonstrating good concordance with clinical data. This indicates that home blood pressure monitoring can be a valuable aid in managing hypertension in this demographic.",2.3685972735685406e-08,0.11191670703313017,0.06489994591671175,0.0018134264647818726,0.0527854480769947,0.02221074380165289,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
90,0.5,8,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
",Is the reliability of home blood pressure readings reported by stroke patients confirmed? This group of elderly stroke patients successfully recorded their blood pressures with accuracy comparable to clinic measurements. This points to home blood pressure monitoring as a useful method for managing hypertension in these patients.,2.3685972735685406e-08,0.11191670703313017,0.06489994591671175,0.0018134264647818726,0.0527854480769947,0.02221074380165289,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
90,0.5,9,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Are stroke patients' self-reported home blood pressure readings accurate? The elderly stroke patients involved were able to reliably measure their blood pressures, showing good agreement with clinical readings. This suggests that home blood pressure monitoring is a beneficial tool for managing hypertension in this population.",7.105791820705622e-08,0.1289713478427008,0.045351473922902494,0.005440279394345618,0.09968068454250645,0.023242630385487524,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
90,0.5,10,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Do elderly stroke patients provide consistent home blood pressure readings? These patients reliably recorded their blood pressures, which closely matched clinic measurements. This supports the idea that home blood pressure monitoring can effectively help manage hypertension in this group.",2.1317375462116844e-07,0.28552430309524457,0.05246913580246914,0.016320838183036854,0.25519089901027137,0.027006172839506164,0.0162972138685758,0.22314355131420927,0.0,2.1317375462116866e-07,0.2288415724288484,0.0
91,0.5,1,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are heightened carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Our findings indicate that reduced vessel compliance and elevated vascular resistance characterize young, obese, normotensive individuals independently of cardiovascular risk factors. Alterations in arterial wall properties may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.5,2,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do increased carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese males? The data suggest that young, obese, normotensive subjects exhibit decreased vessel compliance and increased vascular resistance, beyond traditional cardiovascular risk factors. Changes in arterial wall properties could...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.5,3,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is an increase in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese men? Our study shows that young, obese, normotensive subjects have diminished vessel compliance and heightened vascular resistance, independent of cardiovascular risk factors. Arterial wall property changes may...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.5,4,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Can elevated carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? Results reveal that young, obese, normotensive individuals display reduced vessel compliance and increased vascular resistance, separate from cardiovascular risk factors. This may be due to changes in arterial wall properties...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.5,5,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are increased carotid artery pulsatility and resistance indexes early markers of vascular abnormalities in young obese males? Findings suggest that young, obese, normotensive subjects have impaired vessel compliance and raised vascular resistance, independent of cardiovascular risk factors. This might be linked to changes in arterial wall properties...",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
91,0.5,6,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Does an increase in carotid artery pulsatility and resistance indexes signal early vascular abnormalities in young obese males? Our results imply that young, obese, normotensive individuals show depressed vessel compliance and increased vascular resistance, beyond cardiovascular risk factors. Changes in arterial wall properties may play a role...",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
91,0.5,7,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? The evidence points to reduced vessel compliance and increased vascular resistance in young, obese, normotensive subjects, independent of cardiovascular risk factors. This could be related to alterations in arterial wall properties...",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
91,0.5,8,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is heightened carotid artery pulsatility and resistance indexes a sign of early vascular abnormalities in young obese males? Our findings suggest that young, obese, normotensive individuals have decreased vessel compliance and increased vascular resistance, regardless of cardiovascular risk factors. Changes in arterial wall properties might...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.5,9,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do elevated carotid artery pulsatility and resistance indexes reflect early vascular abnormalities in young obese males? Data indicate that young, obese, normotensive subjects exhibit lowered vessel compliance and heightened vascular resistance, independent of cardiovascular risk factors. This may be associated with changes in arterial wall properties...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.5,10,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Can increased carotid artery pulsatility and resistance indexes be considered early signs of vascular abnormalities in young obese males? The study suggests depressed vessel compliance and increased vascular resistance in young, obese, normotensive individuals, independent of cardiovascular risk factors. Alterations in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
92,0.5,1,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does having an optimistic perspective enhance survival rates in advanced age? Answer: Among the oldest-old women, optimism seems to be a strong indicator of survival. It might also predict survival in men, though the sample size is limited.",1.4211583641411222e-07,0.010929975935384029,0.11176857330703485,0.010880558788691236,0.05356399180841365,0.06937499999999999,0.0108648092457172,0.12114367122916603,0.023795359904818555,1.4211583641411244e-07,0.15822400521489444,0.0
92,0.5,2,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can optimism forecast better survival in very old age? Answer: An optimistic attitude is a notable predictor of survival in the oldest-old women, and possibly for men, but the male sample size is small.",2.3685972735685343e-07,0.14106902273719024,0.08238381664955091,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
92,0.5,3,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does an optimistic outlook influence longevity in advanced years? Answer: For the oldest-old women, optimism is a key predictor of survival. It may also hold true for men, though the sample is small.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.5,4,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is there a link between optimism and survival at advanced ages? Answer: Optimism significantly predicts survival among the oldest-old women and may do so for men, but the male sample size is limited.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.5,5,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does optimism predict better survival among the elderly? Answer: An optimistic outlook is a significant survival predictor for the oldest-old women and possibly men, although the male sample is small.",3.3160361829959463e-07,0.2254588021288475,0.11176857330703485,0.02538797050694626,0.2971860744661661,0.06937499999999999,0.02535122157334018,0.37245809951007214,0.023795359904818555,3.316036182995957e-07,0.4177352006999784,0.0
92,0.5,6,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can an optimistic outlook improve survival chances in old age? Answer: Among oldest-old women, optimism is a significant predictor of survival and may also be for men, but the male sample size is small.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
92,0.5,7,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does having an optimistic attitude correlate with increased survival at advanced age? Answer: Optimism appears to be a significant factor for survival in oldest-old women and potentially men, though the sample size for men is small.",1.8948778188548283e-07,0.04313724533489216,0.11176857330703485,0.014507411718254981,0.10913384296322581,0.06937499999999999,0.01448641232762294,0.17830208506911438,0.023795359904818555,1.8948778188548325e-07,0.21706450523782772,0.0
92,0.5,8,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is optimism a predictor of longevity in advanced age? Answer: For oldest-old women, optimism is a significant survival predictor and may be for men as well, but the male sample size is limited.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.5,9,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does an optimistic perspective influence survival rates in the oldest-old? Answer: Optimism is a significant predictor of survival among oldest-old women and possibly men, but the male sample size is small.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.2632845227904843,0.06937499999999999,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
92,0.5,10,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can optimism be linked to better survival outcomes in advanced age? Answer: Optimistic outlooks significantly predict survival in oldest-old women and may also do so for men, though the sample size for men is small.",2.1317375462116813e-07,0.071308122301589,0.11176857330703485,0.01632083818303686,0.13812137983647732,0.06937499999999999,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
93,0.5,1,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Does the radiographic transition zone correspond to the level of aganglionosis in Hirschsprung's disease specimens? Yes, the radiographic transition zone, marked by a sudden change from normal bowel diameter to a narrowed aganglionic segment, usually indicates the extent of aganglionosis, though exceptions are possible. This relationship is useful for surgical planning and assessing disease severity.",7.105791820705622e-08,0.008127642051876993,0.032793472376406355,0.005440279394345618,0.03170576166550987,0.016804348178992037,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
93,0.5,2,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Is the radiographic transition zone indicative of the aganglionosis level in Hirschsprung's disease specimens? Indeed, the transition zone on radiographs, where the bowel changes abruptly from normal size to a constricted aganglionic segment, typically correlates with the area of aganglionosis, despite occasional mismatches. This helps in preoperative evaluation and determining disease spread.",1.4211583641411244e-07,0.04112406266969293,0.050175720897116416,0.010880558788691236,0.06381817240986454,0.03566529492455417,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
93,0.5,3,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Does the location of the radiographic transition zone match the aganglionosis level in Hirschsprung's disease specimens? Correct, the transition zone seen on imaging, characterized by a sharp shift from normal to narrowed bowel, generally corresponds to the aganglionic segment, although some variation may occur. This alignment assists in surgical planning and understanding disease extent.",9.474389094274162e-08,0.001632036846618501,0.05091477415155428,0.0072537058591274906,0.024597459256582077,0.03566529492455417,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
93,0.5,4,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Is there a correlation between the radiographic transition zone and the aganglionosis level in Hirschsprung's disease? Yes, the radiographic transition zone, where normal bowel caliber abruptly narrows into an aganglionic segment, usually reflects the level of aganglionosis, but discrepancies can happen. This correlation is valuable for preoperative strategy and gauging disease extent.",1.4211583641411244e-07,0.0683063050445929,0.030625366877957715,0.010880558788691236,0.09154405963226253,0.015673624787111436,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
93,0.5,5,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Does the radiographic transition zone reflect the extent of aganglionosis in Hirschsprung's disease specimens? Yes, the transition zone on radiographs, showing an abrupt change from normal bowel diameter to a narrowed aganglionic segment, generally matches the aganglionosis level, although some inconsistencies may arise. This aids in surgical planning and assessing disease scope.",1.4211583641411244e-07,0.04112406266969293,0.050175720897116416,0.010880558788691236,0.06381817240986454,0.03566529492455417,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
93,0.5,6,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Is the radiographic transition zone a reliable indicator of the aganglionosis level in Hirschsprung's disease? Correct, the radiographic transition zone, defined by a sudden change from normal to narrowed bowel, typically correlates with the aganglionic segment, despite possible discrepancies. This helps in preoperative planning and understanding the disease's extent.",2.1317375462116866e-07,0.13232870715788936,0.02818781919579315,0.016320838183036854,0.15518920083263055,0.014398754281832068,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
93,0.5,7,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Does the radiographic transition zone correspond to the aganglionosis level in Hirschsprung's disease? Yes, the area on imaging where normal bowel abruptly narrows to the aganglionic segment generally indicates the extent of aganglionosis, though mismatches can occur. This correlation supports preoperative planning and evaluation of disease severity.",2.6054570009253947e-07,0.1472628904674127,0.04804732583538801,0.0199476911126006,0.16917868806769043,0.03566529492455417,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
93,0.5,8,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Is the radiographic transition zone aligned with the level of aganglionosis in Hirschsprung's disease specimens? Indeed, the transition zone, marked by a sharp change from normal to narrowed bowel on radiographs, usually reflects the aganglionosis level, with occasional exceptions. This aids in planning surgery and understanding disease extent.",2.3685972735685406e-07,0.0956198513090607,0.06977572089711641,0.018134264647818726,0.14719978134891543,0.03566529492455417,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
93,0.5,9,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Does the radiographic transition zone indicate the level of aganglionosis in Hirschsprung's disease? Correct, the radiographic transition zone, where normal bowel caliber suddenly narrows to the aganglionic segment, generally corresponds to the aganglionosis level, although discrepancies may exist. This is useful for preoperative assessment and determining disease extent.",2.3685972735685406e-07,0.18410672542309614,0.006242663045876756,0.018134264647818726,0.17733661528630407,0.013936899862825772,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
93,0.5,10,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Is there a relationship between the radiographic transition zone and aganglionosis level in Hirschsprung's disease? Yes, the radiographic transition zone, characterized by an abrupt change from normal to narrowed bowel, typically correlates with the aganglionic segment, but occasional mismatches can occur. This relationship assists in surgical planning and understanding the extent of the disease.",9.474389094274162e-08,0.027788534226238948,0.03209790467258739,0.0072537058591274906,0.051256966201195464,0.01644191929979446,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
94,0.5,1,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer serve as a novel diagnostic marker for acute appendicitis? Answer: Elevated D-dimer levels should not be used as a diagnostic criterion for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.5,2,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: High D-dimer levels are not reliable for diagnosing acute appendicitis.,1.421158364141118e-07,0.19997019268387461,0.03698224852071005,0.010880558788691277,0.26236426446749217,0.0,0.010864809245717241,0.27443684570175986,0.0,1.4211583641411228e-07,0.28768207245178035,0.0
94,0.5,3,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be introduced as a diagnostic parameter for acute appendicitis? Answer: Increased D-dimer should not be considered a diagnostic indicator for acute appendicitis.,7.10579182070559e-08,0.18196333015267374,0.045662379578463495,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,0.5,4,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Might D-dimer function as a new diagnostic parameter in acute appendicitis? Answer: Raised D-dimer levels should not be regarded as a diagnostic marker for acute appendicitis.,2.36859727356853e-08,0.03971510627504049,0.0014177514792899637,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.5,5,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is it possible for D-dimer to become a diagnostic parameter for acute appendicitis? Answer: Elevated D-dimer values should not be used for diagnosing acute appendicitis.,4.73719454713706e-08,0.025616805539096177,0.03698224852071005,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.5,6,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer levels act as a new diagnostic measure for acute appendicitis? Answer: Increased D-dimer should not be accepted as a diagnostic parameter in acute appendicitis.,2.36859727356853e-08,0.03971510627504049,0.0014177514792899637,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.5,7,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer be a novel diagnostic parameter for acute appendicitis? Answer: High D-dimer levels are not appropriate for diagnosing acute appendicitis.,1.421158364141118e-07,0.19997019268387461,0.03698224852071005,0.010880558788691277,0.26236426446749217,0.0,0.010864809245717241,0.27443684570175986,0.0,1.4211583641411228e-07,0.28768207245178035,0.0
94,0.5,8,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer serve as a diagnostic marker for acute appendicitis? Answer: Elevated D-dimer should not be considered a diagnostic parameter in acute appendicitis.,9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.5,9,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer suitable as a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be used to diagnose acute appendicitis.,9.47438909427412e-08,0.10899841447814662,0.03698224852071005,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.5,10,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be used as a diagnostic parameter for acute appendicitis? Answer: Raised D-dimer levels should not be considered diagnostic for acute appendicitis.,9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
95,0.5,1,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 expression.","Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? Increased expression of TGF-Î²1 and VEGF was observed in polyps compared to nearby normal endometrial tissue, indicating that these cytokines may contribute to polyp development. Moreover, a significant correlation was found between steroid receptor expression and the levels of VEGF and TGF-Î²1.",7.105791820705622e-08,0.03812829180554278,0.062113388768176216,0.005440279394345618,0.02723735466969668,0.016124697661918846,0.0054324046228586,0.05043085362689137,0.0,7.105791820705622e-08,0.05129329438754926,0.0
95,0.5,2,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 expression.","Does endometrial polyp formation correlate with higher expression of vascular endothelial growth factor and transforming growth factor-beta1? The study showed that TGF-Î²1 and VEGF expression was elevated in polyps relative to adjacent normal endometrium, suggesting these cytokines have a role in polyp formation. Additionally, steroid receptor expression significantly correlated with VEGF and TGF-Î²1 levels.",2.3685972735685406e-07,0.06281945084577112,0.07877526753864447,0.018134264647818726,0.15353107999398752,0.016124697661918846,0.018108015409528666,0.17904823144898518,0.0,2.3685972735685406e-07,0.182321556793954,0.0
95,0.5,3,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 expression.","Is there an association between endometrial polyp formation and increased expression of VEGF and TGF-Î²1? Findings revealed enhanced expression of TGF-Î²1 and VEGF in polyps compared to normal endometrial tissue nearby, implying these cytokines might be involved in the formation of polyps. A significant correlation was also found between steroid receptor expression and the expression of VEGF and TGF-Î²1.",1.1842986367842703e-07,0.07729638123499427,0.0268488751225352,0.009067132323909363,0.11036543814858124,0.01891662465213076,0.009054007704764333,0.11027742988673062,0.017851239669421492,1.1842986367842703e-07,0.08701137698962835,0.0
95,0.5,4,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 expression.","Does the development of endometrial polyps involve increased levels of vascular endothelial growth factor and transforming growth factor-beta1? Results demonstrated elevated TGF-Î²1 and VEGF expression in polyps versus adjacent normal endometrial tissue, suggesting these cytokines play a role in polyp formation. Furthermore, a significant association was noted between steroid receptor and VEGF and TGF-Î²1 expression.",2.1317375462116866e-07,0.06979943563213364,0.06026334158634829,0.016320838183036854,0.13448288502329442,0.016124697661918846,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
95,0.5,5,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 expression.","Is increased expression of VEGF and TGF-Î²1 linked to the formation of endometrial polyps? The data showed higher TGF-Î²1 and VEGF levels in polyps compared to surrounding normal endometrium, indicating these cytokines may be involved in polyp development. There was also a significant correlation between steroid receptor expression and the expression of VEGF and TGF-Î²1.",2.1317375462116866e-07,0.12114367122916736,0.023411945739336512,0.016320838183036854,0.18679587978253576,0.02155311856261017,0.0162972138685758,0.18628965253649588,0.01922337562475971,2.1317375462116866e-07,0.16251892949777424,0.0
95,0.5,6,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 expression.","Are vascular endothelial growth factor and transforming growth factor-beta1 expressions elevated in endometrial polyp formation? Elevated TGF-Î²1 and VEGF were detected in polyps relative to adjacent normal tissue, suggesting a role for these cytokines in polyp formation. Additionally, steroid receptor expression significantly correlated with VEGF and TGF-Î²1 levels.",3.789755637709665e-07,0.1829637626878342,0.07877526753864447,0.029014823436509962,0.27613340208632087,0.016124697661918846,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
95,0.5,7,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 expression.","Is the expression of VEGF and TGF-Î²1 increased in endometrial polyps? The study found enhanced TGF-Î²1 and VEGF expression in polyps compared to adjacent normal tissue, implying these cytokines might contribute to polyp formation. Also, a significant correlation existed between steroid receptor expression and VEGF and TGF-Î²1 expression.",3.789755637709665e-07,0.27145063680186965,0.01524220968740482,0.029014823436509962,0.3062702360237095,0.005603697399809551,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
95,0.5,8,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 expression.","Does the formation of endometrial polyps associate with higher expression of vascular endothelial growth factor and transforming growth factor-beta1? Increased TGF-Î²1 and VEGF expression was found in polyps versus neighboring normal endometrial tissue, suggesting these cytokines may be involved in the process. A significant correlation was also observed between steroid receptor expression and VEGF and TGF-Î²1 expression.",1.6580180914979784e-07,0.032514930111312346,0.06092402786922298,0.012693985253473108,0.09744161334294432,0.016124697661918846,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
95,0.5,9,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 expression.","Is there a link between endometrial polyp formation and elevated VEGF and TGF-Î²1 expression? The findings indicated increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrium, suggesting these cytokines play a role in polyp development. Moreover, steroid receptor expression showed a significant correlation with VEGF and TGF-Î²1 expression.",2.8423167282822487e-07,0.1556502164233664,0.03962491351948578,0.02176111757738247,0.22047768036966797,0.0038669724755238874,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
95,0.5,10,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-Î²1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 expression.","Is the development of endometrial polyps associated with increased levels of VEGF and TGF-Î²1? Results showed higher TGF-Î²1 and VEGF expression in polyps relative to normal adjacent tissue, indicating these cytokines might contribute to polyp formation. Additionally, there was a significant correlation between steroid receptor expression and VEGF and TGF-Î²1 levels.",3.079176455639103e-07,0.17654013341454222,0.038844711983088906,0.023574544042164344,0.2129545004647886,0.016124697661918846,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
96,0.5,1,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Question: Is sternal fracture in growing children a rare and frequently overlooked injury? Answer: Isolated sternal fractures in children usually result from common childhood traumas like falls or sports accidents. Although uncommon, these fractures are often missed because of their location and the child's nonspecific symptoms.",7.105791820705622e-08,0.03565738861424084,0.020823902218198284,0.005440279394345618,0.06595796779179608,0.0,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
96,0.5,2,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Question: Are sternal fractures in growing children rare and commonly unnoticed? Answer: In childhood, isolated sternal fractures typically occur from age-related injuries such as falls or sports. These fractures, though rare, can be easily overlooked due to their position and the child's vague symptoms.",1.1842986367842703e-07,0.11335916643797228,0.00241872816728924,0.009067132323909363,0.11247798342669002,0.0,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
96,0.5,3,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Question: Is the sternal fracture in growing children a rare and often undiagnosed injury? Answer: Isolated sternal fractures in children are generally caused by typical childhood trauma like falls or sports injuries. Despite their rarity, they are frequently missed because of their anatomical location and subtle symptoms in children.",0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
96,0.5,4,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Question: Are isolated sternal fractures in children rare and frequently missed? Answer: Childhood sternal fractures often happen due to common injuries like falls or sports-related trauma. These fractures, although rare, can be overlooked because of their site and the child's unclear symptoms.",1.6580180914979784e-07,0.16255986926854238,0.0035510977818017167,0.012693985253473108,0.16126814759612174,0.0,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
96,0.5,5,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Question: Is sternal fracture in growing children an uncommon and often overlooked condition? Answer: In children, isolated sternal fractures usually stem from typical age-related trauma such as falls or sports injuries. These fractures are rare and can be easily missed due to their location and the child's vague symptoms.",0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
96,0.5,6,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Question: Are sternal fractures in growing children rare and often unnoticed? Answer: Isolated sternal fractures in childhood are commonly caused by usual injuries like falls or sports trauma. While uncommon, these fractures can be missed easily because of their position and the child's nonspecific symptoms.",9.474389094274162e-08,0.12114362451720329,0.02452757170470421,0.0072537058591274906,0.12118688976346981,0.023242630385487524,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
96,0.5,7,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Question: Is sternal fracture in children a rare and frequently overlooked injury? Answer: Isolated sternal fractures in children typically arise from common childhood traumas such as falls or sports injuries. Though rare, they are often missed due to their location and subtle symptoms.",1.4211583641411244e-07,0.13765726869928407,0.0029714576866202713,0.010880558788691236,0.13657553500575004,0.0,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
96,0.5,8,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
",Question: Are isolated sternal fractures in childhood uncommon and often overlooked? Answer: Childhood sternal fractures generally result from typical injuries like falls or sports. These fractures are rare and can be easily missed because of their anatomical position and vague symptoms in children.,1.4211583641411244e-07,0.13765726869928407,0.0029714576866202713,0.010880558788691236,0.13657553500575004,0.0,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
96,0.5,9,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Question: Is sternal fracture in growing children a rare and often undetected injury? Answer: Isolated sternal fractures in children are usually caused by normal age-related trauma such as falls or sports injuries. Despite being rare, these fractures can be easily overlooked due to their location and the child's vague symptoms.",2.3685972735685406e-08,0.04950041972606645,0.020823902218198284,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
96,0.5,10,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Question: Are sternal fractures in children rare and frequently missed? Answer: In childhood, isolated sternal fractures often result from common traumas like falls or sports injuries. These fractures, although uncommon, can be missed because of their position and the child's often unclear symptoms.",1.4211583641411244e-07,0.13765726869928407,0.0029714576866202713,0.010880558788691236,0.13657553500575004,0.0,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
97,0.5,1,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight stable? Answer: The findings do not back the idea that African American women are more prone to obesity due to needing fewer calories to maintain their weight.,7.10579182070559e-08,0.09474601728467036,0.008576706069585785,0.005440279394345625,0.13194264838430625,0.033531397991038235,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.5,2,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it true that African American women require fewer calories to sustain their weight? Answer: The results do not support the belief that African American women have a higher obesity risk because they need fewer calories to maintain weight.,9.47438909427412e-08,0.08891717961365497,0.013049591508268829,0.0072537058591274975,0.12410143412991248,0.009041602072670907,0.00724320616381148,0.16096077608021542,0.03334762528744492,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.5,3,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have lower calorie requirements for weight maintenance? Answer: The evidence does not support the notion that African American women are at increased risk of obesity because they require fewer calories to keep their weight.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.5,4,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are fewer calories necessary for African American women to maintain their weight? Answer: The data do not confirm that African American women are more likely to be obese due to lower calorie needs for weight maintenance.,2.36859727356853e-08,0.10958816484199163,0.05701961264398024,0.0018134264647818796,0.11169921724258858,0.058862236208678254,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.5,5,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need a reduced calorie intake to maintain weight? Answer: These findings do not support the view that African American women are at greater risk of obesity because they require fewer calories to maintain their weight.,9.47438909427412e-08,0.16000919813262282,0.03599404555439932,0.0072537058591274975,0.1970642952414865,0.061112382174339036,0.00724320616381148,0.19842819124561784,0.06035379812695108,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.5,6,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the calorie requirement for weight maintenance lower in African American women? Answer: The results do not endorse the idea that African American women face higher obesity risk from needing fewer calories to maintain weight.,0.0,0.11882523095313324,0.08383622164052006,0.0,0.1223200906870483,0.08740894901144641,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305
97,0.5,7,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require a smaller number of calories to keep their weight steady? Answer: The evidence does not uphold the perspective that African American women are more susceptible to obesity due to lower calorie needs.,4.73719454713706e-08,0.13906866209485091,0.05850538342288004,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.5,8,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are African American women at risk of obesity because they require fewer calories to maintain weight? Answer: The findings do not support this claim; African American women do not necessarily need fewer calories to maintain their weight.,4.73719454713706e-08,0.010800998566757869,0.043704474505723304,0.003626852929563752,0.06395397443367212,0.004764320912272871,0.003621603081905747,0.10324992977309444,0.03180708532418292,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.5,9,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is there a lower calorie requirement for weight maintenance among African American women? Answer: The data do not support the hypothesis that African American women have a greater risk of obesity because they need fewer calories.,2.36859727356853e-08,0.14809634153976647,0.08462783240247189,0.0018134264647818796,0.1513076275602998,0.08740894901144641,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.5,10,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to maintain their weight? Answer: The results do not back the notion that African American women are at increased obesity risk due to lower calorie requirements.,4.73719454713706e-08,0.015575301180038803,0.052029136316337134,0.003626852929563759,0.01837377008561525,0.05619146722164411,0.003621603081905747,0.02149748308653887,0.06035379812695108,4.737194547137081e-08,0.02121682235257394,0.031217481789802305
98,0.5,1,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Are UK radiologists content with the training and support provided for suspected child abuse cases? The survey reveals considerable dissatisfaction among consultant radiologists regarding the training and support available for handling suspected child abuse. Issues raised include the absence of standardized training, limited resources, and inadequate ethical guidance. This underscores the necessity for enhanced training and support frameworks to deliver optimal care for children.",1.4211583641411244e-07,0.08380569354387646,0.0003139523599512972,0.010880558788691236,0.0786500129614982,0.007683451235277236,0.0108648092457172,0.0751629710577344,0.013433596318211689,1.4211583641411244e-07,0.07430571978735756,0.01514792899408284
98,0.5,2,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Do UK radiologists feel adequately trained and supported in cases of suspected child abuse? According to the survey, many consultant radiologists express notable dissatisfaction with the training and support they get in suspected child abuse situations. Key concerns involve the lack of uniform training, insufficient resources, and poor guidance on ethical matters. This points to a pressing need to improve training and support systems to better care for children.",2.3685972735685406e-08,0.0800463264725435,0.12064854780215377,0.0018134264647818726,0.05373550636942426,0.07492180325987144,0.0018108015409528666,0.026344043862918554,0.029822485207100586,2.3685972735685406e-08,0.005736987886179712,0.01514792899408284
98,0.5,3,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Is the training and support for suspected child abuse satisfactory to UK radiologists? The survey indicates a significant level of dissatisfaction among consultant radiologists about the training and support they receive in suspected child abuse cases. The main issues include the absence of standardized training programs, inadequate resource availability, and insufficient ethical guidance. This situation calls for better training and support mechanisms to ensure children receive the best care.",2.3685972735685406e-08,0.016890051939348893,0.0024871493206848616,0.0018134264647818726,0.016147049259295443,0.0013631031116149717,0.0018108015409528666,0.005339583845951346,0.014674556213017746,2.3685972735685406e-08,0.005736987886179712,0.01514792899408284
98,0.5,4,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Are consultant radiologists in the UK satisfied with the training and support related to suspected child abuse? Survey results show a marked dissatisfaction among UK consultant radiologists concerning the training and support provided for suspected child abuse cases. Concerns center on the lack of standardized training, limited resources, and inadequate ethical guidance. This highlights the urgent need to enhance training and support systems to improve child care outcomes.",4.737194547137081e-08,0.03406478584024253,0.0050500057810151655,0.0036268529295637453,0.011552792610541651,0.012746244331065734,0.003621603081905733,0.010251033823560185,0.014441625832100586,4.737194547137081e-08,0.009767198649785591,0.01514792899408284
98,0.5,5,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","How satisfied are UK radiologists with the training and support for suspected child abuse? The survey demonstrates considerable dissatisfaction among consultant radiologists about the training and support offered in suspected child abuse cases. Problems noted include the absence of standardized training, resource shortages, and insufficient ethical guidance. This emphasizes the importance of upgrading training and support structures to provide better care for children.",1.6580180914979784e-07,0.1022034395125031,0.002419620293486857,0.012693985253473108,0.09614853785948796,0.006312239892984545,0.012675610786670066,0.09207104196007077,0.01316060643663233,1.6580180914979784e-07,0.09111283810373827,0.01514792899408284
98,0.5,6,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","What is the level of satisfaction among UK radiologists regarding training and support in suspected child abuse? The survey reveals that consultant radiologists are largely dissatisfied with the training and support they receive when managing suspected child abuse. Key issues involve non-standardized training, inadequate resources, and lack of ethical guidance. These findings highlight the need for improved training and support to ensure optimal child care.",1.1842986367842703e-07,0.04407400145549989,0.01931168785746676,0.009067132323909363,0.03944629690523449,0.025344959352324614,0.009054007704764333,0.03617631311841407,0.029822485207100586,1.1842986367842703e-07,0.05777641783614662,0.01514792899408284
98,0.5,7,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Do UK consultant radiologists feel supported and well-trained in suspected child abuse cases? Survey data points to significant dissatisfaction among consultant radiologists in the UK about the training and support for suspected child abuse. Major concerns include the absence of standardized training, insufficient resources, and inadequate ethical guidance. This stresses the need for better training and support systems to enhance child care.",1.8948778188548325e-07,0.05833201745688488,0.09942137002692572,0.014507411718254981,0.0590264962043765,0.07318187122953174,0.014486412327622933,0.08577325425778692,0.029822485207100586,1.8948778188548325e-07,0.10820727146303799,0.01514792899408284
98,0.5,8,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Are UK radiologists happy with the training and support provided for suspected child abuse cases? The survey uncovers notable dissatisfaction among consultant radiologists regarding the training and support they receive in suspected child abuse. Issues include lack of standardized training, poor resource allocation, and insufficient ethical guidance. This indicates a clear need for improved training and support to ensure the best care for children.",1.4211583641411244e-07,0.08380569354387646,0.0003139523599512972,0.010880558788691236,0.0786500129614982,0.007683451235277236,0.0108648092457172,0.0751629710577344,0.013433596318211689,1.4211583641411244e-07,0.07430571978735756,0.01514792899408284
98,0.5,9,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","How do UK radiologists perceive the training and support for suspected child abuse? Survey findings show significant dissatisfaction among consultant radiologists about the training and support in suspected child abuse cases. Concerns focus on the lack of standardized training, inadequate resources, and poor ethical guidance. This calls for enhanced training and support frameworks to better protect and care for children.",2.3685972735685406e-07,0.15948020223819181,0.011191080105606849,0.018134264647818726,0.15054954232905216,0.001909865702479377,0.018108015409528666,0.14458038403281304,0.012284219900978131,2.3685972735685406e-07,0.14329859127430744,0.01514792899408284
98,0.5,10,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Are UK consultant radiologists satisfied with the current training and support for suspected child abuse? The survey highlights considerable dissatisfaction among consultant radiologists regarding the training and support they receive when dealing with suspected child abuse. Key issues include a lack of standardized training, insufficient resources, and inadequate guidance on ethical considerations. This points to the necessity of improving training and support systems to provide the best possible care for children.",2.3685972735685406e-08,0.03641873077148361,0.017211278941207026,0.0018134264647818865,0.0560746005082251,0.031033324515482325,0.0018108015409528666,0.056197007012602995,0.029822485207100586,2.3685972735685406e-08,0.03604233738150775,0.01514792899408284
99,0.5,1,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: Enhancing hospital efficiency by reducing length of stay does not seem to increase readmission rates or the number of physician visits within 30 days post-discharge. Further research is necessary to determine optimal lengths of stay and anticipated readmission rates.,9.474389094274162e-08,0.07459489795819252,0.0013226814394396817,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
99,0.5,2,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is early discharge from Winnipeg hospitals associated with poorer quality of care? Answer: Shortening hospital stays to improve efficiency does not appear to raise readmission rates or physician visit counts within 30 days after discharge. Additional studies are needed to establish ideal lengths of stay and expected readmission rates.,1.8948778188548325e-07,0.1269100160200658,0.01753826530612245,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.5,3,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier discharge from Winnipeg hospitals compromise care quality? Answer: Improving hospital efficiency by decreasing length of stay does not lead to higher readmission rates or more physician visits within 30 days post-discharge. Research is required to identify the best lengths of stay and typical readmission rates.,2.3685972735685406e-07,0.1980783371253132,0.003728275336599654,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
99,0.5,4,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients sooner from Winnipeg hospitals affect the quality of care negatively? Answer: Reducing hospital length of stay to boost efficiency does not seem to cause an increase in readmission or physician visits within 30 days after discharge. More research is needed to find optimal stay durations and expected readmission rates.,1.1842986367842703e-07,0.06748659554926473,0.01753826530612245,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
99,0.5,5,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier patient discharge from Winnipeg hospitals adversely impact care quality? Answer: Shortening hospital stays to improve efficiency does not appear to increase readmission rates or physician visits within 30 days post-discharge. Further investigation is needed to determine optimal lengths of stay and anticipated readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.5,6,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is the quality of care affected by discharging patients earlier from Winnipeg hospitals? Answer: Enhancing hospital efficiency by shortening length of stay does not seem to increase readmissions or physician visits within 30 days after discharge. Research is needed to identify optimal stay lengths and expected readmission rates.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.5,7,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does early discharge from Winnipeg hospitals lead to lower quality care? Answer: Improving hospital efficiency through shorter stays does not appear to increase readmission or physician visit rates within 30 days after discharge. Additional research is required to define optimal lengths of stay and expected readmission rates.,2.3685972735685406e-07,0.16858271242063472,0.01753826530612245,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
99,0.5,8,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier in Winnipeg hospitals reduce care quality? Answer: Reducing length of stay to enhance hospital efficiency does not seem to raise readmission or physician visit rates within 30 days post-discharge. Further research is needed to establish optimal stay lengths and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.5,9,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does shortening hospital stays in Winnipeg hospitals harm quality of care? Answer: Improving efficiency by reducing length of stay does not appear to increase readmission or physician visits within 30 days after discharge. Research is necessary to determine optimal stay durations and expected readmission rates.,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
99,0.5,10,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier discharge from Winnipeg hospitals negatively impact patient care quality? Answer: Enhancing hospital efficiency by decreasing length of stay does not seem to increase rates of readmission or physician visits within 30 days after discharge. Further studies are needed to identify optimal lengths of stay and expected readmission rates.,1.6580180914979784e-07,0.13443319592494518,0.0024534048313202828,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
100,0.5,1,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Is there an initial night effect on sleep bruxism? The findings indicated no general first night effect on the severity of RMMA frequency. However, masseter EMG activity was significantly higher on the first night, implying participants might have been more conscious of their sleep surroundings. More studies are required to explore the influence of the first night effect on sleep bruxism.",1.1842986367842703e-07,0.08755280184188763,0.0188150746429033,0.009067132323909363,0.05954455898600708,0.041558875691178235,0.009054007704764333,0.05617542638914941,0.04639455782312926,1.1842986367842703e-07,0.06172353074086523,0.016124697661918846
100,0.5,2,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Does sleep bruxism exhibit a first night effect? Results revealed no overall first night impact on RMMA frequency severity. Yet, there was a notable rise in masseter EMG activity on the first night, suggesting increased participant awareness of their sleep environment. Additional research is necessary to clarify the first night effect's role in sleep bruxism.",2.6054570009253947e-07,0.0773385983938768,0.13133665828506186,0.0199476911126006,0.0639354183524179,0.14536052858374027,0.019918816950481533,0.1175714645224204,0.08083333333333335,2.6054570009253947e-07,0.17294916585109021,0.016124697661918846
100,0.5,3,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Is there a first night effect related to sleep bruxism? The data showed no overall first night effect on RMMA frequency severity. Still, a significant increase in masseter EMG activity was observed during the first night, indicating participants might have been more aware of their sleeping conditions. Further investigation is needed to understand how the first night effect influences sleep bruxism.",1.1842986367842703e-07,0.018238083785892645,0.0705437655324333,0.009067132323909363,0.012551529795503669,0.07641623803280152,0.009054007704764333,0.00837217255742928,0.08083333333333335,1.1842986367842703e-07,0.06172353074086523,0.016124697661918846
100,0.5,4,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Does the first night affect sleep bruxism? The study found no general first night effect on the severity of RMMA frequency. However, masseter EMG activity significantly increased on the first night, suggesting heightened awareness of the sleep environment by participants. More research is needed to assess the first night effect's impact on sleep bruxism.",2.8423167282822487e-07,0.15985229744074658,0.049266360803324,0.02176111757738247,0.10964312026772438,0.12613715295898056,0.0217296184914344,0.1369895503795231,0.08083333333333335,2.8423167282822487e-07,0.19275179314726998,0.016124697661918846
100,0.5,5,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Is there a first night effect on the severity of sleep bruxism? Findings showed no overall first night effect on RMMA frequency severity. Nevertheless, masseter EMG activity was significantly elevated on the first night, implying participants were more conscious of their sleep environment. Further studies are required to understand the first night effect on sleep bruxism.",2.3685972735685406e-07,0.2024669498946423,0.042984288371767876,0.018134264647818726,0.1673113174144989,0.008239471416259775,0.018108015409528666,0.16070887079709228,0.003939830834294514,2.3685972735685406e-07,0.15353107999398752,0.016124697661918846
100,0.5,6,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Does sleep bruxism experience a first night effect? The results indicated no overall first night effect on RMMA frequency severity. However, a significant rise in masseter EMG activity on the first night suggests participants may have been more aware of their sleep surroundings. Additional research is needed to examine the first night effect on sleep bruxism.",2.3685972735685406e-07,0.14872079003257843,0.003988540221711884,0.018134264647818726,0.12225963873581369,0.08999720678443231,0.018108015409528666,0.12467976693134819,0.061972386587771225,2.3685972735685406e-07,0.15353107999398752,0.016124697661918846
100,0.5,7,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Is there an impact of the first night on sleep bruxism? The findings revealed no overall first night effect on RMMA frequency severity. Yet, masseter EMG activity increased significantly during the first night, suggesting participants were more aware of their sleep environment. Further research is necessary to explore the first night effect's influence on sleep bruxism.",2.3685972735685406e-07,0.11733729121965686,0.05591566635887957,0.018134264647818726,0.07091540313878042,0.1268486026314441,0.018108015409528666,0.0985232695517273,0.08083333333333335,2.3685972735685406e-07,0.15353107999398752,0.016124697661918846
100,0.5,8,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Does the initial night affect sleep bruxism severity? Results showed no overall first night effect on RMMA frequency severity. However, there was a significant increase in masseter EMG activity on the first night, indicating participants might have been more aware of their sleeping environment. More studies are needed to understand the first night effect on sleep bruxism.",2.1317375462116866e-07,0.053285846181646335,0.1549097491991163,0.016320838183036854,0.07730485071279114,0.10904867383115928,0.0162972138685758,0.10550325433808982,0.06232140738103717,2.1317375462116866e-07,0.13448288502329442,0.016124697661918846
100,0.5,9,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Is there a first night effect influencing sleep bruxism? The study found no overall first night effect on the severity of RMMA frequency. Nonetheless, masseter EMG activity was significantly higher on the first night, suggesting increased awareness of the sleep environment among participants. Further investigation is required to clarify the first night effect on sleep bruxism.",2.3685972735685406e-07,0.1677479952603802,0.018016360803324055,0.018134264647818726,0.13194941917589809,0.05078152050992253,0.018108015409528666,0.12467976693134819,0.061972386587771225,2.3685972735685406e-07,0.15353107999398752,0.016124697661918846
100,0.5,10,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Does the first night impact sleep bruxism? The results showed no general first night effect on RMMA frequency severity. However, a significant rise in masseter EMG activity during the first night suggests participants may have been more conscious of their sleep environment. Additional research is needed to better understand the first night effect on sleep bruxism.",2.3685972735685406e-07,0.183439744666841,0.06531697253000923,0.018134264647818726,0.15762153697441494,0.03176052858374026,0.018108015409528666,0.12467976693134819,0.061972386587771225,2.3685972735685406e-07,0.15353107999398752,0.016124697661918846
101,0.5,1,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Grandmultiparous women exhibited higher maternal and neonatal morbidity, as well as increased neonatal mortality, even after adjusting for confounding factors, indicating the necessity for more vigilant monitoring during labor and delivery compared to regular multiparous patients.",9.474389094274162e-08,0.12690248065430154,0.024375,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
101,0.5,2,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Women with grandmultiparity showed elevated maternal and neonatal complications and higher neonatal death rates despite controlling for confounders, highlighting the importance of closer surveillance during labor and delivery than in typical multiparous women.",2.3685972735685406e-08,0.057909609167349885,0.024375,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
101,0.5,3,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a standalone risk factor for negative perinatal results? Grandmultiparous mothers experienced increased maternal and neonatal morbidity and mortality rates after accounting for confounding variables, suggesting they require more careful observation during labor and delivery than standard multiparous patients.",4.7371945471370706e-08,0.01619836298637356,0.024375,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.5,4,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Can grandmultiparity be considered an independent risk factor for adverse outcomes around birth? Even after adjusting for confounders, grandmultiparous women had higher rates of maternal and neonatal morbidity and neonatal mortality, implying the need for closer monitoring during labor and delivery compared to regular multiparous women.",9.474389094274162e-08,0.09609593929608184,0.0021642561983471094,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
101,0.5,5,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently associated with higher risk for poor perinatal outcomes? Grandmultiparous women had greater maternal and neonatal morbidity and neonatal mortality after controlling for confounders, indicating that labor and delivery require more intensive observation than for usual multiparous patients.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.5,6,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does being grandmultiparous independently increase the risk of adverse perinatal outcomes? Grandmultiparous women showed increased maternal and neonatal morbidity and neonatal mortality even after adjusting for confounding factors, suggesting a need for heightened surveillance during labor and delivery relative to regular multiparous women.",2.3685972735685406e-08,0.024902600569258304,0.0005796400951814454,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
101,0.5,7,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent predictor of adverse perinatal outcomes? After controlling for confounders, grandmultiparous women still had elevated maternal and neonatal morbidity and neonatal mortality, pointing to the necessity for closer monitoring during labor and delivery than for typical multiparous women.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019166,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.5,8,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a distinct risk factor for negative perinatal outcomes? Grandmultiparous women experienced increased maternal and neonatal morbidity and neonatal mortality despite controlling for confounders, indicating the need for more careful observation during labor and delivery compared to regular multiparous patients.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.5,9,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently contribute to higher risks of adverse perinatal outcomes? Even after adjusting for confounders, grandmultiparous women had elevated maternal and neonatal morbidity and neonatal mortality, suggesting that closer observation during labor and delivery is warranted compared to regular multiparous women.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.5,10,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for poor perinatal outcomes? Grandmultiparous women had increased maternal and neonatal morbidity and neonatal mortality after controlling for confounders, which suggests a need for more attentive monitoring during labor and delivery than that given to regular multiparous patients.",4.737194547137081e-08,0.0492007028305701,0.0011323696145124768,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
102,0.5,1,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are doctors adequately addressing the needs of family caregivers for the frail elderly? Several hypotheses explain this dissatisfaction. Physicians might lack interest in supporting caregivers; even if they are open to counseling, they may receive insufficient compensation for typical caregiver counseling sessions; and they may also act as professional caregivers to family caregivers.",1.4211583641411244e-07,0.11195717199374444,0.001987302987025024,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
102,0.5,2,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Do physicians fulfill the needs of family caregivers of frail elderly patients? The dissatisfaction may stem from several reasons: physicians might be uninterested in assisting caregivers; even if willing to counsel caregivers, they might be poorly paid for such counseling; and they might serve as professional caregivers to family caregivers.",2.1317375462116866e-07,0.20130452883094785,0.023506344745696735,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
102,0.5,3,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are medical professionals meeting the needs of family members caring for frail elderly individuals? The reasons for dissatisfaction could include physiciansâ€™ lack of interest in aiding caregivers; even if they are willing to offer counseling, the payment for such sessions may be inadequate; and they may also function as professional caregivers to family caregivers.",1.1842986367842703e-07,0.06624947007843796,0.017236072637734686,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
102,0.5,4,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians adequately supporting family caregivers of the frail elderly? Possible explanations for dissatisfaction include physiciansâ€™ disinterest in helping caregivers; even if receptive to counseling, they might be poorly compensated for these sessions; and they might also act as professional caregivers to family caregivers.",3.552895910352811e-07,0.30758067168397085,0.006006557747752838,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
102,0.5,5,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Do physicians meet the needs of family caregivers for frail elderly patients? Hypotheses for this dissatisfaction include physicians possibly being uninterested in helping caregivers; even if they are open to counseling, they may receive low remuneration for such sessions; and they may serve as professional caregivers to family caregivers.",2.3685972735685406e-07,0.19422150524599857,0.003587829580463598,0.018134264647818726,0.19290366612449228,0.0,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
102,0.5,6,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are doctors addressing the needs of family caregivers of frail elderly individuals? Reasons for dissatisfaction may be that physicians are uninterested in helping caregivers; even if they provide counseling, they might be poorly paid for these sessions; and they may also be professional caregivers to family caregivers.",2.8423167282822487e-07,0.2078999871414644,0.017236072637734686,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
102,0.5,7,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians fulfilling the needs of family caregivers of frail elderly people? The dissatisfaction might be due to physiciansâ€™ lack of interest in assisting caregivers; even if they offer counseling, they could be poorly compensated; and they might also act as professional caregivers to family caregivers.",3.079176455639103e-07,0.2298788938602394,0.017236072637734686,0.023574544042164344,0.25886163391628836,0.0,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
102,0.5,8,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians meeting the needs of family caregivers for the frail elderly? The dissatisfaction could be because physicians are uninterested in helping caregivers; even if they counsel caregivers, they might be poorly paid for such sessions; and they may also serve as professional caregivers to family caregivers.",2.8423167282822487e-07,0.2078999871414644,0.017236072637734686,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
102,0.5,9,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are doctors meeting the needs of family caregivers of frail elderly patients? Hypotheses for dissatisfaction include physicians possibly being uninterested in helping caregivers; even if they provide counseling, they might be poorly compensated; and they may also function as professional caregivers to family caregivers.",3.552895910352811e-07,0.27534126793699665,0.017236072637734686,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
102,0.5,10,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians adequately meeting the needs of family caregivers of the frail elderly? Possible reasons for dissatisfaction include physiciansâ€™ lack of interest in helping caregivers; even if they are receptive to counseling, they may be poorly remunerated for such sessions; and they may also act as professional caregivers to family caregivers.",1.8948778188548325e-07,0.1522442654248115,0.0027555974997080478,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
103,0.5,1,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgery might help improve blood lipid profiles in OSA patients, particularly those who are obese or have metabolic syndrome. Nevertheless, more studies are required to verify this link and understand the underlying mechanisms.",2.3685972735685406e-08,0.03829476115600272,0.043388429752066124,0.0018134264647818726,0.00833368550616198,0.02221074380165289,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
103,0.5,2,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Can airway surgery decrease serum lipid levels in obstructive sleep apnea patients? It appears that surgery could enhance lipid levels in the blood of OSA patients, especially among individuals with obesity or metabolic syndrome. However, additional research is necessary to confirm this relationship and clarify the exact processes involved.",4.737194547137081e-08,0.045071017246912426,0.001800528050742864,0.0036268529295637453,0.04479602859327958,0.0009442031589307898,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
103,0.5,3,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Is there a reduction in serum lipid levels after airway surgery in obstructive sleep apnea patients? Airway surgery may lead to improved blood lipid levels in patients with OSA, notably those with obesity or metabolic syndrome, but further investigation is needed to establish this connection and identify the mechanisms.",4.737194547137081e-08,0.045071017246912426,0.001800528050742864,0.0036268529295637453,0.07429165329795806,0.02221074380165289,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
103,0.5,4,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Does performing airway surgery lower blood lipid levels in patients suffering from obstructive sleep apnea? Surgery has the potential to improve serum lipid levels in OSA patients, particularly those with obesity or metabolic syndrome, though more research is required to confirm this and to explore how it works.",2.3685972735685406e-08,0.022788623686384124,0.0009192939495969929,0.0018134264647818726,0.02264861413960606,0.0004823487399244937,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
103,0.5,5,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Can serum lipid levels be lowered through airway surgery in obstructive sleep apnea patients? Surgical intervention may improve lipid profiles in OSA patients, especially in cases involving obesity or metabolic syndrome, but further studies are needed to confirm this and understand the mechanisms.",9.474389094274162e-08,0.030698110330948936,0.043388429752066124,0.0072537058591274906,0.06228388170779198,0.02221074380165289,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
103,0.5,6,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Does airway surgery have an effect on serum lipid levels in obstructive sleep apnea patients? It may improve lipid levels in the blood of OSA patients, particularly those with obesity or metabolic syndrome, although more research is needed to validate this effect and determine the mechanisms.",2.3685972735685406e-08,0.023318321560436672,0.0009598666243535586,0.0018134264647818726,0.023173004519290608,0.0005042372691962185,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
103,0.5,7,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Is airway surgery effective in reducing serum lipid levels in patients with obstructive sleep apnea? Surgery might improve blood lipid concentrations in OSA patients, especially in those who are obese or have metabolic syndrome, but additional research is necessary to confirm and explain this association.",4.737194547137081e-08,0.015821905303945005,0.043388429752066124,0.0036268529295637453,0.014655832718537543,0.02221074380165289,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
103,0.5,8,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Does obstructive sleep apnea airway surgery lead to lower serum lipid levels? Surgery may enhance blood lipid profiles in OSA patients, particularly those with obesity or metabolic syndrome, yet further research is essential to confirm this and understand the underlying mechanisms.",1.4211583641411244e-07,0.07948827450038065,0.043388429752066124,0.010880558788691236,0.1122943022824554,0.02221074380165289,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
103,0.5,9,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Will airway surgery decrease serum lipid levels in obstructive sleep apnea patients? The surgery could potentially improve serum lipid levels in patients with OSA, especially those with obesity or metabolic syndrome, but more research is needed to establish this and clarify the mechanisms involved.",7.105791820705622e-08,0.10388582416167758,0.02598657024793387,0.005440279394345618,0.10420034732491601,0.025289256198347123,0.0054324046228586,0.10442962480224383,0.024375,7.105791820705622e-08,0.07232066157962613,0.0
103,0.5,10,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Is there evidence that airway surgery reduces serum lipid levels in obstructive sleep apnea patients? Surgery may positively affect blood lipid levels in OSA patients, particularly those with obesity or metabolic syndrome; however, further studies are required to confirm this link and uncover the mechanisms.",4.737194547137081e-08,0.04719147474695973,0.00196304417083637,0.0036268529295637453,0.04689523646551175,0.0010318865838346326,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
104,0.5,1,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Does the use of audit to identify maternal mortality vary simply between wealthy and poor settings? Answer: The effectiveness of audit in identifying maternal mortality is greatly affected by differences in healthcare infrastructure, resource availability, and cultural factors. Wealthier areas tend to have strong data collection systems, whereas poorer regions often face challenges with data accuracy and accessibility, which hampers audit efforts.",4.737194547137081e-08,0.05480702186143471,0.01660115898211134,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
104,0.5,2,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the difference in using audits to detect maternal mortality merely a matter of wealth disparity? Answer: Variations in healthcare systems, resource access, and cultural contexts play a major role in how well audits identify maternal mortality. Richer settings usually maintain reliable data collection, while poorer ones often encounter difficulties with data quality and access, limiting audit effectiveness.",1.4211583641411244e-07,0.07677922342075583,0.015621063240110858,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
104,0.5,3,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Does auditing maternal mortality differ only between rich and poor environments? Answer: The success of audits in detecting maternal mortality depends heavily on healthcare infrastructure, available resources, and cultural influences. Wealthier areas typically have comprehensive data systems, whereas poorer settings struggle with data reliability and availability, affecting audit performance.",3.552895910352811e-07,0.2736936575120561,0.004778242315444698,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
104,0.5,4,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the use of audit to find maternal mortality simply a contrast between affluent and impoverished settings? Answer: The impact of healthcare infrastructure, resource availability, and cultural factors significantly affects audit effectiveness. Wealthy regions often benefit from robust data collection, while poorer regions face challenges in data accuracy and accessibility, impeding audit implementation.",2.6054570009253947e-07,0.16693032041505385,0.015621063240110858,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
104,0.5,5,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the disparity in maternal mortality audit usage just a reflection of economic differences? Answer: Healthcare infrastructure, resource availability, and cultural aspects greatly influence audit success in identifying maternal mortality. Wealthier settings generally have better data systems, while poorer ones deal with issues of data accuracy and access, which hinder audits.",3.079176455639103e-07,0.20539660124284964,0.015621063240110858,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
104,0.5,6,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Does identifying maternal mortality through audits differ only between the rich and the poor? Answer: The efficiency of audits is strongly shaped by differences in healthcare infrastructure, resources, and cultural factors. Richer settings often have reliable data collection, whereas poorer settings face barriers related to data accuracy and accessibility, limiting audit effectiveness.",2.8423167282822487e-07,0.18597851538574695,0.015621063240110858,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
104,0.5,7,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the difference in maternal mortality audits solely based on economic status? Answer: Effectiveness of maternal mortality audits is largely determined by healthcare infrastructure, resource availability, and cultural contexts. Wealthier areas tend to have strong data systems, while poorer ones struggle with data quality and access, reducing audit success.",3.552895910352811e-07,0.30198537916756374,0.025121354143320576,0.02720139697172809,0.3008148480069748,0.020823902218198284,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
104,0.5,8,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Are audits used to identify maternal mortality just differentiated by wealth levels? Answer: The success of maternal mortality audits depends on healthcare infrastructure, resource availability, and cultural influences. Wealthier settings usually maintain robust data collection systems, whereas poorer settings often face challenges with data accuracy and accessibility, limiting audit effectiveness.",3.316036182995957e-07,0.2529251157614274,0.004370606897331876,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
104,0.5,9,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the use of auditing to detect maternal mortality merely a difference between rich and poor settings? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors play a crucial role in audit effectiveness. Wealthier areas typically have comprehensive data systems, while poorer settings struggle with data accuracy and accessibility, which hinders audit efforts.",2.3685972735685406e-07,0.1482381874028995,0.015621063240110858,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
104,0.5,10,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the identification of maternal mortality through audits simply a matter of economic disparity? Answer: The effectiveness of audits in identifying maternal mortality is largely influenced by healthcare infrastructure, resource availability, and cultural factors. Wealthier settings often have robust data collection, while poorer ones face challenges with data accuracy and access, limiting audit implementation.",2.3685972735685406e-07,0.17391030520141637,0.002890862712185324,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
105,0.5,1,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Question: How is gender dimorphism characterized after injury and hemorrhagic shock, and are hormonal differences the cause? Answer: The protective effect of being female has been repeatedly noted in both preclinical and clinical research. Although hormones might have some influence, recent studies indicate that factors like immune responses and tissue repair processes are crucial in this gender-specific protection.",0.0,0.024320953703857562,0.017538265306122455,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
105,0.5,2,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Question: What characterizes gender dimorphism following injury and hemorrhagic shock, and do hormones explain this difference? Answer: Female gender consistently shows an independent protective effect in studies. While hormonal factors may play a role, current research highlights the importance of immune system activity and tissue regeneration in this gender-related resilience.",1.8948778188548325e-07,0.1269100160200658,0.017538265306122455,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
105,0.5,3,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Question: In the context of injury and hemorrhagic shock, how is gender dimorphism explained, and are hormonal differences responsible? Answer: The female gender's protective effect has been reliably demonstrated in both animal and human studies. Hormonal differences might contribute, but recent evidence points to other mechanisms such as immune responses and tissue repair being key.",7.105791820705622e-08,0.05541838536493415,0.0009736606461737303,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
105,0.5,4,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Question: How does gender dimorphism manifest after injury and hemorrhagic shock, and is it due to hormonal differences? Answer: Consistent findings show females have a protective advantage. Although hormones may influence this, emerging research underscores the role of immune function and tissue healing in this gender-specific effect.",2.6054570009253947e-07,0.19008891764159808,0.017538265306122455,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
105,0.5,5,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Question: What is the nature of gender dimorphism after injury and hemorrhagic shock, and do hormonal differences account for it? Answer: Female gender offers an independent protective effect, confirmed by preclinical and clinical data. Hormones may be involved, but recent studies suggest immune responses and tissue repair mechanisms are significant contributors.",1.6580180914979784e-07,0.10670730870254719,0.017538265306122455,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
105,0.5,6,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Question: How is gender dimorphism characterized post-injury and hemorrhagic shock, and are hormonal variations the cause? Answer: A protective effect linked to female gender has been consistently observed. While hormones may play a part, recent research emphasizes the importance of immune and tissue repair factors in this gender-specific protection.",2.1317375462116866e-07,0.14752930322280156,0.017538265306122455,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
105,0.5,7,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Question: What defines gender dimorphism after injury and hemorrhagic shock, and are hormones responsible? Answer: The female gender's protective effect is well documented in studies. Hormonal differences might contribute, but current research points to immune response and tissue repair as major factors in this gender-based resilience.",2.8423167282822487e-07,0.21206782436037308,0.017538265306122455,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
105,0.5,8,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Question: How does gender dimorphism present after injury and hemorrhagic shock, and can it be attributed to hormonal differences? Answer: Female gender consistently shows a protective effect. Although hormones could influence this, recent findings highlight other elements like immune response and tissue repair as key to this gender-specific resilience.",2.1317375462116866e-07,0.14752930322280156,0.017538265306122455,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
105,0.5,9,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Question: What characterizes gender dimorphism following injury and hemorrhagic shock, and are hormonal differences the cause? Answer: The protective influence of female gender has been consistently demonstrated in research. Hormonal differences may play a role, but recent studies indicate that immune responses and tissue repair mechanisms are also pivotal.",2.1317375462116866e-07,0.17641043574613224,0.0032856369120758296,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
105,0.5,10,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Question: How is gender dimorphism defined after injury and hemorrhagic shock, and are hormonal differences responsible? Answer: An independent protective effect of female gender is consistently observed in studies. While hormones might contribute, recent research suggests immune system activity and tissue repair processes are important factors in this gender-specific protection.",1.8948778188548325e-07,0.1269100160200658,0.017538265306122455,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
106,0.5,1,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the impact of MPH programs on strengthening health systems in low- and middle-income countries? The answer shows significant effects at multiple levels; graduates are seen as valuable contributors to their workplaces and frequently hold influence nationally. The described impact aligns well with public health education goals. The qualitative study provided deeper insights into the graduates' contributions.,2.3685972735685406e-07,0.16164135155641457,0.0,0.018134264647818726,0.16430305129127465,0.0,0.018108015409528666,0.16705408466316563,0.0,2.3685972735685406e-07,0.16989903679539609,0.0
106,0.5,2,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs affect health system strengthening in low- and middle-income countries? The findings highlight substantial impact across various levels; graduates are regarded as key contributors in their workplaces and often have national influence. Much of the impact corresponds with public health education objectives. The qualitative research offered a more detailed understanding of graduates' effects.,2.8423167282822487e-07,0.19735943415849366,0.0,0.02176111757738247,0.20067069546214888,0.0,0.0217296184914344,0.20409535634351572,0.0,2.8423167282822487e-07,0.20763936477824352,0.0
106,0.5,3,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the influence of MPH programs on health system strengthening in low- and middle-income countries? There was notable impact at several levels; graduates were viewed as making significant contributions to their workplaces and frequently exerted influence nationally. The impact largely reflected the aims of public health education. The qualitative study revealed deeper insights into the graduates' impact.,2.3685972735685406e-07,0.16164135155641457,0.0,0.018134264647818726,0.16430305129127465,0.0,0.018108015409528666,0.16705408466316563,0.0,2.3685972735685406e-07,0.16989903679539609,0.0
106,0.5,4,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs contribute to health system strengthening in low- and middle-income countries? There was considerable impact at multiple levels; graduates were perceived as important contributors to their workplaces and often had influence at the national level. Much of the impact described aligned with public health educational goals. The qualitative method study provided a more in-depth understanding of graduates' impact.,1.6580180914979784e-07,0.11034805716886531,0.0,0.012693985253473108,0.11211729812070548,0.0,0.012675610786670066,0.1139442593492177,0.0,1.6580180914979784e-07,0.11583181552512123,0.0
106,0.5,5,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the role of MPH programs in strengthening health systems in low- and middle-income countries? The evidence shows significant impact at many levels; graduates were seen as capable of making meaningful contributions to their workplaces and often influenced national policies. Much of the described impact matched public health education aims. The qualitative study offered deeper insights into the graduates' impact.,1.6580180914979784e-07,0.11034805716886531,0.0,0.012693985253473108,0.11211729812070548,0.0,0.012675610786670066,0.1139442593492177,0.0,1.6580180914979784e-07,0.11583181552512123,0.0
106,0.5,6,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How significant is the impact of MPH programs on health systems in low- and middle-income countries? There was notable influence at various levels; graduates were perceived to contribute substantially to their workplaces and often had national-level influence. Much of the impact corresponded with public health educational objectives. The qualitative research revealed more detailed understanding of graduates' impact.,2.6054570009253947e-07,0.204096185104385,0.017851239669421492,0.0199476911126006,0.18232155679395312,0.0,0.019918816950481533,0.1854032233313614,0.0,2.6054570009253947e-07,0.18859116980755042,0.0
106,0.5,7,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What impact do MPH programs have on health system strengthening in low- and middle-income countries? There was considerable effect at multiple levels; graduates were viewed as significant contributors to their workplaces and often held national influence. Much of the impact aligned with public health education goals. The qualitative study provided greater insight into graduates' impact.,3.079176455639103e-07,0.21570857282668943,0.0,0.023574544042164344,0.21936282847430322,0.0,0.023540420032387266,0.22314355131420882,0.0,3.079176455639103e-07,0.22705745063534621,0.0
106,0.5,8,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs influence health system strengthening in low- and middle-income countries? The study found substantial impact at various levels; graduates were regarded as valuable contributors to their workplaces and often had influence at the national level. Much of the impact described was consistent with public health educational aims. The qualitative method study revealed deeper understanding of graduates' impact.,1.8948778188548325e-07,0.12715517548524602,0.0,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.5,9,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What contributions do MPH programs make to health system strengthening in low- and middle-income countries? There was considerable impact at many levels; graduates were perceived as able to contribute significantly to their workplaces and often had influence nationally. Much of the impact described aligned with public health education goals. The qualitative study offered more in-depth understanding of graduates' impact.,2.1317375462116866e-07,0.14424960884454574,0.0,0.016320838183036854,0.14660347419187403,0.0,0.0162972138685758,0.14903557916048715,0.0,2.1317375462116866e-07,0.15154989812720032,0.0
106,0.5,10,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs affect health system strengthening efforts in low- and middle-income countries? There was significant impact across multiple levels; graduates were seen as important contributors to their workplaces and frequently influenced national policies. Much of the impact corresponded with public health educational aims. The qualitative research provided deeper insight into graduates' impact.,3.316036182995957e-07,0.23440070583884376,0.0,0.025387970506946217,0.23841102344499632,0.0,0.025351221573340132,0.24256163717131152,0.0,3.316036182995957e-07,0.24686007793152598,0.0
107,0.5,1,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Does neoadjuvant chemotherapy alter the scope of lymphadenectomy in cervical cancer? The occurrence and location of lymph node metastases remain unchanged after NACT, with clinical non-responders exhibiting more affected lymph nodes. Therefore, a comprehensive and systemic lymphadenectomy is recommended for patients undergoing NACT followed by surgery.",9.474389094274162e-08,0.0568660866847992,0.020399305555555556,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
107,0.5,2,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can neoadjuvant chemotherapy influence the extent of lymphadenectomy in cervical cancer? NACT does not change the frequency or anatomical distribution of lymph node metastases, and patients who do not respond clinically have more involved lymph nodes. Hence, extensive systemic lymphadenectomy should be performed in those treated with NACT plus surgery.",0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
107,0.5,3,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is it possible to adjust the extent of lymphadenectomy based on neoadjuvant chemotherapy in cervical cancer? The rate and topographical pattern of lymph node metastases are not altered by NACT, and clinical non-responders show a higher number of involved lymph nodes. Consequently, a thorough systemic lymphadenectomy is necessary for patients receiving NACT and surgery.",9.474389094274162e-08,0.10676333709700225,0.020399305555555556,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
107,0.5,4,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Could neoadjuvant chemotherapy modify lymphadenectomy extent in cervical cancer? The frequency and distribution of lymph node metastases do not change with NACT, and patients who are clinical non-responders have more affected lymph nodes. Thus, systemic and extensive lymphadenectomy should be conducted in patients treated with NACT plus surgery.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
107,0.5,5,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Does neoadjuvant chemotherapy impact the extent of lymphadenectomy in cervical cancer? The occurrence and distribution of lymph node metastases are unaffected by NACT, and clinical non-responders present with more involved lymph nodes. Therefore, patients treated with NACT and surgery require systemic, extensive lymphadenectomy.",1.6580180914979784e-07,0.12585895817175086,0.020399305555555556,0.012693985253473108,0.1576289442035832,0.0,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
107,0.5,6,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can the extent of lymphadenectomy be altered by neoadjuvant chemotherapy in cervical cancer? NACT does not modify the frequency or anatomical distribution of lymph node metastases, and clinical non-responders have a greater number of involved lymph nodes. Accordingly, an extensive systemic lymphadenectomy should be performed in patients undergoing NACT plus surgery.",2.3685972735685406e-08,0.04849442897302669,0.020399305555555556,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
107,0.5,7,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is the extent of lymphadenectomy influenced by neoadjuvant chemotherapy in cervical cancer? The frequency and location of lymph node metastases remain stable after NACT, with non-responders showing increased lymph node involvement. Thus, patients treated with NACT and surgery should undergo a systemic and extensive lymphadenectomy.",1.1842986367842703e-07,0.1108456325623095,0.002315675515293554,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
107,0.5,8,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Could the scope of lymphadenectomy be changed by neoadjuvant chemotherapy in cervical cancer? Lymph node metastasis frequency and distribution are not modified by NACT, and clinical non-responders have more involved lymph nodes. Therefore, a comprehensive systemic lymphadenectomy is advised for patients treated with NACT plus surgery.",9.474389094274162e-08,0.0568660866847992,0.020399305555555556,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
107,0.5,9,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Might neoadjuvant chemotherapy alter the extent of lymphadenectomy in cervical cancer? The pattern and frequency of lymph node metastases are unchanged by NACT, with clinical non-responders exhibiting more involved lymph nodes. Hence, systemic and extensive lymphadenectomy is warranted in patients treated with NACT and surgery.",1.1842986367842703e-07,0.07933894253685692,0.020399305555555556,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
107,0.5,10,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is lymphadenectomy extent modifiable by neoadjuvant chemotherapy in cervical cancer? NACT does not affect the frequency or topographic distribution of lymph node metastases, and non-responders have more involved lymph nodes. Consequently, systemic and extensive lymphadenectomy should be performed in patients receiving NACT plus surgery.",1.4211583641411244e-07,0.10232846076155644,0.020399305555555556,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
108,0.5,1,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
","Are doctors adequately addressing the needs of family caregivers for the frail elderly? Several hypotheses for this dissatisfaction are discussed. Physicians might be indifferent or too pressed for time to manage the intricate needs of caregivers. Additionally, insufficient training in geriatrics or caregiver support might play a role.",4.737194547137081e-08,0.04479602859327958,0.0009442031589307898,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
108,0.5,2,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Do physicians fulfill the needs of family caregivers caring for frail elderly patients? Possible reasons for this dissatisfaction are explored. Physicians may show a lack of interest or have limited time to attend to caregivers' complex needs. A deficiency in geriatrics education or caregiver support training could also be factors.,9.474389094274162e-08,0.11596434969852698,0.02221074380165289,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
108,0.5,3,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are family caregivers of frail elderly individuals receiving sufficient support from physicians? The article proposes hypotheses explaining this dissatisfaction. Physicians may be either uninterested or constrained by time when it comes to caregivers' complex needs. Another contributing factor could be inadequate training in geriatrics or caregiver assistance.,2.3685972735685406e-08,0.0527854480769947,0.02221074380165289,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
108,0.5,4,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are the needs of family caregivers for frail elderly patients being met by physicians? Hypotheses for this dissatisfaction are offered. Physicians might lack interest or have insufficient time to address the complex needs of caregivers. A lack of training in geriatrics or caregiving support might also be a contributing issue.,9.474389094274162e-08,0.0876726280430189,0.0018114382460973355,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
108,0.5,5,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
","Are physicians effectively meeting the needs of family caregivers of frail elderly people? The paper presents hypotheses for this dissatisfaction. Physicians may be uninterested or too busy to handle the complex needs of caregivers. Furthermore, a lack of training in geriatrics or caregiving support may contribute to the problem.",7.105791820705622e-08,0.06646392997246053,0.0013868415834546073,0.005440279394345618,0.06595796779179608,0.0,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
108,0.5,6,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are the complex needs of family caregivers of frail elderly patients adequately addressed by physicians? Hypotheses explaining this dissatisfaction are presented. Physicians may be disinterested or lack the time to meet these needs. Insufficient training in geriatrics or caregiver support could also be a factor.,2.3685972735685406e-08,0.00833368550616198,0.02221074380165289,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
108,0.5,7,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are family caregivers of frail elderly individuals receiving adequate attention from physicians? The article suggests hypotheses for this dissatisfaction. Physicians might be uninterested or constrained by time regarding caregivers' complex needs. Lack of geriatrics or caregiving support training may also contribute.,1.1842986367842703e-07,0.08697649429816368,0.02221074380165289,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
108,0.5,8,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are physicians meeting the demands of family caregivers for the frail elderly? Possible causes for this dissatisfaction are proposed. Physicians may be indifferent or lack sufficient time to address caregivers' complex needs. A shortage of training in geriatrics or caregiving support could also be involved.,2.3685972735685406e-08,0.00833368550616198,0.02221074380165289,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
108,0.5,9,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
","Do physicians adequately support family caregivers of frail elderly patients? Hypotheses for this dissatisfaction are discussed. Physicians may lack interest or time to attend to caregivers' complex needs. Additionally, a lack of training in geriatrics or caregiving support might be a factor.",9.474389094274162e-08,0.06228388170779198,0.02221074380165289,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
108,0.5,10,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are the needs of family caregivers of frail elderly people being met by physicians? The article offers hypotheses for this dissatisfaction. Physicians might be uninterested or have limited time to address the complex needs of caregivers. A lack of training in geriatrics or caregiving support could also contribute.,4.737194547137081e-08,0.04479602859327958,0.0009442031589307898,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
109,0.5,1,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Is neck pain linked to poorer health-related quality of life six months afterward? We discovered that neck pain negatively impacts physical health-related quality of life but does not affect mental health-related quality of life. Our findings indicate that neck pain could be a factor leading to diminished physical HRQoL in the future population. Raising,1.4211583641411244e-07,0.010389951394474739,0.14862461524080406,0.010880558788691236,0.036038663948104066,0.09632716049382717,0.0108648092457172,0.09798090057910613,0.019599999999999992,1.4211583641411244e-07,0.1278333715098836,0.0
109,0.5,2,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Does neck pain correlate with a decline in health-related quality of life after six months? Our study showed that neck pain is associated with worse physical HRQoL but has no significant effect on mental HRQoL. This suggests that neck pain may contribute to future reductions in physical HRQoL among the population. Raising,9.474389094274162e-08,0.09180473203761919,0.010465079554338008,0.0072537058591274906,0.08579255565404154,0.0017367249242856639,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
109,0.5,3,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Is there an association between neck pain and poorer health-related quality of life six months later? We found neck pain to be negatively related to physical HRQoL but not to mental HRQoL. The analysis implies that neck pain might be a cause of future poor physical HRQoL in the population. Raising,7.105791820705622e-08,0.09734821722335019,0.02857282061364086,0.005440279394345618,0.09331573555892092,0.021728395061728398,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
109,0.5,4,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Does experiencing neck pain predict worse health-related quality of life six months down the line? Our results indicate that neck pain adversely affects physical HRQoL but not mental HRQoL. This suggests neck pain could contribute to future declines in physical HRQoL within the population. Raising,7.105791820705622e-08,0.04325460308778206,0.014284294065091074,0.005440279394345618,0.0373044468581436,0.021728395061728398,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
109,0.5,5,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain connected to lower health-related quality of life six months later? We observed that neck pain negatively influences physical HRQoL, while mental HRQoL remains unaffected. Our analysis points to neck pain as a possible factor in future poor physical HRQoL among people. Raising",7.105791820705622e-08,0.011747913062329918,0.03791103605675192,0.005440279394345618,0.0373044468581436,0.021728395061728398,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
109,0.5,6,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Is neck pain associated with a decrease in health-related quality of life six months later? Findings show that neck pain is linked to worse physical HRQoL but not mental HRQoL. This indicates neck pain may be a contributor to future poor physical HRQoL in the population. Raising,2.3685972735685406e-08,0.005823771367561736,0.019469983775013508,0.0018134264647818726,0.008157927218613636,0.021728395061728398,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
109,0.5,7,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Can neck pain predict poorer health-related quality of life six months later? We found that neck pain negatively impacts physical HRQoL but does not affect mental HRQoL. The analysis suggests neck pain might lead to future poor physical HRQoL in the population. Raising,1.1842986367842703e-07,0.09484186031047281,0.00859358915688739,0.009067132323909363,0.08493249584739804,0.021728395061728398,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
109,0.5,8,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain related to diminished health-related quality of life six months afterward? Our study found a negative association between neck pain and physical HRQoL, but no link with mental HRQoL. This suggests neck pain could be a contributor to future poor physical HRQoL in the population. Raising",0.0,0.05899124940935696,0.04396797735178842,0.0,0.03013683393738864,0.021728395061728398,0.0,0.0,0.0,0.0,0.0,0.0
109,0.5,9,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Does neck pain influence health-related quality of life six months later? We found that neck pain is negatively associated with physical HRQoL but not with mental HRQoL. This analysis implies that neck pain may contribute to future poor physical HRQoL in the population. Raising,9.474389094274162e-08,0.10095822443954106,0.012445201112672055,0.0072537058591274906,0.0938419528664296,0.0020669648430901577,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
109,0.5,10,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Is neck pain a factor in worse health-related quality of life six months later? Our research showed neck pain negatively affects physical HRQoL but not mental HRQoL. This suggests neck pain could be a cause of future poor physical HRQoL in the population. Raising,9.474389094274162e-08,0.06871882069256774,0.011506557598701977,0.0072537058591274906,0.06083494426833802,0.021728395061728398,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
110,0.5,1,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Does bile duct sludge have a different clinical significance compared to bile duct stones? Answer: The results suggest that the clinical importance of symptomatic bile duct sludge is comparable to that of common bile duct stones. Bile duct sludge appears to represent an early phase of choledocholithiasis.,9.474389094274162e-08,0.0209720784007561,0.2994915472092361,0.0072537058591274906,0.08533716788007739,0.04134297520661155,0.007243206163811466,0.12690248065430154,0.024375,9.474389094274162e-08,0.09531017980432566,0.0
110,0.5,2,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the clinical relevance of bile duct sludge versus bile duct stones? Answer: Findings show that symptomatic bile duct sludge shares similar clinical significance with common bile duct stones. Bile duct sludge likely represents an initial stage of choledocholithiasis.,7.105791820705622e-08,0.18253074206622966,0.39019591868032855,0.005440279394345618,0.09260259254739323,0.05768626734842948,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
110,0.5,3,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical significance of bile duct sludge distinct from that of bile duct stones? Answer: The evidence indicates that symptomatic bile duct sludge has clinical significance akin to common bile duct stones. Bile duct sludge may be an early form of choledocholithiasis.,0.0,0.15490453955931693,0.4094290236870374,0.0,0.0454652977353458,0.07478796844181461,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.5,4,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does the clinical significance of bile duct sludge compare to bile duct stones? Answer: Research findings reveal that symptomatic bile duct sludge is clinically similar to common bile duct stones. Bile duct sludge seems to be a preliminary stage of choledocholithiasis.,2.3685972735685406e-08,0.1202369750061143,0.36088027085257024,0.0018134264647818726,0.0384697994073715,0.052434253780407655,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
110,0.5,5,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Does bile duct sludge differ clinically from bile duct stones? Answer: The data indicate that symptomatic bile duct sludge holds clinical significance comparable to that of common bile duct stones. Bile duct sludge appears to be an early stage in the development of choledocholithiasis.,2.3685972735685406e-08,0.06144095674332384,0.33448753462603864,0.0018134264647818726,0.01289714562953348,0.04768143961927421,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
110,0.5,6,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the difference in clinical significance between bile duct sludge and bile duct stones? Answer: The findings demonstrate that symptomatic bile duct sludge has clinical significance similar to common bile duct stones. Bile duct sludge seems to represent an early stage of choledocholithiasis.,2.3685972735685406e-08,0.09294764676877598,0.364877511336297,0.0018134264647818726,0.01289714562953348,0.04768143961927421,0.0018108015409528666,0.057909609167349885,0.024375,2.3685972735685406e-08,0.0246926125903717,0.0
110,0.5,7,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is there a clinical difference between bile duct sludge and bile duct stones? Answer: The results indicate that symptomatic bile duct sludge is clinically equivalent to common bile duct stones. Bile duct sludge appears to be an early manifestation of choledocholithiasis.,4.737194547137081e-08,0.15092164994648272,0.3751433094013229,0.0036268529295637453,0.06517206862335545,0.0549930747922438,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
110,0.5,8,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How significant is bile duct sludge clinically compared to bile duct stones? Answer: The findings suggest that symptomatic bile duct sludge carries clinical significance akin to common bile duct stones. Bile duct sludge likely represents an early phase of choledocholithiasis.,7.105791820705622e-08,0.18253074206622966,0.39019591868032855,0.005440279394345618,0.09260259254739323,0.05768626734842948,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
110,0.5,9,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What clinical significance does bile duct sludge have relative to bile duct stones? Answer: Evidence shows that symptomatic bile duct sludge has clinical importance similar to that of common bile duct stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,0.0,0.09042573206536808,0.34734646677822545,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.5,10,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical impact of bile duct sludge different from that of bile duct stones? Answer: Findings indicate that symptomatic bile duct sludge is clinically comparable to common bile duct stones. Bile duct sludge appears to be an initial stage of choledocholithiasis.,2.3685972735685406e-08,0.15324398360420677,0.3931024930747923,0.0018134264647818726,0.07228185699566136,0.07784626038781159,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
111,0.5,1,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Does a previous benign prostate biopsy influence the outcomes for patients treated with radical perineal prostatectomy?,1.0184968276344701e-06,1.2567863017807674,0.06858710562414265,0.07797733798562065,1.3553520308115758,0.035041322314049606,0.07786446626097342,1.4356470768250427,0.017851239669421492,1.018496827634472e-06,1.5224265354444704,0.0
111,0.5,2,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Can a history of benign prostate biopsy predict surgical results in patients undergoing radical perineal prostatectomy?,1.0184968276344701e-06,1.2567863017807674,0.06858710562414265,0.07797733798562065,1.3553520308115758,0.035041322314049606,0.07786446626097342,1.4356470768250427,0.017851239669421492,1.018496827634472e-06,1.5224265354444704,0.0
111,0.5,3,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Is there a predictive relationship between prior benign prostate biopsy and outcomes in radical perineal prostatectomy patients?,9.948108548987847e-07,1.1922477806431968,0.06858710562414265,0.07616391152083878,1.2863591593246237,0.035041322314049606,0.07605366472002054,1.3615391046713214,0.017851239669421492,9.948108548987866e-07,1.442383827770934,0.0
111,0.5,4,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Does having had a benign prostate biopsy before affect the prognosis for patients receiving radical perineal prostatectomy?,9.948108548987847e-07,1.1922477806431968,0.06858710562414265,0.07616391152083878,1.2863591593246237,0.035041322314049606,0.07605366472002054,1.3615391046713214,0.017851239669421492,9.948108548987866e-07,1.442383827770934,0.0
111,0.5,5,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Does a prior benign prostate biopsy serve as a predictor for outcomes after radical perineal prostatectomy?,1.0184968276344701e-06,1.2567863017807674,0.06858710562414265,0.07797733798562065,1.3553520308115758,0.035041322314049606,0.07786446626097342,1.4356470768250427,0.017851239669421492,1.018496827634472e-06,1.5224265354444704,0.0
111,0.5,6,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Can previous benign prostate biopsy status impact the surgical outcomes of radical perineal prostatectomy?,1.065868773105841e-06,1.3998871454214408,0.06858710562414265,0.08160419091518441,1.5095027106388335,0.035041322314049606,0.08148606934287916,1.6027011614882092,0.017851239669421492,1.0658687731058426e-06,1.7047480922384257,0.0
111,0.5,7,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Is prior benign prostate biopsy linked to the surgical results in patients treated with radical perineal prostatectomy?,9.948108548987847e-07,1.1922477806431968,0.06858710562414265,0.07616391152083878,1.2863591593246237,0.035041322314049606,0.07605366472002054,1.3615391046713214,0.017851239669421492,9.948108548987866e-07,1.442383827770934,0.0
111,0.5,8,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Does a history of benign prostate biopsy correlate with outcomes following radical perineal prostatectomy?,1.065868773105841e-06,1.3998871454214408,0.06858710562414265,0.08160419091518441,1.5095027106388335,0.035041322314049606,0.08148606934287916,1.6027011614882092,0.017851239669421492,1.0658687731058426e-06,1.7047480922384257,0.0
111,0.5,9,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Is there an association between prior benign prostate biopsy and the risk of positive surgical margins in radical perineal prostatectomy?,9.237529366917287e-07,1.0203975237165377,0.06858710562414265,0.07072363212649316,1.1040376025306693,0.035041322314049606,0.07062126009716192,1.1673830902303637,0.017851239669421492,9.237529366917306e-07,1.23474446299269,0.0
111,0.5,10,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Does undergoing a benign prostate biopsy before surgery predict the outcome for patients having radical perineal prostatectomy?,9.948108548987847e-07,1.1922477806431968,0.06858710562414265,0.07616391152083878,1.2863591593246237,0.035041322314049606,0.07605366472002054,1.3615391046713214,0.017851239669421492,9.948108548987866e-07,1.442383827770934,0.0
112,0.5,1,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Advanced epithelial ovarian carcinoma in Thai women: is it advisable to keep performing second-look laparotomy? The procedure does not improve overall or disease-free survival rates. Tumor grade remains the sole independent factor predicting patient survival.,1.658018091497972e-07,0.18721154208814594,0.0,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.5,2,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Should second-look laparotomy still be offered for advanced epithelial ovarian carcinoma in Thai women? It shows no beneficial effect on overall survival or disease-free survival. Tumor grade is the only independent prognostic marker for survival.,1.658018091497972e-07,0.18721154208814594,0.0,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.5,3,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"In Thai women with advanced epithelial ovarian carcinoma, is continuing second-look laparotomy justified? This surgery does not enhance overall or disease-free survival. Patient survival is independently predicted only by tumor grade.",2.605457000925384e-07,0.31237468504215293,0.0,0.01994769111260064,0.321583624127463,0.0,0.01991881695048158,0.3313571359544403,0.0,2.6054570009253947e-07,0.341749293722057,0.0
112,0.5,4,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"For advanced epithelial ovarian carcinoma among Thai women, should second-look laparotomy be maintained? The operation does not positively influence overall or disease-free survival, with tumor grade as the only independent survival predictor.",2.368597273568531e-07,0.27958486221916123,0.0,0.01813426464781876,0.28768207245178123,0.0,0.018108015409528708,0.29626581614317127,0.0,2.3685972735685406e-07,0.3053816495511823,0.0
112,0.5,5,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Regarding advanced epithelial ovarian carcinoma in Thai women, is second-look laparotomy still warranted? It lacks a favorable impact on both overall survival and disease-free survival, and tumor grade is the only independent prognostic factor for survival.",1.421158364141119e-07,0.15822400521489444,0.0,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
112,0.5,6,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Is it appropriate to continue second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women? The procedure does not improve overall or disease-free survival; tumor grade alone independently predicts survival.,2.842316728282237e-07,0.3462762367178347,0.0,0.02176111757738252,0.356674943938732,0.0,0.021729618491434455,0.36772478012531495,0.0,2.8423167282822487e-07,0.37948962170490397,0.0
112,0.5,7,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"In cases of advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy continue to be offered? The surgery does not benefit overall or disease-free survival, with tumor grade being the only independent prognostic variable.",1.658018091497972e-07,0.18721154208814594,0.0,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.5,8,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Should second-look laparotomy be continued for advanced epithelial ovarian carcinoma in Thai women? It does not positively affect overall or disease-free survival, and tumor grade is the only independent prognostic factor for patient survival.",1.894877818854825e-07,0.21706450523782772,0.0,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
112,0.5,9,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"For Thai women with advanced epithelial ovarian carcinoma, is second-look laparotomy still beneficial? It does not improve overall or disease-free survival, with tumor grade as the sole independent prognostic indicator.",2.842316728282237e-07,0.3462762367178347,0.0,0.02176111757738252,0.356674943938732,0.0,0.021729618491434455,0.36772478012531495,0.0,2.8423167282822487e-07,0.37948962170490397,0.0
112,0.5,10,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Is second-look laparotomy still indicated in advanced epithelial ovarian carcinoma among Thai women? It fails to enhance overall or disease-free survival, with tumor grade as the only independent prognostic factor for survival.",2.368597273568531e-07,0.27958486221916123,0.0,0.01813426464781876,0.28768207245178123,0.0,0.018108015409528708,0.29626581614317127,0.0,2.3685972735685406e-07,0.3053816495511823,0.0
113,0.5,1,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Can bedside evaluation consistently rule out aspiration after an acute stroke?,8.290090457489866e-07,1.3808512313433954,0.08804283164782867,0.0634699262673657,1.5554583665565898,0.02271498107084911,0.06337805393335051,1.6817585740137266,0.0,8.290090457489885e-07,1.791759469228054,0.0
113,0.5,2,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Is bedside assessment dependable for excluding aspiration following an acute stroke?,8.290090457489866e-07,1.3808512313433954,0.08804283164782867,0.0634699262673657,1.5554583665565898,0.02271498107084911,0.06337805393335051,1.6817585740137266,0.0,8.290090457489885e-07,1.791759469228054,0.0
113,0.5,3,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Does bedside swallowing assessment effectively exclude aspiration risk post-acute stroke?,8.52695018484672e-07,1.4862117470012213,0.08804283164782867,0.06528335273214757,1.6732414022129736,0.02271498107084911,0.06518885547430339,1.8152899666382485,0.0,8.526950184846738e-07,1.945910149055313,0.0
113,0.5,4,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Can aspiration be reliably excluded after an acute stroke using bedside assessment?,8.053230730133013e-07,1.2855410515390702,0.08804283164782867,0.061656499802583815,1.4500978508987639,0.02271498107084911,0.061567252392397645,1.5639755383573428,0.0,8.053230730133032e-07,1.6582280766035322,0.0
113,0.5,5,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Is bedside swallowing evaluation sufficient to rule out aspiration after an acute stroke?,7.816371002776159e-07,1.19852967454944,0.08804283164782867,0.059843073337801936,1.3547876710944387,0.02271498107084911,0.059756450851444765,1.458615022699517,0.0,7.816371002776178e-07,1.5404450409471484,0.0
113,0.5,6,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Does bedside assessment have the reliability to exclude aspiration following an acute stroke?,7.816371002776159e-07,1.19852967454944,0.08804283164782867,0.059843073337801936,1.3547876710944387,0.02271498107084911,0.059756450851444765,1.458615022699517,0.0,7.816371002776178e-07,1.5404450409471484,0.0
113,0.5,7,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Can bedside swallowing tests exclude aspiration risk after an acute stroke with reliability?,7.816371002776159e-07,1.19852967454944,0.08804283164782867,0.059843073337801936,1.3547876710944387,0.02271498107084911,0.059756450851444765,1.458615022699517,0.0,7.816371002776178e-07,1.5404450409471484,0.0
113,0.5,8,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Is bedside assessment an accurate screening tool to exclude aspiration after an acute stroke?,7.579511275419306e-07,1.1184869668759037,0.08804283164782867,0.05802964687302006,1.2677762941048085,0.02271498107084911,0.0579456493104919,1.3633048428951917,0.0,7.579511275419324e-07,1.4350845252893225,0.0
113,0.5,9,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Can bedside evaluation alone reliably rule out aspiration risk after acute stroke?,8.053230730133013e-07,1.2855410515390702,0.08804283164782867,0.061656499802583815,1.4500978508987639,0.02271498107084911,0.061567252392397645,1.5639755383573428,0.0,8.053230730133032e-07,1.6582280766035322,0.0
113,0.5,10,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Is bedside swallowing assessment adequate to exclude aspiration following an acute stroke?,8.053230730133013e-07,1.2855410515390702,0.08804283164782867,0.061656499802583815,1.4500978508987639,0.02271498107084911,0.061567252392397645,1.5639755383573428,0.0,8.053230730133032e-07,1.6582280766035322,0.0
114,0.5,1,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","Did the Catholic bishops' boycott call influence polio vaccination rates in Kenya in 2015? The boycott, motivated by vaccine safety worries, led to a drop in vaccination coverage, heightening public health risks due to polio's severity.",1.0184968276344718e-06,0.6236307189027586,0.12543252595155713,0.07797733798562065,0.745429605750775,0.05179208106586603,0.07786446626097329,0.8159850635419574,0.013155555555555561,1.0184968276344725e-06,0.8517522107365827,0.0
114,0.5,2,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","In 2015, the Catholic bishops' call for a boycott in Kenya notably decreased polio vaccination coverage because of safety concerns, raising the risk of polio outbreaks.",1.255356554991325e-06,0.960102955523972,0.12543252595155713,0.09611160263343946,1.0937363000189917,0.05179208106586603,0.09597248167050203,1.176998409079288,0.013155555555555561,1.2553565549913265e-06,1.2264456601779936,0.0
114,0.5,3,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","The 2015 boycott urged by Catholic bishops in Kenya caused a significant reduction in polio immunization rates, driven by fears about vaccine safety, which posed a public health threat.",1.184298636784269e-06,0.8467742702169678,0.12543252595155713,0.09067132323909381,0.9759532643626074,0.05179208106586603,0.09054007704764341,1.054396086986955,0.013155555555555561,1.1842986367842703e-06,1.0986122886681091,0.0
114,0.5,4,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","Did the 2015 boycott by Catholic bishops affect Kenya's polio vaccine coverage? Yes, it caused a marked decline due to safety concerns, increasing the risk of polio spread.",1.2079846095199542e-06,0.8831419143878425,0.12543252595155713,0.09248474970387568,1.0136935923454544,0.05179208106586603,0.09235087858859628,1.0936168001402375,0.013155555555555561,1.2079846095199557e-06,1.139434283188364,0.0
114,0.5,5,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","The boycott called by Catholic bishops in Kenya in 2015 led to a substantial drop in polio vaccination coverage, as concerns about vaccine safety discouraged immunization, raising outbreak risks.",1.184298636784269e-06,0.8467742702169678,0.12543252595155713,0.09067132323909381,0.9759532643626074,0.05179208106586603,0.09054007704764341,1.054396086986955,0.013155555555555561,1.1842986367842703e-06,1.0986122886681091,0.0
114,0.5,6,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","In Kenya during 2015, the Catholic bishops' boycott call over vaccine safety fears significantly lowered polio vaccination rates, threatening public health.",1.3737864186697514e-06,1.1832465068381817,0.12543252595155713,0.10517873495734885,1.3273511512004967,0.05179208106586603,0.1050264893752664,1.4221208671122727,0.013155555555555561,1.3737864186697533e-06,1.484274769480093,0.0
114,0.5,7,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","The 2015 call for a boycott by Catholic bishops in Kenya had a major impact on polio vaccine uptake, decreasing coverage because of safety apprehensions and increasing polio outbreak risks.",1.1606126640485838e-06,0.8116829504056988,0.12543252595155713,0.08885789677431194,0.9395856201917328,0.05179208106586603,0.08872927550669053,1.016655759004108,0.013155555555555561,1.160612664048585e-06,1.0593915755148267,0.0
114,0.5,8,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","Kenyan Catholic bishops' boycott call in 2015 caused a notable decline in polio vaccination coverage due to safety concerns, which heightened the risk of polio outbreaks.",1.255356554991325e-06,0.960102955523972,0.12543252595155713,0.09611160263343946,1.0937363000189917,0.05179208106586603,0.09597248167050203,1.176998409079288,0.013155555555555561,1.2553565549913265e-06,1.2264456601779936,0.0
114,0.5,9,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","The polio vaccination coverage in Kenya was significantly affected in 2015 by a boycott called by Catholic bishops, driven by vaccine safety worries, leading to a decline in immunization rates.",1.1606126640485838e-06,0.8116829504056988,0.12543252595155713,0.08885789677431194,0.9395856201917328,0.05179208106586603,0.08872927550669053,1.016655759004108,0.013155555555555561,1.160612664048585e-06,1.0593915755148267,0.0
114,0.5,10,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","In 2015, the call for a boycott by Catholic bishops in Kenya led to a significant reduction in polio vaccination rates due to safety concerns, increasing public health risks from polio.",1.1369266913128984e-06,0.7777813987300171,0.12543252595155713,0.08704447030953005,0.9044943003804637,0.05179208106586603,0.08691847396573765,0.9802881148332334,0.013155555555555561,1.1369266913128995e-06,1.0216512475319797,0.0
115,0.5,1,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy achievable? Answer: Performing transgastric endoscopic splenectomy in a pig model seems technically possible. Further long-term survival studies are intended.,0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
115,0.5,2,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be done? Answer: Transgastric endoscopic splenectomy in a porcine model appears to be technically feasible. More long-term survival experiments are planned.,4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.5,3,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is it feasible to perform transgastric endoscopic splenectomy? Answer: The procedure shows technical feasibility in a pig model. Additional long-term survival trials are scheduled.,2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
115,0.5,4,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Transgastric endoscopic splenectomy: is it achievable? Answer: It seems technically feasible in a porcine model, with further long-term survival experiments planned.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.5,5,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy possible? Answer: In a pig model, transgastric endoscopic splenectomy appears technically feasible. Further long-term survival studies are planned.",2.36859727356853e-08,0.11020485479786402,0.046611570247933866,0.0018134264647818796,0.11253403283107888,0.047500000000000014,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.5,6,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can transgastric endoscopic splenectomy be performed? Answer: The technique is technically feasible in a porcine model, with plans for additional long-term survival experiments.",0.0,0.06027366787477817,0.04338842975206613,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
115,0.5,7,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy technically possible? Answer: It appears feasible in a porcine model, and more long-term survival experiments are planned.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.5,8,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is it possible to conduct transgastric endoscopic splenectomy? Answer: The procedure seems technically feasible in a pig model, with further long-term survival studies planned.",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
115,0.5,9,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Transgastric endoscopic splenectomy: can it be done? Answer: Technical feasibility has been demonstrated in a porcine model, and additional long-term survival experiments are intended.",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
115,0.5,10,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy viable? Answer: In a porcine model, it appears technically feasible, with plans for further long-term survival experiments.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
116,0.5,1,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux used for perioperative bridging? Answer: The use of fondaparinux in perioperative bridging is not well established, and it has significant limitations that prevent it from being a standard bridging option.",9.47438909427412e-08,0.04076668226083413,0.055363321799307974,0.007253705859127518,0.08175244668655557,0.02854671280276816,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
116,0.5,2,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux have a role in perioperative bridging? Answer: Fondaparinux's role in perioperative bridge therapy remains unclear, with notable restrictions limiting its routine use as a bridging agent.",1.894877818854824e-07,0.27331910067963516,0.015642595360455355,0.014507411718255037,0.271247020764406,0.008435535717941887,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
116,0.5,3,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Can fondaparinux be used for perioperative bridging? Answer: The application of fondaparinux in perioperative bridging therapy has not been confirmed, and there are key drawbacks to its regular use as a bridging medication.",7.10579182070559e-08,0.009995023594080443,0.055363321799307974,0.005440279394345639,0.05000374837197574,0.02854671280276816,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
116,0.5,4,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Is fondaparinux recommended for perioperative bridging? Answer: Fondaparinux is not currently established as a standard agent for perioperative bridging due to some important limitations.,2.842316728282236e-07,0.38621101975927585,0.013775420097984714,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.5,5,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: What is the role of fondaparinux in perioperative bridging? Answer: Fondaparinux has not been established for use in perioperative bridging, and its routine use is limited by several important factors.",1.421158364141118e-07,0.1515150154357352,0.022069623820711058,0.010880558788691277,0.14844382118522903,0.02854671280276816,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
116,0.5,6,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux effective for perioperative bridging? Answer: The effectiveness of fondaparinux in perioperative bridging therapy is unproven, and it has significant limitations that restrict its routine application.",2.131737546211677e-07,0.2106657190562311,0.055363321799307974,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
116,0.5,7,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Should fondaparinux be used for perioperative bridging? Answer: There is no established role for fondaparinux in perioperative bridging, and its use as a routine bridging agent is limited by important concerns.",1.184298636784265e-07,0.07251538057541396,0.055363321799307974,0.009067132323909398,0.11454226950954727,0.02854671280276816,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
116,0.5,8,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux play a role in perioperative bridge therapy? Answer: Fondaparinux's role in perioperative bridging has not been established, with some important limitations preventing routine use.",2.36859727356853e-07,0.35504407481753164,0.021025567089580907,0.018134264647818796,0.35231560074829726,0.0113838427527874,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.5,9,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux suitable for perioperative bridging? Answer: The suitability of fondaparinux for perioperative bridging is not established, and it is limited by key factors that restrict its routine use.",1.658018091497971e-07,0.18701000890580755,0.020924546289103882,0.012693985253473157,0.18353514099649804,0.02854671280276816,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
116,0.5,10,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Can fondaparinux be considered for perioperative bridging? Answer: Fondaparinux has not been established as a perioperative bridging agent, and there are important limitations to its routine use.",2.131737546211677e-07,0.2106657190562311,0.055363321799307974,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
117,0.5,1,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Question: Do individuals with episodic migraines focus selectively on headache-related visual cues? Answer: Given the extensive sample size and earlier pilot studies of the stimuli shown, this research offers strong proof that episodic migraine sufferers demonstrate an increased attentional bias toward headache-associated visual stimuli. This indicates that selective attention mechanisms might play a role in the development of migraines.",2.3685972735685406e-08,0.06603365011958484,0.035041322314049606,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
117,0.5,2,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Question: Is selective attention to headache-related visual stimuli present in episodic migraine patients? Answer: Considering the large sample and prior pilot testing of the stimuli, this study presents convincing evidence that episodic migraineurs show a pronounced attentional bias toward visual stimuli related to headaches. This implies that selective attention processes may contribute to migraine pathogenesis.",7.105791820705622e-08,0.05676954945959256,0.0019409262066604482,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
117,0.5,3,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Question: Do people with episodic migraines selectively attend to visual stimuli linked to headaches? Answer: Based on the substantial sample size and previous pilot testing of the stimuli, the study strongly supports that episodic migraineurs have an enhanced attentional bias toward headache-related visual cues, suggesting that selective attention could be involved in migraine development.",9.474389094274162e-08,0.024117446874713178,0.035041322314049606,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
117,0.5,4,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Question: Are headache-related visual stimuli selectively attended to by episodic migraine sufferers? Answer: With a large sample size and prior pilot tests of the stimuli, this study provides compelling evidence that episodic migraineurs exhibit heightened attentional bias toward headache-associated visual stimuli, indicating a potential role for selective attention in migraine pathogenesis.",1.6580180914979784e-07,0.08238635499868874,0.035041322314049606,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
117,0.5,5,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Question: Do episodic migraine patients show selective attention to headache-related visual stimuli? Answer: The study, supported by a large sample and earlier pilot testing of the stimuli, demonstrates that episodic migraineurs have a significant attentional bias toward headache-related visual stimuli, suggesting that selective attention mechanisms may be implicated in migraine development.",1.6580180914979784e-07,0.13783812944348428,0.004889233241505961,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
117,0.5,6,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Question: Is there selective attention to headache-related visual cues among episodic migraineurs? Answer: Given the extensive sample size and prior pilot testing of the presented stimuli, this research provides strong evidence that individuals with episodic migraines exhibit a heightened attentional bias to headache-related visual stimuli, implying a role of selective attention in migraine pathogenesis.",9.474389094274162e-08,0.10258693901357496,0.02135867768595042,0.0072537058591274906,0.10076747909833506,0.01922337562475971,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
117,0.5,7,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Question: Do episodic migraine sufferers selectively focus on headache-related visual stimuli? Answer: This study, utilizing a large sample and previous pilot testing of stimuli, offers compelling evidence that episodic migraineurs display increased attentional bias toward headache-related visual cues, suggesting selective attention mechanisms may be involved in migraine onset.",2.3685972735685406e-07,0.17375738342145475,0.013774781671327504,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
117,0.5,8,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Question: Are individuals with episodic migraine selectively attentive to headache-related visual stimuli? Answer: Considering the large sample size and prior pilot testing of stimuli, the findings strongly indicate that episodic migraineurs possess an enhanced attentional bias toward headache-related visual stimuli, which may play a role in the pathogenesis of migraines.",1.8948778188548325e-07,0.13088078397171543,0.01464201675849405,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
117,0.5,9,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Question: Do episodic migraineurs demonstrate selective attention to headache-related visual stimuli? Answer: Based on the large sample and prior pilot testing of stimuli, this study provides robust evidence that episodic migraine sufferers show increased attentional bias toward headache-associated visual stimuli, suggesting selective attention may be involved in migraine pathogenesis.",2.1317375462116866e-07,0.1520894820422738,0.014217420095851321,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
117,0.5,10,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Question: Is selective attention toward headache-related visual stimuli evident in episodic migraine patients? Answer: With a large sample size and previous pilot testing of the stimuli, this study presents strong evidence that episodic migraineurs have a heightened attentional bias to headache-related visual cues, indicating that selective attention mechanisms could contribute to the development of migraines.",7.105791820705622e-08,0.05676954945959256,0.0019409262066604482,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
118,0.5,1,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Does a surgeon's prior experience affect their capability to perform transurethral resection of the prostate? The senior urologist tends to have conducted more procedures, gaining more experience and possibly achieving better results. Nevertheless, personal skill and training are also crucial factors.",2.1317375462116866e-07,0.20294084399669066,0.0,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
118,0.5,2,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the surgeon's previous experience a factor in their ability to carry out transurethral resection of the prostate? Senior urologists usually have completed more operations, resulting in increased experience and potentially improved outcomes. Yet, individual expertise and education remain important.",2.3685972735685396e-07,0.22825865198098239,0.0,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
118,0.5,3,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Does prior surgical experience influence the ability to perform transurethral resection of the prostate? Senior urologists are more likely to have done numerous procedures, thereby gaining extensive experience and possibly better results. However, skill and training of the individual are also vital.",1.8948778188548325e-07,0.21206028899460883,0.024375,0.014507411718254981,0.1823215567939549,0.0,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
118,0.5,4,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the capacity to perform transurethral resection of the prostate dependent on the surgeon's earlier experience? Senior urologists typically have performed a greater number of surgeries, leading to enhanced experience and potentially superior outcomes. Still, individual skill and proper training are significant.",1.8948778188548325e-07,0.17824823140631896,0.0,0.014507411718254981,0.1823215567939549,0.0,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
118,0.5,5,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Does a surgeon's experience level impact their proficiency in transurethral resection of the prostate? Senior urologists often have carried out more procedures, which contributes to their experience and possibly better outcomes. Individual skill and training also play an important role.",2.3685972735685396e-07,0.22825865198098239,0.0,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
118,0.5,6,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the ability to conduct transurethral resection of the prostate affected by the surgeon's past experience? Senior urologists generally have completed more surgeries, resulting in more experience and potentially improved outcomes. Nonetheless, individual skill and training are essential factors.",2.6054570009253926e-07,0.25423413838424036,0.0,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
118,0.5,7,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Does previous surgical experience influence the capability to perform transurethral resection of the prostate? Senior urologists are more likely to have done a higher number of procedures, gaining greater experience and possibly better results. However, individual skill and training remain important.",2.1317375462116866e-07,0.20294084399669066,0.0,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
118,0.5,8,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the surgeon's ability to perform transurethral resection of the prostate influenced by their earlier experience? Senior urologists tend to have carried out more procedures, leading to increased experience and potentially better outcomes. Yet, individual skill and training are also key.",2.1317375462116866e-07,0.20294084399669066,0.0,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
118,0.5,9,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Does the surgeon's prior experience affect their ability to perform transurethral resection of the prostate? Senior urologists usually have conducted more surgeries, resulting in enhanced experience and possibly improved outcomes. Still, individual skill and training are crucial.",3.0791764556390986e-07,0.30830135965451655,0.0,0.023574544042164344,0.31585294941847764,0.0,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
118,0.5,10,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the skill to perform transurethral resection of the prostate dependent on the surgeon's previous experience? Senior urologists often have performed a greater number of procedures, leading to more experience and potentially better results. However, individual skill and training also matter.",2.1317375462116866e-07,0.20294084399669066,0.0,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
119,0.5,1,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Question: Does the link between marital status, living arrangements, and mortality differ by gender? Answer: Assessing living arrangements is essential to uncover and explain gender differences in mortality rates. Research shows that marital status and living conditions, especially among women, greatly influence health outcomes. Grasping these relationships enables the development of focused interventions and policies to enhance health for all genders.",2.3685972735685406e-08,0.01680711831638071,0.0,0.0018134264647818726,0.01709443335929972,0.0,0.0018108015409528666,0.01739174271186883,0.0,2.3685972735685406e-08,0.01769957709940062,0.0
119,0.5,2,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Question: How does marital status and living arrangement relate to mortality across genders? Answer: Analyzing living arrangements is key to understanding and addressing gender disparities in mortality. Evidence suggests that marital status and living circumstances, notably for women, significantly affect health outcomes. Recognizing these connections supports the creation of targeted health strategies and policies for both genders.",7.105791820705622e-08,0.12645152251627811,0.0533997864008544,0.005440279394345618,0.10352052935467126,0.03631185475258099,0.0054324046228586,0.07973933906879171,0.01851192595229618,7.105791820705622e-08,0.05505977718302857,0.0
119,0.5,3,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Question: Is the association between marital status, living arrangements, and mortality influenced by gender? Answer: Evaluating living arrangements is vital for identifying gender differences in mortality. Studies reveal that marital status and living arrangements, particularly among women, have a notable effect on health. Understanding these links allows for gender-sensitive health interventions and policies.",1.6580180914979784e-07,0.15295323226890423,0.01922337562475971,0.012693985253473108,0.12861737782209381,0.0,0.012675610786670066,0.13102826240640475,0.0,1.6580180914979784e-07,0.13353139262452274,0.0
119,0.5,4,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Question: Does gender affect the relationship between marital status, living arrangements, and mortality? Answer: Investigating living arrangements is important to explain gender-based mortality differences. Research indicates marital status and living conditions significantly impact health outcomes, especially for women. This knowledge aids in designing targeted interventions and policies to improve well-being across genders.",1.8948778188548325e-07,0.14571181118139354,0.0,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
119,0.5,5,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Question: How do marital status and living arrangements impact mortality, and does this vary by gender? Answer: Assessing living arrangements is crucial for explaining gender disparities in mortality. Studies show that marital status and living arrangements, mainly for women, strongly influence health outcomes. Understanding these associations helps in crafting targeted health policies for all genders.",1.1842986367842703e-07,0.1912418685355104,0.07359999999999998,0.009067132323909363,0.14246409175353936,0.037677816224529016,0.009054007704764333,0.11846705619773568,0.01922337562475971,1.1842986367842703e-07,0.09352605801082436,0.0
119,0.5,6,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Question: Does the connection between marital status, living arrangements, and mortality vary with gender? Answer: Evaluating living arrangements is essential to identify and explain mortality differences between genders. Research demonstrates that marital status and living conditions, especially for women, significantly affect health outcomes. This understanding supports targeted interventions and policies promoting gender health equity.",1.4211583641411244e-07,0.10724553035359774,0.0,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
119,0.5,7,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Question: Are gender differences evident in the link between marital status, living arrangements, and mortality? Answer: Analyzing living arrangements is key to revealing and explaining gender disparities in mortality rates. Evidence suggests that marital status and living conditions, particularly among women, greatly influence health outcomes. This insight facilitates targeted health interventions and policy development.",1.4211583641411244e-07,0.10724553035359774,0.0,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
119,0.5,8,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Question: How does gender influence the association between marital status, living arrangements, and mortality? Answer: Studying living arrangements is critical for identifying gender disparities in mortality. Research finds that marital status and living arrangements, especially for women, play a significant role in health outcomes. Understanding these factors enables targeted health policies and interventions across genders.",1.1842986367842703e-07,0.11422551513996027,0.01851192595229618,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
119,0.5,9,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Question: Is there a gender variation in the association between marital status, living arrangements, and mortality? Answer: Evaluating living arrangements is fundamental to uncovering and explaining gender differences in mortality. Studies highlight that marital status and living conditions, particularly for women, have a strong impact on health outcomes. This knowledge allows for gender-specific health strategies and policies.",7.105791820705622e-08,0.05218575317056917,0.0,0.005440279394345618,0.05310982531394792,0.0,0.0054324046228586,0.05406722127027486,0.0,7.105791820705622e-08,0.05505977718302857,0.0
119,0.5,10,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Question: Does the relationship between marital status, living arrangements, and mortality differ by gender? Answer: Assessing living arrangements is vital for understanding and addressing gender disparities in mortality. Research indicates that marital status and living arrangements, especially for women, significantly affect health outcomes. Recognizing these associations aids in the development of targeted interventions and policies to improve well-being across genders.",0.0,0.02349651459525237,0.01694411414982164,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
120,0.5,1,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does living in an urban setting affect non-communicable disease risk in Thailand depending on timing? Answer: Urban living was linked to higher behavioral and physiological risk factors, but this might not directly lead to increased biological risk factors. These biological risks probably arise from a complex interplay of long-term exposure and early life influences.",2.1317375462116866e-07,0.088136662631074,0.0475,0.016320838183036854,0.1568424714929706,0.0,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
120,0.5,2,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: In Thailand, does the timing of urban living impact non-communicable disease risk? Answer: Urbanicity correlated with elevated behavioral and physiological risks; however, these do not necessarily result in higher biological risk factors. The biological risks likely stem from a complex interaction between prolonged exposure and early life conditions.",3.552895910352811e-07,0.20591969828745826,0.0475,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
120,0.5,3,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: How does living in an urban area affect non-communicable disease risk in Thailand, and does timing play a role? Answer: Urban living was associated with increased behavioral and physiological risks, yet these may not directly cause rises in biological risk factors. The biological risks probably reflect a complex mix of long-term exposure and early life experiences.",1.6580180914979784e-07,0.05176901846019977,0.0475,0.012693985253473108,0.1198011998126205,0.0,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
120,0.5,4,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does the timing of urban residence influence non-communicable disease risk in Thailand? Answer: Urbanicity was linked to increases in behavioral and physiological risk factors, but these associations might not directly increase biological risks. Biological risk factors likely result from a complex interaction of long-term exposure and early life factors.",3.316036182995957e-07,0.1853004110847225,0.0475,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
120,0.5,5,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: In Thailand, is there a timing effect of urban living on non-communicable disease risk? Answer: Urban living was connected to higher behavioral and physiological risks, though this may not directly translate to increased biological risk factors. The biological risks are probably due to a complex interplay between long-term exposure and early life stages.",2.3685972735685406e-07,0.13298529302284923,0.028639053254437868,0.018134264647818726,0.1758906664636637,0.0,0.018108015409528666,0.17904823144898518,0.0,2.3685972735685406e-07,0.182321556793954,0.0
120,0.5,6,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does living in an urban environment affect the risk of non-communicable diseases in Thailand depending on timing? Answer: Urbanicity was associated with elevated behavioral and physiological risk factors, but these may not directly cause an increase in biological risk factors. The biological risks likely arise from a complex interaction between long-term exposure and early life.",1.8948778188548325e-07,0.06978752396287824,0.0475,0.014507411718254981,0.13815033848081626,0.0,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
120,0.5,7,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: How does the timing of urban living relate to non-communicable disease risk in Thailand? Answer: Urban living correlated with increases in behavioral and physiological risk factors; however, these might not directly lead to heightened biological risk factors. The biological risks are probably a result of complex interactions between prolonged exposure and early life.",2.3685972735685406e-07,0.13298529302284923,0.028639053254437868,0.018134264647818726,0.1758906664636637,0.0,0.018108015409528666,0.17904823144898518,0.0,2.3685972735685406e-07,0.182321556793954,0.0
120,0.5,8,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does timing matter for non-communicable disease risk among urban dwellers in Thailand? Answer: Urbanicity was linked to higher behavioral and physiological risks, but these associations may not directly increase biological risk factors. The biological risks likely result from a complex interplay of long-term exposure and early life conditions.",3.552895910352811e-07,0.20591969828745826,0.0475,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
120,0.5,9,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: What is the impact of urban living timing on non-communicable disease risk in Thailand? Answer: Urban living was associated with increased behavioral and physiological risk factors, though these may not directly increase biological risks. Biological risk factors probably result from a complex interaction between long-term exposure and early life.",3.316036182995957e-07,0.2135921327402306,0.027100694444444445,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
120,0.5,10,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: In Thailand, does the timing of living in an urban area influence non-communicable disease risk? Answer: Urbanicity correlated with increases in behavioral and physiological risk factors, but these might not directly elevate biological risk factors. The biological risks likely stem from a complex interplay of long-term exposure and early life influences.",2.8423167282822487e-07,0.14529507647102413,0.0475,0.02176111757738247,0.21511137961694615,0.0,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
121,0.5,1,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
",Does sex affect the outcome of intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) indicates that women might be less likely than men to have favorable results after intravenous thrombolysis for ischemic stroke. This underscores the importance of further studies to explore sex-specific differences in treatment response.,1.8948778188548325e-07,0.11496495028809672,0.013366242120380803,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
121,0.5,2,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? According to data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR), women may have a reduced chance of achieving positive outcomes compared to men following intravenous thrombolysis for ischemic stroke. This suggests a need for additional research into sex-related differences in treatment effects.",1.4211583641411244e-07,0.07902000094411754,0.013981409152067609,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
121,0.5,3,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Does gender impact the effectiveness of intravenous thrombolysis in ischemic stroke patients? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggest women are less likely than men to experience favorable outcomes after intravenous thrombolysis for ischemic stroke, indicating further research is needed to clarify sex-specific treatment responses.",3.079176455639103e-07,0.21091799422525082,0.011617481789802302,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
121,0.5,4,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Is there a sex-based difference in response to intravenous thrombolysis for ischemic stroke? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) shows women may have a lower probability of favorable outcomes than men after intravenous thrombolysis, highlighting the necessity for more research on sex-specific treatment responses.",3.316036182995957e-07,0.20353837914653106,0.031217481789802295,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
121,0.5,5,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Does biological sex influence the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women might achieve less favorable outcomes compared to men following intravenous thrombolysis, emphasizing the need for further investigation into sex-specific differences.",4.026615365066519e-07,0.2654137828646186,0.031217481789802295,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
121,0.5,6,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Are outcomes after intravenous thrombolysis for ischemic stroke affected by sex? Research from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) indicates women may have a lower chance of favorable results than men, pointing to the need for more studies on sex-specific treatment responses.",4.263475092423373e-07,0.28691998808558195,0.031217481789802295,0.03264167636607371,0.3364722366212156,0.0,0.0325944277371516,0.34294475112682976,0.0,4.263475092423373e-07,0.3496737484797481,0.0
121,0.5,7,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Does sex play a role in the effectiveness of intravenous thrombolysis in ischemic stroke? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggest women might be less likely than men to reach favorable outcomes after intravenous thrombolysis, necessitating further research into sex-specific differences.",4.026615365066519e-07,0.2654137828646186,0.031217481789802295,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
121,0.5,8,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Is the response to intravenous thrombolysis in ischemic stroke patients influenced by gender? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) shows women may have a lower likelihood of favorable outcomes compared to men, indicating a need for further study on sex-specific treatment effects.",3.789755637709665e-07,0.24436037366678542,0.031217481789802295,0.029014823436509962,0.29298712468147725,0.0,0.028972824655245866,0.29849298855599704,0.0,3.789755637709665e-07,0.30421137440299084,0.0
121,0.5,9,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Does gender affect the outcomes of intravenous thrombolysis in ischemic stroke? According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR), women may be less likely than men to achieve positive results after intravenous thrombolysis, highlighting the importance of more research into sex-specific differences.",4.263475092423373e-07,0.28691998808558195,0.031217481789802295,0.03264167636607371,0.3364722366212156,0.0,0.0325944277371516,0.34294475112682976,0.0,4.263475092423373e-07,0.3496737484797481,0.0
121,0.5,10,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Is there a difference between men and women in response to intravenous thrombolysis for ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests women may have a lower probability of favorable outcomes than men, underscoring the need for further investigation into sex-specific responses to treatment.",3.079176455639103e-07,0.1837357518503513,0.031217481789802295,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
122,0.5,1,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Our findings provide initial evidence that reduced beta-endorphin levels during alcohol withdrawal are associated with heightened anxiety symptoms, indicating a possible contribution of beta-endorphin deficiency to withdrawal-induced anxiety.",1.421158364141119e-07,0.19783241553260567,0.02854671280276816,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
122,0.5,2,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is withdrawal-induced anxiety in alcoholism linked to a deficiency in beta-endorphin? The results show first evidence that decreased beta-endorphin levels during alcohol withdrawal correspond with increased anxiety symptoms, suggesting beta-endorphin deficiency may play a role in withdrawal anxiety.",9.474389094274131e-08,0.10265415406008227,0.0,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
122,0.5,3,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is the anxiety experienced during alcohol withdrawal caused by a lack of beta-endorphin? Our study offers the first evidence that lower beta-endorphin levels during alcohol withdrawal correlate with greater anxiety symptoms, implying beta-endorphin deficiency might contribute to withdrawal anxiety.",7.1057918207056e-08,0.14894876808949453,0.05246913580246914,0.005440279394345618,0.11542895663511299,0.027006172839506164,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
122,0.5,4,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Does a beta-endorphin shortage cause withdrawal-induced anxiety in alcoholism? The findings present initial proof that diminished beta-endorphin levels during alcohol withdrawal are linked to elevated anxiety symptoms, indicating a potential role for beta-endorphin deficiency in withdrawal anxiety.",1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
122,0.5,5,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is beta-endorphin deficiency responsible for anxiety during alcohol withdrawal? Our results provide the first evidence that reduced beta-endorphin levels during withdrawal are associated with increased anxiety symptoms, suggesting beta-endorphin deficiency could be involved in withdrawal-induced anxiety.",1.421158364141119e-07,0.19783241553260567,0.02854671280276816,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
122,0.5,6,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is withdrawal anxiety in alcoholism related to beta-endorphin deficiency? The data reveal initial evidence that lower beta-endorphin levels during alcohol withdrawal correspond with heightened anxiety symptoms, pointing to a possible role of beta-endorphin deficiency in withdrawal anxiety.",1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
122,0.5,7,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Could beta-endorphin deficiency underlie anxiety caused by alcohol withdrawal? Our findings offer the first evidence that decreased beta-endorphin levels during withdrawal are linked with increased anxiety symptoms, suggesting a role for beta-endorphin deficiency in withdrawal-induced anxiety.",1.421158364141119e-07,0.19783241553260567,0.02854671280276816,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
122,0.5,8,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is the anxiety seen in alcohol withdrawal due to beta-endorphin deficiency? The results provide initial evidence that beta-endorphin levels drop during withdrawal and correlate with increased anxiety symptoms, implying beta-endorphin deficiency may contribute to withdrawal anxiety.",1.421158364141119e-07,0.15822400521489444,0.0,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
122,0.5,9,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Does a lack of beta-endorphin cause anxiety during alcohol withdrawal? Our study presents first evidence that lowered beta-endorphin levels during withdrawal correlate with heightened anxiety symptoms, indicating beta-endorphin deficiency might play a role in withdrawal-induced anxiety.",1.421158364141119e-07,0.15822400521489444,0.0,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
122,0.5,10,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is beta-endorphin deficiency a factor in withdrawal-induced anxiety in alcoholism? The findings give first evidence that reduced beta-endorphin levels during alcohol withdrawal are associated with increased anxiety symptoms, suggesting a possible role for beta-endorphin deficiency in withdrawal anxiety.",9.474389094274131e-08,0.1401215692254847,0.027006172839506164,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
123,0.5,1,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Question: Are patients at high risk of falls properly prepared for discharge home following rehabilitation according to guidelines? Answer: Evidence shows that individuals at high risk of falls often do not receive sufficient fall risk assessments, interventions, or education during rehabilitation, indicating a shortfall in current practices and a need to better adhere to fall prevention guidelines.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
123,0.5,2,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Question: Do we adhere to guidelines when preparing high-fall-risk patients for discharge home after rehabilitation? Answer: There is limited evidence that patients at high risk of falls are provided with adequate fall risk assessments, interventions, or education during rehabilitation, highlighting a gap in practice and a necessity for improvement in fall prevention measures.",9.474389094274162e-08,0.024913053640556626,0.07100591715976332,0.0072537058591274906,0.000108503552939343,0.05436390532544381,0.007243206163811466,0.025616805539096177,0.036982248520710054,9.474389094274162e-08,0.05231511806187328,0.018860946745562133
123,0.5,3,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Question: Is the preparation of patients at high risk of falls for discharge home after rehabilitation aligned with guidelines? Answer: Findings reveal minimal evidence that high-fall-risk patients receive proper fall risk assessments, interventions, or educational support during rehabilitation, suggesting a deficiency in current care and the need to enhance guideline compliance.",1.4211583641411244e-07,0.014307659512725834,0.07100591715976332,0.010880558788691236,0.03989683106075903,0.05436390532544381,0.0108648092457172,0.06643880005935054,0.036982248520710054,1.4211583641411244e-07,0.0939878144624422,0.018860946745562133
123,0.5,4,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Question: Are guidelines met when preparing patients with a high risk of falls for discharge after rehabilitation? Answer: There is scant evidence that those at high risk of falls are given adequate assessments, interventions, or education about fall risk during rehabilitation, indicating a gap in practice and the requirement for improvement in fall prevention.",7.105791820705622e-08,0.03450824352761206,0.014605917159763289,0.005440279394345618,0.033792424479184735,0.015963905325443797,0.0054324046228586,0.032996420617815936,0.01738224852071006,7.105791820705622e-08,0.03211241074435467,0.018860946745562133
123,0.5,5,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Question: How well do we meet guidelines for preparing high-fall-risk patients for discharge home post-rehabilitation? Answer: The evidence points to a lack of adequate fall risk assessments, interventions, or education for patients at high risk of falls during rehabilitation, suggesting current practices fall short and improvements are needed.",2.1317375462116866e-07,0.07618306323081336,0.07100591715976332,0.016320838183036854,0.10307573268229131,0.05436390532544381,0.0162972138685758,0.13097732119692207,0.036982248520710054,2.1317375462116866e-07,0.15994578225423828,0.018860946745562133
123,0.5,6,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Question: Do patients at high risk of falls receive guideline-based preparation for discharge home after rehabilitation? Answer: Little evidence exists that these patients are adequately assessed, intervened with, or educated about fall risks during rehabilitation, highlighting a practice gap and the need for better adherence to fall prevention guidelines.",1.8948778188548325e-07,0.0551296540329802,0.07100591715976332,0.014507411718254981,0.08156952746132795,0.05436390532544381,0.014486412327622933,0.10899841447814707,0.036982248520710054,1.8948778188548325e-07,0.13747292640218056,0.018860946745562133
123,0.5,7,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Question: Are fall prevention guidelines followed when preparing high-risk patients for discharge home after rehabilitation? Answer: The data indicate insufficient evidence that patients at high risk of falls receive proper assessments, interventions, or education during rehabilitation, pointing to a shortcoming in practice and a need for improvement.",2.3685972735685406e-07,0.09768926845177672,0.07100591715976332,0.018134264647818726,0.12505463940106631,0.05436390532544381,0.018108015409528666,0.15345017704897979,0.036982248520710054,2.3685972735685406e-07,0.1829353004789378,0.018860946745562133
123,0.5,8,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Question: Is the discharge preparation of patients at high risk of falls after rehabilitation in line with guidelines? Answer: Evidence suggests that these patients often do not receive adequate fall risk assessments, interventions, or education during rehabilitation, revealing a gap in current practice and the necessity for enhanced fall prevention efforts.",1.4211583641411244e-07,0.014307659512725834,0.07100591715976332,0.010880558788691236,0.03989683106075903,0.05436390532544381,0.0108648092457172,0.06643880005935054,0.036982248520710054,1.4211583641411244e-07,0.0939878144624422,0.018860946745562133
123,0.5,9,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Question: Do we meet the guidelines in preparing patients at high risk of falls for discharge home post-rehabilitation? Answer: There is limited evidence that high-risk patients receive sufficient fall risk assessments, interventions, or education during rehabilitation, indicating a gap in practice and a need for improvement in fall prevention.",1.8948778188548325e-07,0.0551296540329802,0.07100591715976332,0.014507411718254981,0.08156952746132795,0.05436390532544381,0.014486412327622933,0.10899841447814707,0.036982248520710054,1.8948778188548325e-07,0.13747292640218056,0.018860946745562133
123,0.5,10,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Question: Are patients at high risk of falls adequately prepared for discharge home following rehabilitation according to guidelines? Answer: The evidence shows a lack of adequate fall risk assessments, interventions, or education for these patients during rehabilitation, suggesting a deficiency in current practice and the need to improve compliance with fall prevention guidelines.",9.474389094274162e-08,0.024913053640556626,0.07100591715976332,0.0072537058591274906,0.000108503552939343,0.05436390532544381,0.007243206163811466,0.025616805539096177,0.036982248520710054,9.474389094274162e-08,0.05231511806187328,0.018860946745562133
124,0.5,1,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage effective for postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage appears to be a safe and effective method for both preventing CSF fistula in cases involving large dural tears and compromised or irradiated patients, as well as treating existing CSF leaks.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
124,0.5,2,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage work for postoperative cerebrospinal fluid fistula after spine surgery? It seems that lumbar drainage is both effective and safe in preventing CSF fistula in patients with large dural tears or weakened/irradiated tissues, and also in managing CSF leaks.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
124,0.5,3,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a successful treatment for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage is considered effective and safe for preventing CSF fistula in cases with extensive dural tears and in patients who are debilitated or irradiated, as well as for treating CSF leaks.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,0.5,4,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"How effective is lumbar drainage for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage appears to be a reliable and safe approach to prevent CSF fistula in patients with large dural tears and those who are debilitated or have undergone irradiation, and it also helps in treating CSF leaks.",2.1317375462116866e-07,0.20930648136917895,0.004584257889546365,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
124,0.5,5,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage prevent or treat postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage is effective and safe for preventing CSF fistula in large dural tear cases and in debilitated or irradiated patients, and it is also useful for treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.5,6,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a safe and effective method for postoperative cerebrospinal fluid fistula after spine surgery? It seems lumbar drainage effectively prevents CSF fistula in patients with large dural tears and those who are debilitated or irradiated, and it also treats CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.5,7,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage provide effective treatment for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage is shown to be a safe and effective strategy to prevent CSF fistula in large dural tear cases and debilitated or irradiated patients, as well as to treat CSF leaks.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,0.5,8,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage beneficial for postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage appears to be both an effective and safe option for preventing CSF fistula in cases of significant dural tears and in patients who are debilitated or irradiated, and for treating CSF leaks.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,0.5,9,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"What is the efficacy of lumbar drainage for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage seems to be a safe and effective measure to prevent CSF fistula in patients with large dural tears and those debilitated or irradiated, and to treat CSF leaks.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
124,0.5,10,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective and safe approach for postoperative cerebrospinal fluid fistula after spine surgery? Lumbar drainage is effective in preventing CSF fistula in cases of large dural tears and in debilitated or irradiated patients, as well as in treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
125,0.5,1,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Does using a neuroendoscope at the same time affect the rate of ventriculoperitoneal shunt infections? In this study, we reviewed patient records who had ventriculoperitoneal shunt surgery, comparing those with simultaneous endoscopic third ventriculostomy (ETV) and those without. Results show that neuroendoscope use during shunt placement does not notably raise infection risk.",3.079176455639103e-07,0.14593544604775488,0.057963918414248805,0.023574544042164344,0.1871023761659325,0.03171190540177372,0.023540420032387266,0.2129545004647886,0.016124697661918846,3.079176455639103e-07,0.23967285326541932,0.0
125,0.5,2,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Is the incidence of ventriculoperitoneal shunt infection affected by the simultaneous use of a neuroendoscope? We examined patient data for ventriculoperitoneal shunt insertions, contrasting cases with concurrent endoscopic third ventriculostomy (ETV) against those without. Our results suggest no significant increase in infection risk with neuroendoscope use.",4.500334819780227e-07,0.2747228879850807,0.05535317461259591,0.03445510283085558,0.3149357476758161,0.03171190540177372,0.034405229278104466,0.3435746828818531,0.016124697661918846,4.500334819780227e-07,0.3732042458899425,0.0
125,0.5,3,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Does the concurrent use of a neuroendoscope impact the frequency of infections in ventriculoperitoneal shunts? This study analyzed patient records undergoing shunt placement, comparing those who had simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Findings reveal no meaningful rise in shunt infection risk when a neuroendoscope is used.",3.316036182995957e-07,0.19400760541383066,0.03763336285869324,0.025387970506946217,0.2073050834834511,0.03171190540177372,0.025351221573340132,0.23357378766752435,0.016124697661918846,3.316036182995957e-07,0.2607262624632525,0.0
125,0.5,4,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Does simultaneous neuroendoscope utilization influence ventriculoperitoneal shunt infection rates? We analyzed patient records of ventriculoperitoneal shunt procedures, comparing patients who had simultaneous endoscopic third ventriculostomy (ETV) with those who did not. The study found no significant increase in infection risk due to neuroendoscope use.",4.974054274493935e-07,0.32161812445059246,0.05432128802876127,0.038081955760419325,0.36145576331071005,0.03171190540177372,0.0380268323600102,0.39120273187110755,0.016124697661918846,4.974054274493935e-07,0.4219944100593742,0.0
125,0.5,5,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Does the use of a neuroendoscope at the same time as ventriculoperitoneal shunt placement affect infection rates? Reviewing patient cases, we compared those with simultaneous endoscopic third ventriculostomy (ETV) to those without, concluding that neuroendoscope use does not significantly elevate infection risk.",5.447773729207643e-07,0.3370067696928727,0.0775639184142488,0.04170880868998307,0.41024592748014177,0.03171190540177372,0.04164843544191593,0.441213152445771,0.016124697661918846,5.447773729207643e-07,0.4732877044469239,0.0
125,0.5,6,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Is ventriculoperitoneal shunt infection incidence influenced by simultaneous neuroendoscope use? Patient records of shunt placements were examined, comparing those with and without concurrent endoscopic third ventriculostomy (ETV). The data indicates no significant increase in infection risk associated with neuroendoscope use.",5.92149318392135e-07,0.3870171902675361,0.0775639184142488,0.045335661619546816,0.4615392218676915,0.03171190540177372,0.045270038523821665,0.4938568859311898,0.016124697661918846,5.921493183921352e-07,0.5273549257172001,0.0
125,0.5,7,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Does performing a neuroendoscope procedure simultaneously affect the likelihood of ventriculoperitoneal shunt infections? The study reviewed shunt placement records, comparing patients undergoing simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Results show no notable increase in infection risk from neuroendoscope use.",5.210914001850789e-07,0.31290921811381267,0.0775639184142488,0.0398953822252012,0.38555331488977007,0.03171190540177372,0.039837633900963065,0.41589534446147924,0.016124697661918846,5.210914001850789e-07,0.44731221804366594,0.0
125,0.5,8,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Does the simultaneous application of a neuroendoscope impact the rate of ventriculoperitoneal shunt infections? Analysis of patient records undergoing shunt placement, with or without concurrent endoscopic third ventriculostomy (ETV), suggests no significant rise in infection risk due to neuroendoscope usage.",5.92149318392135e-07,0.3870171902675361,0.0775639184142488,0.045335661619546816,0.4615392218676915,0.03171190540177372,0.045270038523821665,0.4938568859311898,0.016124697661918846,5.921493183921352e-07,0.5273549257172001,0.0
125,0.5,9,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Does using a neuroendoscope concurrently during ventriculoperitoneal shunt surgery alter infection rates? We studied patient data comparing those who had simultaneous endoscopic third ventriculostomy (ETV) to those who did not, finding no significant increase in infection risk linked to neuroendoscope use.",5.684633456564497e-07,0.39635674131124077,0.052580354969146884,0.04352223515476494,0.4355637354644335,0.03171190540177372,0.0434592369828688,0.46718863884902895,0.016124697661918846,5.684633456564497e-07,0.4999559515290848,0.0
125,0.5,10,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
",Does the simultaneous use of a neuroendoscope during ventriculoperitoneal shunt insertion affect infection incidence? Our analysis of patient records comparing those with and without endoscopic third ventriculostomy (ETV) shows neuroendoscope use does not significantly raise shunt infection risk.,6.395212638635056e-07,0.43966092375295496,0.0775639184142488,0.04896251454911056,0.5156064431379677,0.03171190540177372,0.0488916416057274,0.549426737086002,0.016124697661918846,6.39521263863506e-07,0.5845133395571485,0.0
126,0.5,1,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does automatic transmission enhance the driving habits of elderly drivers? Answer: It is often suggested that older drivers switch to automatic transmission to help preserve safe driving and maintain their transportation quality.,7.10579182070559e-08,0.09332544715697333,0.002670768987034146,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,0.5,2,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can automatic transmission benefit the driving performance of senior drivers? Answer: Older drivers may be advised to use automatic transmission to support safer driving and sustain their mobility quality.,1.421158364141118e-07,0.19624707501694916,0.005892062707435933,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.5,3,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Is automatic transmission helpful for improving older drivers' driving behavior? Answer: Transitioning to automatic transmission can be recommended for elderly drivers to promote safe driving and uphold their transport mobility.,1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,0.5,4,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,"Question: Does using automatic transmission positively affect the driving behavior of older adults? Answer: For older drivers, switching to automatic transmission might be suggested to help ensure safe driving and preserve the quality of their transportation.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
126,0.5,5,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can older drivers improve their driving by using automatic transmission? Answer: It is recommended that older drivers adopt automatic transmission to maintain safety on the road and the quality of their mobility.,7.10579182070559e-08,0.09332544715697333,0.002670768987034146,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,0.5,6,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does automatic transmission contribute to better driving behavior in senior drivers? Answer: Older drivers may benefit from switching to automatic transmission as a way to keep their driving safe and maintain transport mobility quality.,2.36859727356853e-08,0.030152490117890007,0.0008380438547157774,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
126,0.5,7,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Is the use of automatic transmission advantageous for elderly drivers' driving behavior? Answer: Switching to automatic transmission is often recommended for older drivers to help sustain safe driving and their transportation quality.,7.10579182070559e-08,0.09332544715697333,0.002670768987034146,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,0.5,8,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,"Question: Does automatic transmission aid in enhancing driving behavior among older drivers? Answer: For older drivers, adopting automatic transmission may be advised to support safe driving and maintain the quality of their mobility.",7.10579182070559e-08,0.09332544715697333,0.002670768987034146,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,0.5,9,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can the use of automatic transmission improve the driving safety of older drivers? Answer: It is suggested that older drivers switch to automatic transmission to promote safe driving and preserve their quality of transport mobility.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
126,0.5,10,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does automatic transmission help older drivers maintain better driving habits? Answer: Older drivers might be encouraged to switch to automatic transmission to ensure safe driving and uphold the quality of their transport mobility.,4.73719454713706e-08,0.10324992977309444,0.03180708532418292,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
127,0.5,1,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia negatively impact the outcomes of colon and rectal surgeries? Answer: This extensive multicenter database study indicates that severe, moderate, and even mild preoperative anemia independently increase the risk of complications and prolong hospital stays following colon surgery.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.5,2,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is there an adverse effect of preoperative anemia on colon and rectal surgery results? Answer: Analysis of a large multicenter database shows that severe, moderate, and mild preoperative anemia are independent risk factors for postoperative complications and extended hospitalization after colon surgery.",4.737194547137081e-08,0.04802033420753293,0.0010803788339694455,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.5,3,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does having anemia before surgery affect the outcomes of colon and rectal procedures? Answer: Findings from a large multicenter database suggest that severe, moderate, and mild preoperative anemia independently contribute to higher complication rates and longer hospital stays after colon surgery.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.5,4,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia influence the success of colon and rectal surgeries? Answer: This large-scale multicenter database analysis reveals that even mild preoperative anemia, along with moderate and severe forms, is an independent risk factor for complications and increased length of hospital stay following colon surgery.",2.3685972735685406e-08,0.053979545877510304,0.02271498107084911,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
127,0.5,5,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia associated with worse outcomes in colon and rectal surgery? Answer: The analysis from a large multicenter database demonstrates that severe, moderate, and mild anemia before surgery independently increase the risk of complications and prolong hospitalization after colon surgery.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.5,6,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: How does preoperative anemia affect colon and rectal surgery outcomes? Answer: According to a large multicenter database analysis, severe, moderate, and mild preoperative anemia independently raise the risk of complications and lengthen hospital stays after colon surgery.",1.6580180914979753e-07,0.17923244641398606,0.004291191768657054,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
127,0.5,7,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does anemia prior to surgery adversely affect colon and rectal surgery outcomes? Answer: This comprehensive multicenter database study suggests that severe, moderate, and mild preoperative anemia are independent predictors of complications and longer hospital stays following colon surgery.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,0.5,8,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is there a negative impact of preoperative anemia on colon and rectal surgical results? Answer: The large multicenter database analysis indicates that severe, moderate, and mild anemia before surgery independently increase the likelihood of complications and extended hospitalization after colon surgery.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.5,9,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does the presence of preoperative anemia affect outcomes in colon and rectal surgery? Answer: Evidence from a large multicenter database analysis shows that severe, moderate, and mild preoperative anemia independently contribute to a higher risk of complications and longer hospital stays post-colon surgery.",2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
127,0.5,10,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia worsen outcomes in colon and rectal surgery? Answer: This analysis of a large multicenter database suggests that even mild preoperative anemia, as well as moderate and severe forms, independently increase the risk of complications and prolong hospital stay after colon surgery.",0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
128,0.5,1,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor for adverse maternal and neonatal outcomes? Early identification of preeclampsia is vital for better maternal and neonatal health. Although ACR serves as a useful marker, studies indicate its prognostic utility in early preeclampsia might be restricted. More research is needed to clarify its predictive power for negative outcomes.",1.1842986367842703e-07,0.08394590900482779,0.003697277563423307,0.009067132323909363,0.08182000813651058,0.0012810193954682567,0.009054007704764333,0.08134563945395268,0.0,1.1842986367842703e-07,0.08269171584511614,0.0
128,0.5,2,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Does the first urinary albumin/creatinine ratio (ACR) test in women with suspected preeclampsia serve as a prognostic indicator for adverse maternal and neonatal events? Early diagnosis of preeclampsia plays a key role in enhancing outcomes for mothers and newborns. While ACR is a helpful biomarker, evidence suggests its early prognostic significance may be limited. Additional studies are necessary to evaluate its predictive accuracy for adverse effects.",2.3685972735685406e-08,0.02641830236442466,0.029970614547902487,0.0018134264647818726,0.0058234190197259394,0.015380859375,0.0018108015409528666,0.015748356968136257,0.0,2.3685972735685406e-08,0.01600034134644357,0.0
128,0.5,3,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict maternal and neonatal complications? Early detection of preeclampsia is essential to improve outcomes for both mother and child. Although ACR is a valuable marker, research indicates its early prognostic value might be constrained. Further investigation is required to assess its ability to predict adverse outcomes.",2.1317375462116866e-07,0.10791104784482819,0.027813208616780032,0.016320838183036854,0.1277079736047959,0.015380859375,0.0162972138685758,0.15154989812720032,0.0,2.1317375462116866e-07,0.15415067982725983,0.0
128,0.5,4,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Is the first measurement of urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a reliable prognostic factor for negative maternal and neonatal results? Detecting preeclampsia early is critical for better maternal and neonatal prognosis. While ACR is a significant marker, current research suggests its prognostic value at initial stages may be limited. More research is needed to determine its predictive potential for adverse outcomes.",4.737194547137081e-08,0.01107997740084432,0.014133992133100196,0.0036268529295637453,0.03192961034713804,0.0004880272014828359,0.003621603081905733,0.031748698314579826,0.0,4.737194547137081e-08,0.03226086221822477,0.0
128,0.5,5,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia act as a prognostic marker for unfavorable maternal and neonatal outcomes? Early recognition of preeclampsia is important for improving outcomes in mothers and newborns. Although ACR is a useful indicator, studies show its prognostic value early on may be limited. Further research is necessary to confirm its predictive capabilities.",1.4211583641411244e-07,0.05540170577208592,0.02868959515243423,0.010880558788691236,0.07552222043422674,0.015380859375,0.0108648092457172,0.0984400728132524,0.0,1.4211583641411244e-07,0.10008345855698497,0.0
128,0.5,6,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Is the first urinary albumin/creatinine ratio (ACR) test in women suspected of preeclampsia an effective prognostic tool for maternal and neonatal adverse outcomes? Early identification of preeclampsia is crucial for enhancing maternal and neonatal health. While ACR is a valuable biomarker, its early prognostic significance may be limited according to research. Additional studies are needed to clarify its predictive value.",1.6580180914979784e-07,0.1195934618555583,0.005350056689342415,0.012693985253473108,0.11651828070938652,0.001855213262734686,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
128,0.5,7,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Can the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia be used as a prognostic factor for adverse maternal and neonatal outcomes? Early detection of preeclampsia is key to improving outcomes for both mother and baby. Although ACR is an important marker, research suggests its early prognostic utility might be limited. More investigation is required to establish its predictive role.",1.1842986367842703e-07,0.01576749780221043,0.04535147392290249,0.009067132323909363,0.05871510211784603,0.015380859375,0.009054007704764333,0.08134563945395268,0.0,1.1842986367842703e-07,0.08269171584511614,0.0
128,0.5,8,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Is the first urinary albumin/creatinine ratio (ACR) measurement in women suspected of preeclampsia a prognostic factor for negative maternal and neonatal outcomes? Early diagnosis of preeclampsia is essential to improve maternal and neonatal prognosis. While ACR is a useful marker, evidence indicates its prognostic value at early stages may be limited. Further studies are needed to evaluate its predictive power for adverse events.",9.474389094274162e-08,0.06658573633945686,0.0029105197570745214,0.0072537058591274906,0.06491193723417421,0.0010080295138888938,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
128,0.5,9,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Does the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia provide prognostic information about maternal and neonatal adverse outcomes? Early detection of preeclampsia is vital for better outcomes in mothers and newborns. Although ACR is a valuable marker, research shows its prognostic value early in the disease may be limited. Additional research is required to determine its predictive accuracy.",1.4211583641411244e-07,0.03229679975342137,0.04535147392290249,0.010880558788691236,0.07552222043422674,0.015380859375,0.0108648092457172,0.0984400728132524,0.0,1.4211583641411244e-07,0.10008345855698497,0.0
128,0.5,10,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Is measuring the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia useful as a prognostic factor for maternal and neonatal adverse outcomes? Early detection of preeclampsia is critical for improving outcomes. While ACR is an important marker, research suggests its prognostic value in the early stages may be limited. More research is needed to confirm its predictive capabilities.",1.6580180914979784e-07,0.07260043266505445,0.028407359773080846,0.012693985253473108,0.09261665379352646,0.015380859375,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
129,0.5,1,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Question: Does PET/CT provide additional benefits over multidetector CT in the preoperative staging of patients with colorectal carcinoma liver metastases? Answer: PET/CT has advantages compared to MDCT in preoperative staging of colorectal liver metastases, especially in identifying small lesions, extrahepatic disease, and evaluating response to neoadjuvant therapy, though its role is still debated and requires further study.",4.737194547137081e-08,0.06387348466928477,0.01969802687475379,0.0036268529295637453,0.037992417039609094,0.0006853637551643317,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
129,0.5,2,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Question: In the preoperative staging of colorectal liver metastases, does PET/CT add value beyond multidetector CT? Answer: PET/CT surpasses MDCT in detecting small lesions, extrahepatic spread, and monitoring neoadjuvant therapy response in colorectal liver metastases, but its clinical utility remains controversial and needs more research.",2.3685972735685406e-07,0.1907914393013681,0.010011847876405466,0.018134264647818726,0.215174704225912,0.004381683639925391,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
129,0.5,3,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Question: For preoperative staging of liver metastases from colorectal cancer, does PET/CT offer any advantages over multidetector CT? Answer: PET/CT provides benefits over MDCT by better detecting small lesions, extrahepatic disease, and assessing neoadjuvant therapy response, though its definitive role is still uncertain and under investigation.",2.1317375462116866e-07,0.10530520339840566,0.05536332179930796,0.016320838183036854,0.15994578225423828,0.018860946745562133,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
129,0.5,4,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Question: Is there a significant benefit of PET/CT compared to multidetector CT in preoperative staging of colorectal liver metastases? Answer: PET/CT improves detection of small lesions, extrahepatic involvement, and response assessment to neoadjuvant therapy versus MDCT, but its application remains controversial and further validation is required.",2.1317375462116866e-07,0.10530520339840566,0.05536332179930796,0.016320838183036854,0.15994578225423828,0.018860946745562133,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
129,0.5,5,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Question: Does PET/CT enhance preoperative staging accuracy for colorectal carcinoma liver metastases compared to multidetector CT? Answer: PET/CT offers superior detection of small lesions, extrahepatic disease, and treatment response evaluation over MDCT, yet its role is debated and additional research is warranted.",3.079176455639103e-07,0.19839562646441733,0.05536332179930796,0.023574544042164344,0.25525596205856393,0.018860946745562133,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
129,0.5,6,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Question: In patients with colorectal liver metastases, does PET/CT add value to multidetector CT during preoperative staging? Answer: PET/CT is advantageous over MDCT for identifying small lesions, extrahepatic disease, and assessing neoadjuvant therapy response, but its role remains controversial and further studies are necessary.",2.6054570009253947e-07,0.1507675774751629,0.05536332179930796,0.0199476911126006,0.20646579788913222,0.018860946745562133,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
129,0.5,7,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Question: How does PET/CT compare to multidetector CT in the preoperative staging of colorectal liver metastases? Answer: PET/CT provides benefits over MDCT in detecting small lesions, extrahepatic spread, and evaluating response to neoadjuvant therapy, although its role is still debated and requires more research.",2.6054570009253947e-07,0.1507675774751629,0.05536332179930796,0.0199476911126006,0.20646579788913222,0.018860946745562133,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
129,0.5,8,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Question: Does PET/CT contribute additional information beyond multidetector CT in staging colorectal liver metastases preoperatively? Answer: PET/CT offers advantages over MDCT in detecting small lesions, extrahepatic disease, and assessing neoadjuvant therapy response, but its clinical role remains controversial and further investigation is needed.",2.8423167282822487e-07,0.1742980748853573,0.05536332179930796,0.02176111757738247,0.23056334946819224,0.018860946745562133,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
129,0.5,9,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Question: Is PET/CT superior to multidetector CT for preoperative staging of colorectal carcinoma liver metastases? Answer: PET/CT has benefits over MDCT in identifying small lesions, extrahepatic disease, and monitoring neoadjuvant therapy response, yet its role is still controversial and demands further research.",3.079176455639103e-07,0.19839562646441733,0.05536332179930796,0.023574544042164344,0.25525596205856393,0.018860946745562133,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
129,0.5,10,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Question: What is the added value of PET/CT compared to multidetector CT in preoperative staging of colorectal liver metastases? Answer: PET/CT enhances detection of small lesions, extrahepatic disease, and response to neoadjuvant therapy beyond MDCT, but its role remains debated and further studies are required.",2.3685972735685406e-07,0.12777805925046337,0.05536332179930796,0.018134264647818726,0.1829353004789378,0.018860946745562133,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
130,0.5,1,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: A history of PIPE could be a risk factor for developing IPE, but its lack of significance in multivariate analysis suggests it is not an independent predictor.",2.3685972735685406e-08,0.022472855852057716,0.0,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
130,0.5,2,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: How significant are postictal psychotic episodes II in the long term? Are they indicators of interictal psychotic episodes? Answer: While a history of PIPE may increase risk for IPE, multivariate analysis shows it is not an independent predictor.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.5,3,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term relevance of postictal psychotic episodes II? Can they forecast interictal psychotic episodes? Answer: Having a history of PIPE might be a risk factor for IPE, but multivariate analysis reveals it is not independently predictive.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
130,0.5,4,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Long-term impact of postictal psychotic episodes II: Are they predictive of interictal psychotic episodes? Answer: PIPE history may pose a risk for IPE, yet multivariate analysis indicates it is not an independent predictor.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
130,0.5,5,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term significance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: A history of PIPE may increase the risk of IPE, but multivariate analysis shows it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.5,6,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Are postictal psychotic episodes II significant predictors of interictal psychotic episodes in the long term? Answer: A history of PIPE might be a risk factor for IPE, but multivariate analysis suggests it is not independently predictive.",2.1317375462116823e-07,0.2616517280119841,0.02775510204081633,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.5,7,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Long-term significance of postictal psychotic episodes II: Are they indicative of interictal psychotic episodes? Answer: PIPE history may be a risk factor for IPE, though multivariate analysis shows it is not an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
130,0.5,8,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: How important are postictal psychotic episodes II over the long term? Can they predict interictal psychotic episodes? Answer: A history of PIPE could increase risk for IPE, but multivariate analysis finds it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.5,9,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term predictive value of postictal psychotic episodes II for interictal psychotic episodes? Answer: PIPE history may pose a risk for IPE, yet multivariate analysis indicates it is not an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
130,0.5,10,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Are postictal psychotic episodes II long-term predictors of interictal psychotic episodes? Answer: While a history of PIPE may be a risk factor for IPE, multivariate analysis shows it is not an independent predictor.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
131,0.5,1,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does having a previous benign prostate biopsy predict the results for patients undergoing radical perineal prostatectomy? A prior benign prostate biopsy might independently correlate with better surgical and biochemical outcomes following prostatectomy. Further research is necessary to validate these results.,4.7371945471370706e-08,0.019666266328761672,0.021582468146067776,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,0.5,2,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can a prior benign prostate biopsy forecast outcomes for patients treated with radical perineal prostatectomy? A history of benign prostate biopsy could be independently linked to improved surgical and biochemical results after prostatectomy. More studies are required to confirm this observation.,2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
131,0.5,3,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is the outcome of radical perineal prostatectomy influenced by a previous benign prostate biopsy? Prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes post-prostatectomy. Additional research is needed to substantiate these findings.,9.474389094274131e-08,0.03868539646061464,0.04570850860093706,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.5,4,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a prior benign prostate biopsy serve as a predictor for outcomes in patients undergoing radical perineal prostatectomy? Such a biopsy might independently predict better surgical and biochemical outcomes after prostatectomy. Further investigations are warranted to confirm these findings.,7.1057918207056e-08,0.025450265786948645,0.07271468144044323,0.005440279394345618,0.008646823413716476,0.049861495844875335,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
131,0.5,5,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can prior benign prostate biopsy independently predict the outcomes for patients treated with radical perineal prostatectomy? It may be associated with more favorable surgical and biochemical outcomes following prostatectomy. Additional studies are needed for confirmation.,1.658018091497972e-07,0.0857753693232759,0.07271468144044323,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
131,0.5,6,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a previous benign prostate biopsy forecast the outcome for patients receiving radical perineal prostatectomy? It may independently relate to improved surgical and biochemical outcomes after prostatectomy. Further research is necessary to verify these findings.,1.658018091497972e-07,0.0857753693232759,0.07271468144044323,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
131,0.5,7,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is prior benign prostate biopsy an independent predictor of outcomes in patients undergoing radical perineal prostatectomy? It may be linked to better surgical and biochemical results post-prostatectomy. More studies are needed to confirm this association.,1.658018091497972e-07,0.0857753693232759,0.07271468144044323,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
131,0.5,8,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does having a benign prostate biopsy before surgery predict outcomes for patients treated with radical perineal prostatectomy? Prior benign biopsy might be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional research is required to confirm this.,4.7371945471370706e-08,0.05142575219020662,0.07271468144044323,0.0036268529295637453,0.018021423668444392,0.049861495844875335,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,0.5,9,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can a history of benign prostate biopsy predict surgical and biochemical outcomes in patients treated with radical perineal prostatectomy? Such a history may be independently associated with better outcomes post-prostatectomy. Further studies are necessary to confirm this.,1.1842986367842661e-07,0.06712513218110239,0.0449595793996269,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
131,0.5,10,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a prior benign prostate biopsy independently predict outcomes for patients undergoing radical perineal prostatectomy? It may be associated with improved surgical and biochemical outcomes after prostatectomy. More research is needed to validate these findings.,1.658018091497972e-07,0.0857753693232759,0.07271468144044323,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
132,0.5,1,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Could neoadjuvant chemotherapy alter the extent of lymphadenectomy required in cervical cancer? The frequency and location of lymph node metastases (LNM), along with treatment response, are crucial considerations. Neoadjuvant chemotherapy may downstage the disease, potentially decreasing the necessity for extensive lymphadenectomy in certain cases.",1.4211583641411244e-07,0.13456786450853064,0.002843324829931968,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
132,0.5,2,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Is it possible to adjust the extent of lymphadenectomy through neoadjuvant chemotherapy in cervical cancer? Key factors include how often and where lymph node metastases occur, as well as how the disease responds to treatment. Neoadjuvant chemotherapy might reduce disease stage, thus lessening the need for extensive lymphadenectomy in some patients.",2.3685972735685406e-08,0.0207685417506287,0.0004076354181128221,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
132,0.5,3,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Can neoadjuvant chemotherapy influence the scope of lymphadenectomy in cervical cancer? Important aspects to evaluate are the frequency and distribution of lymph node metastases and the treatment response. By downstaging the disease, neoadjuvant chemotherapy could reduce the requirement for extensive lymphadenectomy in certain cases.",1.4211583641411244e-07,0.16680726825550485,0.02600164625884065,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
132,0.5,4,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Does neoadjuvant chemotherapy have the potential to modify lymphadenectomy extent in cervical cancer? The critical factors are the incidence and anatomical distribution of lymph node metastases and the effectiveness of treatment. Neoadjuvant chemotherapy might downstage the cancer, which can decrease the need for extensive lymphadenectomy in some instances.",4.737194547137081e-08,0.04287659944973932,0.0008672350871665457,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
132,0.5,5,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Might the extent of lymphadenectomy be adjusted by neoadjuvant chemotherapy in cervical cancer? Considerations include how frequently and where lymph node metastases occur and how the disease responds to therapy. Neoadjuvant chemotherapy could potentially downstage the disease, reducing the necessity for extensive lymphadenectomy in some cases.",9.474389094274162e-08,0.0876726280430189,0.0018114382460973355,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
132,0.5,6,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Is the extent of lymphadenectomy in cervical cancer modifiable by neoadjuvant chemotherapy? The frequency and topographic distribution of lymph node metastases, along with treatment response, are vital factors. Neoadjuvant chemotherapy may downstage the disease, thereby lowering the need for extensive lymphadenectomy in certain situations.",1.4211583641411244e-07,0.13456786450853064,0.002843324829931968,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
132,0.5,7,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Could neoadjuvant chemotherapy affect the extent of lymphadenectomy in cervical cancer? It is important to consider the frequency and location of lymph node metastases and how the disease responds to treatment. Neoadjuvant chemotherapy can potentially reduce disease stage, lessening the need for extensive lymphadenectomy in some cases.",7.105791820705622e-08,0.09516084784080192,0.022989124196510568,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
132,0.5,8,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Can the extent of lymphadenectomy be influenced by neoadjuvant chemotherapy in cervical cancer? Key factors include the incidence and distribution of lymph node metastases and the treatment response. Neoadjuvant chemotherapy might downstage the disease, which could reduce the necessity for extensive lymphadenectomy in some patients.",1.1842986367842703e-07,0.1108456325623095,0.002315675515293554,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
132,0.5,9,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Is it feasible to modify the extent of lymphadenectomy through neoadjuvant chemotherapy in cervical cancer? Essential considerations are the frequency and topographic distribution of lymph node metastases and the response to treatment. Neoadjuvant chemotherapy has the potential to downstage the disease, thereby decreasing the need for extensive lymphadenectomy in some cases.",2.3685972735685406e-08,0.0207685417506287,0.0004076354181128221,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
132,0.5,10,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Could the extent of lymphadenectomy in cervical cancer be changed by neoadjuvant chemotherapy? The frequency and anatomical distribution of lymph node metastases and the treatment response are key factors. Neoadjuvant chemotherapy may downstage the disease, potentially reducing the necessity for extensive lymphadenectomy in certain cases.",1.1842986367842703e-07,0.1108456325623095,0.002315675515293554,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
133,0.5,1,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors play a role in primary systemic vasculitis? Answer: For the first time, a strong link between farming and PSV has been discovered. Additionally, findings confirm earlier reported connections with silica, solvents, and allergies.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.5,2,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental influences significant in primary systemic vasculitis? Answer: A notable association between farming and PSV has been established for the first time. The results also back previously noted links with silica, solvents, and allergic reactions.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.5,3,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there an importance of environmental factors in primary systemic vasculitis? Answer: A significant correlation between farming and PSV has been identified for the first time. The findings also reinforce earlier reported associations with silica, solvents, and allergies.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
133,0.5,4,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors matter in primary systemic vasculitis? Answer: For the first time, a meaningful association between farming and PSV has been found. Results also support previously documented connections with silica, solvents, and allergy.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,0.5,5,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental elements relevant to primary systemic vasculitis? Answer: A significant link between farming and PSV has been reported for the first time. The results also corroborate prior associations with silica, solvents, and allergies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,0.5,6,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there a role for environmental factors in primary systemic vasculitis? Answer: A strong association between farming and PSV has been identified for the first time. The study also supports previously noted links with silica, solvents, and allergies.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
133,0.5,7,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: How important are environmental factors in primary systemic vasculitis? Answer: For the first time, an important association between farming and PSV has been observed. The results also confirm earlier findings related to silica, solvents, and allergy.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.5,8,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental influences linked to primary systemic vasculitis? Answer: A significant connection between farming and PSV has been discovered for the first time. The findings also uphold previously reported associations with silica, solvents, and allergies.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.5,9,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors contribute to primary systemic vasculitis? Answer: A notable association between farming and PSV has been found for the first time. The results also validate earlier reported links with silica, solvents, and allergy.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.5,10,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there an environmental impact on primary systemic vasculitis? Answer: For the first time, a significant association between farming and PSV has been identified. The results also support previously reported connections with silica, solvents, and allergies.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
134,0.5,1,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
134,0.5,2,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies that provide income support could be an important tool for enhancing the health and quality of life of elderly individuals. Although the SSI program mainly offers financial aid, its effects on health outcomes such as disability deserve more investigation.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
134,0.5,3,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support initiatives might serve as a vital mechanism to boost the health and welfare of older populations. Even though SSI focuses on financial help, its influence on disability and other health outcomes warrants additional study.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
134,0.5,4,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Providing income support may represent a key strategy to improve health and well-being among seniors. The SSI program, while primarily financial, could have important effects on disability and overall health that need further research.",4.737194547137081e-08,0.04082199452025437,0.0,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
134,0.5,5,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies have the potential to significantly enhance the health and well-being of elderly adults. Although the SSI program is mainly designed to offer monetary assistance, its role in affecting health outcomes like disability requires more examination.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
134,0.5,6,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Financial support policies could be an effective means to improve the health status and quality of life of older adults. The SSI programâ€™s primary function is financial aid, but its impact on disability and health outcomes should be explored further.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
134,0.5,7,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Supporting income may be a promising approach to enhance the health and well-being of the elderly. While SSI mainly provides financial resources, its effects on disability and health outcomes deserve more detailed study.",7.105791820705622e-08,0.06187540371808753,0.0,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
134,0.5,8,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support could be a crucial factor in improving health and well-being among older adults. Though the SSI program is focused on financial assistance, its influence on health outcomes including disability needs further investigation.",4.737194547137081e-08,0.04082199452025437,0.0,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
134,0.5,9,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies offering income support might be an important avenue for advancing the health and welfare of elderly individuals. The SSI program primarily delivers financial aid, but the extent of its impact on disability and other health measures requires more research.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
134,0.5,10,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Providing financial support through policies like SSI may be a key strategy to improve health outcomes and reduce disability among older adults. While SSIâ€™s main role is economic assistance, its potential health benefits should be examined more closely.",4.737194547137081e-08,0.012561206208669073,0.01922337562475971,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
135,0.5,1,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is primary angioplasty a viable alternative to thrombolysis? Reorganizing care to provide primary angioplasty services significantly reduced mortality, especially in patients with ST-segment elevation myocardial infarction (STEMI).",3.079176455639089e-07,0.4232381127379048,0.012776731301939057,0.023574544042164414,0.41871033485818643,0.0,0.023540420032387342,0.4328640822962804,0.0,3.079176455639103e-07,0.4480247225269607,0.0
135,0.5,2,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Can primary angioplasty be considered an acceptable substitute for thrombolysis? Implementing primary angioplasty services led to a notable decrease in mortality, particularly among patients with ST-segment elevation myocardial infarction (STEMI).",2.36859727356853e-07,0.30852306071540747,0.008815506812143138,0.018134264647818775,0.3053816495511823,0.0,0.01810801540952872,0.3150810466398961,0.0,2.3685972735685406e-07,0.3254224004346278,0.0
135,0.5,3,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is it acceptable to use primary angioplasty instead of thrombolysis? The reorganization of healthcare to include primary angioplasty was linked to a significant drop in death rates, with the greatest benefit seen in STEMI patients.",1.184298636784265e-07,0.14242847581634832,0.003761487959422983,0.009067132323909377,0.14107859825990632,0.0,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
135,0.5,4,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Does primary angioplasty serve as an acceptable alternative to thrombolysis? Introducing primary angioplasty services was associated with a marked reduction in mortality, most evident in patients suffering from ST-segment elevation myocardial infarction (STEMI).",1.658018091497971e-07,0.20560143285543164,0.005594213091741351,0.012693985253473136,0.20359895524123983,0.0,0.012675610786670101,0.20972053098207066,0.0,1.6580180914979784e-07,0.2162231084696371,0.0
135,0.5,5,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is primary angioplasty an effective alternative to thrombolysis? Care restructuring to offer primary angioplasty resulted in significant mortality reduction, especially in patients with ST-segment elevation myocardial infarction (STEMI).",2.842316728282236e-07,0.3835230064628643,0.011358979822649093,0.021761117577382534,0.37948962170490397,0.0,0.02172961849143447,0.39204208777602556,0.0,2.8423167282822487e-07,0.40546510810816505,0.0
135,0.5,6,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Can primary angioplasty replace thrombolysis as an acceptable treatment? Reorganizing care to provide primary angioplasty significantly lowered mortality rates, particularly for patients with ST-segment elevation myocardial infarction (STEMI).",2.842316728282236e-07,0.3835230064628643,0.011358979822649093,0.021761117577382534,0.37948962170490397,0.0,0.02172961849143447,0.39204208777602556,0.0,2.8423167282822487e-07,0.40546510810816505,0.0
135,0.5,7,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is primary angioplasty a suitable alternative to thrombolysis? The introduction of primary angioplasty services was linked to a significant decrease in mortality, most notably in patients with ST-segment elevation myocardial infarction (STEMI).",1.894877818854824e-07,0.2387476053243649,0.006598953524161247,0.014507411718255016,0.23638877806423153,0.0,0.014486412327622974,0.24362208265775243,0.0,1.8948778188548325e-07,0.2513144282809061,0.0
135,0.5,8,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is primary angioplasty considered an acceptable option instead of thrombolysis? Reconfiguring care to offer primary angioplasty was associated with a significant mortality reduction, with the strongest effect in STEMI patients.",2.36859727356853e-07,0.30852306071540747,0.008815506812143138,0.018134264647818775,0.3053816495511823,0.0,0.01810801540952872,0.3150810466398961,0.0,2.3685972735685406e-07,0.3254224004346278,0.0
135,0.5,9,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Could primary angioplasty be an acceptable alternative to thrombolysis? Offering primary angioplasty services through care reorganization was connected to a significant reduction in mortality, especially in patients with ST-segment elevation myocardial infarction (STEMI).",1.658018091497971e-07,0.20560143285543164,0.005594213091741351,0.012693985253473136,0.20359895524123983,0.0,0.012675610786670101,0.20972053098207066,0.0,1.6580180914979784e-07,0.2162231084696371,0.0
135,0.5,10,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is primary angioplasty a preferable alternative to thrombolysis? The restructuring of care to include primary angioplasty led to a significant decrease in mortality, particularly among patients with ST-segment elevation myocardial infarction (STEMI).",1.894877818854824e-07,0.2387476053243649,0.006598953524161247,0.014507411718255016,0.23638877806423153,0.0,0.014486412327622974,0.24362208265775243,0.0,1.8948778188548325e-07,0.2513144282809061,0.0
136,0.5,1,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","This article examines whether culture, attitudes, and faith should be considered in recovery outcome measures, focusing on the RAQ's cultural relevance and the impact of these factors on self-reported recovery.",5.92149318392134e-07,0.5703439809807684,0.036982248520710054,0.045335661619546865,0.6380874033769168,0.0,0.04527003852382172,0.6554068525770984,0.0,5.921493183921352e-07,0.6737290947028427,0.0
136,0.5,2,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","The paper explores the inclusion of cultural, attitudinal, and religious elements in recovery outcome assessments, assessing the RAQ's suitability across diverse cultural contexts.",7.579511275419311e-07,0.8465973576089261,0.036982248520710054,0.05802964687302002,0.9257694758286994,0.0,0.057945649310491835,0.9555114450274376,0.0,7.579511275419329e-07,0.987386653557885,0.0
136,0.5,3,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","Investigating the role of culture, personal attitudes, and spirituality in recovery metrics, this study evaluates the RAQ's cultural sensitivity and its effect on reported recovery progress.",6.868932093348752e-07,0.7187639860990416,0.036982248520710054,0.05258936747867438,0.7922380832041758,0.0,0.052513244687633215,0.8157495026522783,0.0,6.868932093348768e-07,0.8407831793660097,0.0
136,0.5,4,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","This study addresses the cultural appropriateness of the RAQ recovery measure, analyzing how cultural background, beliefs, and attitudes influence recovery reporting.",8.053230730133017e-07,0.9419075374132513,0.036982248520710054,0.06165649980258378,1.0258529343856808,0.0,0.06156725239239758,1.060871960685263,0.0,8.053230730133036e-07,1.0986122886681091,0.0
136,0.5,5,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","The research highlights the importance of incorporating cultural, faith-based, and attitudinal considerations into recovery outcome tools like the RAQ for more accurate assessments.",7.579511275419311e-07,0.8465973576089261,0.036982248520710054,0.05802964687302002,0.9257694758286994,0.0,0.057945649310491835,0.9555114450274376,0.0,7.579511275419329e-07,0.987386653557885,0.0
136,0.5,6,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","Focusing on the RAQ, this paper discusses how cultural factors, individual attitudes, and religious faith impact self-reported recovery and the necessity for culturally tailored interventions.",7.105791820705605e-07,0.7595859806192964,0.036982248520710054,0.05440279394345626,0.8347976976229714,0.0,0.05432404622858609,0.8602012652231124,0.0,7.105791820705622e-07,0.8873031950009036,0.0
136,0.5,7,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","This work reviews the RAQ's effectiveness as a recovery outcome measure in light of cultural diversity, personal beliefs, and attitudes towards recovery.",7.816371002776164e-07,0.89311737324382,0.036982248520710054,0.0598430733378019,0.9745596399981307,0.0,0.05975645085144471,1.0068047394149877,0.0,7.816371002776182e-07,1.0414538748281603,0.0
136,0.5,8,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","The article emphasizes the need for culturally sensitive recovery assessments by examining how culture, faith, and attitudes affect responses on the RAQ.",7.816371002776164e-07,0.89311737324382,0.036982248520710054,0.0598430733378019,0.9745596399981307,0.0,0.05975645085144471,1.0068047394149877,0.0,7.816371002776182e-07,1.0414538748281603,0.0
136,0.5,9,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","Exploring the intersection of culture, attitudes, and religion with recovery outcomes, this paper evaluates the RAQ's cultural fit and the importance of personalized recovery approaches.",7.105791820705605e-07,0.7595859806192964,0.036982248520710054,0.05440279394345626,0.8347976976229714,0.0,0.05432404622858609,0.8602012652231124,0.0,7.105791820705622e-07,0.8873031950009036,0.0
136,0.5,10,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","This paper considers the influence of cultural context, individual perspectives, and faith on recovery outcome measures, advocating for culturally adapted versions of the RAQ.",7.342651548062458e-07,0.802145595038092,0.036982248520710054,0.05621622040823814,0.8792494601938055,0.0,0.05613484776953896,0.9067212808580063,0.0,7.342651548062476e-07,0.9360933591703349,0.0
137,0.5,1,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Is cholecystectomy truly an indication for performing a simultaneous splenectomy in cases of mild hereditary spherocytosis? The recommendation to carry out splenectomy alongside cholecystectomy in mild hereditary spherocytosis is still debated. Although splenectomy may reduce anemia, its advantages need to be balanced with the heightened risk of complications and lifelong vulnerability to infections in patients with mild disease.",4.737194547137081e-08,0.011682414010731001,0.033163265306122444,0.0036268529295637453,0.011189692895409387,0.017236072637734686,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
137,0.5,2,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Does cholecystectomy justify a concurrent splenectomy in mild hereditary spherocytosis? The suggestion to do a splenectomy at the same time as cholecystectomy in mild hereditary spherocytosis remains controversial. While splenectomy can improve anemia, the benefits must be considered alongside the increased risk of post-surgical complications and lifelong infection susceptibility in mild cases.",1.8948778188548325e-07,0.16702876204513029,0.04955888605442177,0.014507411718254981,0.1522442654248115,0.0027555974997080478,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
137,0.5,3,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Is it appropriate to perform a concomitant splenectomy during cholecystectomy in patients with mild hereditary spherocytosis? The recommendation for simultaneous splenectomy during cholecystectomy in mild hereditary spherocytosis is debated. Splenectomy may relieve anemia, but its benefits should be weighed against the risks of complications and lifelong infection susceptibility in mild disease.",2.1317375462116866e-07,0.23365433080380527,0.04806390148652055,0.016320838183036854,0.20130452883094785,0.02350634474569675,0.0162972138685758,0.2007313894499898,0.020823902218198284,2.1317375462116866e-07,0.17520408902509166,0.0
137,0.5,4,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Should a splenectomy be done concurrently with cholecystectomy in mild hereditary spherocytosis? The guidance on performing a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis is controversial. Although splenectomy can reduce anemia symptoms, the increased risk of complications and lifelong infection risk must be carefully considered.",3.316036182995957e-07,0.29280503442430117,0.015624999999999986,0.025387970506946217,0.31536512976320186,0.028115401285167808,0.025351221573340132,0.3140905558879621,0.023242630385487524,3.316036182995957e-07,0.2876820724517817,0.0
137,0.5,5,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Is concomitant splenectomy indicated during cholecystectomy for mild hereditary spherocytosis? The advice to perform splenectomy alongside cholecystectomy in mild hereditary spherocytosis is controversial. While splenectomy may alleviate anemia, its benefits must be balanced against the risk of complications and lifelong infection susceptibility.",4.263475092423373e-07,0.3272878910039436,0.0263265306122449,0.03264167636607371,0.3476619295166228,0.017236072637734686,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
137,0.5,6,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
",Does mild hereditary spherocytosis warrant a simultaneous splenectomy when undergoing cholecystectomy? The recommendation to do splenectomy with cholecystectomy in mild hereditary spherocytosis remains debated. Splenectomy can help reduce anemia but poses increased risks of complications and lifelong infections.,5.210914001850786e-07,0.47106481780654175,0.0031760204081632756,0.0398953822252012,0.4915306218722235,0.010519029403081644,0.039837633900963065,0.48770320634513675,0.0,5.210914001850789e-07,0.49899116611898764,0.0
137,0.5,7,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Is performing a splenectomy during cholecystectomy justified in mild hereditary spherocytosis? The suggestion to carry out concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis is controversial. While splenectomy may improve anemia, the risks of complications and lifelong infection susceptibility must be considered.",4.263475092423373e-07,0.4287240637688132,0.04571921445714884,0.03264167636607371,0.4169766475726169,0.03262542320714065,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
137,0.5,8,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Should splenectomy be routinely done along with cholecystectomy in mild hereditary spherocytosis? The advice for simultaneous splenectomy during cholecystectomy in mild hereditary spherocytosis is debated. Although it can reduce anemia, the increased risk of complications and lifelong infection vulnerability must be weighed.",4.263475092423373e-07,0.3949120061805238,0.022013150828198325,0.03264167636607371,0.4169766475726169,0.03262542320714065,0.0325944277371516,0.41503563096438967,0.025623268698060954,4.263475092423373e-07,0.3877655310087631,0.0
137,0.5,9,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
",Is it standard to perform a splenectomy in conjunction with cholecystectomy for mild hereditary spherocytosis? The recommendation for concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis is controversial. Splenectomy can alleviate anemia but comes with increased risks of complications and lifelong infections.,4.263475092423373e-07,0.3272878910039436,0.0263265306122449,0.03264167636607371,0.3476619295166228,0.017236072637734686,0.0325944277371516,0.37948962170490574,0.0,4.263475092423373e-07,0.3877655310087631,0.0
137,0.5,10,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Does mild hereditary spherocytosis require splenectomy when undergoing cholecystectomy? The advice to perform a concomitant splenectomy with cholecystectomy in mild hereditary spherocytosis remains controversial. While splenectomy may reduce anemia, its benefits must be balanced against the risks of complications and lifelong susceptibility to infections.",3.789755637709665e-07,0.3103265919203477,0.004300578797848696,0.029014823436509962,0.33187877394528265,0.006559287267083869,0.028972824655245866,0.3294792011302423,0.0,3.789755637709665e-07,0.3364722366212134,0.0
138,0.5,1,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is aneurysm repair warranted for patients aged 80 or above following aneurysmal subarachnoid hemorrhage? Surgery tends to yield better outcomes in patients under 80, but the risk-benefit balance must be carefully assessed individually, factoring in overall health, life expectancy, and patient wishes.",3.316036182995957e-07,0.2937611185281632,0.0,0.025387970506946217,0.30010459245033916,0.0,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
138,0.5,2,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Should aneurysm repair be performed on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Outcomes are generally more favorable in those younger than 80, yet the decision should be personalized, weighing risks and benefits alongside health status, life expectancy, and patient preferences.",3.079176455639103e-07,0.2696635669491032,0.0,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
138,0.5,3,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is it appropriate to conduct aneurysm repair in patients 80 years or older after aneurysmal subarachnoid hemorrhage? Surgical intervention shows better prognosis in patients below 80, but individual evaluation of risks and benefits is essential, considering health, expected lifespan, and patient choice.",3.316036182995957e-07,0.3275731761164531,0.024375,0.025387970506946217,0.30010459245033916,0.0,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
138,0.5,4,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Does aneurysm repair justify treatment in patients aged 80+ after aneurysmal subarachnoid hemorrhage? Patients under 80 have better surgical outcomes; however, each case requires careful risk-benefit analysis based on overall health, longevity, and patient preferences.",4.974054274493929e-07,0.48097266061630917,0.0,0.03808195576041934,0.4924764850977952,0.0,0.03802683236001022,0.5045560107523945,0.0,4.974054274493935e-07,0.5172565140962813,0.0
138,0.5,5,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is aneurysm repair recommended for patients aged 80 or more after aneurysmal subarachnoid hemorrhage? Surgery has better results in those under 80 years, but the risk-benefit ratio needs thorough individual consideration including health, life expectancy, and patient desires.",4.26347509242337e-07,0.3964152725882455,0.0,0.03264167636607371,0.40546510810816505,0.0,0.0325944277371516,0.41494385206270756,0.0,4.263475092423373e-07,0.42488319396526597,0.0
138,0.5,6,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Can aneurysm repair be justified in patients aged 80 and older following aneurysmal subarachnoid hemorrhage? Better prognoses are seen in patients younger than 80, yet the risk-benefit ratio must be evaluated carefully for each patient, taking into account health, expected survival, and preferences.",3.079176455639103e-07,0.3026705755471948,0.023795359904818555,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
138,0.5,7,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is aneurysm repair advisable for patients aged 80 years or older after aneurysmal subarachnoid hemorrhage? Patients younger than 80 generally have better surgical outcomes, but the decision should be individualized by assessing risks, benefits, overall health, life expectancy, and patient preferences.",3.552895910352811e-07,0.3184537311185349,0.0,0.02720139697172809,0.3254224004346309,0.0,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
138,0.5,8,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Should patients aged 80 or older undergo aneurysm repair after aneurysmal subarachnoid hemorrhage? Surgery tends to produce better prognoses in those under 80, but the risk-benefit ratio should be carefully weighed on a case-by-case basis, considering health, longevity, and patient wishes.",3.552895910352811e-07,0.3184537311185349,0.0,0.02720139697172809,0.3254224004346309,0.0,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
138,0.5,9,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is aneurysm repair justified in patients aged 80 or above after aneurysmal subarachnoid hemorrhage? Surgical results are more favorable in patients younger than 80, yet the risk-benefit ratio must be carefully evaluated individually, taking into account overall health, life expectancy, and patient preferences.",3.079176455639103e-07,0.3026705755471948,0.023795359904818555,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
138,0.5,10,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is performing aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage justified? Better outcomes are observed in patients under 80, but individual assessment of risks and benefits is crucial, considering health status, life expectancy, and patient preferences.",3.789755637709664e-07,0.34377153910282665,0.0,0.029014823436509962,0.35139788683788886,0.0,0.028972824655245866,0.3593740009078954,0.0,3.789755637709665e-07,0.3677247801253176,0.0
139,0.5,1,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does blood pressure vary in treated hypertensive patients based on whether a nurse or a physician measures it? Systolic BP readings taken by nurses are significantly lower than those taken by physicians and closely match ambulatory BP monitoring, making nurse measurements valuable for diagnosis and control assessment.",6.39521263863506e-07,0.3067063095883551,0.1616212143132716,0.04896251454911062,0.4122413641990734,0.041587901701323246,0.04889164160572741,0.4589649704312255,0.014081632653061225,6.39521263863506e-07,0.4872951263557961,0.0
139,0.5,2,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In treated hypertensive patients, is there a difference in blood pressure readings depending on whether a nurse or a physician measures it? Nurse-measured systolic BP is notably lower than physician-measured values and aligns closely with ambulatory monitoring, supporting nurse measurements for diagnosis and control evaluation.",6.868932093348768e-07,0.3210212382217992,0.183349609375,0.05258936747867436,0.45770373827583066,0.041587901701323246,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
139,0.5,3,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","For treated hypertensive patients, does blood pressure change when measured by a nurse compared to a physician? Systolic BP recorded by nurses is significantly lower than physician's readings and nearly matches ambulatory BP monitoring, suggesting nurse measurements are preferable for diagnosis and monitoring control.",7.105791820705622e-07,0.3440107564464987,0.183349609375,0.054402793943456235,0.4812342356860251,0.041587901701323246,0.05432404622858601,0.5295825376451795,0.014081632653061225,7.105791820705622e-07,0.5596157879354222,0.0
139,0.5,4,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Is blood pressure in treated hypertensive patients influenced by whether a nurse or physician takes the measurement? Nurse-measured systolic BP is markedly lower than physician measurements and is almost identical to ambulatory BP results, indicating nurse measurements are beneficial for diagnosis and control evaluation.",7.105791820705622e-07,0.3440107564464987,0.183349609375,0.054402793943456235,0.4812342356860251,0.041587901701323246,0.05432404622858601,0.5295825376451795,0.014081632653061225,7.105791820705622e-07,0.5596157879354222,0.0
139,0.5,5,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does the method of measurement by a nurse versus a physician affect blood pressure readings in treated hypertensive patients? Nurses record significantly lower systolic BP than physicians, closely resembling ambulatory monitoring, which makes nurse measurements ideal for diagnosis and blood pressure control assessment.",7.342651548062476e-07,0.4005482624547847,0.15955424947018143,0.05621622040823811,0.5053317872650851,0.041587901701323246,0.05613484776953888,0.5542751502355512,0.014081632653061225,7.342651548062476e-07,0.584933595919714,0.0
139,0.5,6,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In patients treated for hypertension, does blood pressure differ when measured by a nurse compared to a physician? Systolic BP values from nurses are significantly lower than those from physicians and almost match ambulatory BP monitoring, highlighting the desirability of nurse measurements for diagnosis and control evaluation.",6.39521263863506e-07,0.27656947565096646,0.183349609375,0.04896251454911062,0.4122413641990734,0.041587901701323246,0.04889164160572741,0.4589649704312255,0.014081632653061225,6.39521263863506e-07,0.4872951263557961,0.0
139,0.5,7,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Are blood pressure readings in treated hypertensive patients different when taken by a nurse rather than a physician? Nurse measurements of systolic BP are significantly lower than physician readings and nearly identical to ambulatory monitoring, making nurse assessments useful for diagnosis and blood pressure control.",6.868932093348768e-07,0.35252792824725177,0.1606346283041509,0.05258936747867436,0.45770373827583066,0.041587901701323246,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
139,0.5,8,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does blood pressure measurement in treated hypertensive patients depend on whether a nurse or physician conducts it? Nurses record lower systolic BP than physicians, closely aligning with ambulatory BP monitoring, thus nurse measurements are preferred for diagnosis and control evaluation.",8.053230730133037e-07,0.44164922601041656,0.183349609375,0.061656499802583725,0.5813176942430065,0.041587901701323246,0.06156725239239748,0.6322366917052618,0.014081632653061225,8.053230730133038e-07,0.6649763035932481,0.0
139,0.5,9,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In treated hypertensive patients, does blood pressure vary depending on whether a nurse or physician measures it? Systolic BP measured by nurses is significantly lower than that measured by physicians and closely matches ambulatory BP monitoring, supporting nurse measurements for diagnosis and control assessment.",7.105791820705622e-07,0.3762501601934729,0.16010697898951248,0.054402793943456235,0.4812342356860251,0.041587901701323246,0.05432404622858601,0.5295825376451795,0.014081632653061225,7.105791820705622e-07,0.5596157879354222,0.0
139,0.5,10,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Is there a difference in blood pressure readings in treated hypertensive patients based on whether the measurement is done by a nurse or a physician? Systolic BP taken by nurses is significantly lower than physician readings and nearly identical to ambulatory BP monitoring, making nurse measurements desirable for diagnosis and control evaluation.",5.210914001850789e-07,0.1733852394157358,0.183349609375,0.039895382225201254,0.30688084854124753,0.041587901701323246,0.03983763390096308,0.3513343062388605,0.014081632653061225,5.210914001850789e-07,0.3772942311414673,0.0
140,0.5,1,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the utilization of audits to detect maternal mortality in various environments merely a matter of wealth disparity? Answer: Variations in maternal mortality extend beyond simple economic differences. Recognizing the scale of maternal deaths and mobilizing robust political commitment are crucial. Nonetheless, there is no universal remedy to lower maternal mortality, and problem identification must be tailored.",3.789755637709665e-07,0.16960967565654617,0.07999633677000212,0.029014823436510018,0.2128062515831317,0.027755102040816333,0.02897282465524588,0.23582141911701626,0.014081632653061225,3.789755637709665e-07,0.25951119548508306,0.0
140,0.5,2,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality across different settings reflect only the gap between rich and poor? Answer: Maternal mortality differences involve more than economic status. It is vital to appreciate the extent of the issue and to foster strong political will to address it. However, no one-size-fits-all solution exists, and identifying specific challenges is necessary.",4.500334819780227e-07,0.22502806102148032,0.07902267612382839,0.034455102830855636,0.2678660287661603,0.027755102040816333,0.03440522927810448,0.29191088576805946,0.014081632653061225,4.500334819780227e-07,0.3166696093250332,0.0
140,0.5,3,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the difference in maternal mortality identified through audits just a reflection of socioeconomic status? Answer: Maternal mortality disparities are more complex than wealth differences alone. Understanding the problem's scale and securing political determination are key. Yet, reducing maternal mortality requires context-specific problem identification rather than a universal approach.",5.684633456564497e-07,0.36378166853384286,0.014238993203331454,0.043522235154765,0.3669569314103902,0.027755102040816333,0.04345923698286881,0.39300700263942945,0.014081632653061225,5.684633456564497e-07,0.41985384556026384,0.0
140,0.5,4,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does the use of audit to track maternal mortality merely highlight the divide between affluent and impoverished areas? Answer: The disparity in maternal mortality is not solely a rich-poor issue. Recognizing the severity and rallying political will are essential. Still, no single solution fits all cases, and problem identification must be context-sensitive.",4.974054274493935e-07,0.2637557781504243,0.07831122645136487,0.03808195576041938,0.3063323095939561,0.027755102040816333,0.03802683236001021,0.3311315989213419,0.014081632653061225,4.974054274493935e-07,0.35667494393873156,0.0
140,0.5,5,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is auditing maternal mortality in different contexts simply about distinguishing between wealth levels? Answer: Maternal mortality differences surpass economic divides. Acknowledging the problem's magnitude and harnessing political resolve are important. There is no universal fix, and identifying issues must be tailored to each setting.",6.868932093348768e-07,0.43565704589442955,0.07481962100527546,0.05258936747867436,0.476957826624719,0.027755102040816333,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
140,0.5,6,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Can audits identifying maternal mortality differences be reduced to just rich versus poor distinctions? Answer: Differences in maternal mortality go beyond economic status. Recognizing the scale and engaging political will are critical. However, a general solution does not exist, requiring careful problem identification.",7.105791820705622e-07,0.4593792778406507,0.07429197169063706,0.054402793943456235,0.5004883240349134,0.027755102040816333,0.05432404622858601,0.5295825376451795,0.014081632653061225,7.105791820705622e-07,0.5596157879354222,0.0
140,0.5,7,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the audit-based identification of maternal mortality differences only about economic disparities? Answer: The variation in maternal mortality is more than just economic gaps. Acknowledging the problem's extent and securing political commitment are vital. No single solution fits all, so identifying problems must be context-specific.",6.632072365991914e-07,0.41248404137513894,0.07532385827447169,0.05077594101389249,0.45396830840001945,0.027755102040816333,0.05070244314668028,0.48195448865592505,0.014081632653061225,6.632072365991914e-07,0.5108256237659905,0.0
140,0.5,8,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality disparities simply reflect the gap between the wealthy and the poor? Answer: Maternal mortality differences involve more than wealth. Recognizing the magnitude and fostering political will are crucial. There is no single universal solution; instead, problem identification needs to be tailored.",6.632072365991914e-07,0.41248404137513894,0.07532385827447169,0.05077594101389249,0.45396830840001945,0.027755102040816333,0.05070244314668028,0.48195448865592505,0.014081632653061225,6.632072365991914e-07,0.5108256237659905,0.0
140,0.5,9,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to",Question: Is the use of audits to identify maternal mortality just highlighting differences between rich and poor populations? Answer: Maternal mortality disparities exceed simple economic differences. Understanding the problem's scale and mobilizing political will are important. No one-size-fits-all solution exists; problem identification must be specific to context.,6.39521263863506e-07,0.3898354272355329,0.07580620701439618,0.04896251454911062,0.43149545254796173,0.027755102040816333,0.04889164160572741,0.4589649704312255,0.014081632653061225,6.39521263863506e-07,0.4872951263557961,0.0
140,0.5,10,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is auditing maternal mortality in various settings only about the rich-poor divide? Answer: Differences in maternal mortality go beyond economic status. It is essential to acknowledge the problem's magnitude and to harness political will. However, no single solution applies universally, and problem identification must be adapted.",6.39521263863506e-07,0.3898354272355329,0.07580620701439618,0.04896251454911062,0.43149545254796173,0.027755102040816333,0.04889164160572741,0.4589649704312255,0.014081632653061225,6.39521263863506e-07,0.4872951263557961,0.0
141,0.5,1,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is it possible for visceral adipose tissue area measurement at a single level to represent visceral adipose tissue volume? Measuring VAT area at a single level 3 cm above the lower border of the L3 vertebra is practical and can indicate changes in VAT volume and body weight. New insights: VAT area at a CT slice 3 cm above...,0.0,0.023901626915860508,0.016353852561432763,0.0,0.024320953703858006,0.017132563126552286,0.0,0.0,0.0,0.0,0.025205352020361893,0.0181755829903978
141,0.5,2,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can visceral adipose tissue volume be represented by measuring its area at a single level? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is achievable and reflects changes in VAT volume and body weight. Knowledge update: VAT area at a CT slice 3 cm above...,1.1842986367842703e-07,0.05672815271118603,0.020484200995925794,0.009067132323909363,0.047842748326917484,0.0313757208971164,0.009054007704764333,0.04401554511368477,0.03566529492455417,1.1842986367842703e-07,0.07010482778396376,0.0181755829903978
141,0.5,3,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Does measuring visceral adipose tissue area at one level correspond to visceral adipose tissue volume? VAT area measurement 3 cm above the lower edge of the L3 vertebra is feasible and can mirror changes in VAT volume and body weight. Advances: VAT area at a CT slice 3 cm above...,2.1317375462116866e-07,0.10984678566637252,0.07367685950413225,0.016320838183036854,0.10344757463455823,0.048951818678918124,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
141,0.5,4,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can a single-level measurement of visceral adipose tissue area represent the volume of visceral adipose tissue? Measuring VAT area at a single level 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Progress in understanding: VAT area at a CT slice 3 cm above...,7.105791820705622e-08,0.004107402389158743,0.06694477301124531,0.005440279394345618,0.03379975985039341,0.014412399097808448,0.0054324046228586,0.03170576166550987,0.016804348178992037,7.105791820705622e-08,0.030884114630681303,0.0181755829903978
141,0.5,5,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is a single-level VAT area measurement indicative of visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is practical and reflects changes in VAT volume and body weight. Knowledge advancement: VAT area at a CT slice 3 cm above...,1.8948778188548325e-07,0.09727986905859387,0.031190123456790064,0.014507411718254981,0.08223887656399986,0.049376415341560856,0.014486412327622933,0.1046401669301189,0.03566529492455417,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
141,0.5,6,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can visceral adipose tissue volume be inferred from a single-level area measurement? VAT area measured 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. New findings: VAT area at a CT slice 3 cm above...,2.6054570009253947e-07,0.06905212319875842,0.13193086419753083,0.0199476911126006,0.11712605653002406,0.06977572089711641,0.019918816950481533,0.16917868806769043,0.03566529492455417,2.6054570009253947e-07,0.19793819929384737,0.0181755829903978
141,0.5,7,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is it valid to use visceral adipose tissue area at one level to represent its volume? Measuring VAT area at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can indicate changes in VAT volume and body weight. Advances in knowledge: VAT area at a CT slice 3 cm above...,4.737194547137081e-08,0.03202321613990389,0.046756785851595484,0.0036268529295637453,0.011155028172629144,0.03346386614453542,0.003621603081905733,0.012529249072251503,0.017153368972257985,4.737194547137081e-08,0.011835919659988203,0.0181755829903978
141,0.5,8,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Does a single-level measurement of visceral adipose tissue area correspond to its volume? VAT area measurement at 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Updates in knowledge: VAT area at a CT slice 3 cm above...,2.1317375462116866e-07,0.024971620699848263,0.13365758261656854,0.016320838183036854,0.07456644211122754,0.06977572089711641,0.0162972138685758,0.12569357612795207,0.03566529492455417,2.1317375462116866e-07,0.15348643672301465,0.0181755829903978
141,0.5,9,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can the volume of visceral adipose tissue be represented by its area at a single level? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Advances: VAT area at a CT slice 3 cm above...,1.1842986367842703e-07,0.05672815271118603,0.020484200995925794,0.009067132323909363,0.047842748326917484,0.0313757208971164,0.009054007704764333,0.04401554511368477,0.03566529492455417,1.1842986367842703e-07,0.07010482778396376,0.0181755829903978
141,0.5,10,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is measuring visceral adipose tissue area at a single level sufficient to represent its volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Knowledge progress: VAT area at a CT slice 3 cm above...,9.474389094274162e-08,0.06061903396488244,0.005092621095518335,0.0072537058591274906,0.053945031605859395,0.013375720897116382,0.007243206163811466,0.051256966201195464,0.01644191929979446,9.474389094274162e-08,0.050302200487784,0.0181755829903978
142,0.5,1,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does the menopausal transition influence quality of life? This long-term study involving 1,000 women over five years found no significant impact of menopausal transition on the quality of life of postmenopausal women, assessing their physical, mental, and social health. The findings indicate that menopause transition does not adversely affect overall quality of life.",1.4211583641411244e-07,0.11851387663433588,0.010358493878239505,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
142,0.5,2,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Is quality of life affected by the menopausal transition? A longitudinal study tracking 1,000 women for five years revealed no meaningful effect of menopausal transition on the quality of life in postmenopausal women, based on evaluations of their physical, mental, and social well-being. The data suggest that entering menopause does not harm overall quality of life.",7.105791820705622e-08,0.057513083521274044,0.004891559489461669,0.005440279394345618,0.07973933906879171,0.01851192595229618,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
142,0.5,3,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does going through menopause alter quality of life? This five-year longitudinal study of 1,000 women showed no significant changes in quality of life related to menopausal transition, considering physical, mental, and social aspects. The results imply that menopause transition does not negatively influence overall quality of life.",2.8423167282822487e-07,0.222723841111498,0.0009090909090909566,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
142,0.5,4,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Is the quality of life impacted by menopausal transition? A study following 1,000 postmenopausal women over five years found no significant effect of menopausal transition on their quality of life, assessing various dimensions including physical, mental, and social well-being. The study suggests that menopause does not reduce overall quality of life.",1.8948778188548325e-07,0.1336103419707002,0.006336662075298385,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
142,0.5,5,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does the transition into menopause affect quality of life? In a longitudinal study of 1,000 women over five years, no significant impact of menopausal transition on quality of life was observed among postmenopausal women, evaluating their physical, mental, and social health. These findings indicate that menopause does not detrimentally affect overall life quality.",1.4211583641411244e-07,0.05513239844194473,0.0687105086727609,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
142,0.5,6,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Is quality of life influenced by the menopausal transition? A five-year longitudinal study of 1,000 women found no significant effect of the menopausal transition on the quality of life of postmenopausal women, with assessments covering physical, mental, and social well-being. The evidence suggests that menopause transition does not impair overall quality of life.",1.4211583641411244e-07,0.14517338357894927,0.03012167125803497,0.010880558788691236,0.1384078774851245,0.019599999999999992,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
142,0.5,7,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does menopausal transition have an effect on quality of life? This longitudinal study tracking 1,000 women over five years found no substantial impact of menopausal transition on the quality of life among postmenopausal women, assessing physical, mental, and social health. The results indicate that entering menopause does not negatively affect overall quality of life.",1.1842986367842703e-07,0.09776679515162323,0.008466115702479377,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
142,0.5,8,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Is the quality of life altered by menopausal transition? A longitudinal study of 1,000 women over five years found no significant influence of menopausal transition on quality of life in postmenopausal women, evaluating their physical, mental, and social well-being. The findings suggest menopause transition does not harm overall quality of life.",1.8948778188548325e-07,0.1613362291930982,0.014374852687540518,0.014507411718254981,0.17952269137943144,0.020399305555555556,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
142,0.5,9,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does menopause transition impact quality of life? In a study following 1,000 women for five years, no significant effect of menopausal transition on quality of life was found among postmenopausal women, with assessments of physical, mental, and social health. The study suggests the transition into menopause does not reduce overall quality of life.",1.4211583641411244e-07,0.09185436968972249,0.00953388429752064,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
142,0.5,10,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Is the quality of life affected during menopausal transition? A five-year longitudinal study involving 1,000 postmenopausal women found no significant impact of menopausal transition on quality of life, based on evaluations of their physical, mental, and social well-being. The results indicate menopause transition does not negatively influence overall quality of life.",1.8948778188548325e-07,0.1336103419707002,0.006336662075298385,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
143,0.5,1,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis for low-tone sudden deafness? Does it always lead to Meniere's disease? We conclude that not every patient with low-tone sudden deafness (SD) experiences endolymphatic hydrops, even if vertigo occurs at onset, and that electrocochleography (ECochG) serves as a valuable prognostic tool.",4.737194547137081e-08,0.015684784721507583,0.020673448681217014,0.0036268529295637453,0.014655832718537543,0.02221074380165289,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
143,0.5,2,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably progress to Meniere's disease? Our findings indicate that not all patients with low-tone sudden deafness (SD) develop endolymphatic hydrops, even when vertigo is present at onset, and that electrocochleography (ECochG) is a useful tool for prognosis.",1.4211583641411244e-07,0.14880299255637475,0.006473066092809211,0.010880558788691236,0.14784031154193933,0.0034125248964080625,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
143,0.5,3,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is the prognosis of low-tone sudden deafness always a progression to Meniere's disease? We conclude that endolymphatic hydrops does not affect all low-tone sudden deafness (SD) patients, even those who experience vertigo initially, and that electrocochleography (ECochG) is an effective prognostic method.",1.1842986367842703e-07,0.12241977708658869,0.005263772746290217,0.009067132323909363,0.12163385332616006,0.0027728196434490295,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
143,0.5,4,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Regarding the prognosis of low-tone sudden deafness, does it necessarily lead to Meniere's disease? Our conclusion is that not all patients with low-tone sudden deafness (SD) have endolymphatic hydrops, even with vertigo attacks at onset, and that electrocochleography (ECochG) is a helpful prognostic tool.",7.105791820705622e-08,0.03940701666772872,0.0201457993665786,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
143,0.5,5,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always progress to Meniere's disease? We found that endolymphatic hydrops is not present in all low-tone sudden deafness (SD) patients, even those with vertigo at onset, and that electrocochleography (ECochG) provides useful prognostic information.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.5,6,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the outlook for low-tone sudden deafness? Does it inevitably develop into Meniere's disease? We conclude that not all patients with low-tone sudden deafness (SD) suffer from endolymphatic hydrops, even if vertigo occurs initially, and that electrocochleography (ECochG) is an effective prognostic tool.",7.105791820705622e-08,0.03940701666772872,0.0201457993665786,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
143,0.5,7,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression to Meniere's disease inevitable in low-tone sudden deafness? Our study shows that endolymphatic hydrops does not affect every patient with low-tone sudden deafness (SD), even those who experience vertigo at onset, and that electrocochleography (ECochG) is a valuable prognostic tool.",1.1842986367842703e-07,0.08860771949829882,0.019013429752066123,0.009067132323909363,0.08697649429816368,0.02221074380165289,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
143,0.5,8,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness invariably lead to Meniere's disease? We conclude that endolymphatic hydrops is not present in all patients with low-tone sudden deafness (SD), even with initial vertigo attacks, and that electrocochleography (ECochG) is a useful tool for prognosis.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
143,0.5,9,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis for patients with low-tone sudden deafness? Does it always progress to Meniere's disease? We conclude that not all low-tone sudden deafness (SD) patients suffer from endolymphatic hydrops, even if vertigo occurs at onset, and that electrocochleography (ECochG) is a beneficial prognostic tool.",2.3685972735685406e-08,0.0074882197977830245,0.021177685950413232,0.0018134264647818726,0.00833368550616198,0.02221074380165289,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
143,0.5,10,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness necessarily progress to Meniere's disease? We conclude that endolymphatic hydrops is not present in every case of low-tone sudden deafness (SD), even when vertigo attacks occur initially, and that electrocochleography (ECochG) is a useful prognostic method.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
144,0.5,1,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Is there a relationship between residents' leadership abilities and their technical skill ratings? General surgery research residents' leadership during operations correlated significantly with attending surgeons' assessments of their technical skills, indicating a close link between leadership and surgical competence. More studies are required to identify which leadership traits influence this connection.",1.6580180914979784e-07,0.13783812944348428,0.004889233241505961,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
144,0.5,2,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Do residents' leadership skills impact how their technical skills are rated? Leadership capabilities of general surgery research residents during surgery were significantly associated with attending surgeons' evaluations of their technical proficiency, suggesting a strong bond between leadership and surgical skill. Additional research is necessary to pinpoint the leadership factors involved.",1.8948778188548325e-07,0.13088078397171543,0.01464201675849405,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
144,0.5,3,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Are leadership skills of residents connected to their technical skill ratings? The intraoperative leadership of general surgery research residents showed a significant correlation with attending surgeons' technical skill ratings, implying a strong relationship between leadership and perceived surgical ability. Further investigation is needed to clarify which leadership elements play a role.",1.6580180914979784e-07,0.11011224222108673,0.015049652176606872,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
144,0.5,4,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Does a resident's leadership ability relate to their technical skill evaluation? In general surgery research residents, intraoperative leadership skills were significantly linked to attending surgeons' ratings of technical skill, indicating a robust association between leadership and surgical competence. More research is required to explore the specific leadership aspects involved.",2.1317375462116866e-07,0.1232083495189431,0.035041322314049606,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
144,0.5,5,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Is there a correlation between residents' leadership skills and their technical skill ratings? General surgery research residents demonstrated a significant relationship between their leadership during surgery and attending surgeons' assessments of their technical skills, highlighting a close connection between leadership and surgical performance. Further studies are needed to determine the leadership characteristics that affect this link.",4.737194547137081e-08,0.012281527214724974,0.016865739323651804,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
144,0.5,6,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Do leadership skills in residents correspond with ratings of their technical expertise? The leadership abilities of general surgery research residents during operations were significantly correlated with attending surgeons' technical skill ratings, suggesting a strong connection between leadership and surgical proficiency. Additional research is needed to understand the leadership factors involved.",1.8948778188548325e-07,0.13088078397171543,0.01464201675849405,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
144,0.5,7,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Are residents' leadership skills associated with their technical skill ratings? In general surgery research residents, intraoperative leadership was significantly correlated with attending surgeons' evaluations of technical skill, indicating a strong relationship between leadership and surgical competence. More research is necessary to identify the leadership components contributing to this association.",2.1317375462116866e-07,0.1232083495189431,0.035041322314049606,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
144,0.5,8,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Does the leadership capability of residents relate to their technical skill scores? General surgery research residents' leadership during surgery showed significant correlation with attending surgeons' ratings of technical skill, pointing to a strong link between leadership and perceived surgical ability. Further research is needed to explore the leadership traits involved.",1.8948778188548325e-07,0.13088078397171543,0.01464201675849405,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
144,0.5,9,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Is there a link between residents' leadership skills and technical skill ratings? The intraoperative leadership skills of general surgery research residents significantly correlated with attending surgeons' assessments of technical skill, suggesting a strong connection between leadership and surgical competence. Additional studies are required to understand the leadership aspects influencing this relationship.",1.6580180914979784e-07,0.11011224222108673,0.015049652176606872,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
144,0.5,10,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Do residents' leadership qualities relate to their technical skill evaluations? Leadership skills demonstrated by general surgery research residents during operations showed significant correlation with attending surgeons' ratings of technical ability, indicating a strong association between leadership and surgical competence. Further research is needed to clarify which leadership factors contribute.",2.1317375462116866e-07,0.1232083495189431,0.035041322314049606,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
145,0.5,1,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
",Is it acceptable for student examiners to act as reasonable substitutes for faculty in an undergraduate OSCE focused on medical emergencies?,8.053230730133017e-07,0.8392190662191847,0.109375,0.06165649980258378,0.9212269448671986,0.07496876301541025,0.06156725239239758,0.9808934398514229,0.057476051645147866,8.053230730133036e-07,1.0442478039183096,0.039150354019158694
145,0.5,2,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
",Can student examiners serve as appropriate substitute examiners for faculty during an undergraduate OSCE on medical emergencies?,9.000669639560431e-07,1.062362617533394,0.109375,0.06891020566171129,1.1576157229314283,0.07496876301541025,0.06881045855620907,1.2322078681323294,0.057476051645147866,9.00066963956045e-07,1.3125117905129886,0.039150354019158694
145,0.5,3,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
",Are student examiners a justifiable alternative to faculty examiners in an undergraduate OSCE on medical emergencies?,9.237529366917285e-07,1.1269011386709646,0.109375,0.07072363212649316,1.2266085944183804,0.07496876301541025,0.07062126009716195,1.3063158402860506,0.057476051645147866,9.237529366917304e-07,1.392554498186525,0.039150354019158694
145,0.5,4,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
",Is it reasonable to use student examiners instead of faculty in an undergraduate OSCE concerning medical emergencies?,9.000669639560431e-07,1.062362617533394,0.109375,0.06891020566171129,1.1576157229314283,0.07496876301541025,0.06881045855620907,1.2322078681323294,0.057476051645147866,9.00066963956045e-07,1.3125117905129886,0.039150354019158694
145,0.5,5,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
",Could student examiners effectively replace faculty examiners in an undergraduate OSCE on medical emergencies?,9.711248821630993e-07,1.270001982311638,0.109375,0.07435048505605692,1.380759274245638,0.07496876301541025,0.0742428631790677,1.4733699249492171,0.057476051645147866,9.71124882163101e-07,1.5748760549804803,0.039150354019158694
145,0.5,6,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
",Is the use of student examiners as substitutes for faculty in an undergraduate OSCE on medical emergencies acceptable?,8.763809912203578e-07,1.001737995716959,0.109375,0.06709677919692941,1.0930772017938577,0.07496876301541025,0.0669996570152562,1.1632149966453773,0.057476051645147866,8.763809912203596e-07,1.2384038183592674,0.039150354019158694
145,0.5,7,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
",May student examiners be considered suitable substitutes for faculty in an undergraduate OSCE on medical emergencies?,9.237529366917285e-07,1.1269011386709646,0.109375,0.07072363212649316,1.2266085944183804,0.07496876301541025,0.07062126009716195,1.3063158402860506,0.057476051645147866,9.237529366917304e-07,1.392554498186525,0.039150354019158694
145,0.5,8,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
",Is it permissible and beneficial to involve student examiners as substitutes for faculty in an undergraduate OSCE on medical emergencies?,8.290090457489871e-07,0.8905123606067349,0.109375,0.06346992626736567,0.9752941661374739,0.07496876301541025,0.06337805393335046,1.0380518536913717,0.057476051645147866,8.29009045748989e-07,1.1048724257347446,0.039150354019158694
145,0.5,9,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
",Are student examiners justified as reasonable replacements for faculty in an undergraduate OSCE on medical emergencies?,9.237529366917285e-07,1.1269011386709646,0.109375,0.07072363212649316,1.2266085944183804,0.07496876301541025,0.07062126009716195,1.3063158402860506,0.057476051645147866,9.237529366917304e-07,1.392554498186525,0.039150354019158694
145,0.5,10,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
",Can student examiners be reasonably employed as substitutes for faculty in an undergraduate OSCE on medical emergencies?,9.000669639560431e-07,1.062362617533394,0.109375,0.06891020566171129,1.1576157229314283,0.07496876301541025,0.06881045855620907,1.2322078681323294,0.057476051645147866,9.00066963956045e-07,1.3125117905129886,0.039150354019158694
146,0.5,1,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream interventions: does the supplemental security income program decrease disability among older adults? Answer: Income support policies could be a powerful tool for enhancing public health, particularly for low-income groups. Although the results are strong, additional studies are necessary to verify their accuracy. Future investigations should explore various income support programs and consider a wider spectrum of policies.",1.4211583641411244e-07,0.10068085033661589,0.0016150093976238285,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
146,0.5,2,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream strategies: can the supplemental security income program lower disability rates in the elderly? Answer: Income support initiatives may offer a promising approach to improving health outcomes, especially for those with lower incomes. Despite robust findings, further research is required to confirm their validity. Upcoming studies should assess multiple income support policies and evaluate a broader range of interventions.",1.1842986367842703e-07,0.08318130465670848,0.0013230509097107834,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
146,0.5,3,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream approaches: does the supplemental security income program help reduce disability among seniors? Answer: Policies providing income support might be an important mechanism to enhance health at the population level, particularly for disadvantaged groups. While the evidence is strong, more analyses are needed to ensure the findings are reliable. Future research should investigate different income support policies and consider a wider array of options.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
146,0.5,4,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Question: Do upstream solutions like the supplemental security income program reduce disability in older adults? Answer: Income support policies may represent a key new method for improving public health, especially for low-income individuals. Though findings are robust, further analysis is necessary to confirm their dependability. Future studies should explore various income support policies and a broader range of approaches.",1.1842986367842703e-07,0.10667781925196085,0.018235508012582266,0.009067132323909363,0.1065933427609762,0.017236072637734686,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
146,0.5,5,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream interventions: is the supplemental security income program effective in lowering disability among the elderly? Answer: Income support policy could be a crucial tool for boosting population health, particularly for lower-income populations. Despite solid findings, additional research is needed to validate their reliability. Future work should examine a variety of income support programs and a wider range of strategies.",1.1842986367842703e-07,0.08318130465670848,0.0013230509097107834,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
146,0.5,6,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program decrease disability in elderly populations? Answer: Income support policies may serve as an important lever for enhancing health outcomes, especially for those with lower incomes. Although the results are strong, further studies are necessary to confirm their reliability. Future research should explore multiple income support policies and a broader range of options.",9.474389094274162e-08,0.0890874837824045,0.017672634738486057,0.0072537058591274906,0.08909379708106879,0.01694411414982164,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
146,0.5,7,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream strategies: can supplemental security income reduce disability among older adults? Answer: Income support policies might be a significant new approach to improving population health, particularly for low-income groups. While findings are robust, further analysis is required to verify their accuracy. Future research should investigate various income support policies and consider a broader spectrum of interventions.",1.8948778188548325e-07,0.16138105612916487,0.02004423168444331,0.014507411718254981,0.16100689317942596,0.0181755829903978,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
146,0.5,8,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Question: Do upstream measures such as the supplemental security income program reduce disability in the elderly? Answer: Income support policies could be a vital new tool for enhancing health at the population level, especially for lower-income individuals. Despite strong findings, more research is needed to confirm their validity. Future studies should examine a variety of income support policies and a wider range of approaches.",0.0,0.02166084939249835,0.015596418549691434,0.0,0.02200467239872772,0.015868886576482836,0.0,0.0,0.0,0.0,0.0,0.0
146,0.5,9,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream approaches: does the supplemental security income program reduce disability in older populations? Answer: Income support policy may be a powerful new lever to improve public health, particularly among lower-income groups. Even though findings are robust, further research is necessary to confirm their reliability. Future investigations should assess various income support policies and a broader range of options.",1.4211583641411244e-07,0.10068085033661589,0.0016150093976238285,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
146,0.5,10,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: is the supplemental security income program effective in reducing disability among elderly individuals? Answer: Income support policies might be an important new mechanism for improving population health, especially for lower-income persons. Although the findings are strong, additional analyses are needed to verify their accuracy. Future research should explore different income support policies and a wider range of strategies.",9.474389094274162e-08,0.0890874837824045,0.017672634738486057,0.0072537058591274906,0.08909379708106879,0.01694411414982164,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
147,0.5,1,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone correspond to the extent of aganglionosis in Hirschsprung's disease specimens? The correlation between the radiographic transition zone on contrast enema and the length of aganglionosis is low. Preoperative systematic biopsy is recommended.,2.36859727356853e-08,0.031562020317604134,0.0028552571166207685,0.0018134264647818726,0.06887952090434402,0.029177863983058775,0.0018108015409528735,0.06976090043560124,0.029384756657483937,2.3685972735685406e-08,0.029852963149681777,0.0
147,0.5,2,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is there a correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease specimens? The relationship between the transition zone seen on contrast enema and aganglionosis length is weak. Systematic biopsy before surgery is advised.,2.36859727356853e-08,0.10357504663219874,0.05405060708091009,0.0018134264647818726,0.06590715088589016,0.02775510204081633,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
147,0.5,3,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone align with the aganglionosis level in Hirschsprung's disease specimens? The correlation between the transition zone on contrast enema and aganglionosis length remains minimal. Preoperative biopsy is systematically performed.,1.184298636784265e-07,0.03863404796788572,0.07530226109357693,0.009067132323909391,0.1110235572731888,0.02775510204081633,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
147,0.5,4,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is the radiographic transition zone indicative of the aganglionosis level in Hirschsprung's disease specimens? The correlation between the transition zone on contrast enema and aganglionosis length is low. Systematic preoperative biopsy is standard.,1.184298636784265e-07,0.03863404796788572,0.07530226109357693,0.009067132323909391,0.1110235572731888,0.02775510204081633,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
147,0.5,5,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Does the radiographic transition zone on contrast enema match the extent of aganglionosis in Hirschsprung's disease specimens? The correlation between these measures is low, necessitating systematic preoperative biopsy.",2.36859727356853e-07,0.1652113859782851,0.10651974288337923,0.01813426464781879,0.28691422373685294,0.02775510204081633,0.018108015409528735,0.3364722366212134,0.0,2.3685972735685406e-07,0.3483066942682167,0.0
147,0.5,6,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Is there a strong link between the radiographic transition zone and the aganglionosis level in Hirschsprung's disease specimens? The correlation is low, and systematic preoperative biopsy is performed.",2.36859727356853e-07,0.1652113859782851,0.10651974288337923,0.01813426464781879,0.28691422373685294,0.02775510204081633,0.018108015409528735,0.3364722366212134,0.0,2.3685972735685406e-07,0.3483066942682167,0.0
147,0.5,7,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Does the level of the radiographic transition zone correlate with the length of aganglionosis in Hirschsprung's disease specimens? The correlation remains low, so systematic preoperative biopsy is essential.",2.36859727356853e-07,0.1652113859782851,0.10651974288337923,0.01813426464781879,0.28691422373685294,0.02775510204081633,0.018108015409528735,0.3364722366212134,0.0,2.3685972735685406e-07,0.3483066942682167,0.0
147,0.5,8,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Is the radiographic transition zone a reliable indicator of aganglionosis length in Hirschsprung's disease? The correlation is low, and systematic biopsy before surgery is recommended.",3.079176455639089e-07,0.28299442163466937,0.10651974288337923,0.023574544042164428,0.40951654582918584,0.02775510204081633,0.023540420032387356,0.4643056081310979,0.0,3.079176455639103e-07,0.4818380868927403,0.0
147,0.5,9,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Does the radiographic transition zone on contrast enema correspond to the aganglionosis level in Hirschsprung's disease specimens? The correlation remains low, requiring systematic preoperative biopsy.",3.079176455639089e-07,0.28299442163466937,0.10651974288337923,0.023574544042164428,0.40951654582918584,0.02775510204081633,0.023540420032387356,0.4643056081310979,0.0,3.079176455639103e-07,0.4818380868927403,0.0
147,0.5,10,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Is the radiographic transition zone correlated with the level of aganglionosis in Hirschsprung's disease specimens? The correlation between the transition zone on contrast enema and aganglionosis length is low, so systematic preoperative biopsy is practiced.",7.10579182070559e-08,0.0245389090711976,0.07713498622589529,0.005440279394345632,0.048503200291855286,0.02775510204081633,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
148,0.5,1,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture in growing children a rare and frequently missed injury? Answer: Isolated sternal fractures in children commonly result from trauma typical for their age group. Ultrasonography serves as an effective diagnostic method for detecting fractures, while radiography is preferred for assessing the degree of dislocation.",7.105791820705622e-08,0.034149516495689536,0.01999167013744273,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
148,0.5,2,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in growing children uncommon and often unnoticed? Answer: In childhood, isolated sternal fractures usually arise from age-specific traumatic events. Ultrasonography is a valuable diagnostic tool for identifying fractures, and radiography is the preferred technique to visualize dislocation extent.",2.1317375462116866e-07,0.20453710908972944,0.0043833298625572704,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
148,0.5,3,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture a rare and often overlooked injury in growing children? Answer: Isolated sternal fractures in children generally occur due to trauma associated with their age. Ultrasonography helps detect fractures effectively, and radiography is the best method to evaluate dislocation severity.",1.8948778188548325e-07,0.14662749992237956,0.01999167013744273,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
148,0.5,4,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in children rare and commonly missed? Answer: Childhood isolated sternal fractures typically stem from trauma related to age. Ultrasonography is useful for fracture detection, and radiography is the method of choice for visualizing dislocation extent.",2.8423167282822466e-07,0.2831923890351473,0.006304896699664643,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
148,0.5,5,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture in pediatric patients a rare and frequently overlooked injury? Answer: Isolated sternal fractures in children often result from trauma typical for their developmental stage. Ultrasonography is an effective diagnostic tool for fracture detection, while radiography is preferred to assess the degree of dislocation.",9.474389094274162e-08,0.055655721716652895,0.01999167013744273,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
148,0.5,6,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are isolated sternal fractures in growing children uncommon and often undiagnosed? Answer: These fractures usually occur due to age-related trauma. Ultrasonography is useful for detecting fractures, and radiography is the preferred method to visualize dislocation extent.",3.3160361829959526e-07,0.30077817974963716,0.01999167013744273,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
148,0.5,7,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is the sternal fracture a rare and often ignored injury in children? Answer: Isolated sternal fractures in childhood are commonly caused by trauma typical of the age group. Ultrasonography is a helpful diagnostic tool for detecting fractures, and radiography is favored for evaluating the extent of dislocation.",7.105791820705622e-08,0.034149516495689536,0.01999167013744273,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
148,0.5,8,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in children a rare and often missed diagnosis? Answer: Isolated sternal fractures typically arise from trauma consistent with the child's age. Ultrasonography is a valuable tool for fracture detection, and radiography is the best method to visualize dislocation.",2.1317375462116866e-07,0.20453710908972944,0.0043833298625572704,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
148,0.5,9,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Is sternal fracture an uncommon and frequently overlooked injury in growing children? Answer: In childhood, isolated sternal fractures usually result from age-related trauma. Ultrasonography is useful for detecting fractures, and radiography is the method of choice for assessing dislocation extent.",2.3685972735685406e-07,0.19541766409181127,0.01999167013744273,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
148,0.5,10,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Question: Are sternal fractures in pediatric patients rare and often overlooked? Answer: Isolated sternal fractures in children often occur due to typical age-specific trauma. Ultrasonography is an effective diagnostic tool for fracture detection, and radiography is preferred for visualizing the extent of dislocation.",1.8948778188548325e-07,0.2126415171185636,0.027508329862557284,0.014507411718254981,0.21206028899460883,0.024375,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
149,0.5,1,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could Aripiprazole be a new risk factor for pathological gambling? Answer: The adverse drug reactions were compared with previously published case reports. The dopamine partial agonist action of Aripiprazole might explain the development of pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.5,2,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is Aripiprazole a potential new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated alongside other published case studies. The mechanism of Aripiprazole as a dopamine partial agonist could account for pathological gambling.,4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.5,3,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: does it represent a new risk factor for pathological gambling? Answer: Reported adverse drug reactions were analyzed in conjunction with existing case reports. The dopamine partial agonist effect of Aripiprazole may explain the emergence of pathological gambling.,1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
149,0.5,4,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could Aripiprazole be linked to pathological gambling as a new risk factor? Answer: Adverse drug reactions were reviewed with reference to other documented case reports. The dopamine partial agonist property of Aripiprazole could underlie the occurrence of pathological gambling.,1.421158364141118e-07,0.1670540846631643,0.0,0.010880558788691257,0.17185025692666,0.0,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
149,0.5,5,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is pathological gambling a new risk factor associated with Aripiprazole? Answer: Adverse drug reactions were compared with other published case reports. The dopamine partial agonist mechanism of Aripiprazole might explain the pathological gambling cases.,2.36859727356853e-08,0.010920400412667952,0.029384756657483937,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.5,6,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Question: Does Aripiprazole pose a new risk for pathological gambling? Answer: The side effects were assessed alongside previously reported cases. The dopamine partial agonist activity of Aripiprazole could clarify the presence of pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.5,7,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole as a novel risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other published case reports. The dopamine partial agonist mechanism of Aripiprazole may explain pathological gambling occurrence.,2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
149,0.5,8,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could pathological gambling be a new adverse effect of Aripiprazole? Answer: Drug reactions were compared with other documented cases. The dopamine partial agonist mechanism of Aripiprazole could account for pathological gambling.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
149,0.5,9,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is Aripiprazole implicated as a new risk factor in pathological gambling? Answer: Adverse reactions were analyzed with other case reports. The dopamine partial agonist effect of Aripiprazole could explain pathological gambling development.,2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
149,0.5,10,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Question: Might Aripiprazole be a new risk factor for pathological gambling? Answer: Adverse drug reactions were cross-referenced with existing case reports. The dopamine partial agonist mechanism of Aripiprazole could be responsible for pathological gambling.,2.36859727356853e-08,0.010920400412667952,0.029384756657483937,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
150,0.5,1,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Does preoperative statin use lower the incidence of atrial fibrillation following coronary artery bypass graft surgery? Our research suggests that taking statins before surgery may decrease the risk of developing AF. Nevertheless, more studies are needed to understand the mechanisms involved and to determine the ideal length of statin treatment. This observation calls for additional research to validate the protective role of statins in preventing AF after CABG.",3.552895910352811e-07,0.28010840775415025,0.01922337562475971,0.02720139697172809,0.257829109302099,0.0,0.027162023114293,0.2623642644674913,0.0,3.552895910352811e-07,0.2670627852490446,0.0
150,0.5,2,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Can administering statins before coronary artery bypass grafting reduce the occurrence of atrial fibrillation? The results from our study indicate that preoperative statin therapy appears to lessen AF onset. However, the precise biological pathways and the best duration for statin use remain unclear and require further study. These findings highlight the need for more research to confirm statins' protective effects against post-CABG AF.",2.3685972735685406e-07,0.20255017340827708,0.01922337562475971,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
150,0.5,3,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Is there a reduction in atrial fibrillation after coronary artery bypass grafting when patients receive statins preoperatively? Our findings show that statins given before surgery seem to reduce the development of AF. Still, the exact mechanisms and optimal treatment duration need further exploration. This result suggests further investigation is necessary to confirm statinsâ€™ protective benefits against AF following CABG.",1.4211583641411244e-07,0.1358587989096045,0.01922337562475971,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
150,0.5,4,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Do statins administered before coronary artery bypass graft surgery help prevent atrial fibrillation? According to our study, preoperative statin therapy appears to decrease the risk of AF. However, the underlying mechanisms and the ideal length of therapy require additional research. This discovery supports the need for further studies to validate the protective impact of statins on post-CABG atrial fibrillation.",1.4211583641411244e-07,0.1358587989096045,0.01922337562475971,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
150,0.5,5,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Does the use of statins before coronary artery bypass grafting reduce the risk of developing atrial fibrillation? Our study suggests that preoperative statin treatment may lower AF incidence. Nevertheless, the detailed mechanisms and the best duration for statin therapy are still unknown and need more investigation. These findings prompt further research to confirm the protective effect of statins against AF after CABG.",2.1317375462116866e-07,0.16356351546895675,0.002834486735870813,0.016320838183036854,0.16251892949777424,0.0,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
150,0.5,6,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Are preoperative statins effective in reducing atrial fibrillation after coronary artery bypass grafting? Our research indicates that statin therapy before surgery seems to reduce AF occurrence. However, more studies are required to elucidate the mechanisms and establish the optimal duration of treatment. This finding encourages further research to confirm the protective role of statins in post-CABG AF.",9.474389094274162e-08,0.10076747909833506,0.01922337562475971,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
150,0.5,7,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Can pre-surgery statin therapy reduce atrial fibrillation following coronary artery bypass grafting? Our study found that preoperative statin use appears to decrease AF development. Yet, the exact mechanisms and the ideal duration of statin therapy remain to be clarified through further research. This suggests additional studies are needed to verify the protective effects of statins against AF post-CABG.",1.1842986367842703e-07,0.09414610249387811,0.0016851103186372555,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
150,0.5,8,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Does taking statins before coronary artery bypass grafting reduce atrial fibrillation occurrence? Our findings indicate that preoperative statin therapy may lower the risk of AF. However, the specific mechanisms and optimal treatment duration require further investigation. This observation calls for more research to confirm the protective benefits of statins in preventing AF after CABG.",2.3685972735685406e-08,0.04570770191530649,0.01922337562475971,0.0018134264647818726,0.019418085857102696,0.0,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
150,0.5,9,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Is preoperative statin therapy associated with a reduced risk of atrial fibrillation after coronary artery bypass grafting? Our study suggests that statins administered before surgery seem to reduce AF incidence. Nevertheless, the mechanisms involved and the best duration of therapy need further study. These results warrant additional research to validate statinsâ€™ protective effect against post-CABG AF.",7.105791820705622e-08,0.08274897359565658,0.01922337562475971,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
150,0.5,10,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Do statins given before coronary artery bypass graft surgery reduce the likelihood of atrial fibrillation? Our research indicates that preoperative statin therapy appears to lower the chance of developing AF. However, the exact biological mechanisms and optimal duration of treatment remain unclear and require further investigation. This finding supports the need for more studies to confirm statinsâ€™ protective role in post-CABG AF.",2.1317375462116866e-07,0.18628965253649588,0.01922337562475971,0.016320838183036854,0.16251892949777424,0.0,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
151,0.5,1,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are there discrepancies between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences exist regarding the clinical importance of certain RBC morphology terms between clinicians and clinical pathologists. Adding interpretive comments to CBC reports is the best method to guarantee RBC morphology changes are understood as intended by clinical pathologists. Reporting methods should be carefully reviewed for improvement.,0.0,0.04471917293935146,0.03222222222222221,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.5,2,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a disagreement between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology? Clinicians and clinical pathologists differ notably in their views on the clinical significance of certain RBC morphology terminology. Including explanatory notes in CBC reports is the most effective way to ensure RBC morphology alterations are interpreted correctly by clinical pathologists. Reporting procedures need critical evaluation for enhancement.,9.474389094274162e-08,0.02051143694739732,0.0302734375,0.0072537058591274906,0.06351340572232633,0.0,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
151,0.5,3,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Do clinical pathologists and clinicians differ in their reporting and interpretation of red blood cell morphology? There are important variations between clinicians and clinical pathologists concerning the clinical relevance of specific RBC morphology terms. The clearest way to ensure RBC morphology changes are interpreted as clinical pathologists intend is by adding interpretive comments on CBC reports. Reporting practices should be critically assessed to promote improvement.,4.737194547137081e-08,0.041409602109235166,0.07954850846546627,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
151,0.5,4,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there discordance between clinicians and clinical pathologists in reporting and interpreting red blood cell morphology? Key differences exist about the clinical relevance of certain RBC morphology terms between these groups. The inclusion of interpretive commentary on CBC reports is the most straightforward way to ensure RBC morphology changes are understood as intended by clinical pathologists. Reporting methods should be examined critically to enhance quality.,4.737194547137081e-08,0.010087848922083253,0.015621063240110858,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
151,0.5,5,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are clinical pathologists and clinicians at odds over reporting and interpreting red blood cell morphology? Significant differences about the clinical importance of some RBC morphology terms exist between these professionals. Incorporating interpretive comments in CBC reports is the clearest approach to guarantee RBC morphology changes are interpreted as clinical pathologists mean. Reporting practices require critical review for improvement.,1.1842986367842703e-07,0.13272502461825741,0.035041322314049606,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
151,0.5,6,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a mismatch between clinical pathologists and clinicians in how they report and interpret red blood cell morphology? Important differences regarding the clinical relevance of certain RBC morphology terms are present between clinicians and clinical pathologists. Adding interpretive remarks on CBC reports is the best way to ensure RBC morphology changes are understood as intended by clinical pathologists. Reporting procedures should be critically examined to improve.,9.474389094274162e-08,0.02051143694739732,0.0302734375,0.0072537058591274906,0.06351340572232633,0.0,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
151,0.5,7,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Do clinical pathologists and clinicians have differing views on reporting and interpreting red blood cell morphology? Notable differences exist about the clinical significance of some RBC morphology terms between these groups. Including interpretive comments on CBC reports is the clearest method to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be scrutinized critically for enhancement.,7.105791820705622e-08,0.0965899703298776,0.03385657125269313,0.005440279394345618,0.05043085362689137,0.0,0.0054324046228586,0.05129329438754926,0.0,7.105791820705622e-08,0.05218575317056917,0.0
151,0.5,8,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a divergence between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? There are important differences concerning the clinical relevance of certain RBC morphology terms between clinicians and clinical pathologists. The best way to ensure RBC morphology changes are interpreted as intended by clinical pathologists is to include interpretive comments on CBC reports. Reporting methods should be critically reviewed for improvement.,1.1842986367842703e-07,0.03617631311841407,0.02982248520710059,0.009067132323909363,0.07878087785311383,0.0,0.009054007704764333,0.08004270767353727,0.0,1.1842986367842703e-07,0.08134563945395268,0.0
151,0.5,9,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are clinical pathologists and clinicians inconsistent in their reporting and interpretation of red blood cell morphology? Differences about the clinical relevance of certain RBC morphology terms exist between these professionals. Inclusion of interpretive comments in CBC reports is the clearest way to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be critically assessed to improve.,7.105791820705622e-08,0.0965899703298776,0.033856571252693125,0.005440279394345618,0.05043085362689137,0.0,0.0054324046228586,0.05129329438754926,0.0,7.105791820705622e-08,0.05218575317056917,0.0
151,0.5,10,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there inconsistency between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences about the clinical relevance of certain RBC morphology terms exist between clinicians and clinical pathologists. The clearest approach to ensure RBC morphology changes are interpreted as intended by clinical pathologists is through interpretive comments on CBC reports. Reporting practices should be critically examined for improvement.,0.0,0.04471917293935146,0.0322222222222222,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
152,0.5,1,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Is there a connection between viral infections and benign paroxysmal positional vertigo? BPPV has been linked to positive viral serology, especially for vestibular neuritis, indicating a potential association between viral infections and BPPV development. Nonetheless, the precise mechanisms are not fully understood and more studies are required.",0.0,0.060273667874777725,0.04317155085498335,0.0,0.061613082716439393,0.04434829637641968,0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0
152,0.5,2,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Do viral infections contribute to benign paroxysmal positional vertigo? Evidence shows BPPV is related to positive viral serology, particularly in cases of vestibular neuritis, implying a possible role of viral infections in BPPV onset. However, the exact processes are still unknown and additional research is necessary.",2.3685972735685406e-08,0.02264861413960606,0.0004823487399244937,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
152,0.5,3,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Are viral infections involved in benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, notably for vestibular neuritis, suggesting viral infections may play a part in BPPV development. The exact mechanism remains unclear, requiring further investigation.",2.3685972735685364e-07,0.25349380079337047,0.006026706979087932,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
152,0.5,4,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Can viral infections play a role in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially linked to vestibular neuritis, which suggests a potential connection between viral infections and BPPV. However, the detailed mechanisms are not yet understood and further research is needed.",2.3685972735685406e-08,0.02264861413960606,0.0004823487399244937,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
152,0.5,5,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Is there a role of viral infections in benign paroxysmal positional vertigo? Positive viral serology, particularly for vestibular neuritis, is found in BPPV patients, indicating a possible link with viral infections. Still, the exact mechanism is unclear, and more research is warranted.",1.1842986367842703e-07,0.08493249584739804,0.021728395061728398,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
152,0.5,6,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Do viral infections have an influence on benign paroxysmal positional vertigo? BPPV shows association with positive viral serology, mainly related to vestibular neuritis, hinting at a possible viral involvement in BPPV development. The precise mechanisms remain uncertain and further studies are needed.",1.1842986367842703e-07,0.08493249584739804,0.021728395061728398,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
152,0.5,7,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Could viral infections be involved in benign paroxysmal positional vertigo? The presence of positive viral serology, especially for vestibular neuritis, in BPPV cases suggests a possible viral role. Yet, the exact mechanisms are not fully known and additional research is essential.",1.4211583641411244e-07,0.10962510843776974,0.021728395061728398,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
152,0.5,8,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Are viral infections a factor in benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, particularly vestibular neuritis, which may indicate a role for viral infections in its development. However, the mechanisms are unclear and more research is required.",1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
152,0.5,9,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Do viral infections contribute to the development of benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially for vestibular neuritis, suggesting a potential viral connection. The exact mechanisms are still unknown, necessitating further research.",2.3685972735685364e-07,0.21498562409559563,0.021728395061728398,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
152,0.5,10,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Is benign paroxysmal positional vertigo related to viral infections? Positive viral serology, particularly for vestibular neuritis, is associated with BPPV, implying a possible viral involvement. Nonetheless, the precise mechanisms remain unclear and additional investigation is needed.",2.6054570009253894e-07,0.24315650106229247,0.021728395061728398,0.019947691112600606,0.2803019651541576,0.0,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
153,0.5,1,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Transient tachypnea of the newborn (TTN) may be influenced by polymorphisms in the beta-adrenergic receptor (ADRB) genes, which affect lung function and response to adrenergic signals, according to some research.",9.000669639560443e-07,0.8373967894044916,0.0,0.06891020566171122,0.85745023185122,0.0,0.06881045855620899,0.8785504038913072,0.0,9.000669639560454e-07,0.9007865453381889,0.0
153,0.5,2,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Research indicates that genetic variations in ADRB genes, which regulate lung responsiveness to adrenergic stimulation, might play a role in the development of transient tachypnea of the newborn (TTN).",9.237529366917296e-07,0.8724881092157606,0.0,0.07072363212649309,0.8938178760220947,0.0,0.07062126009716185,0.9162907318741542,0.0,9.237529366917308e-07,0.9400072584914714,0.0
153,0.5,3,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","The role of beta-adrenergic receptor (ADRB) gene polymorphisms is being studied for their potential impact on transient tachypnea of the newborn (TTN), as these genes influence lung function and adrenergic response.",8.76380991220359e-07,0.8034952377288098,0.0,0.06709677919692933,0.822358912039951,0.0,0.06699965701525612,0.8421827597204325,0.0,8.7638099122036e-07,0.8630462173553419,0.0
153,0.5,4,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Some studies suggest that polymorphisms in the ADRB genes, which encode beta-adrenergic receptors, could contribute to the susceptibility of transient tachypnea of the newborn (TTN).",1.0184968276344708e-06,1.0266387890430195,0.0,0.0779773379856206,1.0541605260972746,0.0,0.07786446626097335,1.0833448165373212,0.0,1.0184968276344725e-06,1.1143606456362498,0.0
153,0.5,5,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Transient tachypnea of the newborn (TTN) may be partially explained by genetic variations in ADRB genes that affect lung function and adrenergic receptor responsiveness, as ongoing research suggests.",9.474389094274149e-07,0.9088557533866353,0.0,0.07253705859127496,0.9315582040049417,0.0,0.07243206163811473,0.9555114450274367,0.0,9.474389094274162e-07,0.9808292530117262,0.0
153,0.5,6,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Ongoing research is investigating whether polymorphisms in beta-adrenergic receptor (ADRB) genes are linked to the risk of transient tachypnea of the newborn (TTN), due to their role in lung function.",9.000669639560443e-07,0.8373967894044916,0.0,0.06891020566171122,0.85745023185122,0.0,0.06881045855620899,0.8785504038913072,0.0,9.000669639560454e-07,0.9007865453381889,0.0
153,0.5,7,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Genetic differences in the ADRB genes, which modulate lung response to adrenergic stimulation, are being explored for their association with transient tachypnea of the newborn (TTN).",9.948108548987854e-07,0.9858167945227647,0.0,0.07616391152083873,1.011600911678479,0.0,0.07605366472002048,1.0388930539664871,0.0,9.94810854898787e-07,1.0678406300013559,0.0
153,0.5,8,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
",There is evidence that polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes might influence the development of transient tachypnea of the newborn (TTN) by affecting lung function.,9.711248821631002e-07,0.9465960813694823,0.0,0.07435048505605685,0.9707789171582242,0.0,0.07424286317906761,0.9963334395476915,0.0,9.711248821631017e-07,1.0233888674305218,0.0
153,0.5,9,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","The complex causes of transient tachypnea of the newborn (TTN) may include genetic polymorphisms in ADRB genes that regulate lung responsiveness to adrenergic signals, as some studies indicate.",9.474389094274149e-07,0.9088557533866353,0.0,0.07253705859127496,0.9315582040049417,0.0,0.07243206163811473,0.9555114450274367,0.0,9.474389094274162e-07,0.9808292530117262,0.0
153,0.5,10,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Studies are ongoing to clarify the relationship between specific ADRB gene polymorphisms and transient tachypnea of the newborn (TTN), highlighting the genetic component of this condition.",9.948108548987854e-07,0.9858167945227647,0.0,0.07616391152083873,1.011600911678479,0.0,0.07605366472002048,1.0388930539664871,0.0,9.94810854898787e-07,1.0678406300013559,0.0
154,0.5,1,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it. Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
154,0.5,2,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Question: How do parents, their children, and children's doctors differ in perceiving body image? Answer: A significant number of children underestimated their overweight or obesity status, whereas parents tended to overestimate it. Physicians' assessments mostly aligned with the children's own views. This indicates a gap between children's self-perception and the perceptions held by parents and doctors.",4.737194547137081e-08,0.011397128898221531,0.017538265306122455,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
154,0.5,3,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Question: Are there differences in body image perception among parents, their children, and the children's physicians? Answer: Many children tend to underestimate their overweight or obesity, while parents are more prone to overestimating it. Physicians usually concur with the children's self-assessment. This highlights a disconnect between children's self-view and the perspectives of parents and physicians.",7.105791820705622e-08,0.08109050316345101,0.0194439832145876,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
154,0.5,4,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Question: Do parents, children, and children's doctors perceive body image differently? Answer: Many children underestimate how overweight or obese they are, but their parents often overestimate it. Physicians generally agree with the children's self-perceptions, indicating a disconnect between children's and adults' views on weight.",3.316036182995957e-07,0.2575301984371303,0.017538265306122455,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
154,0.5,5,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Question: Body image perception: is there a difference between parents, their children, and the children's physicians? Answer: Children frequently underestimate their overweight or obesity levels, whereas parents tend to overestimate them. Physicians usually side with the children's self-perceptions. This points to a disconnect in how children see themselves compared to their parents and doctors.",9.474389094274162e-08,0.07459489795819252,0.0013226814394396783,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
154,0.5,6,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Question: How do perceptions of body image differ among children, their parents, and the children's physicians? Answer: Many children underestimate their overweight or obesity, while their parents are more likely to overestimate it. Physicians typically agree with the children's own assessments. This suggests a disconnect between children's self-perception and adult perceptions.",1.6580180914979784e-07,0.13443319592494518,0.0024534048313202793,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
154,0.5,7,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Question: Do parents, children, and children's physicians have different views on body image? Answer: Many children underestimate their overweight or obesity, whereas parents often overestimate it. Physicians usually align with the children's self-perceptions. This reflects a disconnect between how children see themselves and how adults perceive their weight.",2.3685972735685406e-07,0.16858271242063472,0.017538265306122455,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
154,0.5,8,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Question: Is there a difference in body image perception between children, their parents, and the children's physicians? Answer: Children often underestimate their overweight or obesity, while parents tend to overestimate it. Physicians generally agree with the children's self-assessments, indicating a disconnect between children's and adults' perceptions.",2.8423167282822487e-07,0.24287436571859278,0.004672478495530437,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
154,0.5,9,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Question: How do children, parents, and physicians differ in perceiving body image? Answer: Many children underestimate their level of overweight or obesity, while parents are more likely to overestimate it. Physicians mostly agree with the children's perceptions. This suggests a gap between children's self-view and the views of parents and doctors.",1.6580180914979784e-07,0.10670730870254719,0.017538265306122455,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
154,0.5,10,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Question: Are perceptions of body image different among children, their parents, and physicians? Answer: Many children underestimate their overweight or obesity, with parents more likely to overestimate it. Physicians typically concur with the children's self-perceptions, highlighting a disconnect between children's and adults' views on weight.",3.079176455639103e-07,0.2345406802124308,0.017538265306122455,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
155,0.5,1,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Is there a link between neck pain and poorer health-related quality of life six months afterward? Our study showed that neck pain was linked to a decline in health-related quality of life half a year later. People with neck pain initially had notably lower SF-36 scores, reflecting worse physical function, role limitations, pain, overall health, energy, and mental well-being.",0.0,0.02390162691585962,0.017357037080727417,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
155,0.5,2,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Does neck pain predict worse health-related quality of life after six months? We observed that neck pain was associated with a reduction in health-related quality of life six months later. Those with neck pain at the start had significantly decreased SF-36 scores, indicating impaired physical functioning, role restrictions, pain, general health, vitality, and mental health.",9.474389094274162e-08,0.05707805219957196,0.008087729718140119,0.0072537058591274906,0.07643044163395452,0.002636493910479411,0.007243206163811466,0.07601222264976526,0.0013721359553382183,9.474389094274162e-08,0.07550755250814589,0.0
155,0.5,3,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Is neck pain correlated with diminished health-related quality of life six months later? Our findings revealed that neck pain negatively impacted health-related quality of life after six months. Individuals reporting neck pain initially showed substantially lower SF-36 questionnaire scores, suggesting poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",1.4211583641411244e-07,0.10012800977598202,0.002913712327996504,0.010880558788691236,0.11694821245230846,0.004109031705109088,0.0108648092457172,0.11629931608083233,0.002140430468021242,1.4211583641411244e-07,0.11551288712184427,0.0
155,0.5,4,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Does experiencing neck pain relate to worse health-related quality of life six months later? We found that neck pain was linked to a decline in health-related quality of life half a year later. Participants with baseline neck pain had significantly lower SF-36 scores, reflecting reduced physical functioning, role limitation, bodily pain, overall health, vitality, and mental health.",4.737194547137081e-08,0.01578003769181624,0.012889330230293733,0.0036268529295637453,0.03748687923508642,0.0012705324385313826,0.003621603081905733,0.0372845055208213,0.0006606862828746896,4.737194547137081e-08,0.037041271680350096,0.0
155,0.5,5,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Is there an association between neck pain and poorer health-related quality of life six months later? Our study found neck pain to be negatively associated with health-related quality of life after six months. Those with neck pain at baseline reported markedly lower SF-36 scores, indicating worse physical function, role limitations, pain, general health, vitality, and mental well-being.",4.737194547137081e-08,0.01578003769181624,0.012889330230293733,0.0036268529295637453,0.03748687923508642,0.0012705324385313826,0.003621603081905733,0.0372845055208213,0.0006606862828746896,4.737194547137081e-08,0.037041271680350096,0.0
155,0.5,6,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Does neck pain predict worse health-related quality of life six months later? We discovered that neck pain correlated with lower health-related quality of life scores six months following initial assessment. Individuals with neck pain initially had significantly reduced SF-36 scores, showing poorer physical functioning, role restrictions, bodily pain, general health, vitality, and mental health.",1.1842986367842703e-07,0.10453140654290616,0.013383254625375929,0.009067132323909363,0.09648465573463305,0.003358677685950405,0.009054007704764333,0.09595304393715409,0.0017487603305785006,1.1842986367842703e-07,0.09531017980432566,0.0
155,0.5,7,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Is neck pain linked to reduced health-related quality of life six months later? Our research indicated a negative association between neck pain and health-related quality of life after six months. Those experiencing neck pain at baseline showed significantly lower SF-36 questionnaire scores, reflecting diminished physical function, role limitations, pain, general health, vitality, and mental well-being.",9.474389094274162e-08,0.05707805219957196,0.008087729718140119,0.0072537058591274906,0.07643044163395452,0.002636493910479411,0.007243206163811466,0.07601222264976526,0.0013721359553382183,9.474389094274162e-08,0.07550755250814589,0.0
155,0.5,8,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Does the presence of neck pain affect health-related quality of life six months later? We found that neck pain was associated with worse health-related quality of life half a year later. Individuals with neck pain at baseline had notably lower SF-36 scores, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",7.105791820705622e-08,0.036218906814418084,0.010532544378698216,0.005440279394345618,0.05676954945959256,0.0019409262066604482,0.0054324046228586,0.056461018114079664,0.001009707076140641,7.105791820705622e-08,0.056089466651043196,0.0
155,0.5,9,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Is neck pain associated with poorer health-related quality of life six months later? We observed a negative relationship between neck pain and health-related quality of life six months later. Participants reporting neck pain at baseline had significantly lower SF-36 scores, showing worse physical function, role limitations, pain, general health, vitality, and mental health.",1.4211583641411244e-07,0.1534470236652088,0.03526992475710419,0.010880558788691236,0.17131269720210884,0.04282196424095268,0.0108648092457172,0.17175109052562743,0.04190430582627794,1.4211583641411244e-07,0.17209633043286,0.040742417383431435
155,0.5,10,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Does neck pain correspond to a decline in health-related quality of life six months later? Our findings demonstrated that neck pain was negatively linked to health-related quality of life six months afterward. Those with neck pain at baseline reported significantly lower SF-36 questionnaire scores, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",2.3685972735685406e-08,0.04438692941950251,0.01986745562130174,0.0018134264647818726,0.0680786954859629,0.03596459484571371,0.0018108015409528666,0.06887930511519391,0.036512665656022306,2.3685972735685406e-08,0.06969337426522948,0.036982248520710054
156,0.5,1,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Is (18)F-FDG an effective surrogate tracer for assessing tumor hypoxia? This research indicates that FDG is not a dependable surrogate marker for tumor hypoxia, as its uptake mirrors glucose metabolism influenced by factors beyond hypoxia, including tumor cell growth and inflammation.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
156,0.5,2,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
",Can (18)F-FDG serve as a surrogate tracer to measure tumor hypoxia? The study concluded that FDG does not reliably indicate tumor hypoxia since its uptake is tied to glucose metabolism affected by other elements like tumor proliferation and inflammation.,1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
156,0.5,3,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Does (18)F-FDG act as a surrogate tracer for tumor hypoxia measurement? Findings show FDG is an unreliable marker for tumor hypoxia because its uptake represents glucose metabolism, which is also impacted by tumor cell proliferation and inflammation.",2.1317375462116823e-07,0.30015990470975895,0.055363321799307974,0.016320838183036854,0.2684499827465596,0.02854671280276816,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
156,0.5,4,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Is (18)F-FDG a valid surrogate tracer to evaluate tumor hypoxia? This study demonstrated that FDG uptake is not a trustworthy indicator of tumor hypoxia, as it reflects glucose metabolism influenced by factors such as tumor growth and inflammation.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
156,0.5,5,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Can (18)F-FDG be used as a surrogate tracer to detect tumor hypoxia? The research revealed that FDG is not a reliable surrogate for tumor hypoxia, since its uptake depends on glucose metabolism affected by tumor proliferation and inflammation.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
156,0.5,6,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
",Is (18)F-FDG a surrogate tracer for tumor hypoxia? The study found that FDG uptake does not reliably indicate tumor hypoxia because it reflects glucose metabolism influenced by tumor cell proliferation and inflammation.,3.3160361829959473e-07,0.3726752852851729,0.0,0.02538797050694625,0.3829922522561069,0.0,0.025351221573340174,0.39390428570708913,0.0,3.316036182995957e-07,0.4054651081081637,0.0
156,0.5,7,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Does (18)F-FDG reliably measure tumor hypoxia as a surrogate tracer? According to the study, FDG is not a dependable marker for tumor hypoxia since its uptake is governed by glucose metabolism and other factors like inflammation and tumor growth.",1.6580180914979763e-07,0.20555776059971942,0.026296566837107373,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
156,0.5,8,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
",Is (18)F-FDG a dependable surrogate tracer for tumor hypoxia measurement? The study showed that FDG uptake is not a reliable indicator of tumor hypoxia because it reflects glucose metabolism affected by tumor proliferation and inflammation.,2.6054570009253883e-07,0.32107532871650735,0.029384756657483937,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
156,0.5,9,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Can (18)F-FDG reliably serve as a surrogate tracer for tumor hypoxia? This study showed FDG is not a reliable surrogate marker since its uptake reflects glucose metabolism, which can be influenced by tumor cell proliferation and inflammation.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
156,0.5,10,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
",Is (18)F-FDG an accurate surrogate tracer for tumor hypoxia assessment? The study demonstrated that FDG uptake is not a trustworthy marker for tumor hypoxia because it reflects glucose metabolism influenced by factors like tumor proliferation and inflammation.,2.1317375462116823e-07,0.30015990470975895,0.055363321799307974,0.016320838183036854,0.2684499827465596,0.02854671280276816,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
157,0.5,1,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain considered a clinically significant issue in general adult psychiatry? Our findings indicate that pain is indeed a notable clinical problem among psychiatric patients, often underestimated within psychiatry. Patients in general adult psychiatry present unique risk factors distinct from those in other clinical subpopulations.",1.8948778188548325e-07,0.15008894388023064,0.012124577722245372,0.014507411718254981,0.17568267840283758,0.0036426303854875317,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
157,0.5,2,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Does pain represent a clinically relevant concern in general adult psychiatry? Evidence suggests that pain is a substantial clinical problem in psychiatric patients, frequently underrecognized in psychiatric practice. The patients studied in general adult psychiatry exhibit specific risk factors that differ from other clinical subgroups.",1.8948778188548325e-07,0.18159563390568279,0.010340724083585065,0.014507411718254981,0.17568267840283758,0.0036426303854875317,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
157,0.5,3,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically important problem in the field of general adult psychiatry? Research shows that pain can be a major clinical issue for psychiatric patients, which appears to be underappreciated in psychiatry. The patients assessed in general adult psychiatry have distinct risk factors compared to clinical subpopulations from other disciplines.",4.737194547137081e-08,0.013031920458159707,0.03748438150770513,0.0036268529295637453,0.01282309223879885,0.019599999999999992,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
157,0.5,4,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"In general adult psychiatry, is pain a clinically relevant issue? Our study found that pain constitutes a significant clinical problem among psychiatric patients, often underestimated in psychiatric care. These patients possess unique risk factors that set them apart from other clinical groups.",2.6054570009253947e-07,0.15769313104327987,0.057476051645147866,0.0199476911126006,0.2157639362354895,0.019599999999999992,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
157,0.5,5,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a notable clinical problem in general adult psychiatry? Evidence reveals that pain is a critical clinical issue in psychiatric patients and tends to be underestimated within psychiatry. The patients examined in general adult psychiatry show particular risk factors unlike those found in other medical subpopulations.,1.4211583641411244e-07,0.10289746913327091,0.014087621893081742,0.010880558788691236,0.12878744193732583,0.002610743801652899,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
157,0.5,6,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Can pain be considered a clinically relevant problem in general adult psychiatry? Findings demonstrate that pain is a significant problem in psychiatric patients, often underrecognized in psychiatry. The patients involved in general adult psychiatry have specific risk factors different from other clinical subpopulations.",2.3685972735685406e-07,0.2326166052584986,0.013529865514615436,0.018134264647818726,0.22488338123340768,0.004775000000000008,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
157,0.5,7,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain an important clinical concern in general adult psychiatry? The evidence indicates that pain is a considerable clinical problem among psychiatric patients, frequently underestimated in psychiatric settings. Patients in general adult psychiatry display particular risk factors that differ from other clinical subpopulations.",2.3685972735685406e-07,0.1996095966604039,0.009976051645147851,0.018134264647818726,0.22488338123340768,0.004775000000000008,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
157,0.5,8,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Does pain pose a clinically relevant problem in general adult psychiatry? Research indicates that pain is a significant clinical issue for psychiatric patients, often overlooked in psychiatry. The patients studied in general adult psychiatry are characterized by distinct risk factors unlike those in other disciplines.",1.8948778188548325e-07,0.15008894388023064,0.012124577722245372,0.014507411718254981,0.17568267840283758,0.0036426303854875317,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
157,0.5,9,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically significant problem in general adult psychiatry? The data suggest that pain is a major clinical concern in psychiatric patients, which seems to be underestimated in psychiatric practice. Patients in general adult psychiatry have unique risk factors that differ from clinical subpopulations in other fields.",1.1842986367842703e-07,0.10960447015156527,0.006057006206091786,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
157,0.5,10,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain recognized as a clinically relevant problem in general adult psychiatry? Evidence points to pain being a significant clinical issue among psychiatric patients, often underestimated within psychiatry. The patients investigated in general adult psychiatry possess specific risk factors that are distinct from other clinical subpopulations.",1.6580180914979784e-07,0.12621579069370759,0.013127755268728183,0.012693985253473108,0.15196044645661644,0.0031149810708491175,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
158,0.5,1,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Are clinical predictors sufficient to identify cervical spine fractures in elderly patients with blunt trauma from low-energy mechanisms? Clinical predictors seem insufficient due to often subtle symptoms and delayed onset, making high suspicion and proper imaging essential for timely diagnosis and treatment.",3.552895910352811e-07,0.32083642517056177,0.006523760330578509,0.02720139697172809,0.3184537311185349,0.0,0.027162023114293,0.3254224004346309,0.0,3.552895910352811e-07,0.33270575382573453,0.0
158,0.5,2,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","In geriatric blunt trauma cases with low-energy mechanisms, are clinical predictors reliable for detecting cervical spine fractures? Clinical predictors are generally inadequate because symptoms can be subtle and delayed, necessitating vigilant suspicion and appropriate imaging for prompt diagnosis and care.",4.026615365066518e-07,0.37258079741641925,0.007772029028639462,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
158,0.5,3,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Do clinical predictors effectively identify cervical spine fractures in elderly blunt trauma patients with low-energy impacts? They appear inadequate due to subtle presentations and possible delayed symptoms, so maintaining a high suspicion level and using proper imaging is critical for timely diagnosis and management.",3.079176455639103e-07,0.23939631859301747,0.017851239669421492,0.023574544042164344,0.2696635669491032,0.0,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
158,0.5,4,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Are clinical signs enough to detect cervical spine fractures in elderly patients after low-energy blunt trauma? Clinical predictors are often inadequate because of subtle and delayed symptoms, requiring a strong suspicion and proper imaging to ensure timely diagnosis and treatment.",4.026615365066518e-07,0.3370347881569353,0.017851239669421492,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
158,0.5,5,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Can clinical predictors reliably detect cervical spine fractures in geriatric patients with low-energy blunt trauma? They tend to be insufficient due to subtle presentations and delayed symptom onset, making high clinical suspicion and appropriate imaging vital for timely diagnosis and management.",3.789755637709665e-07,0.3117169801726436,0.017851239669421492,0.029014823436509962,0.34377153910282665,0.0,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
158,0.5,6,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","In elderly blunt trauma patients with low-energy mechanisms, are clinical predictors adequate for identifying cervical spine fractures? Clinical predictors often fall short because symptoms are subtle and may appear late, so a high index of suspicion and suitable imaging are essential for prompt diagnosis and treatment.",2.6054570009253947e-07,0.22474048587447992,0.0043595041322314,0.0199476911126006,0.22314355131420927,0.0,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
158,0.5,7,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Are clinical predictors effective for identifying cervical spine fractures in geriatric blunt trauma patients with low-energy injuries? They are generally inadequate due to subtle and delayed symptoms, thus requiring a high suspicion index and appropriate imaging for timely diagnosis and care.",3.789755637709665e-07,0.3117169801726436,0.017851239669421492,0.029014823436509962,0.34377153910282665,0.0,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
158,0.5,8,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Is the use of clinical predictors sufficient to detect cervical spine fractures in elderly patients after low-energy blunt trauma? Clinical predictors are inadequate because symptoms can be subtle and delayed, making vigilant suspicion and proper imaging crucial for timely diagnosis and management.",3.552895910352811e-07,0.32083642517056177,0.006523760330578509,0.02720139697172809,0.3184537311185349,0.0,0.027162023114293,0.3254224004346309,0.0,3.552895910352811e-07,0.33270575382573453,0.0
158,0.5,9,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Do clinical predictors provide adequate identification of cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? They appear insufficient due to subtle clinical presentations and delayed symptoms, so maintaining high suspicion and using appropriate imaging is key for timely diagnosis and treatment.",3.079176455639103e-07,0.23939631859301747,0.017851239669421492,0.023574544042164344,0.2696635669491032,0.0,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
158,0.5,10,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Are clinical predictors enough to identify cervical spine fractures in elderly patients with low-energy blunt trauma? They seem inadequate because symptoms may be subtle and delayed, necessitating a high index of suspicion and appropriate imaging for prompt diagnosis and management.",4.026615365066518e-07,0.3370347881569353,0.017851239669421492,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
159,0.5,1,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Is there a difference in target motion between the superior and inferior parts of the clinical target volume? Answer: No statistically significant motion differences exist between the SUP-CTV and INF-CTV. The current uniform planning target volume (PTV) margins sufficiently cover both CTV regions.,0.0,0.02432095370385845,0.017503057007927147,0.0,0.024755256448569796,0.017851239669421492,0.0,0.0,0.0,0.0,0.0,0.0
159,0.5,2,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: When assessing prostate bed target interfractional motion with RTOG consensus definitions and daily CT on rails, does target motion vary between the superior and inferior clinical target volume sections? Answer: There are no statistically significant differences in motion between the superior (SUP-CTV) and inferior (INF-CTV) portions. The uniform planning target volume (PTV) margins currently used adequately cover both areas.",4.737194547137081e-08,0.01085797490212359,0.032396694214876044,0.0036268529295637453,0.03594494934397918,0.0006151670316868058,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
159,0.5,3,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails to analyze prostate bed target interfractional motion, is there a difference in motion between the superior and inferior parts of the clinical target volume? Answer: No statistically notable motion differences were found between SUP-CTV and INF-CTV. The existing uniform planning target volume (PTV) margins are sufficient for covering both parts of the CTV.",1.1842986367842703e-07,0.08800585167890596,0.002819100091827391,0.009067132323909363,0.0875512928191915,0.001462350780532598,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
159,0.5,4,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does target motion differ between superior and inferior portions of the clinical target volume in prostate bed interfractional motion assessed by RTOG consensus definitions and daily CT on rails? Answer: Statistically, there is no apparent difference in motion between the SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins adequately cover both CTV sections.",4.737194547137081e-08,0.012281527214724974,0.016865739323651797,0.0036268529295637453,0.01161238772230444,0.017851239669421492,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
159,0.5,5,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: In prostate bed target interfractional motion studied using RTOG consensus definitions and daily CT on rails, is there a difference in motion between the superior and inferior clinical target volume? Answer: No statistically significant motion difference is seen between the superior (SUP-CTV) and inferior (INF-CTV) volumes. The uniform planning target volume (PTV) margins currently applied are sufficient for both.",4.737194547137081e-08,0.012638539693127449,0.015660208298195304,0.0036268529295637453,0.03594494934397918,0.0006151670316868058,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
159,0.5,6,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does interfractional motion of the prostate bed target, based on RTOG consensus definitions and daily CT on rails, differ between the superior and inferior parts of the clinical target volume? Answer: There are no statistically significant motion differences between SUP-CTV and INF-CTV. The uniform planning target volume (PTV) margins in use effectively cover both portions.",4.737194547137081e-08,0.012281527214724974,0.016865739323651797,0.0036268529295637453,0.01161238772230444,0.017851239669421492,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
159,0.5,7,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: When evaluating prostate bed target interfractional motion with RTOG consensus definitions and daily CT on rails, is there a difference in motion between the superior and inferior CTV? Answer: No statistically significant differences in motion are observed between the superior (SUP-CTV) and inferior (INF-CTV) parts. Current uniform planning target volume (PTV) margins adequately cover both.",4.737194547137081e-08,0.08789758327581021,0.03723857003504689,0.0036268529295637453,0.0372845055208213,0.000660686282874693,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
159,0.5,8,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Prostate bed target interfractional motion assessed by RTOG consensus definitions and daily CT on rails: does motion differ between the superior and inferior clinical target volume? Answer: There is no statistically significant difference in motion between SUP-CTV and INF-CTV. The uniform planning target volume (PTV) margins currently used cover both adequately.,1.4211583641411244e-07,0.06258372770250897,0.0350413223140496,0.010880558788691236,0.08857342885843433,0.017851239669421492,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
159,0.5,9,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, does prostate bed target interfractional motion differ between the superior and inferior clinical target volume sections? Answer: No statistically significant motion difference is present between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are sufficient for both.",2.1317375462116866e-07,0.1520894820422738,0.014217420095851314,0.016320838183036854,0.15044883257652186,0.017851239669421492,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
159,0.5,10,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Is there a difference in prostate bed target interfractional motion between the superior and inferior clinical target volume according to RTOG consensus definitions and daily CT on rails? Answer: No statistically significant motion differences exist between the superior (SUP-CTV) and inferior (INF-CTV) parts. The current uniform planning target volume (PTV) margins adequately cover both portions of the CTV.,2.3685972735685406e-08,0.0295728575438563,0.03354578331009305,0.0018134264647818726,0.018133879844112855,0.00031297436329903727,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
160,0.5,1,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Are laboratories accurately reporting serum quantitative hCG results? Many factors can lead to incorrect hCG reporting, such as (a) differences in assay methods, (b) improper handling of samples, (c) human error by operators, and (d) insufficient quality control procedures.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
160,0.5,2,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Do laboratories report serum quantitative hCG results correctly? Errors in hCG reporting often arise due to (a) variability in assay techniques, (b) mishandling of samples, (c) mistakes made by operators, and (d) lack of proper quality control.",4.73719454713706e-08,0.05406722127027619,0.0,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
160,0.5,3,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Is the reporting of serum quantitative hCG results by laboratories accurate? Several factors cause inaccurate hCG results, including (a) assay methodology differences, (b) improper sample management, (c) operator mistakes, and (d) poor quality control.",1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
160,0.5,4,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Are serum quantitative hCG results being reported correctly by laboratories? Errors in reporting can result from (a) assay method variations, (b) incorrect sample handling, (c) operator error, and (d) inadequate quality control.",1.658018091497971e-07,0.20359895524123983,0.0,0.012693985253473143,0.20972053098207066,0.0,0.012675610786670108,0.2162231084696371,0.0,1.6580180914979784e-07,0.22314355131420927,0.0
160,0.5,5,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Do laboratories provide correct serum quantitative hCG results? Multiple factors contribute to errors, such as (a) assay method variability, (b) sample mishandling, (c) operator errors, and (d) substandard quality control.",2.131737546211677e-07,0.2702903297399133,0.0,0.016320838183036902,0.27871340246902143,0.0,0.016297213868575855,0.2876820724517808,0.0,2.1317375462116866e-07,0.29725152346793093,0.0
160,0.5,6,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Are laboratory reports of serum quantitative hCG results accurate? Incorrect reporting is often due to (a) differences in assay methodologies, (b) improper sample handling, (c) errors by operators, and (d) insufficient quality control.",1.421158364141118e-07,0.17185025692666,0.0,0.010880558788691264,0.17693070815907896,0.0,0.010864809245717234,0.18232155679395534,0.0,1.4211583641411244e-07,0.18805223150294026,0.0
160,0.5,7,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Is the serum quantitative hCG reporting by labs accurate? Errors arise from (a) assay methodology variability, (b) sample handling mistakes, (c) operator errors, and (d) poor quality control measures.",2.36859727356853e-07,0.3053816495511823,0.0,0.018134264647818782,0.3150810466398961,0.0,0.01810801540952873,0.3254224004346278,0.0,2.3685972735685406e-07,0.3364722366212134,0.0
160,0.5,8,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Are serum quantitative hCG results correctly reported by laboratories? Common causes of errors include (a) assay method differences, (b) improper handling of samples, (c) operator mistakes, and (d) inadequate quality control.",1.894877818854824e-07,0.23638877806423153,0.0,0.014507411718255023,0.24362208265775243,0.0,0.014486412327622981,0.2513144282809061,0.0,1.8948778188548325e-07,0.25951119548508395,0.0
160,0.5,9,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Do laboratories accurately report serum quantitative hCG results? Errors can stem from (a) variation in assay methods, (b) improper sample handling, (c) operator errors, and (d) lack of quality control.",2.131737546211677e-07,0.2702903297399133,0.0,0.016320838183036902,0.27871340246902143,0.0,0.016297213868575855,0.2876820724517808,0.0,2.1317375462116866e-07,0.29725152346793093,0.0
160,0.5,10,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Are serum quantitative hCG results being reported accurately by laboratories? Factors leading to errors include (a) assay methodology differences, (b) mishandling of samples, (c) operator errors, and (d) insufficient quality control.",1.894877818854824e-07,0.23638877806423153,0.0,0.014507411718255023,0.24362208265775243,0.0,0.014486412327622981,0.2513144282809061,0.0,1.8948778188548325e-07,0.25951119548508395,0.0
161,0.5,1,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","We present for the first time that the etiology of ESLD serves as a prognostic factor for HRS, based on a large retrospective study. This suggests that ESLD etiology could be useful for risk stratification in HRS patients, though further research is required to confirm and understand its clinical impact.",2.6054570009253947e-07,0.17941935809280807,0.016661878770468257,0.0199476911126006,0.20633643299782767,0.0,0.019918816950481533,0.2102954088363611,0.0,2.6054570009253947e-07,0.21440987134545564,0.0
161,0.5,2,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","Our study identifies ESLD etiology as a novel prognostic factor for HRS, derived from extensive retrospective analysis. This discovery indicates potential for ESLD etiology in risk stratification of HRS cases, warranting additional research to validate and elucidate clinical relevance.",5.210914001850787e-07,0.47013492703283477,0.009634688066639117,0.0398953822252012,0.46661953126149314,0.0,0.039837633900963065,0.47692407209030874,0.0,5.210914001850789e-07,0.48770320634513675,0.0
161,0.5,3,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","For the first time, we report ESLD etiology as a prognostic indicator for HRS, supported by a large retrospective study. This suggests that considering ESLD etiology may aid in risk assessment of HRS patients, but further studies are necessary to confirm and explore its clinical significance.",3.552895910352811e-07,0.29538370779133505,0.005548865031184635,0.02720139697172809,0.2933478099874569,0.0,0.027162023114293,0.2992428948528567,0.0,3.552895910352811e-07,0.3053816495511823,0.0
161,0.5,4,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","This large retrospective study reveals ESLD etiology as a newly identified prognostic factor for HRS. Our findings imply that ESLD etiology might be valuable for risk stratification in HRS, with further investigation needed to validate and assess clinical applications.",5.210914001850787e-07,0.47013492703283477,0.009634688066639117,0.0398953822252012,0.46661953126149314,0.0,0.039837633900963065,0.47692407209030874,0.0,5.210914001850789e-07,0.48770320634513675,0.0
161,0.5,5,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","We report ESLD etiology as a prognostic factor for HRS for the first time, based on a substantial retrospective study. This finding proposes that ESLD etiology could assist in stratifying risk among HRS patients, though additional research is essential to confirm and clarify its clinical implications.",3.552895910352811e-07,0.29538370779133505,0.005548865031184635,0.02720139697172809,0.2933478099874569,0.0,0.027162023114293,0.2992428948528567,0.0,3.552895910352811e-07,0.3053816495511823,0.0
161,0.5,6,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","Based on a large retrospective study, we identify ESLD etiology as a novel prognostic factor for HRS. This suggests that ESLD etiology may be an effective tool for risk stratification in HRS patients, pending further validation and exploration of clinical consequences.",4.737194547137081e-07,0.4170175611174951,0.008321684674633664,0.03626852929563745,0.4139757977760743,0.0,0.03621603081905733,0.42285685082003255,0.0,4.737194547137081e-07,0.4321333551903246,0.0
161,0.5,7,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","Our retrospective study is the first to highlight ESLD etiology as a prognostic factor for HRS. This finding indicates ESLD etiology's potential utility in risk stratification for HRS, with further research required to substantiate and understand its clinical utility.",5.210914001850787e-07,0.43365349647704843,0.016661878770468257,0.0398953822252012,0.46661953126149314,0.0,0.039837633900963065,0.47692407209030874,0.0,5.210914001850789e-07,0.48770320634513675,0.0
161,0.5,8,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","We document for the first time that ESLD etiology is a prognostic factor for HRS, supported by a large retrospective study. This suggests ESLD etiology may be useful for risk stratification in HRS patients, though further studies are needed to validate and explore clinical relevance.",3.789755637709665e-07,0.31855671231062566,0.006053102300380853,0.029014823436509962,0.31633732821215643,0.0,0.028972824655245866,0.32277339226305113,0.0,3.789755637709665e-07,0.3294792011302423,0.0
161,0.5,9,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","This study is the first to report ESLD etiology as a prognostic factor in HRS, based on extensive retrospective analysis. Our findings imply that ESLD etiology might aid in risk stratification, but additional research is necessary to confirm and investigate clinical implications.",4.500334819780227e-07,0.3914796470874169,0.007713121229531744,0.03445510283085558,0.38865798979178257,0.0,0.034405229278104466,0.3968813644167746,0.0,4.500334819780227e-07,0.4054651081081637,0.0
161,0.5,10,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","For the first time, ESLD etiology has been identified as a prognostic factor for HRS in a large retrospective study. This finding suggests ESLD etiology could serve as a risk stratification tool for HRS patients, with further research needed to validate and explore its clinical significance.",3.552895910352811e-07,0.35699679050777444,0.04966465184177663,0.02720139697172809,0.2933478099874569,0.0,0.027162023114293,0.2992428948528567,0.0,3.552895910352811e-07,0.3053816495511823,0.0
162,0.5,1,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does using oversized cups in cup-cage reconstruction offer initial stability in total hip arthroplasty (THA) for patients with osteoporotic acetabular fractures? Most acetabular components in this study remained stable despite minimal contact between the component and pelvic bone, although 3 out of 10 showed migration beyond thresholds associated with future loosening.",2.3685972735685406e-08,0.019802627296179764,0.0,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
162,0.5,2,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In THA for osteoporotic acetabular fractures, does cup-cage reconstruction with oversized cups ensure initial stability? The majority of acetabular components were stable despite limited contact with the pelvic bone, but 3 of 10 migrated beyond the limits indicating potential loosening.",2.8423167282822477e-07,0.26826398659468076,0.0,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
162,0.5,3,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Is initial stability achieved in THA for osteoporotic acetabular fractures using cup-cage reconstruction with oversized cups? Most components stayed stable despite the small contact surface with the pelvic bone; however, 3 out of 10 migrated beyond the predictive limits for loosening.",2.6054570009253947e-07,0.24294617861038903,0.0,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
162,0.5,4,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does the use of oversized cups in cup-cage reconstruction provide initial stability in THA for osteoporotic acetabular fractures? Although the contact surface between component and pelvic bone was small, most acetabular components were stable, but 3 of 10 migrated past the thresholds that predict loosening.",1.6580180914979784e-07,0.14763599880606337,0.0,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
162,0.5,5,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Can cup-cage reconstruction with oversized cups achieve initial stability in THA for osteoporotic acetabular fractures? Despite a small contact area with pelvic bone, most components remained stable, with 3 out of 10 migrating beyond limits that suggest future loosening.",3.0791764556391007e-07,0.29423947299793873,0.0,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
162,0.5,6,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In cases of osteoporotic acetabular fractures treated by THA, does cup-cage reconstruction using oversized cups provide initial stability? The majority of acetabular components were stable even with limited pelvic bone contact, though 3 of 10 migrated beyond the limits predictive of loosening.",2.3685972735685406e-07,0.21825356602001733,0.0,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
162,0.5,7,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does cup-cage reconstruction with oversized cups ensure initial stability in THA for osteoporotic acetabular fractures? Most acetabular components were stable despite minimal contact with pelvic bone; however, 3 out of 10 exceeded migration limits that forecast loosening.",3.5528959103528067e-07,0.3483066942682149,0.0,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
162,0.5,8,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Is initial stability provided by cup-cage reconstruction with oversized cups in THA for osteoporotic acetabular fractures? While the contact surface was small, most components remained stable, but 3 of 10 migrated beyond thresholds that predict loosening.",3.7897556377096597e-07,0.37647757123491177,0.0,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
162,0.5,9,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does the use of oversized cups in cup-cage reconstruction yield initial stability in THA for osteoporotic acetabular fractures? Despite limited contact between the component and pelvic bone, most acetabular components were stable, although 3 of 10 migrated beyond limits associated with loosening.",2.3685972735685406e-07,0.21825356602001733,0.0,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
162,0.5,10,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In THA for osteoporotic acetabular fractures, does cup-cage reconstruction with oversized cups provide initial stability? Most acetabular components were stable despite a small contact surface with pelvic bone, but 3 out of 10 migrated beyond predictive limits for loosening.",3.0791764556391007e-07,0.29423947299793873,0.0,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
163,0.5,1,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study data indicates a potential link between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.5,2,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Does cervical cord plaque relate to discopathy in patients with multiple sclerosis? The research suggests a possible association between cervical discopathy and cervical MS plaques.,1.421158364141118e-07,0.17693373927688016,0.033293697978596916,0.010880558788691277,0.23180161405732358,0.0,0.010864809245717241,0.24116205681688863,0.0,1.4211583641411244e-07,0.2513144282809079,0.0
163,0.5,3,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any association between cervical cord plaques and discopathy in multiple sclerosis cases? Study findings imply a possible correlation between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.15021004549256967,0.005106302021403095,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
163,0.5,4,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques connected to discopathy in multiple sclerosis patients? The study data points to a potential relationship between cervical discopathy and cervical MS plaques.,1.184298636784265e-07,0.13611174475662535,0.033293697978596916,0.009067132323909398,0.18924199963852795,0.0,0.009054007704764368,0.19671029424605457,0.0,1.1842986367842703e-07,0.20479441264601395,0.0
163,0.5,5,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a relationship between cervical cord plaques and discopathy in individuals with multiple sclerosis? The study suggests a possible link between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.5,6,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Can cervical cord plaques be related to discopathy in patients with multiple sclerosis? Data from the study suggests a potential correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.059150703620495904,0.033293697978596916,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.5,7,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any link between cervical cord plaques and discopathy in multiple sclerosis patients? The study data implies a possible association between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.5,8,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Do cervical cord plaques correlate with discopathy in patients with multiple sclerosis? The study indicates a potential connection between cervical discopathy and cervical MS plaques.,1.421158364141118e-07,0.17693373927688016,0.033293697978596916,0.010880558788691277,0.23180161405732358,0.0,0.010864809245717241,0.24116205681688863,0.0,1.4211583641411244e-07,0.2513144282809079,0.0
163,0.5,9,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a possible relationship between cervical cord plaques and discopathy in multiple sclerosis patients? The study data suggests a likely correlation between cervical discopathy and cervical MS plaques.,4.73719454713706e-08,0.07229357234676037,0.0023715969459572606,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
163,0.5,10,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study findings suggest a possible association between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
164,0.5,1,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair warranted for patients aged 80 or above following aneurysmal subarachnoid hemorrhage? The study shows improved outcomes when ruptured aneurysms are surgically repaired in elderly patients compared to conservative treatment. Therefore, definitive surgery should be confidently offered to elderly patients with aSAH.",2.3685972735685406e-07,0.18901820684629156,0.0144351858390415,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.5,2,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should patients aged 80 or older undergo aneurysm repair after aneurysmal subarachnoid hemorrhage? Findings indicate that elderly patients have better prognoses with surgical repair of ruptured aneurysms than with conservative management. Hence, definitive surgery is recommended for elderly individuals with aSAH.",3.079176455639103e-07,0.2290994646789435,0.03767781622452902,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
164,0.5,3,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to perform aneurysm repair on patients aged 80+ after aneurysmal subarachnoid hemorrhage? The study reveals that elderly patients achieve better outcomes with surgical repair of ruptured aneurysms than with non-surgical treatment. Based on these results, definitive surgery should be offered without hesitation to elderly aSAH patients.",1.1842986367842703e-07,0.04677790788498859,0.03767781622452902,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
164,0.5,4,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Does aneurysm repair benefit patients aged 80 and above after aneurysmal subarachnoid hemorrhage? Results demonstrate superior prognosis when ruptured aneurysms are repaired surgically in elderly patients compared to conservative care. Consequently, definitive surgery should be considered for elderly patients with aSAH.",3.079176455639103e-07,0.26375682370693987,0.012694252779427106,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
164,0.5,5,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair justified for octogenarians after aneurysmal subarachnoid hemorrhage? The research indicates that elderly patients have improved outcomes with aneurysm repair over conservative treatment. Therefore, definitive surgical intervention should be offered to elderly individuals with aSAH.",4.026615365066515e-07,0.3729681570345442,0.009922714183712694,0.030828249901291835,0.39589565709201446,0.0,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
164,0.5,6,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 or older with aneurysmal subarachnoid hemorrhage, is aneurysm repair advisable? The study shows better prognosis following surgical repair of ruptured aneurysms versus conservative treatment in the elderly. Thus, definitive surgery should be pursued in elderly patients with aSAH.",2.8423167282822487e-07,0.2044068520885718,0.03767781622452902,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
164,0.5,7,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should aneurysm repair be performed on patients aged 80+ after aneurysmal subarachnoid hemorrhage? Evidence suggests that elderly patients fare better with surgical repair of ruptured aneurysms than with conservative management. From this study, definitive surgery should not be withheld from elderly aSAH patients.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
164,0.5,8,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is surgical repair of aneurysms appropriate for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The findings show improved outcomes in elderly patients undergoing aneurysm repair compared to conservative treatment. Hence, definitive surgery should be offered to elderly patients with aSAH without reluctance.",2.3685972735685406e-07,0.18901820684629156,0.0144351858390415,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.5,9,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it justified to repair aneurysms in patients aged 80 and above following aneurysmal subarachnoid hemorrhage? The study results indicate a better prognosis for elderly patients who receive surgical repair rather than conservative care. Accordingly, definitive surgery should be considered for elderly aSAH patients.",2.3685972735685406e-07,0.18901820684629156,0.0144351858390415,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.5,10,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For elderly patients aged 80 or more with aneurysmal subarachnoid hemorrhage, is aneurysm repair warranted? The study demonstrates that repairing ruptured aneurysms leads to better outcomes than conservative treatment in this age group. Therefore, definitive surgery should be confidently offered to elderly patients with aSAH.",2.1317375462116866e-07,0.16529597490007042,0.014962835153679913,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
165,0.5,1,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do individuals with episodic migraines show selective attention to headache-related visual cues? Answer: Considering the substantial sample size and previous pilot testing of the images, findings indicate that episodic migraine sufferers do not specifically focus on headache-related facial stimuli. Although there is some limited evidence of attentional biases in chronic headache groups, these results suggest otherwise.",1.8948778188548325e-07,0.24079407739725145,0.06222222222222222,0.014507411718254981,0.18668120822709167,0.0212665406427221,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
165,0.5,2,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are episodic migraine patients more attentive to headache-associated visual stimuli? Answer: Based on a large sample and prior pilot studies of the images shown, the data imply that those with episodic migraines do not exhibit selective attention towards headache-related facial images. While modest attentional biases have been noted in chronic headache cases, these findings do not support that for episodic migraineurs.",3.079176455639103e-07,0.30359011376787315,0.04583333333333332,0.023574544042164344,0.27369258521672,0.0212665406427221,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
165,0.5,3,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do people with episodic migraines pay special attention to headache-related visual stimuli? Answer: Given the large sample size and earlier pilot testing of the images, the results suggest that episodic migraineurs do not preferentially attend to headache-related facial stimuli. Although some evidence points to attentional biases in chronic headache populations, this study does not find the same for episodic migraine sufferers.",3.079176455639103e-07,0.30359011376787315,0.04583333333333332,0.023574544042164344,0.27369258521672,0.0212665406427221,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
165,0.5,4,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Is selective attention to headache-related visual stimuli present in episodic migraineurs? Answer: Taking into account the large sample and prior pilot testing of the images, the findings indicate that episodic migraineurs do not show differential attention to headache-related facial stimuli. There is modest evidence for attentional biases among chronic headache sufferers, but these results do not confirm such biases in episodic cases.",3.316036182995957e-07,0.25313842582848967,0.001987052450786092,0.025387970506946217,0.26749575010039184,0.004877651753833204,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
165,0.5,5,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do episodic migraine sufferers focus more on headache-related visual cues? Answer: With a large sample size and previous pilot testing of images, results suggest that episodic migraineurs do not selectively attend to headache-related facial stimuli. Although modest evidence exists for attentional biases in chronic headache groups, this is not evident in episodic migraineurs.",1.1842986367842703e-07,0.18573430021422288,0.06222222222222222,0.009067132323909363,0.13059174157604847,0.0212665406427221,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
165,0.5,6,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are headache-related visual stimuli selectively attended to by episodic migraine patients? Answer: Considering the large sample and prior pilot testing, findings suggest episodic migraineurs do not differentially attend to headache-related facial stimuli. While there is some modest evidence of attentional biases in chronic headache sufferers, these results do not extend to episodic migraineurs.",1.1842986367842703e-07,0.159577802834602,0.04336127547666009,0.009067132323909363,0.13059174157604847,0.0212665406427221,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
165,0.5,7,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do individuals suffering from episodic migraines show selective attention to headache-related facial images? Answer: Based on a large sample size and earlier pilot tests of the images, results indicate episodic migraineurs do not focus more on headache-related facial stimuli. Some modest attentional biases have been reported in chronic headache patients, but not in episodic migraineurs.",1.6580180914979784e-07,0.19757021987421108,0.04404663923182442,0.012693985253473108,0.1683320695588959,0.0212665406427221,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
165,0.5,8,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Is there selective attention toward headache-related visual stimuli among episodic migraineurs? Answer: Given the large sample and prior pilot testing of presented images, results suggest that episodic migraineurs do not show selective attention to headache-related facial stimuli. There is some modest evidence of attentional biases in chronic headache sufferers, but not in episodic migraineurs.",1.4211583641411244e-07,0.17875431542786036,0.043710296269926036,0.010880558788691236,0.14963993654674157,0.0212665406427221,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
165,0.5,9,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do episodic migraine patients exhibit selective attention to headache-related visual stimuli? Answer: Taking into consideration the large sample size and previous pilot testing, the data suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Though modest evidence exists for attentional biases in chronic headache groups, these findings do not apply to episodic migraineurs.",1.8948778188548325e-07,0.19128356450011186,0.02655692729766805,0.014507411718254981,0.18668120822709167,0.0212665406427221,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
165,0.5,10,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are headache-related facial stimuli selectively attended to by individuals with episodic migraines? Answer: With a large sample and prior pilot testing of images, results indicate episodic migraineurs do not selectively focus on headache-related facial stimuli. While modest attentional biases have been observed in chronic headache populations, this pattern is not seen in episodic migraine sufferers.",1.6580180914979784e-07,0.19757021987421108,0.04404663923182442,0.012693985253473108,0.1683320695588959,0.0212665406427221,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
166,0.5,1,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does the allocation of health care benefits in Kenya align with the principles of universal coverage? The principles of universal coverage dictate that everyone should have access to quality health care regardless of their financial status. Although Kenya has progressed towards universal coverage, inequalities still exist, especially in rural and marginalized areas. Access to necessary services and financial safeguards continue to be major issues.",2.3685972735685406e-08,0.02694426123817184,0.030513273858667457,0.0018134264647818726,0.016993622067507985,0.0005269877749050703,0.0018108015409528666,0.01690807090233637,0.0002729898815793594,2.3685972735685406e-08,0.01680711831638071,0.0
166,0.5,2,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Is Kenya's distribution of health care benefits consistent with the ideals of universal coverage? Universal coverage means all individuals should receive quality health care without financial barriers. Kenya has advanced toward universal coverage, but disparities remain, notably in rural and underserved communities. Challenges persist in providing access to essential services and financial protection.",2.3685972735685406e-07,0.13547141399924945,0.029038618055217305,0.018134264647818726,0.13359595731390694,0.03274920999712727,0.018108015409528666,0.15921665077528946,0.016661878770468257,2.3685972735685406e-07,0.1857171457950919,0.0
166,0.5,3,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does Kenya's health care benefits distribution fulfill the universal coverage principles? Universal coverage principles state that quality health care should be accessible to all, regardless of payment ability. Kenya has made progress in this area, yet disparities endure, particularly in rural and marginalized regions. Ensuring access to key services and financial protection is still a significant challenge.",1.4211583641411244e-07,0.08421444779805398,0.012596698755422846,0.010880558788691236,0.05808840480576105,0.03274920999712727,0.0108648092457172,0.08225560963915957,0.016661878770468257,1.4211583641411244e-07,0.10724553035359774,0.0
166,0.5,4,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does the way health care benefits are distributed in Kenya conform to universal coverage principles? Universal coverage requires that everyone benefits from quality health care irrespective of their ability to pay. Kenya has made notable progress toward universal coverage but still faces disparities, especially in rural and marginalized communities. Access to essential health services and financial protection remain critical challenges.",7.105791820705622e-08,0.061876338122281105,0.03815382264655357,0.005440279394345618,0.004978579491813129,0.03274920999712727,0.0054324046228586,0.02818838836888471,0.016661878770468257,7.105791820705622e-08,0.05218575317056917,0.0
166,0.5,5,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","To what extent does Kenya's distribution of health care benefits adhere to universal coverage principles? Universal coverage principles emphasize that all individuals should have quality health care access regardless of payment capacity. Kenya has advanced toward these goals but continues to experience disparities, mainly in rural and marginalized areas. Providing access to essential services and financial security remains a challenge.",7.105791820705622e-08,0.029511210920849962,0.01440542242728389,0.005440279394345618,0.004978579491813129,0.03274920999712727,0.0054324046228586,0.02818838836888471,0.016661878770468257,7.105791820705622e-08,0.05218575317056917,0.0
166,0.5,6,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does the distribution system of health care benefits in Kenya meet the standards of universal coverage? Universal coverage principles require universal access to quality health care without financial discrimination. Kenya has taken steps toward universal coverage, but disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remains a significant hurdle.",1.6580180914979784e-07,0.1031331444443162,0.01195013892739602,0.012693985253473108,0.07643754347395681,0.03274920999712727,0.012675610786670066,0.1009477426513139,0.016661878770468257,1.6580180914979784e-07,0.12629372532429084,0.0
166,0.5,7,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Is the distribution of health care benefits in Kenya in line with the principles of universal coverage? Universal coverage principles ensure that all individuals receive quality health care regardless of their ability to pay. Kenya has made progress toward universal coverage, yet disparities still exist, especially in rural and marginalized areas. Challenges with access to essential services and financial protection remain.",4.737194547137081e-08,0.01118403056737094,0.03160011490950876,0.0036268529295637453,0.012115853867486592,0.03274920999712727,0.003621603081905733,0.01079664565701588,0.016661878770468257,4.737194547137081e-08,0.03448617607116855,0.0
166,0.5,8,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does Kenya's health care benefits distribution satisfy the principles of universal coverage? Universal coverage demands that everyone benefits from quality health care without financial barriers. Kenya has moved forward in achieving universal coverage, but disparities continue, particularly in rural and marginalized communities. Access to essential services and financial protection are ongoing challenges.",2.6054570009253947e-07,0.15541223528663828,0.028661993679977023,0.0199476911126006,0.1533985846100867,0.03274920999712727,0.019918816950481533,0.17941935809280807,0.016661878770468257,2.6054570009253947e-07,0.20633643299782767,0.0
166,0.5,9,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","How well does Kenya's distribution of health care benefits align with universal coverage principles? Universal coverage principles mean that quality health care should be accessible to all, regardless of ability to pay. Kenya has made advances toward universal coverage, though disparities remain, especially in rural and marginalized areas. Ensuring access to essential services and financial protection remains a major challenge.",7.105791820705622e-08,0.029511210920849962,0.01440542242728389,0.005440279394345618,0.004978579491813129,0.03274920999712727,0.0054324046228586,0.02818838836888471,0.016661878770468257,7.105791820705622e-08,0.05218575317056917,0.0
166,0.5,10,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does the way health care benefits are distributed in Kenya comply with universal coverage principles? The principles of universal coverage require that everyone has access to quality health care, regardless of their financial means. Kenya has made progress toward universal coverage, but disparities continue, particularly in rural and marginalized communities. Access to essential services and financial protection are significant challenges.",7.105791820705622e-08,0.029511210920849962,0.01440542242728389,0.005440279394345618,0.004978579491813129,0.03274920999712727,0.0054324046228586,0.02818838836888471,0.016661878770468257,7.105791820705622e-08,0.05218575317056917,0.0
167,0.5,1,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Can a new surgical method for the temporomandibular joint enhance access and lower complication rates? The VMPA technique allows direct access and visualization of the joint, reducing harm to adjacent tissues. This approach may lead to better surgical results and fewer postoperative issues.",4.737194547137081e-08,0.04802033420753293,0.0010803788339694455,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
167,0.5,2,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Is it possible that an innovative surgical approach to the temporomandibular joint can improve access and decrease complications? Using the VMPA provides direct joint access and clear visualization, minimizing damage to nearby structures. This method holds promise for improved outcomes and reduced postoperative complications.",2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
167,0.5,3,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Could a novel surgical technique for the temporomandibular joint improve accessibility and reduce complications? The VMPA offers direct visualization and access to the joint, limiting collateral damage to surrounding areas. This technique could enhance surgical success and lower postoperative complication rates.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
167,0.5,4,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Does a new surgical approach to the temporomandibular joint improve access and reduce risks? The VMPA allows surgeons direct access and visualization of the joint, minimizing injury to adjacent structures. This method may result in better surgical outcomes and fewer postoperative complications.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
167,0.5,5,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Might a novel surgical method for the temporomandibular joint provide better access and fewer complications? The VMPA technique enables direct joint visualization and access, reducing collateral damage to surrounding tissues. This approach shows potential for improved surgical outcomes and less postoperative morbidity.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
167,0.5,6,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Can a new surgical technique for the temporomandibular joint improve joint access and decrease complications? The VMPA provides direct visualization and access to the joint, minimizing harm to surrounding structures. This method offers potential for enhanced surgical results and reduced postoperative complications.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
167,0.5,7,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Is a novel surgical approach to the temporomandibular joint capable of improving access and lowering complication rates? The VMPA technique gives direct joint access and visualization, which limits damage to nearby tissues. This approach may improve surgical outcomes and reduce postoperative complications.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
167,0.5,8,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Could an innovative surgical approach to the temporomandibular joint improve access and minimize complications? The VMPA allows direct visualization and access to the joint, decreasing collateral damage. This technique holds promise for better surgical outcomes and fewer postoperative issues.",1.4211583641411222e-07,0.15157821472220911,0.0035815857662582634,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
167,0.5,9,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Does a novel surgical method for the temporomandibular joint enhance access and reduce complications? The VMPA provides direct joint visualization and access, minimizing injury to surrounding structures. This approach may result in improved surgical success and reduced postoperative complications.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
167,0.5,10,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Might a new surgical technique for the temporomandibular joint improve access and reduce risks? The VMPA offers direct visualization and access to the joint, limiting collateral damage to adjacent tissues. This method shows potential for better surgical outcomes and fewer postoperative complications.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
168,0.5,1,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Does the position of the head affect anterior chamber depth in pseudoexfoliation syndrome? In patients showing unilateral pseudoexfoliation, the anterior chamber depth was notably shallower in the affected eye than the unaffected one, independent of head positioning. This indicates that pseudoexfoliation, not head position, causes differences in anterior chamber depth.",9.474389094274162e-08,0.04965411146350407,0.052159072031266185,0.0072537058591274906,0.04554236200447637,0.057576097781801686,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
168,0.5,2,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? Clinical observations in unilateral pseudoexfoliation patients reveal a significantly shallower anterior chamber depth in the affected eye compared to the unaffected eye, regardless of how the head is positioned, implying that the syndrome itself is responsible for the depth variations.",7.105791820705622e-08,0.01065051992195798,0.11667086052107921,0.005440279394345618,0.024333663933918004,0.05800069444444442,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
168,0.5,3,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Does head orientation impact anterior chamber depth in cases of pseudoexfoliation syndrome? Among patients with clinically evident unilateral pseudoexfoliation, the anterior chamber depth was significantly reduced in the affected eye relative to the unaffected eye, independent of head position, suggesting that the syndrome rather than head positioning affects depth.",1.1842986367842703e-07,0.032481965200162666,0.11501351437531152,0.009067132323909363,0.06721026338365732,0.05713345935727787,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
168,0.5,4,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","In pseudoexfoliation syndrome, does head position alter anterior chamber depth? Studies show that in unilateral pseudoexfoliation, the anterior chamber depth is considerably shallower in the affected eye compared to the unaffected eye regardless of head posture, indicating that the condition itself influences depth differences.",2.3685972735685406e-07,0.11695999911480381,0.13335878569114726,0.018134264647818726,0.15019262210566886,0.07839999999999997,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
168,0.5,5,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Can head positioning change anterior chamber depth in pseudoexfoliation syndrome? Findings demonstrate that in patients with unilateral pseudoexfoliation, the anterior chamber depth is significantly shallower in the affected eye than in the unaffected eye, irrespective of head position, meaning pseudoexfoliation is the main factor affecting depth.",1.8948778188548325e-07,0.13167784536573146,0.09027488546438989,0.014507411718254981,0.1351792964962275,0.055685018929150856,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
168,0.5,6,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Does the anterior chamber depth vary with head position in pseudoexfoliation syndrome? Research indicates that patients with clinically apparent unilateral pseudoexfoliation have a notably shallower anterior chamber depth in the affected eye compared to the unaffected eye, no matter the head position, pointing to pseudoexfoliation as the cause of depth differences.",7.105791820705622e-08,0.01065051992195798,0.11667086052107921,0.005440279394345618,0.024333663933918004,0.05800069444444442,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
168,0.5,7,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Is anterior chamber depth dependent on head position in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, the anterior chamber depth was consistently shallower in the affected eye than the unaffected eye regardless of head orientation, suggesting that the syndrome itself, not head position, is responsible for the depth variation.",1.1842986367842703e-07,0.032481965200162666,0.11501351437531152,0.009067132323909363,0.06721026338365732,0.05713345935727787,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
168,0.5,8,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Does the head's position influence anterior chamber depth in pseudoexfoliation syndrome? Clinical evidence from unilateral pseudoexfoliation cases shows a significantly shallower anterior chamber depth in the affected eye compared to the unaffected eye, independent of head position, implying that pseudoexfoliation itself affects depth.",2.6054570009253947e-07,0.20727211857230277,0.08559549891687147,0.0199476911126006,0.2419142888613086,0.02974779750164363,0.019918816950481533,0.2776035376383854,0.02498356344510192,2.6054570009253947e-07,0.248461359298501,0.0
168,0.5,9,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","In cases of pseudoexfoliation syndrome, does head positioning affect anterior chamber depth? Data reveal that the anterior chamber depth is significantly shallower in the affected eye of patients with unilateral pseudoexfoliation compared to the unaffected eye, regardless of head positioning, indicating that pseudoexfoliation is the key factor.",1.6580180914979784e-07,0.04741614850968601,0.1348730210149064,0.012693985253473108,0.0811997506187172,0.07839999999999997,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
168,0.5,10,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Does head position have an effect on anterior chamber depth in pseudoexfoliation syndrome? Observations in patients with clinically evident unilateral pseudoexfoliation show a significantly shallower anterior chamber depth in the affected eye versus the unaffected eye, independent of head position, suggesting the syndrome itself causes the depth differences.",1.4211583641411244e-07,0.08425998346536945,0.09306835822539512,0.010880558788691236,0.11949451177471992,0.035011570247933846,0.0108648092457172,0.15596968431222535,0.02221074380165289,1.4211583641411244e-07,0.1278333715098836,0.0
169,0.5,1,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is there a link between the CYP2D6*4 allele and breast cancer risk? A potential reduced activation of procarcinogens in CYP2D6*4 poor metabolizers might offer protection against carcinogens.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
169,0.5,2,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does the CYP2D6*4 allele influence breast cancer risk? Poor metabolizers with CYP2D6*4 may have decreased conversion of procarcinogens, potentially providing a protective effect against carcinogens.",1.184298636784265e-07,0.18924199963852795,0.0,0.009067132323909398,0.19671029424605457,0.0,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
169,0.5,3,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is breast cancer risk associated with the CYP2D6*4 allele? CYP2D6*4 poor metabolizers may transform fewer procarcinogens, which could protect against carcinogen exposure.",1.894877818854824e-07,0.3227733922630516,0.0,0.014507411718255037,0.33647223662121384,0.0,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
169,0.5,4,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,What is the relationship between the CYP2D6*4 allele and breast cancer risk? Reduced procarcinogen metabolism in CYP2D6*4 poor metabolizers might confer protection from carcinogens.,1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.5,5,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Does carrying the CYP2D6*4 allele affect breast cancer risk? The decreased activation of procarcinogens by CYP2D6*4 poor metabolizers may result in a protective effect against carcinogens.,9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.5,6,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there an association between the CYP2D6*4 allele and breast cancer risk? Poor metabolizers of CYP2D6*4 might have reduced transformation of procarcinogens, offering a protective effect.",9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.5,7,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,How does the CYP2D6*4 allele relate to breast cancer risk? A possible decrease in procarcinogen metabolism in CYP2D6*4 poor metabolizers could lead to protection from carcinogens.,9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.5,8,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Can the CYP2D6*4 allele impact breast cancer risk? CYP2D6*4 poor metabolizers might exhibit lower procarcinogen activation, potentially providing carcinogen protection.",2.368597273568531e-07,0.422856850820033,0.0,0.018134264647818796,0.4418327522790393,0.0,0.018108015409528732,0.4626235219481134,0.0,2.368597273568538e-07,0.48550781578170144,0.0
169,0.5,9,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is the CYP2D6*4 allele linked to breast cancer risk? The poor metabolism of procarcinogens by CYP2D6*4 carriers may have a protective effect against carcinogens.,1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.5,10,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,What association exists between the CYP2D6*4 allele and breast cancer risk? Decreased procarcinogen transformation by CYP2D6*4 poor metabolizers might protect against carcinogens.,1.894877818854824e-07,0.3227733922630516,0.0,0.014507411718255037,0.33647223662121384,0.0,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
170,0.5,1,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call impact Kenya's 2015 polio vaccination coverage? The boycott did not significantly affect the campaign, but a future repetition could.",4.026615365066502e-07,0.2605473836945853,0.33996539792387537,0.030828249901291918,0.388593394884571,0.20987654320987656,0.030783626196198823,0.48801055518147507,0.1051862673484295,4.026615365066519e-07,0.5930637220029649,0.0
170,0.5,2,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was the 2015 polio vaccination coverage in Kenya influenced by the Catholic bishops' boycott call? The campaign was not notably impacted, though a repeated boycott might have consequences.",3.316036182995943e-07,0.14276434803820104,0.33996539792387537,0.02538797050694628,0.2659910727922381,0.20987654320987656,0.025351221573340202,0.3601771836715906,0.1051862673484295,3.316036182995957e-07,0.45953232937844124,0.0
170,0.5,3,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call alter the 2015 polio vaccination efforts in Kenya? The campaign remained largely unaffected, but future similar calls could pose risks.",3.789755637709649e-07,0.2197253891743305,0.33996539792387537,0.02901482343651004,0.3460337804657754,0.20987654320987656,0.02897282465524595,0.443558792610641,0.1051862673484295,3.789755637709665e-07,0.5465437063680709,0.0
170,0.5,4,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","In 2015, did the boycott call from Catholic bishops impact Kenya's polio vaccination coverage? The campaign was not significantly affected, yet a recurrence could be problematic.",3.789755637709649e-07,0.2197253891743305,0.33996539792387537,0.02901482343651004,0.3460337804657754,0.20987654320987656,0.02897282465524595,0.443558792610641,0.1051862673484295,3.789755637709665e-07,0.5465437063680709,0.0
170,0.5,5,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the boycott urged by Catholic bishops affect Kenya's 2015 polio vaccination coverage? It did not have a major effect, but repeating such calls could.",4.026615365066502e-07,0.2605473836945853,0.33996539792387537,0.030828249901291918,0.388593394884571,0.20987654320987656,0.030783626196198823,0.48801055518147507,0.1051862673484295,4.026615365066519e-07,0.5930637220029649,0.0
170,0.5,6,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was there a significant effect on Kenya's 2015 polio vaccination coverage due to the Catholic bishops' boycott? The campaign was mostly unaffected, but future calls might affect it.",3.316036182995943e-07,0.14276434803820104,0.33996539792387537,0.02538797050694628,0.2659910727922381,0.20987654320987656,0.025351221573340202,0.3601771836715906,0.1051862673484295,3.316036182995957e-07,0.45953232937844124,0.0
170,0.5,7,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call influence the 2015 polio vaccination campaign in Kenya? The campaign was not significantly impacted, but future repetitions might.",4.263475092423355e-07,0.30310699811338093,0.33996539792387537,0.0326416763660738,0.43304515745540506,0.20987654320987656,0.032594427737151696,0.534530570816369,0.1051862673484295,4.2634750924233726e-07,0.6418538861723961,0.0
170,0.5,8,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the call for boycott by Catholic bishops impact Kenya's 2015 polio vaccination coverage? It did not significantly affect the campaign, but future calls could.",4.026615365066502e-07,0.2605473836945853,0.33996539792387537,0.030828249901291918,0.388593394884571,0.20987654320987656,0.030783626196198823,0.48801055518147507,0.1051862673484295,4.026615365066519e-07,0.5930637220029649,0.0
170,0.5,9,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the boycott call from Catholic bishops affect the 2015 polio vaccination coverage in Kenya? The campaign was not notably influenced, though future calls might.",4.026615365066502e-07,0.2605473836945853,0.33996539792387537,0.030828249901291918,0.388593394884571,0.20987654320987656,0.030783626196198823,0.48801055518147507,0.1051862673484295,4.026615365066519e-07,0.5930637220029649,0.0
170,0.5,10,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' call for boycott affect the polio vaccination coverage in Kenya in 2015? It did not significantly impact the campaign, but repeated calls could have effects.",3.07917645563909e-07,0.10639670386732636,0.33996539792387537,0.0235745440421644,0.22825074480939112,0.20987654320987656,0.02354042003238733,0.3209564705183081,0.1051862673484295,3.079176455639103e-07,0.41871033485818643,0.0
171,0.5,1,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","Research indicates that KCNQ1 mutations may increase susceptibility to atrial fibrillation, with disease manifestation depending on both genetic predispositions and environmental influences like hypertension and aging.",8.52695018484673e-07,0.8465457651700321,0.03274920999712727,0.0652833527321475,0.8931858258554897,0.016661878770468257,0.06518885547430328,0.9420432279765691,0.0,8.526950184846746e-07,0.9694005571881035,0.0
171,0.5,2,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","Findings imply that mutations in KCNQ1 can predispose people to atrial fibrillation, but the onset of the condition is probably due to a mix of genetic and environmental factors, including hypertension and aging.",6.868932093348759e-07,0.5996856872385057,0.03274920999712727,0.052589367478674334,0.6372524517182883,0.016661878770468257,0.052513244687633166,0.6763400622435638,0.0,6.868932093348768e-07,0.6931471805599458,0.0
171,0.5,3,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","Evidence suggests KCNQ1 mutations could make individuals more prone to atrial fibrillation, although the condition's development likely requires a combination of genetic and environmental triggers such as hypertension and aging.",7.579511275419318e-07,0.698125760051759,0.03274920999712727,0.05802964687301997,0.7390351460282307,0.016661878770468257,0.05794564931049179,0.7817005779013892,0.0,7.57951127541933e-07,0.8023464725249365,0.0
171,0.5,4,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","Data indicate that while KCNQ1 mutations may predispose individuals to atrial fibrillation, the actual occurrence of the disease is influenced by both genetic and environmental factors like hypertension and aging.",7.579511275419318e-07,0.698125760051759,0.03274920999712727,0.05802964687301997,0.7390351460282307,0.016661878770468257,0.05794564931049179,0.7817005779013892,0.0,7.57951127541933e-07,0.8023464725249365,0.0
171,0.5,5,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","These results propose that KCNQ1 mutations might increase the risk of atrial fibrillation, but the disease likely arises from an interplay between genetic predisposition and environmental factors, including hypertension and aging.",7.342651548062465e-07,0.6642242083760772,0.03274920999712727,0.05621622040823809,0.7039438262169617,0.016661878770468257,0.05613484776953891,0.7453329337305146,0.0,7.342651548062476e-07,0.7646061445420895,0.0
171,0.5,6,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","The data suggest that mutations in KCNQ1 could predispose individuals to atrial fibrillation, with environmental elements such as hypertension and aging potentially triggering the condition.",8.763809912203583e-07,0.8873677596902869,0.03274920999712727,0.06709677919692937,0.9357454402742853,0.016661878770468257,0.06699965701525615,0.9864949905474032,0.0,8.7638099122036e-07,1.0159205728229974,0.0
171,0.5,7,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","KCNQ1 mutations may predispose individuals to atrial fibrillation, but the disease's development probably involves a combination of genetic factors and environmental triggers like hypertension and aging.",8.52695018484673e-07,0.8465457651700321,0.03274920999712727,0.0652833527321475,0.8931858258554897,0.016661878770468257,0.06518885547430328,0.9420432279765691,0.0,8.526950184846746e-07,0.9694005571881035,0.0
171,0.5,8,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","It appears that KCNQ1 mutations can increase susceptibility to atrial fibrillation, yet the manifestation of the disease likely depends on both genetic and environmental factors, including hypertension and aging.",7.816371002776171e-07,0.733217079863028,0.03274920999712727,0.05984307333780185,0.7754027901991054,0.016661878770468257,0.05975645085144466,0.8194409058842362,0.0,7.816371002776184e-07,0.841567185678219,0.0
171,0.5,9,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","Research shows that KCNQ1 mutations might lead to a higher risk of atrial fibrillation, but the condition's onset is likely due to a combination of genetic and environmental factors such as hypertension and aging.",6.632072365991906e-07,0.6109229486056877,0.002475772497127271,0.050775941013892455,0.6055037534037084,0.016661878770468257,0.05070244314668029,0.6435502394205721,0.0,6.632072365991914e-07,0.6592456288842641,0.0
171,0.5,10,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","The evidence suggests KCNQ1 mutations could predispose to atrial fibrillation, but the actual development of the disease probably involves both genetic predispositions and environmental factors like hypertension and aging.",7.816371002776171e-07,0.733217079863028,0.03274920999712727,0.05984307333780185,0.7754027901991054,0.016661878770468257,0.05975645085144466,0.8194409058842362,0.0,7.816371002776184e-07,0.841567185678219,0.0
172,0.5,1,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in this condition remains uncertain. Surgery may alleviate compression, but the inflammatory characteristics of sarcoidosis could restrict lasting improvements. More studies are required to determine the best treatment approach.",1.8948778188548325e-07,0.03375654994010002,0.09506564056134,0.014507411718254981,0.08907878990606388,0.05859375,0.014486412327622933,0.14662749992237956,0.019991670137442734,1.8948778188548325e-07,0.17824823140631896,0.0
172,0.5,2,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Does decompressive surgery work for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The impact of decompression is not well defined. Although surgery can reduce compression, the chronic inflammation in sarcoidosis might limit sustained benefits. Additional research is necessary to identify optimal therapies.",2.3685972735685406e-07,0.08027656557499396,0.09506564056134,0.018134264647818726,0.13670683889531832,0.05859375,0.018108015409528666,0.19541766409181127,0.019991670137442734,2.3685972735685406e-07,0.22825865198098239,0.0
172,0.5,3,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Is decompressive surgery effective in treating spinal cord sarcoidosis with compressive cervical myelopathy? The therapeutic value of decompression is unclear. Surgery can relieve pressure, yet the inflammatory process of sarcoidosis may hinder long-term outcomes. Further investigation is needed to develop effective treatment plans.",2.3685972735685406e-07,0.08027656557499396,0.09506564056134,0.018134264647818726,0.13670683889531832,0.05859375,0.018108015409528666,0.19541766409181127,0.019991670137442734,2.3685972735685406e-07,0.22825865198098239,0.0
172,0.5,4,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Can decompressive surgery effectively manage spinal cord sarcoidosis with compressive cervical myelopathy? The role of decompression is uncertain. While surgical intervention can ease compression, the inflammatory nature of sarcoidosis may reduce lasting benefits. More research is essential to establish the best treatment options.",2.3685972735685406e-07,0.08027656557499396,0.09506564056134,0.018134264647818726,0.13670683889531832,0.05859375,0.018108015409528666,0.19541766409181127,0.019991670137442734,2.3685972735685406e-07,0.22825865198098239,0.0
172,0.5,5,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Is decompression surgery a viable treatment for spinal cord sarcoidosis with compressive cervical myelopathy? Its effectiveness remains ambiguous. Surgery may help by relieving compression, but the persistent inflammation caused by sarcoidosis could limit long-term success. Further studies are warranted to find optimal management strategies.",2.1317375462116866e-07,0.056746068164799546,0.09506564056134,0.016320838183036854,0.1126092873162583,0.05859375,0.0162972138685758,0.17072505150143957,0.019991670137442734,2.1317375462116866e-07,0.20294084399669066,0.0
172,0.5,6,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","How effective is decompressive surgery for spinal cord sarcoidosis with compressive cervical myelopathy? The benefits of decompression are not clearly established. Surgery might alleviate compression, but sarcoidosis' inflammatory nature could diminish long-term efficacy. Additional research is needed to optimize treatment.",3.079176455639102e-07,0.1543845377287174,0.09506564056134,0.023574544042164344,0.21269274587323972,0.05859375,0.023540420032387266,0.27337920556152184,0.019991670137442734,3.079176455639103e-07,0.30830135965451655,0.0
172,0.5,7,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Is decompressive surgery a useful intervention for spinal cord sarcoidosis with compressive cervical myelopathy? The efficacy is uncertain. Although decompression can relieve pressure, the underlying inflammation from sarcoidosis may restrict lasting benefits. More research is required to clarify treatment protocols.",3.079176455639102e-07,0.1543845377287174,0.09506564056134,0.023574544042164344,0.21269274587323972,0.05859375,0.023540420032387266,0.27337920556152184,0.019991670137442734,3.079176455639103e-07,0.30830135965451655,0.0
172,0.5,8,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Does decompressive surgery provide benefits in spinal cord sarcoidosis with compressive cervical myelopathy? Its effectiveness is unclear. Surgery may reduce compression symptoms, but the inflammatory aspect of sarcoidosis might limit sustained improvement. Further studies are necessary to determine optimal care.",3.079176455639102e-07,0.1543845377287174,0.09506564056134,0.023574544042164344,0.21269274587323972,0.05859375,0.023540420032387266,0.27337920556152184,0.019991670137442734,3.079176455639103e-07,0.30830135965451655,0.0
172,0.5,9,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Is decompressive surgery effective for spinal cord sarcoidosis when compressive cervical myelopathy is present? The impact of decompression remains uncertain. Surgery can relieve compression, but the inflammatory pathology of sarcoidosis may limit long-term outcomes. More research is needed to guide treatment decisions.",2.6054570009253947e-07,0.10437411715405398,0.09506564056134,0.0199476911126006,0.16139945148569002,0.05859375,0.019918816950481533,0.220735472076103,0.019991670137442734,2.6054570009253947e-07,0.25423413838424036,0.0
172,0.5,10,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Can decompressive surgery effectively treat spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness is not well defined. While surgery can ease compression, the inflammatory nature of sarcoidosis may reduce long-term benefits. Additional research is essential to establish best practices.",3.079176455639102e-07,0.1543845377287174,0.09506564056134,0.023574544042164344,0.21269274587323972,0.05859375,0.023540420032387266,0.27337920556152184,0.019991670137442734,3.079176455639103e-07,0.30830135965451655,0.0
173,0.5,1,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,The notion that Indigenous Australians experience premature aging is not strongly backed by this study examining various specific conditions. The current emphasis and nature of services offered by aged care may not be appropriate.,2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
173,0.5,2,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,This study on several distinct conditions does not strongly support the belief that Indigenous Australians age prematurely. The present focus and types of aged care services might be inadequate.,3.316036182995944e-07,0.4054651081081637,0.0,0.025387970506946272,0.4177352006999784,0.0,0.025351221573340195,0.43078291609245367,0.0,3.316036182995957e-07,0.4446858212614444,0.0
173,0.5,3,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,"According to this study of discrete conditions, the idea that Indigenous Australians age earlier than usual lacks strong evidence. The existing aged care services and their focus may not be well suited.",2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
173,0.5,4,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,The concept that Indigenous Australians undergo premature aging is not well substantiated by this research on a range of specific conditions. The current aged care sector's focus and services may be insufficient.,2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
173,0.5,5,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,This investigation into various distinct conditions does not provide strong support for the claim that Indigenous Australians age prematurely. The aged care services currently provided may not be aligned with their needs.,2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
173,0.5,6,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,The belief that Indigenous Australians age prematurely is not strongly supported by this study of several separate conditions. The aged care sector's current focus and service types may be lacking.,3.079176455639091e-07,0.3703737882968947,0.0,0.023574544042164393,0.3813675565291037,0.0,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
173,0.5,7,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Research on a series of discrete conditions does not strongly validate the idea that Indigenous Australians experience premature aging. The present aged care services and focus may be inappropriate.,3.316036182995944e-07,0.4054651081081637,0.0,0.025387970506946272,0.4177352006999784,0.0,0.025351221573340195,0.43078291609245367,0.0,3.316036182995957e-07,0.4446858212614444,0.0
173,0.5,8,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,The study of various distinct conditions offers little support for the notion that Indigenous Australians age prematurely. The current aged care sector's focus and service offerings might not be adequate.,3.079176455639091e-07,0.3703737882968947,0.0,0.023574544042164393,0.3813675565291037,0.0,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
173,0.5,9,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,This study examining specific conditions does not strongly back the idea that Indigenous Australians age earlier than others. The aged care services currently provided may not be the best fit.,3.079176455639091e-07,0.3703737882968947,0.0,0.023574544042164393,0.3813675565291037,0.0,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
173,0.5,10,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,The idea that Indigenous Australians undergo premature aging is not well supported by this research on a series of discrete conditions. The current focus and types of services in aged care may not be suitable.,1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
174,0.5,1,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero central line-associated bloodstream infection rate achievable? Consistent high-quality training, adherence to evidence-based protocols, and meticulous documentation are linked to notable decreases in CLABSIs. Careful organization can enhance understanding of what enables a unit to manage peak demands and maintain exceptional long-term performance.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.5,2,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be sustained? Rigorous training, strict adherence to evidence-based guidelines, and comprehensive documentation correlate with major reductions in CLABSIs. Thoughtful management may improve insights into a unit's capacity to handle peak workloads and sustain outstanding performance over time.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.5,3,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to sustain a zero central line-associated bloodstream infection rate? Effective high-quality training, strict compliance with evidence-based standards, and detailed documentation contribute to significant CLABSI reductions. Mindful structuring can foster better comprehension of how a unit copes with peak demands and maintains exceptional long-term outcomes.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.5,4,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.",Is a zero central line-associated bloodstream infection rate maintainable? High-quality training paired with strict observance of evidence-based guidelines and thorough documentation is associated with significant CLABSI decreases. Careful organization might lead to improved understanding of a unit's ability to handle peak demands and sustain exceptional long-term performance.,1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.5,5,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero central line-associated bloodstream infections be consistently maintained? Strong training programs, adherence to evidence-based protocols, and comprehensive documentation are linked to significant CLABSI reductions. Mindful organization may help better grasp what supports a unitâ€™s capacity to manage peak demands and sustain extraordinary performance long-term.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.5,6,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining a zero central line-associated bloodstream infection rate feasible? High-quality training, strict compliance with evidence-based guidelines, and thorough documentation are tied to significant CLABSI reduction. Thoughtful organization may provide a clearer understanding of how a unit handles peak demands and sustains exceptional performance over time.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.5,7,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it feasible to maintain a zero central line-associated bloodstream infection rate? Consistent, high-quality training, strict adherence to evidence-based guidelines, and detailed documentation are associated with notable declines in CLABSIs. Mindful organization can enhance understanding of how a unit manages peak demands and sustains extraordinary long-term performance.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.5,8,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is zero central line-associated bloodstream infection rate sustainability possible? High-quality training, rigorous compliance with evidence-based protocols, and meticulous documentation correlate with significant CLABSI reductions. Careful organization may improve insights into a unitâ€™s ability to manage peak demands and maintain exceptional performance over the long term.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.5,9,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be sustained over time? Effective high-quality training, strict adherence to evidence-based guidelines, and comprehensive documentation are linked to marked reductions in CLABSIs. Mindful organization might enhance understanding of how a unit handles peak demands and sustains outstanding long-term performance.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
174,0.5,10,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining zero central line-associated bloodstream infection rates achievable? Robust training, strict compliance with evidence-based protocols, and thorough documentation have been associated with significant decreases in CLABSIs. Thoughtful organization may lead to better insight into a unitâ€™s ability to manage peak demands and sustain exceptional performance long-term.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
175,0.5,1,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Does pretreating with estradiol and antagonists before microdose leuprolide enhance IVF success in women with PCOS?,8.290090457489869e-07,0.9821657065467528,0.15419501133786845,0.06346992626736567,1.1113043602178285,0.10072314049586774,0.06337805393335048,1.219608255876361,0.06222222222222221,8.290090457489888e-07,1.3357453272173787,0.021266540642722105
175,0.5,2,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Can estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF results in women suffering from PCOS?,8.053230730133015e-07,0.9176271854091822,0.15419501133786845,0.061656499802583795,1.0423114887308764,0.10072314049586774,0.0615672523923976,1.1455002837226398,0.06222222222222221,8.053230730133034e-07,1.2557026195438423,0.021266540642722105
175,0.5,3,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",This study investigates whether estradiol and antagonist pretreatment combined with microdose leuprolide improves IVF outcomes in PCOS patients.,7.816371002776162e-07,0.8570025635927472,0.15419501133786845,0.05984307333780192,0.9777729675933058,0.10072314049586774,0.05975645085144474,1.0765074122356877,0.06222222222222221,7.81637100277618e-07,1.181594647390121,0.021266540642722105
175,0.5,4,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Is there an improvement in IVF outcomes for PCOS women when estradiol and antagonist pretreatment is given before microdose leuprolide?,7.342651548062455e-07,0.7457769284825231,0.15419501133786845,0.05621622040823817,0.859989931936922,0.10072314049586774,0.05613484776953899,0.951344269281682,0.06222222222222221,7.342651548062474e-07,1.0480632547655984,0.021266540642722105
175,0.5,5,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",The article examines the effectiveness of estradiol and antagonist pretreatment before microdose leuprolide in enhancing IVF success in women with PCOS.,7.105791820705601e-07,0.6944836340949729,0.15419501133786845,0.05440279394345629,0.8059227106666467,0.10072314049586774,0.054324046228586116,0.8941858554417332,0.06222222222222221,7.10579182070562e-07,0.9874386329491633,0.021266540642722105
175,0.5,6,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Does pretreatment with estradiol and antagonists before administering microdose leuprolide lead to better IVF outcomes in women diagnosed with PCOS?,7.342651548062455e-07,0.7457769284825231,0.15419501133786845,0.05621622040823817,0.859989931936922,0.10072314049586774,0.05613484776953899,0.951344269281682,0.06222222222222221,7.342651548062474e-07,1.0480632547655984,0.021266540642722105
175,0.5,7,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Exploring whether estradiol and antagonist pretreatment plus microdose leuprolide improves IVF success rates in women with PCOS.,8.053230730133015e-07,0.9176271854091822,0.15419501133786845,0.061656499802583795,1.0423114887308764,0.10072314049586774,0.0615672523923976,1.1455002837226398,0.06222222222222221,8.053230730133034e-07,1.2557026195438423,0.021266540642722105
175,0.5,8,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Can the combination of estradiol and antagonist pretreatment before microdose leuprolide boost IVF outcomes in women who have PCOS?,7.579511275419309e-07,0.7998441497527984,0.15419501133786845,0.05802964687302005,0.9171483457768708,0.10072314049586774,0.057945649310491856,1.011968891098117,0.06222222222222221,7.579511275419327e-07,1.112601775903169,0.021266540642722105
175,0.5,9,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",This article evaluates if pretreatment with estradiol and antagonists prior to microdose leuprolide enhances IVF outcomes in PCOS patients.,7.579511275419309e-07,0.7998441497527984,0.15419501133786845,0.05802964687302005,0.9171483457768708,0.10072314049586774,0.057945649310491856,1.011968891098117,0.06222222222222221,7.579511275419327e-07,1.112601775903169,0.021266540642722105
175,0.5,10,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Investigating the potential benefits of estradiol and antagonist pretreatment before microdose leuprolide for improving IVF success in women with PCOS.,7.342651548062455e-07,0.7457769284825231,0.15419501133786845,0.05621622040823817,0.859989931936922,0.10072314049586774,0.05613484776953899,0.951344269281682,0.06222222222222221,7.342651548062474e-07,1.0480632547655984,0.021266540642722105
176,0.5,1,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (Ã—10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival in ESCC, particularly in patients with positive lymph nodes. A cutoff of 205 (Ã—10(9)/L) is suggested for survival prediction in ESCC patients.",2.6054570009253936e-07,0.1704589788301898,0.09207766324883446,0.0199476911126006,0.23413212562901098,0.014445850546324062,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
176,0.5,2,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (Ã—10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count serve as a prognostic indicator in esophageal squamous cell carcinoma? It is a predictive factor for long-term survival in ESCC, especially among nodal-positive cases, with 205 (Ã—10(9)/L) as the optimal cutoff for survival prediction.",3.0791764556390996e-07,0.15201069379664034,0.1432098765432099,0.023574544042164344,0.2517179163435008,0.040742417383431435,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
176,0.5,3,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (Ã—10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","In esophageal squamous cell carcinoma, is the preoperative platelet count a prognostic marker? Yes, it predicts long-term survival in ESCC, notably in patients with lymph node involvement, with 205 (Ã—10(9)/L) identified as the best cutoff point.",3.5528959103528056e-07,0.2075805449514525,0.1432098765432099,0.027201396971728097,0.3088763301834492,0.040742417383431435,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
176,0.5,4,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (Ã—10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count a predictor of prognosis in esophageal squamous cell carcinoma? It is linked to long-term survival outcomes in ESCC patients, particularly those with positive nodes, with an optimal cutoff value of 205 (Ã—10(9)/L).",3.3160361829959526e-07,0.17940966798475566,0.1432098765432099,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
176,0.5,5,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (Ã—10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? It is a significant prognostic factor for long-term survival in ESCC, especially in nodal-positive patients, with 205 (Ã—10(9)/L) as the ideal cutoff.",4.2634750924233646e-07,0.2971927036411395,0.1432098765432099,0.032641676366073735,0.40124965031446447,0.040742417383431435,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
176,0.5,6,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (Ã—10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the platelet count before surgery predict survival in esophageal squamous cell carcinoma? Preoperative platelet count is a prognostic factor for long-term survival in ESCC, notably in patients with positive lymph nodes, with 205 (Ã—10(9)/L) as the optimal threshold.",2.8423167282822466e-07,0.1983053078260526,0.09074074074074076,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
176,0.5,7,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (Ã—10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a useful prognostic factor in esophageal squamous cell carcinoma? It predicts long-term survival in ESCC, especially in those with lymph node metastasis, with an optimal cutoff of 205 (Ã—10(9)/L).",4.2634750924233646e-07,0.2971927036411395,0.1432098765432099,0.032641676366073735,0.40124965031446447,0.040742417383431435,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
176,0.5,8,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (Ã—10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the platelet count before surgery a prognostic factor in esophageal squamous cell carcinoma? It serves as a predictive marker for long-term survival in ESCC, particularly in nodal-positive patients, with 205 (Ã—10(9)/L) as the best cutoff.",3.5528959103528056e-07,0.2075805449514525,0.1432098765432099,0.027201396971728097,0.3088763301834492,0.040742417383431435,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
176,0.5,9,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (Ã—10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? It is a predictor of long-term survival in ESCC, especially in patients with positive lymph nodes, with 205 (Ã—10(9)/L) as the optimal cutoff point.",3.5528959103528056e-07,0.2075805449514525,0.1432098765432099,0.027201396971728097,0.3088763301834492,0.040742417383431435,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
176,0.5,10,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (Ã—10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count associated with prognosis in esophageal squamous cell carcinoma? It acts as a predictive factor for long-term survival in ESCC, mainly in nodal-positive patients, with 205 (Ã—10(9)/L) being the ideal cutoff for predicting survival.",3.0791764556390996e-07,0.15201069379664034,0.1432098765432099,0.023574544042164344,0.2517179163435008,0.040742417383431435,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
177,0.5,1,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is cholecystectomy truly a reason to perform a simultaneous splenectomy in mild hereditary spherocytosis? The recommendation to carry out a concurrent splenectomy in children with mild HS having cholecystectomy for symptomatic gallstones requires reevaluation. With the advent of minimally invasive surgery, the necessity of splenectomy in these children should be assessed independently.",4.737194547137081e-08,0.014748434477405592,0.01643331945022905,0.0036268529295637453,0.012561206208669073,0.01922337562475971,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
177,0.5,2,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should cholecystectomy be considered an indication for a concurrent splenectomy in mild hereditary spherocytosis? The suggestion to do a simultaneous splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs to be reconsidered. In the context of minimally invasive surgery, the decision for splenectomy should be made on its own basis.",2.3685972735685406e-08,0.0426343967096785,0.07717662437524028,0.0018134264647818726,0.007241421087510691,0.01922337562475971,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
177,0.5,3,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is performing a splenectomy alongside cholecystectomy justified in mild hereditary spherocytosis? The practice of recommending concomitant splenectomy in children with mild HS during cholecystectomy for symptomatic gallstones warrants reevaluation. Given the rise of minimal access surgery, the indication for splenectomy should be evaluated independently.",2.3685972735685406e-07,0.1207496992335737,0.09639999999999999,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
177,0.5,4,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy warrant a simultaneous splenectomy in cases of mild hereditary spherocytosis? The advice to perform concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones should be revisited. With minimal access surgery becoming standard, the decision for splenectomy must be considered on its own merits.",1.4211583641411244e-07,0.06129783792175658,0.07513345935727789,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
177,0.5,5,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is a concurrent splenectomy necessary when performing cholecystectomy in mild hereditary spherocytosis? The recommendation to carry out splenectomy alongside cholecystectomy in children with mild HS for symptomatic gallstones needs to be reviewed. In the era of minimally invasive surgery, splenectomy should be judged independently.",2.3685972735685406e-07,0.1529891029805479,0.07315736961451247,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
177,0.5,6,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should splenectomy be done simultaneously with cholecystectomy in mild hereditary spherocytosis cases? The guidance to perform concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones requires reassessment. With minimal access surgery available, the need for splenectomy should be evaluated on its own.",2.1317375462116866e-07,0.09776018100887418,0.09639999999999999,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
177,0.5,7,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is concomitant splenectomy indicated during cholecystectomy for mild hereditary spherocytosis? The advice to perform simultaneous splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs reconsideration. In the era of minimal access surgery, the necessity of splenectomy should be independently judged.",2.6054570009253947e-07,0.1772872052418597,0.07260464009518143,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
177,0.5,8,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does mild hereditary spherocytosis justify splenectomy during cholecystectomy? The recommendation to perform concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones should be revisited. Given the advances in minimal access surgery, splenectomy indications should be evaluated separately.",3.316036182995956e-07,0.2539341780569755,0.07077673130193904,0.025387970506946217,0.28699805191042804,0.01922337562475971,0.025351221573340132,0.3209077200800996,0.0,3.316036182995957e-07,0.32850406697203516,0.0
177,0.5,9,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is it appropriate to perform splenectomy along with cholecystectomy in mild hereditary spherocytosis? The suggestion to do a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs to be reconsidered. With the development of minimally invasive surgery, the decision for splenectomy should be made independently.",1.1842986367842703e-07,0.01074880401924494,0.09639999999999999,0.009067132323909363,0.0744366099267566,0.01922337562475971,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
177,0.5,10,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should children with mild hereditary spherocytosis undergoing cholecystectomy for symptomatic gallstones also have a splenectomy? The advice to perform concomitant splenectomy in such cases requires reevaluation. In the era of minimal access surgery, the necessity of splenectomy should be assessed on its own merits.",2.3685972735685406e-07,0.1207496992335737,0.09639999999999999,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
178,0.5,1,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
","Is measuring visceral adipose tissue area at a single level an accurate representation of visceral adipose tissue volume? VAT area measured at one level offers convenience but serves as an imprecise estimate of total VAT volume. Since VAT volume can differ greatly at various abdominal levels, relying on a single measurement may not capture the full extent of visceral fat.",7.105791820705622e-08,0.021373591957100757,0.07999999999999989,0.005440279394345618,0.01657206772740505,0.0480147737765466,0.0054324046228586,0.005083482350220159,0.033293697978596916,7.105791820705622e-08,0.0286892385753168,0.01694411414982164
178,0.5,2,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
","Can a single-level measurement of visceral adipose tissue area reliably indicate the overall visceral adipose tissue volume? Measuring VAT area at just one level is convenient but does not precisely represent VAT volume, as the amount of visceral fat can vary substantially across abdominal regions, making single-level assessments potentially inaccurate.",3.079176455639103e-07,0.1552326604235068,0.08647393335312215,0.023574544042164344,0.17764943751859352,0.04442694419608301,0.023540420032387266,0.19798714847471244,0.033293697978596916,3.079176455639103e-07,0.22539953282137182,0.01694411414982164
178,0.5,3,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
","Does measuring visceral adipose tissue area at one level accurately represent the total visceral adipose tissue volume? While single-level VAT area measurement is easy to perform, it is an imprecise proxy because VAT volume varies widely at different abdominal levels, so a single measurement might not reflect total visceral fat accurately.",2.8423167282822487e-07,0.13333244980665748,0.08768247103322609,0.02176111757738247,0.15644073944803516,0.04485154085872574,0.0217296184914344,0.17693373927687928,0.033293697978596916,2.8423167282822487e-07,0.20389332760040846,0.01694411414982164
178,0.5,4,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
","Is the visceral adipose tissue area measured at a single abdominal level a good indicator of total visceral adipose tissue volume? Although convenient, single-level VAT area measurements are an imprecise approximation since visceral fat volume can change significantly across different parts of the abdomen, thus not fully representing total VAT.",3.079176455639103e-07,0.12694093876799872,0.10669559914549409,0.023574544042164344,0.17764943751859352,0.04442694419608301,0.023540420032387266,0.19798714847471244,0.033293697978596916,3.079176455639103e-07,0.22539953282137182,0.01694411414982164
178,0.5,5,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
","Can a single-level visceral adipose tissue area measurement serve as a reliable estimate of visceral adipose tissue volume? Single-level VAT area measurements are convenient but do not precisely reflect total VAT volume due to significant variation in visceral fat across abdominal levels, making single-point assessment less accurate.",3.789755637709665e-07,0.193810064953293,0.1040495867768594,0.029014823436509962,0.24411336749105406,0.0430401026126284,0.028972824655245866,0.2639451162665085,0.033293697978596916,3.789755637709665e-07,0.29284081361690406,0.01694411414982164
178,0.5,6,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
","Does a single-level measurement of visceral adipose tissue area accurately reflect visceral adipose tissue volume? Measuring VAT at one level is convenient but imprecise because visceral fat volume varies markedly at different abdominal levels, so one measurement may not capture the total VAT amount.",4.500334819780227e-07,0.26545648536799593,0.1010370647145293,0.03445510283085558,0.3153067062178776,0.041455486509462736,0.034405229278104466,0.3345626834804625,0.033293697978596916,4.500334819780227e-07,0.3651614751965302,0.01694411414982164
178,0.5,7,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
","Is measuring VAT area at a single level sufficient to represent the total visceral adipose tissue volume? While easy to perform, single-level VAT area measurement is an imprecise proxy since visceral fat volume can differ significantly throughout the abdomen, leading to potential inaccuracies in total VAT estimation.",3.789755637709665e-07,0.16367323101590392,0.1257096214671971,0.029014823436509962,0.21330682613283436,0.06525084641428129,0.028972824655245866,0.2639451162665085,0.033293697978596916,3.789755637709665e-07,0.29284081361690406,0.01694411414982164
178,0.5,8,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
","Can the area of visceral adipose tissue measured at one level accurately represent its total volume? Single-level VAT area measurement, though convenient, is an imprecise indicator of total VAT volume because visceral fat varies considerably across different abdominal levels, making a single measurement insufficient.",4.500334819780227e-07,0.20097767787404752,0.14743801652892552,0.03445510283085558,0.282299697619786,0.06525084641428129,0.034405229278104466,0.3345626834804625,0.033293697978596916,4.500334819780227e-07,0.3651614751965302,0.01694411414982164
178,0.5,9,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
","Is a single-level visceral adipose tissue area measurement an accurate proxy for visceral adipose tissue volume? Although measuring VAT area at one level is straightforward, it does not precisely represent total VAT volume due to significant variability in visceral fat distribution along the abdomen, limiting its accuracy.",3.789755637709665e-07,0.193810064953293,0.1040495867768594,0.029014823436509962,0.24411336749105406,0.0430401026126284,0.028972824655245866,0.2639451162665085,0.033293697978596916,3.789755637709665e-07,0.29284081361690406,0.01694411414982164
178,0.5,10,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
","Does measuring visceral adipose tissue area at a single level provide an accurate estimate of visceral adipose tissue volume? Single-level VAT area measurement is convenient but imprecise, as the volume of visceral fat can vary widely across abdominal levels, so it may not accurately reflect the total visceral fat amount.",3.079176455639103e-07,0.1835243820790149,0.06645036220793786,0.023574544042164344,0.17764943751859352,0.04442694419608301,0.023540420032387266,0.19798714847471244,0.033293697978596916,3.079176455639103e-07,0.22539953282137182,0.01694411414982164
179,0.5,1,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT creates a localized passage for chemotherapeutic drugs to enter brain tissue, which could be significant for brain tumor treatment.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
179,0.5,2,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy locally open the rodent blood-brain barrier for paclitaxel as a novel adjuvant glioma treatment? Answer: LITT facilitates a targeted entry of chemotherapy agents into brain tissue, potentially benefiting brain tumor therapies.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
179,0.5,3,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is locoregional opening of the rodent blood-brain barrier with Nd:YAG laser-induced thermo therapy a new approach for adjuvant glioma treatment using paclitaxel? Answer: LITT enables localized delivery of chemotherapeutic drugs into brain tissue, offering promise for brain tumor treatment.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
179,0.5,4,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the blood-brain barrier in rodents by Nd:YAG laser-induced thermo therapy for paclitaxel: a novel adjuvant glioma therapy concept? Answer: LITT induces a localized passage for chemotherapy agents to penetrate brain tissue, which may be valuable for treating brain tumors.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
179,0.5,5,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Question: Does Nd:YAG laser-induced thermo therapy allow locoregional opening of the rodent blood-brain barrier for paclitaxel as a new glioma adjuvant therapy? Answer: LITT promotes local entry of chemotherapeutic agents into brain tissue, potentially useful for brain tumor treatment.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
179,0.5,6,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy locally open the rodent blood-brain barrier to enhance paclitaxel delivery as an adjuvant glioma therapy? Answer: LITT induces localized passage of chemotherapy drugs into brain tissue, which might improve brain tumor treatments.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
179,0.5,7,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Question: Is the locoregional opening of the rodent blood-brain barrier by Nd:YAG laser-induced thermo therapy a novel strategy for adjuvant glioma therapy with paclitaxel? Answer: LITT enables targeted chemotherapeutic agent passage into brain tissue, offering potential for brain tumor therapy.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.5,8,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional blood-brain barrier opening in rodents using Nd:YAG laser-induced thermo therapy for paclitaxel: a new adjuvant glioma treatment concept? Answer: LITT facilitates a localized route for chemotherapy agents to enter brain tissue, potentially aiding brain tumor treatment.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
179,0.5,9,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Question: Does Nd:YAG laser-induced thermo therapy provide locoregional opening of the rodent blood-brain barrier for paclitaxel as a new glioma adjuvant therapy? Answer: LITT creates localized access for chemotherapeutic drugs into brain tissue, which may be beneficial for brain tumor therapy.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.5,10,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy induce locoregional opening of the rodent blood-brain barrier to deliver paclitaxel as an adjuvant glioma therapy? Answer: LITT allows localized penetration of chemotherapy agents into brain tissue, which could be important for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
180,0.5,1,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Does a geriatric oncology consultation alter the cancer treatment strategy for elderly patients? The consultation resulted in changes to the treatment plan in 32% of cases, including adjustments to dosage, timing, or therapy type, highlighting the need for personalized care in older adults.",1.4211583641411244e-07,0.04688799505453023,0.06222222222222222,0.010880558788691236,0.10707991030107156,0.0212665406427221,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
180,0.5,2,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Can a geriatric oncology consultation change the cancer treatment plan for elderly patients? In 32% of cases, the consultation led to modifications in dose, schedule, or therapy type, demonstrating a customized approach for older individuals.",3.3160361829959505e-07,0.2581970887217362,0.06222222222222222,0.02538797050694623,0.3241444155388993,0.0212665406427221,0.025351221573340153,0.3629054936893681,0.0,3.316036182995957e-07,0.3726752852851729,0.0
180,0.5,3,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Is the cancer treatment plan for elderly patients modified after a geriatric oncology consultation? The consultation caused a change in treatment plans in 32% of cases, involving alterations in dose, schedule, or therapy type to suit older adults.",2.6054570009253915e-07,0.17363970069367252,0.06222222222222222,0.0199476911126006,0.23713303854926915,0.0212665406427221,0.019918816950481533,0.2732933349996811,0.0,2.6054570009253947e-07,0.2803019651541576,0.0
180,0.5,4,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Does consulting geriatric oncology influence the cancer treatment plan for older patients? Treatment plans were adjusted in 32% of cases following consultation, with changes to dosage, timing, or therapy reflecting tailored care for the elderly.",3.3160361829959505e-07,0.2581970887217362,0.06222222222222222,0.02538797050694623,0.3241444155388993,0.0212665406427221,0.025351221573340153,0.3629054936893681,0.0,3.316036182995957e-07,0.3726752852851729,0.0
180,0.5,5,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Does a geriatric oncology consultation impact the cancer treatment plan for elderly patients? In 32% of instances, the consultation led to modifications in the treatment plan, including dose, schedule, or therapy type adjustments, emphasizing individualized care.",3.0791764556390975e-07,0.22920955184848468,0.06222222222222222,0.02357454404216435,0.2942914523892175,0.0212665406427221,0.02354042003238728,0.3321338350226144,0.0,3.079176455639103e-07,0.3409265869705931,0.0
180,0.5,6,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Can a geriatric oncology consultation modify cancer treatment plans for older patients? The consultation prompted changes in 32% of cases, such as dose, schedule, or therapy type alterations, underscoring the need for personalized treatment.",3.5528959103528035e-07,0.28805005187141797,0.06222222222222222,0.02720139697172811,0.35491607420565296,0.0212665406427221,0.027162023114293027,0.3946541920039479,0.0,3.552895910352811e-07,0.4054651081081646,0.0
180,0.5,7,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Does a geriatric oncology consultation result in changes to cancer treatment plans for elderly patients? Treatment plans were modified in 32% of cases post-consultation, involving adjustments in dose, schedule, or therapy type tailored to older adults.",3.0791764556390975e-07,0.2688179621661959,0.03367550941945406,0.02357454404216435,0.2942914523892175,0.0212665406427221,0.02354042003238728,0.3321338350226144,0.0,3.079176455639103e-07,0.3409265869705931,0.0
180,0.5,8,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Is the cancer treatment approach for elderly patients changed by a geriatric oncology consultation? The consultation led to treatment plan modifications in 32% of cases, including dose, schedule, or therapy type changes to accommodate older patients.",3.0791764556390975e-07,0.22920955184848468,0.06222222222222222,0.02357454404216435,0.2942914523892175,0.0212665406427221,0.02354042003238728,0.3321338350226144,0.0,3.079176455639103e-07,0.3409265869705931,0.0
180,0.5,9,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Does a geriatric oncology consultation affect the cancer treatment plan for elderly patients? In 32% of cases, the consultation resulted in changes to treatment plans, such as dose, schedule, or therapy type, reflecting a tailored approach for seniors.",2.6054570009253915e-07,0.17363970069367252,0.06222222222222222,0.0199476911126006,0.23713303854926915,0.0212665406427221,0.019918816950481533,0.2732933349996811,0.0,2.6054570009253947e-07,0.2803019651541576,0.0
180,0.5,10,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Does the cancer treatment plan for elderly patients get altered after a geriatric oncology consultation? The consultation modified treatment plans in 32% of cases, including changes to dose, schedule, or therapy type, highlighting the importance of personalized care for older adults.",1.8948778188548325e-07,0.09567815922396194,0.06222222222222222,0.014507411718254981,0.15709033087573498,0.0212665406427221,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
181,0.5,1,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is it practical to implement an advance care planning model in community palliative care? An advance care planning model is indeed practical for community palliative care services. Incorporating quality audit processes is vital to the model, with documentation of advance care planning discussions recognized as a key outcome measure.",2.3685972735685406e-08,0.0258187269351402,0.005231632956573501,0.0018134264647818726,0.024313062569826904,0.0029052904738603447,0.0018108015409528666,0.023318321560436672,0.0009598666243535586,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185
181,0.5,2,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Can an advance care planning model be effectively applied in community palliative care? Yes, an advance care planning model is effective for community palliative care services. Quality audit processes form a crucial part of the model, with the documentation of advance care planning discussions serving as an important outcome indicator.",4.737194547137081e-08,0.05100882911039717,0.010248015873015964,0.0036268529295637453,0.04805637672698815,0.005687674518843333,0.003621603081905733,0.046106945246820796,0.0018791605739505515,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
181,0.5,3,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is the use of an advance care planning model viable within community palliative care? The advance care planning model is viable for community palliative care services. Quality audit processes are a critical element of the model, and documenting advance care planning discussions is a significant outcome metric.",2.3685972735685406e-08,0.0036581232514074635,0.016875000000000084,0.0018134264647818726,0.005896028075075499,0.01984126984126984,0.0018108015409528666,0.007633536838929089,0.021633315305570573,2.3685972735685406e-08,0.008517171800753065,0.02271498107084911
181,0.5,4,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Does an advance care planning model work in community palliative care settings? An advance care planning model works well for community palliative care services. Quality audit processes are essential to the model, with documentation of advance care planning discussions being a key outcome measure.",9.474389094274162e-08,0.14246458756726765,0.04623724489795922,0.0072537058591274906,0.13654281493683085,0.03714083636863555,0.007243206163811466,0.09910145552615202,0.004303906121936658,9.474389094274162e-08,0.09846084880686945,0.002268582374252811
181,0.5,5,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is implementing an advance care planning model feasible in community palliative care? Implementing an advance care planning model is feasible for community palliative care services. Quality audit processes play a fundamental role in the model, with documentation of advance care planning discussions as a vital outcome measure.",2.3685972735685406e-08,0.056615544623371594,0.027093144044321227,0.0018134264647818726,0.055717054641363895,0.02558815192743763,0.0018108015409528666,0.0553798432119752,0.02346847935231325,2.3685972735685406e-08,0.055961635693195344,0.023685970743547096
181,0.5,6,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is an advance care planning model workable in community palliative care? An advance care planning model is workable for community palliative care services. Integral to the model are quality audit processes, with the documentation of advance care planning discussions considered an important outcome measure.",9.474389094274162e-08,0.11022518382029345,0.023371913580246817,0.0072537058591274906,0.10353580633873838,0.013027556359570563,0.007243206163811466,0.09910145552615202,0.004303906121936658,9.474389094274162e-08,0.09846084880686945,0.002268582374252811
181,0.5,7,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Can an advance care planning model be successfully used in community palliative care? Yes, it can be successfully used in community palliative care services. Quality audit processes are an essential feature of the model, with the documentation of advance care planning discussions as a key outcome measure.",2.3685972735685406e-08,0.0037287913918722104,0.09710346811308357,0.0018134264647818726,0.04408931811326289,0.02441184807256236,0.0018108015409528666,0.0553798432119752,0.02346847935231325,2.3685972735685406e-08,0.055961635693195344,0.023685970743547096
181,0.5,8,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is the advance care planning model suitable for community palliative care? The advance care planning model is suitable for community palliative care services. Quality audit processes are a necessary part of the model, and documenting advance care planning discussions is an important outcome metric.",9.474389094274162e-08,0.1747039913142423,0.0679087370242214,0.0072537058591274906,0.16954982353492332,0.06065759637188206,0.007243206163811466,0.13291351311444233,0.028366385064023544,9.474389094274162e-08,0.09846084880686945,0.002268582374252811
181,0.5,9,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is an advance care planning model applicable in community palliative care? An advance care planning model is applicable for community palliative care services. Quality audit processes are a crucial component of the model, with documentation of advance care planning discussions identified as a significant outcome measure.",4.737194547137081e-08,0.053651123112664845,0.011165166204986032,0.0036268529295637453,0.0504482305434073,0.0062131519274376545,0.003621603081905733,0.048328098854266255,0.0020526554379765236,4.737194547137081e-08,0.04802033420753293,0.0010803788339694455
181,0.5,10,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Is it feasible to adopt an advance care planning model in community palliative care? Adopting an advance care planning model is feasible for community palliative care services. Quality audit processes are essential within the model, with documentation of advance care planning discussions as a key outcome measure.",2.3685972735685406e-08,0.026478710685982954,0.005460634451018881,0.0018134264647818726,0.024910513283144198,0.003036471380144401,0.0018108015409528666,0.023873153186523055,0.0010031775464828113,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
182,0.5,1,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
","Does central venous pressure indicate fluid responsiveness? No evidence supports using central venous pressure to guide fluid therapy. Although CVP helps assess volume status, it doesn't reliably predict fluid responsiveness. Dynamic indices offer better insights into fluid needs.",4.974054274493932e-07,0.476656674401279,0.019438775510204086,0.038081955760419325,0.4737195523723572,0.010216836734693875,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
182,0.5,2,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
",Is central venous pressure a predictor of fluid responsiveness? Current data do not endorse using CVP for guiding fluid administration. CVP can evaluate volume status but is unreliable for predicting fluid responsiveness. Dynamic measures are more accurate for fluid assessment.,4.500334819780226e-07,0.34907811058505445,0.03443877551020409,0.03445510283085558,0.38114415440430616,0.017538265306122455,0.034405229278104466,0.41443377809092397,0.0,4.500334819780227e-07,0.4238142467763608,0.0
182,0.5,3,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
","Can central venous pressure predict fluid responsiveness? There is no data backing the common use of CVP to guide fluid management. While CVP assesses volume status, it fails as a reliable predictor of fluid responsiveness. Dynamic indices yield more precise fluid requirement information.",3.789755637709665e-07,0.274970138431331,0.03443877551020409,0.029014823436509962,0.30515824742638475,0.017538265306122455,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
182,0.5,4,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
",Does measuring central venous pressure help predict fluid responsiveness? Evidence does not support the routine use of CVP to direct fluid therapy. CVP can assess volume but is not a dependable predictor of fluid responsiveness. Other dynamic parameters provide clearer guidance on fluid needs.,3.552895910352811e-07,0.2514396410211366,0.03443877551020409,0.02720139697172809,0.28106069584732474,0.017538265306122455,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
182,0.5,5,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
","Is central venous pressure useful for predicting fluid responsiveness? No data validate using CVP to guide fluid administration. Although CVP assesses volume status, it is not a reliable fluid responsiveness predictor. Dynamic indices are more accurate indicators of fluid requirements.",4.500334819780226e-07,0.34907811058505445,0.03443877551020409,0.03445510283085558,0.38114415440430616,0.017538265306122455,0.034405229278104466,0.41443377809092397,0.0,4.500334819780227e-07,0.4238142467763608,0.0
182,0.5,6,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
",Can central venous pressure be used to forecast fluid responsiveness? There is no evidence supporting the widespread use of CVP for fluid management. CVP helps assess volume status but is not a reliable predictor of fluid responsiveness. More precise dynamic indices exist for this purpose.,3.316036182995957e-07,0.22845012279643706,0.03443877551020409,0.025387970506946217,0.2575301984371303,0.017538265306122455,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
182,0.5,7,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
",Does central venous pressure reliably predict fluid responsiveness? Data do not support using CVP to guide fluid therapy. CVP assesses volume status but is not a consistent predictor of fluid responsiveness. Dynamic indices provide more reliable fluid requirement information.,4.737194547137079e-07,0.3750535969883124,0.03443877551020409,0.03626852929563745,0.407812401486467,0.017538265306122455,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
182,0.5,8,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
","Is central venous pressure a dependable predictor of fluid responsiveness? There is no data justifying the common practice of using CVP to guide fluid administration. While CVP can assess volume, it does not reliably predict fluid responsiveness. Dynamic measures offer better fluid guidance.",3.789755637709665e-07,0.274970138431331,0.03443877551020409,0.029014823436509962,0.30515824742638475,0.017538265306122455,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
182,0.5,9,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
",Does central venous pressure effectively predict fluid responsiveness? No data back the common use of CVP for fluid guidance. CVP can evaluate volume status but is unreliable for predicting fluid responsiveness. Dynamic indices provide more accurate fluid requirement data.,4.737194547137079e-07,0.3750535969883124,0.03443877551020409,0.03626852929563745,0.407812401486467,0.017538265306122455,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
182,0.5,10,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
",Is central venous pressure a valid predictor of fluid responsiveness? Current evidence does not support using CVP to guide fluid therapy. CVP assesses volume status but is not reliable in predicting fluid responsiveness. Dynamic indices yield better insights into fluid needs.,4.263475092423373e-07,0.3237603026007627,0.03443877551020409,0.03264167636607371,0.3551686680010482,0.017538265306122455,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
183,0.5,1,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is it essential to routinely place a nasobiliary drainage tube after endoscopic clearance of the common bile duct in choledocholithiasis patients? Although nasobiliary drainage tubes provide a safe and effective method for managing post-ERCP complications, their routine use in all choledocholithiasis cases is debated. Research indicates that selective insertion based on patient-specific risk factors might be adequate.",9.474389094274162e-08,0.047538315898190575,0.015442458309175424,0.0072537058591274906,0.07020425867324764,0.0,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
183,0.5,2,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in patients with choledocholithiasis? Nasobiliary drainage tubes are a safe and effective option for handling post-ERCP complications, but routine placement in every choledocholithiasis patient is controversial. Evidence suggests selective application depending on individual risk factors is sufficient.",1.8948778188548325e-07,0.12355053854795583,0.014070322353837206,0.014507411718254981,0.14571181118139354,0.0,0.014486412327622933,0.14842000511827358,0.0,1.8948778188548325e-07,0.15123096972392336,0.0
183,0.5,3,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is routine nasobiliary drainage tube insertion necessary after endoscopic removal of common bile duct stones in choledocholithiasis patients? While nasobiliary drainage tubes safely manage post-ERCP complications, routine use for all choledocholithiasis patients is debated. Studies recommend selective use based on patient risk profiles.",4.263475092423373e-07,0.34347214049949404,0.00949833807377836,0.03264167636607371,0.36396537720141087,0.0,0.0325944277371516,0.37156355643248284,0.0,4.263475092423373e-07,0.37948962170490574,0.0
183,0.5,4,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Do patients with choledocholithiasis require routine nasobiliary drainage tube placement after endoscopic clearance of the common bile duct? Nasobiliary drainage tubes are effective and safe for post-ERCP complication management, yet their routine insertion in all cases is controversial. Research supports selective use according to individual patient risk.",3.316036182995957e-07,0.24963018763306444,0.011565302916868518,0.025387970506946217,0.2708749541353992,0.0,0.025351221573340132,0.2762533766281572,0.0,3.316036182995957e-07,0.2818511521409879,0.0
183,0.5,5,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is it standard practice to insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in choledocholithiasis patients? Although these tubes help manage post-ERCP complications safely and effectively, routine use in every patient remains debated. Studies advocate selective insertion guided by patient-specific risk factors.",3.316036182995957e-07,0.2194933536956758,0.033293697978596916,0.025387970506946217,0.2708749541353992,0.0,0.025351221573340132,0.2762533766281572,0.0,3.316036182995957e-07,0.2818511521409879,0.0
183,0.5,6,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is routine insertion of a nasobiliary drainage tube necessary after endoscopic clearance of the common bile duct in choledocholithiasis? Nasobiliary drainage tubes offer a safe and effective approach to post-ERCP complication management, but their routine use in all patients is controversial. Evidence favors selective use based on individual risk factors.",2.6054570009253947e-07,0.1846061737296516,0.01289439242304136,0.0199476911126006,0.20633643299782767,0.0,0.019918816950481533,0.2102954088363611,0.0,2.6054570009253947e-07,0.21440987134545564,0.0
183,0.5,7,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","After endoscopic clearance of the common bile duct in choledocholithiasis patients, is it necessary to routinely insert a nasobiliary drainage tube? While nasobiliary drainage tubes are a safe and effective means to manage post-ERCP complications, routine application in all cases is debated. Research suggests selective use tailored to patient risk is sufficient.",2.1317375462116866e-07,0.14349135983534467,0.01369369797859692,0.016320838183036854,0.1655144384775733,0.0,0.0162972138685758,0.1686227124357922,0.0,2.1317375462116866e-07,0.17185025692665912,0.0
183,0.5,8,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is it required to routinely place a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis? Nasobiliary drainage tubes provide safe and effective management of post-ERCP complications, yet routine insertion in all patients remains controversial. Studies recommend selective use based on individual risk factors.",2.6054570009253947e-07,0.1846061737296516,0.01289439242304136,0.0199476911126006,0.20633643299782767,0.0,0.019918816950481533,0.2102954088363611,0.0,2.6054570009253947e-07,0.21440987134545564,0.0
183,0.5,9,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is routine nasobiliary drainage tube placement necessary following endoscopic clearance of the common bile duct in choledocholithiasis patients? Although these tubes effectively manage post-ERCP complications, routine use in all patients is debated. Research supports selective insertion based on patient-specific risks.",4.974054274493934e-07,0.3845731040551259,0.033293697978596916,0.038081955760419325,0.43995128417933227,0.0,0.0380268323600102,0.4495250979021934,0.0,4.974054274493935e-07,0.4595323293784399,0.0
183,0.5,10,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Should nasobiliary drainage tubes be routinely inserted after endoscopic common bile duct clearance in choledocholithiasis patients? They offer a safe and effective way to manage post-ERCP complications, but routine placement in every patient is controversial. Studies suggest selective use depending on individual risk factors is adequate.",3.552895910352811e-07,0.2414722604144508,0.033293697978596916,0.02720139697172809,0.2933478099874569,0.0,0.027162023114293,0.2992428948528567,0.0,3.552895910352811e-07,0.3053816495511823,0.0
184,0.5,1,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the length of psychological treatment for depression influence the likelihood of returning for further treatment? Answer: Findings indicate that extended treatment duration might reduce the chance of returning to mental health services for certain groups. However, due to the study's design, no causal conclusions can be made. Additional research, ideally through a randomized controlled trial (RCT), is necessary to explore whether lower intensity treatments are linked to this trend.",1.1842986367842703e-07,0.11828658366193778,0.03176307192435243,0.009067132323909377,0.07522342123759085,0.0,0.009054007704764333,0.0763729787845735,0.0,1.1842986367842703e-07,0.07755823434587317,0.0
184,0.5,2,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is there a relationship between the duration of psychological treatment for depression and the probability of re-entering treatment? Answer: The results imply that longer treatment durations could help prevent some patients from returning to mental health care. Nevertheless, the study's design does not allow for causal claims. Further studies, preferably randomized controlled trials, are required to confirm if lower intensity treatments are connected to this pattern.",2.3685972735685406e-08,0.07925028879785856,0.046045785639958384,0.0018134264647818726,0.015504186535965303,0.0,0.0018108015409528666,0.015748356968136257,0.0,2.3685972735685406e-08,0.01600034134644357,0.0
184,0.5,3,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of depression treatment affect the chance of patients returning for further mental health care? Answer: The data suggest that longer treatment periods may reduce the likelihood of return in some groups. However, the study's methodology prevents causal inference. More research, ideally via RCTs, is needed to verify whether trends toward less intensive treatments are related.",1.6580180914979784e-07,0.04996144268214664,0.046045785639958384,0.012693985253473108,0.11583181552512123,0.0,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
184,0.5,4,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the length of psychological treatment for depression linked to patients returning for additional care? Answer: Results suggest that longer treatment duration might decrease the risk of returning to mental health services in certain populations. However, due to the study design, no causal relationship can be established. Further investigation, preferably through randomized controlled trials, is needed to assess if lower intensity treatments are associated.",2.3685972735685406e-08,0.04847863013110576,0.046045785639958384,0.0018134264647818726,0.015748356968136257,0.0,0.0018108015409528666,0.01600034134644357,0.0,2.3685972735685406e-08,0.016260520871781203,0.0
184,0.5,5,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the treatment duration for depression influence the chance of returning to mental health care? Answer: Findings indicate that extended treatment may help prevent some groups from needing further treatment. However, no causal conclusions can be drawn because of the study design. Additional research, ideally randomized controlled trials, is necessary to explore the association with lower intensity treatments.",1.6580180914979784e-07,0.04996144268214664,0.046045785639958384,0.012693985253473108,0.11583181552512123,0.0,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
184,0.5,6,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is there an association between how long psychological treatment for depression lasts and the likelihood of returning to treatment? Answer: The findings suggest longer treatments might reduce return rates in some groups, but the study's design limits causal conclusions. Further research, preferably RCTs, is needed to determine if lower intensity treatments contribute to this trend.",2.3685972735685406e-07,0.10307126799609456,0.046045785639958384,0.018134264647818726,0.16989903679539609,0.0,0.018108015409528666,0.17284281283941416,0.0,2.3685972735685406e-07,0.1758906664636637,0.0
184,0.5,7,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of psychological treatment for depression correlate with the chance of re-entering treatment? Answer: Results indicate that longer treatment duration may prevent some patients from returning to mental health care, but causal inferences cannot be made due to the study design. More research, especially randomized controlled trials, is needed to understand if lower intensity treatments are related.",1.4211583641411244e-07,0.03286700932284692,0.046045785639958384,0.010880558788691236,0.0984400728132524,0.0,0.0108648092457172,0.10008345855698497,0.0,1.4211583641411244e-07,0.10178269430994202,0.0
184,0.5,8,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the length of treatment for depression related to patients returning for further mental health care? Answer: The study suggests that longer treatment durations might reduce the likelihood of return in some groups, though causal relationships cannot be established due to the study's design. Further research, preferably RCTs, is required to explore the link with lower intensity treatments.",1.6580180914979784e-07,0.04996144268214664,0.046045785639958384,0.012693985253473108,0.11583181552512123,0.0,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
184,0.5,9,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of psychological treatment for depression impact the likelihood of patients returning to treatment? Answer: The results imply that longer treatment may prevent return to mental health care in certain groups, but no causal inference is possible given the study design. Additional research, ideally in randomized controlled trials, is necessary to examine the association with lower intensity treatments.",1.1842986367842703e-07,0.01605989100646621,0.046045785639958384,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
184,0.5,10,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the length of psychological treatment for depression associated with the risk of returning to treatment? Answer: Findings suggest that longer treatment duration could lower return rates in some groups; however, due to the study design, causal conclusions cannot be drawn. Further studies, preferably randomized controlled trials, are needed to investigate if lower intensity treatments are linked to this trend.",1.1842986367842703e-07,0.01605989100646621,0.046045785639958384,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
185,0.5,1,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Is it possible to predict discordance between TEOAE and AABR results in newborns? Given current screening methods, predicting discordant TEOAE and AABR outcomes in newborns is unreliable. Although some research hints at possible links, no definitive pattern exists to forecast such discordance. More studies are required to better understand these complex interactions.",7.105791820705622e-08,0.0929035346366276,0.023071868203063527,0.005440279394345618,0.0931407659050465,0.022477465665026397,0.0054324046228586,0.09331573555892092,0.021728395061728398,7.105791820705622e-08,0.06453852113757153,0.0
185,0.5,2,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Can discordance in TEOAE and AABR test results be predicted in newborn infants? With the screening technologies presently available, it is not dependable to predict discordance between TEOAE and AABR outcomes. Some studies indicate potential associations, but no consistent pattern has been established. Additional research is necessary to elucidate these relationships.",4.737194547137081e-08,0.07201361764545178,0.022291666666666654,0.0036268529295637453,0.0723722241544178,0.022069830246913575,0.003621603081905733,0.07269644835618516,0.021728395061728398,4.737194547137081e-08,0.04348511193973836,0.0
185,0.5,3,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Is the discordance between TEOAE and AABR outcomes in newborns predictable? Based on current screening technology, discordant results between TEOAE and AABR in newborns cannot be reliably anticipated. While certain studies suggest possible correlations, no clear pattern has been identified. Further investigation is needed to clarify these complex dynamics.",0.0,0.028881132523331132,0.02042240587695135,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
185,0.5,4,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Are discordant TEOAE and AABR results in newborns predictable? Using existing screening tools, predicting discordance between TEOAE and AABR outcomes in newborns is not reliable. Some research points to potential correlations, but no established pattern allows for prediction. More research is required to understand these complex relationships.",4.737194547137081e-08,0.04632671866097038,0.0026777236944895283,0.0036268529295637453,0.0153004038886011,0.02025839200081624,0.003621603081905733,0.01431492863344408,0.021728395061728398,4.737194547137081e-08,0.04546237407675724,0.0
185,0.5,5,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Can we reliably predict discordance in TEOAE and AABR outcomes in newborns? With the current screening technologies, it is not possible to reliably predict discordant TEOAE and AABR results in newborns. Although some studies suggest possible links, no definitive pattern has been established. Further study is needed to clarify these complex relationships.",7.105791820705622e-08,0.06572129226172807,0.0036284722222222204,0.005440279394345618,0.0931407659050465,0.022477465665026397,0.0054324046228586,0.09331573555892092,0.021728395061728398,7.105791820705622e-08,0.06453852113757153,0.0
185,0.5,6,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Is it feasible to predict discordant outcomes between TEOAE and AABR in newborns? Given the screening technologies available today, such discordance cannot be reliably predicted. While some evidence suggests potential correlations, no consistent pattern has been demonstrated. Additional research is necessary to better understand these complexities.",7.105791820705622e-08,0.022104876432421428,0.06222222222222222,0.005440279394345618,0.006966718382439119,0.04246913580246913,0.0054324046228586,0.0373044468581436,0.021728395061728398,7.105791820705622e-08,0.06899287148695166,0.0
185,0.5,7,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Are discordant TEOAE and AABR screening results in newborns foreseeable? According to current screening technology, predicting discordance between TEOAE and AABR is not dependable. Some studies show possible associations, but no clear pattern exists to anticipate discordance. Further research is needed to clarify these complex interactions.",7.105791820705622e-08,0.039508206284017966,0.017873925845802538,0.005440279394345618,0.03847340840789171,0.01975415473162002,0.0054324046228586,0.0373044468581436,0.021728395061728398,7.105791820705622e-08,0.06899287148695166,0.0
185,0.5,8,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Is predicting discordance between TEOAE and AABR outcomes in newborns possible? With present screening technologies, discordant results between TEOAE and AABR cannot be reliably forecasted. Although some studies indicate potential correlations, no established pattern exists. More research is essential to understand these complexities.",1.4211583641411244e-07,0.14590902084880897,0.008783694937541081,0.010880558788691236,0.1452084007729728,0.00618306669588721,0.0108648092457172,0.14428246746576612,0.003255168383373523,1.4211583641411244e-07,0.1431008436406751,0.0
185,0.5,9,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Can discordance in TEOAE and AABR results be anticipated in newborns? Given current screening tools, it is unreliable to predict discordant TEOAE and AABR outcomes. While some research points to possible links, no definitive pattern has been found. Further investigation is necessary to clarify these complex relationships.",4.737194547137081e-08,0.016189884723581294,0.018833792470156097,0.0036268529295637453,0.0153004038886011,0.02025839200081624,0.003621603081905733,0.01431492863344408,0.021728395061728398,4.737194547137081e-08,0.04546237407675724,0.0
185,0.5,10,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Is it possible to foresee discordance in TEOAE and AABR outcomes in newborns? Based on available screening technologies, discordant TEOAE and AABR results cannot be reliably predicted. Some studies suggest potential correlations, but no established pattern exists. Additional research is required to better understand these complex relationships.",4.737194547137081e-08,0.016189884723581294,0.018833792470156097,0.0036268529295637453,0.0153004038886011,0.02025839200081624,0.003621603081905733,0.01431492863344408,0.021728395061728398,4.737194547137081e-08,0.04546237407675724,0.0
186,0.5,1,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic surgery resulted in observable damage to Kupffer cells, indicating a possible effect on liver function. Additional studies are necessary to explore the long-term consequences of this observation.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
186,0.5,2,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? The laparoscopic approach caused noticeable injury to Kupffer cells, implying a potential impact on liver function. More research is required to determine the long-term effects.",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
186,0.5,3,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Does laparoscopic cholecystectomy impact the activity of peri-sinusoidal cells? Damage to Kupffer cells was detected following laparoscopic procedures, suggesting an influence on liver function. Further investigation is needed to understand the lasting implications.",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
186,0.5,4,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Can laparoscopic cholecystectomy alter peri-sinusoidal cell activity? The procedure led to measurable harm to Kupffer cells, pointing to a possible effect on liver function. Additional research is needed to clarify the long-term outcomes.",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
186,0.5,5,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Does the laparoscopic removal of the gallbladder affect peri-sinusoidal cell function? Evidence shows laparoscopic surgery caused damage to Kupffer cells, hinting at a potential impact on liver function. Further studies are necessary to assess long-term effects.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
186,0.5,6,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Is there an effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Laparoscopic methods resulted in detectable Kupffer cell damage, which may influence liver function. More research is needed to evaluate long-term implications.",9.47438909427412e-08,0.1213608570042668,0.0,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
186,0.5,7,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Does undergoing laparoscopic cholecystectomy influence peri-sinusoidal cell behavior? The procedure caused observable damage to Kupffer cells, suggesting possible liver function impact. Further investigation is required to understand long-term consequences.",1.658018091497971e-07,0.22314355131420927,0.0,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
186,0.5,8,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cells? The surgery caused damage to Kupffer cells, indicating a potential impact on liver function. Additional research is necessary to explore long-term effects.",1.184298636784265e-07,0.1541506798272585,0.0,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
186,0.5,9,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? Detectable Kupffer cell injury occurred after laparoscopic procedures, suggesting an influence on liver function. Further studies are needed to determine long-term outcomes.",1.421158364141118e-07,0.18805223150294026,0.0,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
186,0.5,10,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Does laparoscopic cholecystectomy impact Kupffer cells and peri-sinusoidal activity? The procedure caused damage to Kupffer cells, implying a potential effect on liver function. More research is required to understand the long-term implications.",9.47438909427412e-08,0.1213608570042668,0.0,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
187,0.5,1,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Does reimbursement based on case-mix encourage the advancement of process-focused care delivery? This research shows that hospitals can promote process-oriented care by adopting case-mix based reimbursement, which drives efficiency, standardizes procedures, and enhances patient outcomes.",3.5528959103528046e-07,0.19570944356141684,0.1200648999459167,0.027201396971728103,0.25916891934808683,0.08264462809917356,0.02716202311429302,0.295924824796296,0.06353305785123965,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
187,0.5,2,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Can case-mix based reimbursement foster the growth of process-oriented care delivery? The study indicates that implementing case-mix reimbursement motivates hospital management to develop process-driven care, improving efficiency and patient results through standardized workflows.",4.0266153650665106e-07,0.2563340653778523,0.1200648999459167,0.030828249901291863,0.32168927632942035,0.08264462809917356,0.030783626196198767,0.36046334593386753,0.06353305785123965,4.026615365066519e-07,0.40107189862784365,0.043388429752066124
187,0.5,3,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Is process-oriented care delivery stimulated by case-mix based reimbursement? Findings reveal that hospitals adopting case-mix reimbursement can encourage process-oriented care, focusing on efficiency, standardization, and better patient outcomes.",5.210914001850776e-07,0.4262331021732493,0.1200648999459167,0.03989538222520126,0.4975799427930845,0.08264462809917356,0.039837633900963135,0.5427849027278224,0.06353305785123965,5.210914001850789e-07,0.5903138982663716,0.043388429752066124
187,0.5,4,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Does the use of case-mix based reimbursement promote process-oriented care delivery? The research demonstrates that hospital management can enhance process-driven care by applying case-mix reimbursement, which boosts efficiency and patient care quality.",4.2634750924233636e-07,0.28808276369243213,0.1200648999459167,0.03264167636607374,0.35447909915241205,0.08264462809917356,0.03259442773715164,0.3943648976095493,0.06353305785123965,4.263475092423373e-07,0.43616321843911265,0.043388429752066124
187,0.5,5,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Can the development of process-oriented care be driven by case-mix based reimbursement? This study confirms that hospitals using case-mix reimbursement can stimulate process improvements, leading to standardized care and improved patient outcomes.",4.2634750924233636e-07,0.28808276369243213,0.1200648999459167,0.03264167636607374,0.35447909915241205,0.08264462809917356,0.03259442773715164,0.3943648976095493,0.06353305785123965,4.263475092423373e-07,0.43616321843911265,0.043388429752066124
187,0.5,6,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Does implementing case-mix based reimbursement encourage the evolution of process-oriented care delivery? The study finds that hospital management can foster process-focused care through case-mix reimbursement, enhancing efficiency and patient results.",4.7371945471370696e-07,0.3547741381911056,0.1200648999459167,0.0362685292956375,0.4234719706393628,0.08264462809917356,0.03621603081905739,0.465823861591693,0.06353305785123965,4.737194547137081e-07,0.5102711905928343,0.043388429752066124
187,0.5,7,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Is the advancement of process-oriented care delivery influenced by case-mix based reimbursement? Research shows that hospitals can promote process-oriented care by applying case-mix reimbursement, resulting in standardized processes and better outcomes.",4.5003348197802166e-07,0.3670823985527534,0.08677120196731977,0.03445510283085562,0.3883806508280938,0.08264462809917356,0.034405229278104514,0.4294562174208183,0.06353305785123965,4.500334819780227e-07,0.47253086260998733,0.043388429752066124
187,0.5,8,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Does case-mix based reimbursement act as a catalyst for process-oriented care delivery development? This study illustrates that hospital management can drive process improvements by adopting case-mix reimbursement, improving efficiency and patient outcomes.",4.2634750924233636e-07,0.28808276369243213,0.1200648999459167,0.03264167636607374,0.35447909915241205,0.08264462809917356,0.03259442773715164,0.3943648976095493,0.06353305785123965,4.263475092423373e-07,0.43616321843911265,0.043388429752066124
187,0.5,9,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
",Can case-mix based reimbursement lead to the enhancement of process-oriented care delivery? The findings suggest that hospitals implementing case-mix reimbursement encourage process standardization and improved patient care.,5.447773729207629e-07,0.46397343015609627,0.1200648999459167,0.04170880868998314,0.536800655946367,0.08264462809917356,0.04164843544191601,0.5836068972480772,0.06353305785123965,5.447773729207643e-07,0.6328735126851672,0.043388429752066124
187,0.5,10,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Is process-oriented care delivery development stimulated by case-mix based reimbursement? The study demonstrates that hospitals can use case-mix reimbursement to promote efficient, standardized care and better patient outcomes.",5.210914001850776e-07,0.4262331021732493,0.1200648999459167,0.03989538222520126,0.4975799427930845,0.08264462809917356,0.039837633900963135,0.5427849027278224,0.06353305785123965,5.210914001850789e-07,0.5903138982663716,0.043388429752066124
188,0.5,1,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Can bedside evaluation effectively rule out aspiration after an acute stroke? Bedside swallowing assessments do not have sufficient sensitivity to serve as a screening tool in acute stroke cases, and there are doubts regarding the reliance on videofluoroscopy as the definitive standard.",2.3685972735685406e-08,0.0940073306463658,0.049861495844875335,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
188,0.5,2,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Is bedside assessment a reliable method to exclude aspiration post-acute stroke? The sensitivity of bedside swallowing assessments is inadequate for screening in acute stroke, and the use of videofluoroscopy as a gold standard is questioned.",1.421158364141118e-07,0.09320421144178015,0.049861495844875335,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
188,0.5,3,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Does bedside assessment reliably exclude aspiration following an acute stroke? Bedside swallowing tests lack the sensitivity needed for screening in acute stroke, and concerns exist about using videofluoroscopy as the gold standard.",2.131737546211677e-07,0.18557753157279544,0.049861495844875335,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
188,0.5,4,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Can aspiration be confidently ruled out through bedside assessment after an acute stroke? Bedside swallowing assessments are not sensitive enough to be used for screening in acute stroke, and there are issues with considering videofluoroscopy as the gold standard.",4.73719454713706e-08,0.018021423668444392,0.049861495844875335,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
188,0.5,5,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Is bedside swallowing assessment sufficient to exclude aspiration after an acute stroke? The sensitivity of bedside assessments is insufficient for screening purposes in acute stroke, and the validity of videofluoroscopy as a gold standard is debated.",1.184298636784265e-07,0.06421667456852864,0.049861495844875335,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
188,0.5,6,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Can bedside assessment reliably detect the absence of aspiration following acute stroke? Bedside swallowing assessments lack the required sensitivity for screening in acute stroke, and there are concerns about videofluoroscopy's role as the gold standard.",1.421158364141118e-07,0.09320421144178015,0.049861495844875335,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
188,0.5,7,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Is it possible to exclude aspiration after acute stroke using bedside assessment? Bedside swallowing tests do not have the necessary sensitivity for screening acute stroke patients, and the use of videofluoroscopy as the gold standard is under scrutiny.",7.10579182070559e-08,0.046114238579118894,0.02285532300536917,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
188,0.5,8,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Does bedside assessment provide reliable exclusion of aspiration post-acute stroke? The sensitivity of bedside swallowing assessments is inadequate for screening in acute stroke, and videofluoroscopy as a gold standard is questioned.",2.36859727356853e-07,0.21836735439578714,0.049861495844875335,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
188,0.5,9,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Can aspiration be excluded with confidence by bedside assessment following acute stroke? Bedside swallowing assessments lack sufficient sensitivity for screening in acute stroke, and there are reservations about videofluoroscopy as the gold standard.",1.894877818854824e-07,0.1538288332582156,0.049861495844875335,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
188,0.5,10,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Is bedside assessment a dependable tool to exclude aspiration after acute stroke? Bedside swallowing assessments do not have enough sensitivity to be used for screening in acute stroke, and the use of videofluoroscopy as the gold standard raises concerns.",4.73719454713706e-08,0.018021423668444392,0.049861495844875335,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
189,0.5,1,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Are musculoskeletal symptoms related to aromatase inhibitors best addressed by preventing osteoporosis? Answer: Patients treated with AIs who develop osteoporosis have a higher risk of musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates lowers the risk of osteoporosis and these symptoms. Those previously on tamoxifen before starting AIs show fewer musculoskeletal side effects. Our recommendation is,0.0,0.02432095370385845,0.017503057007927147,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
189,0.5,2,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Is osteoporosis prevention the key to avoiding musculoskeletal symptoms associated with aromatase inhibitors? Answer: Patients undergoing AI therapy who develop osteoporosis face increased chances of musculoskeletal pain and fractures. Using calcium and bisphosphonates alongside reduces these risks. Patients with prior tamoxifen use before AIs experience fewer musculoskeletal symptoms. We suggest,1.6580180914979784e-07,0.10670730870254719,0.01753826530612245,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
189,0.5,3,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Does preventing osteoporosis hold the key to eliminating musculoskeletal symptoms caused by aromatase inhibitors? Answer: Osteoporosis in AI-treated patients raises the risk of musculoskeletal symptoms and fractures. Concurrent treatment with calcium and bisphosphonates decreases this risk. Prior tamoxifen administration before AIs is linked to lower incidence of musculoskeletal symptoms. Our advice is,1.1842986367842703e-07,0.1208056094384915,0.02086173469387756,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
189,0.5,4,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Are aromatase inhibitor-induced musculoskeletal symptoms best managed by osteoporosis prevention? Answer: Patients on AIs who develop osteoporosis are more prone to musculoskeletal symptoms and fractures. Co-administration of calcium and bisphosphonates reduces the chance of these complications. Patients previously treated with tamoxifen before AIs show reduced musculoskeletal side effects. We recommend,1.6580180914979784e-07,0.13443319592494518,0.0024534048313202828,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
189,0.5,5,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Is the prevention of osteoporosis critical to eliminating musculoskeletal symptoms related to aromatase inhibitors? Answer: AI patients who develop osteoporosis have a heightened risk of musculoskeletal symptoms and bone fractures. Comedication with calcium and bisphosphonates lowers these risks. Those who had tamoxifen prior to AI therapy are less likely to experience these symptoms. We advise,4.737194547137081e-08,0.036602480918583424,0.00063731768427535,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
189,0.5,6,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Could preventing osteoporosis be the solution to aromatase inhibitor-related musculoskeletal symptoms? Answer: Patients receiving AIs who develop osteoporosis are at greater risk for musculoskeletal symptoms and fractures. Using calcium and bisphosphonates in combination reduces these risks. Patients with tamoxifen treatment before AIs tend to have fewer musculoskeletal symptoms. Our recommendation is,1.4211583641411244e-07,0.08690468140636742,0.01753826530612245,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
189,0.5,7,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Is stopping osteoporosis the key to resolving musculoskeletal symptoms caused by aromatase inhibitors? Answer: AI-treated patients developing osteoporosis show increased musculoskeletal symptoms and fracture risk. Co-treatment with calcium and bisphosphonates mitigates these risks. Prior tamoxifen use before AIs correlates with fewer musculoskeletal side effects. We recommend,2.6054570009253947e-07,0.22022575157898672,0.004190129755605947,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
189,0.5,8,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Does managing osteoporosis prevent musculoskeletal symptoms linked to aromatase inhibitors? Answer: Patients on aromatase inhibitors who develop osteoporosis face higher risks of musculoskeletal symptoms and fractures. Calcium and bisphosphonate comedication reduces these risks. Patients treated with tamoxifen before AIs are less prone to these symptoms. We suggest,2.3685972735685406e-07,0.1980783371253132,0.0037282753365996506,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
189,0.5,9,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Is osteoporosis prevention essential to avoid musculoskeletal symptoms from aromatase inhibitors? Answer: Developing osteoporosis while on AIs increases the risk of musculoskeletal symptoms and bone fractures. Co-administration of calcium and bisphosphonates decreases these risks. Prior tamoxifen therapy before AIs is associated with fewer musculoskeletal symptoms. Our recommendation is,2.1317375462116866e-07,0.17641043574613224,0.003285636912075833,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
189,0.5,10,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Could the key to eliminating aromatase inhibitor-related musculoskeletal symptoms be osteoporosis prevention? Answer: Patients on AIs who develop osteoporosis have a greater likelihood of musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates reduces this likelihood. Tamoxifen use before AIs is linked to a lower risk of these symptoms. We recommend,1.4211583641411244e-07,0.11408692378126695,0.0020617346938775413,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
190,0.5,1,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Do higher depression rates in women result from differences in symptom reporting? Both men and women in this community sample showed similar depressive symptom patterns, with no gender differences in symptom presentation observed.",1.894877818854824e-07,0.2751295898562076,0.037238658777120306,0.014507411718255009,0.2742936145838488,0.0322222222222222,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
190,0.5,2,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Is the higher prevalence of depression in women explained by how symptoms are reported? Men and women reported comparable depressive symptoms in this community sample, with no gender-based variation in symptom presentation found.",1.894877818854824e-07,0.18848619228621333,0.024983563445101917,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
190,0.5,3,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Are women's elevated depression rates due to differences in reporting symptoms? In this community sample, men and women exhibited similar depressive symptom patterns, and no gender differences in symptom expression were detected.",2.131737546211677e-07,0.26495406354014417,0.007238658777120283,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.5,4,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Could the higher depression rates among women be explained by differential symptom reporting? This community sample revealed that men and women reported depressive symptoms similarly, with no evidence of gender differences in symptom presentation.",1.658018091497971e-07,0.15771453361945964,0.024983563445101917,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
190,0.5,5,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Is the greater incidence of depression in women accounted for by how symptoms are reported? Men and women in this community sample reported depressive symptoms in similar ways, and no gender differences were found in symptom presentation.",9.47438909427412e-08,0.07070315662982951,0.024983563445101917,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
190,0.5,6,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Are the increased depression rates in women attributable to differences in symptom reporting? The community sample showed men and women had comparable depressive symptom patterns, with no gender-based differences in symptom presentation.",2.131737546211677e-07,0.30967323647949563,0.0392257112279064,0.01632083818303689,0.30857407650481905,0.033293697978596916,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.5,7,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Does the higher rate of depression in women stem from different symptom reporting? Men and women in this community sample reported depressive symptoms similarly, with no gender differences found in symptom presentation.",2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.5,8,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Is the disparity in depression rates between men and women due to differential symptom reporting? In this community sample, depressive symptom patterns were alike for both genders, with no evidence of gender differences in symptom presentation.",1.184298636784265e-07,0.09887403359652636,0.024983563445101917,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.5,9,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Are higher depression rates among women explained by variations in symptom reporting? Men and women in this community sample showed similar depressive symptom patterns, with no gender differences detected in symptom presentation.",2.131737546211677e-07,0.26495406354014417,0.007238658777120283,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.5,10,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Could differential symptom reporting explain why women have higher depression rates? This community sample found men and women reported depressive symptoms similarly, with no gender difference in symptom presentation observed.",2.605457000925383e-07,0.2869262650994666,0.024983563445101917,0.019947691112600648,0.3313571359544403,0.0,0.019918816950481588,0.341749293722057,0.0,2.6054570009253947e-07,0.3528213746227431,0.0
191,0.5,1,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is it possible to implement an advance care planning model in community palliative care? Yes, such a model is viable within community palliative care services. Research indicates that advance care planning enhances communication, alleviates distress, and ensures care aligns with patient values, resulting in more compassionate and effective end-of-life care.",4.737194547137081e-08,0.08591473209366685,0.16372599946882482,0.0036268529295637453,0.051665384721297336,0.10204944371752951,0.003621603081905733,0.014910746910446804,0.040742417383431435,4.737194547137081e-08,0.013678481895465833,0.020823902218198284
191,0.5,2,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Can an advance care planning model be applied in community palliative care? An advance care planning model is indeed feasible for use in community palliative care. Qualitative research demonstrates that it improves communication, reduces patient distress, and aligns care with patient preferences, fostering better and more compassionate end-of-life care.",7.105791820705622e-08,0.023116185282531454,0.10224110305279145,0.005440279394345618,0.05848939077191906,0.03850341624400254,0.0054324046228586,0.06686912618529428,0.0026460123686346884,7.105791820705622e-08,0.06646392997246053,0.0013868415834546073
191,0.5,3,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is the use of an advance care planning model practical in community palliative care? The model is feasible for community palliative care services. Studies have found that advance care planning facilitates better communication, decreases distress, and ensures care corresponds with patient values, enhancing the quality and compassion of end-of-life care.",4.737194547137081e-08,0.08591473209366685,0.16372599946882482,0.0036268529295637453,0.051665384721297336,0.10204944371752951,0.003621603081905733,0.014910746910446804,0.040742417383431435,4.737194547137081e-08,0.013678481895465833,0.020823902218198284
191,0.5,4,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Could an advance care planning model be effectively used in community palliative care? Yes, implementing such a model is feasible. Qualitative studies reveal that advance care planning improves communication, lessens distress, and aligns care with what patients value, leading to more compassionate and effective end-of-life care.",1.4211583641411244e-07,0.024019006003443977,0.18034178626820851,0.010880558788691236,0.037971549770453805,0.10015836486487868,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
191,0.5,5,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is implementing an advance care planning model in community palliative care achievable? An advance care planning model is feasible in community palliative care. Research shows that it helps improve communication, reduce distress, and align care with patient values, thereby providing more effective and compassionate end-of-life care.",1.4211583641411244e-07,0.0992071594294357,0.09451256785172873,0.010880558788691236,0.13249161984681024,0.0328733459357278,0.0108648092457172,0.1385155465999972,0.005658534430964771,1.4211583641411244e-07,0.13765726869928407,0.0029714576866202713
191,0.5,6,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is an advance care planning model workable within community palliative care? It is feasible to use an advance care planning model in community palliative care services. Qualitative evidence suggests that advance care planning enhances communication, lowers distress, and aligns care with patient preferences, resulting in better and more compassionate care at the end of life.",7.105791820705622e-08,0.0688692600440568,0.012829512250784852,0.005440279394345618,0.06513882388425207,0.007088256389705297,0.0054324046228586,0.06268784989259002,0.002342417383431425,7.105791820705622e-08,0.0623235119648653,0.0012239022181982917
191,0.5,7,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Can community palliative care incorporate an advance care planning model? Yes, it is feasible to implement such a model. Studies have demonstrated that advance care planning improves communication, diminishes distress, and aligns care with patient values, leading to more compassionate and effective end-of-life care.",1.8948778188548325e-07,0.024309092850822278,0.17828913083023198,0.014507411718254981,0.08599188397798674,0.09907798603090924,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
191,0.5,8,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is an advance care planning model suitable for community palliative care? The model is feasible for community palliative care services. Qualitative research highlights that advance care planning enhances communication, reduces distress, and aligns care with patient values, promoting more effective and compassionate end-of-life care.",1.8948778188548325e-07,0.08878790034477024,0.13264537521530537,0.014507411718254981,0.11899889257607921,0.07537334593572778,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
191,0.5,9,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is it feasible to adopt an advance care planning model in community palliative care? Yes, an advance care planning model can be effectively applied in community palliative care. Studies indicate it improves communication, decreases distress, and aligns care with patient values, resulting in more compassionate and effective care at the end of life.",2.3685972735685406e-08,0.07025627586331229,0.1112685325501102,0.0018134264647818726,0.032442169561462286,0.04501005938072551,0.0018108015409528666,0.02133437618373879,0.0008118618278758691,2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282
191,0.5,10,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Does an advance care planning model work in community palliative care? An advance care planning model is feasible for community palliative care services. Qualitative studies confirm that it improves communication, reduces distress, and aligns care with patient values, leading to more effective and compassionate end-of-life care.",1.4211583641411244e-07,0.06840061807121511,0.1153150826446282,0.010880558788691236,0.1009849298213581,0.055056570206994865,0.0108648092457172,0.1385155465999972,0.005658534430964771,1.4211583641411244e-07,0.13765726869928407,0.0029714576866202713
192,0.5,1,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Question: Advanced epithelial ovarian carcinoma in Thai women: should second-look laparotomy still be offered? Answer: For patients with advanced epithelial ovarian carcinoma in Thailand, second-look laparotomy does not provide notable survival or quality of life benefits. It carries considerable morbidity and might be a procedure worth discontinuing.",2.3685972735685406e-07,0.24837343813872081,0.03607320241192022,0.018134264647818726,0.2174742634757254,0.011962625286801087,0.018108015409528666,0.21646355709988452,0.00836922540219244,2.3685972735685406e-07,0.215174704225912,0.004381683639925391
192,0.5,2,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Question: Should second-look laparotomy be continued for advanced epithelial ovarian carcinoma in Thai women? Answer: In Thailand, second-look laparotomy for advanced epithelial ovarian carcinoma patients shows no significant improvement in survival or quality of life and is linked with high morbidity, suggesting it may be a practice to stop.",1.8948778188548325e-07,0.19953531664963542,0.031752330541696905,0.014507411718254981,0.1700564015753634,0.009169152525795851,0.014486412327622933,0.1692720823529248,0.00640618123135607,1.8948778188548325e-07,0.16827946776040026,0.0033497970560907586
192,0.5,3,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Question: Advanced epithelial ovarian carcinoma in Thai women: is it advisable to keep offering second-look laparotomy? Answer: Second-look laparotomy in Thai patients with advanced epithelial ovarian carcinoma fails to significantly enhance survival or quality of life and is associated with considerable morbidity, indicating it should potentially be abandoned.",2.1317375462116866e-07,0.19416556204952728,0.013364012531961941,0.016320838183036854,0.16334940055706904,0.010975475573377677,0.0162972138685758,0.16178386255514177,0.014771504719057162,2.1317375462116866e-07,0.15994578225423828,0.018860946745562133
192,0.5,4,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Question: For advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy remain an option? Answer: The procedure does not significantly improve survival or quality of life, carries substantial morbidity, and might be considered for discontinuation in Thailand.",4.500334819780224e-07,0.31541275229664567,0.07100591715976332,0.03445510283085558,0.3481981907152756,0.0543639053254438,0.034405229278104466,0.3822917494778282,0.036982248520710054,4.500334819780227e-07,0.4177748915563382,0.018860946745562133
192,0.5,5,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Question: Advanced epithelial ovarian carcinoma in Thai women: is continuing second-look laparotomy justified? Answer: Second-look laparotomy offers no meaningful survival or quality of life advantages and involves notable morbidity, thus it may be a practice to discontinue in Thailand.",4.263475092423371e-07,0.32522593577027115,0.04470935032265594,0.03264167636607371,0.32079921652716026,0.0543639053254438,0.0325944277371516,0.35412087251113133,0.036982248520710054,4.263475092423373e-07,0.38878735468308667,0.018860946745562133
192,0.5,6,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Question: Should second-look laparotomy still be practiced for advanced epithelial ovarian carcinoma in Thai women? Answer: It does not provide significant survival or quality of life benefits and is associated with high morbidity, suggesting it might be best to stop this practice in Thailand.",3.079176455639103e-07,0.16513054924730897,0.07100591715976332,0.023574544042164344,0.19404751088801797,0.0543639053254438,0.023540420032387266,0.22406774426293374,0.036982248520710054,3.079176455639103e-07,0.25525596205856393,0.018860946745562133
192,0.5,7,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy beneficial to continue? Answer: The procedure does not improve survival or quality of life significantly and has considerable morbidity, indicating it may be a practice to abandon in Thailand.",4.026615365066518e-07,0.26276901881122683,0.07100591715976332,0.030828249901291835,0.2941309694449994,0.0543639053254438,0.030783626196198732,0.326721898323016,0.036982248520710054,4.026615365066519e-07,0.3606164777163898,0.018860946745562133
192,0.5,8,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Question: Is it appropriate to continue offering second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women? Answer: The second-look laparotomy does not yield significant benefits in survival or quality of life and is linked to substantial morbidity, suggesting it should be discontinued in Thailand.",2.8423167282822487e-07,0.17364772104806203,0.0482909360889142,0.02176111757738247,0.17051701347782355,0.0543639053254438,0.0217296184914344,0.19997019268387373,0.036982248520710054,2.8423167282822487e-07,0.23056334946819224,0.018860946745562133
192,0.5,9,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Question: Should second-look laparotomy be offered for advanced epithelial ovarian carcinoma in Thai women? Answer: This procedure does not offer significant survival or quality of life benefits and carries significant morbidity, thus it may be considered for abandonment in Thailand.",4.026615365066518e-07,0.26276901881122683,0.07100591715976332,0.030828249901291835,0.2941309694449994,0.0543639053254438,0.030783626196198732,0.326721898323016,0.036982248520710054,4.026615365066519e-07,0.3606164777163898,0.018860946745562133
192,0.5,10,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still a viable option? Answer: It does not significantly improve survival or quality of life and is associated with considerable morbidity, so it may be a practice that should be stopped in Thailand.",3.079176455639103e-07,0.16513054924730897,0.07100591715976332,0.023574544042164344,0.19404751088801797,0.0543639053254438,0.023540420032387266,0.22406774426293374,0.036982248520710054,3.079176455639103e-07,0.25525596205856393,0.018860946745562133
193,0.5,1,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Does obstructive sleep apnea impact aerobic fitness? In a US Air Force cohort, obstructive sleep apnea (OSA) does not appear to reduce aerobic fitness significantly. There might be a minor, clinically negligible reduction in VO2 max among those with OSA. Further studies are necessary to understand OSA's effect on aerobic fitness in other groups.",7.105791820705622e-08,0.10877401287332056,0.038548760330578524,0.005440279394345618,0.08274897359565658,0.01922337562475971,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
193,0.5,2,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Is aerobic fitness affected by obstructive sleep apnea? Data from a US Air Force population indicate that OSA does not predict lower aerobic fitness. A slight, clinically insignificant drop in VO2 max may occur in individuals with OSA. Additional research is needed to assess OSA's influence on aerobic fitness in different populations.",1.1842986367842703e-07,0.09595304393715409,0.0017487603305785006,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
193,0.5,3,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Does obstructive sleep apnea influence aerobic fitness? Research within the US Air Force shows OSA does not lead to decreased aerobic fitness. There could be a small, clinically irrelevant decline in VO2 max for OSA sufferers. More investigation is required to evaluate the effects of OSA on aerobic fitness across other populations.",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
193,0.5,4,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Can obstructive sleep apnea reduce aerobic fitness? Findings from a US Air Force group reveal that OSA does not significantly lower aerobic fitness. A minor, clinically insignificant decrease in VO2 max might be present in those with OSA. Further research is essential to explore OSA's impact on aerobic fitness in other demographics.",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
193,0.5,5,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Is aerobic fitness compromised by obstructive sleep apnea? In a US Air Force sample, OSA does not predict a reduction in aerobic fitness. There may be a slight, clinically insignificant decrease in VO2 max among individuals with OSA. More studies are needed to clarify OSA's effect on aerobic fitness in other populations.",1.1842986367842703e-07,0.09595304393715409,0.0017487603305785006,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
193,0.5,6,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Does obstructive sleep apnea affect aerobic fitness levels? Evidence from a US Air Force population suggests OSA does not cause a decline in aerobic fitness. A small, clinically insignificant reduction in VO2 max may be observed in those with OSA. Additional research is required to determine OSA's impact on aerobic fitness in other groups.",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
193,0.5,7,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","How does obstructive sleep apnea affect aerobic fitness? Within a US Air Force cohort, OSA is not associated with decreased aerobic fitness. There might be a minor, clinically insignificant drop in VO2 max for individuals with OSA. More research is needed to understand OSA's effects on aerobic fitness in other populations.",1.4211583641411244e-07,0.08857342885843433,0.017851239669421492,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
193,0.5,8,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Is there an effect of obstructive sleep apnea on aerobic fitness? Studies in a US Air Force population show that OSA does not predict reduced aerobic fitness. A slight, clinically insignificant decrease in VO2 max could exist for those with OSA. Further investigation is necessary to assess OSA's impact on aerobic fitness in other groups.",4.737194547137081e-08,0.0372845055208213,0.0006606862828746896,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
193,0.5,9,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Does obstructive sleep apnea impact aerobic capacity? Research from a US Air Force population indicates OSA does not lead to diminished aerobic fitness. There may be a small, clinically insignificant reduction in VO2 max among individuals with OSA. Additional studies are needed to explore the effects of OSA on aerobic fitness in other populations.",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
193,0.5,10,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Is aerobic fitness influenced by obstructive sleep apnea? Data from the US Air Force population shows that OSA does not predict a decrease in aerobic fitness. A minor, clinically insignificant drop in VO2 max might be present in those with OSA. Further research is required to determine OSA's impact on aerobic fitness in other populations.",4.737194547137081e-08,0.0372845055208213,0.0006606862828746896,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
194,0.5,1,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is advanced age a contraindication for laparoscopic surgery for GERD? Laparoscopic antireflux surgery remains a safe and effective treatment for GERD in elderly patients. Although older age may raise the risk of complications, thorough patient evaluation and careful selection help reduce these risks.",1.1842986367842703e-07,0.11247798342669002,0.0,0.009067132323909363,0.11506932978478668,0.0,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
194,0.5,2,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Does advanced age contraindicate GERD laparoscopic surgery? Laparoscopic antireflux surgery is a safe and effective treatment for GERD, including in older adults. While age can increase complication risks, careful patient assessment and selection can mitigate these risks.",2.6054570009253904e-07,0.26662866325394763,0.0,0.0199476911126006,0.2732933349996811,0.0,0.01991881695048154,0.2803019651541576,0.0,2.6054570009253947e-07,0.2876820724517817,0.0
194,0.5,3,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is GERD laparoscopic surgery contraindicated in elderly patients? Laparoscopic antireflux surgery is both safe and effective for treating GERD in older individuals. Although increased age may heighten complication risks, thorough evaluation and patient selection minimize these risks.",2.6054570009253904e-07,0.26662866325394763,0.0,0.0199476911126006,0.2732933349996811,0.0,0.01991881695048154,0.2803019651541576,0.0,2.6054570009253947e-07,0.2876820724517817,0.0
194,0.5,4,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is advanced age a reason to avoid laparoscopic surgery for GERD? Laparoscopic antireflux surgery is a safe and effective option for treating GERD even in the elderly. While age may raise the likelihood of complications, careful patient evaluation and selection reduce these risks.",1.1842986367842703e-07,0.11247798342669002,0.0,0.009067132323909363,0.11506932978478668,0.0,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
194,0.5,5,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Does advanced age prevent GERD laparoscopic surgery? Laparoscopic antireflux surgery is a safe and effective treatment for GERD in older patients. Although older age can increase complication risks, thorough evaluation and careful patient selection help minimize these risks.",2.3685972735685374e-07,0.2392296890658323,0.0,0.018134264647818726,0.24512245803298427,0.0,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
194,0.5,6,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is advanced age a contraindication for laparoscopic antireflux surgery in GERD patients? Laparoscopic antireflux surgery is safe and effective for GERD, even in elderly patients. While age may elevate complication risks, careful patient evaluation and selection can lower these risks.",1.8948778188548314e-07,0.25767797409938176,0.05113221329437545,0.014507411718254981,0.22753666731849442,0.026296566837107373,0.014486412327622933,0.19574457712609394,0.0,1.8948778188548325e-07,0.20067069546215155,0.0
194,0.5,7,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is laparoscopic surgery for GERD contraindicated in advanced age? Laparoscopic antireflux surgery remains a safe and effective treatment for GERD in older adults. Although age can increase complication risks, thorough evaluation and patient selection minimize these risks.",2.6054570009253904e-07,0.30513683995172247,0.02775510204081633,0.0199476911126006,0.2732933349996811,0.0,0.01991881695048154,0.2803019651541576,0.0,2.6054570009253947e-07,0.2876820724517817,0.0
194,0.5,8,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Can advanced age contraindicate laparoscopic surgery for GERD? Laparoscopic antireflux surgery is safe and effective for treating GERD in elderly patients. While age may increase the risk of complications, careful evaluation and selection of patients can reduce these risks.",2.1317375462116844e-07,0.21256144198367144,0.0,0.016320838183036854,0.21772348384486895,0.0,0.0162972138685758,0.22314355131420927,0.0,2.1317375462116866e-07,0.2288415724288484,0.0
194,0.5,9,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is advanced age a barrier to GERD laparoscopic surgery? Laparoscopic antireflux surgery is a safe and effective treatment for GERD in older patients. Though age may raise complication risks, thorough evaluation and patient selection help minimize these risks.",2.3685972735685374e-07,0.2392296890658323,0.0,0.018134264647818726,0.24512245803298427,0.0,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
194,0.5,10,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Does elderly age contraindicate laparoscopic surgery for GERD? Laparoscopic antireflux surgery remains a safe and effective treatment option for GERD in older individuals. While age can increase complication risks, careful patient evaluation and selection can mitigate these risks.",2.3685972735685374e-07,0.2392296890658323,0.0,0.018134264647818726,0.24512245803298427,0.0,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
195,0.5,1,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean individuals? Both hsCRP levels and carotid IMT showed a strong correlation with conventional factors.,7.10579182070559e-08,0.06643880005935099,0.03698224852071005,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
195,0.5,2,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Does high-sensitivity C-reactive protein relate to carotid atherosclerosis among healthy Koreans? Both hsCRP and carotid IMT were found to be strongly linked with traditional measures.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
195,0.5,3,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid intima-media thickness had a strong correlation with conventional variables.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
195,0.5,4,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Are hsCRP levels associated with carotid atherosclerosis in healthy Korean subjects? Both hsCRP and carotid IMT demonstrated a strong correlation with standard factors.,4.73719454713706e-08,0.08701137698962969,0.0,0.003626852929563759,0.090971778205728,0.0,0.003621603081905747,0.09531017980432521,0.0,4.7371945471370706e-08,0.10008345855698142,0.0
195,0.5,5,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there a connection between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean people? Both hsCRP and carotid IMT were strongly correlated with conventional indicators.,2.36859727356853e-08,0.014629779924540287,0.03993055555555556,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
195,0.5,6,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Does high-sensitivity C-reactive protein associate with carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT were strongly linked to conventional parameters.,4.73719454713706e-08,0.08701137698962969,0.0,0.003626852929563759,0.090971778205728,0.0,0.003621603081905747,0.09531017980432521,0.0,4.7371945471370706e-08,0.10008345855698142,0.0
195,0.5,7,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is high-sensitivity C-reactive protein related to carotid atherosclerosis in healthy Korean individuals? Both hsCRP and carotid IMT were strongly correlated with traditional factors.,4.73719454713706e-08,0.08701137698962969,0.0,0.003626852929563759,0.090971778205728,0.0,0.003621603081905747,0.09531017980432521,0.0,4.7371945471370706e-08,0.10008345855698142,0.0
195,0.5,8,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there a relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT had strong correlations with conventional measures.,2.36859727356853e-08,0.014629779924540287,0.03993055555555556,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
195,0.5,9,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is high-sensitivity C-reactive protein connected to carotid atherosclerosis in healthy Korean subjects? Both hsCRP and carotid IMT were strongly associated with standard clinical factors.,2.36859727356853e-08,0.04255961441879563,0.0,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
195,0.5,10,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Does high-sensitivity C-reactive protein show an association with carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT correlated strongly with conventional risk factors.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
196,0.5,1,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Is fondaparinux used in perioperative bridging? The use of fondaparinux for perioperative bridging is developing. Although it has been traditionally employed for prophylaxis, its effectiveness and safety in bridging patients at risk of venous thromboembolism (VTE) are gaining acknowledgment. Nonetheless, it is important to carefully evaluate individual patient factors and possible drug interactions.",2.3685972735685406e-08,0.03326479978854824,0.037677816224529016,0.0018134264647818726,0.007241421087510691,0.01922337562475971,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
196,0.5,2,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","What is the role of fondaparinux in perioperative bridging? Fondaparinuxâ€™s role in perioperative bridge therapy is evolving. It has been mainly used for prophylaxis, but its efficacy and safety for bridging patients with venous thromboembolism (VTE) risk are increasingly recognized. However, individual patient factors and potential drug interactions must be carefully considered.",4.737194547137081e-08,0.013335528443453981,0.018077816224529024,0.0036268529295637453,0.012561206208669073,0.01922337562475971,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
196,0.5,3,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Does fondaparinux have a role in perioperative bridging? Fondaparinux is increasingly recognized for its role in perioperative bridging therapy. Traditionally used for prophylaxis, its effectiveness and safety in patients at risk of venous thromboembolism (VTE) are being acknowledged. Careful assessment of patient-specific factors and drug interactions remains essential.",1.4211583641411244e-07,0.1268225664921787,0.004791319577940115,0.010880558788691236,0.1260796490851086,0.0025050194369686876,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
196,0.5,4,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Can fondaparinux be used in perioperative bridging? The role of fondaparinux in perioperative bridging is growing. While it has traditionally been used for prophylaxis, its safety and efficacy in bridging patients with venous thromboembolism (VTE) risk are becoming more accepted. Careful consideration of patient factors and drug interactions is necessary.",9.474389094274162e-08,0.054450342337760915,0.01727851066897346,0.0072537058591274906,0.05338320072892344,0.01922337562475971,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
196,0.5,5,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Is fondaparinux applicable in perioperative bridging therapy? Fondaparinuxâ€™s role in perioperative bridge therapy is expanding. Although traditionally a prophylactic agent, its safety and efficacy for bridging patients at risk of venous thromboembolism (VTE) are increasingly recognized. Attention to individual patient factors and drug interactions is crucial.",1.8948778188548325e-07,0.1421229703807798,0.015467072422876125,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
196,0.5,6,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","What role does fondaparinux play in perioperative bridging? Fondaparinux is increasingly utilized in perioperative bridging therapy. Traditionally used for prophylaxis, its safety and efficacy in patients at risk for venous thromboembolism (VTE) are gaining recognition. Careful evaluation of patient-specific factors and potential drug interactions is important.",1.8948778188548325e-07,0.1421229703807798,0.015467072422876125,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
196,0.5,7,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Is there an indication for fondaparinux in perioperative bridging? Fondaparinuxâ€™s indication in perioperative bridging is evolving. While historically used for prophylaxis, it is now recognized for its effective and safe use in bridging patients at risk of venous thromboembolism (VTE). Individual patient factors and possible drug interactions require careful consideration.",9.474389094274162e-08,0.054450342337760915,0.01727851066897346,0.0072537058591274906,0.05338320072892344,0.01922337562475971,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
196,0.5,8,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","How is fondaparinux used in perioperative bridging? The use of fondaparinux in perioperative bridging is developing. Traditionally a prophylactic agent, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk are increasingly acknowledged. Careful attention to patient-specific factors and drug interactions is essential.",2.1317375462116866e-07,0.16529597490007042,0.014962835153679906,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
196,0.5,9,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Does fondaparinux have a place in perioperative bridging therapy? Fondaparinuxâ€™s role in perioperative bridging therapy is evolving. Though traditionally used for prophylaxis, its safety and efficacy in bridging patients at risk of venous thromboembolism (VTE) are increasingly recognized. Individual patient factors and drug interactions must be carefully evaluated.",1.4211583641411244e-07,0.1268225664921787,0.004791319577940115,0.010880558788691236,0.1260796490851086,0.0025050194369686876,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
196,0.5,10,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Is fondaparinux considered for perioperative bridging? Fondaparinux is increasingly considered for perioperative bridging therapy. While it has been traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk are gaining recognition. Careful assessment of individual patient factors and potential drug interactions is important.",1.1842986367842703e-07,0.10454017293165041,0.003910085476794244,0.009067132323909363,0.10393223463143508,0.0020431650179623916,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
197,0.5,1,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Is there an importance of environmental factors in primary systemic vasculitis? A notable link between farming and PSV has been discovered for the first time, indicating that environmental exposures like those in farming might contribute to this autoimmune disease's development. More studies are necessary to pinpoint the exact environmental elements and their mechanisms.",2.3685972735685406e-07,0.15353107999398752,0.016124697661918846,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
197,0.5,2,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Do environmental factors play a role in primary systemic vasculitis? A significant connection between farming and PSV has been found initially, implying that environmental exposures related to farming could influence the onset of this autoimmune disorder. Additional research is required to clarify the specific environmental contributors and how they act.",3.079176455639103e-07,0.2129545004647886,0.016124697661918846,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
197,0.5,3,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Are environmental influences significant in primary systemic vasculitis? For the first time, a strong association between farming and PSV has been identified, suggesting that environmental exposures encountered in farming may be involved in causing this autoimmune disease. Further investigation is essential to determine the particular environmental factors and their mechanisms.",3.079176455639103e-07,0.2129545004647886,0.016124697661918846,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
197,0.5,4,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Is there a relationship between environmental factors and primary systemic vasculitis? A major association between farming and PSV has been recognized for the first time, suggesting that environmental exposures such as those in farming might play a role in the disease's development. More research is needed to explore the specific environmental factors and their effects.",1.8948778188548325e-07,0.1671349876081738,0.020857550858791207,0.014507411718254981,0.16673844800081028,0.018860946745562133,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
197,0.5,5,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Do environmental factors matter in primary systemic vasculitis? A significant link between farming and PSV has been observed for the first time, indicating that environmental exposures encountered in farming may contribute to this autoimmune disease. Further studies are necessary to understand the precise environmental factors and their mechanisms.",3.552895910352811e-07,0.284122821570036,0.005141842980803255,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
197,0.5,6,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
",Are environmental factors relevant in primary systemic vasculitis? A newly identified significant association between farming and PSV suggests that environmental exposures related to farming could influence the development of this autoimmune condition. Additional research is needed to clarify the specific environmental contributors and their action mechanisms.,4.026615365066519e-07,0.29811230880509587,0.016124697661918846,0.030828249901291835,0.32668423025504856,0.0,0.030783626196198732,0.33314444652853714,0.0,4.026615365066519e-07,0.33986782562235085,0.0
197,0.5,7,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","How important are environmental factors in primary systemic vasculitis? A significant correlation between farming and PSV has been found for the first time, implying that environmental exposures encountered in farming may play a role in the onset of this autoimmune disease. Further research is necessary to identify the exact environmental factors and their mechanisms.",2.1317375462116866e-07,0.1606393824029153,0.0027362490836432864,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
197,0.5,8,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Is there an impact of environmental factors on primary systemic vasculitis? A first-time significant association between farming and PSV has been noted, suggesting that environmental exposures such as those in farming might be involved in this autoimmune disease's development. More investigation is required to understand the specific environmental factors and how they work.",2.3685972735685406e-07,0.1801905869386009,0.0030986779628408637,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
197,0.5,9,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Are environmental elements significant in primary systemic vasculitis? For the first time, a strong association between farming and PSV has been discovered, indicating that environmental exposures encountered in farming may contribute to the disease's development. Further research is essential to determine the particular environmental factors and their mechanisms.",3.552895910352811e-07,0.2546271968653575,0.016124697661918846,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
197,0.5,10,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Do environmental exposures influence primary systemic vasculitis? A significant association between farming and PSV has been identified for the first time, suggesting that environmental factors encountered in farming might play a role in this autoimmune disease. Additional studies are needed to understand the specific environmental factors and their mechanisms of action.",2.8423167282822487e-07,0.22047768036966797,0.0038669724755238874,0.02176111757738247,0.21905356606268356,0.0,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
198,0.5,1,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the menopausal transition impact quality of life? This longitudinal study observed no notable effect of menopausal transition on quality of life in Taiwanese women. The decrease in role limitations caused by emotional issues was linked to vasomotor symptoms.,7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.5,2,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Is quality of life affected by menopausal transition? According to this longitudinal study, menopausal transition did not significantly influence quality of life among Taiwanese women. The reduction in role limitations related to emotional problems was associated with vasomotor symptoms.",7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.11542895663511299,0.027006172839506164,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.5,3,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does undergoing menopausal transition influence quality of life? The longitudinal study showed no significant impact of menopausal transition on the quality of life of Taiwanese women. The decline in role limitations due to emotional problems correlated with vasomotor symptoms.,7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.5,4,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the transition through menopause affect quality of life? This longitudinal research found no significant effect of menopausal transition on the quality of life of Taiwanese women. The decrease in role limitations caused by emotional difficulties was linked to vasomotor symptoms.,2.3685972735685406e-08,0.008274143558211655,0.02366863905325442,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
198,0.5,5,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Is there an effect of menopausal transition on quality of life? This longitudinal study indicated no significant impact of menopausal transition on quality of life among Taiwanese women. The decline in role limitations due to emotional problems was associated with vasomotor symptoms.,0.0,0.1014361727648696,0.07094656293374246,0.0,0.1386294361119882,0.09876543209876545,0.0,0.10663802777845222,0.0763888888888889,0.0,0.07296286111157313,0.05246913580246914
198,0.5,6,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does menopausal transition alter quality of life? Findings from this longitudinal study revealed no significant effect of menopausal transition on the quality of life of Taiwanese women. The reduction in role limitations from emotional problems was related to vasomotor symptoms.,4.7371945471370706e-08,0.053478323917051984,0.0024800107960191095,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,0.5,7,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does going through menopausal transition affect quality of life? The longitudinal study found no significant influence of menopausal transition on quality of life in Taiwanese women. The decline in role limitations caused by emotional problems was linked to vasomotor symptoms.,4.7371945471370706e-08,0.053478323917051984,0.0024800107960191095,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,0.5,8,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Is quality of life influenced by menopausal transition? This longitudinal study reported no significant effect of menopausal transition on quality of life among Taiwanese women. The decrease in role limitations due to emotional problems was related to vasomotor symptoms.,7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.11542895663511299,0.027006172839506164,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,0.5,9,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Does menopausal transition have an impact on quality of life? According to this longitudinal study, menopausal transition did not significantly affect quality of life in Taiwanese women. The decline in role limitations related to emotional problems was connected to vasomotor symptoms.",2.3685972735685406e-08,0.02638321546978606,0.0012092933465189942,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
198,0.5,10,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the menopausal transition change quality of life? This longitudinal study found no significant impact of menopausal transition on the quality of life of Taiwanese women. The reduction in role limitations caused by emotional problems was associated with vasomotor symptoms.,4.7371945471370706e-08,0.053478323917051984,0.0024800107960191095,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
199,0.5,1,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Grandmultiparous women experienced higher rates of maternal and neonatal complications such as preterm delivery, low birth weight, and postpartum bleeding, indicating that grandmultiparity independently contributes to adverse perinatal results. More studies are required to explore the causes and create effective treatments.",9.474389094274162e-08,0.07707166565497081,0.109375,0.0072537058591274906,0.05231087145660851,0.0933159722222222,0.007243206163811466,0.02659532010491672,0.07638888888888888,9.474389094274162e-08,0.00013130388956827943,0.05859375
199,0.5,2,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Women with grandmultiparity showed elevated maternal and newborn morbidity, including premature birth, low birth weight, and postpartum hemorrhage, implying that grandmultiparity is an independent risk factor. Additional research is necessary to clarify the mechanisms and develop interventions.",1.8948778188548325e-07,0.006309943284080077,0.109375,0.014507411718254981,0.032846936883698774,0.0933159722222222,0.014486412327622933,0.06041605688471252,0.07638888888888888,1.8948778188548325e-07,0.08907878990606388,0.05859375
199,0.5,3,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity a standalone risk factor for unfavorable perinatal outcomes? Data reveal that grandmultiparous women suffer from increased maternal and neonatal health issues such as preterm birth, low birth weight, and postpartum hemorrhage, suggesting grandmultiparity itself raises risk. Further investigation is needed to understand the causes and improve care strategies.",1.1842986367842703e-07,0.0568689583374522,0.109375,0.009067132323909363,0.03169158425387275,0.0933159722222222,0.009054007704764333,0.005541910907083558,0.07638888888888888,1.1842986367842703e-07,0.02163750911053164,0.05859375
199,0.5,4,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Can grandmultiparity be considered an independent risk factor for poor perinatal outcomes? Increased maternal and neonatal morbidity, including early delivery, low birth weight, and postpartum bleeding, was observed in grandmultiparous women, indicating grandmultiparity independently affects perinatal health. More research is essential to identify underlying factors and develop effective interventions.",1.4211583641411244e-07,0.036249671134716444,0.109375,0.010880558788691236,0.01063817505603959,0.0933159722222222,0.0108648092457172,0.0159642943138798,0.07638888888888888,1.4211583641411244e-07,0.04361641582930664,0.05859375
199,0.5,5,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity independently linked to adverse perinatal outcomes? Grandmultiparous women showed higher incidences of maternal and neonatal complications such as preterm labor, low birth weight, and postpartum hemorrhage, suggesting an independent risk association. Further studies are required to uncover mechanisms and improve prevention.",2.8423167282822487e-07,0.09728172148980674,0.109375,0.02176111757738247,0.12593735994971045,0.0933159722222222,0.0217296184914344,0.15572623668903818,0.07638888888888888,2.8423167282822487e-07,0.18671725946998174,0.05859375
199,0.5,6,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Does being grandmultiparous independently increase the risk of negative perinatal outcomes? Evidence shows grandmultiparous women have greater maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage, supporting the idea that grandmultiparity is an independent risk factor. Additional research is needed to explore causes and intervention methods.",1.1842986367842703e-07,0.0568689583374522,0.109375,0.009067132323909363,0.03169158425387275,0.0933159722222222,0.009054007704764333,0.005541910907083558,0.07638888888888888,1.1842986367842703e-07,0.02163750911053164,0.05859375
199,0.5,7,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity an independent contributor to adverse perinatal outcomes? The increased rates of maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage among grandmultiparous women, suggest grandmultiparity itself raises risk. Further research should focus on mechanisms and interventions.",3.079176455639103e-07,0.12137927306886676,0.109375,0.023574544042164344,0.15062997254008215,0.0933159722222222,0.023540420032387266,0.1810440446733299,0.07638888888888888,3.079176455639103e-07,0.21269274587323972,0.05859375
199,0.5,8,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Does grandmultiparity serve as an independent risk factor for adverse perinatal events? Grandmultiparous women experienced more maternal and neonatal complications like preterm birth, low birth weight, and postpartum hemorrhage, indicating an independent risk from grandmultiparity. More investigation is necessary to understand and address these risks.",2.3685972735685406e-07,0.11377508590581753,0.0640235260770975,0.018134264647818726,0.11054871470743022,0.07007334183673466,0.018108015409528666,0.10693607251960646,0.07638888888888888,2.3685972735685406e-07,0.13670683889531832,0.05859375
199,0.5,9,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity independently associated with poor perinatal outcomes? The higher maternal and neonatal morbidity rates, including preterm delivery, low birth weight, and postpartum hemorrhage in grandmultiparous women, imply that grandmultiparity is an independent risk factor. Further study is needed to elucidate mechanisms and treatment options.",2.3685972735685406e-07,0.0507617058549128,0.109375,0.018134264647818726,0.07830931096045601,0.0933159722222222,0.018108015409528666,0.10693607251960646,0.07638888888888888,2.3685972735685406e-07,0.13670683889531832,0.05859375
199,0.5,10,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity a distinct risk factor for adverse perinatal outcomes? Increased maternal and neonatal health issues such as premature birth, low birth weight, and postpartum hemorrhage among grandmultiparous women suggest that grandmultiparity independently contributes to negative perinatal outcomes. Additional research is required to understand and mitigate these risks.",1.6580180914979784e-07,0.015196261936883282,0.109375,0.012693985253473108,0.01086803016492377,0.0933159722222222,0.012675610786670066,0.037943201032654805,0.07638888888888888,1.6580180914979784e-07,0.06608927168136436,0.05859375
200,0.5,1,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Is the estimation of basal metabolic rate in Chinese individuals accurate using current prediction equations? Answer: So far, the newly developed Singapore equation is the most precise BMR prediction formula for Chinese populations and is suitable for use.",9.47438909427412e-08,0.0747442045544382,0.026296566837107373,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
200,0.5,2,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Are the existing prediction equations valid for estimating basal metabolic rate in Chinese people? Answer: Up to now, the Singapore equation, recently developed, remains the most accurate for predicting BMR in Chinese and is applicable.",2.36859727356853e-08,0.010620873444459722,0.02854671280276816,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
200,0.5,3,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: How well do current prediction equations estimate basal metabolic rate in Chinese individuals? Answer: Currently, the Singapore equation is the most accurate BMR prediction model for Chinese and can be applied effectively.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
200,0.5,4,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Can basal metabolic rate in Chinese be accurately estimated with current prediction equations? Answer: To date, the Singapore equation developed recently is the most reliable for predicting BMR in Chinese and is applicable.",2.36859727356853e-08,0.07186188318361753,0.0302734375,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
200,0.5,5,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for",Question: Are the current BMR prediction equations appropriate for Chinese populations? Answer: The newly developed Singapore equation is presently the most accurate predictor of basal metabolic rate in Chinese and is suitable for use.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
200,0.5,6,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Is the basal metabolic rate estimation in Chinese accurate using existing prediction equations? Answer: The Singapore equation, developed recently, is the most precise BMR prediction tool for Chinese and is applicable.",7.10579182070559e-08,0.1370924930703663,0.0322222222222222,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
200,0.5,7,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Do current equations accurately predict basal metabolic rate in Chinese individuals? Answer: So far, the Singapore equation is the most accurate and applicable for estimating BMR in Chinese populations.",1.184298636784265e-07,0.20686794846140888,0.03443877551020409,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
200,0.5,8,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for",Question: Are the current basal metabolic rate prediction equations valid for Chinese? Answer: The newly created Singapore equation is the most accurate BMR prediction method for Chinese and is applicable.,1.184298636784265e-07,0.15906469462968875,0.0,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
200,0.5,9,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: How applicable are current basal metabolic rate prediction equations for Chinese? Answer: The Singapore equation, recently developed, is the most accurate and suitable for predicting BMR in Chinese.",1.421158364141118e-07,0.19415601444095776,0.0,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
200,0.5,10,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Is the estimation of basal metabolic rate in Chinese people reliable with current equations? Answer: To date, the Singapore equation is the most accurate and applicable BMR prediction equation for Chinese.",7.10579182070559e-08,0.1370924930703663,0.0322222222222222,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
201,0.5,1,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it essential to routinely place a nasobiliary drainage tube following endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? A routinely placed ENBD tube did not enhance the clinical outcome, although patients experienced longer procedure times and more discomfort, making the insertion unnecessary.",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
201,0.5,2,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted after endoscopic removal of common bile duct stones in patients with choledocholithiasis-related cholangitis? Routine ENBD tube insertion did not improve clinical progression and caused increased procedure duration and patient discomfort, thus it is unnecessary.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.5,3,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is the routine insertion of a nasobiliary drainage tube required after endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis? Routine ENBD tube placement did not benefit the clinical course and resulted in longer procedures and more discomfort, so it is not needed.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
201,0.5,4,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Do patients with choledocholithiasis-induced cholangitis require routine nasobiliary drainage tube insertion after endoscopic common bile duct clearance? Routine insertion of an ENBD tube failed to improve clinical outcomes and increased procedure time and discomfort, making it unnecessary.",3.789755637709661e-07,0.3677247801253176,0.0,0.029014823436509962,0.37647757123491177,0.0,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
201,0.5,5,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion necessary following endoscopic clearance of the common bile duct in choledocholithiasis-associated cholangitis patients? The routine use of an ENBD tube did not improve clinical course and caused longer procedure times and discomfort, thus it is unnecessary.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.5,6,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","After endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis, is it necessary to routinely insert a nasobiliary drainage tube? Routine ENBD tube insertion did not improve clinical outcomes despite increased procedure time and patient discomfort, making it unnecessary.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.5,7,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it required to routinely place a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? Routine ENBD tube placement did not enhance clinical progress and led to longer procedures and discomfort, so it is unnecessary.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
201,0.5,8,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","In patients with choledocholithiasis-induced cholangitis, is routine nasobiliary drainage tube insertion necessary after endoscopic clearance of the common bile duct? The routine insertion of an ENBD tube did not improve the clinical course and increased procedure time and discomfort, thus it is unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.5,9,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion after endoscopic clearance of the common bile duct necessary in patients with cholangitis from choledocholithiasis? Routine ENBD tube insertion did not improve clinical outcomes and caused longer procedures and more discomfort, so it is not required.",2.6054570009253947e-07,0.2714837094654099,0.024375,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.5,10,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube insertion did not improve clinical course and resulted in increased procedure time and discomfort, therefore it is unnecessary.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
202,0.5,1,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are Pap smears with glandular cell abnormalities identified by rapid prescreening? Pap smears showing glandular cell abnormalities are frequently marked as abnormal through RPS, yielding a sensitivity of 36.4% at the AGC threshold. Notably, RPS detects certain AGC cases on Pap smears.",2.3685972735685406e-07,0.1735187593855927,0.06764448680152275,0.018134264647818726,0.17462324867501255,0.03477198205059751,0.018108015409528666,0.17167520866996666,0.040742417383431435,2.3685972735685406e-07,0.2047337186581739,0.020823902218198284
202,0.5,2,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Yes, Pap smears with glandular cell abnormalities are commonly flagged as abnormal by RPS, achieving a sensitivity of 36.4% at the AGC cutoff. Importantly, RPS identifies some AGC occurrences in Pap smears.",2.1317375462116866e-07,0.14700606083594137,0.06935325108220268,0.016320838183036854,0.14908533464493434,0.03538054549569943,0.0162972138685758,0.14635740068567493,0.040742417383431435,2.1317375462116866e-07,0.17875823225491594,0.020823902218198284
202,0.5,3,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Can rapid prescreening detect glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are often recognized as abnormal by RPS, with a sensitivity rate of 36.4% at the AGC threshold. Crucially, RPS detects a number of AGC cases on Pap smears.",1.8948778188548325e-07,0.08893334512541662,0.09395821642756977,0.014507411718254981,0.12418273407567604,0.03596018559088088,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
202,0.5,4,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are glandular cell abnormalities in Pap smears detected by rapid prescreening? RPS frequently flags Pap smears with glandular cell abnormalities as abnormal, showing a sensitivity of 36.4% at the AGC threshold. Significantly, some AGC cases are identified on Pap smears by RPS.",2.3685972735685406e-07,0.2200929668217979,0.010115630881481735,0.018134264647818726,0.17462324867501255,0.03477198205059751,0.018108015409528666,0.17167520866996666,0.040742417383431435,2.3685972735685406e-07,0.2047337186581739,0.020823902218198284
202,0.5,5,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Pap smears exhibiting glandular cell abnormalities are often marked abnormal by RPS, with a sensitivity of 36.4% at the AGC threshold. Importantly, RPS detects certain AGC cases in Pap smears.",2.3685972735685406e-07,0.1735187593855927,0.06764448680152275,0.018134264647818726,0.17462324867501255,0.03477198205059751,0.018108015409528666,0.17167520866996666,0.040742417383431435,2.3685972735685406e-07,0.2047337186581739,0.020823902218198284
202,0.5,6,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Does rapid prescreening detect glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are commonly flagged abnormal by RPS, resulting in a sensitivity of 36.4% at the AGC threshold. Most importantly, some AGC cases are detected on Pap smears by RPS.",1.8948778188548325e-07,0.12117274887239127,0.07098416824196599,0.014507411718254981,0.12418273407567604,0.03596018559088088,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
202,0.5,7,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are Pap smears with glandular cell abnormalities detected by rapid prescreening? Such Pap smears are often identified as abnormal by RPS, with a sensitivity of 36.4% at the AGC cutoff. Crucially, RPS detects some AGC cases on Pap smears.",3.0791764556391007e-07,0.1845499241544304,0.1140626014048586,0.023574544042164344,0.21792743111672674,0.05975554549569943,0.023540420032387266,0.2517179163435008,0.040742417383431435,3.079176455639103e-07,0.28697181689514695,0.020823902218198284
202,0.5,8,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Can rapid prescreening identify glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are frequently flagged as abnormal by RPS, achieving a sensitivity of 36.4% at the AGC threshold. Notably, RPS detects certain AGC cases in Pap smears.",2.6054570009253947e-07,0.20074727629508526,0.06585222887016175,0.0199476911126006,0.20082970689079183,0.03413227679763848,0.019918816950481533,0.19765069507322464,0.040742417383431435,2.6054570009253947e-07,0.23140196574033478,0.020823902218198284
202,0.5,9,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Is the detection of glandular cell abnormalities in Pap smears possible through rapid prescreening? Pap smears with glandular cell abnormalities are often marked as abnormal by RPS, with a sensitivity of 36.4% at the AGC threshold. Importantly, RPS identifies some AGC cases on Pap smears.",1.6580180914979784e-07,0.09598508948312556,0.07254239251323305,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
202,0.5,10,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Does rapid prescreening identify glandular cell abnormalities in Pap smears? Pap smears showing glandular cell abnormalities are commonly flagged as abnormal by RPS, resulting in a sensitivity of 36.4% at the AGC cutoff. Most importantly, some AGC cases are detected on Pap smears by RPS.",1.6580180914979784e-07,0.09598508948312556,0.07254239251323305,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
203,0.5,1,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Does initiating migraine treatment early reduce the time to reach headache peak and lessen its intensity? Early intervention with triptans can shorten the duration to headache peak and decrease severity. Triptans are migraine-specific medications, and early use can enhance results. Consult your healthcare provider for tailored advice and treatment plans.",2.1317375462116866e-07,0.08179639425164664,0.06132858853372831,0.016320838183036854,0.07912662093070022,0.06608438180547041,0.0162972138685758,0.07618306323081336,0.07100591715976332,2.1317375462116866e-07,0.10307573268229131,0.05436390532544381
203,0.5,2,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Can early migraine therapy shorten the time it takes for the headache to peak and diminish its severity? Using triptans promptly may reduce the time to headache peak and alleviate its severity. Triptans are medications targeted for migraines, and early administration can improve outcomes. Seek medical advice for personalized treatment.",2.1317375462116866e-07,0.08179639425164664,0.061328588533728315,0.016320838183036854,0.05024548840736953,0.0869082840236687,0.0162972138685758,0.07618306323081336,0.07100591715976332,2.1317375462116866e-07,0.10307573268229131,0.05436390532544381
203,0.5,3,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Does treating migraines early help shorten the time to headache peak and lower its severity? Early use of triptans might lead to a quicker peak and milder headache. Triptans are designed specifically for migraines, and starting treatment early can yield better results. Consult your doctor for individualized guidance.",2.6054570009253947e-07,0.09638127204587832,0.08080446527443765,0.0199476911126006,0.09280510282616605,0.0869082840236687,0.019918816950481533,0.11966817517055173,0.07100591715976332,2.6054570009253947e-07,0.14752749525312403,0.05436390532544381
203,0.5,4,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Is early migraine treatment effective in reducing the time to headache peak and its severity? Administering triptans early can shorten the time until headache peak and reduce how severe it is. Triptans are migraine-specific drugs, and early use can improve the condition. Check with your physician for personalized treatment options.",2.1317375462116866e-07,0.11008811590715473,0.04110692274135637,0.016320838183036854,0.07912662093070022,0.06608438180547041,0.0162972138685758,0.07618306323081336,0.07100591715976332,2.1317375462116866e-07,0.10307573268229131,0.05436390532544381
203,0.5,5,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Does starting migraine treatment early reduce the time to headache peak and lessen its severity? Early treatment with triptans may lead to a faster peak and decreased headache intensity. Triptans are medications meant for migraines, and early use can enhance effectiveness. Consult a healthcare professional for tailored advice.",2.6054570009253947e-07,0.09638127204587832,0.08080446527443765,0.0199476911126006,0.09280510282616605,0.0869082840236687,0.019918816950481533,0.11966817517055173,0.07100591715976332,2.6054570009253947e-07,0.14752749525312403,0.05436390532544381
203,0.5,6,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Can early intervention in migraine treatment shorten the time to headache peak and reduce severity? Using triptans early may shorten the time to peak headache and lessen its severity. Triptans are migraine-specific medications, and early treatment can improve outcomes. Discuss with your doctor for personalized treatment plans.",2.8423167282822487e-07,0.17880235437433,0.037171060000447995,0.02176111757738247,0.17639709226138045,0.04255998764724901,0.0217296184914344,0.17364772104806203,0.0482909360889142,2.8423167282822487e-07,0.17051701347782355,0.05436390532544381
203,0.5,7,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Does early treatment of migraines help in shortening the time to headache peak and reducing severity? Early use of triptans might lead to quicker headache peak and less severe pain. Triptans are designed for migraines, and early administration can improve results. Consult your healthcare provider for personalized advice.",2.6054570009253947e-07,0.1258768967505568,0.05960187011469061,0.0199476911126006,0.1229419367635547,0.0651798889619403,0.019918816950481533,0.11966817517055173,0.07100591715976332,2.6054570009253947e-07,0.14752749525312403,0.05436390532544381
203,0.5,8,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Will early migraine treatment shorten the time it takes for the headache to peak and reduce its severity? Early use of triptans can decrease the time to headache peak and reduce severity. Triptans are medications specifically for migraines, and starting them early can improve outcomes. Seek medical advice for personalized treatment.",1.8948778188548325e-07,0.08818790529030585,0.042315460421460324,0.014507411718254981,0.05791792286014186,0.06650897846811314,0.014486412327622933,0.0551296540329802,0.07100591715976332,1.8948778188548325e-07,0.08156952746132795,0.05436390532544381
203,0.5,9,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Does treating a migraine early shorten the time to headache peak and lessen the severity? Early administration of triptans may lead to a shorter time to headache peak and reduced severity. Triptans are migraine-specific drugs, and early use can improve outcomes. Consult a doctor for personalized treatment options.",2.6054570009253947e-07,0.18486814615991376,0.017701076225434487,0.0199476911126006,0.18321560463833286,0.022008338106956946,0.019918816950481533,0.18128125788699112,0.026657620783343633,2.6054570009253947e-07,0.17903418527857662,0.0316489242545947
203,0.5,10,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Is early migraine treatment beneficial in reducing the time to headache peak and its severity? Early use of triptans can shorten the headache peak time and reduce severity. Triptans are designed for migraines, and early treatment can enhance results. Talk to your healthcare provider for personalized advice.",2.8423167282822487e-07,0.11852868649955184,0.08034261085543135,0.02176111757738247,0.11478400954494106,0.0869082840236687,0.0217296184914344,0.14214103102260944,0.07100591715976332,2.8423167282822487e-07,0.17051701347782355,0.05436390532544381
204,0.5,1,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Does cup-cage reconstruction using oversized cups offer initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Most studies indicate that it does, as the larger cup size increases the surface area for bone-implant contact, resulting in more secure fixation.",4.974054274493935e-07,0.19473303938398212,0.15763168012302964,0.038081955760419325,0.24594366794313682,0.13017751479289943,0.0380268323600102,0.29897219660781804,0.10039159843360625,4.974054274493935e-07,0.3539185902387523,0.06858710562414265
204,0.5,2,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? Evidence from numerous studies supports this, attributing stability to the enhanced bone-implant interface due to the oversized cup.",6.632072365991906e-07,0.4291138520653739,0.12735824262302964,0.050775941013892455,0.4437694112730548,0.13017751479289943,0.05070244314668029,0.5025711518490579,0.10039159843360625,6.632072365991914e-07,0.5636391212208229,0.06858710562414265
204,0.5,3,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","In THA addressing osteoporotic acetabular fractures, does cup-cage reconstruction with oversized cups ensure initial stability? The consensus in research suggests yes, because the oversized cup provides a larger contact area with bone, enhancing fixation strength.",6.395212638635053e-07,0.35725196888175637,0.15763168012302964,0.048962514549110575,0.4129977526063011,0.13017751479289943,0.04889164160572742,0.47082245353447805,0.10039159843360625,6.39521263863506e-07,0.5308492983978312,0.06858710562414265
204,0.5,4,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Can cup-cage reconstruction with oversized cups provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? The majority of literature confirms this, citing the increased bone-implant contact area from the oversized cup as a key factor.",5.921493183921347e-07,0.300093555041808,0.15763168012302964,0.045335661619546816,0.35415725258336783,0.13017751479289943,0.04527003852382167,0.4101978317180426,0.10039159843360625,5.921493183921352e-07,0.4683289414164977,0.06858710562414265
204,0.5,5,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Does the use of oversized cups in cup-cage reconstruction yield initial stability in THA for osteoporotic acetabular fractures? Studies predominantly show that it does, likely due to the greater surface area improving bone-implant fixation.",6.632072365991906e-07,0.38710493203143814,0.15763168012302964,0.050775941013892455,0.4437694112730548,0.13017751479289943,0.05070244314668029,0.5025711518490579,0.10039159843360625,6.632072365991914e-07,0.5636391212208229,0.06858710562414265
204,0.5,6,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Is initial stability in THA for osteoporotic acetabular fractures achieved by cup-cage reconstruction with oversized cups? Research largely affirms this, emphasizing that the increased surface area of the oversized cup enhances secure fixation.",6.868932093348759e-07,0.41787659069819183,0.15763168012302964,0.052589367478674334,0.47551810958763463,0.13017751479289943,0.052513244687633166,0.5353609746720496,0.10039159843360625,6.868932093348768e-07,0.5975406728965047,0.06858710562414265
204,0.5,7,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Does employing oversized cups in cup-cage reconstruction provide initial stability in THA for osteoporotic acetabular fractures? Most studies have demonstrated this effect, attributing it to the larger bone-implant contact area.",7.579511275419318e-07,0.5163166635114451,0.15763168012302964,0.05802964687301997,0.5773008038975771,0.13017751479289943,0.05794564931049179,0.640721490329875,0.10039159843360625,7.57951127541933e-07,0.7067399648614954,0.06858710562414265
204,0.5,8,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","In the context of THA for osteoporotic acetabular fractures, does cup-cage reconstruction with oversized cups offer initial stability? The prevailing evidence suggests yes, due to the increased surface area that facilitates better bone-implant contact.",6.632072365991906e-07,0.38710493203143814,0.15763168012302964,0.050775941013892455,0.4437694112730548,0.13017751479289943,0.05070244314668029,0.5025711518490579,0.10039159843360625,6.632072365991914e-07,0.5636391212208229,0.06858710562414265
204,0.5,9,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Is initial stability in total hip arthroplasty for osteoporotic acetabular fractures ensured by cup-cage reconstruction with oversized cups? The bulk of studies support this, noting that the oversized cup's greater surface area allows for more secure fixation.",5.921493183921347e-07,0.300093555041808,0.15763168012302964,0.045335661619546816,0.35415725258336783,0.13017751479289943,0.04527003852382167,0.4101978317180426,0.10039159843360625,5.921493183921352e-07,0.4683289414164977,0.06858710562414265
204,0.5,10,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Does cup-cage reconstruction featuring oversized cups provide initial stability in THA for osteoporotic acetabular fractures? The majority of research indicates it does, primarily because the oversized cup increases the bone-implant contact surface, leading to stronger fixation.",6.1583529112782e-07,0.32826443200850486,0.15763168012302964,0.047149088084328696,0.38314478945661934,0.13017751479289943,0.047080840064774546,0.44005079486772436,0.10039159843360625,6.158352911278206e-07,0.4991006000832514,0.06858710562414265
205,0.5,1,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is imaging necessary to diagnose appendicitis in children? Clinical evaluation remains the primary method for diagnosing appendicitis. However, ultrasound can be useful in girls over 10 and boys over 12 to exclude other causes of abdominal pain.",7.10579182070559e-08,0.008950689154565872,0.05113221329437545,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
205,0.5,2,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Do we require imaging to identify appendicitis in pediatric patients? The main diagnostic tool is clinical assessment, but ultrasound may assist in ruling out alternative causes of abdominal pain in girls older than 10 and boys older than 12.",2.36859727356853e-08,0.008635101559923974,0.024835646457268074,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
205,0.5,3,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is imaging needed for diagnosing appendicitis in children? Diagnosis mainly relies on clinical examination, though ultrasound can help exclude other abdominal pain causes in girls above 10 and boys above 12.",2.131737546211677e-07,0.1912722459485212,0.05113221329437545,0.016320838183036895,0.2702903297399133,0.0,0.016297213868575848,0.27871340246902143,0.0,2.1317375462116866e-07,0.2876820724517808,0.0
205,0.5,4,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Should imaging be used to diagnose appendicitis in children? Clinical assessment is crucial for diagnosis, but ultrasound can aid in excluding other abdominal pain etiologies in girls older than 10 and boys older than 12.",1.184298636784265e-07,0.10688246655686395,0.021747456636891517,0.009067132323909377,0.14107859825990632,0.0,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
205,0.5,5,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Do children with suspected appendicitis require imaging? Appendicitis diagnosis is primarily clinical, yet ultrasound is helpful in girls over 10 and boys over 12 to rule out other causes of abdominal pain.",1.894877818854824e-07,0.15848242312552951,0.05113221329437545,0.014507411718255016,0.23638877806423153,0.0,0.014486412327622974,0.24362208265775243,0.0,1.8948778188548325e-07,0.2513144282809061,0.0
205,0.5,6,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is imaging essential for diagnosing appendicitis in children? The diagnosis depends mainly on clinical evaluation, but ultrasound can be beneficial in girls older than 10 and boys older than 12 to exclude other sources of abdominal pain.",7.10579182070559e-08,0.047458865852340715,0.02337711125355912,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
205,0.5,7,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Must imaging be performed to diagnose appendicitis in children? Diagnosis is chiefly clinical, with ultrasound serving to rule out other abdominal pain causes in girls older than 10 and boys older than 12.",1.658018091497971e-07,0.17005542359594727,0.019914731504573152,0.012693985253473136,0.20359895524123983,0.0,0.012675610786670101,0.20972053098207066,0.0,1.6580180914979784e-07,0.2162231084696371,0.0
205,0.5,8,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is imaging necessary to confirm appendicitis in children? Clinical assessment is key, although ultrasound may assist in excluding other causes of abdominal pain in girls over 10 and boys over 12.",2.131737546211677e-07,0.1912722459485212,0.05113221329437545,0.016320838183036895,0.2702903297399133,0.0,0.016297213868575848,0.27871340246902143,0.0,2.1317375462116866e-07,0.2876820724517808,0.0
205,0.5,9,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Do we rely on imaging for diagnosing appendicitis in children? Clinical evaluation is fundamental, but ultrasound can help rule out alternative abdominal pain causes in girls older than 10 and boys older than 12.",1.421158364141118e-07,0.13797098617813175,0.02085877579437545,0.010880558788691257,0.17185025692666,0.0,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
205,0.5,10,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is imaging required to diagnose appendicitis in children? The primary diagnostic approach is clinical assessment; however, ultrasound can help exclude other causes of abdominal pain in girls older than 10 and boys older than 12.",1.184298636784265e-07,0.10688246655686395,0.021747456636891517,0.009067132323909377,0.14107859825990632,0.0,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
206,0.5,1,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Does cognitive ability forecast how well listeners with normal hearing and cognition recognize frequency compressed speech?,9.474389094274139e-07,1.0976401679673673,0.14124038026256222,0.07253705859127504,1.1958940101579167,0.109375,0.07243206163811482,1.3007165665721017,0.07496876301541024,9.474389094274158e-07,1.386358547959587,0.057476051645147866
206,0.5,2,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Is there a predictive relationship between cognitive function and recognition of frequency compressed speech in individuals with normal hearing and cognition?,8.290090457489871e-07,0.8099580955155874,0.14124038026256222,0.06346992626736565,0.8905123606067349,0.109375,0.06337805393335044,0.9752941661374739,0.07496876301541024,8.29009045748989e-07,1.0380518536913717,0.057476051645147866
206,0.5,3,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Can cognitive function determine the recognition accuracy of frequency compressed speech in people with normal hearing and cognition?,9.000669639560432e-07,0.9724770250133616,0.14124038026256222,0.06891020566171129,1.062362617533394,0.109375,0.06881045855620907,1.1576157229314283,0.07496876301541024,9.00066963956045e-07,1.2322078681323294,0.057476051645147866
206,0.5,4,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Does cognitive performance influence how listeners with normal hearing and cognition perceive frequency compressed speech?,9.711248821630993e-07,1.1666330394543194,0.14124038026256222,0.07435048505605692,1.270001982311638,0.109375,0.07424286317906768,1.380759274245638,0.07496876301541024,9.71124882163101e-07,1.4733699249492171,0.057476051645147866
206,0.5,5,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Is cognitive function a predictor of frequency compressed speech recognition in those with normal hearing and normal cognition?,9.000669639560432e-07,0.9724770250133616,0.14124038026256222,0.06891020566171129,1.062362617533394,0.109375,0.06881045855620907,1.1576157229314283,0.07496876301541024,9.00066963956045e-07,1.2322078681323294,0.057476051645147866
206,0.5,6,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",How does cognitive functioning relate to the recognition of frequency compressed speech in listeners with normal hearing and cognition?,8.763809912203579e-07,0.9153186111734128,0.14124038026256222,0.06709677919692941,1.001737995716959,0.109375,0.06699965701525619,1.0930772017938577,0.07496876301541024,8.763809912203597e-07,1.1632149966453773,0.057476051645147866
206,0.5,7,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Does the level of cognitive function affect the ability to recognize frequency compressed speech in individuals with normal hearing and cognition?,8.290090457489871e-07,0.8099580955155874,0.14124038026256222,0.06346992626736565,0.8905123606067349,0.109375,0.06337805393335044,0.9752941661374739,0.07496876301541024,8.29009045748989e-07,1.0380518536913717,0.057476051645147866
206,0.5,8,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Is there a clear connection between cognitive ability and recognition of frequency compressed speech in people with normal hearing and cognition?,8.290090457489871e-07,0.8099580955155874,0.14124038026256222,0.06346992626736565,0.8905123606067349,0.109375,0.06337805393335044,0.9752941661374739,0.07496876301541024,8.29009045748989e-07,1.0380518536913717,0.057476051645147866
206,0.5,9,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Does cognitive function impact the recognition of frequency compressed speech in listeners who have normal hearing and cognition?,9.000669639560432e-07,0.9724770250133616,0.14124038026256222,0.06891020566171129,1.062362617533394,0.109375,0.06881045855620907,1.1576157229314283,0.07496876301541024,9.00066963956045e-07,1.2322078681323294,0.057476051645147866
206,0.5,10,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Is the recognition of frequency compressed speech in normal hearing and cognition listeners predicted by cognitive function?,9.237529366917285e-07,1.0331016468297967,0.14124038026256222,0.07072363212649316,1.1269011386709646,0.109375,0.07062126009716194,1.2266085944183804,0.07496876301541024,9.237529366917304e-07,1.3063158402860506,0.057476051645147866
207,0.5,1,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant but modest correlation with bone turnover parameters in iliac cancellous bone. The iliac crest bone might not be representative.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.5,2,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do biochemical markers of bone turnover reflect bone histomorphometry in 370 postmenopausal women? There was a significant yet modest association between bone turnover markers and bone turnover parameters assessed in iliac cancellous bone. The iliac crest bone may not fully represent the entire bone.,1.1842986367842682e-07,0.17018056665149484,0.04032876446235842,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
207,0.5,3,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover representative of bone histomorphometry among 370 postmenopausal women? Bone turnover markers were significantly but moderately linked to bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not be entirely representative.,2.36859727356853e-08,0.029134819215083763,0.0035657596371881373,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
207,0.5,4,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Can biochemical markers of bone turnover serve as representatives of bone histomorphometry in 370 postmenopausal women? Bone turnover markers correlated significantly but modestly with bone turnover parameters in the iliac cancellous bone. The iliac crest bone might not be fully indicative.,4.73719454713706e-08,0.022796634342612254,0.018810783572688367,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
207,0.5,5,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? Bone turnover markers had a significant yet modest association with bone turnover parameters in iliac cancellous bone. The iliac crest bone may not represent the entire bone structure.,7.1057918207056e-08,0.08500156402629955,0.010163943693821037,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
207,0.5,6,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do biochemical markers of bone turnover correspond to bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly but modestly related to bone turnover parameters in iliac cancellous bone. The iliac crest bone might not be entirely representative.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.5,7,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover reliable indicators of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant yet modest association with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not be fully representative.,7.1057918207056e-08,0.08500156402629955,0.010163943693821037,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
207,0.5,8,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Is there a representative relationship between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly but modestly linked with bone turnover parameters in iliac cancellous bone. The iliac crest bone might not be representative.,7.1057918207056e-08,0.11881362161458986,0.03557595030122497,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
207,0.5,9,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover indicative of bone histomorphometry in a group of 370 postmenopausal women? Bone turnover markers had a significant but modest association with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not fully represent the bone.,1.4211583641411222e-07,0.1634053805093063,0.0189129405480217,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
207,0.5,10,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do biochemical markers of bone turnover accurately represent bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly yet modestly associated with bone turnover parameters in iliac cancellous bone. The iliac crest bone might not be fully representative.,0.0,0.03648143055578679,0.027485512723607983,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
208,0.5,1,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","In patients with coronary disease, profound hypotensive episodes, especially low diastolic pressures, can temporally trigger both symptomatic and silent myocardial ischemia, indicating susceptibility to ischemic events.",6.15835291127819e-07,0.5939610708317304,0.12041647804436403,0.047149088084328765,0.6785174006354047,0.039930555555555566,0.047080840064774615,0.7563260821814772,0.0,6.158352911278206e-07,0.7801585575495755,0.0
208,0.5,2,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Patients suffering from ischemic heart disease who experience hypotension, notably in diastolic blood pressure, may develop symptomatic and silent ischemic episodes linked in time to the hypotension, suggesting a risk of myocardial ischemia.",4.5003348197802187e-07,0.347100992900204,0.12041647804436403,0.03445510283085561,0.42258402649820326,0.039930555555555566,0.0344052292781045,0.4906229164484719,0.0,4.500334819780227e-07,0.5039051809214179,0.0
208,0.5,3,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","There is a temporal association between hypotension and the occurrence of symptomatic and silent ischemia in patients with coronary disease, particularly when diastolic pressure drops, implying that profound hypotensive events can cause myocardial ischemic events.",4.0266153650665127e-07,0.28647637108376856,0.12041647804436403,0.03082824990129185,0.36006366951686974,0.039930555555555566,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
208,0.5,4,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","In individuals with ischemic heart disease, episodes of significant hypotension, especially low diastolic pressure, have been temporally related to both silent and symptomatic ischemia, indicating that these patients may be vulnerable to myocardial ischemic incidents.",4.0266153650665127e-07,0.28647637108376856,0.12041647804436403,0.03082824990129185,0.36006366951686974,0.039930555555555566,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
208,0.5,5,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Symptomatic and silent myocardial ischemia have been observed in a time-related manner with hypotensive episodes, mainly diastolic hypotension, in patients with coronary disease, suggesting that profound hypotension can precipitate ischemic events.",4.974054274493925e-07,0.41163951403777554,0.12041647804436403,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5596157879354227,0.0,4.974054274493935e-07,0.5753641449035616,0.0
208,0.5,6,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Among patients with coronary artery disease, profound drops in blood pressure, particularly diastolic hypotension, are temporally connected to the onset of silent and symptomatic ischemic episodes, indicating a potential causative link.",4.974054274493925e-07,0.41163951403777554,0.12041647804436403,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5596157879354227,0.0,4.974054274493935e-07,0.5753641449035616,0.0
208,0.5,7,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Patients with ischemic heart disease may experience myocardial ischemia, both symptomatic and silent, in temporal relation to hypotensive events, especially when diastolic pressure is low, suggesting susceptibility to ischemic complications.",5.210914001850778e-07,0.4455410657134573,0.12041647804436403,0.03989538222520125,0.5243667208081457,0.039930555555555566,0.03983763390096312,0.5959834321062973,0.0,5.210914001850789e-07,0.6131044728864086,0.0
208,0.5,8,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","In coronary disease patients, significant hypotensive events, notably involving diastolic pressure, have been linked in time to ischemic episodes, both silent and symptomatic, implying a causal relationship.",5.921493183921337e-07,0.554740357678448,0.12041647804436403,0.045335661619546885,0.6376954061151499,0.039930555555555566,0.04527003852382174,0.7137664677626816,0.0,5.921493183921352e-07,0.7357067949787415,0.0
208,0.5,9,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","There is evidence that in patients with ischemic heart disease, profound hypotension, particularly of the diastolic type, can cause temporally related symptomatic and silent myocardial ischemia, highlighting their vulnerability to ischemic events.",4.7371945471370717e-07,0.37884969121478385,0.12041647804436403,0.03626852929563749,0.45537384932119496,0.039930555555555566,0.036216030819057374,0.5245244681241537,0.0,4.737194547137081e-07,0.5389965007326869,0.0
208,0.5,10,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Hypotension, especially low diastolic pressure, in patients with coronary disease is temporally associated with the occurrence of symptomatic and silent myocardial ischemia, suggesting that such profound hypotensive events may trigger ischemic episodes.",4.7371945471370717e-07,0.37884969121478385,0.12041647804436403,0.03626852929563749,0.45537384932119496,0.039930555555555566,0.036216030819057374,0.5245244681241537,0.0,4.737194547137081e-07,0.5389965007326869,0.0
209,0.5,1,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive ability predict how well listeners with normal hearing and cognition recognize frequency compressed speech? The link between cognitive function and recognition of frequency compressed speech in noisy environments was not statistically significant. Results might have differed if the participants had...,2.3685972735685406e-08,0.024902600569258304,0.0005796400951814454,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
209,0.5,2,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is there a predictive relationship between cognitive function and recognition of frequency compressed speech among individuals with normal hearing and cognition? The study found no significant statistical correlation between cognitive function and frequency compressed speech recognition in noise. Different outcomes might have occurred if participants had...,7.105791820705622e-08,0.052032826706055246,0.08557964009518144,0.005440279394345618,0.02390250286240292,0.06781677572873293,0.0054324046228586,0.04008125783265193,0.023242630385487524,7.105791820705622e-08,0.07410797215372344,0.0
209,0.5,3,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Can cognitive function forecast the recognition of frequency compressed speech in listeners with normal hearing and cognition? The association between cognitive performance and frequency compressed speech-in-noise recognition was not statistically significant. The results could have varied if the participants had...,7.105791820705611e-08,0.07664697281511579,0.0018279087932423985,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
209,0.5,4,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive functioning serve as a predictor for recognizing frequency compressed speech in people with normal hearing and cognition? The data showed no statistically significant relationship between cognitive function and frequency compressed speech recognition amidst noise. Findings might have been different if the participants had...,4.737194547137081e-08,0.01651364418208079,0.02155611401808394,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
209,0.5,5,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is cognitive ability an indicator of frequency compressed speech recognition in listeners with normal hearing and cognition? No statistically significant relationship was found between cognitive function and recognition of frequency compressed speech in noise. The findings might have changed if the participants had...,0.0,0.06601401719618716,0.047210557254944746,0.0,0.06762411517657974,0.04865220249835634,0.0,0.03465735902799638,0.02498356344510192,0.0,0.0,0.0
209,0.5,6,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,To what extent does cognitive function predict recognition of frequency compressed speech in individuals with normal hearing and cognition? The study revealed no significant statistical link between cognitive function and frequency compressed speech recognition in noisy settings. The outcomes may have differed if participants had...,4.737194547137081e-08,0.014993045843371355,0.044021415823914375,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
209,0.5,7,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive function influence the recognition of frequency compressed speech in listeners who have normal hearing and cognition? There was no statistically significant correlation found between cognitive functioning and recognition of frequency compressed speech in noise. The results might have been different if the participants had...,7.105791820705622e-08,0.052032826706055246,0.08557964009518144,0.005440279394345618,0.05540919288785506,0.09,0.0054324046228586,0.024397549661296924,0.06937499999999999,7.105791820705622e-08,0.008093954957539395,0.047500000000000014
209,0.5,8,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Can cognitive functioning predict how well frequency compressed speech is recognized by those with normal hearing and cognition? The relationship between cognitive function and recognition of frequency compressed speech in noise was not statistically significant. The findings could have been different if the participants had...,4.737194547137081e-08,0.01651364418208079,0.02155611401808394,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
209,0.5,9,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is there a connection between cognitive function and recognition of frequency compressed speech in individuals with normal hearing and cognition? The study did not find a statistically significant association between cognitive function and frequency compressed speech recognition in noise. The results might have differed if participants had...,9.474389094274162e-08,0.02670538288312585,0.08328375966686498,0.0072537058591274906,0.0006707989913525836,0.06632653061224489,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
209,0.5,10,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive function have predictive value for frequency compressed speech recognition in listeners with normal hearing and cognition? The findings showed no statistically significant relationship between cognitive function and recognition of frequency compressed speech in noisy environments. Different results may have been observed if the participants had...,9.474389094274162e-08,0.03356828499165143,0.04110458601189319,0.0072537058591274906,0.06228388170779198,0.02221074380165289,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
210,0.5,1,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Does increased neutrophil migratory activity after major trauma contribute to the development of acute respiratory distress syndrome? Answer: The data show that major blunt trauma boosts the migratory ability of circulating neutrophils, evident within 2 hours of admission and possibly...",4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
210,0.5,2,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Is elevated neutrophil migration following major trauma a factor in causing acute respiratory distress syndrome? Answer: Findings suggest that major blunt trauma increases the migratory potential of circulating neutrophils, observable within 2 hours after admission and may...",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
210,0.5,3,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Could increased neutrophil migration after significant trauma play a role in acute respiratory distress syndrome? Answer: The evidence indicates that major blunt trauma enhances circulating neutrophils' migratory capacity, apparent within 2 hours of hospital admission and might...",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
210,0.5,4,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Does major trauma-induced neutrophil migration contribute to the etiology of acute respiratory distress syndrome? Answer: Data indicate that major blunt trauma augments the migratory activity of circulating neutrophils, noticeable within 2 hours of admission and possibly...",1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
210,0.5,5,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Is the increased migration of neutrophils after major trauma a factor in acute respiratory distress syndrome development? Answer: These results demonstrate that major blunt trauma elevates the migratory capacity of circulating neutrophils, evident within 2 hours of admission and may...",4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
210,0.5,6,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Could the enhanced migratory activity of neutrophils post-major trauma contribute to acute respiratory distress syndrome? Answer: The data reveal that major blunt trauma increases the migratory function of circulating neutrophils, detectable within 2 hours of admission and potentially...",9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
210,0.5,7,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Does the rise in neutrophil migration after major trauma influence the onset of acute respiratory distress syndrome? Answer: Findings show that major blunt trauma boosts circulating neutrophils' migratory capacity, observable within 2 hours of admission and may...",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
210,0.5,8,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Is enhanced neutrophil migration following major trauma involved in acute respiratory distress syndrome? Answer: Evidence suggests that major blunt trauma enhances the migratory activity of circulating neutrophils, apparent within 2 hours of admission and possibly...",1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
210,0.5,9,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Does increased neutrophil migratory activity post-major trauma affect the development of acute respiratory distress syndrome? Answer: Data indicate that major blunt trauma enhances the migratory ability of circulating neutrophils, evident within 2 hours of admission and might...",1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
210,0.5,10,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Can the increased migratory capacity of neutrophils after major trauma be a factor in acute respiratory distress syndrome? Answer: These findings indicate that major blunt trauma augments the migratory capacity of circulating neutrophils, noticeable within 2 hours of admission and may...",2.3685972735685406e-08,0.09172166675563975,0.04865220249835634,0.0018134264647818726,0.05934997161836808,0.02498356344510192,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
211,0.5,1,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","The impact of MPH programs was significant across various levels, as they provided graduates with essential skills such as epidemiological analysis and program management, enabling them to play a key role in strengthening health systems, shaping policies, and preventing diseases in low- and middle-income countries.",2.1317375462116866e-07,0.13378928487461783,0.037677816224529016,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
211,0.5,2,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","MPH programs had a substantial effect at multiple levels by equipping graduates with vital skills including epidemiological analysis and program management, which helped them to contribute meaningfully to health system enhancement, policy formulation, and disease prevention in these regions.",3.552895910352809e-07,0.2803927590664932,0.037677816224529016,0.02720139697172809,0.3136662989925889,0.01922337562475971,0.027162023114293,0.3483066942682149,0.0,3.552895910352811e-07,0.356674943938732,0.0
211,0.5,3,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","Graduates of MPH programs gained important skills like epidemiological analysis and program management, leading to a notable impact on health system strengthening, policy development, and disease prevention efforts in low- and middle-income countries.",4.974054274493927e-07,0.4522430159931532,0.037677816224529016,0.03808195576041935,0.4905970071516679,0.01922337562475971,0.03802683236001023,0.5306282510621703,0.0,4.974054274493935e-07,0.5447271754416723,0.0
211,0.5,4,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","The influence of MPH programs was evident at many levels, as they trained graduates in critical skills such as epidemiological analysis and program management, allowing them to significantly support health system strengthening, policy creation, and disease prevention initiatives in these countries.",3.079176455639103e-07,0.2290994646789435,0.037677816224529016,0.023574544042164344,0.26102256550717007,0.01922337562475971,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
211,0.5,5,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","MPH programs made a considerable difference by preparing graduates with key competencies like epidemiological analysis and program management, which enabled them to contribute effectively to health system strengthening, policy-making, and disease prevention in low- and middle-income settings.",4.026615365066515e-07,0.3344599803367694,0.037677816224529016,0.030828249901291835,0.3692361501474011,0.01922337562475971,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
211,0.5,6,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","There was a marked impact from MPH programs at various levels, with graduates equipped with essential skills such as epidemiological analysis and program management, facilitating their significant involvement in health system strengthening, policy development, and disease prevention in these contexts.",3.316036182995956e-07,0.2544172726632352,0.037677816224529016,0.025387970506946217,0.28699805191042804,0.01922337562475971,0.025351221573340132,0.3209077200800996,0.0,3.316036182995957e-07,0.32850406697203516,0.0
211,0.5,7,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","MPH programs significantly influenced health systems by providing graduates with crucial skills like epidemiological analysis and program management, which empowered them to aid substantially in strengthening health systems, developing policies, and preventing diseases in low- and middle-income countries.",3.789755637709662e-07,0.30706100614865406,0.037677816224529016,0.029014823436509962,0.34106527318070423,0.01922337562475971,0.028972824655245866,0.37647757123491177,0.0,3.789755637709665e-07,0.3856624808119835,0.0
211,0.5,8,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","The contribution of MPH programs to health system strengthening in low- and middle-income countries was considerable, as graduates acquired vital skills including epidemiological analysis and program management, enabling them to impact policy and disease prevention efforts positively.",4.026615365066515e-07,0.3344599803367694,0.037677816224529016,0.030828249901291835,0.3692361501474011,0.01922337562475971,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
211,0.5,9,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","MPH programs had a profound impact at multiple levels, equipping graduates with important skills such as epidemiological analysis and program management, which allowed them to contribute significantly to health system strengthening, policy development, and disease prevention in these regions.",3.552895910352809e-07,0.2803927590664932,0.037677816224529016,0.02720139697172809,0.3136662989925889,0.01922337562475971,0.027162023114293,0.3483066942682149,0.0,3.552895910352811e-07,0.356674943938732,0.0
211,0.5,10,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","Graduates from MPH programs were equipped with essential skills like epidemiological analysis and program management, resulting in a substantial impact on health system strengthening, policy formulation, and disease prevention efforts in low- and middle-income countries.",4.500334819780221e-07,0.39161839417671773,0.037677816224529016,0.034455102830855594,0.42807665017033436,0.01922337562475971,0.034405229278104486,0.46608972992459874,0.0,4.500334819780227e-07,0.4780358009429988,0.0
212,0.5,1,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a role for polymorphisms in beta-adrenergic receptor (ADRB) genes in transient tachypnea of the newborn (TTN)? Answer: We find that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both representing loss-of-function mutations, could increase susceptibility to TTN.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,0.5,2,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in beta-adrenergic receptor (ADRB) encoding genes contribute to transient tachypnea of the newborn (TTN)? Answer: Our conclusion is that homozygosity for beta1Gly49 and the TACC haplotype in the ADRB2 gene, both loss-of-function variants, may predispose infants to TTN.",7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.5,3,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We conclude that the beta1Gly49 homozygous genotype and the ADRB2 gene's TACC haplotype, both causing loss-of-function, might increase the risk of TTN.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.5,4,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): is there a connection to polymorphisms in the beta-adrenergic receptor (ADRB) genes? Answer: We determine that beta1Gly49 homozygosity and the TACC haplotype of ADRB2, both loss-of-function genetic alterations, may predispose to TTN.",2.36859727356853e-08,0.026668247082160867,0.0,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.5,5,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Can polymorphisms in beta-adrenergic receptor (ADRB) genes influence transient tachypnea of the newborn (TTN)? Answer: It appears that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, are potential genetic risk factors for TTN.",2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.5,6,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Is there a genetic role of beta-adrenergic receptor (ADRB) polymorphisms in transient tachypnea of the newborn (TTN)? Answer: We conclude that the loss-of-function beta1Gly49 homozygosity and TACC haplotype in the ADRB2 gene may predispose newborns to TTN.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.5,7,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Question: Does transient tachypnea of the newborn (TTN) relate to polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: Our findings indicate that homozygosity for beta1Gly49 and the TACC haplotype of ADRB2, both loss-of-function variants, could increase susceptibility to TTN.",4.73719454713706e-08,0.05264373348541884,0.0,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
212,0.5,8,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could genetic variations in beta-adrenergic receptor (ADRB) genes be involved in transient tachypnea of the newborn (TTN)? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of ADRB2, both loss-of-function mutations, may predispose infants to TTN.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.5,9,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is transient tachypnea of the newborn (TTN) associated with polymorphisms in the beta-adrenergic receptor (ADRB) genes? Answer: We find that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic variants, may increase the risk of TTN.",7.10579182070559e-08,0.04330418244171419,0.02498356344510192,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.5,10,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Does the beta-adrenergic receptor (ADRB) gene polymorphism play a role in transient tachypnea of the newborn (TTN)? Answer: We conclude that loss-of-function variants such as beta1Gly49 homozygosity and the TACC haplotype of ADRB2 may predispose to TTN.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
213,0.5,1,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to the diagnostic characteristics of child bipolar I disorder? Generalization of the RCT sample was supported since only 7.8% of Phenomenology subjects did not meet RCT criteria. However, because RCT subjects were more severely ill, it is uncertain if RCT treatment findings apply to children with milder mania.",1.6580180914979784e-07,0.02918841795512961,0.1451222789572694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.5,2,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Regarding the diagnostic features of child bipolar I disorder, does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? The RCT sample generalization was supported as only 7.8% of Phenomenology participants failed to meet RCT criteria. Still, since RCT participants were more severely affected, it remains unclear if treatment results from the RCT extend to children with less severe mania.",1.1842986367842703e-07,0.01819875647921343,0.12817816480744776,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
213,0.5,3,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to child bipolar I disorder's diagnostic traits? Generalization of the RCT sample was confirmed because just 7.8% of Phenomenology subjects did not satisfy RCT criteria. Nonetheless, due to the greater severity of illness in RCT subjects, applicability of RCT treatment outcomes to children with milder mania is uncertain.",1.6580180914979784e-07,0.02918841795512961,0.1451222789572694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.5,4,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Is the ""Treatment of Early Age Mania (TEAM)"" sample representative of the diagnostic characteristics of child bipolar I disorder? Support for RCT sample generalization exists since only 7.8% of Phenomenology subjects failed to meet RCT criteria. However, as RCT subjects were more severely ill, it is unclear if RCT treatment findings are relevant for children with less severe mania.",1.4211583641411244e-07,0.011796675243260779,0.1451222789572694,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
213,0.5,5,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Can the ""Treatment of Early Age Mania (TEAM)"" sample be generalized to child bipolar I disorder's diagnostic features? The RCT sample generalization was supported because a mere 7.8% of Phenomenology subjects did not fit RCT criteria. Yet, since RCT subjects were more severely ill, applicability of treatment findings from the RCT to children with milder mania remains uncertain.",1.6580180914979784e-07,0.05350937165898717,0.12758401365114694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.5,6,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the sample from the ""Treatment of Early Age Mania (TEAM)"" study generalize to the diagnostic characteristics of child bipolar I disorder? Generalization was supported as only 7.8% of Phenomenology subjects failed RCT criteria. Nevertheless, since RCT subjects were more severely ill, it is unclear if RCT treatment findings apply to children with less severe mania.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
213,0.5,7,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Regarding child bipolar I disorder diagnosis, does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? The RCT sample generalization was supported because only 7.8% of Phenomenology subjects did not meet RCT criteria. However, due to greater illness severity in RCT subjects, it is uncertain if RCT treatment results are applicable to children with milder mania.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
213,0.5,8,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Is the ""Treatment of Early Age Mania (TEAM)"" sample generalizable to the diagnostic characteristics of child bipolar I disorder? Support for RCT sample generalization came from only 7.8% of Phenomenology subjects not fitting RCT criteria. Still, since RCT subjects were more severely ill, it remains unclear if treatment findings from the RCT apply to children with less severe mania.",1.4211583641411244e-07,0.011796675243260779,0.1451222789572694,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
213,0.5,9,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the diagnostic profile of child bipolar I disorder generalize from the ""Treatment of Early Age Mania (TEAM)"" sample? Generalization of the RCT sample was supported because only 7.8% of Phenomenology subjects did not meet RCT criteria. Nevertheless, since RCT subjects were more severely ill, it is uncertain if RCT treatment findings apply to children with milder mania.",1.6580180914979784e-07,0.02918841795512961,0.1451222789572694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.5,10,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Can the diagnostic features of child bipolar I disorder be generalized from the ""Treatment of Early Age Mania (TEAM)"" sample? The RCT sample generalization was supported as only 7.8% of Phenomenology subjects did not fit RCT criteria. However, due to increased severity of illness in RCT subjects, it is unclear if treatment findings from the RCT will apply to children with less severe mania.",2.3685972735685406e-08,0.026885695804398146,0.11341037355549569,0.0018134264647818726,0.01600034134644357,0.0,0.0018108015409528666,0.016260520871781203,0.0,2.3685972735685406e-08,0.01652930195121094,0.0
214,0.5,1,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Is external palliative radiotherapy an effective treatment for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative option for managing gallbladder carcinoma, helping to relieve pain, enhance quality of life, and control tumor growth, though it is not curative.",1.6580180914979784e-07,0.1576289442035832,0.0,0.012693985253473108,0.16126814759612174,0.0,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
214,0.5,2,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Does external palliative radiotherapy work well for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative treatment for gallbladder carcinoma that can reduce pain, improve quality of life, and manage tumor progression, but it does not cure the disease.",1.8948778188548325e-07,0.21697891582195128,0.02498356344510192,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
214,0.5,3,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Is external radiotherapy effective as palliative care for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative treatment for gallbladder carcinoma, providing pain relief, better quality of life, and tumor control, though it is not a cure.",2.1317375462116855e-07,0.2787313832972149,0.05113221329437545,0.016320838183036854,0.21256144198367144,0.0,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
214,0.5,4,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy is a safe and effective palliative approach for gallbladder carcinoma, offering pain alleviation, improved quality of life, and tumor growth control, but it is not curative.",3.0791764556390975e-07,0.31585294941847764,0.0,0.02357454404216435,0.323787077093896,0.0,0.02354042003238728,0.3321338350226144,0.0,3.079176455639103e-07,0.3409265869705931,0.0
214,0.5,5,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","How effective is external palliative radiotherapy for treating gallbladder carcinoma? External radiotherapy is a safe and effective method for palliative management of gallbladder carcinoma, helping to ease pain, enhance quality of life, and control tumor growth, without curing the disease.",2.1317375462116855e-07,0.20763936477824663,0.0,0.016320838183036854,0.21256144198367144,0.0,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
214,0.5,6,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Is external radiotherapy a viable palliative treatment for gallbladder carcinoma? External radiotherapy is considered safe and effective for palliating gallbladder carcinoma, aiding in pain relief, quality of life improvement, and tumor control, though it does not cure the cancer.",2.3685972735685385e-07,0.27009628173729094,0.026296566837107373,0.018134264647818726,0.2392296890658323,0.0,0.018108015409528666,0.24512245803298427,0.0,2.3685972735685406e-07,0.2513144282809061,0.0
214,0.5,7,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Does external radiotherapy provide effective palliative care for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, capable of relieving pain, improving quality of life, and controlling tumor growth, but it is not curative.",1.8948778188548325e-07,0.2862936338779458,0.07450693937180423,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
214,0.5,8,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Is external palliative radiotherapy beneficial for gallbladder carcinoma patients? External radiotherapy is a safe and effective palliative treatment for gallbladder carcinoma that can reduce pain, improve quality of life, and control tumor progression, but it does not offer a cure.",2.1317375462116855e-07,0.2787313832972149,0.05113221329437545,0.016320838183036854,0.24904287253945778,0.026296566837107373,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
214,0.5,9,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","What is the effectiveness of external palliative radiotherapy in gallbladder carcinoma? External radiotherapy is a safe and effective palliative option for gallbladder carcinoma, providing pain relief, quality of life improvement, and tumor growth control, although it is not curative.",2.3685972735685385e-07,0.2336148511815046,0.0,0.018134264647818726,0.2392296890658323,0.0,0.018108015409528666,0.24512245803298427,0.0,2.3685972735685406e-07,0.2513144282809061,0.0
214,0.5,10,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Can external radiotherapy serve as an effective palliative therapy for gallbladder carcinoma? External radiotherapy is a safe and effective palliative treatment for gallbladder carcinoma, helping to alleviate pain, enhance quality of life, and manage tumor growth, but it does not cure the disease.",1.4211583641411244e-07,0.23255241841880192,0.07100591715976329,0.010880558788691236,0.13657553500575004,0.0,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
215,0.5,1,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH? In vitro fertilization success is closely linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Among these, antral follicle assessment predicts IVF results better than age or FSH levels.",2.6054570009253947e-07,0.09979906902310365,0.0629768947187928,0.0199476911126006,0.13567219769740646,0.04525917627683857,0.019918816950481533,0.17941935809280807,0.016661878770468257,2.6054570009253947e-07,0.20633643299782767,0.0
215,0.5,2,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Does antral follicle assessment outperform age and FSH in predicting IVF outcomes? IVF success correlates strongly with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle count being a more accurate predictor than age or FSH.",4.500334819780227e-07,0.25526546038121767,0.06805587176618524,0.03445510283085558,0.282299697619786,0.0652508464142813,0.034405229278104466,0.357667589499127,0.016661878770468257,4.500334819780227e-07,0.38865798979178257,0.0
215,0.5,3,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Can antral follicle assessment better forecast IVF outcomes than age and FSH? The results of in vitro fertilization are closely associated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment serving as a more reliable predictor than age or FSH.",3.079176455639103e-07,0.17184332915555522,0.03780521262002734,0.023574544042164344,0.17764943751859352,0.04442694419608302,0.023540420032387266,0.221092054493377,0.016661878770468257,3.079176455639103e-07,0.2488960474166242,0.0
215,0.5,4,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle count a more effective predictor of IVF success than maternal age and FSH? IVF outcomes have strong correlations with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with the latter being superior to age and FSH as a predictor.",3.552895910352811e-07,0.14866185479723404,0.12076817558299033,0.02720139697172809,0.19132791941405936,0.0652508464142813,0.027162023114293,0.26457716643311535,0.016661878770468257,3.552895910352811e-07,0.2933478099874569,0.0
215,0.5,5,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","How does antral follicle assessment compare to age and FSH in predicting IVF results? The outcome of in vitro fertilization is significantly linked to maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment outperforming age and FSH as a predictor.",3.316036182995957e-07,0.22392386180179402,0.013967435777022502,0.025387970506946217,0.22881296360245296,0.022781710611812174,0.025351221573340132,0.24259825971434035,0.016661878770468257,3.316036182995957e-07,0.2708749541353992,0.0
215,0.5,6,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a better indicator of IVF success than age or FSH? IVF outcomes show strong correlation with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, where antral follicle count is a superior predictor compared to age and FSH.",3.789755637709665e-07,0.18282543813067376,0.0743943361788479,0.029014823436509962,0.21330682613283436,0.0652508464142813,0.028972824655245866,0.28705002228517307,0.016661878770468257,3.789755637709665e-07,0.31633732821215643,0.0
215,0.5,7,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Does antral follicle assessment provide a more accurate prediction of IVF results than age and FSH? In vitro fertilization outcomes are closely related to maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment being the better predictor.",4.026615365066519e-07,0.23720307793037554,0.04929173315416695,0.030828249901291835,0.26728637201034466,0.04253586534343219,0.030783626196198732,0.3100395405098726,0.016661878770468257,4.026615365066519e-07,0.33986782562235085,0.0
215,0.5,8,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Can antral follicle assessment predict IVF outcomes more effectively than age and FSH? IVF success correlates strongly with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment offering better predictive value than age or FSH.",4.500334819780227e-07,0.31974426787516563,0.019910552674085424,0.03445510283085558,0.3153067062178776,0.04145548650946275,0.034405229278104466,0.357667589499127,0.016661878770468257,4.500334819780227e-07,0.38865798979178257,0.0
215,0.5,9,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a more reliable predictor of IVF outcome than age and follicle-stimulating hormone? The outcome of in vitro fertilization is strongly linked to maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with the latter being superior to age and FSH.",3.316036182995957e-07,0.12637946123670574,0.1216494096841362,0.025387970506946217,0.169821714193096,0.0652508464142813,0.025351221573340132,0.24259825971434035,0.016661878770468257,3.316036182995957e-07,0.2708749541353992,0.0
215,0.5,10,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","How effective is antral follicle assessment compared to age and FSH in predicting IVF success? IVF outcome is highly correlated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment proving to be a better predictor than age or FSH.",3.316036182995957e-07,0.16616159675513176,0.05657064471879285,0.025387970506946217,0.19931733889777448,0.04398430577155921,0.025351221573340132,0.24259825971434035,0.016661878770468257,3.316036182995957e-07,0.2708749541353992,0.0
216,0.5,1,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are the home blood pressure readings reported by stroke patients dependable? This cohort of elderly stroke patients successfully recorded their blood pressures at home with reliability. Any bias observed was minimal and unlikely to influence treatment decisions. Given that blood pressure measurements taken in a GP's office often do not accurately reflect true blood pressure, GPs might consider utilizing hypertensive monitoring methods.",9.474389094274162e-08,0.022370322203681958,0.03274920999712727,0.0072537058591274906,0.06899287148694988,0.0,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
216,0.5,2,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Can stroke patients reliably report their home blood pressure measurements? Elderly stroke patients in this study were able to consistently record their blood pressure at home. The bias was minor and unlikely to impact clinical management. Since blood pressure readings taken in general practice settings often do not represent true blood pressure, GPs may want to consider hypertensive monitoring.",2.3685972735685406e-08,0.06333465775579095,0.08793388429752061,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
216,0.5,3,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Do stroke patients provide trustworthy home blood pressure readings? This group of elderly stroke patients showed reliable home blood pressure recording. Any bias present was small and unlikely to affect treatment management. Because blood pressure readings in GP offices often poorly indicate true blood pressure, GPs might consider using hypertensive monitoring.",1.6580180914979784e-07,0.25239677417128714,0.1228733459357278,0.012693985253473108,0.16182311428003082,0.020399305555555556,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
216,0.5,4,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Is the home blood pressure data reported by stroke patients reliable? The elderly stroke patients involved were able to accurately record their blood pressures at home. The bias was minimal and unlikely to change patient management. Since blood pressure readings in GP surgeries often do not reflect true blood pressure, GPs might consider hypertensive monitoring techniques.",4.737194547137081e-08,0.08612878664280244,0.03631185475258099,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
216,0.5,5,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are reports of home blood pressure readings from stroke patients dependable? This elderly stroke patient group reliably recorded their blood pressures at home. Any bias was slight and unlikely to influence clinical decisions. Given that blood pressure measurements in GP surgeries frequently do not provide a true indication of blood pressure, GPs might consider hypertensive monitoring.",4.737194547137081e-08,0.060923434622440986,0.0181755829903978,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
216,0.5,6,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Can elderly stroke patients reliably record their blood pressure at home? This group demonstrated reliable home blood pressure recordings. The bias detected was small and unlikely to affect management. Since blood pressure readings taken in GP surgeries often poorly reflect true blood pressure, GPs might consider hypertensive monitoring approaches.",2.1317375462116866e-07,0.24051352496841583,0.08506616257088842,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
216,0.5,7,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are home blood pressure measurements reported by stroke patients accurate? The elderly stroke patients reliably recorded their blood pressure at home. The bias was minimal and unlikely to impact clinical management. Because blood pressure readings at GP surgeries often fail to indicate true blood pressure, GPs might consider employing hypertensive monitoring.",1.6580180914979784e-07,0.22467088694888915,0.10230873698506115,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
216,0.5,8,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Do elderly stroke patients provide reliable home blood pressure readings? This patient group was able to record their blood pressure at home consistently. Any bias was minor and unlikely to affect treatment. Since blood pressure readings in GP surgeries often poorly represent true blood pressure, GPs may consider hypertensive monitoring.",1.8948778188548325e-07,0.21849294658115426,0.08329560887279312,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
216,0.5,9,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Is the reliability of home blood pressure recordings by stroke patients confirmed? Elderly stroke patients in this study reliably measured their blood pressure at home. The bias was small and unlikely to influence management decisions. Given that blood pressure readings in GP offices are often not indicative of true blood pressure, GPs might consider hypertensive monitoring.",4.737194547137081e-08,0.12084774127706499,0.09282544378698228,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
216,0.5,10,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are stroke patients' self-reported home blood pressure readings trustworthy? This group of elderly stroke patients successfully recorded their blood pressure at home with reliability. Any bias found was minimal and unlikely to affect clinical management. Since blood pressure measurements taken in GP surgeries often do not accurately reflect true blood pressure, GPs might consider hypertensive monitoring methods.",2.3685972735685406e-08,0.07655380684947888,0.07270233196159122,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
217,0.5,1,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","Is untethering required before scoliosis correction in a patient with myelomeningocele? The study indicated that spinal cord untethering before scoliosis correction might not be essential, as it showed no significant neurological improvement.",2.605457000925385e-07,0.3271067424807397,0.016709274673008298,0.019947691112600634,0.3247724394911926,0.008918697978596915,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
217,0.5,2,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","For a patient with myelomeningocele, is it necessary to perform untethering before correcting scoliosis? Research suggests that untethering the spinal cord prior to scoliosis surgery may not be needed since it does not significantly enhance neurological outcomes.",1.42115836414112e-07,0.08813666263107356,0.047500000000000014,0.010880558788691236,0.12441194762660457,0.024375,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
217,0.5,3,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","Should spinal cord untethering be done before scoliosis correction in myelomeningocele patients? The study's findings imply that untethering before scoliosis correction may not be required, given the lack of notable neurological function improvement.",2.3685972735685321e-07,0.29256309585745166,0.014722222222222213,0.018134264647818754,0.2904919775702224,0.0078472222222222,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
217,0.5,4,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","In patients with myelomeningocele, is untethering mandatory before scoliosis correction? According to the study, spinal cord untethering prior to scoliosis surgery may not be necessary as it did not result in meaningful neurological benefits.",2.1317375462116791e-07,0.1751480396207037,0.047500000000000014,0.016320838183036875,0.21402410631629154,0.024375,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
217,0.5,5,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
",Does scoliosis correction in myelomeningocele patients require prior spinal cord untethering? The study suggests that untethering beforehand may not be necessary since it failed to show significant neurological function enhancement.,3.079176455639091e-07,0.30435977110071066,0.047500000000000014,0.023574544042164393,0.34755549894081383,0.024375,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
217,0.5,6,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","Is untethering the spinal cord needed before scoliosis correction in patients with myelomeningocele? Study results indicate that preoperative untethering may not be essential, as it did not significantly improve neurological function.",2.842316728282238e-07,0.2704582194250289,0.047500000000000014,0.021761117577382513,0.31246417912954483,0.024375,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
217,0.5,7,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","For scoliosis correction in myelomeningocele patients, is untethering required beforehand? Findings from the study suggest that spinal cord untethering prior to correction may not provide significant neurological improvement and thus might be unnecessary.",2.3685972735685321e-07,0.20591969828745738,0.047500000000000014,0.018134264647818754,0.24577280463087137,0.024375,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
217,0.5,8,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","In the context of myelomeningocele, is untethering necessary before scoliosis correction? The research indicates that untethering the spinal cord before surgery may not be needed since it did not show significant neurological gains.",2.3685972735685321e-07,0.20591969828745738,0.047500000000000014,0.018134264647818754,0.24577280463087137,0.024375,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
217,0.5,9,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
",Is it essential to perform spinal cord untethering before scoliosis correction in myelomeningocele patients? The study results suggest it may not be necessary as no significant neurological improvement was observed.,3.079176455639091e-07,0.30435977110071066,0.047500000000000014,0.023574544042164393,0.34755549894081383,0.024375,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
217,0.5,10,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","Should patients with myelomeningocele undergo untethering prior to scoliosis correction? According to the study, untethering before scoliosis correction may not be required because it did not significantly improve neurological function.",3.079176455639091e-07,0.30435977110071066,0.047500000000000014,0.023574544042164393,0.34755549894081383,0.024375,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
218,0.5,1,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
",Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair unnecessary? Monitoring spinal cord function and timely intervention show that reimplantation is essential to prevent neurological issues by maintaining adequate blood flow and reducing ischemia risks.,4.263475092423369e-07,0.27056101713467084,0.16495323129251702,0.03264167636607371,0.3004452560581017,0.1157850895460225,0.032594427737151606,0.3715641800760392,0.03840000000000001,4.263475092423373e-07,0.40813582888294553,0.019599999999999992
218,0.5,2,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","During thoracic and thoracoabdominal aneurysm repair, is reimplantation of spinal cord arteries pointless? Evidence indicates that with proper spinal cord monitoring and prompt action, reimplantation is vital to avoid neurological damage by ensuring sufficient spinal cord perfusion.",4.263475092423369e-07,0.32360386449257206,0.0785214821222607,0.03264167636607371,0.3004452560581017,0.1157850895460225,0.032594427737151606,0.3715641800760392,0.03840000000000001,4.263475092423373e-07,0.40813582888294553,0.019599999999999992
218,0.5,3,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","Does reimplantation of spinal cord arteries serve any purpose in thoracic and thoracoabdominal aneurysm repair? When spinal cord function is monitored and addressed timely, reimplantation plays a key role in preventing neurological complications by sustaining blood supply and minimizing ischemia.",3.55289591035281e-07,0.18755614202284576,0.1670850646352724,0.02720139697172809,0.21820715782112865,0.1157850895460225,0.027162023114293,0.2870067920479755,0.03840000000000001,3.552895910352811e-07,0.3211244518933154,0.019599999999999992
218,0.5,4,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
",Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair a futile effort? Careful monitoring and timely intervention confirm its importance in protecting neurological function through adequate spinal cord blood flow and ischemia prevention.,4.500334819780222e-07,0.2998321277213041,0.16416162053056518,0.03445510283085559,0.3294327929313532,0.1157850895460225,0.03440522927810448,0.401417143225721,0.03840000000000001,4.500334819780227e-07,0.4389074875496992,0.019599999999999992
218,0.5,5,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
",Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair a waste of time? Monitoring spinal cord function and intervening promptly demonstrate that reimplantation is critical to prevent neurological deficits by maintaining blood flow and reducing ischemic risk.,3.55289591035281e-07,0.18755614202284576,0.1670850646352724,0.02720139697172809,0.21820715782112865,0.1157850895460225,0.027162023114293,0.2870067920479755,0.03840000000000001,3.552895910352811e-07,0.3211244518933154,0.019599999999999992
218,0.5,6,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","In thoracic and thoracoabdominal aneurysm repair, does reimplanting spinal cord arteries have value? With spinal cord function monitoring and quick intervention, reimplantation is crucial for preventing neurological harm by ensuring sufficient blood supply and reducing ischemia.",4.500334819780222e-07,0.2998321277213041,0.16416162053056518,0.03445510283085559,0.3294327929313532,0.1157850895460225,0.03440522927810448,0.401417143225721,0.03840000000000001,4.500334819780227e-07,0.4389074875496992,0.019599999999999992
218,0.5,7,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
",Is reimplantation of spinal cord arteries unnecessary in thoracic and thoracoabdominal aneurysm repair? Monitoring spinal cord function and timely treatment prove that reimplantation is essential to avoid neurological complications by preserving blood flow and preventing ischemia.,4.500334819780222e-07,0.2998321277213041,0.16416162053056518,0.03445510283085559,0.3294327929313532,0.1157850895460225,0.03440522927810448,0.401417143225721,0.03840000000000001,4.500334819780227e-07,0.4389074875496992,0.019599999999999992
218,0.5,8,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","When repairing thoracic and thoracoabdominal aneurysms, is reimplantation of spinal cord arteries pointless? Evidence shows that with spinal cord monitoring and prompt intervention, reimplantation is vital for neurological protection by maintaining adequate spinal cord perfusion.",4.737194547137075e-07,0.3861476326887363,0.07161458333333334,0.03626852929563747,0.35928575608103497,0.1157850895460225,0.03621603081905735,0.43218880189247466,0.03840000000000001,4.737194547137081e-07,0.47065618586427904,0.019599999999999992
218,0.5,9,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
",Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair ineffective? Careful monitoring and timely action reveal that reimplantation is important to prevent neurological damage by ensuring proper blood flow and minimizing ischemic injury.,4.737194547137075e-07,0.28921125427684435,0.19270833333333334,0.03626852929563747,0.35928575608103497,0.1157850895460225,0.03621603081905735,0.43218880189247466,0.03840000000000001,4.737194547137081e-07,0.47065618586427904,0.019599999999999992
218,0.5,10,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
",Does reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair lack benefit? Monitoring spinal cord function and intervening promptly confirm that reimplantation is key to preserving neurological integrity through adequate blood supply and ischemia prevention.,4.263475092423369e-07,0.27056101713467084,0.16495323129251702,0.03264167636607371,0.3004452560581017,0.1157850895460225,0.032594427737151606,0.3715641800760392,0.03840000000000001,4.263475092423373e-07,0.40813582888294553,0.019599999999999992
219,0.5,1,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Question: Does a preoperative medically supervised weight loss program enhance bariatric surgery results? Answer: MSWM seems to offer no extra advantage over the usual preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes following LAGB in our patients.,1.4211583641411233e-07,0.152579779443204,0.006783916917955768,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.5,2,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Question: Can a medically supervised weight loss program before surgery improve bariatric surgery outcomes? Answer: MSWM does not seem to provide additional benefits compared to the standard preoperative bariatric protocol in terms of weight loss and behavioral outcomes after LAGB in our patient group.,4.737194547137081e-08,0.01608869510729205,0.02110566599093216,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
219,0.5,3,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Question: Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? Answer: MSWM appears not to offer added benefits beyond the standard preoperative bariatric surgery protocol for weight loss and most behavioral results after LAGB in our population.,4.737194547137081e-08,0.048328098854266255,0.0020526554379765166,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
219,0.5,4,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Question: Does undergoing a medically supervised weight loss program before surgery improve outcomes in bariatric surgery? Answer: MSWM does not show significant benefits over the standard preoperative bariatric surgery protocol concerning weight loss and behavioral outcomes post-LAGB in our patients.,1.4211583641411233e-07,0.11703377018371963,0.01872502767835873,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.5,5,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Question: Does a medically supervised weight loss program prior to surgery enhance bariatric surgery results? Answer: MSWM does not seem to provide any additional advantage compared to the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes after LAGB in our patient population.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
219,0.5,6,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Question: Does participation in a preoperative medically supervised weight loss program improve outcomes after bariatric surgery? Answer: MSWM does not appear to yield extra benefits relative to the standard preoperative bariatric surgery protocol regarding weight loss and behavioral outcomes following LAGB in our patients.,4.737194547137081e-08,0.01608869510729205,0.02110566599093216,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
219,0.5,7,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Question: Is there an improvement in bariatric surgery results with a medically supervised weight loss program before surgery? Answer: MSWM does not appear to confer additional benefits beyond the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient group.,7.105791820705622e-08,0.0683893388073491,0.0027603946750964226,0.005440279394345618,0.06595796779179608,0.0,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
219,0.5,8,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Question: Does a preoperative medically supervised weight loss program contribute to better bariatric surgery outcomes? Answer: MSWM does not seem to offer any added benefit compared to the standard preoperative bariatric surgery protocol concerning weight loss and behavioral outcomes after LAGB in our population.,4.737194547137081e-08,0.048328098854266255,0.0020526554379765236,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
219,0.5,9,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Question: Does engaging in a medically supervised weight loss program before bariatric surgery improve surgical outcomes? Answer: MSWM does not appear to provide further benefits over the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes post-LAGB in our patient cohort.,4.737194547137081e-08,0.048328098854266255,0.0020526554379765236,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
219,0.5,10,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Question: Can a preoperative medically supervised weight loss program improve the outcomes of bariatric surgery? Answer: MSWM does not seem to add any benefit beyond the standard preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes after LAGB in our patient population.,4.737194547137081e-08,0.01608869510729205,0.02110566599093216,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
220,0.5,1,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does receiving birth center care during a woman's initial pregnancy influence her later reproductive outcomes? A woman's care model, like birth center care, during her first pregnancy appears not to significantly impact future reproduction in Sweden.",2.6054570009253894e-07,0.2620996538229363,0.007966979892836644,0.019947691112600606,0.2803019651541576,0.0,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
220,0.5,2,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Is birth center care in a woman's first pregnancy linked to changes in her subsequent reproduction? In Sweden, the type of care, including birth center care, during the first pregnancy does not seem to notably affect later reproduction.",2.1317375462116834e-07,0.20224781236350786,0.011022394896303571,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
220,0.5,3,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does the use of birth center care for a woman's first pregnancy affect her future reproductive behavior? Evidence from Sweden suggests that the care model during the first pregnancy, such as birth center care, is not a key factor influencing later reproduction.",1.1842986367842703e-07,0.058470885560909736,0.04052494591671175,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.5,4,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Can birth center care during a woman's first pregnancy influence her reproductive outcomes later on? In Sweden, a woman's care model during her initial pregnancy, including birth center care, does not appear to have a significant effect on future reproduction.",1.6580180914979774e-07,0.1457612670662516,0.013767732622336298,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
220,0.5,5,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Is there an impact of birth center care during a woman's first pregnancy on her subsequent reproduction? The data from Sweden indicates that the model of care, like birth center care, during the first pregnancy is not a major factor in later reproduction.",9.474389094274162e-08,0.0665752935897439,0.017399945916711734,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
220,0.5,6,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does first pregnancy birth center care affect a woman's future reproduction? In Sweden, the choice of care model during the first pregnancy, such as birth center care, does not seem to play a significant role in subsequent reproduction.",2.1317375462116834e-07,0.16478039719810456,0.03789377307720558,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
220,0.5,7,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does receiving birth center care in the first pregnancy influence a woman's future reproductive patterns? Swedish findings suggest that the care model during the first pregnancy, including birth center care, does not significantly affect later reproduction.",2.6054570009253894e-07,0.2620996538229363,0.007966979892836644,0.019947691112600606,0.2803019651541576,0.0,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
220,0.5,8,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Is birth center care during a woman's first pregnancy a determinant of her future reproduction? In Sweden, the type of care during the first pregnancy, such as birth center care, is not considered a crucial factor for subsequent reproduction.",1.8948778188548304e-07,0.1736075960621144,0.012430810114242609,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
220,0.5,9,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does a woman's first pregnancy care model, like birth center care, impact her later reproductive outcomes? Evidence from Sweden shows that birth center care during the first pregnancy is not a significant factor in future reproduction.",2.6054570009253894e-07,0.2620996538229363,0.007966979892836644,0.019947691112600606,0.2803019651541576,0.0,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
220,0.5,10,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Does birth center care during a woman's initial pregnancy have any bearing on her future reproductive behavior? In Sweden, it appears that the care model during the first pregnancy, including birth center care, does not significantly influence subsequent reproduction.",1.8948778188548304e-07,0.1371261655063276,0.03860337907960437,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
221,0.5,1,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Does preoperative anemia negatively impact the outcomes of colon and rectal surgeries? This extensive multicenter database study indicates that both severe and moderate anemia are linked to a greater likelihood of postoperative complications, longer hospital stays, and increased readmission rates after colon and rectal surgery.",2.3685972735685406e-08,0.023873153186523055,0.0010031775464828113,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
221,0.5,2,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Is there an adverse effect of preoperative anemia on colon and rectal surgery results? Analysis of a large multicenter database shows that severe and moderate anemia correlate with higher risks of postoperative complications, extended hospitalization, and more frequent readmissions in these surgeries.",9.474389094274162e-08,0.03147734034957228,0.04434829637641968,0.0072537058591274906,0.06380348977887307,0.02271498107084911,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
221,0.5,3,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Does having anemia before surgery worsen colon and rectal surgery outcomes? Findings from a large multicenter database reveal that severe and moderate anemia are associated with increased postoperative complications, longer hospital stays, and elevated readmission rates.",2.3685972735685353e-07,0.18970134556446672,0.04434829637641968,0.018134264647818733,0.2263224192766473,0.02271498107084911,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
221,0.5,4,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","How does preoperative anemia affect colon and rectal surgery outcomes? Data from a large multicenter study suggest that patients with severe or moderate anemia face greater risks of postoperative complications, prolonged hospitalization, and higher chances of readmission.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641968,0.016320838183036854,0.1973348824033958,0.02271498107084911,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
221,0.5,5,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Is preoperative anemia linked to poorer outcomes in colon and rectal surgery? This analysis of a large multicenter database suggests that severe and moderate anemia increase the risk of postoperative complications, lengthen hospital stays, and raise readmission rates.",1.8948778188548293e-07,0.13413149440965455,0.04434829637641968,0.014507411718254981,0.16916400543669896,0.02271498107084911,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
221,0.5,6,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Does anemia prior to surgery adversely influence the results of colon and rectal procedures? The large multicenter database analysis indicates that severe and moderate anemia are associated with higher postoperative complication rates, longer hospital stays, and increased readmissions.",1.8948778188548293e-07,0.13413149440965455,0.04434829637641968,0.014507411718254981,0.16916400543669896,0.02271498107084911,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
221,0.5,7,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","What impact does preoperative anemia have on the outcomes of colon and rectal surgery? A large multicenter database analysis suggests that severe and moderate anemia correlate with increased postoperative complications, extended hospital stays, and higher readmission rates.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641968,0.016320838183036854,0.1973348824033958,0.02271498107084911,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
221,0.5,8,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Does the presence of anemia before surgery negatively affect colon and rectal surgery outcomes? Results from a large multicenter database study show that severe and moderate anemia increase the risks of postoperative complications, prolonged hospitalization, and more frequent readmissions.",1.6580180914979763e-07,0.10746324732749368,0.04434829637641968,0.012693985253473108,0.14176503124858364,0.02271498107084911,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
221,0.5,9,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Can preoperative anemia lead to worse outcomes in colon and rectal surgeries? Analysis of a large multicenter database finds that severe and moderate anemia are linked to increased postoperative complications, longer hospital stays, and higher readmission rates.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641968,0.016320838183036854,0.1973348824033958,0.02271498107084911,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
221,0.5,10,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Does pre-surgery anemia adversely impact colon and rectal surgery results? This large multicenter database analysis demonstrates that severe and moderate anemia are associated with greater postoperative complication risks, extended hospital stays, and elevated readmission rates.",2.6054570009253883e-07,0.21868888243771822,0.04434829637641968,0.019947691112600613,0.2561753824263291,0.02271498107084911,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
222,0.5,1,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Precursor to Bronchiectasis? Although no conclusive evidence exists, research indicates a possible connection. Dysfunctional macrophages might promote chronic inflammation and airway injury, raising the risk of bronchiectasis. More studies are required to confirm this link.",9.474389094274162e-08,0.08338160893905089,0.0,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
222,0.5,2,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Does Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis Lead to Bronchiectasis? While a direct relationship hasn't been proven, findings suggest a potential association. Impaired macrophage activity could cause ongoing inflammation and damage to airways, potentially increasing bronchiectasis risk. Additional research is necessary to better understand this connection.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
222,0.5,3,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Could Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis Be an Early Indicator of Bronchiectasis? Definitive proof is lacking, but evidence points to a possible link. Reduced macrophage function may contribute to persistent inflammation and airway harm, elevating the risk for bronchiectasis. Further investigation is needed to clarify this relationship.",2.3685972735685406e-08,0.019802627296179764,0.0,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
222,0.5,4,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Is there a link between Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis and Bronchiectasis? Although not definitively established, studies imply a potential correlation. Impaired macrophage function might lead to chronic inflammation and airway damage, increasing the likelihood of bronchiectasis. More research is needed to elucidate this association.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
222,0.5,5,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Does Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis predispose them to Bronchiectasis? While a firm link is yet to be confirmed, research suggests a possible connection. Dysfunction in macrophages may promote persistent inflammation and airway injury, thereby raising bronchiectasis risk. Further studies are required to confirm this hypothesis.",0.0,0.027725887222397994,0.019991670137442734,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
222,0.5,6,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Is Alveolar Macrophage Phagocytic Dysfunction a precursor to Bronchiectasis in children suffering from Protracted Bacterial Bronchitis? A definitive connection hasn't been established, but studies indicate a potential association. Impaired macrophage function could contribute to chronic airway inflammation and damage, increasing bronchiectasis risk. Additional research is needed to clarify this link.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
222,0.5,7,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Could dysfunction of Alveolar Macrophage Phagocytosis in children with Protracted Bacterial Bronchitis be an early sign of Bronchiectasis? Although conclusive evidence is absent, studies suggest a possible correlation. Impaired macrophage activity may facilitate chronic inflammation and airway damage, heightening bronchiectasis risk. Further investigation is essential to confirm this relationship.",4.737194547137081e-08,0.04082199452025437,0.0,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
222,0.5,8,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Is there evidence that Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis precedes Bronchiectasis? Definitive proof is lacking, but research suggests a potential link. Dysfunctional macrophages might contribute to ongoing inflammation and airway injury, increasing the risk of bronchiectasis. More studies are necessary to establish this connection.",4.737194547137081e-08,0.04082199452025437,0.0,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
222,0.5,9,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Does Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis act as a forerunner to Bronchiectasis? While no definitive link has been proven, studies indicate a potential association. Impaired macrophage function may lead to chronic inflammation and airway damage, raising bronchiectasis risk. Further research is needed to better understand this relationship.",2.3685972735685406e-08,0.019802627296179764,0.0,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
222,0.5,10,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Is Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis an early factor in the development of Bronchiectasis? Although conclusive evidence is missing, findings suggest a possible correlation. Reduced macrophage function could contribute to persistent inflammation and airway damage, increasing the risk of bronchiectasis. Additional studies are required to clarify this association.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
223,0.5,1,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","Is neck dissection necessary when metastatic carcinoma is found in cervical nodes but the primary head and neck tumor is unknown? In our practice, we typically advise neck dissection. Even if the original tumor site isn't identified, metastatic cancer in cervical nodes suggests a significant risk of disease advancement. Performing neck dissection aids in disease control, cancer staging, and may help locate the primary tumor.",2.1317375462116866e-07,0.1232680867888547,0.005900615148019983,0.01632083818303691,0.13628197667436304,0.001982752872852612,0.016297213868575813,0.13554549199622468,0.0,2.1317375462116866e-07,0.137621377876048,0.0
223,0.5,2,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","When metastatic carcinoma is detected in cervical lymph nodes without an identified primary tumor in the head and neck, should neck dissection be performed? Based on our experience, neck dissection is usually recommended. The presence of metastatic cancer in cervical nodes indicates a high chance of disease progression, and neck dissection assists in managing the disease, staging the cancer, and possibly finding the primary site.",2.1317375462116866e-07,0.10978298964267719,0.01142567109522409,0.01632083818303691,0.11427730427563532,0.013886133703630227,0.016297213868575813,0.13554549199622468,0.0,2.1317375462116866e-07,0.137621377876048,0.0
223,0.5,3,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","Is neck dissection indicated for metastatic carcinoma to cervical nodes with an unknown primary tumor in the head and neck? Our experience suggests that neck dissection is generally advised. Although the primary tumor is unknown, metastatic involvement of cervical nodes implies a high risk of disease progression. Neck dissection facilitates disease control, cancer staging, and may uncover the primary tumor.",3.316036182995957e-07,0.2443215142552546,0.05293340405636955,0.025387970506946272,0.19696902012075146,0.013886133703630227,0.025351221573340146,0.21962860920676608,0.0,3.316036182995957e-07,0.22314355131420882,0.0
223,0.5,4,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","For metastatic carcinoma in cervical lymph nodes from an unknown head and neck primary, is neck dissection needed? We generally recommend neck dissection in these cases. The presence of metastatic carcinoma in cervical nodes signals a high likelihood of disease progression. Neck dissection helps in controlling the disease, staging the cancer, and potentially locating the primary tumor.",4.026615365066519e-07,0.30327608093917036,0.059520376778162284,0.03082824990129189,0.3004895494754227,0.022425721048950763,0.030783626196198746,0.2993679482755578,0.01851192595229618,4.026615365066519e-07,0.2782033284972374,0.0
223,0.5,5,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","Should neck dissection be performed when metastatic carcinoma is present in cervical nodes but the primary head and neck tumor is unknown? Our experience indicates that neck dissection is typically recommended. Metastatic carcinoma in cervical nodes suggests a significant risk for disease progression, and neck dissection aids in disease control, staging, and possibly identifying the primary site.",4.026615365066519e-07,0.35278659383630906,0.09514246875220676,0.03082824990129189,0.2752841974550613,0.004289449286767574,0.030783626196198746,0.27369583047704094,0.0,4.026615365066519e-07,0.2782033284972374,0.0
223,0.5,6,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","In cases of metastatic carcinoma to cervical nodes with an unknown primary tumor in the head and neck, is neck dissection necessary? We usually recommend neck dissection. The detection of metastatic cancer in cervical nodes represents a high probability of disease progression. Neck dissection assists in controlling the disease, staging the cancer, and may help find the primary tumor.",3.552895910352811e-07,0.20676964277969567,0.016552589436357894,0.027201396971728145,0.2143607628326203,0.013886133703630227,0.027162023114293013,0.2373281863061667,0.0,3.552895910352811e-07,0.2411620568168873,0.0
223,0.5,7,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","Is neck dissection warranted for metastatic carcinoma in cervical nodes when the primary head and neck tumor is unknown? Our experience generally supports neck dissection. The presence of metastatic carcinoma in cervical nodes indicates a high risk of disease progression; neck dissection helps control the disease, stage the cancer, and potentially identify the primary tumor.",4.500334819780227e-07,0.360556432805359,0.041252162629757796,0.034455102830855636,0.36558960925391126,0.0425138662963698,0.03440522927810448,0.36475517234911514,0.03840000000000001,4.500334819780227e-07,0.3438518516999327,0.019599999999999992
223,0.5,8,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","When metastatic carcinoma is found in cervical nodes from an unknown head and neck primary, is neck dissection advised? Based on our experience, neck dissection is commonly recommended. Metastatic involvement of cervical nodes suggests a high likelihood of disease progression. Neck dissection aids in disease control, cancer staging, and may reveal the primary tumor.",4.737194547137081e-07,0.3135579576513976,0.028277162629757782,0.03626852929563751,0.3061683120857426,0.013886133703630227,0.036216030819057346,0.33085424431699106,0.0,4.737194547137081e-07,0.33647223662121295,0.0
223,0.5,9,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","Is neck dissection necessary for metastatic carcinoma in cervical lymph nodes with an unknown primary tumor in the head and neck region? We generally suggest neck dissection. The presence of metastatic carcinoma in cervical nodes signifies a high chance of disease progression. Neck dissection helps manage the disease, stage the cancer, and potentially locate the primary tumor.",4.026615365066519e-07,0.26917710763766234,0.002883079789521112,0.03082824990129189,0.3004895494754227,0.022425721048950763,0.030783626196198746,0.2993679482755578,0.01851192595229618,4.026615365066519e-07,0.2782033284972374,0.0
223,0.5,10,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","For metastatic carcinoma to cervical nodes from an unknown head and neck primary site, is neck dissection required? Our experience recommends neck dissection in such scenarios. Even if the primary tumor is not identified, metastatic carcinoma in cervical nodes indicates a high risk of disease progression. Neck dissection assists in disease control, staging, and may help discover the primary tumor.",3.316036182995957e-07,0.24432151425525417,0.05293340405636955,0.025387970506946272,0.19696902012075146,0.013886133703630227,0.025351221573340146,0.21962860920676608,0.0,3.316036182995957e-07,0.22314355131420882,0.0
224,0.5,1,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
224,0.5,2,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The mortality rate following emergency laparotomy is notably high, particularly among patients older than 70, indicating a pressing need for enhanced care strategies.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
224,0.5,3,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomies are associated with significant mortality rates, especially in elderly patients above 70 years, highlighting the urgency for better intervention methods.",9.474389094274162e-08,0.09531017980432566,0.0,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
224,0.5,4,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: There is a considerable mortality risk linked to emergency laparotomy, particularly for those aged over 70, emphasizing the necessity for improvements in patient outcomes.",4.737194547137081e-08,0.04652001563489394,0.0,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
224,0.5,5,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: High mortality rates in emergency laparotomy, especially in patients older than 70, point to a critical need for advancements in treatment and care.",7.105791820705622e-08,0.1382416823905337,0.04865220249835634,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
224,0.5,6,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The risk of death following emergency laparotomy is elevated, mainly among individuals over 70 years, underscoring the demand for better outcome measures.",9.474389094274162e-08,0.09531017980432566,0.0,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
224,0.5,7,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy mortality remains high, particularly in the elderly population above 70 years, indicating an urgent call for improved healthcare interventions.",1.1842986367842692e-07,0.12062798778861739,0.0,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
224,0.5,8,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality rates after emergency laparotomy are alarmingly high, especially in patients older than 70, necessitating focused efforts to enhance survival rates.",1.1842986367842692e-07,0.12062798778861739,0.0,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
224,0.5,9,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: There is a significant concern regarding mortality following emergency laparotomy in patients over 70, which calls for intensified efforts to improve clinical outcomes.",7.105791820705622e-08,0.07061756721395396,0.0,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
224,0.5,10,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy is linked to a high mortality rate, particularly in those over 70 years old, highlighting the urgent need for improvements in patient care.",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
225,0.5,1,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Question: Is the visual loss caused by amblyopia permanent? Answer: In older adults with a history of amblyopia, if the previously unaffected eye suffers visual loss, the vision loss may be permanent. This permanence occurs because amblyopia impairs the brain's capacity to interpret visual signals from the affected eye.",1.1842986367842703e-07,0.14224029896130297,0.023242630385487524,0.009067132323909363,0.11247798342669002,0.0,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
225,0.5,2,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Question: Does amblyopia lead to permanent visual loss? Answer: Among older individuals who have had amblyopia, visual loss in the formerly normal eye can result in permanent vision impairment due to the brain's reduced ability to process images from the amblyopic eye.",4.737194547137081e-08,0.01538864524228023,0.023242630385487524,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
225,0.5,3,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
",Question: Is vision loss from amblyopia irreversible? Answer: Older patients with amblyopia who develop vision loss in their previously healthy eye might experience permanent visual deficits because amblyopia diminishes the brain's processing of visual input from the affected eye.,1.1842986367842682e-07,0.12785598277598798,0.0030539364516198493,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
225,0.5,4,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Question: Can amblyopia cause lasting visual loss? Answer: In older people with amblyopia, if the eye that was once normal loses vision, the loss may be permanent since amblyopia compromises the brain's processing of visual information from the impaired eye.",9.474389094274152e-08,0.06539906581694366,0.023242630385487524,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
225,0.5,5,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
",Question: Does amblyopia result in permanent vision loss? Answer: Visual loss in the previously normal eye of older adults with amblyopia history can be permanent because amblyopia weakens the brain's ability to handle visual data from the affected eye.,1.1842986367842682e-07,0.09137455222020163,0.023242630385487524,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
225,0.5,6,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Question: Is the vision loss associated with amblyopia permanent? Answer: For older individuals who have amblyopia, developing vision loss in the previously unaffected eye may lead to permanent impairment due to the brain's reduced processing capacity for that eye.",1.1842986367842682e-07,0.12785598277598798,0.0030539364516198493,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
225,0.5,7,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
",Question: Is visual impairment from amblyopia lasting? Answer: Older adults with a history of amblyopia who experience vision loss in their previously normal eye may suffer permanent loss since amblyopia reduces the brain's ability to process visual cues from the affected eye.,4.737194547137081e-08,0.01538864524228023,0.023242630385487524,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
225,0.5,8,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Question: Does amblyopia cause permanent loss of vision? Answer: In older people with amblyopia, loss of vision in the previously normal eye can be permanent because the brain's ability to process images from the amblyopic eye is weakened.",1.4211583641411212e-07,0.15551021446776492,0.0037635424540186403,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
225,0.5,9,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
",Question: Is the loss of vision in amblyopia permanent? Answer: Older individuals with amblyopia who develop visual loss in their previously unaffected eye may have permanent vision loss due to impaired brain processing of visual information from the affected eye.,9.474389094274152e-08,0.06539906581694366,0.023242630385487524,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
225,0.5,10,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Question: Can vision loss from amblyopia be permanent? Answer: Among older adults with a history of amblyopia, permanent vision loss may occur if the previously normal eye loses vision because amblyopia reduces the brain's capacity to process visual information from the affected eye.",2.3685972735685406e-08,0.024298102261311794,0.0005527295193310314,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
226,0.5,1,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners serve as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears acceptable and justified to have medical students act as examiners in formative OSCE assessments for emergency medicine, though this may not be appropriate for summative evaluations.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
226,0.5,2,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it reasonable for student examiners to replace faculty in an undergraduate OSCE focused on medical emergencies? Encouraging medical students to examine in formative emergency medicine OSCEs seems valid and justified, but this does not necessarily apply to summative assessments.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.5,3,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners suitable substitutes for faculty in undergraduate OSCEs on medical emergencies? It is generally acceptable and justified to involve medical students as examiners during formative OSCE testing in emergency medicine, but perhaps not during summative assessments.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
226,0.5,4,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May medical students act as reasonable substitute examiners for faculty in undergraduate emergency medicine OSCEs? It seems justifiable and appropriate to encourage medical students to officiate in formative OSCEs, although this may not extend to summative assessment situations.",1.8948778188548293e-07,0.23321199229149636,0.027006172839506164,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
226,0.5,5,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners reasonably replace faculty in an undergraduate OSCE on medical emergencies? Involving medical students as examiners in formative emergency medicine OSCEs appears admissible and justified, but their role in summative assessments is less clear.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
226,0.5,6,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it permissible for student examiners to substitute for faculty in an undergraduate emergency medicine OSCE? It seems reasonable and justified to allow medical students to serve as examiners in formative OSCE testing, but not necessarily in summative evaluations.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.5,7,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners reasonable substitutes for faculty in undergraduate OSCEs on medical emergencies? Encouraging medical students to act as examiners during formative OSCEs is justifiable, though this may not be appropriate for summative assessments.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
226,0.5,8,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can medical students be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? It appears acceptable and justified to have students officiate in formative OSCEs, but not necessarily in summative assessment contexts.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
226,0.5,9,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it appropriate for student examiners to replace faculty in an undergraduate OSCE on medical emergencies? It seems justifiable and acceptable to encourage medical students to examine in formative OSCE assessments, but not necessarily in summative ones.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
226,0.5,10,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May student examiners serve as reasonable substitutes for faculty in undergraduate emergency medicine OSCEs? Encouraging medical students to officiate in formative OSCE testing is generally justified, though this may not apply to summative assessments.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
227,0.5,1,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Are high flow nasal cannulae louder than bubble CPAP for preterm infants? At the studied gas flows, HFNC are not louder than BCPAP for preterm infants.",4.73719454713706e-08,0.08517611883165488,0.0057950850661626085,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
227,0.5,2,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? The gas flows examined show HFNC are not noisier than BCPAP for preterm infants.,0.0,0.10268847119406654,0.07359999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
227,0.5,3,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Is the noise level of high flow nasal cannulae greater than that of bubble CPAP for preterm infants? At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",9.47438909427412e-08,0.19611963673553268,0.041377777777777784,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,0.5,4,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Are high flow nasal cannulae noisier compared to bubble CPAP for preterm infants? According to the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
227,0.5,5,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Do high flow nasal cannulae generate more noise than bubble CPAP in preterm infants? The research on gas flows indicates HFNC are not noisier than BCPAP for preterm infants.,2.36859727356853e-08,0.13905611536494122,0.07359999999999998,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.5,6,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Is there more noise from high flow nasal cannulae than from bubble CPAP for preterm infants? At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.1263441813444901,0.03916122448979589,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.5,7,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Are high flow nasal cannulae more noisy than bubble CPAP for preterm infants? The gas flows studied show HFNC are not noisier than BCPAP for preterm infants.,2.36859727356853e-08,0.011629129321992782,0.035199999999999974,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
227,0.5,8,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Does high flow nasal cannulae create more noise than bubble CPAP for preterm infants? Based on the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",2.36859727356853e-08,0.08954560246780208,0.03793470507544581,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.5,9,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Are high flow nasal cannulae noisier than bubble CPAP in preterm infants? The gas flows studied confirm HFNC are not noisier than BCPAP for preterm infants.,4.73719454713706e-08,0.029724344386858004,0.033669444444444425,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
227,0.5,10,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Do high flow nasal cannulae have higher noise levels than bubble CPAP for preterm infants? At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",2.36859727356853e-08,0.08954560246780208,0.03793470507544581,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
228,0.5,1,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
","Question: Does having both major depression and alcohol use disorder during adolescence result in worse depression outcomes? Answer: The findings indicate that adolescents with both major depression and alcohol use disorder tend to have poorer outcomes in terms of depression. Specifically, those with this comorbidity experience longer and more severe depressive symptoms than those suffering from depression alone.",4.026615365066519e-07,0.1725850807363205,0.16729480463209234,0.030828249901291904,0.215458014570435,0.11180915851663786,0.030783626196198746,0.24009514111157992,0.0709707963561377,4.026615365066519e-07,0.26524140093957627,0.030624648795479284
228,0.5,2,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
","Question: Is the combination of major depression and alcohol use disorder in adolescence linked to worse depression outcomes? Answer: Analysis results suggest that adolescents with both major depression and alcohol use disorder may face worse outcomes for depression, including prolonged and more intense depressive symptoms compared to those with only depression.",5.684633456564497e-07,0.2963170570315681,0.1723356009070293,0.04352223515476501,0.338380011574142,0.11924903206954486,0.04345923698286881,0.3620493049247058,0.08102846648301197,5.684633456564497e-07,0.3860527418076001,0.04351883479231811
228,0.5,3,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Question: Does comorbid major depression and alcohol use disorder in adolescents lead to poorer depression prognosis? Answer: The data indicate that adolescents with both conditions are more likely to endure longer-lasting and more severe depressive symptoms than adolescents with depression alone.,8.053230730133038e-07,0.41548853126178464,0.24611746956069283,0.06165649980258374,0.4534717769330925,0.20023668639053252,0.06156725239239748,0.5090207585362174,0.1432506887052342,8.053230730133038e-07,0.5662911814640754,0.08598797059478724
228,0.5,4,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
","Question: In adolescence, does having both major depression and alcohol use disorder affect depression outcomes negatively? Answer: Results show that comorbidity of these disorders is associated with worse depression outcomes, including extended duration and increased severity of depressive symptoms compared to depression alone.",7.57951127541933e-07,0.33204100806435655,0.27110103300579474,0.058029646873019994,0.40346135635842906,0.20023668639053252,0.057945649310491745,0.4577274641486677,0.1432506887052342,7.57951127541933e-07,0.5136474479786566,0.08598797059478724
228,0.5,5,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Question: Does the coexistence of major depression and alcohol use disorder during adolescence result in poorer depression outcomes? Answer: The analyses suggest that adolescents with both disorders experience longer and more severe depressive episodes than those with only major depression.,8.290090457489891e-07,0.40614898021808,0.27110103300579474,0.06346992626736561,0.47944726333635046,0.20023668639053252,0.06337805393335035,0.5356890056183783,0.1432506887052342,8.290090457489892e-07,0.5936901556521907,0.08598797059478724
228,0.5,6,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Question: Are depression outcomes worse in adolescents with both major depression and alcohol use disorder? Answer: Findings reveal that adolescents with this comorbidity have a higher likelihood of prolonged and more severe depressive symptoms than those with depression alone.,8.526950184846744e-07,0.4686058971771243,0.24480446616868737,0.06528335273214748,0.5061155104185113,0.20023668639053252,0.06518885547430321,0.5630879798064936,0.1432506887052342,8.526950184846746e-07,0.6218610326188876,0.08598797059478724
228,0.5,7,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Question: Does having both major depression and alcohol use disorder in adolescence correlate with worse outcomes for depression? Answer: The results imply that adolescents with comorbid depression and alcohol use disorder tend to have longer-lasting and more severe depressive symptoms compared to those with only depression.,6.868932093348768e-07,0.3862743020102837,0.18305820135796608,0.052589367478674376,0.427363859220832,0.1324199106617996,0.052513244687633145,0.44988561006299,0.09684973689083798,6.868932093348768e-07,0.4725464844230247,0.06219261068996869
228,0.5,8,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Question: Is adolescent depression prognosis poorer when accompanied by alcohol use disorder? Answer: The study suggests that adolescents with both major depression and alcohol use disorder experience more severe and longer depressive symptoms than those with depression alone.,8.763809912203597e-07,0.49626012886890125,0.2440948601662886,0.06709677919692936,0.5335144846066266,0.20023668639053252,0.06699965701525608,0.5912588567731905,0.1432506887052342,8.7638099122036e-07,0.6508485694921391,0.08598797059478724
228,0.5,9,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Question: Does the presence of alcohol use disorder alongside major depression in adolescence worsen depression outcomes? Answer: Analyses indicate that adolescents with both conditions are more prone to extended and intensified depressive symptoms than those with only major depression.,8.526950184846744e-07,0.43212446662133797,0.27110103300579474,0.06528335273214748,0.5061155104185113,0.20023668639053252,0.06518885547430321,0.5630879798064936,0.1432506887052342,8.526950184846746e-07,0.6218610326188876,0.08598797059478724
228,0.5,10,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
","Question: In adolescents, does comorbidity of major depression and alcohol use disorder lead to worse depression outcomes? Answer: The findings suggest that having both disorders is linked to a longer duration and greater severity of depressive symptoms compared to having major depression alone.",7.57951127541933e-07,0.3650480166624481,0.24730567310097618,0.058029646873019994,0.40346135635842906,0.20023668639053252,0.057945649310491745,0.4577274641486677,0.1432506887052342,7.57951127541933e-07,0.5136474479786566,0.08598797059478724
229,0.5,1,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","In patients with ischemic heart disease, severe hypotensive episodes can markedly decrease coronary perfusion pressure, which may result in myocardial ischemia due to reduced oxygenated blood supply to the heart muscle.",4.974054274493925e-07,0.4218992815625704,0.07786328655500228,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5596157879354227,0.0,4.974054274493935e-07,0.5753641449035616,0.0
229,0.5,2,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","Profound hypotension in individuals with coronary artery disease can significantly lower coronary perfusion pressure, potentially causing myocardial ischemic events by limiting oxygen delivery to the heart tissue.",5.921493183921337e-07,0.5650001252032428,0.07786328655500228,0.045335661619546885,0.6376954061151499,0.039930555555555566,0.04527003852382174,0.7137664677626816,0.0,5.921493183921352e-07,0.7357067949787415,0.0
229,0.5,3,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","Severe drops in blood pressure in patients with ischemic heart disease can reduce coronary perfusion pressure enough to provoke myocardial ischemia, as the heart muscle receives less oxygenated blood.",5.447773729207631e-07,0.49089215304952116,0.07786328655500228,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6337237600891443,0.0,5.447773729207643e-07,0.652325186039691,0.0
229,0.5,4,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","In those suffering from coronary disease, extreme hypotensive events can lead to a significant decline in coronary perfusion pressure, increasing the risk of myocardial ischemia because of diminished oxygen supply to the myocardium.",4.5003348197802187e-07,0.35736076042499887,0.07786328655500228,0.03445510283085561,0.42258402649820326,0.039930555555555566,0.0344052292781045,0.4906229164484719,0.0,4.500334819780227e-07,0.5039051809214179,0.0
229,0.5,5,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","Profound hypotensive episodes in patients with ischemic heart conditions may cause a substantial decrease in coronary perfusion pressure, thereby triggering myocardial ischemic events due to insufficient oxygenated blood flow to the heart.",4.7371945471370717e-07,0.3891094587395787,0.07786328655500228,0.03626852929563749,0.45537384932119496,0.039930555555555566,0.036216030819057374,0.5245244681241537,0.0,4.737194547137081e-07,0.5389965007326869,0.0
229,0.5,6,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","For patients with coronary artery disease, severe hypotension can drastically reduce coronary perfusion pressure, which might induce myocardial ischemia by lowering the oxygenated blood reaching the heart muscle.",5.684633456564484e-07,0.5272597972203958,0.07786328655500228,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6729444732424268,0.0,5.684633456564497e-07,0.6931471805599458,0.0
229,0.5,7,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","In coronary disease patients, significant hypotensive events can cause a notable drop in coronary perfusion pressure, potentially leading to myocardial ischemia as oxygen delivery to the heart muscle diminishes.",5.447773729207631e-07,0.5404026659466603,0.04219799163044811,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6337237600891443,0.0,5.447773729207643e-07,0.652325186039691,0.0
229,0.5,8,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","Hypotensive events of a profound nature in ischemic heart disease patients can greatly decrease coronary perfusion pressure, which could result in myocardial ischemic episodes from reduced oxygenated blood supply.",5.447773729207631e-07,0.49089215304952116,0.07786328655500228,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6337237600891443,0.0,5.447773729207643e-07,0.652325186039691,0.0
229,0.5,9,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","Profound hypotension in patients with coronary artery disease can cause a marked reduction in coronary perfusion pressure, potentially resulting in myocardial ischemia due to decreased oxygen delivery to the heart muscle.",4.974054274493925e-07,0.4218992815625704,0.07786328655500228,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5596157879354227,0.0,4.974054274493935e-07,0.5753641449035616,0.0
229,0.5,10,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","In ischemic heart disease patients, severe hypotensive incidents can substantially lower coronary perfusion pressure, increasing the likelihood of myocardial ischemia by limiting oxygenated blood flow to the myocardium.",5.684633456564484e-07,0.5272597972203958,0.07786328655500228,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6729444732424268,0.0,5.684633456564497e-07,0.6931471805599458,0.0
230,0.5,1,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should male HIV-infected patients over 52 years old with at least two additional cardiovascular risk factors be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening in this group was about four times more likely to detect positive results compared to the general population, suggesting physicians might recommend more systematic SMI screening in these patients.",2.3685972735685406e-07,0.10504046767197295,0.04250255845752961,0.018134264647818726,0.12439887355178492,0.03073822121441168,0.018108015409528666,0.1482381874028995,0.015621063240110858,2.3685972735685406e-07,0.17284281283941416,0.0
230,0.5,2,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","In male HIV-positive patients above 52 years with two or more cardiovascular risk factors, screening for silent myocardial ischemia via myocardial SPECT was approximately four times more likely to be positive than in the general population, indicating a need for more routine SMI screening in this group.",4.737194547137081e-07,0.27699550546945817,0.060353798126951096,0.03626852929563745,0.32506956901393647,0.03073822121441168,0.03621603081905733,0.353032600048913,0.015621063240110858,4.737194547137081e-07,0.38193461069797285,0.0
230,0.5,3,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","For male HIV-infected individuals older than 52 years who have at least two other cardiovascular risk factors, myocardial SPECT screening for silent myocardial ischemia showed a positivity rate about four times higher than the general population, which could encourage physicians to implement more systematic screening.",5.210914001850789e-07,0.3214472680402909,0.060353798126951096,0.0398953822252012,0.3705319430906937,0.03073822121441168,0.039837633900963065,0.39955261568380696,0.015621063240110858,5.210914001850789e-07,0.4295626596872273,0.0
230,0.5,4,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Male HIV-infected patients aged over 52 with at least two additional cardiovascular risk factors are about four times more likely to have positive silent myocardial ischemia screening results using gated myocardial perfusion SPECT compared to the general population, suggesting a rationale for more frequent screening.",5.210914001850789e-07,0.3214472680402909,0.060353798126951096,0.0398953822252012,0.3705319430906937,0.03073822121441168,0.039837633900963065,0.39955261568380696,0.015621063240110858,5.210914001850789e-07,0.4295626596872273,0.0
230,0.5,5,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Among male HIV-infected patients older than 52 years and carrying at least two other cardiovascular risk factors, the likelihood of positive silent myocardial ischemia detection via myocardial SPECT is roughly quadrupled relative to the general population, motivating more systematic screening.",6.395212638635059e-07,0.4420752558289083,0.060353798126951096,0.04896251454911056,0.49414589905786954,0.03073822121441168,0.0488916416057274,0.5263043213229492,0.015621063240110858,6.39521263863506e-07,0.5596157879354249,0.0
230,0.5,6,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Screening for silent myocardial ischemia with gated myocardial perfusion SPECT in male HIV-infected patients over 52 years old with at least two cardiovascular risk factors is about four times more likely to yield positive results than in the general population, supporting more proactive screening approaches.",5.210914001850789e-07,0.3214472680402909,0.060353798126951096,0.0398953822252012,0.3705319430906937,0.03073822121441168,0.039837633900963065,0.39955261568380696,0.015621063240110858,5.210914001850789e-07,0.4295626596872273,0.0
230,0.5,7,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","In male HIV-infected patients older than 52 who also have two or more cardiovascular risk factors, myocardial SPECT screening for silent myocardial ischemia is approximately four times more likely to be positive than in the general population, which may prompt physicians to recommend systematic screening.",5.210914001850789e-07,0.3214472680402909,0.060353798126951096,0.0398953822252012,0.3705319430906937,0.03073822121441168,0.039837633900963065,0.39955261568380696,0.015621063240110858,5.210914001850789e-07,0.4295626596872273,0.0
230,0.5,8,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","The probability of positive silent myocardial ischemia screening via gated myocardial perfusion SPECT is about four times higher in male HIV-infected patients older than 52 years with at least two other cardiovascular risk factors compared to the general population, suggesting the need for more systematic screening.",4.974054274493935e-07,0.2989744121882332,0.060353798126951096,0.038081955760419325,0.3475424248659942,0.03073822121441168,0.0380268323600102,0.37602211827361254,0.015621063240110858,4.974054274493935e-07,0.40546510810816727,0.0
230,0.5,9,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Male HIV-infected patients aged above 52 years with at least two additional cardiovascular risk factors demonstrate about a fourfold increase in positive silent myocardial ischemia screening results by myocardial SPECT compared to the general population, encouraging more routine screening.",6.632072365991912e-07,0.46805074223216625,0.060353798126951096,0.050775941013892434,0.5208141461400304,0.03073822121441168,0.050702443146680265,0.5537032955110646,0.015621063240110858,6.632072365991914e-07,0.5877866649021217,0.0
230,0.5,10,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","In male HIV-infected patients older than 52 years and with two or more cardiovascular risk factors, screening for silent myocardial ischemia using myocardial SPECT is nearly four times more likely to be positive than in the general population, which may lead physicians to advise more systematic screening.",4.737194547137081e-07,0.27699550546945817,0.060353798126951096,0.03626852929563745,0.32506956901393647,0.03073822121441168,0.03621603081905733,0.353032600048913,0.015621063240110858,4.737194547137081e-07,0.38193461069797285,0.0
231,0.5,1,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study demonstrated for the first time that robotically assisted laparoscopic radical prostatectomy results in reduced blood loss and fewer transfusions compared to retropubic radical prostatectomy, indicating a less invasive procedure.",2.3685972735685406e-08,0.026673747855450625,0.0027864741267681625,0.0018134264647818726,0.025187659389265704,0.0015582242712670613,0.0018108015409528666,0.025065707112430058,0.0010990481856038084,2.3685972735685406e-08,0.024902600569258304,0.0005796400951814454
231,0.5,2,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Does robotically assisted laparoscopic radical prostatectomy offer a less invasive alternative to retropubic radical prostatectomy? Answer: This research revealed for the first time that robotically assisted laparoscopic radical prostatectomy is linked to decreased blood loss and a lower need for transfusions versus retropubic radical prostatectomy, implying a less invasive method.",1.1842986367842703e-07,0.09611855325036034,0.006112371632195218,0.009067132323909363,0.08898384764668998,0.013170878592254728,0.009054007704764333,0.11671743766161535,0.004813050113072946,1.1842986367842703e-07,0.11598936732010312,0.0025288192620964538
231,0.5,3,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is the robotically assisted laparoscopic radical prostatectomy less invasive than the retropubic radical prostatectomy? Answer: The study found, for the first time, that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions than retropubic radical prostatectomy, suggesting it is a less invasive technique.",7.105791820705622e-08,0.07609097414690424,0.007728535201062703,0.005440279394345618,0.07199116375411752,0.004283717877493279,0.0054324046228586,0.07164642041470293,0.003012522062330082,7.105791820705622e-08,0.07119333872682354,0.001584616103165664
231,0.5,4,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is robotically assisted laparoscopic radical prostatectomy considered less invasive than retropubic radical prostatectomy? Answer: This study showed initially that robotically assisted laparoscopic radical prostatectomy leads to less blood loss and fewer transfusions compared to retropubic radical prostatectomy, indicating a less invasive approach.",7.105791820705622e-08,0.08219567492618873,0.008711374095989433,0.005440279394345618,0.07753366990246713,0.004897905711710296,0.0054324046228586,0.07715657214167182,0.003460544030479129,7.105791820705622e-08,0.07664697281511579,0.0018279087932423985
231,0.5,5,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Does robotically assisted laparoscopic radical prostatectomy cause less invasiveness than retropubic radical prostatectomy? Answer: For the first time, this study demonstrated that robotically assisted laparoscopic radical prostatectomy is associated with reduced blood loss and fewer transfusions than retropubic radical prostatectomy, suggesting a less invasive option.",0.0,0.0,2.7755575615628914e-17,0.0,0.03150669002545259,0.022183224271267066,0.0,0.0,0.0,0.0,0.0,0.0
231,0.5,6,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? Answer: This study revealed for the first time that robotically assisted laparoscopic radical prostatectomy results in less blood loss and fewer transfusions compared to retropubic radical prostatectomy, indicating a less invasive technique.",2.3685972735685406e-08,0.0041396826936290765,0.017094017094017033,0.0018134264647818726,0.006233239504464194,0.020226055919095737,0.0018108015409528666,0.0244549456677432,0.0010494778914937122,2.3685972735685406e-08,0.024298102261311794,0.0005527295193310314
231,0.5,7,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? Answer: According to this study, robotically assisted laparoscopic radical prostatectomy is linked to less blood loss and fewer transfusions than retropubic radical prostatectomy, suggesting it is less invasive.",2.3685972735685406e-08,0.004832942170002408,0.01840894148586461,0.0018134264647818726,0.025187659389265704,0.0015582242712670613,0.0018108015409528666,0.025065707112430058,0.0010990481856038084,2.3685972735685406e-08,0.024902600569258304,0.0005796400951814454
231,0.5,8,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is robotically assisted laparoscopic radical prostatectomy less invasive relative to retropubic radical prostatectomy? Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy involves less blood loss and fewer transfusions in comparison to retropubic radical prostatectomy, implying a less invasive procedure.",0.0,0.030806541358219697,0.020099493517349826,0.0,0.03150669002545259,0.022183224271267066,0.0,0.0,0.0,0.0,0.0,0.0
231,0.5,9,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is robotically assisted laparoscopic radical prostatectomy a minimally invasive alternative to retropubic radical prostatectomy? Answer: The study indicated for the first time that robotically assisted laparoscopic radical prostatectomy is associated with decreased blood loss and reduced transfusion rates compared to retropubic radical prostatectomy, suggesting a less invasive approach.",7.105791820705622e-08,0.07609097414690424,0.007728535201062717,0.005440279394345618,0.042495539049439035,0.016553153962992326,0.0054324046228586,0.07164642041470293,0.003012522062330082,7.105791820705622e-08,0.07119333872682354,0.001584616103165664
231,0.5,10,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Does robotically assisted laparoscopic radical prostatectomy present a less invasive option than retropubic radical prostatectomy? Answer: This study identified for the first time that robotically assisted laparoscopic radical prostatectomy leads to less blood loss and fewer transfusions than retropubic radical prostatectomy, indicating a less invasive method.",2.3685972735685406e-08,0.03427651663101727,0.03602747135668499,0.0018134264647818726,0.03703978086268389,0.04155822427126707,0.0018108015409528666,0.0244549456677432,0.0010494778914937122,2.3685972735685406e-08,0.024298102261311794,0.0005527295193310314
232,0.5,1,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",This research introduces a new technique to enhance paclitaxel delivery to the brain by temporarily disrupting the blood-brain barrier using Nd:YAG laser-induced thermo therapy.,8.290090457489874e-07,0.8293422869538283,0.06858710562414265,0.06346992626736564,0.9033669070685186,0.035041322314049606,0.06337805393335043,0.9560739965631582,0.017851239669421492,8.290090457489892e-07,1.0116009116784808,0.0
232,0.5,2,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",The study presents a novel method for improving paclitaxel transport into the brain via locoregional opening of the blood-brain barrier with Nd:YAG laser-induced thermo therapy.,8.053230730133021e-07,0.7867826725350326,0.06858710562414265,0.06165649980258375,0.8589151444976846,0.035041322314049606,0.061567252392397555,0.9095539809282642,0.017851239669421492,8.053230730133038e-07,0.9628107475090495,0.0
232,0.5,3,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",A new concept is proposed for facilitating paclitaxel delivery to brain tumors by transiently opening the blood-brain barrier using Nd:YAG laser-induced thermo therapy.,8.526950184846727e-07,0.8737940495246623,0.06858710562414265,0.06528335273214751,0.9498869227034126,0.035041322314049606,0.06518885547430331,1.0048641607325894,0.017851239669421492,8.526950184846745e-07,1.062894206066031,0.0
232,0.5,4,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",This work suggests a pioneering approach to increase paclitaxel penetration into the brain through temporary blood-brain barrier disruption with Nd:YAG laser-induced thermo therapy.,8.526950184846727e-07,0.8737940495246623,0.06858710562414265,0.06528335273214751,0.9498869227034126,0.035041322314049606,0.06518885547430331,1.0048641607325894,0.017851239669421492,8.526950184846745e-07,1.062894206066031,0.0
232,0.5,5,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",The study explores a novel strategy to enhance chemotherapy delivery by opening the rodent blood-brain barrier locally with Nd:YAG laser-induced thermo therapy for paclitaxel administration.,8.053230730133021e-07,0.7867826725350326,0.06858710562414265,0.06165649980258375,0.8589151444976846,0.035041322314049606,0.061567252392397555,0.9095539809282642,0.017851239669421492,8.053230730133038e-07,0.9628107475090495,0.0
232,0.5,6,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",Researchers propose a method to improve paclitaxel treatment efficacy for brain tumors by using Nd:YAG laser-induced thermo therapy to temporarily open the blood-brain barrier.,8.290090457489874e-07,0.8293422869538283,0.06858710562414265,0.06346992626736564,0.9033669070685186,0.035041322314049606,0.06337805393335043,0.9560739965631582,0.017851239669421492,8.290090457489892e-07,1.0116009116784808,0.0
232,0.5,7,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",This investigation offers a new concept for targeted paclitaxel delivery to the brain by employing Nd:YAG laser-induced thermo therapy to transiently disrupt the blood-brain barrier.,8.053230730133021e-07,0.7867826725350326,0.06858710562414265,0.06165649980258375,0.8589151444976846,0.035041322314049606,0.061567252392397555,0.9095539809282642,0.017851239669421492,8.053230730133038e-07,0.9628107475090495,0.0
232,0.5,8,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",The paper introduces a novel approach to facilitate paclitaxel delivery into the brain through locoregional blood-brain barrier opening induced by Nd:YAG laser thermo therapy.,8.290090457489874e-07,0.8293422869538283,0.06858710562414265,0.06346992626736564,0.9033669070685186,0.035041322314049606,0.06337805393335043,0.9560739965631582,0.017851239669421492,8.290090457489892e-07,1.0116009116784808,0.0
232,0.5,9,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",A new technique is presented for enhancing paclitaxel delivery to brain tissue by temporarily opening the blood-brain barrier with Nd:YAG laser-induced thermo therapy.,8.526950184846727e-07,0.8737940495246623,0.06858710562414265,0.06528335273214751,0.9498869227034126,0.035041322314049606,0.06518885547430331,1.0048641607325894,0.017851239669421492,8.526950184846745e-07,1.062894206066031,0.0
232,0.5,10,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",This study proposes a cutting-edge method to boost paclitaxel delivery and treatment outcomes for brain tumors by locally opening the blood-brain barrier using Nd:YAG laser-induced thermo therapy.,7.579511275419315e-07,0.7067399648614954,0.06858710562414265,0.058029646873019994,0.7755335355586341,0.035041322314049606,0.05794564931049181,0.8225426039386345,0.017851239669421492,7.57951127541933e-07,0.8718389693033215,0.0
233,0.5,1,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Is colorectal cancer in young patients a unique clinical entity?,1.4211583641411216e-06,1.9766082593862628,0.04338842975206611,0.10880558788691251,2.119679481715098,0.014702606371129419,0.10864809245717219,2.258782470335651,0.0,1.4211583641411235e-06,2.3978952727983693,0.0
233,0.5,2,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Could colorectal cancer in younger individuals represent a distinct clinical condition?,1.3974723914054364e-06,1.871247743728437,0.04338842975206611,0.10699216142213064,2.0018964460587143,0.014702606371129419,0.10683729091621931,2.125251077711129,0.0,1.3974723914054383e-06,2.2437445929711104,0.0
233,0.5,3,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Is colorectal cancer among young patients considered a separate clinical entity?,1.3974723914054364e-06,1.871247743728437,0.04338842975206611,0.10699216142213064,2.0018964460587143,0.014702606371129419,0.10683729091621931,2.125251077711129,0.0,1.3974723914054383e-06,2.2437445929711104,0.0
233,0.5,4,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Does colorectal cancer in young people constitute a unique clinical syndrome?,1.3974723914054364e-06,1.871247743728437,0.04338842975206611,0.10699216142213064,2.0018964460587143,0.014702606371129419,0.10683729091621931,2.125251077711129,0.0,1.3974723914054383e-06,2.2437445929711104,0.0
233,0.5,5,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Is colorectal cancer in younger patients a different clinical entity?,1.4211583641411216e-06,1.9766082593862628,0.04338842975206611,0.10880558788691251,2.119679481715098,0.014702606371129419,0.10864809245717219,2.258782470335651,0.0,1.4211583641411235e-06,2.3978952727983693,0.0
233,0.5,6,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Could colorectal cancer in young individuals be classified as a distinct clinical entity?,1.3501004459340656e-06,1.6889261869344816,0.04338842975206611,0.10336530849256688,1.8012257505965632,0.014702606371129419,0.10321568783431356,1.9021075263969194,0.0,1.3501004459340675e-06,1.9924301646902047,0.0
233,0.5,7,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Is colorectal cancer in young patients characterized as a unique clinical entity?,1.373786418669751e-06,1.7759375639241117,0.04338842975206611,0.10517873495734875,1.8965359304008884,0.014702606371129419,0.10502648937526644,2.0074680420547453,0.0,1.373786418669753e-06,2.1102132003465885,0.0
233,0.5,8,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Might colorectal cancer in young patients be a separate clinical entity?,1.3974723914054364e-06,1.871247743728437,0.04338842975206611,0.10699216142213064,2.0018964460587143,0.014702606371129419,0.10683729091621931,2.125251077711129,0.0,1.3974723914054383e-06,2.2437445929711104,0.0
233,0.5,9,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Is colorectal cancer in young adults a distinct clinical entity?,1.4211583641411216e-06,1.9766082593862628,0.04338842975206611,0.10880558788691251,2.119679481715098,0.014702606371129419,0.10864809245717219,2.258782470335651,0.0,1.4211583641411235e-06,2.3978952727983693,0.0
233,0.5,10,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Does colorectal cancer in younger patients represent a unique clinical entity?,1.3974723914054364e-06,1.871247743728437,0.04338842975206611,0.10699216142213064,2.0018964460587143,0.014702606371129419,0.10683729091621931,2.125251077711129,0.0,1.3974723914054383e-06,2.2437445929711104,0.0
234,0.5,1,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Can analyzing APC mutations aid in making treatment decisions for familial adenomatous polyposis? Since the age of onset and disease progression can be affected by the particular APC mutation, genetic testing can inform therapy choices. For instance, individuals with truncating mutations might require earlier monitoring and possibly more intensive treatments.",9.474389094274162e-08,0.07847161544149417,0.0,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
234,0.5,2,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Is APC mutation testing useful for guiding therapy in familial adenomatous polyposis? Because the specific APC mutation can influence when symptoms appear and how the disease progresses, genetic analysis can assist in planning treatment. Patients with truncating mutations may need earlier surveillance and potentially more aggressive management.",1.6580180914979784e-07,0.1717873510004151,0.021728395061728398,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
234,0.5,3,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Does APC mutation analysis help in therapeutic decision-making for familial adenomatous polyposis? Given that the mutation type can affect disease onset and progression, genetic testing can provide valuable information for treatment strategies. Those with truncating mutations could benefit from earlier screening and more proactive interventions.",2.1317375462116866e-07,0.18610227963385917,0.0,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
234,0.5,4,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Can genetic testing for APC mutations inform treatment approaches in familial adenomatous polyposis? Since the APC mutation influences age at disease manifestation and progression, such analysis can guide therapy. Patients harboring truncating mutations might be candidates for earlier monitoring and possibly intensified treatment.",2.6054570009253947e-07,0.2326222952687531,0.0,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
234,0.5,5,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Is it possible for APC mutation analysis to impact therapeutic choices in familial adenomatous polyposis? Because specific APC mutations affect the disease course and onset age, genetic testing can aid in therapy planning. For example, truncating mutation carriers may require earlier surveillance and more aggressive treatment options.",1.6580180914979784e-07,0.14165051706302645,0.0,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
234,0.5,6,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","How does APC mutation analysis contribute to treatment decisions in familial adenomatous polyposis? The age of disease onset and its progression can depend on the APC mutation type, so genetic testing helps tailor therapy. Patients with truncating mutations might benefit from earlier and more rigorous monitoring and interventions.",1.4211583641411244e-07,0.14963993654674157,0.0212665406427221,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
234,0.5,7,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Can APC mutation testing influence therapeutic strategies in familial adenomatous polyposis? Since the mutation type can alter the age at which symptoms appear and the disease trajectory, genetic analysis is useful for treatment guidance. Individuals with truncating mutations may need earlier and potentially more intensive care.",1.8948778188548325e-07,0.16362942378180145,0.0,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
234,0.5,8,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Does analyzing APC mutations help in deciding therapy for familial adenomatous polyposis? The specific mutation affects the age of onset and disease course, making genetic testing valuable for treatment decisions. Those with truncating mutations could benefit from earlier surveillance and possibly stronger interventions.",2.6054570009253947e-07,0.2326222952687531,0.0,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
234,0.5,9,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Is APC mutation analysis valuable for therapeutic decision-making in familial adenomatous polyposis? Because the mutation can impact when the disease manifests and how it progresses, genetic testing can direct treatment plans. Patients with truncating mutations may require earlier and more aggressive monitoring and therapy.",2.3685972735685406e-07,0.2090917978585587,0.0,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
234,0.5,10,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Can APC mutation analysis be used to guide therapeutic decisions in familial adenomatous polyposis? Since the specific mutation influences disease onset and progression, genetic testing can help in selecting treatment strategies. Patients with truncating mutations might benefit from earlier surveillance and more intensive interventions.",2.3685972735685406e-07,0.2090917978585587,0.0,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
235,0.5,1,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Older adults participating in PICT with more symptoms might trade quality of life for experimental therapy.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
235,0.5,2,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptoms be considered when choosing patients for phase I clinical trials? Answer: Older adults enrolled in PICT who have more symptoms may compromise their quality of life in exchange for experimental treatment.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
235,0.5,3,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms play a role in selecting patients for phase I clinical trials? Answer: Older adults in PICT with a higher symptom burden may sacrifice quality of life to undergo experimental treatment.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.5,4,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom presence relevant when enrolling patients in phase I clinical trials? Answer: Older adults with more symptoms in PICT might give up quality of life for the sake of experimental therapy.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.5,5,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are patient symptoms significant when considering them for phase I clinical trials? Answer: Older adults enrolled in PICT exhibiting more symptoms may accept a lower quality of life to receive experimental treatment.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.5,6,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Does symptom severity affect patient selection for phase I clinical trials? Answer: Older adults in PICT who experience more symptoms may compromise their quality of life to try experimental treatments.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.5,7,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should the presence of symptoms influence patient inclusion in phase I clinical trials? Answer: Older adults with greater symptom burden enrolled in PICT may sacrifice quality of life for experimental interventions.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.5,8,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is it important to consider symptoms when enrolling patients in phase I clinical trials? Answer: Older adults in PICT having more symptoms might trade off quality of life for experimental treatment.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.5,9,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms influence the decision to enroll patients in phase I clinical trials? Answer: Older adults participating in PICT with more symptoms may give up quality of life in pursuit of experimental therapies.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
235,0.5,10,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms a factor in selecting patients for phase I clinical trials? Answer: Older adults enrolled in PICT who have more symptoms may sacrifice their quality of life to receive experimental treatment.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
236,0.5,1,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does a surgeon's prior experience affect their skill in performing transurethral resection of the prostate? The senior urologist was able to resect tissue at a rate four times greater than that of less experienced surgeons. Hence, experience might be crucial in lowering the chances of needing a secondary TURP because of recurrent adenomas.",7.105791820705622e-08,0.056089466651043196,0.0,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
236,0.5,2,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the proficiency in conducting transurethral resection of the prostate dependent on the surgeon's previous experience? The senior urologist resected tissue four times faster than inexperienced surgeons, suggesting that experience may be key in minimizing the risk of secondary TURP from recurring adenomas.",3.079176455639103e-07,0.2696635669491032,0.0,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
236,0.5,3,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does previous surgical experience influence the ability to perform transurethral resection of the prostate? The senior urologist removed tissue at a rate four times higher than less experienced surgeons, indicating that experience could be important to reduce the likelihood of repeat TURP due to recurrent adenomas.",2.3685972735685406e-07,0.20067069546215155,0.0,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
236,0.5,4,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the surgeon's past experience a factor in their capability to perform transurethral resection of the prostate? The senior urologist resected four times more tissue per unit time than inexperienced surgeons, implying that experience may help lower the risk of secondary TURP caused by recurring adenomas.",2.3685972735685406e-07,0.20067069546215155,0.0,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
236,0.5,5,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the ability to carry out transurethral resection of the prostate depend on the surgeon's experience? The senior urologist achieved a tissue resection rate four times that of less experienced surgeons, suggesting that experience might be significant in preventing secondary TURP from adenoma recurrence.",2.8423167282822487e-07,0.2461330695389088,0.0,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
236,0.5,6,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the skill in performing transurethral resection of the prostate affected by the surgeon's previous experience? The senior urologist resected four times more tissue per time unit than the less experienced surgeons, indicating that experience may be vital to reduce secondary TURP risks due to recurring adenomas.",2.1317375462116866e-07,0.17869178874337655,0.0,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
236,0.5,7,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does a surgeon's experience influence their performance in transurethral resection of the prostate? The senior urologist was capable of resecting tissue at a rate four times greater than that of less experienced surgeons, suggesting that experience could be important in lowering the risk of secondary TURP from recurrent adenomas.",1.6580180914979784e-07,0.13613217432458002,0.0,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
236,0.5,8,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the capability to perform transurethral resection of the prostate impacted by the surgeon's prior experience? The senior urologist resected four times more tissue per time unit than less experienced surgeons, indicating that experience may play a role in reducing secondary TURP due to recurring adenomas.",2.3685972735685406e-07,0.20067069546215155,0.0,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
236,0.5,9,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does prior surgical experience affect the ability to perform transurethral resection of the prostate? The senior urologist was able to resect tissue four times faster than less experienced surgeons, suggesting that experience might be crucial in minimizing secondary TURP risks from recurrent adenomas.",3.079176455639103e-07,0.2696635669491032,0.0,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
236,0.5,10,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the effectiveness in performing transurethral resection of the prostate influenced by the surgeon's experience? The senior urologist resected tissue at a rate four times that of inexperienced surgeons, implying that experience may be important to reduce the chance of secondary TURP due to recurring adenomas.",2.3685972735685406e-07,0.20067069546215155,0.0,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
237,0.5,1,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does pretreatment with estradiol and antagonist before microdose leuprolide enhance IVF results in poor responders compared to oral contraceptive pills? It appears that E2 and antagonist pretreatment does not improve IVF outcomes over standard OCP in poor responders within the ML protocol. Well-powered randomized trials are needed.,1.8948778188548325e-07,0.12239256289476375,0.026728542213234133,0.014507411718254981,0.1421229703807798,0.015467072422876132,0.014486412327622933,0.14039457771855268,0.01922337562475971,1.8948778188548325e-07,0.1706255170307629,0.0
237,0.5,2,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,"In poor responders undergoing IVF, does estradiol and antagonist pretreatment before microdose leuprolide yield better outcomes than oral contraceptive pills? Evidence suggests E2 plus antagonist pretreatment does not enhance IVF success compared to OCP in the ML protocol. Further robust randomized studies are required.",2.6054570009253947e-07,0.13166274562510383,0.06838585774445835,0.0199476911126006,0.18030930050951177,0.03767781622452902,0.019918816950481533,0.21101214493250664,0.01922337562475971,2.6054570009253947e-07,0.24294617861038903,0.0
237,0.5,3,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does administering estradiol and antagonist prior to microdose leuprolide improve IVF outcomes in poor responders relative to oral contraceptive pills? Current data indicate no improvement with E2 and antagonist pretreatment versus standard OCP in the ML protocol. Adequately powered randomized trials remain necessary.,2.8423167282822487e-07,0.15596084788641562,0.06783312822512733,0.02176111757738247,0.2044068520885718,0.03767781622452902,0.0217296184914344,0.23570475752287834,0.01922337562475971,2.8423167282822487e-07,0.26826398659468076,0.0
237,0.5,4,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Is IVF success improved in poor responders by estradiol and antagonist pretreatment before microdose leuprolide compared to oral contraceptive pills? Findings show that E2 plus antagonist pretreatment does not outperform OCP in the ML protocol. More randomized trials with sufficient power are warranted.,2.8423167282822487e-07,0.15596084788641562,0.06783312822512733,0.02176111757738247,0.2044068520885718,0.03767781622452902,0.0217296184914344,0.23570475752287834,0.01922337562475971,2.8423167282822487e-07,0.26826398659468076,0.0
237,0.5,5,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does pretreatment with estradiol and antagonist before microdose leuprolide enhance IVF outcomes in poor responders compared to oral contraceptive pills? The evidence suggests no benefit of E2 and antagonist pretreatment over OCP in the ML protocol. Randomized controlled trials with adequate sample size are needed.,2.3685972735685406e-07,0.10794051367888269,0.06891350705909677,0.018134264647818726,0.15677880309931735,0.03767781622452902,0.018108015409528666,0.18691459335344662,0.01922337562475971,2.3685972735685406e-07,0.21825356602001733,0.0
237,0.5,6,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,"In poor responders, does estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF results compared to oral contraceptive pills? Results indicate that E2 plus antagonist pretreatment does not improve outcomes relative to OCP in the ML protocol. Further large-scale randomized trials are necessary.",2.6054570009253947e-07,0.13166274562510383,0.06838585774445835,0.0199476911126006,0.18030930050951177,0.03767781622452902,0.019918816950481533,0.21101214493250664,0.01922337562475971,2.6054570009253947e-07,0.24294617861038903,0.0
237,0.5,7,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Can estradiol and antagonist pretreatment before microdose leuprolide improve IVF success in poor responders versus oral contraceptive pills? Data reveal no improvement with E2 and antagonist pretreatment over standard OCP in the ML protocol. Additional randomized studies with sufficient power are required.,3.079176455639103e-07,0.2146755060439638,0.04297628563158954,0.023574544042164344,0.26375682370693987,0.012694252779427102,0.023540420032387266,0.26102256550717007,0.01922337562475971,3.079176455639103e-07,0.29423947299793873,0.0
237,0.5,8,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does the use of estradiol and antagonist pretreatment before microdose leuprolide lead to better IVF outcomes in poor responders compared to oral contraceptive pills? E2 plus antagonist pretreatment does not seem to improve IVF success relative to OCP in the ML protocol. More adequately powered randomized trials are needed.,1.4211583641411244e-07,0.018303579187131547,0.0708045859117476,0.010880558788691236,0.06783131708282175,0.03767781622452902,0.0108648092457172,0.09594281514771996,0.01922337562475971,1.4211583641411244e-07,0.12516314295400566,0.0
237,0.5,9,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Is IVF outcome enhanced in poor responders by estradiol and antagonist pretreatment prior to microdose leuprolide compared to oral contraceptive pills? Evidence does not support improvement with E2 and antagonist pretreatment versus OCP in the ML protocol. Further randomized trials with sufficient power are necessary.,2.3685972735685406e-07,0.13944720370433483,0.04627701420704339,0.018134264647818726,0.18901820684629156,0.0144351858390415,0.018108015409528666,0.18691459335344662,0.01922337562475971,2.3685972735685406e-07,0.21825356602001733,0.0
237,0.5,10,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does estradiol and antagonist pretreatment before microdose leuprolide improve IVF outcomes in poor responders when compared to oral contraceptive pills? Current findings suggest no benefit of E2 plus antagonist pretreatment over the standard OCP in the ML protocol. Well-powered randomized trials are still required.,2.6054570009253947e-07,0.13166274562510383,0.06838585774445835,0.0199476911126006,0.18030930050951177,0.03767781622452902,0.019918816950481533,0.21101214493250664,0.01922337562475971,2.6054570009253947e-07,0.24294617861038903,0.0
238,0.5,1,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Does minimal access major surgery in newborns cause less pain?,9.474389094274136e-07,1.6663039991188993,0.020399305555555556,0.07253705859127506,1.7917594692280554,0.0,0.07243206163811486,1.904237452654744,0.0,9.474389094274154e-07,2.0368819272610397,0.0
238,0.5,2,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Is pain reduced with minimal access major surgery in newborn infants?,9.237529366917282e-07,1.5609434834610734,0.020399305555555556,0.07072363212649319,1.6739764335716716,0.0,0.07062126009716198,1.7707060600302222,0.0,9.237529366917301e-07,1.8827312474337807,0.0
238,0.5,3,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Do newborns experience less pain from minimal access major surgery?,9.474389094274136e-07,1.6663039991188993,0.020399305555555556,0.07253705859127506,1.7917594692280554,0.0,0.07243206163811486,1.904237452654744,0.0,9.474389094274154e-07,2.0368819272610397,0.0
238,0.5,4,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Is minimal access surgery less painful for newborns undergoing major procedures?,9.237529366917282e-07,1.5609434834610734,0.020399305555555556,0.07072363212649319,1.6739764335716716,0.0,0.07062126009716198,1.7707060600302222,0.0,9.237529366917301e-07,1.8827312474337807,0.0
238,0.5,5,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Does performing major surgery with minimal access techniques in newborns result in less pain?,8.526950184846722e-07,1.2985792189935816,0.020399305555555556,0.06528335273214755,1.3862943611198904,0.0,0.06518885547430336,1.4522523289116873,0.0,8.52695018484674e-07,1.5260563034950492,0.0
238,0.5,6,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Are pain levels lower in newborns after minimal access major surgery?,9.237529366917282e-07,1.5609434834610734,0.020399305555555556,0.07072363212649319,1.6739764335716716,0.0,0.07062126009716198,1.7707060600302222,0.0,9.237529366917301e-07,1.8827312474337807,0.0
238,0.5,7,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Does minimal access surgery for major conditions in newborns lead to less pain?,8.763809912203575e-07,1.378621926667118,0.020399305555555556,0.06709677919692943,1.4733057381095205,0.0,0.06699965701525623,1.5475625087160125,0.0,8.763809912203594e-07,1.631416819152875,0.0
238,0.5,8,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Is there less pain in newborns following minimal access major surgical procedures?,9.000669639560429e-07,1.4656333036567482,0.020399305555555556,0.0689102056617113,1.5686159179138457,0.0,0.06881045855620911,1.6529230243738384,0.0,9.000669639560448e-07,1.7491998548092589,0.0
238,0.5,9,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Do newborns suffer less pain with minimal access approaches in major surgery?,9.000669639560429e-07,1.4656333036567482,0.020399305555555556,0.0689102056617113,1.5686159179138457,0.0,0.06881045855620911,1.6529230243738384,0.0,9.000669639560448e-07,1.7491998548092589,0.0
238,0.5,10,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Is pain diminished in newborns undergoing minimal access major surgery?,9.474389094274136e-07,1.6663039991188993,0.020399305555555556,0.07253705859127506,1.7917594692280554,0.0,0.07243206163811486,1.904237452654744,0.0,9.474389094274154e-07,2.0368819272610397,0.0
239,0.5,1,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Does the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism contribute to chronic kidney disease in patients with hypertension? This is a complex and ongoing research topic. Some studies indicate a possible connection, especially regarding the insertion/deletion (I/D) polymorphism, but others find no link. Further investigation is required to reach a definitive conclusion.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
239,0.5,2,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Is there a relationship between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients? The issue is complicated and under active study. Certain research points to an association, notably with the insertion/deletion (I/D) polymorphism, while other studies do not support this. More research is necessary to clarify this.",2.3685972735685406e-08,0.02061928720273576,0.0,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
239,0.5,3,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Does ACE-1 gene polymorphism cause chronic kidney disease among those with hypertension? This question remains complex and is actively researched. Some evidence suggests a connection, particularly with the insertion/deletion (I/D) polymorphism, but other findings show no correlation. Additional studies are needed to provide a clear answer.",9.474389094274162e-08,0.08515780834030728,0.0,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
239,0.5,4,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Can the polymorphism of the angiotensin-converting enzyme-1 (ACE-1) gene lead to chronic kidney disease in hypertensive individuals? This is a complex subject with ongoing research. Some studies suggest a link, especially involving the insertion/deletion (I/D) polymorphism, whereas others find no association. More research is required to confirm this.",4.737194547137081e-08,0.04167269640056892,0.0,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
239,0.5,5,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Does the ACE-1 gene polymorphism influence the development of chronic kidney disease in patients with hypertension? This is a complex and actively studied area. While some research indicates a connection, particularly for the insertion/deletion (I/D) polymorphism, other studies do not find an association. Further research is needed to definitively answer this question.",4.737194547137081e-08,0.04000533461369837,0.0,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
239,0.5,6,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Is chronic kidney disease among hypertensive patients caused by angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? This remains a complex and actively researched topic. Some studies show a potential link, especially with the insertion/deletion (I/D) polymorphism, but others report no association. More research is necessary to reach a definitive conclusion.",4.737194547137081e-08,0.04167269640056892,0.0,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
239,0.5,7,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Does polymorphism in the ACE-1 gene contribute to chronic kidney disease in hypertensive patients? This is a complex and actively studied question. Some evidence points to a link, particularly the insertion/deletion (I/D) polymorphism, but other studies find no association. Additional research is needed to clarify this.",9.474389094274162e-08,0.08515780834030728,0.0,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
239,0.5,8,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Is there an association between ACE-1 gene polymorphism and chronic kidney disease in patients with hypertension? This is a complex issue under active investigation. Some studies suggest a connection, especially concerning the insertion/deletion (I/D) polymorphism, while others do not find any association. More research is needed to provide a definitive answer.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
239,0.5,9,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Does the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism play a role in chronic kidney disease among hypertensive patients? This is a complex and ongoing research area. Some studies indicate a link, particularly the insertion/deletion (I/D) polymorphism, but others show no association. Further research is required to reach a conclusive answer.",2.3685972735685406e-08,0.02061928720273576,0.0,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
239,0.5,10,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Can chronic kidney disease in hypertensive patients be linked to ACE-1 gene polymorphism? This question is complex and actively researched. Some studies suggest a link, especially with the insertion/deletion (I/D) polymorphism, while others show no association. More research is necessary to definitively resolve this question.",1.1842986367842703e-07,0.107630664192365,0.0,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
240,0.5,1,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Does receiving care at a birth center during a woman's initial pregnancy affect her later reproductive outcomes?,9.948108548987847e-07,1.2161494075590564,0.051570247933884296,0.07616391152083878,1.3350010667323398,0.0,0.07605366472002054,1.3862943611198912,0.0,9.948108548987866e-07,1.442383827770934,0.0
240,0.5,2,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Is there any effect of birth center care during a woman's first pregnancy on her future reproductive health?,9.711248821630993e-07,1.1555247857426214,0.051570247933884296,0.0743504850560569,1.2704625455947691,0.0,0.07424286317906767,1.3173014896329391,0.0,9.711248821631012e-07,1.3682758556172128,0.0
240,0.5,3,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
","Can the type of care during a first pregnancy, such as birth center care, impact a woman's subsequent reproduction?",9.474389094274141e-07,1.0983663719026726,0.051570247933884296,0.07253705859127503,1.209837923778334,0.0,0.07243206163811479,1.2527629684953685,0.0,9.474389094274159e-07,1.2992829841302607,0.0
240,0.5,4,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
","Does the setting of care in a first pregnancy, including birth centers, influence a woman's future reproductive health?",9.711248821630993e-07,1.1555247857426214,0.051570247933884296,0.0743504850560569,1.2704625455947691,0.0,0.07424286317906767,1.3173014896329391,0.0,9.711248821631012e-07,1.3682758556172128,0.0
240,0.5,5,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Is a woman's future reproduction affected by whether she had birth center care during her first pregnancy?,9.948108548987847e-07,1.2161494075590564,0.051570247933884296,0.07616391152083878,1.3350010667323398,0.0,0.07605366472002054,1.3862943611198912,0.0,9.948108548987866e-07,1.442383827770934,0.0
240,0.5,6,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Does care at a birth centers during a woman's first pregnancy have consequences for her later reproductive health?,9.711248821630993e-07,1.1555247857426214,0.051570247933884296,0.0743504850560569,1.2704625455947691,0.0,0.07424286317906767,1.3173014896329391,0.0,9.711248821631012e-07,1.3682758556172128,0.0
240,0.5,7,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Is there a relationship between birth center care in a first pregnancy and future reproductive outcomes?,1.0184968276344701e-06,1.280687928696627,0.051570247933884296,0.07797733798562065,1.4039939382192919,0.0,0.07786446626097342,1.4604023332736125,0.0,1.018496827634472e-06,1.5224265354444704,0.0
240,0.5,8,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
","Does the model of care, like birth center care, during a first pregnancy impact future reproductive health?",9.948108548987847e-07,1.2161494075590564,0.051570247933884296,0.07616391152083878,1.3350010667323398,0.0,0.07605366472002054,1.3862943611198912,0.0,9.948108548987866e-07,1.442383827770934,0.0
240,0.5,9,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Can birth center care during a first pregnancy influence a woman's reproductive health in later pregnancies?,1.0184968276344701e-06,1.280687928696627,0.051570247933884296,0.07797733798562065,1.4039939382192919,0.0,0.07786446626097342,1.4604023332736125,0.0,1.018496827634472e-06,1.5224265354444704,0.0
240,0.5,10,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
","Does the type of care during a woman's first pregnancy, such as birth center care, affect her future reproductive health?",9.237529366917287e-07,1.0442991506323973,0.051570247933884296,0.07072363212649316,1.1526795099383853,0.0,0.07062126009716192,1.1921383466789335,0.0,9.237529366917306e-07,1.23474446299269,0.0
241,0.5,1,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Is there a connection between the CYP2D6*4 allele and breast cancer risk? This allele may cause decreased activation of procarcinogens due to reduced enzyme activity, resulting in slower metabolism of some substances. Although some research indicates a potential association with lowered breast cancer risk, more studies are required to confirm this link.",7.105791820705622e-08,0.03299642061781638,0.017382248520710075,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
241,0.5,2,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Does the CYP2D6*4 allele affect breast cancer risk? The allele is linked to diminished enzyme function, which could slow the metabolism of procarcinogens. Some evidence points to a possible reduced risk of breast cancer, but additional investigation is necessary to validate these findings.",2.8423167282822487e-07,0.19997019268387417,0.03698224852071007,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
241,0.5,3,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","What is the relationship between the CYP2D6*4 allele and breast cancer risk? This allele is characterized by reduced enzyme activity, possibly leading to decreased conversion of procarcinogens. While certain studies hint at a lower breast cancer risk, conclusive evidence is still lacking.",3.079176455639103e-07,0.25787980185122406,0.012607248520710067,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
241,0.5,4,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Can the CYP2D6*4 allele influence breast cancer risk? Due to its association with decreased enzyme activity, this allele might slow the metabolism of certain compounds, potentially lowering breast cancer risk. However, further research is needed to confirm this association.",3.789755637709663e-07,0.33653508179664193,0.010685681683602694,0.029014823436509962,0.3593740009078954,0.0,0.028972824655245866,0.3677247801253176,0.0,3.789755637709665e-07,0.37647757123491177,0.0
241,0.5,5,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Is the CYP2D6*4 allele linked to breast cancer risk? It is associated with reduced enzyme activity, which may result in slower procarcinogen metabolism. Some studies suggest this could correlate with a decreased breast cancer risk, but more research is required to establish a definitive link.",2.3685972735685406e-07,0.18495686707443282,0.014267267449860958,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
241,0.5,6,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Does carrying the CYP2D6*4 allele impact breast cancer risk? This allele leads to reduced enzyme function, potentially causing slower metabolism of procarcinogens. While some findings imply a possible reduction in breast cancer risk, more comprehensive studies are needed.",4.026615365066516e-07,0.3641893134884189,0.009976075681203903,0.030828249901291835,0.3867729750960107,0.0,0.030783626196198732,0.39589565709201446,0.0,4.026615365066519e-07,0.4054651081081633,0.0
241,0.5,7,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","What association exists between the CYP2D6*4 allele and breast cancer risk? The allele's reduced enzyme activity might cause a decreased transformation of procarcinogens, possibly lowering breast cancer risk. Nonetheless, further research is essential to confirm this potential connection.",4.026615365066516e-07,0.3641893134884189,0.009976075681203903,0.030828249901291835,0.3867729750960107,0.0,0.030783626196198732,0.39589565709201446,0.0,4.026615365066519e-07,0.4054651081081633,0.0
241,0.5,8,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Is there an association between the CYP2D6*4 allele and breast cancer risk? This allele results in reduced enzyme activity, which may slow down the metabolism of certain compounds, possibly reducing breast cancer risk. Additional studies are necessary to establish a firm relationship.",3.079176455639103e-07,0.25787980185122406,0.012607248520710067,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
241,0.5,9,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","How does the CYP2D6*4 allele relate to breast cancer risk? It is linked to diminished enzyme activity that could lead to slower metabolism of procarcinogens, potentially decreasing breast cancer risk. However, more research is needed to verify this association.",3.789755637709663e-07,0.33653508179664193,0.010685681683602694,0.029014823436509962,0.3593740009078954,0.0,0.028972824655245866,0.3677247801253176,0.0,3.789755637709665e-07,0.37647757123491177,0.0
241,0.5,10,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Does the CYP2D6*4 allele have any connection to breast cancer risk? This allele is associated with lower enzyme activity and may slow the metabolism of procarcinogens, which might reduce breast cancer risk. Further investigation is required to confirm this hypothesis.",3.55289591035281e-07,0.30962417409708154,0.011358979822649114,0.02720139697172809,0.33270575382573453,0.0,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
242,0.5,1,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean individuals? Both hsCRP levels and carotid intima-media thickness (IMT) were notably elevated in subjects with carotid atherosclerosis compared to those without, indicating a significant association between hsCRP and carotid atherosclerosis development in healthy Koreans.",0.0,0.018362685475644458,0.026407251379631735,0.0,0.06027366787477817,0.04317155085498335,0.0,0.030806541358219697,0.02221074380165289,0.0,0.0,0.0
242,0.5,2,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Does high-sensitivity C-reactive protein correlate with carotid atherosclerosis in healthy Koreans? Subjects with carotid atherosclerosis showed significantly higher hsCRP levels and carotid IMT than those without, suggesting a strong relationship between hsCRP and carotid atherosclerosis in this population.",2.3685972735685374e-07,0.2526019191591087,0.020629810194824516,0.018134264647818726,0.23172830961636715,0.009536624117403775,0.018108015409528666,0.2205078869226864,0.02221074380165289,2.3685972735685406e-07,0.2578291093020999,0.0
242,0.5,3,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is high-sensitivity C-reactive protein linked to carotid atherosclerosis among healthy Koreans? The findings showed that both hsCRP and carotid IMT were significantly increased in individuals with carotid atherosclerosis, indicating a strong correlation between hsCRP and carotid atherosclerosis development.",2.3685972735685374e-07,0.16352524710493777,0.09325630031555612,0.018134264647818726,0.1932201329185923,0.03714484387589542,0.018108015409528666,0.2205078869226864,0.02221074380165289,2.3685972735685406e-07,0.2578291093020999,0.0
242,0.5,4,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean people? Subjects with carotid atherosclerosis had considerably higher hsCRP levels and carotid IMT than those without, implying a strong link between hsCRP and carotid atherosclerosis.",2.1317375462116844e-07,0.1476687341877323,0.038195923223542844,0.016320838183036854,0.12731298203270214,0.06489994591671175,0.0162972138685758,0.19233700995598957,0.02221074380165289,2.1317375462116866e-07,0.2288415724288484,0.0
242,0.5,5,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Does high-sensitivity C-reactive protein have a relationship with carotid atherosclerosis in healthy Koreans? The study found significantly elevated hsCRP and carotid IMT in individuals with carotid atherosclerosis compared to those without, indicating a strong association between hsCRP and carotid atherosclerosis.",1.8948778188548314e-07,0.14066330516124648,0.0724816375092571,0.014507411718254981,0.1736075960621144,0.012430810114242609,0.014486412327622933,0.16493803576787425,0.02221074380165289,1.8948778188548325e-07,0.20067069546215155,0.0
242,0.5,6,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Korean subjects? Both hsCRP levels and carotid IMT were significantly greater in subjects with carotid atherosclerosis, suggesting a strong correlation between hsCRP and carotid atherosclerosis in healthy Koreans.",2.3685972735685374e-07,0.2384600774357426,0.041870189805175484,0.018134264647818726,0.23172830961636715,0.009536624117403775,0.018108015409528666,0.26011629724039764,0.006335969001115268,2.3685972735685406e-07,0.2578291093020999,0.0
242,0.5,7,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is there a connection between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? The data revealed significantly higher hsCRP and carotid IMT in subjects with carotid atherosclerosis, supporting a strong association between hsCRP and carotid atherosclerosis development.",2.3685972735685374e-07,0.21513450399370626,0.0065803238157356725,0.018134264647818726,0.23172830961636715,0.009536624117403775,0.018108015409528666,0.2205078869226864,0.02221074380165289,2.3685972735685406e-07,0.2578291093020999,0.0
242,0.5,8,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is high-sensitivity C-reactive protein related to carotid atherosclerosis in healthy Korean individuals? Subjects exhibiting carotid atherosclerosis had markedly increased hsCRP levels and carotid IMT, indicating a strong correlation between hsCRP and carotid atherosclerosis.",3.5528959103528024e-07,0.2829484090232226,0.11148390508295326,0.027201396971728117,0.3042436901917811,0.06489994591671175,0.027162023114293034,0.3746585667499449,0.02221074380165289,3.552895910352811e-07,0.41689380393178865,0.0
242,0.5,9,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Does high-sensitivity C-reactive protein associate with carotid atherosclerosis among healthy Koreans? The study demonstrated significantly elevated hsCRP and carotid IMT in those with carotid atherosclerosis, suggesting a strong link between hsCRP and carotid atherosclerosis.",3.3160361829959494e-07,0.29156011288828276,0.08370612730517545,0.025387970506946238,0.31581669066219886,0.03368246412690945,0.02535122157334016,0.3418687439269532,0.02221074380165289,3.316036182995957e-07,0.3829922522561069,0.0
242,0.5,10,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is there a significant association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT were significantly higher in subjects with carotid atherosclerosis, indicating a strong correlation between hsCRP and the presence of carotid atherosclerosis.",1.6580180914979784e-07,0.00781881916701499,0.14872256386007357,0.012693985253473108,0.0746692485472833,0.06489994591671175,0.012675610786670066,0.13826978868571338,0.02221074380165289,1.6580180914979784e-07,0.17327172127403623,0.0
243,0.5,1,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crÃªpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is the fragility of the esophageal mucosa a diagnostic endoscopic hallmark of primary eosinophilic esophagitis? Primary eosinophilic esophagitis features a delicate esophageal lining that easily tears with minimal trauma during routine diagnostic endoscopy. This 'crÃªpe-paper' appearance can help endoscopists recognize the disease when other signs are absent.,9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
243,0.5,2,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crÃªpe-paper"" sign may alert endoscopists to the presence of the disease when other","Question: Does the fragile nature of the esophageal mucosa serve as a pathognomonic endoscopic indicator of primary eosinophilic esophagitis? Answer: In primary eosinophilic esophagitis, the esophageal mucosa is notably fragile and tears easily with slight trauma during standard endoscopic procedures. This characteristic 'crÃªpe-paper' sign may assist endoscopists in diagnosing the condition when other features are not evident.",1.4211583641411244e-07,0.09451469040609073,0.013469230845298837,0.010880558788691236,0.09030753510148237,0.0181755829903978,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
243,0.5,3,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crÃªpe-paper"" sign may alert endoscopists to the presence of the disease when other","Is the fragile esophageal mucosa an endoscopic sign specific to primary eosinophilic esophagitis? Primary eosinophilic esophagitis is marked by a mucosa that tears easily under minor trauma during diagnostic endoscopy, producing a 'crÃªpe-paper' effect that can alert clinicians to the disease in the absence of other signs.",9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
243,0.5,4,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crÃªpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Can the fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is distinguished by a fragile esophageal lining that tears readily with minimal trauma during routine endoscopy. This 'crÃªpe-paper' sign may help endoscopists identify the disease when other indications are lacking.,2.3685972735685406e-08,0.048072159366075784,0.020330555555555574,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
243,0.5,5,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crÃªpe-paper"" sign may alert endoscopists to the presence of the disease when other","Is the delicate nature of the esophageal mucosa a definitive endoscopic marker of primary eosinophilic esophagitis? The disease is characterized by an esophageal mucosa that is fragile and tears easily upon minor trauma during diagnostic endoscopy, producing a 'crÃªpe-paper' appearance that may alert endoscopists to its presence.",9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
243,0.5,6,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crÃªpe-paper"" sign may alert endoscopists to the presence of the disease when other","Question: Does primary eosinophilic esophagitis present with a fragile esophageal mucosa as a pathognomonic endoscopic sign? Answer: The condition is characterized by a mucosa that is easily torn during diagnostic endoscopy due to its fragility, resulting in a 'crÃªpe-paper' sign that may alert the endoscopist to the disease when other signs are absent.",4.737194547137081e-08,0.094672487598078,0.039930555555555566,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
243,0.5,7,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crÃªpe-paper"" sign may alert endoscopists to the presence of the disease when other","Is the fragility of the esophageal mucosa a characteristic endoscopic feature of primary eosinophilic esophagitis? This disease involves an esophageal mucosa that tears readily with minor trauma during diagnostic endoscopy, showing a 'crÃªpe-paper' sign that can help identify the condition when other signs are not obvious.",1.1842986367842703e-07,0.08071528257125005,0.017719811753902675,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
243,0.5,8,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crÃªpe-paper"" sign may alert endoscopists to the presence of the disease when other","Question: Is fragile esophageal mucosa a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is defined by an esophageal mucosa that is fragile and easily tears with slight trauma during an otherwise routine diagnostic endoscopy, producing a 'crÃªpe-paper' sign that may alert endoscopists to the disease.",4.737194547137081e-08,0.07201361764545178,0.022291666666666654,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
243,0.5,9,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crÃªpe-paper"" sign may alert endoscopists to the presence of the disease when other","Is the fragile esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? The disease features an esophageal lining that tears easily with minor trauma during diagnostic endoscopy, creating a 'crÃªpe-paper' appearance that may signal the presence of the condition when other signs are missing.",1.4211583641411244e-07,0.07238159706508807,0.039930555555555566,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
243,0.5,10,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crÃªpe-paper"" sign may alert endoscopists to the presence of the disease when other","Question: Can the fragile esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is marked by a delicate esophageal mucosa that tears easily during diagnostic endoscopy with minimal trauma, producing a 'crÃªpe-paper' sign which may help endoscopists recognize the disease in the absence of other signs.",4.737194547137081e-08,0.04135347370885123,0.0015305555555555558,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
244,0.5,1,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
","Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Enhancing hospital efficiency by reducing the length of stay does not inherently diminish patient care quality. Properly structured discharge planning programs, along with suitable support services, can guarantee patients obtain necessary care promptly and safely, even with shorter hospital stays.",1.1842986367842703e-07,0.09180754925312229,0.0,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
244,0.5,2,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
",Is there a detrimental effect on care quality when patients are discharged earlier from Winnipeg hospitals? Increasing hospital efficiency by shortening stays doesnâ€™t automatically reduce the quality of patient care. Effective discharge planning combined with adequate support ensures patients receive timely and safe care despite shorter hospital admissions.,2.3685972735685406e-07,0.19290366612449228,0.0,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
244,0.5,3,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
","Does earlier discharge from hospitals in Winnipeg harm the quality of patient care? Improving efficiency by decreasing length of stay does not necessarily affect patient care negatively. Well-organized discharge plans and appropriate support services can provide patients with timely and safe care, even if their hospital stay is brief.",2.1317375462116866e-07,0.17185025692665912,0.0,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
244,0.5,4,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
","Does releasing patients sooner from Winnipeg hospitals adversely affect care quality? Streamlining hospital efficiency by reducing length of stay doesnâ€™t inherently compromise patient care. With well-designed discharge planning and proper support, patients can still receive safe and timely care despite shorter hospital stays.",3.552895910352811e-07,0.3053816495511823,0.0,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
244,0.5,5,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
","Is the quality of care compromised by discharging patients earlier from Winnipeg hospitals? Shortening hospital stays to improve efficiency does not automatically jeopardize patient care. Thoughtful discharge planning and adequate support services ensure patients get the care they need promptly and safely, even with reduced hospital time.",2.6054570009253947e-07,0.21440987134545564,0.0,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
244,0.5,6,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
","Does earlier patient discharge from Winnipeg hospitals negatively impact the quality of care? Enhancing hospital efficiency through shorter stays does not necessarily harm patient care. Effective discharge planning programs and appropriate support services help patients receive timely and safe care, even when hospital stays are shorter.",2.8423167282822487e-07,0.23638877806423064,0.0,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
244,0.5,7,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
",Does discharging patients sooner from Winnipeg hospitals reduce the quality of care? Improving hospital efficiency by cutting down length of stay doesnâ€™t inherently lower patient care standards. Proper discharge planning and support services can ensure patients get the necessary care safely and promptly despite shorter stays.,2.8423167282822487e-07,0.23638877806423064,0.0,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
244,0.5,8,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
",Is patient care quality affected by earlier discharge from Winnipeg hospitals? Shortening hospital stays to boost efficiency does not automatically compromise care quality. Well-planned discharge programs with adequate support can ensure timely and safe patient care even with abbreviated hospital stays.,4.026615365066519e-07,0.3888291727486104,0.02498356344510192,0.030828249901291835,0.3617900446055051,0.0,0.030783626196198732,0.3697470255060846,0.0,4.026615365066519e-07,0.37806613392004973,0.0
244,0.5,9,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
","Does earlier hospital discharge in Winnipeg harm the quality of patient care? Increasing efficiency by reducing the length of stay does not necessarily affect care quality negatively. Discharge planning programs designed well, along with suitable support, ensure patients receive timely and safe care despite shorter hospital admissions.",2.6054570009253947e-07,0.21440987134545564,0.0,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
244,0.5,10,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
","Does releasing patients earlier from Winnipeg hospitals adversely affect care quality? Enhancing hospital efficiency by shortening stays does not inherently reduce patient care quality. Properly structured discharge planning and support services can guarantee patients receive necessary care safely and promptly, even with shorter hospital stays.",3.079176455639103e-07,0.25886163391628836,0.0,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
245,0.5,1,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a relationship between androgens and sexual desire in women? In this study, free testosterone (FT) and androstenedione showed a statistically significant correlation with sexual desire across the entire group of women. ADT-G did not demonstrate a stronger correlation with sexual desire than circulating androgens and thus is not a better measure than circulating androgens assessed by mass spectrometry.",7.105791820705622e-08,0.036716793941979464,0.009355621301775113,0.005440279394345618,0.03181564860708974,0.015258393181303315,0.0054324046228586,0.029746267566417295,0.01753826530612245,7.105791820705622e-08,0.05505977718302857,0.0
245,0.5,2,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does a link exist between androgens and sexual desire in women? According to the current research, FT and androstenedione were significantly correlated with sexual desire in the overall female cohort. The correlation of ADT-G with sexual desire was not stronger than that of circulating androgens, indicating it is not superior to measuring circulating androgens via mass spectrometry.",0.0,0.0495105128971387,0.036132544378698256,0.0,0.0,6.938893903907228e-18,0.0,0.0,0.0,0.0,0.0,0.0
245,0.5,3,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is sexual desire in women connected to androgens? The study found that FT and androstenedione had a statistically significant correlation with sexual desire among all women studied. ADT-G did not show a stronger correlation than circulating androgens and therefore is not a better indicator than circulating androgen levels measured by mass spectrometry.,1.1842986367842703e-07,0.009984712783731808,0.10644964598084133,0.009067132323909363,0.044899475763602315,0.036311854752580995,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.5,4,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Are androgens related to sexual desire in women? This study revealed that FT and androstenedione were significantly correlated with sexual desire in the total female cohort. ADT-G did not correlate more strongly with sexual desire than circulating androgens, suggesting it is not a superior measurement compared to circulating androgens measured by mass spectrometry.",9.474389094274162e-08,0.03293320869098393,0.027544444444444455,0.0072537058591274906,0.07946133321722204,0.0028384992665776987,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
245,0.5,5,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there an association between androgens and sexual desire in women? The present study demonstrated a statistically significant correlation between FT, androstenedione, and sexual desire in the full group of women. ADT-G did not have a stronger correlation with sexual desire than circulating androgens, so it is not better than measuring circulating androgens by mass spectrometry.",2.3685972735685406e-08,0.0295217393463294,0.034104421376393745,0.0018134264647818726,0.019282670224506138,0.0006703937681290587,0.0018108015409528666,0.044848630391775224,0.018860946745562133,2.3685972735685406e-08,0.0190481949706931,0.0
245,0.5,6,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Do androgens correlate with sexual desire in women? Findings from this study indicate that FT and androstenedione significantly correlate with sexual desire among the female cohort. ADT-Gâ€™s correlation with sexual desire was not stronger than that of circulating androgens, making it less effective than measuring circulating androgens through mass spectrometry.",1.6580180914979784e-07,0.1384718124501374,0.046032231404958684,0.012693985253473108,0.18326587084894452,0.07035481191408563,0.012675610786670066,0.1683320695588959,0.0212665406427221,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.5,7,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is sexual desire in women influenced by androgens? The current research showed a statistically significant correlation between FT, androstenedione, and sexual desire across all women studied. ADT-G did not correlate more strongly with sexual desire compared to circulating androgens and is therefore not superior to mass spectrometry measurement of circulating androgens.",1.4211583641411244e-07,0.02137016708273487,0.06400277777777781,0.010880558788691236,0.06510218308112092,0.036311854752580995,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
245,0.5,8,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a connection between androgens and sexual desire in women? In this study, FT and androstenedione were found to be significantly correlated with sexual desire in the total cohort of women. ADT-G did not exhibit a stronger correlation with sexual desire than circulating androgens, thus it is not a better method than measuring circulating androgens by mass spectrometry.",4.737194547137081e-08,0.08833854797210527,0.039975857338820364,0.0036268529295637453,0.03748687923508642,0.0012705324385313965,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
245,0.5,9,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Are androgen levels linked to sexual desire in women? The study found statistically significant correlations between FT, androstenedione, and sexual desire in the entire female cohort. ADT-G did not correlate more strongly with sexual desire than circulating androgens and is therefore not superior to measuring circulating androgens by mass spectrometry.",1.6580180914979784e-07,0.09950155724841414,0.02016790123456791,0.012693985253473108,0.11460260280718737,0.015487952534382711,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.5,10,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a statistical correlation between androgens and sexual desire in women? The present study demonstrated that FT and androstenedione were significantly correlated with sexual desire in the total group of women. ADT-G did not show a stronger correlation with sexual desire than circulating androgens, indicating it is not a better measure than circulating androgens assessed by mass spectrometry.",4.737194547137081e-08,0.06443692105624521,0.022424492702029217,0.0036268529295637453,0.03748687923508642,0.0012705324385313896,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
246,0.5,1,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does participating in a preoperative medically supervised weight loss program enhance the results of bariatric surgery? MSWM seems to offer no extra advantage over usual preoperative care. Although certain studies indicate possible benefits in weight reduction and metabolic health, these results are not consistently confirmed. More research is required to conclusively determine the impact of MSWM on bariatric surgery success.",4.737194547137081e-08,0.012115853867486592,0.03274920999712727,0.0036268529295637453,0.03390155167568043,0.0,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
246,0.5,2,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Is a medically supervised weight loss program before surgery effective in improving bariatric surgery outcomes? MSWM does not seem to provide additional benefits beyond standard preoperative care. Some research points to potential improvements in weight loss and metabolic measures, but these findings are inconsistent. Further investigation is necessary to clarify the role of MSWM in enhancing bariatric surgery results.",7.105791820705622e-08,0.052781833323533256,0.0016895655130768003,0.005440279394345618,0.05129329438754926,0.0,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
246,0.5,3,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does a preoperative weight loss program under medical supervision improve outcomes of bariatric surgery? MSWM does not appear to offer benefits beyond those of standard preoperative care. While some studies report possible improvements in weight and metabolic parameters, these are not consistently observed. Additional studies are needed to firmly establish the effectiveness of MSWM in optimizing bariatric surgery outcomes.",7.105791820705622e-08,0.004978579491813129,0.03274920999712727,0.005440279394345618,0.05129329438754926,0.0,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
246,0.5,4,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does engaging in a medically supervised weight loss program before bariatric surgery improve surgical outcomes? MSWM does not appear to provide added benefits compared to typical preoperative care. Although some research suggests improved weight loss and metabolic outcomes, the evidence is inconsistent. More research is needed to definitively evaluate MSWM's role in bariatric surgery success.",1.6580180914979784e-07,0.12778177907099053,0.004233038523582783,0.012693985253473108,0.12405264866997845,0.0,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
246,0.5,5,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Is there an improvement in bariatric surgery outcomes from a preoperative medically supervised weight loss program? MSWM does not seem to confer extra advantages over standard preoperative care. Certain studies suggest potential benefits in weight loss and metabolism, yet these findings lack consistent replication. Further research is essential to determine MSWM's effectiveness in bariatric surgery optimization.",1.4211583641411244e-07,0.13370446086684584,0.021614695328316516,0.010880558788691236,0.13103263345634097,0.01851192595229618,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
246,0.5,6,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does a preoperative medically supervised weight loss program enhance the results of bariatric surgery? MSWM appears to provide no significant benefit beyond standard preoperative care. Some studies indicate possible improvements in weight loss and metabolic parameters, but these results are not consistently replicated. More research is necessary to conclusively assess MSWM's role in bariatric surgery outcomes.",1.4211583641411244e-07,0.08329375682612294,0.01457362700672947,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
246,0.5,7,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Can a medically supervised weight loss program before surgery improve bariatric surgery outcomes? MSWM does not seem to offer additional benefits compared to standard preoperative care. While some studies show potential improvements in weight loss and metabolic health, these findings are inconsistent. Further research is needed to definitively understand MSWM's impact on bariatric surgery results.",1.6580180914979784e-07,0.12778177907099053,0.004233038523582783,0.012693985253473108,0.12405264866997845,0.0,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
246,0.5,8,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does undergoing a medically supervised weight loss program prior to bariatric surgery improve surgical outcomes? MSWM does not appear to provide added benefits over standard preoperative care. Although some studies suggest improvements in weight loss and metabolic measures, these findings are not consistently duplicated. Additional research is needed to confirm the role of MSWM in optimizing bariatric surgery results.",7.105791820705622e-08,0.052781833323533256,0.0016895655130768211,0.005440279394345618,0.05129329438754926,0.0,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
246,0.5,9,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Is the outcome of bariatric surgery improved by a preoperative medically supervised weight loss program? MSWM does not seem to offer benefits beyond standard preoperative care. Some studies suggest potential enhancements in weight loss and metabolic parameters, but these are not consistently supported. More research is necessary to definitively evaluate MSWM's effectiveness in bariatric surgery.",1.6580180914979784e-07,0.10210966127247367,0.01423728404483109,0.012693985253473108,0.12405264866997845,0.0,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
246,0.5,10,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does a medically supervised weight loss program before bariatric surgery improve the surgery outcomes? MSWM does not appear to confer additional benefits compared to standard preoperative care. While some studies indicate possible improvements in weight loss and metabolic parameters, these findings are inconsistent. Further research is required to conclusively assess MSWM's role in bariatric surgery optimization.",1.4211583641411244e-07,0.1084991088464844,0.003562644755453717,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
247,0.5,1,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
","What are the diagnostic features of child bipolar I disorder, and can the 'Treatment of Early Age Mania (TEAM)' sample be generalized?",7.57951127541931e-07,0.9257694758286994,0.0,0.05802964687302003,0.9555114450274376,0.0,0.05794564931049184,0.987386653557885,0.0,7.579511275419328e-07,1.0216512475319806,0.0
247,0.5,2,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Do the diagnostic characteristics of child bipolar I disorder found in the 'Treatment of Early Age Mania (TEAM)' sample apply broadly?,7.816371002776163e-07,0.9745596399981307,0.0,0.05984307333780191,1.0068047394149877,0.0,0.059756450851444716,1.0414538748281603,0.0,7.816371002776182e-07,1.0788096613719294,0.0
247,0.5,3,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Can the findings from the 'Treatment of Early Age Mania (TEAM)' sample regarding child bipolar I disorder be generalized?,8.290090457489871e-07,1.0799201556559561,0.0,0.06346992626736567,1.1180303745252118,0.0,0.06337805393335046,1.1592369104845441,0.0,8.290090457489889e-07,1.203972804325935,0.0
247,0.5,4,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",How well do the diagnostic traits of child bipolar I disorder from the 'TEAM' study generalize to other populations?,8.290090457489871e-07,1.0799201556559561,0.0,0.06346992626736567,1.1180303745252118,0.0,0.06337805393335046,1.1592369104845441,0.0,8.290090457489889e-07,1.203972804325935,0.0
247,0.5,5,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Is the 'Treatment of Early Age Mania (TEAM)' sample representative enough to generalize diagnostic characteristics of child bipolar I disorder?,8.053230730133017e-07,1.0258529343856808,0.0,0.06165649980258379,1.060871960685263,0.0,0.06156725239239759,1.0986122886681091,0.0,8.053230730133036e-07,1.1394342831883644,0.0
247,0.5,6,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Does the 'TEAM' sample accurately reflect the diagnostic features of child bipolar I disorder in a broader context?,8.526950184846724e-07,1.137078569495905,0.0,0.06528335273214754,1.1786549963416468,0.0,0.06518885547430334,1.2237754316221148,0.0,8.526950184846742e-07,1.272965675812887,0.0
247,0.5,7,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Are the diagnostic criteria for child bipolar I disorder from the 'TEAM' study applicable to a wider population?,8.526950184846724e-07,1.137078569495905,0.0,0.06528335273214754,1.1786549963416468,0.0,0.06518885547430334,1.2237754316221148,0.0,8.526950184846742e-07,1.272965675812887,0.0
247,0.5,8,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",To what extent do the 'TEAM' sample findings on child bipolar I disorder diagnosis generalize?,9.237529366917285e-07,1.3312345839368627,0.0,0.07072363212649317,1.3862943611198908,0.0,0.07062126009716195,1.4469189829363245,0.0,9.237529366917303e-07,1.5141277326297748,0.0
247,0.5,9,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Is it possible to generalize the diagnostic characteristics of child bipolar I disorder from the 'TEAM' sample?,8.763809912203577e-07,1.19770319131234,0.0,0.06709677919692941,1.2431935174792175,0.0,0.0669996570152562,1.2927683031090669,0.0,8.763809912203596e-07,1.3470736479666083,0.0
247,0.5,10,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",How generalizable are the diagnostic findings from the 'Treatment of Early Age Mania (TEAM)' sample for child bipolar I disorder?,8.053230730133017e-07,1.0258529343856808,0.0,0.06165649980258379,1.060871960685263,0.0,0.06156725239239759,1.0986122886681091,0.0,8.053230730133036e-07,1.1394342831883644,0.0
248,0.5,1,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular issues in young obese males? Our findings indicate that reduced vessel compliance, reflected by higher carotid artery pulsatility and resistance indexes, might signal early vascular dysfunction in young obese males, even in the absence of clear cardiovascular disease.",7.105791820705622e-08,0.015897694846942922,0.028695430632595678,0.005440279394345618,0.04023794003525882,0.014236279273227195,0.0054324046228586,0.0376889914602514,0.017286409693230302,7.105791820705622e-08,0.036732292247905196,0.019014022321703038
248,0.5,2,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Do increased carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese males? The results imply that decreased vessel compliance, shown by raised carotid artery pulsatility and resistance indexes, could be an early sign of vascular dysfunction in young obese males without obvious cardiovascular disease.",4.737194547137081e-08,0.02002586815316043,0.012470444153417692,0.0036268529295637453,0.017261009361230872,0.015893253051413106,0.003621603081905733,0.015406597899723096,0.018167643794376173,4.737194547137081e-08,0.014584877794231677,0.019475876740709334
248,0.5,3,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Can higher carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? Our study suggests that impaired vessel compliance, evidenced by increased carotid artery pulsatility and resistance indexes, may represent early vascular dysfunction in young obese males, even without manifest cardiovascular disease.",1.6580180914979784e-07,0.1469509627617409,0.0015166777317369151,0.012693985253473108,0.137751547033373,0.0068809073724007686,0.012675610786670066,0.13212403556133845,0.013354593681303227,1.6580180914979784e-07,0.1305742451143348,0.01694705747861288
248,0.5,4,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Are increased carotid artery pulsatility and resistance indexes indicative of early vascular dysfunction in young obese males? The data suggest that diminished vessel compliance, as demonstrated by elevated carotid artery pulsatility and resistance indexes, might be an early sign of vascular abnormalities in young obese males lacking overt cardiovascular disease.",7.105791820705622e-08,0.015897694846942922,0.028695430632595678,0.005440279394345618,0.04023794003525882,0.014236279273227195,0.0054324046228586,0.0376889914602514,0.017286409693230302,7.105791820705622e-08,0.036732292247905196,0.019014022321703038
248,0.5,5,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Is an increase in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Findings suggest that reduced vessel compliance, indicated by increased carotid artery pulsatility and resistance indexes, may reflect early vascular dysfunction in young obese males without evident cardiovascular disease.",1.1842986367842703e-07,0.06479380954253466,0.023834691078214912,0.009067132323909363,0.08782036011028671,0.010713106918886009,0.009054007704764333,0.0837959367070722,0.01540724911927975,1.1842986367842703e-07,0.08255391090680186,0.018027436312582325
248,0.5,6,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Do increased pulsatility and resistance indexes in the carotid artery indicate early vascular dysfunction in young obese males? Our results suggest that lowered vessel compliance, as shown by raised carotid artery pulsatility and resistance indexes, could be an early marker of vascular abnormalities in young obese males even without clear cardiovascular disease.",2.3685972735685406e-08,0.05794675782530412,0.05187942320611161,0.0018134264647818726,0.060656810133524086,0.0569503518168452,0.0018108015409528666,0.06297495434967448,0.05975554549569943,2.3685972735685406e-08,0.035964156108279965,0.040742417383431435
248,0.5,7,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Are heightened carotid artery pulsatility and resistance indexes early signs of vascular dysfunction in young obese males? The evidence points to depressed vessel compliance, reflected by increased carotid artery pulsatility and resistance indexes, as a possible early indicator of vascular abnormalities in young obese males without overt cardiovascular disease.",9.474389094274162e-08,0.0689345797799481,0.0071779391448419105,0.0072537058591274906,0.06374931795848182,0.012510977680675509,0.007243206163811466,0.06047761514663552,0.01636711574363331,9.474389094274162e-08,0.059380906387511256,0.018531673581778544
248,0.5,8,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Can increased carotid artery pulsatility and resistance indexes be early markers of vascular dysfunction in young obese males? Our research suggests that impaired vessel compliance, indicated by elevated carotid artery pulsatility and resistance indexes, might signal early vascular abnormalities in young obese males, even without obvious cardiovascular disease.",1.1842986367842703e-07,0.06479380954253466,0.023834691078214912,0.009067132323909363,0.08782036011028671,0.010713106918886009,0.009054007704764333,0.0837959367070722,0.01540724911927975,1.1842986367842703e-07,0.08255391090680186,0.018027436312582325
248,0.5,9,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Are elevated carotid artery pulsatility and resistance indexes early signs of vascular dysfunction in young obese males? The findings suggest that decreased vessel compliance, as evidenced by increased carotid artery pulsatility and resistance indexes, may represent early vascular abnormalities in young obese males without apparent cardiovascular disease.",1.4211583641411244e-07,0.09014727015976032,0.02126033057851237,0.010880558788691236,0.11247809651238505,0.008838075724572098,0.0108648092457172,0.10766908989359525,0.01440407157279694,1.4211583641411244e-07,0.106276142853023,0.01749978699794391
248,0.5,10,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Is increased carotid artery pulsatility and resistance indexes a sign of early vascular dysfunction in young obese males? Our results indicate that depressed vessel compliance, shown by higher carotid artery pulsatility and resistance indexes, might be an early indicator of vascular abnormalities in young obese males even in the absence of overt cardiovascular disease.",2.3685972735685406e-08,0.07538526624987574,0.03739772306379989,0.0018134264647818726,0.04869126995314854,0.020492018483511884,0.0018108015409528666,0.048615804213573366,0.02060519147654074,2.3685972735685406e-08,0.04906026340613634,0.0207507472459887
249,0.5,1,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Should neck dissection be performed for metastatic carcinoma in cervical nodes when the primary head and neck tumor is unknown? Answer: Based on our experience, definitive radiotherapy targeting the neck and possible mucosal sites, with or without prior neck dissection, effectively achieves good local control in cases of unknown primary head and neck cancer. The role of neck dissection, especially in early nodal disease, is considered accordingly.",9.474389094274162e-08,0.08217528202978208,0.01728954108876666,0.007253705859127518,0.10084942005686948,0.0302734375,0.007243206163811466,0.08104684025731679,0.015380859375,9.474389094274162e-08,0.06062462181643724,0.0
249,0.5,2,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection necessary for metastatic carcinoma in cervical nodes from an unknown primary head and neck tumor? Answer: Our experience shows that definitive radiotherapy to the neck and potential mucosal regions, regardless of preceding neck dissection, effectively ensures good local control in unknown primary head and neck cancers. Neck dissection indication, particularly for early nodal involvement, is evaluated carefully.",2.6054570009253947e-07,0.2252840268370524,0.04047334782235692,0.019947691112600627,0.24144734192939676,0.0507015306122449,0.019918816950481533,0.22146674788256338,0.03443877551020409,2.6054570009253947e-07,0.20077739104541603,0.017538265306122455
249,0.5,3,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: For metastatic carcinoma to cervical nodes from an unknown head and neck primary, is neck dissection required? Answer: We have found that definitive radiotherapy to both the neck and possible mucosal sites, whether preceded by neck dissection or not, provides effective local control in unknown primary head and neck cancer. The decision to perform neck dissection, especially in early nodal stages, is made based on specific indications.",9.474389094274162e-08,0.06148432141605209,0.002506454098183404,0.007253705859127518,0.07984496003990138,0.01514792899408284,0.007243206163811466,0.059719234701625545,0.0,9.474389094274162e-08,0.06062462181643724,0.0
249,0.5,4,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Does metastatic carcinoma in cervical nodes from an unknown head and neck primary necessitate neck dissection? Answer: Our experience indicates that definitive radiotherapy targeting the neck and potential mucosal areas, with or without prior neck dissection, achieves good local control in unknown primary head and neck cancer. Neck dissection is considered particularly in early nodal cases.",3.552895910352811e-07,0.22826288112781867,0.006505985352262426,0.027201396971728117,0.2663674088372492,0.0181755829903978,0.027162023114293,0.24512245803298693,0.0,3.552895910352811e-07,0.24921579162398766,0.0
249,0.5,5,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection needed for metastatic carcinoma in cervical lymph nodes from an unknown primary site in the head and neck? Answer: According to our experience, definitive radiotherapy to the neck and possible mucosal sites, whether or not preceded by neck dissection, is effective for good local control in unknown primary head and neck cancer. The indication for neck dissection, especially in early nodal disease, is evaluated.",9.474389094274162e-08,0.06148432141605209,0.002506454098183404,0.007253705859127518,0.05884050002293417,0.0,0.007243206163811466,0.059719234701625545,0.0,9.474389094274162e-08,0.06062462181643724,0.0
249,0.5,6,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Should patients with metastatic carcinoma to cervical nodes from an unknown head and neck primary undergo neck dissection? Answer: Our findings suggest definitive radiotherapy to the neck and mucosal sites, regardless of prior neck dissection, effectively achieves good local control in unknown primary head and neck cancer. Neck dissection is indicated particularly for early nodal involvement.",3.552895910352811e-07,0.22826288112781867,0.006505985352262426,0.027201396971728117,0.2663674088372492,0.0181755829903978,0.027162023114293,0.24512245803298693,0.0,3.552895910352811e-07,0.24921579162398766,0.0
249,0.5,7,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: In cases of metastatic carcinoma to cervical nodes from an unknown head and neck primary site, is neck dissection necessary? Answer: From our experience, definitive radiotherapy to the neck and potential mucosal sites, whether preceded by neck dissection or not, is effective in achieving good local control in unknown primary head and neck cancers. Neck dissection indication is especially relevant for early nodal disease.",1.6580180914979784e-07,0.14004012542247057,0.05338427527873895,0.012693985253473136,0.12736518805655095,0.01586888657648284,0.012675610786670066,0.10697211955217067,0.0,1.6580180914979784e-07,0.10863384100279827,0.0
249,0.5,8,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: For metastatic carcinoma involving cervical nodes from an unknown primary tumor in the head and neck, is neck dissection required? Answer: Our experience demonstrates that definitive radiotherapy to the neck and possible mucosal sites, with or without prior neck dissection, provides effective local control in unknown primary head and neck cancer. The role of neck dissection is particularly considered in early nodal stages.",1.8948778188548325e-07,0.12698334977047931,0.005328719723183412,0.014507411718255009,0.1213608570042668,0.0,0.014486412327622933,0.12323264042395188,0.0,1.8948778188548325e-07,0.1251631429540092,0.0
249,0.5,9,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection indicated for metastatic carcinoma to cervical nodes when the primary head and neck tumor is unknown? Answer: Based on our experience, definitive radiotherapy targeting the neck and potential mucosal sites, whether or not preceded by neck dissection, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection is especially considered for early nodal disease.",2.3685972735685406e-07,0.18413474306267474,0.023079566137464695,0.018134264647818754,0.20036049186458804,0.033293697978596916,0.018108015409528666,0.1800655752867959,0.01694411414982164,2.3685972735685406e-07,0.15906469462968964,0.0
249,0.5,10,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Does metastatic carcinoma to cervical nodes from an unknown head and neck primary site require neck dissection? Answer: Our experience shows that definitive radiotherapy to the neck and possible mucosal sites, whether preceded by neck dissection or not, effectively achieves good local control in unknown primary head and neck cancer. The indication for neck dissection, particularly in early nodal disease, is carefully assessed.",1.8948778188548325e-07,0.1049786773717507,0.010459374875042879,0.014507411718255009,0.14372044347394297,0.016124697661918846,0.014486412327622933,0.12323264042395188,0.0,1.8948778188548325e-07,0.1251631429540092,0.0
250,0.5,1,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy affect the activity of peri-sinusoidal cells? Laparoscopic surgery results in noticeable injury to Kupffer and endothelial cells, indicated by increased post-operative serum HA levels. However, the harm to liver hepatocytes and peri-sinusoidal cells is clinically insignificant.",2.36859727356853e-08,0.00957052285622595,0.025623268698060954,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,0.5,2,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is peri-sinusoidal cell activity altered by laparoscopic cholecystectomy? The laparoscopic approach induces measurable damage to Kupffer and endothelial cells, shown by elevated HA levels after surgery. The injury to hepatocytes and peri-sinusoidal cells does not have clinical consequences.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
250,0.5,3,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does undergoing laparoscopic cholecystectomy impact peri-sinusoidal cell function? Laparoscopic techniques cause detectable damage to Kupffer and endothelial cells, as evidenced by raised serum HA post-operation. The resulting damage to liver hepatocytes and peri-sinusoidal cells lacks clinical significance.",7.10579182070559e-08,0.08300487511182508,0.002131833342755376,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
250,0.5,4,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Can laparoscopic cholecystectomy influence the activity of peri-sinusoidal cells? The procedure leads to measurable injury of Kupffer and endothelial cells, reflected by increased HA serum levels after surgery. This damage to liver hepatocytes and peri-sinusoidal cells is clinically irrelevant.",2.36859727356853e-08,0.00957052285622595,0.025623268698060954,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,0.5,5,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy modify peri-sinusoidal cell activity? Laparoscopic surgery causes observable damage to Kupffer and endothelial cells, indicated by elevated post-operative HA levels. The injury to hepatocytes and peri-sinusoidal cells does not translate into clinical issues.",9.47438909427412e-08,0.07266757538074708,0.025623268698060954,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
250,0.5,6,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is there an effect on peri-sinusoidal cell activity from laparoscopic cholecystectomy? Laparoscopic methods induce detectable damage to Kupffer and endothelial cells, marked by increased serum HA post-surgery. The damage to liver hepatocytes and peri-sinusoidal cells has no clinical impact.",2.36859727356853e-08,0.026910907699560394,0.0006732981390464195,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,0.5,7,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cell activity? The laparoscopic procedure causes identifiable injury to Kupffer and endothelial cells, evidenced by raised HA serum levels after operation. The damage to hepatocytes and peri-sinusoidal cells is clinically insignificant.",2.36859727356853e-08,0.00957052285622595,0.025623268698060954,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,0.5,8,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy cause changes in peri-sinusoidal cell activity? The surgery results in measurable harm to Kupffer and endothelial cells, as shown by elevated post-operative HA levels. The injury to liver hepatocytes and peri-sinusoidal cells lacks clinical relevance.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
250,0.5,9,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Laparoscopic intervention leads to detectable damage of Kupffer and endothelial cells, indicated by increased HA serum levels post-operation. The damage to hepatocytes and peri-sinusoidal cells does not have clinical importance.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
250,0.5,10,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy impact peri-sinusoidal cell activity? The procedure causes measurable damage to Kupffer and endothelial cells, reflected by elevated serum HA levels after surgery. The injury to liver hepatocytes and peri-sinusoidal cells is not clinically significant.",7.10579182070559e-08,0.04449669841405024,0.025623268698060954,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
251,0.5,1,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does losing consciousness indicate neuropsychological decline following a concussion? The findings of this research question the significance of LOC in forecasting neuropsychological test outcomes during the early recovery period after mild traumatic brain injury. Neuropsychological testing,1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
251,0.5,2,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness a predictor of neuropsychological impairments after a concussion? This study's results challenge the role of LOC as a reliable indicator of neuropsychological test performance in the acute phase following mild traumatic brain injury. Neuropsychological testing,9.474389094274141e-08,0.13656488911276776,0.026296566837107373,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
251,0.5,3,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Can loss of consciousness predict neuropsychological deficits post-concussion? The study's findings undermine the value of LOC as a predictor of neuropsychological test results during the initial recovery phase from mild traumatic brain injury. Neuropsychological testing,1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
251,0.5,4,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness forecast neuropsychological decline after a concussion? The research casts doubt on LOC's predictive power regarding neuropsychological test performance in the early recovery stage of mild traumatic brain injury. Neuropsychological testing,2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
251,0.5,5,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness an indicator of neuropsychological decline following concussion? The study suggests LOC may not be a significant predictor of neuropsychological test performance during the acute recovery phase from mild traumatic brain injury. Neuropsychological testing,1.42115836414112e-07,0.19265885652503245,0.02775510204081633,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
251,0.5,6,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness serve as a predictor for neuropsychological deficits after concussion? The results question the relevance of LOC in predicting neuropsychological test outcomes during the acute phase of mild traumatic brain injury recovery. Neuropsychological testing,1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
251,0.5,7,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Can loss of consciousness predict neuropsychological test performance after a concussion? Findings from this study doubt the importance of LOC as a predictor during the acute recovery period following mild traumatic brain injury. Neuropsychological testing,1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
251,0.5,8,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is LOC a reliable predictor of neuropsychological impairment after concussion? This study challenges the importance of LOC in forecasting neuropsychological testing performance during the early phase of mild traumatic brain injury recovery. Neuropsychological testing,2.1317375462116791e-07,0.2831709768508235,0.0302734375,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
251,0.5,9,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness predict cognitive decline after concussion? The study's results suggest that LOC is not a significant predictor of neuropsychological test performance in the acute phase of mild traumatic brain injury recovery. Neuropsychological testing,1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
251,0.5,10,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness associated with neuropsychological decrements post-concussion? The findings cast doubt on LOC's role as a predictor of neuropsychological testing outcomes during the acute recovery phase from mild traumatic brain injury. Neuropsychological testing,1.8948778188548261e-07,0.2520824572295557,0.029384756657483933,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
252,0.5,1,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Preoperative staging of patients with liver metastases from colorectal carcinoma. Does PET/CT provide additional value over multidetector CT? Answer: PET/CT plays a limited role in the hepatic staging of LMCRC. While PET/CT shows higher sensitivity for detecting extrahepatic disease in certain anatomical areas, its findings are",2.3685972735685406e-08,0.02214741445367352,0.00046185441900629606,0.0018134264647818726,0.021978906718775004,0.0,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
252,0.5,2,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In preoperative staging of colorectal carcinoma liver metastases, does PET/CT offer benefits beyond multidetector CT? Answer: PET/CT has a restricted role in staging liver metastases of colorectal cancer. Although it is more sensitive for identifying extrahepatic disease in some regions, its results are",9.474389094274162e-08,0.09169126505879133,0.0019760897427654224,0.0072537058591274906,0.09097177820572666,0.0,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
252,0.5,3,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: For preoperative evaluation of liver metastases in colorectal cancer patients, does PET/CT add value compared to multidetector CT? Answer: The role of PET/CT in hepatic staging of LMCRC is limited. It has greater sensitivity in detecting extrahepatic disease in some anatomical sites, but its results are",2.3685972735685406e-08,0.007989419483715121,0.0212665406427221,0.0018134264647818726,0.021978906718775004,0.0,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
252,0.5,4,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: When staging liver metastases of colorectal carcinoma before surgery, does PET/CT contribute more than multidetector CT? Answer: PET/CT is of limited use in hepatic staging of LMCRC. Despite its higher sensitivity for extrahepatic disease detection in certain locations, the outcomes are",1.4211583641411244e-07,0.10707991030107156,0.0212665406427221,0.010880558788691236,0.13976194237515838,0.0,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
252,0.5,5,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT improve preoperative staging for liver metastases in colorectal carcinoma compared to multidetector CT? Answer: PET/CT plays only a limited role in hepatic staging of LMCRC. It is more sensitive in detecting extrahepatic disease in some anatomical areas, though its results are",9.474389094274162e-08,0.05945186131181712,0.0212665406427221,0.0072537058591274906,0.09097177820572666,0.0,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
252,0.5,6,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In patients with colorectal carcinoma liver metastases, does PET/CT add value to preoperative staging beyond multidetector CT? Answer: PET/CT has a limited role in staging LMCRC in the liver. While it detects extrahepatic disease with higher sensitivity in some locations, its results are",9.474389094274162e-08,0.05945186131181712,0.0212665406427221,0.0072537058591274906,0.09097177820572666,0.0,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
252,0.5,7,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Is PET/CT beneficial for preoperative staging of liver metastases in colorectal carcinoma compared to multidetector CT? Answer: PET/CTâ€™s role in hepatic staging of LMCRC is limited. It offers higher sensitivity for extrahepatic disease detection in certain anatomical sites, but its results are",1.1842986367842703e-07,0.11598936732010312,0.0025288192620964538,0.009067132323909363,0.11506932978478668,0.0,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
252,0.5,8,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: For preoperative staging of colorectal carcinoma liver metastases, does PET/CT provide additional information beyond multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although it is more sensitive for detecting extrahepatic disease in some areas, its results are",1.1842986367842703e-07,0.11598936732010312,0.0025288192620964538,0.009067132323909363,0.11506932978478668,0.0,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
252,0.5,9,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT add value over multidetector CT in the preoperative staging of liver metastases from colorectal carcinoma? Answer: PET/CT has limited utility in hepatic staging of LMCRC. It can detect extrahepatic disease with higher sensitivity in certain anatomical regions, but its results are",9.474389094274162e-08,0.09169126505879133,0.0019760897427654224,0.0072537058591274906,0.09097177820572666,0.0,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
252,0.5,10,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In the context of preoperative staging of liver metastases in colorectal carcinoma, does PET/CT offer advantages over multidetector CT? Answer: PET/CT plays a limited role in hepatic staging of LMCRC. Despite its improved sensitivity for extrahepatic disease detection in some locations, its results are",7.105791820705622e-08,0.06796903311257019,0.0014484404281270083,0.005440279394345618,0.06744128079553224,0.0,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
253,0.5,1,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease in high-risk groups warranted? Long-term adherence to diet among screen-detected patients was excellent. Their quality of life and bone mineral density matched those of non-coeliac individuals and the general population. Therefore, active screening in coeliac disease risk groups appears justified and not detrimental.",4.737194547137081e-08,0.013706843861276408,0.039697542533081276,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
253,0.5,2,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should coeliac disease screening be conducted in at-risk populations? Patients identified through screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were similar to non-coeliac subjects and the wider population. Hence, proactive screening in coeliac risk groups seems reasonable and safe.",9.474389094274162e-08,0.0002826433737834755,0.060964083175803374,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.5,3,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it appropriate to screen for coeliac disease in groups at risk? Screen-detected patients showed strong long-term dietary adherence. Their quality of life and bone mineral density were on par with non-coeliac people and the general population. Thus, active screening in these risk groups is likely beneficial rather than harmful.",0.0,0.08487516496652381,0.060964083175803374,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
253,0.5,4,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Does screening for coeliac disease in risk groups make sense? Those diagnosed via screening adhered well to dietary recommendations over the long term. Their quality of life and bone mineral density were comparable to those without coeliac disease and the general populace. Active screening in these groups seems justified and not harmful.,4.737194547137081e-08,0.09769825720532266,0.04136408317580338,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.5,5,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening justified in populations at risk? Screen-detected patients demonstrated good long-term compliance with dietary guidelines. Their quality of life and bone mineral density were equivalent to non-coeliac individuals and the general population. Active screening in risk groups appears to be a reasonable approach.,9.474389094274162e-08,0.0002826433737834755,0.060964083175803374,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.5,6,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it reasonable to screen for coeliac disease in risk groups? Patients found through screening maintained good dietary compliance over time. Their quality of life and bone mineral density were similar to those of non-coeliac subjects and the general population. Therefore, active screening in these groups seems appropriate rather than harmful.",2.3685972735685406e-08,0.10507787228404242,0.060964083175803374,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.5,7,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Should coeliac disease be actively screened for in at-risk groups? Screen-detected patients adhered well to dietary restrictions long term. Their quality of life and bone mineral density were comparable with non-coeliac individuals and the general population. Active screening in these groups appears sensible and not harmful.,9.474389094274162e-08,0.0002826433737834755,0.060964083175803374,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.5,8,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is screening for coeliac disease in risk groups justified? Patients detected by screening had good long-term dietary adherence. Their quality of life and bone mineral density matched those of non-coeliac subjects and the general population. Active screening in coeliac risk groups seems reasonable and not detrimental.,9.474389094274162e-08,0.031089184732003172,0.038753339374150486,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.5,9,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is proactive screening for coeliac disease in risk groups warranted? Screen-detected patients showed strong long-term compliance with dietary measures. Their quality of life and bone mineral density were comparable to non-coeliac individuals and the general population. Active screening in these groups seems justified and safe.,1.1842986367842703e-07,0.02275549922584119,0.060964083175803374,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
253,0.5,10,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to screen for coeliac disease in groups at risk? Patients identified through screening maintained good dietary compliance over the long term. Their quality of life and bone mineral density were similar to those without coeliac disease and the general population. Active screening in coeliac risk groups appears reasonable rather than harmful.,9.474389094274162e-08,0.1371902830283971,0.042103136430241245,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
254,0.5,1,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: We determine that the elevated cardiovascular risk linked to the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. However, we observe heightened sensitivity in NIDDM patients with the ACE DD genotype.",7.105791820705622e-08,0.08756418518915021,0.021069608809993434,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
254,0.5,2,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism associated with insulin resistance? Answer: Our findings indicate that the increased cardiovascular risk associated with the DD genotype is unrelated to insulin resistance or fibrinolysis defects. On the other hand, we note increased sensitivity in NIDDM individuals carrying the ACE DD genotype.",4.737194547137081e-08,0.04135347370885123,0.0015305555555555558,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
254,0.5,3,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the insertion allele of the ACE gene I/D polymorphism be a candidate gene for insulin resistance? Answer: We conclude that the cardiovascular risk elevation in DD genotype carriers is not caused by insulin resistance or fibrinolytic abnormalities. Conversely, increased sensitivity is observed in NIDDM subjects with the ACE DD genotype.",2.3685972735685406e-08,0.048072159366075784,0.020330555555555574,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
254,0.5,4,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele a candidate for insulin resistance? Answer: Our conclusion is that the DD genotype's heightened cardiovascular risk is not mediated by insulin resistance or fibrinolysis issues, but NIDDM patients with the ACE DD genotype show increased sensitivity.",1.4211583641411244e-07,0.10388828709054065,0.017215574484706456,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
254,0.5,5,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the ACE gene I/D polymorphism insertion allele contribute to insulin resistance? Answer: We find that the DD genotype's increased cardiovascular risk is not driven by insulin resistance or fibrinolysis abnormalities, while NIDDM subjects with the ACE DD genotype exhibit greater sensitivity.",1.8948778188548325e-07,0.1519086212980736,0.01613519565073701,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
254,0.5,6,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism linked to insulin resistance? Answer: We conclude that the increased cardiovascular risk in individuals with the DD genotype is not due to insulin resistance or fibrinolytic dysfunction. Conversely, NIDDM patients with the ACE DD genotype demonstrate increased sensitivity.",4.737194547137081e-08,0.10089475016878291,0.042714072543618004,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
254,0.5,7,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Can the insertion allele of the ACE gene I/D polymorphism be considered a candidate gene for insulin resistance? Answer: We conclude that the elevated cardiovascular risk associated with the DD genotype does not arise from insulin resistance or fibrinolysis abnormalities, but there is increased sensitivity in NIDDM subjects with the ACE DD genotype.",7.105791820705622e-08,0.061407687809529765,0.00225273933102655,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
254,0.5,8,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele implicated in insulin resistance? Answer: We conclude that the heightened cardiovascular risk of the DD genotype is not mediated by insulin resistance or fibrinolytic abnormalities. Instead, increased sensitivity is reported in NIDDM individuals with the ACE DD genotype.",9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,0.5,9,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism indicate insulin resistance susceptibility? Answer: We find that the increased cardiovascular risk linked to the DD genotype is not mediated through insulin resistance or fibrinolysis abnormalities; however, increased sensitivity is noted in NIDDM subjects with the ACE DD genotype.",2.3685972735685406e-08,0.02133437618373879,0.0008118618278758691,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
254,0.5,10,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele a factor in insulin resistance? Answer: We conclude that the cardiovascular risk elevation observed in the DD genotype is not due to insulin resistance or fibrinolysis abnormalities, but increased sensitivity is found in NIDDM patients with the ACE DD genotype.",4.737194547137081e-08,0.014251352598789513,0.019106653337357282,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
255,0.5,1,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? The current study found that employing an endoscope during VPS surgeries did not raise the infection risk.,1.421158364141118e-07,0.15338265087860803,0.029384756657483937,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
255,0.5,2,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is the incidence of ventriculoperitoneal shunt infection impacted by the concurrent use of a neuroendoscope? This study showed that using an endoscope during VPS operations does not increase infection risk.,1.184298636784265e-07,0.11829133106733902,0.029384756657483937,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
255,0.5,3,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical","Does simultaneous neuroendoscope use influence ventriculoperitoneal shunt infection rates? According to this study, endoscope use during VPS procedures does not elevate infection risk.",2.842316728282236e-07,0.39454470769549665,0.029384756657483937,0.021761117577382555,0.45198512374305855,0.0,0.021729618491434483,0.47000362924573613,0.0,2.8423167282822477e-07,0.48954822531870645,0.0
255,0.5,4,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the combined use of a neuroendoscope affect the likelihood of ventriculoperitoneal shunt infection? The study indicated no increased infection risk when an endoscope is used during VPS surgeries.,1.421158364141118e-07,0.15338265087860803,0.029384756657483937,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
255,0.5,5,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is there an effect on ventriculoperitoneal shunt infection incidence from using a neuroendoscope simultaneously? The present research demonstrated that endoscope use during VPS does not heighten infection risk.,1.658018091497971e-07,0.1897502950494827,0.029384756657483937,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
255,0.5,6,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the simultaneous employment of a neuroendoscope change the ventriculoperitoneal shunt infection rate? Findings suggest that using an endoscope during VPS does not increase surgical infection risk.,1.894877818854824e-07,0.2274906230323297,0.029384756657483937,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
255,0.5,7,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does using a neuroendoscope at the same time influence ventriculoperitoneal shunt infection occurrence? The study found no increase in infection risk with endoscope use during VPS procedures.,1.894877818854824e-07,0.2274906230323297,0.029384756657483937,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
255,0.5,8,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the concurrent use of a neuroendoscope impact the frequency of ventriculoperitoneal shunt infections? This study concludes that endoscope use during VPS does not raise infection risk.,1.894877818854824e-07,0.2274906230323297,0.029384756657483937,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
255,0.5,9,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the simultaneous application of a neuroendoscope affect ventriculoperitoneal shunt infection incidence? The current findings show no increased infection risk from using an endoscope during VPS.,2.131737546211677e-07,0.26671133618561216,0.029384756657483937,0.016320838183036916,0.3184537311185349,0.0,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
255,0.5,10,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is ventriculoperitoneal shunt infection risk altered by simultaneous neuroendoscope use? The study results indicate that endoscope use during VPS operations does not increase infection risk.,2.36859727356853e-07,0.30753333070586697,0.029384756657483937,0.018134264647818796,0.36101334553733055,0.0,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
256,0.5,1,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation analysis inform therapeutic choices in familial adenomatous polyposis? Answer: Since the age of onset and disease progression can vary widely even among carriers of the same germline mutations, treatment decisions should rely on colonoscopy results for each patient instead of mutation location. Nevertheless, in patients with mutations",1.4211583641411244e-07,0.08857342885843433,0.017851239669421492,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
256,0.5,2,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is APC mutation analysis useful for guiding therapy in familial adenomatous polyposis? Answer: Because the age at disease onset and its progression can differ significantly among individuals with identical germline mutations, therapeutic strategies should be determined based on colonoscopic evaluation of each patient rather than mutation site. However, in patients with mutations",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
256,0.5,3,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Does APC mutation analysis aid in therapeutic decision-making for familial adenomatous polyposis? Answer: Given that disease manifestation age and progression can vary even among carriers of the same germline mutations, treatment decisions should be guided by colonoscopic findings for each patient rather than the mutation location. Nonetheless, in patients with mutations",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,0.5,4,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can analysis of APC mutations impact treatment plans in familial adenomatous polyposis? Answer: Because the age at which symptoms appear and disease course may vary considerably, even among those with identical germline mutations, therapy should be based on colonoscopy findings per patient instead of mutation site. Still, in patients with mutations",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,0.5,5,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is APC mutation testing relevant for therapeutic decisions in familial adenomatous polyposis? Answer: Since the onset age and disease trajectory can be quite variable among carriers of the same germline mutations, treatment choices should depend on individual colonoscopic assessments rather than mutation position. However, in patients with mutations",1.8948778188548325e-07,0.1293954233786887,0.017851239669421492,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
256,0.5,6,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can therapeutic decisions in familial adenomatous polyposis be guided by APC mutation analysis? Answer: As the age of disease manifestation and progression may differ even among carriers of identical germline mutations, therapeutic approaches should be informed by colonoscopic findings in each patient rather than mutation site. Yet, in patients with mutations",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,0.5,7,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Does analyzing APC mutations contribute to treatment decisions in familial adenomatous polyposis? Answer: Because the timing and course of the disease can vary among individuals with the same germline mutations, treatment should be based on colonoscopy results for each patient instead of mutation location. However, in patients with mutations",1.6580180914979784e-07,0.10877613617595294,0.017851239669421492,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
256,0.5,8,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation analysis influence therapy choices in familial adenomatous polyposis? Answer: Since the age at disease onset and progression can fluctuate even in carriers of identical germline mutations, therapeutic decisions should focus on colonoscopic findings per patient rather than mutation site. Nonetheless, in patients with mutations",2.1317375462116866e-07,0.15044883257652186,0.017851239669421492,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
256,0.5,9,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is APC mutation analysis a factor in therapeutic decisions for familial adenomatous polyposis? Answer: Given the variability in age at manifestation and disease course among carriers of the same germline mutations, treatment decisions should be made based on individual colonoscopic findings rather than mutation location. However, in patients with mutations",1.4211583641411244e-07,0.08857342885843433,0.017851239669421492,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
256,0.5,10,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation testing guide therapeutic management in familial adenomatous polyposis? Answer: As the disease onset age and progression can be quite variable even among those with identical germline mutations, therapy should be tailored according to colonoscopic findings in each patient instead of mutation site. Still, in patients with mutations",1.4211583641411244e-07,0.08857342885843433,0.017851239669421492,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
257,0.5,1,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Are general practice traits linked to the adoption of an IT innovation in primary care? Answer: The analysis indicates that structural traits of a practice do not affect the adoption of a new IT tool, but usage may be influenced by post-graduate training in the related clinical area. For this diabetes system, the involvement of practice nurses was crucial.",7.105791820705622e-08,0.0753673119857785,0.0184793083900227,0.005440279394345618,0.07433248054275143,0.017236072637734686,0.0054324046228586,0.05129329438754926,0.0,7.105791820705622e-08,0.05218575317056917,0.0
257,0.5,2,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Do characteristics of general practices affect the uptake of IT innovations in primary care? Answer: The study finds no association between practice structural features and adoption of new IT services, though usage might be impacted by post-graduate education in the clinical condition concerned. Specifically for the diabetes system, practice nurse participation was key.",2.1317375462116866e-07,0.11212329855361913,0.0322222222222222,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
257,0.5,3,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Is the uptake of IT innovation in primary care influenced by general practice characteristics? Answer: Findings reveal that structural aspects of a practice do not correlate with the adoption of new IT facilities, but post-graduate education in the relevant clinical field may affect usage. For the diabetes system, practice nurse involvement was essential.",2.1317375462116866e-07,0.11212329855361913,0.0322222222222222,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
257,0.5,4,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Do the features of general practices impact the adoption of IT innovations in primary care? Answer: Results show that structural characteristics are not linked to the uptake of a new IT system, but its use could be influenced by advanced education in the related clinical condition. In the case of this diabetes system, practice nurse use was pivotal.",9.474389094274162e-08,0.04587382847518118,0.014986149584487515,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
257,0.5,5,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Are general practice attributes associated with the uptake of IT innovations in primary care? Answer: The data suggests that structural characteristics of practices do not determine uptake of new IT facilities, but usage may depend on post-graduate clinical education. Practice nurse engagement was critical for this diabetes system.",3.316036182995957e-07,0.24009533372117975,0.011398320004023917,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
257,0.5,6,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Does the nature of general practice affect the adoption of IT innovations in primary care? Answer: Analysis demonstrates no connection between structural practice features and IT uptake, but usage might be influenced by post-graduate training in the clinical area involved. For the diabetes system, practice nurse use was vital.",3.079176455639103e-07,0.1905949139951133,0.0322222222222222,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
257,0.5,7,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Do structural characteristics of general practices influence the acceptance of IT innovations in primary care? Answer: The study shows no link between structural features and IT adoption, though post-graduate education in the relevant clinical condition may affect usage. Practice nurses played a crucial role in the diabetes system.",3.316036182995957e-07,0.24009533372117975,0.011398320004023917,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
257,0.5,8,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Are general practice structural features related to the uptake of IT innovations in primary care? Answer: The analyses indicate that structural features are not associated with IT adoption, but post-graduate clinical education may impact usage. For this diabetes system, the involvement of practice nurses was important.",3.789755637709665e-07,0.2839106495540342,0.010493827160493803,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
257,0.5,9,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Does general practice structure affect the uptake of IT innovations in primary care? Answer: Findings suggest no association between structural characteristics and IT adoption, but usage may be influenced by post-graduate education in the clinical condition. Practice nurse participation was key for this diabetes system.",4.026615365066519e-07,0.2757527223354206,0.0322222222222222,0.030828249901291835,0.32668423025504856,0.0,0.030783626196198732,0.33314444652853714,0.0,4.026615365066519e-07,0.33986782562235085,0.0
257,0.5,10,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Are the characteristics of general practices linked to the adoption of IT innovations in primary care? Answer: The analysis reveals that structural characteristics do not influence uptake of new IT tools, but usage might be affected by post-graduate education in the relevant clinical field. Practice nurse use was critical for this diabetes system.",2.1317375462116866e-07,0.11212329855361913,0.0322222222222222,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
258,0.5,1,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","Does the timing of living in an urban setting affect the risk of non-communicable diseases in Thailand? Urban living was linked to higher rates of NCDs, especially among individuals relocating to cities later in life, implying that early urban exposure might offer some defense against these diseases and emphasizing the need to study urbanization's long-term health effects.",1.6580180914979784e-07,0.09577836325765787,0.015868886576482836,0.012693985253473108,0.1198011998126205,0.0,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
258,0.5,2,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","In Thailand, how does the timing of urban residence influence non-communicable disease risk? Findings show urbanicity correlates with increased NCD prevalence, notably in those who moved to urban areas at an older age, suggesting early urban exposure could be protective and underscoring the importance of examining urbanization's health impacts over time.",3.079176455639103e-07,0.209107048564662,0.015868886576482836,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
258,0.5,3,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","What is the impact of living in urban areas on non-communicable disease risk in Thailand, considering timing? Urban living is associated with greater NCD prevalence, particularly among late-life urban migrants, indicating that early exposure to urban environments may reduce NCD risk and highlighting the significance of understanding urbanization's long-term health consequences.",3.079176455639103e-07,0.209107048564662,0.015868886576482836,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
258,0.5,4,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","Does living in an urban environment at different life stages affect non-communicable disease risk in Thailand? Urbanicity increases NCD prevalence, especially in those who move to cities later in life, suggesting early urban exposure might protect against these diseases and stressing the importance of studying urbanization's prolonged health effects.",3.552895910352811e-07,0.24992904308491637,0.015868886576482836,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
258,0.5,5,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","How does the timing of urban residency relate to non-communicable disease risk in Thailand? Increased NCD rates are linked to urban living, particularly for those who relocate to urban areas later in life, indicating early urban exposure could offer protection and highlighting the need to understand the enduring health effects of urbanization.",2.8423167282822487e-07,0.21648666364338176,0.00373111342351716,0.02176111757738247,0.21511137961694615,0.0,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
258,0.5,6,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","In Thailand, is the risk of non-communicable diseases influenced by when one lives in an urban area? Urbanicity is connected to higher NCD prevalence, mainly among individuals who move to cities later in life, suggesting that early exposure to urban settings may be protective and emphasizing the importance of long-term health impact research related to urbanization.",1.8948778188548325e-07,0.11379686876033634,0.015868886576482836,0.014507411718254981,0.13815033848081626,0.0,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
258,0.5,7,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","Does the timing of moving to urban areas affect non-communicable disease risk in Thailand? Urban living is associated with increased NCD prevalence, particularly in those who migrate to cities later in life, implying early urban exposure might confer some protection and underscoring the importance of understanding urbanization's long-term health impacts.",3.316036182995957e-07,0.2293097558821806,0.015868886576482836,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
258,0.5,8,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","What role does timing play in the relationship between urban living and non-communicable disease risk in Thailand? Urbanicity correlates with elevated NCD rates, especially among late-life urban movers, suggesting early exposure to urban environments may be protective and highlighting the necessity to study urbanization's health effects over time.",3.789755637709665e-07,0.27098245228274953,0.015868886576482836,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
258,0.5,9,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","How does the age of urban exposure influence non-communicable disease risk in Thailand? Living in urban areas is linked to higher NCD prevalence, particularly for individuals who move to cities later in life, indicating that early urban exposure might provide protection and emphasizing the importance of understanding the long-term health impacts of urbanization.",2.6054570009253947e-07,0.19654584235599293,0.0033544890482768742,0.0199476911126006,0.1953087523207664,0.0,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
258,0.5,10,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","Is the timing of urban residence important for non-communicable disease risk in Thailand? Urbanicity is associated with increased prevalence of NCDs, especially in those who relocate to urban areas later in life, suggesting early urban exposure may offer some protection and highlighting the need to explore the long-term health consequences of urbanization.",2.8423167282822487e-07,0.18930442126848224,0.015868886576482836,0.02176111757738247,0.21511137961694615,0.0,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
259,0.5,1,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is anxiety caused by withdrawal in alcoholism linked to beta-endorphin deficiency? Answer: Our findings provide the first evidence that reduced beta-endorphin levels during alcohol withdrawal might play a role in the anxiety commonly observed in this condition.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
259,0.5,2,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Answer: Our results offer initial proof that decreased beta-endorphin during alcohol withdrawal may be a factor contributing to anxiety, a frequent symptom in this phase.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,0.5,3,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is withdrawal anxiety in alcoholism associated with a lack of beta-endorphin? Answer: Our study presents the first evidence suggesting that lowered beta-endorphin levels during alcohol withdrawal could contribute to the anxiety often experienced during this period.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,0.5,4,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Is beta-endorphin deficiency responsible for anxiety during alcohol withdrawal in alcoholism? Answer: Our results provide the first indication that reduced beta-endorphin during alcohol withdrawal may be linked to anxiety, a common issue in this state.",4.73719454713706e-08,0.02037632061248873,0.056932966023875105,0.003626852929563759,0.019851258254085735,0.029384756657483937,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
259,0.5,5,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does a deficiency in beta-endorphin cause withdrawal-induced anxiety in alcoholism? Answer: Our findings are the first to show that decreased beta-endorphin levels during alcohol withdrawal might contribute to the anxiety frequently seen in this condition.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
259,0.5,6,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety seen in alcoholism withdrawal due to beta-endorphin deficiency? Answer: Our results provide initial evidence that lowered beta-endorphin during alcohol withdrawal may be involved in the anxiety commonly present in this state.,2.36859727356853e-08,0.010920400412667952,0.029384756657483937,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.5,7,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Is withdrawal anxiety in alcoholism based on a reduction in beta-endorphin? Answer: Our study reveals for the first time that decreased beta-endorphin during alcohol withdrawal may contribute to anxiety, a typical disturbance during this phase.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
259,0.5,8,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is beta-endorphin shortage the cause of anxiety during alcohol withdrawal in alcoholism? Answer: Our findings provide the first evidence that reduced beta-endorphin levels during alcohol withdrawal might be responsible for the anxiety often encountered in this state.,9.47438909427412e-08,0.03947552084693973,0.05387755102040818,0.007253705859127511,0.07927485895860897,0.02775510204081633,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
259,0.5,9,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does alcohol withdrawal anxiety stem from beta-endorphin deficiency in alcoholism? Answer: Our results give first evidence that lowered beta-endorphin during alcohol withdrawal may play a role in the anxiety commonly experienced at this time.,2.36859727356853e-08,0.010920400412667952,0.029384756657483937,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.5,10,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety associated with alcohol withdrawal in alcoholism linked to low beta-endorphin levels? Answer: Our study offers initial evidence that decreased beta-endorphin during alcohol withdrawal may contribute to the anxiety frequently observed during this condition.,7.10579182070559e-08,0.009995023594080443,0.055363321799307974,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
260,0.5,1,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts truly exist? Answer: Based on our study's findings and international literature, the concept of the globulomaxillary cyst is no longer supported.",9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.5,2,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts real? Answer: Our research and global literature indicate that the globulomaxillary cyst is an outdated entity.,2.131737546211678e-07,0.387765531008764,0.0,0.016320838183036916,0.4054651081081646,0.0,0.01629721386857586,0.4248831939652664,0.0,2.131737546211684e-07,0.446287102628419,0.0
260,0.5,3,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst a genuine condition? Answer: Findings from our study and international sources show that the globulomaxillary cyst is no longer a valid diagnosis.,4.73719454713706e-08,0.18074599993217522,0.07638888888888888,0.003626852929563759,0.13241281558092455,0.03993055555555556,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
260,0.5,4,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts actually exist? Answer: According to our study and worldwide literature, the term globulomaxillary cyst is no longer justified.",1.658018091497971e-07,0.28768207245178257,0.0,0.012693985253473157,0.30010459245033916,0.0,0.012675610786670115,0.3136575588550423,0.0,1.6580180914979768e-07,0.32850406697203516,0.0
260,0.5,5,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts a recognized pathology? Answer: Evidence from our research and international studies suggests the globulomaxillary cyst is no longer a recognized entity.,9.47438909427412e-08,0.21191294487391943,0.04158790170132326,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.5,6,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is there such a thing as a globulomaxillary cyst? Answer: Our study results and international literature conclude that the globulomaxillary cyst is no longer a justified entity.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
260,0.5,7,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts exist as a distinct condition? Answer: The data from our study and global literature no longer support the existence of the globulomaxillary cyst.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
260,0.5,8,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts valid clinical entities? Answer: Based on our findings and international literature, the globulomaxillary cyst is no longer considered valid.",1.421158364141118e-07,0.24116205681688863,0.0,0.010880558788691277,0.2513144282809079,0.0,0.010864809245717241,0.26236426446749217,0.0,1.4211583641411233e-07,0.27443684570175986,0.0
260,0.5,9,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the globulomaxillary cyst a real clinical entity? Answer: According to our research and international data, the globulomaxillary cyst is no longer justified.",1.184298636784265e-07,0.31725762999561047,0.08616780045351473,0.009067132323909398,0.26780779269691823,0.04535147392290251,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.5,10,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts exist according to current research? Answer: Our study and international literature indicate that the globulomaxillary cyst is no longer a justified entity.,7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
261,0.5,1,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea impact aerobic fitness? In a US Air Force cohort, OSA generally does not correlate with reduced aerobic fitness based on cycle ergometry. Yet, individuals with an apnea-hypopnea index over 20 show a significant decline in aerobic fitness relative to the normal population, according to this study.",1.1842986367842703e-07,0.0484391167136069,0.03496401624375241,0.009067132323909363,0.04677790788498859,0.03767781622452902,0.009054007704764333,0.0744366099267566,0.01922337562475971,1.1842986367842703e-07,0.10318423623523065,0.0
261,0.5,2,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Is aerobic fitness affected by obstructive sleep apnea? Research in a US Air Force group indicates that OSA does not typically predict lower aerobic fitness as assessed by cycle ergometry. Nevertheless, those with an apnea-hypopnea index exceeding 20 exhibit a statistically significant reduction in aerobic fitness compared to normal individuals.",1.1842986367842703e-07,0.08740937191532971,0.027932287073485162,0.009067132323909363,0.04677790788498859,0.03767781622452902,0.009054007704764333,0.0744366099267566,0.01922337562475971,1.1842986367842703e-07,0.10318423623523065,0.0
261,0.5,3,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea influence aerobic fitness levels? Among US Air Force personnel, OSA does not generally lead to decreased aerobic fitness measured by cycle ergometry. However, patients with an apnea-hypopnea index greater than 20 have a notably lower aerobic fitness than the normal population, as shown in this study.",1.1842986367842703e-07,0.08740937191532971,0.027932287073485162,0.009067132323909363,0.04677790788498859,0.03767781622452902,0.009054007704764333,0.0744366099267566,0.01922337562475971,1.1842986367842703e-07,0.10318423623523065,0.0
261,0.5,4,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","How does obstructive sleep apnea affect aerobic fitness? In a study of US Air Force members, OSA was not found to predict diminished aerobic fitness via cycle ergometry. Still, subjects with an apnea-hypopnea index above 20 demonstrated a significant drop in aerobic fitness compared to normal controls.",1.8948778188548325e-07,0.11346313061701974,0.03363492673757956,0.014507411718254981,0.11131642902256011,0.03767781622452902,0.014486412327622933,0.14039457771855268,0.01922337562475971,1.8948778188548325e-07,0.1706255170307629,0.0
261,0.5,5,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Is there an effect of obstructive sleep apnea on aerobic fitness? Findings from a US Air Force population reveal that OSA does not forecast reduced aerobic fitness when measured by cycle ergometry. However, those with an apnea-hypopnea index over 20 experience a statistically meaningful decrease in aerobic fitness relative to normal individuals.",7.105791820705622e-08,0.007324302819299966,0.03576332179930797,0.005440279394345618,0.005955913364734222,0.03767781622452902,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
261,0.5,6,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea reduce aerobic fitness? According to research on US Air Force personnel, OSA overall does not predict a decline in aerobic fitness as measured through cycle ergometry. Yet, patients with an apnea-hypopnea index higher than 20 show a significant decrease in aerobic fitness compared to normal populations.",1.1842986367842703e-07,0.07673083836911454,0.014620904415876532,0.009067132323909363,0.07565904040831928,0.01685391400633074,0.009054007704764333,0.0744366099267566,0.01922337562475971,1.1842986367842703e-07,0.10318423623523065,0.0
261,0.5,7,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","What is the impact of obstructive sleep apnea on aerobic fitness? In a US Air Force cohort, OSA generally does not predict lower aerobic fitness by cycle ergometry. However, individuals with an apnea-hypopnea index greater than 20 have a statistically significant reduction in aerobic fitness compared to typical populations.",1.4211583641411244e-07,0.06964781478416526,0.034539419581109676,0.010880558788691236,0.06783131708282175,0.03767781622452902,0.0108648092457172,0.09594281514771996,0.01922337562475971,1.4211583641411244e-07,0.12516314295400566,0.0
261,0.5,8,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does OSA affect aerobic fitness? In a US Air Force study, obstructive sleep apnea did not predict a decrease in aerobic fitness as measured by cycle ergometry overall. Still, patients with an apnea-hypopnea index above 20 had a statistically significant lower aerobic fitness than the normal population.",1.8948778188548325e-07,0.11346313061701974,0.03363492673757956,0.014507411718254981,0.11131642902256011,0.03767781622452902,0.014486412327622933,0.14039457771855268,0.01922337562475971,1.8948778188548325e-07,0.1706255170307629,0.0
261,0.5,9,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","How does obstructive sleep apnea influence aerobic fitness? Research involving US Air Force members shows OSA does not generally predict reduced aerobic fitness via cycle ergometry. Nonetheless, those with an apnea-hypopnea index exceeding 20 show a significant decline in aerobic fitness compared to normal individuals.",2.3685972735685406e-07,0.1592847492759164,0.03264834072845885,0.018134264647818726,0.15677880309931735,0.03767781622452902,0.018108015409528666,0.18691459335344662,0.01922337562475971,2.3685972735685406e-07,0.21825356602001733,0.0
261,0.5,10,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea have an impact on aerobic fitness? In a US Air Force population, OSA does not typically predict decreased aerobic fitness measured by cycle ergometry. However, patients with an apnea-hypopnea index over 20 have a statistically significant reduction in aerobic fitness relative to the normal population.",1.4211583641411244e-07,0.06964781478416526,0.034539419581109676,0.010880558788691236,0.06783131708282175,0.03767781622452902,0.0108648092457172,0.09594281514771996,0.01922337562475971,1.4211583641411244e-07,0.12516314295400566,0.0
262,0.5,1,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
","Are globulomaxillary cysts truly existent? Based on our study findings and international literature, the term globulomaxillary cyst appears to be a misnomer. Our research indicates these lesions are actually lateral periodontal cysts or radicular cysts originating from the maxillary canine or lateral incisor.",2.1317375462116866e-07,0.1669737720660578,0.019599999999999996,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
262,0.5,2,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
",Do globulomaxillary cysts really exist? Our study results and global literature suggest that the so-called globulomaxillary cyst is likely a misnomer. These lesions are more accurately lateral periodontal cysts or radicular cysts from the maxillary canine or lateral incisor.,3.0791764556391007e-07,0.2670572306230392,0.019599999999999996,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
262,0.5,3,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
","Is the globulomaxillary cyst a real entity? According to our study and international data, the term globulomaxillary cyst is probably incorrect. Our findings show these lesions are lateral periodontal cysts or radicular cysts associated with the maxillary canine or lateral incisor.",2.6054570009253947e-07,0.2504212952634859,0.005383563445101925,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
262,0.5,4,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
",Are globulomaxillary cysts genuine? The results of our research and evidence from worldwide literature imply that the globulomaxillary cyst is a misnomer. These lesions are in fact lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor.,2.6054570009253947e-07,0.2157639362354895,0.019599999999999996,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
262,0.5,5,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
",Do globulomaxillary cysts actually exist? Our study and international literature data indicate that the globulomaxillary cyst is likely a misnomer. These lesions are lateral periodontal cysts or radicular cysts originating from the maxillary canine or lateral incisor.,3.5528959103528067e-07,0.3211244518933154,0.019599999999999996,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
262,0.5,6,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
","Is the globulomaxillary cyst a valid diagnosis? Based on our study and global literature, the so-called globulomaxillary cyst is probably a misnomer. Our research suggests these lesions are lateral periodontal or radicular cysts from the maxillary canine or lateral incisor.",2.8423167282822477e-07,0.27662775347926516,0.006023268698060958,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
262,0.5,7,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
","Are globulomaxillary cysts a real pathological entity? According to our findings and international literature, the term globulomaxillary cyst is likely inaccurate. These lesions are actually lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor.",3.0791764556391007e-07,0.2670572306230392,0.019599999999999996,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
262,0.5,8,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
",Do globulomaxillary cysts exist in reality? Our research and global literature data suggest that the term globulomaxillary cyst is a misnomer. The lesions are lateral periodontal cysts or radicular cysts from the maxillary canine or lateral incisor.,3.5528959103528067e-07,0.3211244518933154,0.019599999999999996,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
262,0.5,9,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
","Is the globulomaxillary cyst a recognized cyst? Based on our study and international literature, the globulomaxillary cyst is probably a misnomer. These lesions represent lateral periodontal cysts or radicular cysts originating from the maxillary canine or lateral incisor.",3.3160361829959537e-07,0.3686603080360058,0.03427755102040818,0.025387970506946217,0.36701224366981,0.02775510204081633,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
262,0.5,10,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
",Are globulomaxillary cysts legitimate? Our study and data from international literature indicate the so-called globulomaxillary cyst is likely a misnomer. Our findings show these lesions are lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor.,2.8423167282822477e-07,0.24108174421978124,0.019599999999999996,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
263,0.5,1,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Answer: For patients undergoing MMT and receiving medical care at various locations, opioid dependence and MMT are documented in most medical records, though some records lack this information.",4.737194547137081e-08,0.013705450822062204,0.043392504930966504,0.0036268529295637453,0.017433506001244048,0.02251643655489808,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
263,0.5,2,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Answer: Among patients treated with MMT and medical care at different sites, documentation of opioid dependence and MMT is present in the majority of medical records but absent in some.",0.0,0.032239403746973316,0.022669707429322852,0.0,0.03300700859809247,0.023704640095181445,0.0,0.0,0.0,0.0,0.0,0.0
263,0.5,3,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Answer: For patients on MMT receiving care at various sites, the majority have opioid dependence and MMT recorded in their medical records, though some records do not include this information.",4.737194547137081e-08,0.11280690634821422,0.04769641105290316,0.0036268529295637453,0.0810273428056254,0.02478501892915089,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
263,0.5,4,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) recorded in patients' medical records? Answer: Among patients receiving MMT and medical care at multiple sites, most medical records document opioid dependence and MMT, but some do not.",1.6580180914979742e-07,0.12573991564510534,0.03668138563001487,0.012693985253473108,0.15591594991548163,0.01895328719723184,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
263,0.5,5,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Documentation of opioid dependence and MMT occurs in the majority of medical records for patients receiving MMT and care at different locations, but some records are missing this information.",0.0,0.032239403746973316,0.022669707429322852,0.0,0.03300700859809247,0.023704640095181445,0.0,0.0,0.0,0.0,0.0,0.0
263,0.5,6,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) included in the medical record? Answer: Among patients undergoing MMT and receiving care at various sites, most medical records include documentation of opioid dependence and MMT, though some records lack it.",9.474389094274152e-08,0.03977287309498978,0.040912494134947394,0.0072537058591274906,0.07055087191658371,0.021203433162892627,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
263,0.5,7,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Answer: For patients on MMT receiving medical care at different locations, opioid dependence and MMT are documented in most medical records, but some records are incomplete.",9.474389094274152e-08,0.03977287309498978,0.040912494134947394,0.0072537058591274906,0.07055087191658371,0.021203433162892627,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
263,0.5,8,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: The majority of patients receiving MMT and medical care at various sites have opioid dependence and MMT recorded in their medical records, although some records are missing this documentation.",0.0,0.06447880749394796,0.04564375561492664,0.0,0.03300700859809247,0.023704640095181445,0.0,0.0,0.0,0.0,0.0,0.0
263,0.5,9,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Answer: Among patients treated with MMT and receiving medical care at different sites, documentation of opioid dependence and MMT is found in most medical records but absent in a few.",0.0,0.06447880749394796,0.04564375561492664,0.0,0.03300700859809247,0.023704640095181445,0.0,0.0,0.0,0.0,0.0,0.0
263,0.5,10,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: For patients receiving MMT and medical care at various sites, opioid dependence and MMT documentation is present in the majority of medical records, but some records do not include it.",2.3685972735685406e-08,0.05742706313623902,0.024227931700589928,0.0018134264647818726,0.05730511085940426,0.024257369614512476,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
264,0.5,1,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the quantity of needles influence acupuncture treatment for neck pain? Answer: In this condition, using either 5 or 11 needles does not appear to significantly affect the therapeutic outcome, provided the stimulation duration is identical in both groups.",1.6580180914979774e-07,0.10480608248467238,0.043388429752066124,0.012693985253473108,0.13826978868571338,0.02221074380165289,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
264,0.5,2,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Is the number of needles relevant in acupuncture therapy for neck pain? Answer: For this ailment, the therapeutic effect seems unaffected by whether 5 or 11 needles are used, as long as the stimulation time is consistent between groups.",1.6580180914979774e-07,0.10480608248467238,0.043388429752066124,0.012693985253473108,0.13826978868571338,0.02221074380165289,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
264,0.5,3,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: When treating neck pain with acupuncture, does needle count matter? Answer: The number of needles, whether 5 or 11, does not seem to be a critical factor in the treatment's effectiveness if the stimulation duration is the same across groups.",1.4211583641411244e-07,0.07948827450038065,0.043388429752066124,0.010880558788691236,0.1122943022824554,0.02221074380165289,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
264,0.5,4,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does acupuncture needle quantity impact neck pain treatment outcomes? Answer: For this condition, the therapeutic effect does not significantly differ between using 5 or 11 needles when the stimulation time is equal in both groups.",2.6054570009253894e-07,0.2130196671249034,0.043388429752066124,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
264,0.5,5,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In acupuncture for neck pain, is the number of needles important? Answer: The therapeutic effect appears similar whether 5 or 11 needles are used, provided the stimulation duration remains constant between the groups.",3.0791764556390954e-07,0.2718601671478367,0.043388429752066124,0.023574544042164365,0.3101200456123734,0.02221074380165289,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
264,0.5,6,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Is the number of needles a key factor in acupuncture treatment for neck pain? Answer: For this pathology, the therapeutic results seem independent of using 5 versus 11 needles, given the stimulation time is the same in both groups.",1.6580180914979774e-07,0.1403520917441563,0.01776516105400517,0.012693985253473108,0.13826978868571338,0.02221074380165289,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
264,0.5,7,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Question: Does the number of acupuncture needles influence neck pain therapy? Answer: Using either 5 or 11 needles does not seem to impact the therapeutic effect when stimulation time is equal in the two groups.,2.8423167282822424e-07,0.2420072039981549,0.043388429752066124,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
264,0.5,8,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Is needle count significant in acupuncture treatment of neck pain? Answer: The therapeutic effect for this condition does not appear to depend on whether 5 or 11 needles are used, as long as the stimulation duration is consistent.",1.8948778188548304e-07,0.13078156888793036,0.043388429752066124,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
264,0.5,9,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: When treating neck pain with acupuncture, how important is the number of needles? Answer: The number of needles, 5 or 11, seems not to affect the therapeutic outcome if the stimulation time is the same in both groups.",1.8948778188548304e-07,0.24022586055529072,0.03497891718670938,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
264,0.5,10,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the number of needles used in acupuncture affect neck pain treatment efficacy? Answer: For this pathology, the therapeutic effect is not significantly influenced by using 5 or 11 needles, provided the stimulation time is equal in both groups.",1.6580180914979774e-07,0.10480608248467238,0.043388429752066124,0.012693985253473108,0.13826978868571338,0.02221074380165289,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
265,0.5,1,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-Î²1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
","Is the formation of endometrial polyps linked to higher levels of vascular endothelial growth factor and transforming growth factor-beta1? There is an elevated expression of VEGF and TGF-Î²1 in endometrial polyps relative to normal endometrial tissue, indicating these factors might contribute to polyp development and growth.",3.316036182995957e-07,0.1372058933268523,0.09428333903858378,0.025387970506946217,0.18064686896471605,0.06858710562414265,0.025351221573340132,0.2575301984371303,0.017538265306122455,3.316036182995957e-07,0.2876820724517817,0.0
265,0.5,2,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-Î²1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
","Does endometrial polyp formation correlate with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Studies show that both VEGF and TGF-Î²1 are expressed at higher levels in endometrial polyps than in normal endometrium, suggesting their involvement in polyp formation.",4.263475092423373e-07,0.19948977503464427,0.11649408284023667,0.03264167636607371,0.2759570487690417,0.06858710562414265,0.0325944277371516,0.3551686680010482,0.017538265306122455,4.263475092423373e-07,0.3877655310087631,0.0
265,0.5,3,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-Î²1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
","Is there an association between endometrial polyp formation and elevated vascular endothelial growth factor and transforming growth factor-beta1 expression? Research indicates increased VEGF and TGF-Î²1 expression in endometrial polyps compared to normal endometrium, implying these growth factors may influence polyp development.",4.500334819780227e-07,0.22418238762501597,0.11649408284023667,0.03445510283085558,0.30127485675333343,0.06858710562414265,0.034405229278104466,0.38114415440430616,0.017538265306122455,4.500334819780227e-07,0.41443377809092397,0.0
265,0.5,4,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-Î²1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
","Are vascular endothelial growth factor and transforming growth factor-beta1 expressions increased in endometrial polyps? The expression levels of VEGF and TGF-Î²1 are higher in endometrial polyps than in normal tissue, suggesting these growth factors play a role in polyp growth.",4.73719454713708e-07,0.2850462048687916,0.09087081414217571,0.03626852929563745,0.3272503431565914,0.06858710562414265,0.03621603081905733,0.407812401486467,0.017538265306122455,4.737194547137081e-07,0.4418327522790393,0.0
265,0.5,5,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-Î²1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
","Does increased expression of vascular endothelial growth factor and transforming growth factor-beta1 occur in endometrial polyp formation? Elevated VEGF and TGF-Î²1 levels are found in endometrial polyps compared to normal endometrium, indicating their potential role in polyp development.",5.210914001850786e-07,0.33961134426012896,0.0894879100007305,0.0398953822252012,0.3813175644268676,0.06858710562414265,0.039837633900963065,0.4633822526412792,0.017538265306122455,5.210914001850789e-07,0.49899116611898764,0.0
265,0.5,6,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-Î²1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
","Is the increased expression of vascular endothelial growth factor and transforming growth factor-beta1 associated with the formation of endometrial polyps? Endometrial polyps exhibit higher VEGF and TGF-Î²1 expression than normal endometrium, suggesting these factors contribute to their growth.",5.210914001850786e-07,0.30214392909472654,0.11649408284023667,0.0398953822252012,0.3813175644268676,0.06858710562414265,0.039837633900963065,0.4633822526412792,0.017538265306122455,5.210914001850789e-07,0.49899116611898764,0.0
265,0.5,7,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-Î²1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
","Is there a link between endometrial polyp formation and increased vascular endothelial growth factor and transforming growth factor-beta1 expression? Both VEGF and TGF-Î²1 show elevated expression in endometrial polyps relative to normal endometrium, implying a role in polyp development.",4.974054274493933e-07,0.27547568201256567,0.11649408284023667,0.038081955760419325,0.3539185902387523,0.06858710562414265,0.0380268323600102,0.43521137567458235,0.017538265306122455,4.974054274493935e-07,0.47000362924573613,0.0
265,0.5,8,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-Î²1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
","Does endometrial polyp formation involve increased levels of vascular endothelial growth factor and transforming growth factor-beta1? Expression of VEGF and TGF-Î²1 is elevated in endometrial polyps compared to normal tissue, suggesting these growth factors may aid in polyp growth.",4.974054274493933e-07,0.27547568201256567,0.11649408284023667,0.038081955760419325,0.3539185902387523,0.06858710562414265,0.0380268323600102,0.43521137567458235,0.017538265306122455,4.974054274493935e-07,0.47000362924573613,0.0
265,0.5,9,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-Î²1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
","Is the development of endometrial polyps associated with higher expression of vascular endothelial growth factor and transforming growth factor-beta1? Increased VEGF and TGF-Î²1 expression is observed in endometrial polyps versus normal endometrium, indicating their involvement in polyp formation.",5.210914001850786e-07,0.33961134426012896,0.0894879100007305,0.0398953822252012,0.3813175644268676,0.06858710562414265,0.039837633900963065,0.4633822526412792,0.017538265306122455,5.210914001850789e-07,0.49899116611898764,0.0
265,0.5,10,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-Î²1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
","Are vascular endothelial growth factor and transforming growth factor-beta1 expressions elevated in endometrial polyps compared to normal endometrium? Yes, these growth factors have increased expression in polyps, suggesting a role in their development and growth.",5.921493183921345e-07,0.3867013171227902,0.11649408284023667,0.04533566161954683,0.4683289414164977,0.06858710562414265,0.045270038523821686,0.5529944113309662,0.017538265306122455,5.921493183921352e-07,0.5913644862500029,0.0
266,0.5,1,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Is gestational age misclassification responsible for the birthweight differences between Australian Aborigines and whites? Evidence suggests it is unlikely, as gestational age is accurately measured in both groups, with socioeconomic factors and maternal health playing bigger roles.",5.210914001850785e-07,0.4108042214045624,0.07786904062036334,0.0398953822252012,0.4633822526412792,0.017538265306122455,0.03983763390096307,0.49899116611898764,0.0,5.210914001850789e-07,0.5108256237659909,0.0
266,0.5,2,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
",Could the difference in birthweights between Australian Aborigines and whites be due to gestational age misclassification? This is improbable since gestational age assessments are reliable in both populations; other influences like socioeconomic status and maternal health are more probable causes.,4.500334819780226e-07,0.3277993462927373,0.08000087396311872,0.03445510283085558,0.38114415440430616,0.017538265306122455,0.034405229278104466,0.41443377809092397,0.0,4.500334819780227e-07,0.4238142467763608,0.0
266,0.5,3,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Does misclassifying gestational age explain why Australian Aborigines and whites have different birthweights? No, because gestational age is correctly determined in both groups, and factors like socioeconomic conditions and maternal health are more significant contributors.",5.684633456564491e-07,0.47022782210908565,0.07623938600369573,0.04352223515476496,0.5222227526642125,0.017538265306122455,0.04345923698286882,0.5596157879354231,0.0,5.684633456564497e-07,0.5733459807473245,0.0
266,0.5,4,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Is the disparity in birthweights between Australian Aborigines and whites caused by errors in gestational age classification? Gestational age is accurately recorded in both populations, so this is unlikely; other factors such as maternal health and socioeconomic status are more relevant.",4.263475092423373e-07,0.30159288807695805,0.08064057921607776,0.03264167636607371,0.3551686680010482,0.017538265306122455,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
266,0.5,5,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Can gestational age misclassification account for birthweight differences between Australian Aborigines and whites? It is unlikely, as gestational age is precisely assessed in both groups, with socioeconomic and maternal health factors being more influential.",5.921493183921344e-07,0.5013163417303534,0.07535070516117967,0.04533566161954684,0.5529944113309662,0.017538265306122455,0.04527003852382169,0.5913644862500029,0.0,5.921493183921352e-07,0.6061358035703162,0.0
266,0.5,6,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Does the misclassification of gestational age explain birthweight differences between Australian Aborigines and whites? This explanation is unlikely because gestational age is reliably measured in both groups, and other factors like socioeconomic status and maternal health are more impactful.",4.737194547137079e-07,0.3547102539922977,0.0793275758240723,0.03626852929563745,0.407812401486467,0.017538265306122455,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
266,0.5,7,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? Studies indicate this is unlikely since gestational age is accurately evaluated in both populations, with socioeconomic and maternal health factors playing a larger role.",4.737194547137079e-07,0.3547102539922977,0.0793275758240723,0.03626852929563745,0.407812401486467,0.017538265306122455,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
266,0.5,8,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
",Could inaccuracies in gestational age classification explain the birthweight gap between Australian Aborigines and whites? This is improbable because gestational age is assessed correctly in both groups; socioeconomic and maternal health issues are more likely causes.,5.447773729207638e-07,0.44007533199119564,0.07707742985841151,0.04170880868998308,0.4923697895145307,0.017538265306122455,0.041648435441915946,0.5288441292686694,0.0,5.447773729207643e-07,0.5415972824327446,0.0
266,0.5,9,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Does gestational age misclassification cause the birthweight differences observed between Australian Aborigines and whites? It is an unlikely cause, as gestational age is accurately assessed for both, with other factors like socioeconomic status and maternal health contributing more.",4.974054274493932e-07,0.38236448568407466,0.0786179698216735,0.038081955760419325,0.43521137567458235,0.017538265306122455,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
266,0.5,10,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Is gestational age misclassification the reason for the birthweight disparity between Australian Aborigines and whites? This is unlikely since gestational age is precisely determined in both populations, and other elements such as socioeconomic status and maternal health are more significant contributors.",4.263475092423373e-07,0.30159288807695805,0.08064057921607776,0.03264167636607371,0.3551686680010482,0.017538265306122455,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
267,0.5,1,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does the distribution of health care benefits in Kenya align with the principles of universal coverage? The principles of universal coverage demand that everyone receives health care based on their needs. However, the Kenyan health sector is evidently inequitable, with benefits not allocated according to need. Intentional actions must be taken to reform the Kenyan health system.",9.474389094274162e-08,0.07889497406637913,0.006834567901234573,0.0072537058591274906,0.07533077094857576,0.0036623747131989057,0.007243206163811466,0.07322945486480048,0.0012758533145614953,9.474389094274162e-08,0.07275935428242919,0.0
267,0.5,2,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does Kenya's health care benefits distribution adhere to universal coverage principles? Universal coverage principles stipulate that health care should be provided to all according to their needs. The Kenyan health sector, however, is clearly unequal, and benefits are not distributed based on need. Focused efforts are necessary to restructure Kenya's health system.",2.1317375462116866e-07,0.10543622051048551,0.040171682098765454,0.016320838183036854,0.09502489469181619,0.0507015306122449,0.0162972138685758,0.14472108551993212,0.017236072637734686,2.1317375462116866e-07,0.17185025692665912,0.0
267,0.5,3,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Universal coverage means everyone should receive health care according to their needs. The Kenyan health sector is evidently unfair, with benefits not allocated by need. There should be targeted measures to overhaul the Kenyan health system.",2.6054570009253947e-07,0.17706171462151632,0.017777777777777795,0.0199476911126006,0.16472802173540124,0.029877628394046618,0.019918816950481533,0.18639378192050104,0.017236072637734686,2.6054570009253947e-07,0.21440987134545564,0.0
267,0.5,4,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does Kenya's allocation of health care benefits fulfill the universal coverage principles? Universal coverage requires that all individuals benefit from health care according to their needs. The Kenyan health sector is clearly inequitable, with benefits not distributed by need. Intentional restructuring of the Kenyan health system is needed.",3.079176455639103e-07,0.22355002321876727,0.014395502407040198,0.023574544042164344,0.20854333756825572,0.028973135550516504,0.023540420032387266,0.2298788938602394,0.017236072637734686,3.079176455639103e-07,0.25886163391628836,0.0
267,0.5,5,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is the health care benefits distribution in Kenya in line with universal coverage principles? Universal coverage principles state that health care should be accessible to all based on need. The Kenyan health sector is evidently unequal, and benefits do not reflect need. Deliberate reforms should be made to restructure the Kenyan health system.",1.8948778188548325e-07,0.1377689422517494,0.003699791537425459,0.014507411718254981,0.10240450977053595,0.031101530612244906,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
267,0.5,6,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does the Kenyan health care benefits distribution satisfy the principles of universal coverage? According to universal coverage, everyone should access health care according to their needs. The Kenyan health sector is clearly inequitable, with benefits not distributed on a needs basis. Purposeful efforts should be directed at restructuring the health system in Kenya.",1.8948778188548325e-07,0.1111094353071369,0.022376543209876573,0.014507411718254981,0.10240450977053595,0.03110153061224491,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
267,0.5,7,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is the distribution of health care benefits in Kenya aligned with universal coverage principles? Universal coverage requires that all receive health care according to need. The Kenyan health sector is evidently unfair, and benefits are not allocated based on need. Focused restructuring of the Kenyan health system is essential.",2.8423167282822487e-07,0.20003864529554427,0.016120803999591884,0.02176111757738247,0.1863959231145822,0.029434989969522797,0.0217296184914344,0.2078999871414644,0.017236072637734686,2.8423167282822487e-07,0.23638877806423064,0.0
267,0.5,8,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does Kenya's distribution of health care benefits meet the universal coverage principles? Universal coverage principles mandate that health care benefits be given to all according to need. The Kenyan health sector is clearly inequitable, with benefits not distributed according to need. Intentional efforts should be made to reform the Kenyan health system.",2.1317375462116866e-07,0.21416519001008494,0.03501555963677175,0.016320838183036854,0.17820255635900928,0.009054014883454531,0.0162972138685758,0.14472108551993212,0.017236072637734686,2.1317375462116866e-07,0.17185025692665912,0.0
267,0.5,9,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is the health care benefits distribution in Kenya compliant with universal coverage principles? Universal coverage demands that everyone benefits from health care according to their needs. The Kenyan health sector is evidently unequal, with benefits not allocated by need. Deliberate restructuring of the Kenyan health system is necessary.",3.079176455639103e-07,0.22355002321876727,0.014395502407040198,0.023574544042164344,0.20854333756825572,0.028973135550516504,0.023540420032387266,0.2298788938602394,0.017236072637734686,3.079176455639103e-07,0.25886163391628836,0.0
267,0.5,10,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does the distribution of health care benefits in Kenya correspond to the principles of universal coverage? The principles of universal coverage require health care to be provided to all based on need. The Kenyan health sector is clearly inequitable, and benefits are not distributed on this basis. Purposeful efforts should be undertaken to restructure the Kenyan health system.",7.105791820705622e-08,0.058589580498708216,0.005040796274936976,0.005440279394345618,0.055961978730521,0.0026982557886095077,0.0054324046228586,0.05441355041844975,0.000939510352663115,7.105791820705622e-08,0.05406722127027486,0.0
268,0.5,1,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Does a history of postictal psychotic episodes (PIPE) reliably predict interictal psychotic episodes? While PIPE history alone isn't a certain predictor of interictal psychosis, those with PIPE might face a higher risk of psychosis, especially if they have familial or other risk factors.",3.079176455639103e-07,0.16884215886765608,0.07227989234909649,0.023574544042164344,0.22406774426293374,0.036982248520710054,0.023540420032387266,0.25525596205856393,0.018860946745562133,3.079176455639103e-07,0.28768207245178345,0.0
268,0.5,2,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Are postictal psychotic episodes (PIPE) indicative of future interictal psychotic episodes? Although PIPE does not conclusively forecast interictal psychosis, individuals with PIPE may be more susceptible to psychosis, particularly with a family history or additional risk factors.",4.500334819780223e-07,0.3229928386949137,0.07227989234909649,0.03445510283085558,0.3822917494778282,0.036982248520710054,0.03440522927810447,0.4177748915563382,0.018860946745562133,4.500334819780227e-07,0.45473615711494775,0.0
268,0.5,3,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Is the long-term occurrence of postictal psychotic episodes (PIPE) a predictor for interictal psychotic episodes? A history of PIPE is not a definitive predictor of interictal psychosis, but those affected may have an elevated risk, especially if they possess a family history or other risk elements.",2.3685972735685406e-07,0.09984928738070442,0.07227989234909649,0.018134264647818726,0.15345017704897979,0.036982248520710054,0.018108015409528666,0.1829353004789378,0.018860946745562133,2.3685972735685406e-07,0.21357410029806,0.0
268,0.5,4,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Do postictal psychotic episodes (PIPE) predict the onset of interictal psychotic episodes? PIPE history alone isn't conclusively predictive of interictal psychosis; however, individuals with PIPE could have an increased likelihood of psychosis, notably if they have family or other risk factors.",3.552895910352811e-07,0.2522896820650842,0.047296328903994565,0.02720139697172809,0.27407816483759717,0.036982248520710054,0.027162023114293,0.30654925644611364,0.018860946745562133,3.552895910352811e-07,0.3403258059372023,0.0
268,0.5,5,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Can postictal psychotic episodes (PIPE) forecast interictal psychotic episodes? While PIPE is not definitively predictive of interictal psychosis, those with PIPE might be at greater risk, particularly if there is a family history or other contributing risk factors.",4.26347509242337e-07,0.29559386450679836,0.07227989234909649,0.03264167636607371,0.35412087251113133,0.036982248520710054,0.0325944277371516,0.38878735468308667,0.018860946745562133,4.263475092423373e-07,0.42488319396526597,0.0
268,0.5,6,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Is there a predictive link between postictal psychotic episodes (PIPE) and interictal psychotic episodes? A history of PIPE does not definitively predict interictal psychosis, but individuals with PIPE may have a heightened risk, especially with familial or other risk factors.",3.789755637709664e-07,0.24295013102137952,0.07227989234909649,0.029014823436509962,0.30005365124085515,0.036982248520710054,0.028972824655245866,0.3332175035282745,0.018860946745562133,3.789755637709665e-07,0.3677247801253176,0.0
268,0.5,7,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Are individuals with postictal psychotic episodes (PIPE) more likely to develop interictal psychotic episodes? Although PIPE history isn't a certain predictor of interictal psychosis, those with PIPE may have an increased risk, particularly if family history or other risks are present.",3.552895910352811e-07,0.2176323230370878,0.07227989234909649,0.02720139697172809,0.27407816483759717,0.036982248520710054,0.027162023114293,0.30654925644611364,0.018860946745562133,3.552895910352811e-07,0.3403258059372023,0.0
268,0.5,8,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Does having postictal psychotic episodes (PIPE) imply a risk for interictal psychotic episodes? A history of PIPE is not a definitive indicator of interictal psychosis, but those with PIPE might have a higher chance of psychosis, especially if family history or other risk factors exist.",2.6054570009253947e-07,0.12232214323276214,0.07227989234909649,0.0199476911126006,0.1764396952736793,0.036982248520710054,0.019918816950481533,0.20646579788913222,0.018860946745562133,2.6054570009253947e-07,0.23767165187712003,0.0
268,0.5,9,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Is a history of postictal psychotic episodes (PIPE) a reliable predictor of interictal psychotic episodes? PIPE history alone does not definitively predict interictal psychosis, but individuals with PIPE may be at increased risk, particularly if other risk factors or family history are involved.",3.079176455639103e-07,0.16884215886765608,0.07227989234909649,0.023574544042164344,0.22406774426293374,0.036982248520710054,0.023540420032387266,0.25525596205856393,0.018860946745562133,3.079176455639103e-07,0.28768207245178345,0.0
268,0.5,10,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Do postictal psychotic episodes (PIPE) serve as a predictor for interictal psychotic episodes? While PIPE is not conclusively predictive of interictal psychosis, individuals with PIPE could have an elevated risk, especially if there is a family history or other risk factors.",3.552895910352811e-07,0.2176323230370878,0.07227989234909649,0.02720139697172809,0.27407816483759717,0.036982248520710054,0.027162023114293,0.30654925644611364,0.018860946745562133,3.552895910352811e-07,0.3403258059372023,0.0
269,0.5,1,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","Does aerobic fitness affect microvascular function in healthy adults who are at risk of Type 2 diabetes? Aerobic fitness significantly enhances microvascular function in this at-risk group, boosting blood flow and endothelial health, thereby reducing the risk of Type 2 diabetes.",1.4211583641411244e-07,0.19702192685619746,0.03824960015149989,0.010880558788691236,0.15731924734446867,0.010062358276644007,0.0108648092457172,0.12007152469675697,0.01905490708579512,1.4211583641411244e-07,0.1180427993023625,0.023242630385487524
269,0.5,2,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","In healthy adults at risk for Type 2 diabetes, does aerobic fitness influence microvascular function? Yes, aerobic fitness positively impacts microvascular function by improving blood flow and endothelial function, lowering the likelihood of developing Type 2 diabetes.",2.3685972735685364e-07,0.17145464174158986,0.05171579777237556,0.018134264647818726,0.15889480420624702,0.06632653061224489,0.018108015409528673,0.19481572925119517,0.045351473922902494,2.3685972735685406e-07,0.23245315048010795,0.023242630385487524
269,0.5,3,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","Is microvascular function influenced by aerobic fitness in healthy adults at risk of Type 2 diabetes? Aerobic fitness greatly benefits microvascular function in this population, enhancing blood flow and endothelial performance, which helps prevent Type 2 diabetes.",2.3685972735685364e-07,0.2099628184393647,0.024434491472509992,0.018134264647818726,0.15889480420624702,0.06632653061224489,0.018108015409528673,0.19481572925119517,0.045351473922902494,2.3685972735685406e-07,0.23245315048010795,0.023242630385487524
269,0.5,4,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","Does aerobic fitness play a role in microvascular function among healthy adults at risk for Type 2 diabetes? Aerobic fitness positively affects microvascular function by improving blood flow and endothelial function, thus reducing diabetes risk.",2.8423167282822424e-07,0.23314342931068843,0.048485369571683534,0.021761117577382486,0.2177353042291803,0.06632653061224489,0.02172961849143442,0.25544035106763063,0.045351473922902494,2.8423167282822487e-07,0.29497350746144146,0.023242630385487524
269,0.5,5,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","In adults at risk of Type 2 diabetes, how does aerobic fitness affect microvascular function? Aerobic fitness significantly improves microvascular function by enhancing blood flow and endothelial health, thereby lowering the risk of developing Type 2 diabetes.",2.3685972735685364e-07,0.2099628184393647,0.024434491472509992,0.018134264647818726,0.15889480420624702,0.06632653061224489,0.018108015409528673,0.19481572925119517,0.045351473922902494,2.3685972735685406e-07,0.23245315048010795,0.023242630385487524
269,0.5,6,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","For healthy adults at risk of Type 2 diabetes, does aerobic fitness influence microvascular function? Aerobic fitness has a strong positive effect on microvascular function, improving blood flow and endothelial function to reduce diabetes risk.",2.8423167282822424e-07,0.19237006574833826,0.0776943629141996,0.021761117577382486,0.2177353042291803,0.06632653061224489,0.02172961849143442,0.25544035106763063,0.045351473922902494,2.8423167282822487e-07,0.29497350746144146,0.023242630385487524
269,0.5,7,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","Does aerobic fitness impact microvascular function in healthy adults with a risk of Type 2 diabetes? Aerobic fitness markedly improves microvascular function by enhancing blood flow and endothelial function, which helps mitigate the risk of Type 2 diabetes.",2.1317375462116834e-07,0.2543763899849383,0.024756817928316466,0.016320838183036854,0.20774028063509986,0.010963208812936914,0.0162972138685758,0.2054366026956549,0.016804761120134334,2.1317375462116866e-07,0.20260018733042617,0.023242630385487524
269,0.5,8,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","In healthy adults at risk for Type 2 diabetes, is microvascular function affected by aerobic fitness? Aerobic fitness significantly improves microvascular function by boosting blood flow and endothelial function, thus decreasing the chance of developing Type 2 diabetes.",2.1317375462116834e-07,0.14197414448873058,0.053201568551275356,0.016320838183036854,0.13072392723955018,0.06632653061224489,0.0162972138685758,0.16582819237794366,0.045351473922902494,2.1317375462116866e-07,0.20260018733042617,0.023242630385487524
269,0.5,9,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","How does aerobic fitness influence microvascular function in healthy adults at risk of Type 2 diabetes? Aerobic fitness positively impacts microvascular function by enhancing blood flow and endothelial health, lowering the risk of Type 2 diabetes.",2.6054570009253894e-07,0.3206512169012927,0.03180976931720533,0.019947691112600606,0.26942906820419843,0.007732780612244888,0.019918816950481547,0.2666776124348127,0.015078036422902494,2.6054570009253947e-07,0.26322480914686164,0.023242630385487524
269,0.5,10,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","Does aerobic fitness affect microvascular function in healthy adults who are predisposed to Type 2 diabetes? Aerobic fitness has a beneficial effect on microvascular function, improving blood flow and endothelial function to reduce the risk of Type 2 diabetes.",1.8948778188548304e-07,0.11333392818733712,0.054609983769214394,0.014507411718254981,0.10332495305143485,0.06632653061224489,0.014486412327622933,0.13765731541124682,0.045351473922902494,1.8948778188548325e-07,0.17361265045717467,0.023242630385487524
270,0.5,1,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does initiating migraine treatment early reduce the time to reach headache peak and lessen its intensity? Early intervention with triptans might shorten the interval from migraine onset to peak but does not diminish headache severity.,7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
270,0.5,2,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Can early migraine treatment shorten the time until the headache peaks and decrease its severity? Using triptans early may reduce the duration from migraine start to peak but does not relieve the headache.,1.184298636784265e-07,0.14518200984449914,0.0,0.009067132323909391,0.14953173397096364,0.0,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
270,0.5,3,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is early treatment of migraines effective in shortening the time to headache peak and reducing headache severity? Early administration of triptans may lead to a quicker peak but does not ease the headache pain.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
270,0.5,4,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does treating migraines early cut down the time to headache peak and lessen how severe it is? Early use of triptans might shorten the time from migraine onset to peak but doesnâ€™t reduce headache severity.,7.10579182070559e-08,0.1253307515904134,0.029384756657483937,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
270,0.5,5,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Will early migraine treatment shorten the time until the headache reaches its peak and lower its severity? Early triptan use may reduce the duration to peak but does not alleviate the headache itself.,1.184298636784265e-07,0.18850370862949672,0.031217481789802305,0.009067132323909391,0.14953173397096364,0.0,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
270,0.5,6,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early intervention in migraine treatment reduce the time to peak headache and its severity? Early triptan treatment may shorten the period from onset to peak but does not mitigate headache severity.,1.421158364141118e-07,0.22164988109842998,0.0322222222222222,0.01088055878869127,0.18232155679395534,0.0,0.010864809245717241,0.18805223150294026,0.0,1.4211583641411244e-07,0.19415601444095776,0.0
270,0.5,7,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is early migraine treatment associated with a shorter time to headache peak and reduced headache severity? Early use of triptans can shorten the time to peak but does not relieve the headache.,1.421158364141118e-07,0.22164988109842998,0.0322222222222222,0.01088055878869127,0.18232155679395534,0.0,0.010864809245717241,0.18805223150294026,0.0,1.4211583641411244e-07,0.19415601444095776,0.0
270,0.5,8,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Can early administration of migraine treatment decrease the time to headache peak and the severity of the headache? Early triptan use may lead to a shorter duration to peak but does not reduce headache severity.,7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
270,0.5,9,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does starting migraine treatment early reduce the time to reach headache peak and lessen headache severity? Early treatment with triptans might shorten the interval to peak but does not alleviate headache pain.,1.421158364141118e-07,0.17693070815907896,0.0,0.01088055878869127,0.18232155679395534,0.0,0.010864809245717241,0.18805223150294026,0.0,1.4211583641411244e-07,0.19415601444095776,0.0
270,0.5,10,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early migraine treatment shorten the time to headache peak and reduce headache severity? Early triptan use may lead to a shorter duration to peak but does not ease headache symptoms.,1.658018091497971e-07,0.20972053098207066,0.0,0.01269398525347315,0.2162231084696371,0.0,0.012675610786670115,0.22314355131420927,0.0,1.6580180914979784e-07,0.23052365861183244,0.0
271,0.5,1,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation change the cancer treatment strategy for elderly patients? The consultation resulted in changes to the treatment plan in over one-third of cases. Additional research is required to assess if these changes enhance outcomes for older patients.,2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.5,2,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation alter the cancer treatment plan for elderly individuals? More than one-third of cases saw treatment plan modifications following the consultation. Further studies are necessary to evaluate whether these changes benefit the patients' outcomes.,3.0791764556390996e-07,0.19994307183733318,0.07175925925925929,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
271,0.5,3,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients modified after a geriatric oncology consultation? The consultation led to changes in the treatment plan in over a third of cases. More research is needed to determine if these modifications improve patient outcomes.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.5,4,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Does consulting a geriatric oncologist influence the cancer treatment plan for elderly patients? In over one-third of cases, the treatment plan was changed after the consultation. Additional research is needed to understand if these changes improve outcomes for older patients.",2.6054570009253936e-07,0.14537793244599584,0.07314216340070451,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.23140196574033478,0.020823902218198284,2.6054570009253947e-07,0.26662866325394763,0.0
271,0.5,5,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation impact the cancer treatment plan for elderly patients? Treatment plans were altered in more than one-third of cases following the consultation. Further studies are required to confirm if these changes improve patient outcomes.,3.0791764556390996e-07,0.16247565667193076,0.09876543209876545,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
271,0.5,6,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,How does a geriatric oncology consultation affect cancer treatment plans for elderly patients? The consultation resulted in treatment plan modifications in more than one-third of cases. More research is needed to establish if these modifications lead to better outcomes.,2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.5,7,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does the involvement of a geriatric oncology consultation modify cancer treatment plans for elderly patients? Over one-third of cases experienced changes in their treatment plans after the consultation. Further investigation is needed to see if these changes improve patient outcomes.,2.6054570009253936e-07,0.14537793244599584,0.07314216340070451,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.23140196574033478,0.020823902218198284,2.6054570009253947e-07,0.26662866325394763,0.0
271,0.5,8,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation lead to changes in the cancer treatment plan for elderly patients? More than one-third of cases had their treatment plans modified following the consultation. Additional studies are necessary to determine if these changes improve outcomes.,2.6054570009253936e-07,0.10983192318651191,0.09876543209876545,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.23140196574033478,0.020823902218198284,2.6054570009253947e-07,0.26662866325394763,0.0
271,0.5,9,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients adjusted after a geriatric oncology consultation? The consultation caused modifications in treatment plans in over one-third of cases. Further research is required to assess whether these adjustments improve patient outcomes.,3.0791764556390996e-07,0.16247565667193076,0.09876543209876545,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
271,0.5,10,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Do geriatric oncology consultations result in modifications to cancer treatment plans for elderly patients? In more than one-third of cases, the treatment plans were altered following consultation. Further studies are needed to evaluate if these modifications improve outcomes.",3.0791764556390996e-07,0.19994307183733318,0.07175925925925929,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
272,0.5,1,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Question: Is computerized tomography a viable alternative to bone scintigraphy for detecting bone metastases in breast cancer? Answer: Our results indicate that routine bone scintigraphy might not be essential for patients with newly diagnosed, high-risk breast cancer. CT scans, due to their higher sensitivity for certain bone lesions, could serve as a more effective initial screening method.",1.1842986367842703e-07,0.09595304393715409,0.0017487603305785006,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
272,0.5,2,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Question: Can CT scans replace bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our research suggests that routine bone scintigraphy may not be required for patients newly diagnosed with high-risk breast cancer. CT imaging, with greater sensitivity for detecting specific bone lesions, might be a better option for initial screening.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
272,0.5,3,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Question: Is computerized tomography an effective substitute for bone scintigraphy in detecting breast cancer bone metastases? Answer: Findings indicate that routine bone scintigraphy may be unnecessary for patients presenting with newly diagnosed, high-risk breast cancer. CT scans, being more sensitive to certain bone lesions, could offer a more efficient initial screening alternative.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
272,0.5,4,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Question: Can CT imaging replace bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: Our study suggests that routine bone scintigraphy might not be needed for newly diagnosed high-risk breast cancer patients. CT scans, which are more sensitive in identifying specific bone lesions, could be a superior initial screening tool.",0.0,0.027182242374899968,0.0195503540191587,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
272,0.5,5,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Question: Does computerized tomography have the potential to substitute bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings imply that routine bone scintigraphy may not be necessary for patients with newly diagnosed, high-risk breast cancer. CT scans, being more sensitive to certain bone lesions, may provide a more efficient initial screening approach.",7.105791820705622e-08,0.058668538416332794,0.001088074047703811,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
272,0.5,6,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Question: Can CT replace bone scintigraphy in the detection of bone metastases from breast cancer? Answer: The data suggests that routine bone scintigraphy is potentially unnecessary for patients newly diagnosed with high-risk breast cancer. CT scans, with heightened sensitivity for specific bone lesions, could be a more effective initial screening method.",2.3685972735685406e-08,0.020346272143678235,0.00039167013744274143,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
272,0.5,7,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Question: Is computerized tomography capable of replacing bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our findings indicate that routine bone scintigraphy may not be essential for patients with newly diagnosed high-risk breast cancer. CT scans, due to their increased sensitivity for certain bone lesions, might be a more efficient option for initial screening.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021913,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
272,0.5,8,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Question: Can CT scans serve as an alternative to bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our results suggest that routine bone scintigraphy may not be necessary for patients presenting with newly diagnosed, high-risk breast cancer. CT imaging, being more sensitive to specific bone lesions, could provide a more efficient initial screening alternative.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021913,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
272,0.5,9,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Question: Is computerized tomography a suitable replacement for bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Findings suggest that routine bone scintigraphy may be unnecessary for patients newly diagnosed with high-risk breast cancer. CT scans, which are more sensitive in detecting specific bone lesions, could be a more efficient initial screening tool.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021913,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
272,0.5,10,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Question: Can CT scans effectively replace bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: Our findings suggest that routine bone scintigraphy might not be required for patients presenting with newly diagnosed, high-risk breast cancer. CT scans, being more sensitive to particular bone lesions, could serve as a more efficient initial screening method.",7.105791820705622e-08,0.058668538416332794,0.001088074047703811,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
273,0.5,1,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Should male HIV-infected patients over 50 with at least one cardiovascular risk factor be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? It may be beneficial to detect silent myocardial ischemia and reduce cardiovascular events.,3.3160361829959526e-07,0.26689098425559576,0.04340211029945749,0.025387970506946217,0.3194972036279089,0.012195704580663273,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
273,0.5,2,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Is it advisable to screen HIV-positive men older than 50 who have an additional cardiovascular risk factor for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening might help identify silent ischemia and lower cardiovascular event risk.,3.3160361829959526e-07,0.18987463086004608,0.09876543209876545,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
273,0.5,3,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
","For male HIV patients above 50 years with one or more cardiovascular risk factors, could gated myocardial perfusion SPECT screening for silent myocardial ischemia be useful? This approach may help detect silent ischemia and decrease cardiovascular incidents.",3.3160361829959526e-07,0.18987463086004608,0.09876543209876545,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
273,0.5,4,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
","In HIV-infected males aged over 50 with at least one cardiovascular risk factor, is screening with gated myocardial perfusion SPECT recommended to find silent myocardial ischemia? Such screening could be advantageous in identifying silent ischemia and preventing cardiovascular events.",2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
273,0.5,5,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Should men living with HIV who are older than 50 and have an additional cardiovascular risk factor undergo gated myocardial perfusion SPECT screening to detect silent myocardial ischemia? This screening may be helpful in identifying silent ischemia and reducing cardiovascular complications.,2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.17167520866996666,0.040742417383431435,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
273,0.5,6,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Is screening for silent myocardial ischemia using gated myocardial perfusion SPECT beneficial in HIV-positive male patients over 50 years old with at least one cardiovascular risk factor? It may aid in early detection and decrease cardiovascular event rates.,3.0791764556390996e-07,0.16247565667193076,0.09876543209876545,0.023574544042164344,0.2517179163435008,0.040742417383431435,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
273,0.5,7,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
","For HIV-infected men older than 50 with one or more cardiovascular risk factors, is gated myocardial perfusion SPECT screening for silent myocardial ischemia advantageous? This could assist in identifying silent ischemia and lowering the risk of cardiovascular events.",3.0791764556390996e-07,0.16247565667193076,0.09876543209876545,0.023574544042164344,0.2517179163435008,0.040742417383431435,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
273,0.5,8,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Could screening with gated myocardial perfusion SPECT be recommended for male HIV patients above 50 years with at least one cardiovascular risk factor to detect silent myocardial ischemia? It may provide benefits by identifying silent ischemia and preventing cardiovascular events.,2.6054570009253936e-07,0.10983192318651191,0.09876543209876545,0.0199476911126006,0.19765069507322464,0.040742417383431435,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
273,0.5,9,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
","In male HIV-infected patients aged over 50 who have at least one cardiovascular risk factor, does screening with gated myocardial perfusion SPECT help identify silent myocardial ischemia and reduce cardiovascular events? It may be beneficial to do so.",3.0791764556390996e-07,0.16247565667193076,0.09876543209876545,0.023574544042164344,0.2517179163435008,0.040742417383431435,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
273,0.5,10,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Is it beneficial to screen male HIV-infected patients older than 50 with at least one cardiovascular risk factor for silent myocardial ischemia using gated myocardial perfusion SPECT? This screening might help detect silent ischemia and reduce cardiovascular event risk.,2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
274,0.5,1,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Is there a link between crime and the sale of syringes over the counter at pharmacies? Our research shows that OTC pharmacy syringe sales do not lead to higher crime rates. Data from various areas revealed no connection between syringe access and criminal behavior.,2.3685972735685406e-08,0.08954451460637847,0.047500000000000014,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
274,0.5,2,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Does the sale of syringes over the counter at pharmacies relate to crime? Our study indicates no increase in crime rates due to OTC syringe sales. Analysis across multiple regions found no association between syringe availability and crime.,1.1842986367842671e-07,0.06073768844295824,0.047500000000000014,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
274,0.5,3,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Are crime rates affected by over-the-counter pharmacy syringe sales? Findings indicate that OTC syringe sales at pharmacies are not linked to rises in crime. Data from different jurisdictions showed no correlation between syringe sales and criminal incidents.,1.42115836414112e-07,0.1266448393288484,0.019744897959183685,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
274,0.5,4,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Is crime connected to the sale of syringes in pharmacies without a prescription? Our results demonstrate no increase in crime related to OTC syringe sales. Examination of data from several locations found no relationship between syringe sales and crime levels.,7.105791820705611e-08,0.008093954957539395,0.047500000000000014,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
274,0.5,5,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Does selling syringes over the counter in pharmacies influence crime rates? The study's findings show no association between OTC syringe sales and crime increases. Multiple jurisdiction data confirmed no link between syringe availability and criminal activity.,1.6580180914979731e-07,0.1163075395977704,0.047500000000000014,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
274,0.5,6,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Is there an association between crime and over-the-counter pharmacy syringe sales? Our findings reveal that OTC syringe sales were not linked to higher crime rates. Analysis from various jurisdictions found no correlation between syringe access and crime.,1.42115836414112e-07,0.08813666263107356,0.047500000000000014,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
274,0.5,7,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Are over-the-counter pharmacy syringe sales tied to crime? Research indicates no rise in crime rates due to OTC syringe availability. Data from multiple regions showed no connection between syringe sales and criminal behavior.,2.3685972735685321e-07,0.24924139707245496,0.01628251821019771,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
274,0.5,8,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Is crime related to the sale of syringes over the counter at pharmacies? Our study found no evidence that OTC syringe sales increase crime rates. Data analyzed from several jurisdictions revealed no correlation between syringe availability and crime.,1.1842986367842671e-07,0.06073768844295824,0.047500000000000014,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
274,0.5,9,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Do over-the-counter pharmacy syringe sales correlate with crime? Our findings show no association between OTC syringe sales and crime rate increases. Analysis of data from multiple areas found no link between syringe sales and criminal activity.,1.6580180914979731e-07,0.25008271751560507,0.09996093749999999,0.012693985253473115,0.22798490565049567,0.029384756657483937,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
274,0.5,10,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Is there a connection between crime and the sale of syringes at pharmacies without prescriptions? The study demonstrated that OTC syringe sales do not cause crime rates to rise. Data from various jurisdictions indicated no relationship between syringe availability and crime.,4.737194547137081e-08,0.017223853026752334,0.047500000000000014,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
275,0.5,1,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Can D-dimer be used as a new diagnostic marker for acute appendicitis? Elevated D-dimer levels should not be used as a definitive diagnostic tool for acute appendicitis. Although D-dimer may increase in some instances, it is not specific to appendicitis and can be elevated due to other conditions. Using D-dimer alone could result in misdiagnosis and incorrect treatment.",7.105791820705622e-08,0.10236729716565174,0.03648202291851949,0.005440279394345618,0.10169626606770876,0.03566529492455417,0.0054324046228586,0.07831517733430982,0.0181755829903978,7.105791820705622e-08,0.05406722127027486,0.0
275,0.5,2,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Is D-dimer a viable new diagnostic parameter for acute appendicitis? Increased D-dimer levels are not reliable for diagnosing acute appendicitis. While D-dimer can be elevated in some cases, it lacks specificity for appendicitis and may rise due to other diseases. Sole reliance on D-dimer may cause diagnostic errors and inappropriate therapy.",2.3685972735685406e-07,0.1361117447566249,0.033293697978596916,0.018134264647818726,0.1857171457950919,0.0,0.018108015409528666,0.18924199963852795,0.0,2.3685972735685406e-07,0.19290366612449228,0.0
275,0.5,3,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Could D-dimer serve as a novel diagnostic indicator for acute appendicitis? Raised D-dimer levels should not be considered a diagnostic criterion for acute appendicitis. Although elevations may be seen, D-dimer is nonspecific and can be elevated in various other conditions. Depending only on D-dimer can lead to misdiagnosis and improper treatment.",2.3685972735685406e-07,0.1638376319790229,0.013302027841154182,0.018134264647818726,0.1857171457950919,0.0,0.018108015409528666,0.18924199963852795,0.0,2.3685972735685406e-07,0.19290366612449228,0.0
275,0.5,4,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Is it possible for D-dimer to become a new diagnostic marker for acute appendicitis? Elevated D-dimer should not be used to diagnose acute appendicitis. While it may be increased in some patients, D-dimer is not specific to appendicitis and may rise due to other causes. Relying solely on D-dimer risks misdiagnosis and wrong treatment.",1.6580180914979784e-07,0.07784283663264935,0.033293697978596916,0.012693985253473108,0.12629372532429084,0.0,0.012675610786670066,0.12861737782209381,0.0,1.6580180914979784e-07,0.13102826240640475,0.0
275,0.5,5,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Can D-dimer levels be a new diagnostic tool for acute appendicitis? High D-dimer levels should not be interpreted as diagnostic for acute appendicitis. Though D-dimer can be elevated in certain cases, it is not specific to appendicitis and can be elevated in other conditions. Using only D-dimer for diagnosis can cause misdiagnosis and inappropriate management.",1.4211583641411244e-07,0.18751129261307842,0.05833479015134895,0.010880558788691236,0.15955852511283908,0.03767781622452902,0.0108648092457172,0.1358587989096045,0.01922337562475971,1.4211583641411244e-07,0.11122563511022499,0.0
275,0.5,6,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
",Is D-dimer a potential new diagnostic parameter for acute appendicitis? Increased levels of D-dimer are not diagnostic for acute appendicitis. Elevated D-dimer may appear in some cases but it is nonspecific and can result from various other illnesses. Relying exclusively on D-dimer could lead to incorrect diagnosis and treatment.,2.8423167282822487e-07,0.20581487180020996,0.012469795760398632,0.02176111757738247,0.22738984219566083,0.0,0.0217296184914344,0.23180161405732447,0.0,2.8423167282822487e-07,0.23638877806423064,0.0
275,0.5,7,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Could D-dimer be established as a new diagnostic parameter for acute appendicitis? Elevated D-dimer levels should not be used as a sole diagnostic marker for acute appendicitis. While D-dimer may rise in some cases, it lacks specificity and can be elevated due to other conditions. Sole reliance on D-dimer might cause misdiagnosis and improper care.",1.4211583641411244e-07,0.11049493921752873,0.003688550542113138,0.010880558788691236,0.10724553035359774,0.0,0.0108648092457172,0.10919929196499112,0.0,1.4211583641411244e-07,0.11122563511022499,0.0
275,0.5,8,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Is D-dimer a suitable new diagnostic marker for acute appendicitis? Higher D-dimer levels should not be used to diagnose acute appendicitis. Although D-dimer may increase in certain patients, it is not specific to appendicitis and can be elevated by other diseases. Depending only on D-dimer can lead to misdiagnosis and incorrect treatment.",2.1317375462116866e-07,0.11630911746044514,0.033293697978596916,0.016320838183036854,0.1655144384775733,0.0,0.0162972138685758,0.1686227124357922,0.0,2.1317375462116866e-07,0.17185025692665912,0.0
275,0.5,9,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Can D-dimer act as a new diagnostic parameter for acute appendicitis? Elevated D-dimer should not be considered diagnostic for acute appendicitis. While D-dimer levels may be raised in some instances, they are not specific to appendicitis and can be caused by other conditions. Relying solely on D-dimer can result in misdiagnosis and improper treatment.",1.6580180914979784e-07,0.10399933401227024,0.014432751233034783,0.012693985253473108,0.12629372532429084,0.0,0.012675610786670066,0.12861737782209381,0.0,1.6580180914979784e-07,0.13102826240640475,0.0
275,0.5,10,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Is D-dimer an effective new diagnostic parameter for acute appendicitis? Increased D-dimer levels are not diagnostic for acute appendicitis. Although D-dimer may be elevated in some cases, it is not specific to appendicitis and can be elevated by other conditions. Using D-dimer alone for diagnosis can lead to misdiagnosis and inappropriate therapy.",2.1317375462116866e-07,0.17067360221024463,0.005856656040561778,0.016320838183036854,0.1655144384775733,0.0,0.0162972138685758,0.1686227124357922,0.0,2.1317375462116866e-07,0.17185025692665912,0.0
276,0.5,1,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Does the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, prevent colon cancer in patients with coronary artery disease?",9.000669639560433e-07,1.1102246763904149,0.017851239669421492,0.06891020566171129,1.174119841176255,0.0,0.06881045855620906,1.2163953243244943,0.0,9.000669639560451e-07,1.2622417124499106,0.0
276,0.5,2,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","In patients with coronary artery disease, does bezafibrate, a ligand for peroxisome proliferator-activated receptors that lowers lipids, help prevent colon cancer?",8.526950184846725e-07,1.0048641607325894,0.017851239669421492,0.06528335273214753,1.062894206066031,0.0,0.06518885547430331,1.0986122886681104,0.0,8.526950184846744e-07,1.137078569495905,0.0
276,0.5,3,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Is the use of bezafibrate, a peroxisome proliferator-activated receptor ligand that lowers lipids, effective in preventing colon cancer among coronary artery disease patients?",8.053230730133019e-07,0.9095539809282642,0.017851239669421492,0.06165649980258377,0.9628107475090495,0.0,0.06156725239239757,0.993251773010285,0.0,8.053230730133037e-07,1.0258529343856808,0.0
276,0.5,4,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Can bezafibrate, which lowers lipids by activating peroxisome proliferator-activated receptors, prevent colon cancer in individuals with coronary artery disease?",9.000669639560433e-07,1.1102246763904149,0.017851239669421492,0.06891020566171129,1.174119841176255,0.0,0.06881045855620906,1.2163953243244943,0.0,9.000669639560451e-07,1.2622417124499106,0.0
276,0.5,5,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Does the lipid-lowering drug bezafibrate, targeting peroxisome proliferator-activated receptors, offer protection against colon cancer in coronary artery disease patients?",9.000669639560433e-07,1.1102246763904149,0.017851239669421492,0.06891020566171129,1.174119841176255,0.0,0.06881045855620906,1.2163953243244943,0.0,9.000669639560451e-07,1.2622417124499106,0.0
276,0.5,6,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Is there evidence that bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, prevents colon cancer in those with coronary artery disease?",8.763809912203579e-07,1.0561574551201396,0.017851239669421492,0.06709677919692941,1.1169614273363062,0.0,0.06699965701525619,1.1557707025080592,0.0,8.763809912203598e-07,1.19770319131234,0.0
276,0.5,7,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Does bezafibrate, known for lipid-lowering effects through peroxisome proliferator-activated receptor activation, reduce colon cancer risk in coronary artery disease patients?",8.763809912203579e-07,1.0561574551201396,0.017851239669421492,0.06709677919692941,1.1169614273363062,0.0,0.06699965701525619,1.1557707025080592,0.0,8.763809912203598e-07,1.19770319131234,0.0
276,0.5,8,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
",Is bezafibrate effective at preventing colon cancer in patients suffering from coronary artery disease due to its role as a peroxisome proliferator-activated receptor ligand?,7.816371002776166e-07,0.8651022183574302,0.017851239669421492,0.05984307333780189,0.9162907318741556,0.0,0.059756450851444695,0.9444616088408537,0.0,7.816371002776184e-07,0.9745596399981307,0.0
276,0.5,9,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","In coronary artery disease patients, does treatment with bezafibrate, a peroxisome proliferator-activated receptor ligand that lowers lipids, prevent colon cancer?",8.763809912203579e-07,1.0561574551201396,0.017851239669421492,0.06709677919692941,1.1169614273363062,0.0,0.06699965701525619,1.1557707025080592,0.0,8.763809912203598e-07,1.19770319131234,0.0
276,0.5,10,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Does the administration of bezafibrate, a peroxisome proliferator-activated receptor ligand with lipid-lowering properties, prevent colon cancer in patients with coronary artery disease?",8.290090457489872e-07,0.9560739965631582,0.017851239669421492,0.06346992626736564,1.0116009116784808,0.0,0.06337805393335044,1.0445450673978351,0.0,8.29009045748989e-07,1.0799201556559561,0.0
277,0.5,1,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","These findings imply that the R14C KCNQ1 mutation by itself does not cause atrial fibrillation (AF). Instead, we propose a model where a 'second hit,' such as an environmental factor like hypertension that induces atrial stretch, is necessary.",4.026615365066516e-07,0.35239401612153287,0.01851192595229618,0.030828249901291835,0.3867729750960107,0.0,0.030783626196198732,0.39589565709201446,0.0,4.026615365066519e-07,0.4054651081081633,0.0
277,0.5,2,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The data indicate that the R14C KCNQ1 mutation alone is inadequate to trigger AF. We suggest a model involving a 'second hit,' for example, hypertension causing atrial stretch, contributing to the condition.",5.447773729207634e-07,0.5293247242806118,0.01851192595229618,0.041708808689983105,0.5690945318899661,0.0,0.041648435441915974,0.5839478885949547,0.0,5.447773729207643e-07,0.599621122549121,0.0
277,0.5,3,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Our results suggest that the R14C KCNQ1 mutation is not sufficient on its own to cause atrial fibrillation. Rather, a 'second hit' like an environmental factor such as hypertension leading to atrial stretch may be required.",4.500334819780222e-07,0.40796386727634504,0.01851192595229618,0.03445510283085559,0.44393138893595907,0.0,0.03440522927810448,0.45473615711494775,0.0,4.500334819780227e-07,0.46608972992459874,0.0
277,0.5,4,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","These results propose that the R14C KCNQ1 mutation alone cannot cause AF. Instead, a model is suggested where a 'second hit,' such as hypertension causing atrial stretch, plays a role.",5.92149318392134e-07,0.5960160987792853,0.01851192595229618,0.045335661619546865,0.6380874033769168,0.0,0.04527003852382172,0.6554068525770984,0.0,5.921493183921352e-07,0.6737290947028427,0.0
277,0.5,5,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The evidence points to the R14C KCNQ1 mutation alone being insufficient for AF development, proposing a model where a 'second hit,' like hypertension-induced atrial stretch, is involved.",6.632072365991899e-07,0.705215390744276,0.01851192595229618,0.0507759410138925,0.751416088683921,0.0,0.05070244314668034,0.7731898882334827,0.0,6.632072365991914e-07,0.7963314167951756,0.0
277,0.5,6,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","It appears that the R14C KCNQ1 mutation by itself does not cause atrial fibrillation; instead, a 'second hit' such as hypertension that promotes atrial stretch may be necessary.",6.395212638635046e-07,0.667475062761429,0.01851192595229618,0.048962514549110624,0.7121953755306385,0.0,0.04889164160572747,0.7323678937132279,0.0,6.39521263863506e-07,0.75377180237638,0.0
277,0.5,7,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The R14C KCNQ1 mutation alone does not seem enough to cause AF; we propose that a 'second hit,' like environmental hypertension causing atrial stretch, contributes to the disease.",6.395212638635046e-07,0.667475062761429,0.01851192595229618,0.048962514549110624,0.7121953755306385,0.0,0.04889164160572747,0.7323678937132279,0.0,6.39521263863506e-07,0.75377180237638,0.0
277,0.5,8,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby",Our data suggest the R14C KCNQ1 mutation is not solely responsible for AF; a 'second hit' such as hypertension-induced atrial stretch is likely required.,7.342651548062458e-07,0.8278177128366089,0.01851192595229618,0.05621622040823814,0.8792494601938055,0.0,0.05613484776953896,0.9067212808580063,0.0,7.342651548062476e-07,0.9360933591703349,0.0
277,0.5,9,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","We conclude that the R14C KCNQ1 mutation alone cannot cause atrial fibrillation, but a 'second hit' like hypertension leading to atrial stretch may be essential.",7.105791820705605e-07,0.7852580984178132,0.01851192595229618,0.05440279394345626,0.8347976976229714,0.0,0.05432404622858609,0.8602012652231124,0.0,7.105791820705622e-07,0.8873031950009036,0.0
277,0.5,10,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","These findings support a model where the R14C KCNQ1 mutation alone is insufficient for AF, and a 'second hit' such as hypertension-induced atrial stretch is necessary.",6.868932093348752e-07,0.7444361038975584,0.01851192595229618,0.05258936747867438,0.7922380832041758,0.0,0.052513244687633215,0.8157495026522783,0.0,6.868932093348768e-07,0.8407831793660097,0.0
278,0.5,1,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient for assessing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for evaluating the cervical spine in elderly trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.5,2,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors reliably detect cervical spine fractures in geriatric blunt trauma patients with low-energy injuries? Answer: Clinical predictors do not seem reliable for cervical spine assessment in geriatric trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.5,3,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors effective in identifying cervical spine fractures in elderly patients with blunt trauma from low-energy impacts? Answer: Clinical predictors appear inadequate for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,0.0,0.08154672712469946,0.052811791383219966,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,0.5,4,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the use of clinical predictors adequate for cervical spine fracture diagnosis in geriatric blunt trauma cases involving low-energy mechanisms? Answer: Clinical predictors are inadequate for assessing the cervical spine in geriatric trauma patients with low-energy mechanisms.,7.10579182070559e-08,0.21679532390595302,0.0879175199491562,0.005440279394345632,0.17102921705750251,0.06035379812695108,0.005432404622858621,0.13293385747468456,0.031217481789802305,7.105791820705622e-08,0.09237332013101529,0.0
278,0.5,5,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors provide an accurate evaluation of cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for cervical spine evaluation in geriatric trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.07558566665879374,0.02947845804988669,0.0018134264647818796,0.03232407609285426,0.0017600481269510818,0.0018108015409528735,0.032084437417815526,0.0009440442898023052,2.3685972735685406e-08,0.031748698314579826,0.0
278,0.5,6,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors enough to evaluate cervical spine injuries in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear inadequate for assessing cervical spine injuries in elderly trauma patients with low-energy mechanisms.,0.0,0.04077336356235017,0.02367654880882389,0.0,0.08401784006787194,0.05855226608232362,0.0,0.0433216987849967,0.031004740432419922,0.0,0.0,0.0
278,0.5,7,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: How effective are clinical predictors in diagnosing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem inadequate for cervical spine evaluation in geriatric trauma patients with low-energy mechanisms.,0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.5,8,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors adequately assess cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear insufficient for cervical spine assessment in elderly trauma patients with low-energy mechanisms.,4.73719454713706e-08,0.032592934367321025,0.01747571456566166,0.003626852929563759,0.0679408627921636,0.0038554765460572307,0.003621603081905747,0.06742663438990348,0.0020762161887946107,4.737194547137081e-08,0.06669137449867346,0.0
278,0.5,9,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors reliable for evaluating cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem inadequate for cervical spine evaluation in geriatric trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.004742618054735637,0.02168367346938782,0.0018134264647818796,0.03339721616887559,0.0018684240952711456,0.0018108015409528735,0.033146172468933255,0.0010047404324198955,2.3685972735685406e-08,0.0327898228229917,0.0
278,0.5,10,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the evaluation of cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms adequately supported by clinical predictors? Answer: Clinical predictors appear insufficient for assessing cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,7.10579182070559e-08,0.1793279087405506,0.06184760405539633,0.005440279394345632,0.09401286366195283,0.004990476327643108,0.005432404622858621,0.09332544715697333,0.002670768987034146,7.105791820705622e-08,0.09237332013101529,0.0
279,0.5,1,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","This research examines the interfractional movement of the prostate bed using RTOG consensus guidelines and daily CT on rails, focusing on whether motion varies between the superior and inferior regions.",8.053230730133026e-07,0.5337875000190482,0.16678994082840226,0.06165649980258372,0.6607723560518326,0.09566326530612247,0.06156725239239752,0.7241324498988244,0.06525084641428129,8.053230730133038e-07,0.7669333061446233,0.049861495844875335
279,0.5,2,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
",The study explores interfractional motion in the prostate bed with RTOG consensus definitions and daily CT imaging to assess differences in movement between the upper and lower parts.,8.526950184846732e-07,0.6052464640011919,0.16678994082840226,0.06528335273214747,0.7348803282055543,0.09566326530612247,0.06518885547430327,0.8010934910349539,0.06525084641428129,8.526950184846746e-07,0.8469760138181606,0.049861495844875335
279,0.5,3,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","Using RTOG consensus criteria and daily CT on rails, this investigation analyzes prostate bed interfractional motion to determine if there is a significant difference between its superior and inferior sections.",8.053230730133026e-07,0.5337875000190482,0.16678994082840226,0.06165649980258372,0.6607723560518326,0.09566326530612247,0.06156725239239752,0.7241324498988244,0.06525084641428129,8.053230730133038e-07,0.7669333061446233,0.049861495844875335
279,0.5,4,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","This study assesses interfractional motion in the prostate bed based on RTOG consensus and daily CT scans, aiming to identify variations in target motion between the superior and inferior portions.",8.053230730133026e-07,0.5337875000190482,0.16678994082840226,0.06165649980258372,0.6607723560518326,0.09566326530612247,0.06156725239239752,0.7241324498988244,0.06525084641428129,8.053230730133038e-07,0.7669333061446233,0.049861495844875335
279,0.5,5,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
",The research focuses on prostate bed interfractional motion by applying RTOG consensus definitions and daily CT on rails to see if motion differs between the upper and lower prostate bed areas.,7.816371002776173e-07,0.546095760380696,0.13349624284980535,0.05984307333780184,0.6256810362405636,0.09566326530612247,0.05975645085144465,0.6877648057279497,0.06525084641428129,7.816371002776184e-07,0.7291929781617763,0.049861495844875335
279,0.5,6,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","By employing RTOG consensus definitions and daily CT on rails, this study evaluates interfractional motion in the prostate bed, specifically comparing motion in the superior versus inferior parts.",8.526950184846732e-07,0.7079349351952584,0.09318994082840228,0.06528335273214747,0.788199342094781,0.05726326530612246,0.06518885547430327,0.8010934910349539,0.06525084641428129,8.526950184846746e-07,0.8469760138181606,0.049861495844875335
279,0.5,7,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","This investigation uses daily CT on rails and RTOG consensus guidelines to study interfractional motion in the prostate bed, examining whether the target moves differently in its superior and inferior regions.",7.816371002776173e-07,0.4998859483433664,0.16678994082840226,0.05984307333780184,0.6256810362405636,0.09566326530612247,0.05975645085144465,0.6877648057279497,0.06525084641428129,7.816371002776184e-07,0.7291929781617763,0.049861495844875335
279,0.5,8,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","The study utilizes RTOG consensus definitions and daily CT imaging to explore interfractional motion in the prostate bed, with a focus on differences between superior and inferior portions.",8.526950184846732e-07,0.6052464640011919,0.16678994082840226,0.06528335273214747,0.7348803282055543,0.09566326530612247,0.06518885547430327,0.8010934910349539,0.06525084641428129,8.526950184846746e-07,0.8469760138181606,0.049861495844875335
279,0.5,9,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","Using daily CT on rails and RTOG consensus criteria, this research analyzes interfractional motion in the prostate bed to determine if there is a disparity in movement between its superior and inferior areas.",7.342651548062467e-07,0.4353474272057949,0.16678994082840226,0.05621622040823808,0.5589896617418901,0.09566326530612247,0.0561348477695389,0.618771934240999,0.06525084641428129,7.342651548062476e-07,0.6577340141796326,0.049861495844875335
279,0.5,10,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","This analysis investigates prostate bed interfractional motion via RTOG consensus definitions and daily CT on rails, aiming to establish if target motion varies between the superior and inferior sections.",8.290090457489879e-07,0.5688788198303172,0.16678994082840226,0.0634699262673656,0.6971400002227073,0.09566326530612247,0.06337805393335039,0.7618727778816714,0.06525084641428129,8.290090457489892e-07,0.8061540192979058,0.049861495844875335
280,0.5,1,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
",Can functional magnetic resonance imaging of mental imagery forecast recovery in patients with consciousness disorders?,8.763809912203577e-07,1.1296748488596675,0.11555555555555556,0.06709677919692943,1.2361700990770172,0.07939508506616257,0.06699965701525622,1.3220384833561023,0.060964083175803374,8.763809912203595e-07,1.4155434730628587,0.04158790170132326
280,0.5,2,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
",Is it possible for mental imagery fMRI to predict recovery outcomes in patients suffering from disorders of consciousness?,8.053230730133016e-07,0.9355188344187098,0.11555555555555556,0.061656499802583795,1.0285307342987733,0.07939508506616257,0.0615672523923976,1.0988949320418926,0.060964083175803374,8.053230730133034e-07,1.174381416245971,0.04158790170132326
280,0.5,3,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
",Does mental imagery functional MRI serve as a reliable predictor for recovery in patients with consciousness impairments?,8.290090457489869e-07,0.9961434562351448,0.11555555555555556,0.06346992626736567,1.093069255436344,0.07939508506616257,0.06337805393335047,1.1678878035288447,0.060964083175803374,8.290090457489888e-07,1.2484893883996921,0.04158790170132326
280,0.5,4,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
",Can the mental imagery fMRI paradigm effectively anticipate recovery in patients experiencing disorders of consciousness?,8.763809912203577e-07,1.1296748488596675,0.11555555555555556,0.06709677919692943,1.2361700990770172,0.07939508506616257,0.06699965701525622,1.3220384833561023,0.060964083175803374,8.763809912203595e-07,1.4155434730628587,0.04158790170132326
280,0.5,5,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
",Is functional MRI based on mental imagery a useful tool for predicting recovery in consciousness disorder patients?,8.290090457489869e-07,0.9961434562351448,0.11555555555555556,0.06346992626736567,1.093069255436344,0.07939508506616257,0.06337805393335047,1.1678878035288447,0.060964083175803374,8.290090457489888e-07,1.2484893883996921,0.04158790170132326
280,0.5,6,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
",Can mental imagery using fMRI demonstrate predictive value for recovery in patients with consciousness disorders?,8.763809912203577e-07,1.1296748488596675,0.11555555555555556,0.06709677919692943,1.2361700990770172,0.07939508506616257,0.06699965701525622,1.3220384833561023,0.060964083175803374,8.763809912203595e-07,1.4155434730628587,0.04158790170132326
280,0.5,7,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
",Does the mental imagery fMRI technique correlate well with clinical outcomes to forecast recovery in consciousness disorder patients?,8.053230730133016e-07,0.9355188344187098,0.11555555555555556,0.061656499802583795,1.0285307342987733,0.07939508506616257,0.0615672523923976,1.0988949320418926,0.060964083175803374,8.053230730133034e-07,1.174381416245971,0.04158790170132326
280,0.5,8,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
",Can mental imagery functional MRI be used to predict recovery prospects in patients with disorders of consciousness?,8.290090457489869e-07,0.9961434562351448,0.11555555555555556,0.06346992626736567,1.093069255436344,0.07939508506616257,0.06337805393335047,1.1678878035288447,0.060964083175803374,8.290090457489888e-07,1.2484893883996921,0.04158790170132326
280,0.5,9,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
",Is the mental imagery fMRI approach a promising method for anticipating recovery in patients with disorders of consciousness?,8.053230730133016e-07,0.9355188344187098,0.11555555555555556,0.061656499802583795,1.0285307342987733,0.07939508506616257,0.0615672523923976,1.0988949320418926,0.060964083175803374,8.053230730133034e-07,1.174381416245971,0.04158790170132326
280,0.5,10,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
",Can functional MRI mental imagery paradigms accurately predict recovery in patients with disorders of consciousness?,8.763809912203577e-07,1.1296748488596675,0.11555555555555556,0.06709677919692943,1.2361700990770172,0.07939508506616257,0.06699965701525622,1.3220384833561023,0.060964083175803374,8.763809912203595e-07,1.4155434730628587,0.04158790170132326
281,0.5,1,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? This study shows that hospital management can promote care programme development by integrating case-mix reimbursement into hospital budgeting. Further research is needed to validate this and assess if care programmes eventually result in more process-oriented care.,3.316036182995957e-07,0.1501786356396817,0.08264462809917351,0.025387970506946217,0.20038541034964208,0.0507015306122449,0.025351221573340132,0.2523517497122971,0.017236072637734686,3.316036182995957e-07,0.2818511521409879,0.0
281,0.5,2,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is process-oriented care delivery fostered by case-mix based reimbursement? The study indicates that hospital management can drive care programme growth by adopting case-mix reimbursement in budgeting. Additional studies should confirm these results and explore if care programmes lead to enhanced care delivery over time.,4.026615365066519e-07,0.24985932018218815,0.05940199771368599,0.030828249901291835,0.26937828183659374,0.0507015306122449,0.030783626196198732,0.3229693169262511,0.017236072637734686,4.026615365066519e-07,0.354171813720614,0.0
281,0.5,3,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Can case-mix reimbursement stimulate process-oriented care delivery development? Findings reveal hospital management can encourage care programmes by incorporating case-mix reimbursement into budgeting. Future research should verify this and investigate whether care programmes will ultimately improve care delivery.,5.684633456564493e-07,0.47231744706821566,0.02728130629986554,0.04352223515476494,0.4516998386305482,0.0507015306122449,0.043459236982868805,0.510180859014397,0.017236072637734686,5.684633456564497e-07,0.54654370636807,0.0
281,0.5,4,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does adopting case-mix based reimbursement promote the growth of process-oriented care delivery? The study demonstrates hospital management's ability to foster care programmes through case-mix reimbursement in budgeting. Further investigation is recommended to confirm this and determine if care programmes result in better care delivery.,4.026615365066519e-07,0.24985932018218815,0.05940199771368599,0.030828249901291835,0.26937828183659374,0.0507015306122449,0.030783626196198732,0.3229693169262511,0.017236072637734686,4.026615365066519e-07,0.354171813720614,0.0
281,0.5,5,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is the development of process-oriented care delivery stimulated by case-mix reimbursement? This research shows hospital management can support care programme creation by using case-mix reimbursement in budgeting. Future studies are advised to confirm these findings and assess if care programmes enhance care delivery.,4.263475092423373e-07,0.24115041384540836,0.08264462809917351,0.03264167636607371,0.29347583341565375,0.0507015306122449,0.0325944277371516,0.3476619295166228,0.017236072637734686,4.263475092423373e-07,0.37948962170490574,0.0
281,0.5,6,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix reimbursement encourage the establishment of process-oriented care delivery? The study finds hospital management can boost care programmes by applying case-mix reimbursement in budgeting. Additional research is suggested to validate this and see if care programmes lead to improved care delivery.,4.500334819780227e-07,0.3328720806010481,0.03399242560081718,0.03445510283085558,0.31816844600602545,0.0507015306122449,0.034405229278104466,0.3729797375009145,0.017236072637734686,4.500334819780227e-07,0.4054651081081637,0.0
281,0.5,7,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Can process-oriented care delivery be stimulated through case-mix based reimbursement? Research indicates hospital management can promote care programmes by adopting case-mix reimbursement in budgeting processes. Further studies should confirm this and explore the long-term impact on care delivery.,5.44777372920764e-07,0.36790211948455065,0.08264462809917351,0.04170880868998307,0.42352896166385134,0.0507015306122449,0.04164843544191593,0.4811933221411455,0.017236072637734686,5.447773729207643e-07,0.5166907432183883,0.0
281,0.5,8,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is process-oriented care delivery development driven by case-mix reimbursement? The study reveals that hospital management can facilitate care programme development by integrating case-mix reimbursement into budgeting. Future research is necessary to verify this and evaluate the eventual effects on care delivery.,4.737194547137081e-07,0.2899405780148401,0.08264462809917351,0.03626852929563745,0.3434862539903172,0.0507015306122449,0.03621603081905733,0.3989552239041725,0.017236072637734686,4.737194547137081e-07,0.4321333551903246,0.0
281,0.5,9,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement promote care programme development and process-oriented care delivery? This study suggests hospital management can stimulate care programmes by using case-mix reimbursement in budgeting. Further research is needed to confirm these findings and determine the long-term benefits.,4.974054274493934e-07,0.3152583859991318,0.08264462809917351,0.038081955760419325,0.36946174039357516,0.0507015306122449,0.0380268323600102,0.42562347098633335,0.017236072637734686,4.974054274493935e-07,0.4595323293784399,0.0
281,0.5,10,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is the adoption of case-mix reimbursement effective in stimulating process-oriented care delivery? The research shows hospital management can encourage care programme growth through case-mix reimbursement in budgeting. Additional research is recommended to confirm this and assess the eventual impact on care delivery.,4.500334819780227e-07,0.29906002301275825,0.058269628099173514,0.03445510283085558,0.31816844600602545,0.0507015306122449,0.034405229278104466,0.3729797375009145,0.017236072637734686,4.500334819780227e-07,0.4054651081081637,0.0
282,0.5,1,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
","Does glomerular hyperfiltration during pregnancy cause kidney damage in women with many pregnancies? Our study indicates that glomerular hyperfiltration in pregnancy is unlikely to lead to long-term kidney damage, even among women with multiple pregnancies, supporting the idea that pregnancy-related physiological changes are typically reversible.",1.6580180914979784e-07,0.10192040935736824,0.0325118126320998,0.012693985253473108,0.12309700251218514,0.019991670137442734,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
282,0.5,2,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
","Is kidney damage linked to glomerular hyperfiltration in pregnant women with numerous births? Findings from our research suggest that glomerular hyperfiltration in pregnancy does not result in permanent kidney injury, even for women with several pregnancies, reinforcing that pregnancy adaptations are usually reversible.",2.1317375462116866e-07,0.18444807073563618,0.0068573693952389825,0.016320838183036854,0.20453710908972944,0.004383329862557267,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
282,0.5,3,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
","Does increased glomerular filtration in pregnancy harm kidneys in women who have had multiple pregnancies? Our study proposes that such hyperfiltration during pregnancy may not cause lasting kidney damage, even in women with multiple births, indicating that pregnancy-related physiological changes are generally reversible.",2.1317375462116866e-07,0.11843405353944902,0.05406792665018373,0.016320838183036854,0.17072505150143957,0.019991670137442734,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
282,0.5,4,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
","Can glomerular hyperfiltration during pregnancy damage the kidneys of women with many parities? According to our study, glomerular hyperfiltration in pregnancy might not be connected to chronic kidney damage in women with multiple pregnancies, supporting the concept that these physiological changes are mostly reversible.",1.8948778188548325e-07,0.12637535502511144,0.031462334740606085,0.014507411718254981,0.14662749992237956,0.019991670137442734,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
282,0.5,5,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
","Does pregnancy-induced glomerular hyperfiltration damage kidneys in women with higher parity? Our research suggests that this hyperfiltration does not correlate with long-term kidney damage, even in women who have had several pregnancies, implying that pregnancy adaptations are reversible.",3.3160361829959537e-07,0.24964616574590215,0.050857113715496116,0.025387970506946217,0.30077817974963716,0.019991670137442734,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
282,0.5,6,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
","Is there kidney damage from glomerular hyperfiltration in women with multiple pregnancies? The study indicates that glomerular hyperfiltration during pregnancy may not lead to permanent kidney harm, even in women with many pregnancies, supporting the idea that physiological changes in pregnancy are reversible.",2.1317375462116866e-07,0.18444807073563618,0.0068573693952389825,0.016320838183036854,0.20453710908972944,0.004383329862557267,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
282,0.5,7,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
","Does glomerular hyperfiltration during pregnancy cause lasting kidney damage in women with multiple births? Our findings suggest that this condition may not be associated with chronic kidney damage, even in multiparous women, highlighting that pregnancy-related physiological adaptations tend to be reversible.",2.6054570009253947e-07,0.13421720911078916,0.07786328655500228,0.0199476911126006,0.220735472076103,0.019991670137442734,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
282,0.5,8,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
","Does the increase in glomerular filtration during pregnancy damage kidneys in women with multiple pregnancies? Our study suggests that such hyperfiltration is unlikely to cause long-term kidney damage, even in women with many pregnancies, supporting that physiological changes during pregnancy are reversible.",2.3685972735685406e-07,0.2109607692852875,0.005148605114559057,0.018134264647818726,0.23007502311980765,0.004991893307659187,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
282,0.5,9,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
","Is glomerular hyperfiltration in pregnancy harmful to kidneys of women with several pregnancies? Findings from our research indicate that it may not result in persistent kidney damage, even in women with multiple pregnancies, which supports the notion that pregnancy-related physiological adaptations are generally reversible.",1.8948778188548325e-07,0.09413595127813723,0.05462065616951476,0.014507411718254981,0.14662749992237956,0.019991670137442734,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
282,0.5,10,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
","Does glomerular hyperfiltration in pregnant women with multiple parities lead to kidney damage? Our study suggests that this hyperfiltration is not linked to long-lasting kidney damage, even in women with multiple pregnancies, reinforcing that the physiological changes during pregnancy are typically reversible.",2.3685972735685406e-07,0.1771487116969972,0.029211084056645943,0.018134264647818726,0.23007502311980765,0.004991893307659187,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
283,0.5,1,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? The current study indicates that septoplasty does not significantly impact the compensatory hypertrophy of the middle turbinate. The middle turbinate's dimensions stayed mostly the same following the surgery, suggesting that this hypertrophy is independent of septal deviation.",2.1317375462116866e-07,0.0013542555344376872,0.1884895125999697,0.016320838183036854,0.017328833480735994,0.14560000000000003,0.0162972138685758,0.10307573268229131,0.05436390532544381,2.1317375462116866e-07,0.15664943899543893,0.01851192595229618
283,0.5,2,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Is there a change in the dimensions of compensatory hypertrophy of the middle turbinate after septoplasty? Findings from this study show that septoplasty does not notably affect the compensatory hypertrophy of the middle turbinate. The size of the middle turbinate remained largely unchanged post-operation, implying that the hypertrophy occurs separately from the septal deviation.",9.474389094274162e-08,0.0048511358858363,0.07918264429499178,0.0072537058591274906,0.05959271563559643,0.007981167949298346,0.007243206163811466,0.08143822357176012,0.004229844674556192,9.474389094274162e-08,0.07901481056001103,0.0014797441851465525
283,0.5,3,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty affect the size of compensatory hypertrophy in the middle turbinate? The study results suggest no significant change in the compensatory hypertrophy of the middle turbinate due to septoplasty. The middle turbinate's dimensions were relatively stable after the procedure, indicating that the hypertrophy is distinct from the septal deviation.",1.8948778188548325e-07,0.00432747686598578,0.16972408050120422,0.014507411718254981,0.003724575717097167,0.14560000000000003,0.014486412327622933,0.08156952746132795,0.05436390532544381,1.8948778188548325e-07,0.13467053227666392,0.01851192595229618
283,0.5,4,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Can septoplasty modify the dimensions of compensatory hypertrophy in the middle turbinate? According to the study, septoplasty does not significantly alter the compensatory hypertrophy of the middle turbinate. The measurements of the middle turbinate remained mostly consistent following surgery, suggesting the hypertrophy is separate from septal deviation.",2.6054570009253947e-07,0.07558325371588204,0.16136933119407398,0.0199476911126006,0.09162048677869405,0.12338925619834715,0.019918816950481533,0.14752749525312403,0.05436390532544381,2.6054570009253947e-07,0.20211181307219617,0.01851192595229618
283,0.5,5,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty influence the size of compensatory hypertrophy in the middle turbinate? The present study suggests that septoplasty does not have a significant effect on compensatory hypertrophy of the middle turbinate. The dimensions of the middle turbinate stayed relatively stable post-surgery, indicating that the hypertrophy is likely independent of septal deviation.",1.6580180914979784e-07,0.018352138854897504,0.17228283333090855,0.012693985253473108,0.003947858735675158,0.12520069444444448,0.012675610786670066,0.06051611826349479,0.05436390532544381,1.6580180914979784e-07,0.11316432705570056,0.01851192595229618
283,0.5,6,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Is the compensatory hypertrophy of the middle turbinate affected by septoplasty? The study findings indicate that septoplasty does not significantly change the compensatory hypertrophy of the middle turbinate. The size of the middle turbinate remained fairly constant after the procedure, implying that the hypertrophy is a separate condition from septal deviation.",1.6580180914979784e-07,0.103016372909984,0.04572307269067258,0.012693985253473108,0.1560850005594303,0.02097652785289339,0.012675610786670066,0.17604064835681887,0.028280722773729748,1.6580180914979784e-07,0.17215557646505752,0.02395720985017295
283,0.5,7,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty impact the size of the compensatory hypertrophy in the middle turbinate? The current study shows that septoplasty does not significantly affect the compensatory hypertrophy of the middle turbinate. The middle turbinate's dimensions were relatively unchanged after surgery, suggesting the hypertrophy is independent of septal deviation.",2.6054570009253947e-07,0.10572008765327068,0.1392965718900748,0.0199476911126006,0.09162048677869405,0.12338925619834715,0.019918816950481533,0.14752749525312403,0.05436390532544381,2.6054570009253947e-07,0.20211181307219617,0.01851192595229618
283,0.5,8,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Will septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Study results suggest that septoplasty does not significantly alter the compensatory hypertrophy of the middle turbinate. The middle turbinate's size remained largely unchanged post-procedure, indicating the hypertrophy is likely a distinct condition from septal deviation.",2.6054570009253947e-07,0.10572008765327023,0.1392965718900748,0.0199476911126006,0.15323356949513345,0.07927346938775515,0.019918816950481533,0.21054087530402876,0.009012431402541314,2.6054570009253947e-07,0.23435121681917037,0.004730704433191343
283,0.5,9,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty cause changes in the size of compensatory hypertrophy of the middle turbinate? The findings of this study suggest that septoplasty does not significantly modify the compensatory hypertrophy of the middle turbinate. The dimensions of the middle turbinate stayed relatively constant after the surgery, indicating the hypertrophy is separate from septal deviation.",1.1842986367842703e-07,0.0011406065009458288,0.09477810743298803,0.009067132323909363,0.05463953949086342,0.02518352195563603,0.009054007704764333,0.07514589818803596,0.014433349769888242,1.1842986367842703e-07,0.09978335231063973,0.0018873796032593745
283,0.5,10,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Is compensatory hypertrophy of the middle turbinate altered by septoplasty? The study findings suggest that septoplasty does not significantly influence the compensatory hypertrophy of the middle turbinate. The size of the middle turbinate remained relatively stable following the procedure, indicating that this hypertrophy is likely independent of the septal deviation.",1.8948778188548325e-07,0.14578608514352576,0.05701514732467833,0.014507411718254981,0.15158208989465294,0.003669875608436929,0.014486412327622933,0.1700564015753634,0.009169152525795844,1.8948778188548325e-07,0.16480736621405256,0.0032164691094322163
284,0.5,1,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Does premature aging occur among Indigenous Australians? The notion that Indigenous Australians experience premature aging lacks strong evidence from this study, which examined specific conditions. Although some Indigenous communities show higher chronic disease rates, these are mainly attributed to social and environmental influences rather than accelerated aging. More research is necessary to clarify the intricate links between aging and health inequalities among Indigenous Australians.",1.4211583641411244e-07,0.13498112300318432,0.03171190540177372,0.010880558788691236,0.09237332013101707,0.0,0.0108648092457172,0.09381875521765437,0.0,1.4211583641411244e-07,0.09531017980432477,0.0
284,0.5,2,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
",Is premature aging a phenomenon in Indigenous Australians? This study of certain conditions does not strongly support the claim that Indigenous Australians age prematurely. Elevated chronic disease rates in some Indigenous populations are primarily caused by social and environmental factors instead of a quicker aging process. Additional studies are required to better understand the complex interactions between aging and health disparities in Indigenous Australians.,1.4211583641411244e-07,0.11297645060445483,0.01586888657648284,0.010880558788691236,0.09237332013101707,0.0,0.0108648092457172,0.09381875521765437,0.0,1.4211583641411244e-07,0.09531017980432477,0.0
284,0.5,3,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Do Indigenous Australians exhibit signs of premature aging? The hypothesis that Indigenous Australians age prematurely is not strongly backed by this research focusing on various conditions. While chronic diseases are more prevalent in some Indigenous groups, these are mostly due to social and environmental causes rather than an accelerated aging mechanism. Further investigation is essential to comprehend the complex relationship between aging and health differences in Indigenous Australians.",4.737194547137081e-08,0.05010484582002661,0.014921946740128552,0.0036268529295637453,0.02985296314968444,0.0,0.003621603081905733,0.030305349495328038,0.0,4.737194547137081e-08,0.0307716586667528,0.0
284,0.5,4,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Is there evidence of premature aging among Indigenous Australians? This study on distinct conditions does not provide substantial support for the idea that Indigenous Australians age prematurely. Higher rates of chronic illness in certain Indigenous communities are largely linked to social and environmental factors, not an expedited aging process. More research is needed to explore the complex association between aging and health disparities in Indigenous Australians.",9.474389094274162e-08,0.059719234701625545,0.0,0.0072537058591274906,0.06062462181643724,0.0,0.007243206163811466,0.0615578929994296,0.0,9.474389094274162e-08,0.06252035698133263,0.0
284,0.5,5,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Do Indigenous Australians age faster than others? The concept of premature aging in Indigenous Australians is not well substantiated by this study of specific health conditions. Although chronic diseases are more common in some Indigenous populations, these are mainly influenced by social and environmental factors rather than accelerated aging. Further research is required to understand the complex connection between aging and health disparities in Indigenous Australians.",9.474389094274162e-08,0.10237444581300625,0.030738221214411676,0.0072537058591274906,0.06062462181643724,0.0,0.007243206163811466,0.0615578929994296,0.0,9.474389094274162e-08,0.06252035698133263,0.0
284,0.5,6,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Is premature aging a characteristic of Indigenous Australians? This investigation into various conditions does not strongly confirm that Indigenous Australians experience premature aging. Increased chronic disease rates in some Indigenous communities stem largely from social and environmental factors, not from a faster aging process. Additional research is necessary to unravel the complex interplay between aging and health disparities in Indigenous Australians.",2.1317375462116866e-07,0.13976194237516282,0.0,0.016320838183036854,0.14197026127038992,0.0,0.0162972138685758,0.14424960884454574,0.0,2.1317375462116866e-07,0.14660347419187403,0.0
284,0.5,7,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Are Indigenous Australians prone to premature aging? The evidence from this study of discrete conditions does not strongly support the belief that Indigenous Australians age prematurely. While some Indigenous groups have higher chronic disease rates, these are mostly due to social and environmental causes rather than accelerated aging. More research is needed to better understand the complex relationship between aging and health disparities in Indigenous Australians.",9.474389094274162e-08,0.08104684025731679,0.015380859375,0.0072537058591274906,0.06062462181643724,0.0,0.007243206163811466,0.0615578929994296,0.0,9.474389094274162e-08,0.06252035698133263,0.0
284,0.5,8,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Does premature aging affect Indigenous Australians? This study focusing on specific conditions does not provide strong support for the idea that Indigenous Australians age prematurely. Although chronic diseases are more prevalent in some Indigenous communities, these are mainly caused by social and environmental factors, not by a faster aging process. Further research is essential to clarify the complex connections between aging and health disparities in Indigenous Australians.",7.105791820705622e-08,0.04445176257083805,0.0,0.005440279394345618,0.04512043528047194,0.0,0.0054324046228586,0.04580953603129334,0.0,7.105791820705622e-08,0.046520015634889056,0.0
284,0.5,9,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
",Is there premature aging in Indigenous Australian populations? The study of certain conditions does not strongly back the notion that Indigenous Australians age prematurely. Higher chronic disease rates in some Indigenous groups are largely due to social and environmental influences rather than accelerated aging. More research is necessary to understand the complex relationship between aging and health disparities in Indigenous Australians.,2.1317375462116866e-07,0.16286684839382737,0.016661878770468257,0.016320838183036854,0.14197026127038992,0.0,0.0162972138685758,0.14424960884454574,0.0,2.1317375462116866e-07,0.14660347419187403,0.0
284,0.5,10,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Do Indigenous Australians experience premature aging? This research on a series of distinct conditions does not strongly support the idea that Indigenous Australians age prematurely. Elevated chronic disease rates in some Indigenous populations are chiefly linked to social and environmental factors, not a faster aging process. Additional studies are needed to explore the complex relationship between aging and health disparities in Indigenous Australians.",1.6580180914979784e-07,0.12933170602184685,0.016124697661918846,0.012693985253473108,0.10863384100279827,0.0,0.012675610786670066,0.11034805716886531,0.0,1.6580180914979784e-07,0.11211729812070548,0.0
285,0.5,1,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Are there discrepancies between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences in understanding the clinical importance of red blood cell morphology exist between clinical pathologists and clinicians, potentially causing misinterpretations and improper patient care.",4.737194547137081e-08,0.0570419163189535,0.005575349204692867,0.0036268529295637453,0.055212275588245596,0.0036742074484456544,0.003621603081905733,0.053117365915339665,0.0013130033920054525,4.737194547137081e-08,0.05264373348541884,0.0
285,0.5,2,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Is there a mismatch between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology? Clinical pathologists and clinicians hold differing views on the clinical significance of red blood cell morphology, which may result in misunderstandings and incorrect patient management.",4.737194547137081e-08,0.05402160849809823,0.005105057080109013,0.0036268529295637453,0.052346010513201424,0.0033396814404432484,0.003621603081905733,0.05044051459933652,0.0011882035402833654,4.737194547137081e-08,0.05001042057466343,0.0
285,0.5,3,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Do clinical pathologists and clinicians differ in their reporting and interpretation of red blood cell morphology? There are notable differences regarding the clinical relevance of red blood cell morphology between clinical pathologists and clinicians, leading to possible misinterpretations and flawed patient treatment.",2.3685972735685406e-08,0.02812279653004568,0.002725135044954946,0.0018134264647818726,0.027228516909492573,0.0017922579313609938,0.0018108015409528666,0.02620645821577927,0.000639705252959033,2.3685972735685406e-08,0.025975486403257975,0.0
285,0.5,4,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
",Is there a discordance between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Differences in opinions about the clinical importance of red blood cell morphology between clinical pathologists and clinicians can cause misinterpretations and inappropriate management of patients.,2.3685972735685406e-08,0.037110285828160894,0.03976217208199191,0.0018134264647818726,0.03950131864653361,0.044158948946700624,0.0018108015409528666,0.04208620114650152,0.047731117995341306,2.3685972735685406e-08,0.009339551043704652,0.02498356344510192
285,0.5,5,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? Important differences exist between clinical pathologists and clinicians concerning the clinical relevance of red blood cell morphology, which may lead to misinterpretations and unsuitable patient care.",2.3685972735685406e-08,0.06193485411833599,0.025167185939386785,0.0018134264647818726,0.06188587593748984,0.026050750658322228,0.0018108015409528666,0.06175246747526364,0.02614864984927353,2.3685972735685406e-08,0.025975486403257975,0.0
285,0.5,6,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Is there a difference between clinical pathologists and clinicians regarding the reporting and interpretation of red blood cell morphology? Clinical pathologists and clinicians differ significantly on the clinical significance of red blood cell morphology, potentially resulting in misinterpretations and improper patient management.",2.3685972735685406e-08,0.061934854118336435,0.025167185939386785,0.0018134264647818726,0.06188587593748984,0.026050750658322214,0.0018108015409528666,0.06175246747526364,0.02614864984927353,2.3685972735685406e-08,0.025975486403257975,0.0
285,0.5,7,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Do clinical pathologists and clinicians have conflicting views on reporting and interpreting red blood cell morphology? There are critical differences in how clinical pathologists and clinicians perceive the clinical relevance of red blood cell morphology, which can lead to misinterpretations and inappropriate patient care.",2.3685972735685406e-08,0.027368521665787515,0.0026077024093046075,0.0018134264647818726,0.026512698549651326,0.0017087642806799391,0.0018108015409528666,0.025537914030078213,0.0006085634451019201,2.3685972735685406e-08,0.02531780798429173,0.0
285,0.5,8,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
",Is there disagreement between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Differences in understanding the clinical importance of red blood cell morphology between clinical pathologists and clinicians may cause misinterpretations and incorrect patient management.,4.737194547137081e-08,0.12635663437494893,0.050252173102296,0.0036268529295637453,0.1263042941072139,0.05271784451111383,0.003621603081905733,0.12608022702691368,0.053383783493673585,4.737194547137081e-08,0.09011114865082126,0.027006172839506164
285,0.5,9,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Are clinical pathologists and clinicians in disagreement about the reporting and interpretation of red blood cell morphology? Significant differences exist between clinical pathologists and clinicians regarding the clinical relevance of red blood cell morphology, potentially leading to misinterpretations and unsuitable patient treatment.",2.3685972735685406e-08,0.06193485411833599,0.025167185939386785,0.0018134264647818726,0.06188587593748984,0.026050750658322214,0.0018108015409528666,0.06175246747526364,0.02614864984927353,2.3685972735685406e-08,0.025975486403257975,0.0
285,0.5,10,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
",Is there a lack of concordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Important differences about the clinical relevance of red blood cell morphology between clinical pathologists and clinicians can result in misinterpretations and inappropriate management of patients.,2.3685972735685406e-08,0.004870882081187133,0.01899196493791093,0.0018134264647818726,0.006494310048441143,0.02146814404432129,0.0018108015409528666,0.008274143558211655,0.02366863905325442,2.3685972735685406e-08,0.009339551043704652,0.02498356344510192
286,0.5,1,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better health outcomes? Individuals diagnosed with type 2 diabetes who have lower initial blood sugar levels, indicating an earlier stage of the disease, tend to experience fewer negative clinical events despite similar progression of blood sugar levels. Because most of these individuals show no symptoms at diagnosis, proactive screening programs are necessary to detect them.",1.4211583641411244e-07,0.07352124199811438,0.011553736744392407,0.01088055878869125,0.09288522797952403,0.001379267199320201,0.0108648092457172,0.09237332013101707,0.0,1.4211583641411244e-07,0.09381875521765437,0.0
286,0.5,2,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there an association between lower fasting plasma glucose levels at type 2 diabetes diagnosis and improved clinical outcomes? Patients with type 2 diabetes presenting with lower initial glycemia, possibly indicating earlier disease stages, exhibit fewer adverse outcomes even though their glycemic progression is comparable. Since many of these patients are asymptomatic when diagnosed, active case-finding initiatives are needed to identify them.",7.105791820705622e-08,0.05013979453644435,0.0015317282073249762,0.005440279394345618,0.04989039778937254,0.0007929921939854173,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
286,0.5,3,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Do lower fasting plasma glucose levels at the diagnosis of type 2 diabetes correlate with better outcomes? People diagnosed with type 2 diabetes who have lower initial blood glucose, suggesting an earlier phase of the disease, experience fewer harmful clinical outcomes despite similar glycemic progression. Because most are asymptomatic at diagnosis, active detection programs are essential to find these individuals.",1.1842986367842703e-07,0.0850169698594625,0.0026390894628908305,0.009067132323909363,0.08458867036224849,0.0013671860612518467,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
286,0.5,4,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are improved outcomes associated with lower fasting plasma glucose levels at the onset of type 2 diabetes? Individuals with type 2 diabetes who present with lower initial glycemia, likely earlier in their disease course, have fewer adverse clinical outcomes despite similar progression in glycemic levels. Since these patients are often asymptomatic at diagnosis, active screening programs are required to identify them.",9.474389094274162e-08,0.06742663438990615,0.002076216188794621,0.0072537058591274906,0.0435926100870887,0.01586888657648284,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
286,0.5,5,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Does having lower fasting plasma glucose levels at type 2 diabetes diagnosis relate to better health outcomes? Those presenting with type 2 diabetes with lower initial blood sugar levels, potentially earlier in the disease progression, show fewer negative clinical outcomes despite similar glycemic trends. Because most are asymptomatic at diagnosis, active case detection efforts are necessary to find them.",1.4211583641411244e-07,0.1029216278599776,0.0032212937204017973,0.010880558788691236,0.10239973986211481,0.0016693787296396152,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
286,0.5,6,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is a lower fasting plasma glucose level at the time of type 2 diabetes diagnosis linked to improved clinical outcomes? Patients with type 2 diabetes who have lower initial glycemia, indicating an earlier disease stage, tend to have fewer adverse outcomes despite similar glycemic progression. Due to the asymptomatic nature at diagnosis, active screening programs are needed to identify these individuals.",9.474389094274162e-08,0.06742663438990615,0.002076216188794621,0.0072537058591274906,0.06708912468234107,0.0010752275733388016,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
286,0.5,7,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are better outcomes observed in type 2 diabetes patients with lower fasting plasma glucose levels at diagnosis? People diagnosed with type 2 diabetes at lower initial glycemia, possibly earlier in their disease, experience fewer adverse clinical outcomes despite comparable glycemic progression. Since most are asymptomatic at diagnosis, active case detection programs are essential to identify them.",2.1317375462116866e-07,0.15863890338292874,0.005094372962778693,0.016320838183036854,0.15781812522704897,0.002643039375813342,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
286,0.5,8,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there a connection between lower fasting plasma glucose levels at diagnosis and improved outcomes in type 2 diabetes? Individuals with type 2 diabetes presenting with lower initial blood glucose, which may indicate earlier disease stages, have fewer adverse clinical outcomes despite similar glycemic progression. As most are asymptomatic at diagnosis, active detection programs are required to find them.",1.4211583641411244e-07,0.07902000094411754,0.013981409152067609,0.010880558788691236,0.07807878615825725,0.01586888657648284,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
286,0.5,9,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Do patients with lower fasting plasma glucose levels at type 2 diabetes diagnosis have improved outcomes? Those presenting with lower initial glycemia, suggesting an earlier phase of type 2 diabetes, show fewer adverse clinical outcomes despite similar progression of blood sugar. Because most are asymptomatic at diagnosis, active screening efforts are necessary to identify these patients.",2.1317375462116866e-07,0.15863890338292874,0.005094372962778693,0.016320838183036854,0.1321460074285321,0.01586888657648284,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
286,0.5,10,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis associated with better clinical outcomes? People with type 2 diabetes who have lower initial glycemia, likely earlier in their disease course, experience fewer adverse clinical events despite similar glycemic progression. Since most are asymptomatic at diagnosis, active case detection programs are essential for identification.",1.6580180914979784e-07,0.12115202414784232,0.0038238405242473107,0.012693985253473108,0.12053361970622767,0.0019823530929386525,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
287,0.5,1,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.5,2,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A large number of children did not accurately assess how overweight they were. This misunderstanding was also present among their parents and the doctors who treated them. The findings highlight the importance of improving physician education on identifying obesity and overweight to better support children and their families.",1.8948778188548325e-07,0.13900222078069824,0.0023066964139149618,0.014507411718254981,0.13815033848081626,0.0,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
287,0.5,3,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many kids underestimated their own overweight status, a misjudgment shared by their parents and even their doctors. This research underscores the necessity for enhanced physician training to identify obesity and overweight conditions to provide appropriate guidance to children and their families.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
287,0.5,4,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Numerous children failed to recognize the extent of their overweight condition, a misconception also held by their parents and attending physicians. The study indicates a pressing need to educate physicians more thoroughly on obesity recognition to aid in counseling affected children and families.",7.105791820705622e-08,0.07831517733430982,0.0181755829903978,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
287,0.5,5,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children did not accurately perceive their overweight status, and this misperception was common among their parents and doctors as well. The research points to the critical need for better physician education on obesity to effectively counsel children and their families.",2.3685972735685406e-08,0.01846860107447057,0.0003243433209763093,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
287,0.5,6,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Children often underestimated how overweight they were, and this inaccurate perception was shared by their parents and their physicians. The study emphasizes the importance of educating doctors to identify overweight and obesity to support families and children effectively.",4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
287,0.5,7,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children did not fully recognize their overweight status, a misunderstanding mirrored by their parents and doctors. This research highlights the necessity for enhanced physician training in obesity identification to better counsel children and their families.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021913,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
287,0.5,8,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A significant number of children underestimated their overweight condition, a misperception also common among parents and physicians. The study reveals the need for improved education for physicians to recognize obesity and provide better counseling to children and their families.",2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
287,0.5,9,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their overweight degree, with parents and physicians sharing this misperception. The study shows the importance of educating physicians to identify obesity and overweight to counsel children and their families effectively.",1.6580180914979784e-07,0.13980795482754882,0.002648319227800483,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
287,0.5,10,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Children frequently underestimated their overweight status, a misconception also shared by their parents and doctors. This study highlights the need to better educate physicians in recognizing obesity and overweight to provide proper counseling for children and their families.",4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
288,0.5,1,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is screening for coeliac disease in high-risk groups warranted? Long-term adherence to diet among patients identified through screening was strong. Those diagnosed via screening showed notable improvements in quality of life and health outcomes compared to undiagnosed individuals. These results indicate that screening at-risk populations for coeliac disease is advantageous.,0.0,0.02829172165550764,0.02034311182787588,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0
288,0.5,2,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Does screening for coeliac disease in risk groups make sense? Patients detected by screening maintained good long-term dietary compliance. Their quality of life and health-related outcomes improved significantly when compared to those who were not diagnosed. This evidence supports the benefit of screening for coeliac disease in at-risk groups.,2.3685972735685406e-08,0.10785209564055176,0.062245322543618004,0.0018134264647818726,0.1095402833118686,0.06353305785123965,0.0018108015409528666,0.08177987309574108,0.043388429752066124,2.3685972735685406e-08,0.0527854480769947,0.02221074380165289
288,0.5,3,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is it justified to screen at-risk groups for coeliac disease? Screen-detected patients adhered well to dietary recommendations over the long term. They experienced significant improvements in quality of life and health outcomes compared to undiagnosed patients. These findings imply that screening for coeliac disease in risk populations is beneficial.,2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
288,0.5,4,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Should coeliac disease screening be conducted in risk groups? Patients identified through screening showed good long-term compliance with diet. Their quality of life and health outcomes improved markedly compared to those who remained undiagnosed. This suggests that screening for coeliac disease among at-risk individuals is justified.,9.474389094274162e-08,0.0876726280430189,0.0018114382460973355,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
288,0.5,5,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is coeliac disease screening warranted in high-risk populations? Individuals diagnosed by screening maintained strong long-term dietary compliance. They had significantly better quality of life and health-related outcomes than those undiagnosed. These findings support the benefit of screening at-risk groups for coeliac disease.,1.8948778188548325e-07,0.14995650975081087,0.020399305555555556,0.014507411718254981,0.1823215567939549,0.0,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
288,0.5,6,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is screening for coeliac disease in risk groups justified? Long-term dietary adherence was good among patients detected by screening. These patients showed significant improvements in quality of life and health outcomes compared to undiagnosed individuals. The results suggest screening at-risk individuals for coeliac disease is beneficial.,9.474389094274162e-08,0.1184791694012386,0.023948990820864127,0.0072537058591274906,0.11851806701508183,0.02271498107084911,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
288,0.5,7,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Does screening for coeliac disease in risk populations have justification? Patients found through screening demonstrated good long-term diet compliance. Their health-related outcomes and quality of life improved significantly versus those undiagnosed. This evidence suggests screening at-risk groups for coeliac disease is advantageous.,1.8948778188548325e-07,0.2175806249273906,0.028252896942800785,0.014507411718254981,0.21697891582195128,0.02498356344510192,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
288,0.5,8,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is it beneficial to screen at-risk groups for coeliac disease? Screen-detected patients adhered well to diet over time and experienced significant improvements in quality of life and health outcomes compared to undiagnosed patients. These results indicate the value of screening for coeliac disease in risk populations.,9.474389094274162e-08,0.0876726280430189,0.0018114382460973355,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
288,0.5,9,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is coeliac disease screening in risk groups appropriate? Patients diagnosed through screening showed good long-term dietary compliance and significantly better quality of life and health outcomes than those undiagnosed. These findings suggest that screening at-risk individuals for coeliac disease is beneficial.,2.1317375462116866e-07,0.20930648136917895,0.004584257889546365,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
288,0.5,10,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is screening for coeliac disease justified in risk groups? Screen-detected patients maintained good long-term adherence to diet and experienced significant improvements in quality of life and health outcomes compared to those undiagnosed. This supports the benefit of screening at-risk populations for coeliac disease.,1.6580180914979784e-07,0.15886596676984244,0.0033960543492629995,0.012693985253473108,0.1576289442035832,0.0,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
289,0.5,1,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching locations mirror community practice? The residency training sites at Northeastern Ohio Universities College of Medicine offer patient care experiences akin to those reported in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.5,2,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites representative of community practice? The residency training locations at Northeastern Ohio Universities College of Medicine provide patient care opportunities comparable to those identified in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.5,3,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,"Do residency teaching sites for family practice reflect the nature of community practice? At Northeastern Ohio Universities College of Medicine, residency training sites offer patient care experiences similar to those found in a national survey of family and general practitioners.",2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.5,4,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice during residency at teaching sites resemble community practice? The residency training sites affiliated with Northeastern Ohio Universities College of Medicine deliver patient care opportunities like those documented in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.5,5,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is the family practice at residency teaching sites consistent with community practice? The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care experiences that align with findings from a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.5,6,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do residency teaching sites for family practice reflect community practice patterns? The residency training locations at Northeastern Ohio Universities College of Medicine present patient care opportunities comparable to those in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.5,7,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites correspond to community practice? The residency training sites at Northeastern Ohio Universities College of Medicine provide patient care experiences similar to those reported in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.5,8,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites aligned with community practice? The residency training sites of Northeastern Ohio Universities College of Medicine offer patient care opportunities that match those found in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.5,9,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do residency teaching sites for family practice offer patient care reflective of community practice? The residency training sites at Northeastern Ohio Universities College of Medicine provide care opportunities similar to those in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.5,10,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites parallel community practice? The residency training sites affiliated with Northeastern Ohio Universities College of Medicine provide patient care opportunities comparable to those identified in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
290,0.5,1,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. Monitoring end-tidal CO2 is useful for tracking trends.,4.737194547137081e-08,0.011965540180375545,0.036458333333333315,0.0036268529295637453,0.01282309223879885,0.019599999999999996,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
290,0.5,2,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is there a correlation between end-tidal and arterial carbon dioxide levels in extremely low birth weight infants in their first week? End-tidal CO2 and arterial CO2 show good correlation and agreement in ELBW infants when EtCO2 is between 30-50 mmHg. End-tidal CO2 monitoring helps in observing trends.,1.4211583641411244e-07,0.07623796218865753,0.03300045913682276,0.010880558788691236,0.09798090057910613,0.019599999999999996,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
290,0.5,3,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does measuring end-tidal carbon dioxide correspond with arterial carbon dioxide in extremely low birth weight infants in the initial week? A strong correlation and agreement exist between end-tidal CO2 and arterial CO2 in ELBW infants with EtCO2 values from 30 to 50 mmHg. End-tidal CO2 monitoring aids in trend analysis.,7.105791820705622e-08,0.009368836003363246,0.035646471505457446,0.005440279394345618,0.03344237944153461,0.019599999999999996,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
290,0.5,4,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is there a relationship between end-tidal and arterial CO2 in extremely low birth weight infants during the first week of life? End-tidal CO2 correlates well and agrees with arterial CO2 in ELBW infants within the EtCO2 range of 30 to 50 mmHg. Monitoring end-tidal CO2 can be beneficial for trend monitoring.,4.737194547137081e-08,0.015760347042022005,0.016633343393189448,0.0036268529295637453,0.041114813894306934,0.00079930555555556,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
290,0.5,5,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Do end-tidal carbon dioxide measurements align with arterial carbon dioxide levels in extremely low birth weight infants in their first week? There is good correlation and agreement between end-tidal and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. End-tidal CO2 monitoring is helpful for tracking.,7.105791820705622e-08,0.018922885652144394,0.05598958333333333,0.005440279394345618,0.03344237944153461,0.019599999999999996,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
290,0.5,6,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is end-tidal CO2 measurement consistent with arterial CO2 in extremely low birth weight infants during their first week? End-tidal CO2 shows strong correlation and agreement with arterial CO2 in ELBW infants at EtCO2 levels between 30 and 50 mmHg. Monitoring EtCO2 can assist in trend assessment.,1.6580180914979784e-07,0.1611693664655336,0.011653942758939773,0.012693985253473108,0.18346713648206858,0.025751473922902498,0.012675610786670066,0.18306229348155734,0.023242630385487524,1.6580180914979784e-07,0.15415067982725894,0.0
290,0.5,7,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal carbon dioxide monitoring correlate with arterial carbon dioxide in extremely low birth weight infants in the first week? There is a good correlation and agreement between end-tidal and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring helps in observing trends.,9.474389094274162e-08,0.0022858124184139683,0.0555649866706906,0.0072537058591274906,0.05449578863936777,0.019599999999999996,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
290,0.5,8,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is there good agreement between end-tidal and arterial CO2 measurements in extremely low birth weight infants during the first week? End-tidal CO2 correlates well with arterial CO2 in ELBW infants at EtCO2 levels of 30-50 mmHg. Monitoring end-tidal CO2 can be useful for trend tracking.,1.8948778188548325e-07,0.12342943693561725,0.031037414965986387,0.014507411718254981,0.14344327465586337,0.019599999999999996,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
290,0.5,9,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Do end-tidal CO2 readings correspond with arterial CO2 in extremely low birth weight infants in their first week? There is strong correlation and agreement between end-tidal and arterial CO2 in ELBW infants when EtCO2 is between 30 and 50 mmHg. End-tidal CO2 monitoring is beneficial for trend observation.,1.1842986367842703e-07,0.08294496320695188,0.012855831037649229,0.009067132323909363,0.10613882779771977,0.002128395061728402,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
290,0.5,10,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is there a correlation between end-tidal and arterial carbon dioxide in extremely low birth weight infants within the first week of life? End-tidal CO2 shows good correlation and agreement with arterial CO2 in ELBW infants at EtCO2 levels from 30 to 50 mmHg. Monitoring end-tidal CO2 can aid in tracking trends.,4.737194547137081e-08,0.039691427402773094,0.05639721875144615,0.0036268529295637453,0.01282309223879885,0.019599999999999996,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
291,0.5,1,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH? Answer: IVF success depends on multiple factors. Although age and FSH are common predictors, antral follicle count (AFC) has gained attention as a reliable indicator. AFC measures ovarian reserve and correlates strongly with IVF results, possibly outperforming age and FSH in forecasting success.",2.8423167282822487e-07,0.18618425960983087,0.0038489947321855705,0.021761117577382486,0.19528496784163885,0.003048645928959816,0.0217296184914344,0.1941560144409591,0.0,2.8423167282822487e-07,0.19735943415849366,0.0
291,0.5,2,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Can antral follicle count better predict IVF results than age and FSH? Answer: Success in IVF is affected by several factors. While age and FSH are traditional predictors, AFC has emerged as a valuable marker. Since AFC reflects ovarian reserve, it shows a strong association with IVF outcomes and may be a better predictor than age and FSH.",2.8423167282822487e-07,0.1622826326939708,0.013841263631473477,0.021761117577382486,0.19528496784163885,0.0030486459289598197,0.0217296184914344,0.1941560144409591,0.0,2.8423167282822487e-07,0.19735943415849366,0.0
291,0.5,3,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Does antral follicle count provide a better prediction of IVF success than age and FSH levels? Answer: IVF outcomes are influenced by many variables. Age and FSH are commonly used, but AFC, which indicates ovarian reserve, has shown a strong link to IVF success, potentially making it a superior predictor.",4.737194547137081e-07,0.28542801178938015,0.061844592373438534,0.03626852929563747,0.3504867055172127,0.005909686178392921,0.03621603081905733,0.3483066942682176,0.0,4.737194547137081e-07,0.35454501768090685,0.0
291,0.5,4,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Is AFC a more effective predictor of IVF success than age and FSH? Answer: IVF success rates hinge on various factors. Although age and FSH are standard predictors, AFC, representing ovarian reserve, has demonstrated strong predictive value and might outperform the other two.",6.39521263863506e-07,0.44527793457311615,0.055374196114597894,0.048962514549110575,0.4763456636889636,0.014489619377162635,0.0488916416057274,0.5059356384718008,0.0,6.39521263863506e-07,0.5158131652770286,0.0
291,0.5,5,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: How does antral follicle assessment compare to age and FSH in predicting IVF outcomes? Answer: Multiple factors influence IVF success. Age and FSH are widely used, but AFC, which reflects ovarian reserve, has been identified as a strong predictor, possibly exceeding the predictive power of age and FSH.",5.210914001850789e-07,0.3683426324299268,0.004891518737672518,0.03989538222520121,0.39336330496695204,0.006776921265559467,0.039837633900963065,0.3908663086870141,0.0,5.210914001850789e-07,0.3980301296206452,0.0
291,0.5,6,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Is antral follicle count a better indicator of IVF success than age and FSH? Answer: IVF success is determined by several factors. Age and FSH are traditional markers, but AFC, reflecting ovarian reserve, has shown a strong correlation with outcomes and may be a better predictor.",5.684633456564497e-07,0.4037683480958023,0.03687520201228235,0.04352223515476496,0.4073527922020119,0.014489619377162635,0.0434592369828688,0.43531807125784683,0.0,5.684633456564497e-07,0.44349250369740245,0.0
291,0.5,7,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Does assessing antral follicles offer superior IVF outcome prediction compared to age and FSH? Answer: IVF success is affected by various factors. While age and FSH are commonly used predictors, AFC, which measures ovarian reserve, has demonstrated a strong relationship with IVF success and might be more accurate.",5.210914001850789e-07,0.3285604969115008,0.06018724622767084,0.03989538222520121,0.36386768026227356,0.014489619377162635,0.039837633900963065,0.3908663086870141,0.0,5.210914001850789e-07,0.3980301296206452,0.0
291,0.5,8,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Can AFC outperform age and FSH in forecasting IVF success? Answer: IVF outcomes depend on multiple factors. Though age and FSH levels are standard predictors, AFC, indicating ovarian reserve, has shown a strong correlation with success and may serve as a better predictor.",6.39521263863506e-07,0.44527793457311615,0.055374196114597894,0.048962514549110575,0.5093526722870552,0.00930574052765592,0.0488916416057274,0.5059356384718008,0.0,6.39521263863506e-07,0.5158131652770286,0.0
291,0.5,9,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Is antral follicle count a more reliable predictor of IVF outcomes than age and FSH? Answer: Several factors influence IVF success. Age and FSH are widely used, but AFC, which reflects ovarian reserve, has emerged as a strong and possibly superior predictor.",6.632072365991914e-07,0.43733663308745374,0.07797978802417554,0.05077594101389245,0.5004432152680236,0.014489619377162635,0.050702443146680265,0.5306282510621725,0.0,6.632072365991914e-07,0.5411309732613203,0.0
291,0.5,10,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: How effective is antral follicle assessment compared to age and FSH in predicting IVF success? Answer: IVF success is influenced by many factors. While age and FSH are common predictors, AFC, representing ovarian reserve, has shown a strong association with success and may be a better predictor.",5.447773729207643e-07,0.3508428904720291,0.05930601212652497,0.041708808689983085,0.41551071942062556,0.007238775684565763,0.04164843544191593,0.4128452154057891,0.0,5.447773729207643e-07,0.42050298547270293,0.0
292,0.5,1,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a viable alternative to thrombolysis? Reorganizing services to provide primary angioplasty was well accepted by patients and their caregivers. Satisfaction remained high regardless of treatment type, except in areas of discharge and aftercare.",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
292,0.5,2,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty be considered an acceptable substitute for thrombolysis? Patients and carers accepted the reorganization of care to offer primary angioplasty. Overall satisfaction was high, irrespective of the care method, except for discharge and aftercare.",1.8948778188548272e-07,0.14137324671020046,0.046400951814396206,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
292,0.5,3,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an appropriate alternative to thrombolysis? The restructuring of care to include primary angioplasty was well received by patients and their carers. Satisfaction levels were generally high regardless of treatment type, except concerning discharge and aftercare.",1.4211583641411212e-07,0.12327081072079071,0.01939477897489004,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
292,0.5,4,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Does primary angioplasty serve as an acceptable alternative to thrombolysis? Patients and carers accepted care reorganization to provide primary angioplasty services. Satisfaction was high across all care types, with the exception of discharge and aftercare.",2.1317375462116802e-07,0.2111341471458017,0.01701619515691227,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,0.5,5,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable option instead of thrombolysis? Care reorganization to offer primary angioplasty was accepted by patients and carers. Satisfaction levels were high regardless of the care received, except for discharge and aftercare.",2.1317375462116802e-07,0.2111341471458017,0.01701619515691227,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,0.5,6,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty replace thrombolysis acceptably? Patients and their carers accepted the reorganization of care to provide primary angioplasty. Satisfaction remained high across all types of care, except in discharge and aftercare.",2.842316728282239e-07,0.26273410371446726,0.046400951814396206,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
292,0.5,7,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a suitable alternative to thrombolysis? Offering primary angioplasty through care reorganization was acceptable to patients and carers. Satisfaction was high no matter the care type, except for discharge and aftercare.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.5,8,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty considered an acceptable alternative to thrombolysis? Patients and carers accepted the reorganization of services to provide primary angioplasty. Satisfaction levels were consistently high regardless of care type, except for discharge and aftercare.",2.1317375462116802e-07,0.17036078358345197,0.046400951814396206,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,0.5,9,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a feasible alternative to thrombolysis? The reorganization of care to deliver primary angioplasty was accepted by patients and carers. Satisfaction was high irrespective of the care received, except for discharge and aftercare.",2.1317375462116802e-07,0.2111341471458017,0.01701619515691227,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,0.5,10,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable substitute for thrombolysis? Patients and carers found the reorganization of care to provide primary angioplasty acceptable. Satisfaction levels were high regardless of care type, with discharge and aftercare being the only exceptions.",1.6580180914979742e-07,0.1902187231390533,0.008962369984911768,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
293,0.5,1,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better health outcomes?,8.526950184846725e-07,0.8578734480413774,0.2044444444444444,0.06528335273214754,0.9801395852181809,0.11136260751471248,0.06518885547430332,1.0720169685631933,0.07638888888888888,8.526950184846743e-07,1.1422287044974158,0.05859375
293,0.5,2,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Does having lower fasting plasma glucose when diagnosed with type 2 diabetes correlate with improved patient outcomes?,9.000669639560431e-07,0.9756564836977613,0.2044444444444444,0.06891020566171129,1.1053027281721866,0.11136260751471248,0.06881045855620907,1.205548361187716,0.07638888888888888,9.00066963956045e-07,1.285329548138089,0.05859375
293,0.5,3,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Is there an association between lower fasting plasma glucose levels at type 2 diabetes diagnosis and enhanced clinical outcomes?,8.526950184846725e-07,0.8578734480413774,0.2044444444444444,0.06528335273214754,0.9801395852181809,0.11136260751471248,0.06518885547430332,1.0720169685631933,0.07638888888888888,8.526950184846743e-07,1.1422287044974158,0.05859375
293,0.5,4,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Do individuals diagnosed with type 2 diabetes with lower fasting plasma glucose levels tend to have better health outcomes?,8.526950184846725e-07,0.8578734480413774,0.2044444444444444,0.06528335273214754,0.9801395852181809,0.11136260751471248,0.06518885547430332,1.0720169685631933,0.07638888888888888,8.526950184846743e-07,1.1422287044974158,0.05859375
293,0.5,5,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Are improved outcomes observed in type 2 diabetes patients who have lower fasting plasma glucose levels at diagnosis?,8.763809912203578e-07,0.9150318618813262,0.2044444444444444,0.06709677919692941,1.040764207034616,0.11136260751471248,0.0669996570152562,1.136555489700764,0.07638888888888888,8.763809912203596e-07,1.2112215759843679,0.05859375
293,0.5,6,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Is a lower fasting plasma glucose level at the point of type 2 diabetes diagnosis connected to a decrease in complications and better prognosis?,7.342651548062458e-07,0.6127509900083927,0.2044444444444444,0.05621622040823814,0.7223104759160814,0.11136260751471248,0.05613484776953896,0.8000832530795527,0.07638888888888888,7.342651548062476e-07,0.8545466320456359,0.05859375
293,0.5,7,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Can lower fasting plasma glucose levels at diagnosis of type 2 diabetes predict more favorable outcomes?,9.237529366917285e-07,1.040195004835332,0.2044444444444444,0.07072363212649316,1.1742955996591387,0.11136260751471248,0.07062126009716195,1.2796563333414372,0.07638888888888888,9.237529366917304e-07,1.3653722558116255,0.05859375
293,0.5,8,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Are patients with type 2 diabetes who present with lower fasting plasma glucose levels at diagnosis more likely to experience improved health outcomes?,7.579511275419311e-07,0.6572027525792268,0.2044444444444444,0.05802964687302002,0.7688304915509754,0.11136260751471248,0.057945649310491835,0.848873417248984,0.07638888888888888,7.579511275419329e-07,0.905839926433186,0.05859375
293,0.5,9,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Is there evidence that lower fasting plasma glucose at diagnosis of type 2 diabetes is associated with reduced complications and better outcomes?,7.816371002776164e-07,0.7037227682141207,0.2044444444444444,0.0598430733378019,0.8176206557204067,0.11136260751471248,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,0.9599071477034613,0.05859375
293,0.5,10,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Do lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis relate to a reduced risk of complications and improved patient prognosis?,7.105791820705605e-07,0.5701913755895971,0.2044444444444444,0.05440279394345626,0.6778587133452474,0.11136260751471248,0.05432404622858609,0.7535632374446588,0.07638888888888888,7.105791820705622e-07,0.8057564678762046,0.05859375
294,0.5,1,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Is anterior chamber depth affected by head positioning in pseudoexfoliation syndrome? Answer: In patients with clinically evident unilateral pseudoexfoliation, the lens appears to be more mobile in the affected eye, leading to a shallower anterior chamber when the head is positioned prone.",7.105791820705622e-08,0.040386797368603844,0.020552936471601127,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
294,0.5,2,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Does the position of the head impact anterior chamber depth in pseudoexfoliation syndrome? Answer: For patients with clinically obvious unilateral pseudoexfoliation, increased lens mobility in the affected eye causes the anterior chamber to become shallower when the head is prone.",1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
294,0.5,3,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: How does head positioning affect anterior chamber depth in pseudoexfoliation syndrome? Answer: In clinically apparent unilateral pseudoexfoliation cases, the affected eye's lens shows greater mobility, resulting in a reduced anterior chamber depth when the head is prone.",1.8948778188548293e-07,0.20906632474046027,0.009529254643988495,0.014507411718254981,0.2391788721599264,0.02775510204081633,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
294,0.5,4,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Is anterior chamber depth influenced by head posture in pseudoexfoliation syndrome? Answer: Patients with clinically evident unilateral pseudoexfoliation have a more mobile lens in the affected eye, causing the anterior chamber to shallow when the head is placed prone.",1.4211583641411233e-07,0.11703377018371963,0.01872502767835873,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
294,0.5,5,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Does head position alter anterior chamber depth in pseudoexfoliation syndrome? Answer: In unilateral pseudoexfoliation with clinical signs, the lens in the affected eye is more mobile, which leads to a shallower anterior chamber when the head is prone.",1.6580180914979763e-07,0.14394467788328003,0.01805172953931231,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
294,0.5,6,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Can head positioning change anterior chamber depth in pseudoexfoliation syndrome? Answer: The lens in the affected eye of patients with clinically apparent unilateral pseudoexfoliation tends to be more mobile, resulting in a shallower anterior chamber in the prone head position.",1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
294,0.5,7,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Does the anterior chamber depth vary with head positioning in pseudoexfoliation syndrome? Answer: In patients showing unilateral pseudoexfoliation clinically, the lens mobility in the affected eye increases, causing a shallower anterior chamber when the head is prone.",1.8948778188548293e-07,0.17159890957505697,0.017342123536913518,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
294,0.5,8,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: How does head position influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In clinically evident unilateral pseudoexfoliation, the affected eye's lens is more mobile, which leads to a shallower anterior chamber when the head is prone.",2.1317375462116823e-07,0.20003864529554471,0.016593194335603353,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
294,0.5,9,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Is there an effect of head positioning on anterior chamber depth in pseudoexfoliation syndrome? Answer: Patients with unilateral pseudoexfoliation show increased lens mobility in the affected eye, resulting in a shallower anterior chamber when the head is in the prone position.",9.474389094274162e-08,0.09910145552615202,0.004303906121936658,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
294,0.5,10,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Does positioning the head affect anterior chamber depth in pseudoexfoliation syndrome? Answer: In unilateral pseudoexfoliation patients with clinical signs, the lens is more mobile in the affected eye, causing the anterior chamber to become shallower when the head is prone.",1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
295,0.5,1,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Does using an automatic transmission enhance driving behavior in elderly drivers? Switching to an automatic transmission is often suggested for older drivers to help sustain safe driving habits. Without the need for manual gear changes, cognitive demands decrease and the chance of stalling is removed, enabling drivers to concentrate better on traffic and road conditions.",7.105791820705622e-08,0.007324302819299522,0.03576332179930797,0.005440279394345618,0.03211241074435467,0.018860946745562133,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
295,0.5,2,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Is automatic transmission beneficial for improving driving behavior among senior drivers? Older drivers may benefit from switching to automatic transmission as it supports safer driving. The elimination of manual shifting lessens mental effort and removes stalling risks, allowing greater focus on the surrounding traffic and road.",1.4211583641411244e-07,0.12878744193732583,0.002610743801652899,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
295,0.5,3,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Can automatic transmissions help older drivers drive more safely? It is advisable for older drivers to consider automatic transmissions to maintain safety. The lack of manual gear changes reduces mental strain and prevents stalling, helping drivers pay more attention to traffic and road situations.",1.8948778188548325e-07,0.20792208214981178,0.026800951814396214,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
295,0.5,4,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Does an automatic transmission improve the driving habits of elderly drivers? For older drivers, using an automatic transmission is recommended to promote safe driving. It reduces cognitive load by removing manual shifting and prevents stalling, so drivers can better focus on the road and traffic.",1.6580180914979784e-07,0.18346713648206858,0.0257514739229025,0.012693985253473108,0.18306229348155734,0.023242630385487524,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
295,0.5,5,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Will automatic transmission enhance driving behavior in senior drivers? Switching older drivers to automatic transmissions may help uphold safe driving. The absence of manual gear shifting lowers mental effort and eliminates stalling risk, allowing drivers to concentrate on road and traffic conditions.",2.3685972735685406e-07,0.22488338123340768,0.004775000000000008,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
295,0.5,6,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Is it beneficial for older drivers to use automatic transmissions to improve driving safety? Automatic transmissions are suggested for elderly drivers to maintain safe driving. By removing manual shifting, cognitive demands decrease and stalling is avoided, helping drivers focus on traffic and the road.",1.8948778188548325e-07,0.20792208214981178,0.026800951814396214,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
295,0.5,7,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Does automatic transmission contribute to safer driving in older adults? Older drivers may be advised to adopt automatic transmissions to support safe driving. Without manual shifting, cognitive load is reduced and stalling risk is removed, enabling better attention to road and traffic.",2.3685972735685406e-07,0.1910713236451178,0.019599999999999992,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
295,0.5,8,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Can switching to automatic transmission improve the driving performance of elderly drivers? Automatic transmissions are often recommended for older drivers to enhance safety. The elimination of manual gear changes reduces mental workload and prevents stalling, allowing drivers to focus more effectively on traffic and road conditions.",1.4211583641411244e-07,0.12878744193732583,0.002610743801652899,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
295,0.5,9,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Is automatic transmission recommended for older drivers to improve their driving behavior? For senior drivers, automatic transmission can help maintain safe driving by reducing cognitive demands and eliminating the possibility of stalling, which allows better concentration on traffic and road conditions.",2.6054570009253947e-07,0.2504212952634859,0.0053835634451019285,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
295,0.5,10,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Does using an automatic transmission help older drivers maintain safer driving habits? Switching to automatic transmission is often advised for elderly drivers to improve safety. The lack of manual shifting decreases mental effort and removes stalling risk, enabling drivers to focus on traffic and road conditions.",1.4211583641411244e-07,0.15959398329554553,0.02474829637641969,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
296,0.5,1,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does participation in provider service networks lead to reduced expenses compared to HMOs or primary care case management within Florida's Medicaid program? Evidence suggests the Medicaid Demonstration in Florida yields lower per member per month (PMPM) costs. Provider Service Networks (PSNs) under the demonstration showed marginally higher expenditure reductions than Demonstration HMOs. PSNs seem to be an effective approach for providing care to Medicaid beneficiaries.,1.4211583641411244e-07,0.12682325477583856,0.020352766144082015,0.010880558788691236,0.10239973986211481,0.0016693787296396152,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
296,0.5,2,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks associated with lower costs than HMOs or primary care case management in Florida's Medicaid program? The Florida Medicaid Demonstration appears to lower PMPM spending. Demonstration PSNs achieved slightly greater cost reductions than Demonstration HMOs. PSNs may represent a promising care delivery model for Medicaid enrollees.,2.3685972735685406e-07,0.11753711889094687,0.05157024793388431,0.018134264647818726,0.16858271242063472,0.017538265306122455,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
296,0.5,3,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks reduce expenditures more than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida seems to reduce PMPM expenditures. Demonstration PSNs produced somewhat larger decreases in spending compared to Demonstration HMOs. PSNs appear to be a viable model for Medicaid care delivery.,1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.5,4,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Is there a cost advantage to provider service networks over HMOs or primary care case management in Florida's Medicaid program? The Florida Medicaid Demonstration shows lower PMPM expenditures. Demonstration PSNs led to slightly greater expenditure reductions than Demonstration HMOs. PSNs look promising for delivering care to Medicaid enrollees.,2.6054570009253947e-07,0.13859052808878003,0.05157024793388431,0.0199476911126006,0.19008891764159808,0.017538265306122455,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
296,0.5,5,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks result in lower Medicaid spending than HMOs or primary care case management in Florida? The Medicaid Demonstration in Florida is associated with reduced PMPM costs. Demonstration PSNs achieved marginally better expenditure reductions compared to Demonstration HMOs. PSNs seem to offer a promising care delivery model for Medicaid members.,1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,0.5,6,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are expenditures lower in provider service networks compared to HMOs or primary care case management within Florida's Medicaid program? The Medicaid Demonstration in Florida appears to lower PMPM expenditures. Demonstration PSNs had slightly greater reductions in costs than Demonstration HMOs. PSNs seem to be an effective model for Medicaid care delivery.,1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.5,7,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does Florida's Medicaid program see lower costs with provider service networks compared to HMOs or primary care case management? The Medicaid Demonstration in Florida shows reduced PMPM spending. Demonstration PSNs generated somewhat greater expenditure reductions than Demonstration HMOs. PSNs appear to be a promising approach for Medicaid care.,2.6054570009253947e-07,0.13859052808878003,0.05157024793388431,0.0199476911126006,0.19008891764159808,0.017538265306122455,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
296,0.5,8,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Is the expenditure lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida appears to decrease PMPM costs. Demonstration PSNs resulted in slightly larger expenditure reductions than Demonstration HMOs. PSNs seem to be a promising model for Medicaid care delivery.,1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,0.5,9,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks lead to cost savings over HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida shows lower PMPM expenditures. Demonstration PSNs achieved marginally greater expenditure reductions than Demonstration HMOs. PSNs appear to be a promising care delivery model for Medicaid enrollees.,2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.5,10,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks more cost-effective than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida results in reduced PMPM expenditures. Demonstration PSNs yielded slightly greater reductions in spending compared to Demonstration HMOs. PSNs seem to be a promising care delivery model for Medicaid recipients.,1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
297,0.5,1,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers release GABA? Answer: We have presented strong evidence indicating the presence of a GABAergic signal from mossy fibers. The functional significance of this mossy fiber GABAergic signal remains unclear, though it might play a role in development. Additional findings imply that this",7.105791820705622e-08,0.10420034732491601,0.025289256198347116,0.005440279394345618,0.10442962480224383,0.024375,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,0.5,2,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers responsible for releasing GABA? Answer: Our data strongly support the existence of a GABAergic signal originating from mossy fibers. The physiological function of this signal is not yet understood but could be crucial during development. Other studies indicate that this,2.3685972735685406e-08,0.08954451460637847,0.04750000000000001,0.0018134264647818726,0.057909609167349885,0.024375,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
297,0.5,3,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers emit GABA? Answer: We have gathered compelling proof that mossy fibers generate a GABAergic signal. The exact physiological role of this mossy fiber GABAergic signal is uncertain, but it may have developmental significance. Further evidence suggests that this",2.3685972735685406e-08,0.008104408028834165,0.023125000000000007,0.0018134264647818726,0.009119444997918169,0.024375,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
297,0.5,4,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Is GABA released by mossy fibers? Answer: There is convincing evidence that mossy fibers release a GABAergic signal. Although the physiological role of this signal is still unknown, it may be important for development. Additional data also point to this",4.737194547137081e-08,0.017223853026752334,0.04750000000000001,0.0036268529295637453,0.01619836298637356,0.024375,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
297,0.5,5,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers secrete GABA? Answer: We have provided strong evidence for a GABAergic signal from mossy fibers. While the physiological purpose of this signal is not fully understood, it might be important during developmental stages. Other findings support that this",2.3685972735685406e-08,0.04191646561712403,0.04750000000000001,0.0018134264647818726,0.009119444997918169,0.024375,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
297,0.5,6,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers a source of GABA release? Answer: Compelling evidence shows a GABAergic signal from mossy fibers. The physiological role of this signal is unclear but potentially significant in development. Other research suggests that this,1.42115836414112e-07,0.08813666263107356,0.04750000000000001,0.010880558788691236,0.12441194762660457,0.024375,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
297,0.5,7,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Do mossy fibers discharge GABA? Answer: Evidence strongly supports the presence of a GABAergic signal from mossy fibers. The physiological function of this signal is uncertain but may be developmentally important. Further evidence indicates that this,1.42115836414112e-07,0.08813666263107356,0.04750000000000001,0.010880558788691236,0.12441194762660457,0.024375,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
297,0.5,8,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Is there a GABA release from mossy fibers? Answer: We have demonstrated convincing evidence of a mossy fiber GABAergic signal. The physiological role of this signal is not well defined but could be relevant to development. Additional evidence suggests that this,2.3685972735685406e-08,0.04191646561712403,0.04750000000000001,0.0018134264647818726,0.009119444997918169,0.024375,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
297,0.5,9,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Do mossy fibers produce GABA? Answer: Strong evidence indicates that mossy fibers produce a GABAergic signal. The physiological role of this signal remains uncertain but may hold developmental importance. Other evidence points to this,1.8948778188548261e-07,0.2268418035957218,0.011093749999999993,0.014507411718254995,0.2252613676834736,0.005898437499999999,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
297,0.5,10,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Can mossy fibers release GABA? Answer: We have found compelling evidence for a GABAergic signal originating from mossy fibers. The physiological significance of this signal is unclear but might be important in development. Other evidence suggests that this,9.474389094274141e-08,0.03406944136079737,0.04750000000000001,0.0072537058591274906,0.0688420964717924,0.024375,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
298,0.5,1,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","What is the prognosis for low-tone sudden deafness? Does it always develop into Meniere's disease? Our conclusion is that low-tone sudden deafness does not inevitably lead to Meniere's disease. Although some symptoms may overlap, Meniere's diagnosis depends on fluctuating hearing loss, tinnitus, and vertigo.",7.105791820705622e-08,0.009270182730339638,0.041657315531224225,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
298,0.5,2,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Does low-tone sudden deafness always progress to Meniere's disease? The prognosis indicates that not every case of low-tone sudden deafness advances to Meniere's disease. Key diagnostic features for Meniere's include fluctuating hearing loss, tinnitus, and vertigo, which are not present in all cases.",9.474389094274162e-08,0.09958230218783859,0.006105971243051553,0.0072537058591274906,0.09609593929608184,0.0021642561983471094,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
298,0.5,3,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Is progression from low-tone sudden deafness to Meniere's disease inevitable? We determine that low-tone sudden deafness does not always evolve into Meniere's disease. While some symptoms may be similar, the diagnosis of Meniere's requires fluctuating hearing loss, tinnitus, and vertigo.",1.6580180914979774e-07,0.1457612670662516,0.013767732622336298,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
298,0.5,4,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","What is the likelihood that low-tone sudden deafness develops into Meniere's disease? It is concluded that not all instances of low-tone sudden deafness progress to Meniere's disease. The diagnosis of Meniere's disease hinges on symptoms like fluctuating hearing loss, tinnitus, and vertigo.",1.1842986367842703e-07,0.0922829431491996,0.016247743418355408,0.009067132323909363,0.12163385332616006,0.0027728196434490295,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
298,0.5,5,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Does low-tone sudden deafness necessarily lead to Meniere's disease? Our findings show that low-tone sudden deafness does not invariably progress to Meniere's disease. Although some clinical features may overlap, the presence of fluctuating hearing loss, tinnitus, and vertigo is essential for diagnosing Meniere's disease.",7.105791820705622e-08,0.10598839397126181,0.027144761512611096,0.005440279394345618,0.07119333872682354,0.001584616103165664,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
298,0.5,6,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Is Meniere's disease an inevitable outcome of low-tone sudden deafness? We conclude that progression to Meniere's disease is not certain in cases of low-tone sudden deafness. The diagnosis depends on the presence of fluctuating hearing loss, tinnitus, and vertigo, which are not always observed.",7.105791820705622e-08,0.07374899022428849,0.0044750540832882435,0.005440279394345618,0.07119333872682354,0.001584616103165664,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
298,0.5,7,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Can low-tone sudden deafness result in Meniere's disease? The prognosis suggests that not all low-tone sudden deafness cases develop into Meniere's disease. Diagnosis of Meniere's disease requires fluctuating hearing loss, tinnitus, and vertigo, which may not be present in every case.",1.4211583641411244e-07,0.11866615861898566,0.015038450071836414,0.010880558788691236,0.14784031154193933,0.0034125248964080625,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.5,8,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Does low-tone sudden deafness always turn into Meniere's disease? Our conclusion is that it does not always do so. While some symptoms may resemble each other, Meniere's disease diagnosis depends on fluctuating hearing loss, tinnitus, and vertigo.",2.3685972735685364e-07,0.15471195622081746,0.06489994591671175,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
298,0.5,9,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Is it guaranteed that low-tone sudden deafness will progress to Meniere's disease? We find that low-tone sudden deafness does not necessarily lead to Meniere's disease. The key diagnostic criteria for Meniere's include fluctuating hearing loss, tinnitus, and vertigo.",2.1317375462116834e-07,0.27718264269431314,0.04161979696666748,0.016320838183036854,0.26935336335153925,0.033152577997655086,0.0162972138685758,0.2684499827465596,0.02854671280276816,2.1317375462116866e-07,0.23483959107740038,0.0
298,0.5,10,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","What is the prognosis of low-tone sudden deafness in relation to Meniere's disease? It is concluded that not all low-tone sudden deafness cases progress to Meniere's disease. The diagnosis requires fluctuating hearing loss, tinnitus, and vertigo, which are critical for Meniere's disease identification.",9.474389094274162e-08,0.09958230218783859,0.006105971243051553,0.0072537058591274906,0.09609593929608184,0.0021642561983471094,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
299,0.5,1,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Is it possible to use mental imagery functional magnetic resonance imaging to predict recovery in patients with consciousness disorders? Answer: The mental imagery fMRI paradigm shows a strong agreement with the subsequent clinical progression of patients in a vegetative state. All five patients in a vegetative state who exhibited significant activation in regions of interest experienced a favorable clinical course through the observation period. Therefore, we",1.1842986367842703e-07,0.0629414489878597,0.011305046640625302,0.009067132323909363,0.060492402580821114,0.014076342443943422,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
299,0.5,2,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can mental imagery fMRI forecast recovery in patients suffering from disorders of consciousness? Answer: The mental imagery paradigm using fMRI demonstrates a high correlation with the later clinical outcomes of patients in a vegetative state. Each of the five patients in a VS who showed notable activation in ROIs had a positive clinical progression by the end of the study. Hence, we",2.3685972735685406e-08,0.0049994138043043534,0.015160523186682512,0.0018134264647818726,0.01690807090233637,0.00027298988157936285,0.0018108015409528666,0.01680711831638071,0.0,2.3685972735685406e-08,0.01709443335929972,0.0
299,0.5,3,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Does mental imagery functional MRI predict recovery outcomes in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm aligns closely with the clinical trajectory of patients in a vegetative state. All five VS patients with significant ROI activation experienced a favorable course throughout the observation period. Consequently, we",2.6054570009253947e-07,0.18612422198734357,0.009118195930770241,0.0199476911126006,0.17941935809280807,0.016661878770468257,0.019918816950481533,0.20633643299782767,0.0,2.6054570009253947e-07,0.2102954088363611,0.0
299,0.5,4,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can recovery in patients with disorders of consciousness be predicted using mental imagery fMRI? Answer: The mental imagery fMRI paradigm correlates strongly with the subsequent clinical outcomes of vegetative state patients. All five patients in VS who had significant ROI activation showed a positive course until the end of observation. Thus, we",2.1317375462116866e-07,0.11811124133387851,0.02982537586156609,0.016320838183036854,0.1394140234791097,0.016661878770468257,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
299,0.5,5,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Is mental imagery fMRI an effective predictor of recovery in patients with consciousness disorders? Answer: The mental imagery paradigm with fMRI exhibits high concordance with the clinical progression of patients in a vegetative state. Five VS patients showing significant activation in ROIs all had favorable outcomes during the observation period. Therefore, we",2.1317375462116866e-07,0.11811124133387851,0.02982537586156609,0.016320838183036854,0.1394140234791097,0.016661878770468257,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
299,0.5,6,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,Question: Can functional MRI using mental imagery predict recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm shows strong agreement with the further clinical course of vegetative state patients. All five patients in VS with notable ROI activation had a favorable progression through the observation timeframe. We therefore,2.3685972735685406e-07,0.13805206262126735,0.029448751486325808,0.018134264647818726,0.15921665077528946,0.016661878770468257,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
299,0.5,7,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Does mental imagery fMRI serve as a predictor for recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm demonstrates high concordance with the clinical course of patients in a vegetative state. Each of the five VS patients with significant ROI activation had a positive clinical outcome by the end of observation. Hence, we",9.474389094274162e-08,0.07260704624771641,0.0034203843161433115,0.0072537058591274906,0.07064322191685513,0.0011893608989532352,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
299,0.5,8,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can mental imagery-based functional MRI predict recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm shows a strong correlation with the subsequent clinical course in patients in a vegetative state. All five patients in VS who exhibited significant activation of ROIs had a favorable clinical progression until the observation period ended. Therefore, we",9.474389094274162e-08,0.04828609254385885,0.014007429172276195,0.0072537058591274906,0.04588796546828533,0.016661878770468257,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
299,0.5,9,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Is it possible to predict recovery in disorders of consciousness patients using mental imagery fMRI? Answer: The mental imagery fMRI paradigm shows high concordance with the further clinical course of patients in a vegetative state. All five VS patients with significant activation in ROIs experienced a favorable course until the conclusion of observation. Thus, we",1.4211583641411244e-07,0.060567619758583824,0.030873168495928,0.010880558788691236,0.08225560963915957,0.016661878770468257,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
299,0.5,10,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,Question: Can mental imagery functional MRI be used to predict recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm demonstrates strong alignment with the clinical progression of patients in a vegetative state. All five VS patients who showed significant ROI activation had a positive clinical course until the observation period ended. We therefore,1.1842986367842703e-07,0.042099018684113254,0.03119751181690431,0.009067132323909363,0.0639064709709638,0.016661878770468257,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
